Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cellular response to type I interferon (GO:0071357),0.8683379373161435,2.3886706118390486,0.0,0.0,0.0,18/41,3.86%,IFIT3;RSAD2;OAS3;STAT1;STAT2;SP100;OASL;IRF7;OAS2;SAMHD1;IFIT1;ISG15;XAF1;IFIT2;BST2;IFI35;ADAR;GBP2
prerank,type I interferon signaling pathway (GO:0060337),0.8683379373161435,2.3886706118390486,0.0,0.0,0.0,18/41,3.86%,IFIT3;RSAD2;OAS3;STAT1;STAT2;SP100;OASL;IRF7;OAS2;SAMHD1;IFIT1;ISG15;XAF1;IFIT2;BST2;IFI35;ADAR;GBP2
prerank,defense response to symbiont (GO:0140546),0.7825345310739316,2.386960553647076,0.0,0.0,0.0,24/92,5.01%,IFIT3;RSAD2;OAS3;STAT1;ZBP1;STAT2;OASL;NLRC5;EIF2AK2;IRF7;OAS2;IFIH1;SAMHD1;IFIT1;ISG15;MOV10;IFIT2;BST2;MLKL;CD40;CGAS;RTP4;CNOT7;TLR8
prerank,defense response to virus (GO:0051607),0.7735089716492106,2.3678593784740376,0.0,0.0,0.0,25/100,5.01%,IFIT3;RSAD2;OAS3;STAT1;ZBP1;STAT2;CXCL10;OASL;NLRC5;EIF2AK2;IRF7;OAS2;IFIH1;SAMHD1;IFIT1;ISG15;MOV10;IFIT2;BST2;MLKL;CD40;CGAS;RTP4;CNOT7;TLR8
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.8506519731965688,2.324034665071829,0.0,0.0,0.0,10/36,1.52%,PARP14;ZBP1;NLRC5;AXL;HSPA1B;PARP9;IRGM;CASP4;CXCR4;WNT5A
prerank,negative regulation of viral process (GO:0048525),0.8033495461228101,2.2986339541635634,0.0,0.0,0.0,26/57,10.15%,RSAD2;OAS3;STAT1;OASL;EIF2AK2;OAS2;IFIH1;PARP10;IFIT1;ISG15;PML;TRIM14;ZC3HAV1;BST2;ZFP36;TRIM21;CCL5;ILF3;SLPI;UBP1;N4BP1;PPIA;BANF1;SRPK1;PROX1;TNIP1
prerank,regulation of viral genome replication (GO:0045069),0.7973802111352385,2.2945122858393945,0.0,0.0,0.0,27/56,10.41%,RSAD2;OAS3;OASL;EIF2AK2;OAS2;IFIH1;PARP10;IFIT1;ISG15;ZC3HAV1;BST2;ADAR;PKN2;TARBP2;LARP1;CCL5;CNOT7;ILF3;SLPI;N4BP1;PPIA;BANF1;VAPB;SRPK1;PROX1;TNIP1;STAU1
prerank,negative regulation of viral genome replication (GO:0045071),0.8150661278193814,2.2279093588176964,0.0,0.0,0.0,20/40,10.15%,RSAD2;OAS3;OASL;EIF2AK2;OAS2;IFIH1;PARP10;IFIT1;ISG15;ZC3HAV1;BST2;RESF1;CCL5;ILF3;SLPI;N4BP1;BANF1;SRPK1;PROX1;TNIP1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.7904977830440064,2.1795926042844416,0.0,0.0,0.0,14/45,4.22%,OAS3;STAT1;SP100;OASL;IRF7;OAS2;PML;CAMK2D;TRIM25;B2M;CAMK2B;TRIM21;GBP2;HCK
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.7764835757489138,2.1684372129873175,0.0,0.0,0.0,8/48,0.89%,PARP14;OAS3;USP18;STAT2;NLRC5;SAMHD1;ISG15;NR1H2
prerank,cellular response to interferon-gamma (GO:0071346),0.720627918013033,2.1639616156812598,0.0,0.0,0.0,24/88,5.48%,OAS3;STAT1;GBP4;SP100;OASL;IRF7;OAS2;PML;GBP5;CCL7;DAPK3;CAMK2D;WNT5A;TRIM25;B2M;CAMK2B;GBP3;TRIM21;GBP2;CD47;HCK;CCL5;GBP7;CX3CL1
prerank,negative regulation of innate immune response (GO:0045824),0.8091341811524225,2.1637292459302797,0.0,0.0,0.0,13/34,4.99%,OAS3;USP18;STAT2;TRAFD1;NLRC5;SAMHD1;ISG15;DHX58;NMI;TRIM21;USP15;CNOT7;SUSD4
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.8049322175230825,2.0912589242844635,0.0,0.0,0.0,10/29,4.85%,OAS3;USP18;ZBP1;STAT2;NLRC5;SAMHD1;ISG15;WNT5A;CNOT7;HSP90AB1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.7650272060200015,2.0502493021208332,0.0,0.0005021851020325131,0.007,14/38,7.25%,DDX60;OASL;GBP5;DHX58;IFI35;SASH1;NMI;ADAM8;USP15;CCL5;TLR8;LY86;POLR3B;DHX9
prerank,positive regulation of innate immune response (GO:0045089),0.7825525014235709,2.0311553567258316,0.0,0.0011382862312736962,0.017,11/30,7.25%,ZBP1;NLRC5;GBP5;IFI35;WNT5A;NMI;ADAM8;CCL5;TLR8;POLR3B;DHX9
prerank,response to interferon-gamma (GO:0034341),0.6882987099259881,2.0185841686823247,0.0,0.0013182358928353467,0.021,18/67,7.05%,STAT1;GBP4;SP100;GBP5;BST2;CCL7;DAPK3;WNT5A;GBP3;CD40;CXCL16;TRIM21;GBP2;CD47;CCL5;GBP7;CX3CL1;AQP4
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.8075270853294636,2.013709186564719,0.0,0.0015360956062170986,0.024,8/23,4.85%,PARP14;STAT1;NLRC5;PARP9;IRGM;NR1H2;SOCS1;HSP90AB1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.8803604442321596,2.01287072415098,0.0,0.0015065553060975392,0.025,6/15,0.28%,OAS3;USP18;STAT2;NLRC5;SAMHD1;ISG15
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.8848537281674786,1.984333954063907,0.0,0.0031716953812579774,0.051,4/13,5.38%,PARP10;PARP9;NAMPT;NAPRT
prerank,positive regulation of type I interferon production (GO:0032481),0.6633485419186128,1.9758553328372088,0.0,0.003364640183617838,0.056,22/73,12.41%,OAS3;STAT1;ZBP1;IRF7;OAS2;IFIH1;ISG15;DHX58;DHX33;NFKB2;CGAS;DHX36;TLR8;CTNNB1;NFKB1;POLR3B;DHX9;POLR3GL;POLR2K;RIOK3;PTPN11;PRKDC
prerank,protein mono-ADP-ribosylation (GO:0140289),0.9072993075856225,1.953516948606423,0.0,0.005308813935772282,0.089,5/11,0.46%,PARP14;PARP12;PARP10;PARP9;PARP11
prerank,protein ADP-ribosylation (GO:0006471),0.7522424355322309,1.9438028441899353,0.0,0.0061631807976717514,0.105,7/28,4.17%,PARP14;PARP12;PARP10;PARP9;PARP11;ZC3HAV1;ART4
prerank,regulation of type I interferon production (GO:0032479),0.645925734583743,1.9348682694747923,0.0,0.007248932777164972,0.128,23/84,9.90%,ZBP1;NLRC5;IRF7;IFIH1;ISG15;UBE2L6;ILRUN;DHX58;TRIM25;DHX33;NFKB2;CGAS;TRIM21;IKBKE;DHX36;CTNNB1;NFKB1;POLR3B;CYLD;DHX9;POLR3GL;POLR2K;TRAF3
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.6904456862604262,1.9318957740471825,0.0,0.00728168397947144,0.134,13/49,16.37%,PARP14;PARP9;IL15;CRLF1;CD40;STAT3;CCL5;LYN;JAK2;PIBF1;FGFR3;IL18;ARL2BP
prerank,positive regulation of interferon-beta production (GO:0032728),0.7230044586525805,1.9259691584124938,0.0,0.0076332135508942,0.146,9/33,7.25%,OAS3;IRF7;OAS2;IFIH1;ISG15;DHX58;TLR8;POLR3B;DHX9
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.8136125180310703,1.9210773718835226,0.0,0.008730294850719075,0.172,6/18,4.64%,DDX60;OASL;DHX58;BIRC2;USP15;NOP53
prerank,positive regulation of defense response to virus by host (GO:0002230),0.7581849959631767,1.9098828269048975,0.001310615989515072,0.011345663416290112,0.224,5/24,2.91%,STAT1;PARP9;DTX3L;AIM2;CGAS
prerank,NAD biosynthetic process (GO:0009435),0.7807850300851432,1.8992363856184322,0.0,0.014527497594511987,0.284,4/20,5.38%,PARP10;PARP9;NAMPT;NAPRT
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.9069495561058658,1.8972671315838454,0.0,0.014262056897723372,0.293,2/10,2.19%,CNGB1;CACNA2D4
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.9069495561058658,1.8972671315838454,0.0,0.014262056897723372,0.293,2/10,2.19%,CNGB1;CACNA2D4
prerank,positive regulation of interferon-alpha production (GO:0032727),0.7782224340158822,1.896244648043877,0.0,0.014061182856910364,0.3,6/19,7.25%,STAT1;IRF7;IFIH1;DHX36;TLR8;DHX9
prerank,response to interferon-beta (GO:0035456),0.7548237238962212,1.887161433176684,0.0,0.016823200918089188,0.348,7/22,4.76%,STAT1;IRGM;XAF1;BST2;AIM2;PNPT1;IKBKE
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.8485131274433579,1.8819260896148047,0.0030120481927710845,0.01835258281973366,0.379,4/11,5.98%,STAT1;WNT5A;SOX9;FGFR2
prerank,regulation of innate immune response (GO:0045088),0.6546687685388788,1.8813306472862024,0.0,0.01804912337305091,0.384,19/57,8.26%,USP18;TRAFD1;SAMHD1;PARP9;GBP5;DHX58;IFI35;BIRC2;NMI;TRIM21;ADAM8;CCL5;HSP90AB1;TLR8;ERAP1;POLR3B;DHX9;N4BP1;ABCE1
prerank,erythrocyte development (GO:0048821),-0.7470462692009767,-1.8805914538103425,0.0,1.0,0.788,7/10,23.89%,NCKAP1L;ZBTB7A;DMTN;ABCB10;ALAS1;LYAR;ALAS2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.876008623898141,1.8757316066348841,0.0,0.019915226332032233,0.428,3/11,0.94%,IRF7;AXL;NOD2
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.6537904036221696,1.8736383089007875,0.0,0.02022689994297622,0.441,9/57,4.80%,PARP14;PARP9;IL15;CRLF1;SOCS1;CD40;STAT3;CCL5;CNOT7
prerank,sensory perception of chemical stimulus (GO:0007606),-0.670980610971042,-1.8724915377500273,0.003246753246753247,0.9638156181027373,0.81,5/15,10.65%,GNAL;ADCY3;UBR3;SYT10;GNAS
prerank,cellular response to virus (GO:0098586),0.7044782739331833,1.8577742129329617,0.0,0.027145140650406113,0.542,13/30,18.11%,CXCL10;IFIH1;IRGM;CCL5;MAPK14;ZC3H12A;RIOK3;HSP90AA1;LGALS9;BAX;RRP1B;POU2F2;GBF1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.8494537114572185,1.857547546916454,0.0,0.026668671997410826,0.548,6/13,5.89%,STAT1;OASL;OAS2;CRLF1;STAT3;IL27
prerank,regulation of interferon-alpha production (GO:0032647),0.7318273734887369,1.8538676243057832,0.0,0.02801935338519868,0.579,6/23,7.25%,STAT1;IRF7;IFIH1;DHX36;TLR8;DHX9
prerank,regulation of interferon-beta production (GO:0032648),0.66148697190396,1.8496053228931817,0.0,0.02945315623420689,0.604,14/46,12.29%,OAS3;IRF7;OAS2;IFIH1;ISG15;DHX58;TLR8;POLR3B;DHX9;TRAF3;RIOK3;RELB;PTPN11;REL
prerank,cellular response to interferon-beta (GO:0035458),0.8020422656583859,1.838031743471021,0.0014727540500736377,0.035299938147748844,0.68,4/14,1.78%,STAT1;IRGM;AIM2;PNPT1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.7233285106139418,-1.825395262588535,0.003278688524590164,0.7818708330527309,0.927,3/10,16.70%,MAPK7;KLF4;MAP2K5
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.7233285106139418,-1.825395262588535,0.003278688524590164,0.7818708330527309,0.927,3/10,16.70%,MAPK7;KLF4;MAP2K5
prerank,regulation of defense response to virus by host (GO:0050691),0.6940823156230393,1.8238920270264316,0.0012391573729863693,0.045244486335500704,0.761,7/30,7.25%,STAT1;PARP9;DTX3L;AIM2;CGAS;TARBP2;DHX9
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.8032698986191633,1.8179767764853834,0.0,0.049073995319549306,0.788,4/13,7.25%,AXL;IFIH1;WNT5A;DHX9
prerank,regulation of protein kinase C signaling (GO:0090036),0.780068745706533,1.8168372866880844,0.0014044943820224719,0.04907718042590469,0.798,5/14,10.83%,WNT11;WNT5A;CD40;SPHK2;ADGRV1
prerank,cellular response to zinc ion (GO:0071294),-0.6354820255736774,-1.8081476164740888,0.011029411764705883,0.7378106905108914,0.958,8/15,1.99%,MT1E;MT1F;MT1M;MT1G;MT1A;MT1H;MT1B;MT1X
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5964793925010691,-1.7996293898173081,0.0038022813688212928,0.6687700207243484,0.97,12/18,22.44%,DLG4;GRIN1;PRKCZ;NLGN2;NRXN1;RIMS1;SHANK3;STX1B;CHRNA7;RIMS2;CUX2;SHANK1
prerank,response to interferon-alpha (GO:0035455),0.7721721909748244,1.799378470068014,0.0,0.06430201239802978,0.873,5/16,2.40%,EIF2AK2;AXL;BST2;KLHL20;ADAR
prerank,detection of visible light (GO:0009584),0.772531603545888,1.7948997605612014,0.001392757660167131,0.06727096953748578,0.891,2/16,2.19%,CNGB1;CACNA2D4
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.8023389483978802,1.7905731637862006,0.002844950213371266,0.0707974145971794,0.916,4/14,4.25%,DDX60;OASL;DHX58;USP15
prerank,negative regulation of type I interferon production (GO:0032480),0.6426263518449883,1.7857521031580084,0.0011723329425556857,0.0754533115803851,0.926,12/40,12.29%,NLRC5;IFIH1;ISG15;UBE2L6;ILRUN;DHX58;TRIM25;IKBKE;CYLD;RELB;HAVCR2;REL
prerank,positive regulation of immune response (GO:0050778),0.6110642772153825,1.7799412005395283,0.0,0.08090304480499302,0.933,19/64,17.39%,RSAD2;IL15;NOD2;GBP5;IFI35;NMI;ADAM8;CCL5;TLR8;POLR3B;DHX9;SPHK2;RIOK3;XBP1;FCGR2B;STX4;MYB;LGALS9;PTPRC
prerank,response to cadmium ion (GO:0046686),-0.5379395219317398,-1.7776501297531346,0.004524886877828055,0.7058614672519173,0.983,10/26,5.67%,MT1E;MT1F;MT1M;MT1G;MT1A;MT1H;MT1B;MT1X;EGFR;MAPK3
prerank,maintenance of protein location in nucleus (GO:0051457),0.7251283448226395,1.7773218324931128,0.0,0.08255923077414515,0.94,10/20,11.60%,SP100;PML;SKP1;CHCHD10;MORC3;SUPT7L;TAF8;BARD1;SUN2;TAF3
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.8164053219779827,1.7690436323268028,0.0029985007496251873,0.09190972043865642,0.959,3/10,5.98%,STAT1;SOX9;FGFR2
prerank,metanephric mesenchyme development (GO:0072075),0.827189056911684,1.7643532944190445,0.0029717682020802376,0.09684446544580849,0.962,1/10,0.06%,STAT1
prerank,response to alcohol (GO:0097305),-0.5008761890655837,-1.7601847926451681,0.004424778761061947,0.7186819009475258,0.992,9/27,11.37%,CCR5;TGFB1;GRIN2A;GRIN2B;TGFBR3;GRIN1;ABCA2;CCL3;PMVK
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.7587607773301793,1.7562047678045507,0.007122507122507123,0.10860463470748424,0.976,4/15,2.46%,EIF2AK2;GBP5;USP50;DHX33
prerank,cellular response to leucine starvation (GO:1990253),-0.6919069606306902,-1.7518478230730048,0.012012012012012012,0.688439727216241,0.994,5/10,7.56%,IMPACT;GCN1;RRAGD;RRAGB;LARS1
prerank,positive regulation of response to external stimulus (GO:0032103),0.5647651145510906,1.7492560276389566,0.0,0.11801349897764059,0.989,28/128,11.17%,DDX60;ZBP1;OASL;IL15;AGT;GBP5;DHX58;IFI35;WNT5A;SASH1;NMI;ADAM8;CD47;PTGER4;USP15;CCL5;TLR8;CX3CL1;LY86;LRSAM1;POLR3B;USF1;DHX9;APP;TNIP1;PPM1F;RIOK3;ABCC1
prerank,positive regulation of immune system process (GO:0002684),0.7606252451652511,1.7486181625957475,0.004132231404958678,0.11690869175316904,0.989,3/16,2.00%,RSAD2;IL15;PIK3CD
prerank,chemokine-mediated signaling pathway (GO:0070098),0.6227621113370626,1.7480460498387422,0.0,0.1158792122940024,0.992,12/42,16.64%,CXCL10;CXCL9;CCL7;CCL5;CX3CL1;ACKR3;CIB1;CCL14;GPR35;RBM15;OXSR1;STK39
prerank,regulation of defense response (GO:0031347),0.5920082076103951,1.7476568324246473,0.0010799136069114472,0.11444534167372536,0.992,23/76,16.28%,USP18;ZBP1;SAMHD1;PIK3AP1;CASP4;NOD2;DHX58;WNT5A;BIRC2;HCK;AREL1;ERAP1;BCL6;CYLD;N4BP1;TRAF3;APOE;FCGR2B;BIRC3;JAK2;MYD88;ADAMTS12;LRP8
prerank,myoblast fusion (GO:0007520),-0.6604491632144024,-1.7464403772746193,0.01718213058419244,0.6511656334141046,0.995,6/12,13.76%,CD81;KCNH1;JAM2;PTGFRN;CD9;ADGRB3
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.7704012405412208,1.7462051950562356,0.0029411764705882353,0.1152774560079462,0.994,5/13,10.58%,MOV10;ZC3HAV1;PNPT1;CNOT7;ZC3H12A
prerank,UV-damage excision repair (GO:0070914),-0.6510328730881663,-1.745102415612916,0.024822695035460994,0.5987637471645669,0.995,6/12,19.06%,INO80;XPC;SIRT1;ACTR5;ERCC1;XPA
prerank,response to peptide (GO:1901652),0.647898977854012,1.7424665768283014,0.0024813895781637717,0.11960517040272667,0.994,8/33,9.50%,STAT1;STAT2;NOD2;IRS1;STAT3;CACNA1A;EIF2B2;PRNP
prerank,positive regulation of T cell migration (GO:2000406),0.7113216229886734,1.7414842474500003,0.0026917900403768506,0.11948657527693593,0.994,8/20,16.64%,CXCL10;DOCK8;WNT5A;CCL5;APP;OXSR1;AIF1;STK39
prerank,cellular response to cadmium ion (GO:0071276),-0.5395352692126468,-1.7367586241780542,0.009302325581395349,0.5926318651786474,0.999,10/24,5.67%,MT1E;MT1F;MT1M;MT1G;MT1A;MT1H;MT1B;MT1X;EGFR;MAPK3
prerank,regulation of T cell chemotaxis (GO:0010819),0.7856010935026241,1.7330607633004995,0.004392386530014641,0.13160542690314353,0.996,3/11,4.35%,CXCL10;WNT5A;CCL5
prerank,hematopoietic stem cell proliferation (GO:0071425),0.7947635588240853,1.731117999525418,0.005917159763313609,0.1328036602084691,0.996,6/11,8.45%,WNT5A;SFRP2;RUNX1;YJEFN3;ETV6;YTHDF2
prerank,defense response to bacterium (GO:0042742),0.5728171941447813,1.726084786287679,0.0,0.14062777095329518,0.997,12/105,5.78%,OAS3;GBP4;OAS2;ISG15;IRGM;GALP;NOD2;NOD1;STAB2;GBP2;GBP7;SLPI
prerank,lymphocyte chemotaxis (GO:0048247),0.640044528661577,1.7236884665085495,0.0060901339829476245,0.14318552721702027,0.999,8/34,5.88%,CXCL10;CCL7;PIK3CD;CXCL16;ADAM8;CCL5;CX3CL1;CH25H
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.7362415918253142,1.7219359700380115,0.004207573632538569,0.144490242741724,0.999,7/16,10.96%,MOV10;ZFP36;TARDBP;PLEKHN1;DHX36;ZC3H12A;ZFP36L1
prerank,embryonic heart tube development (GO:0035050),0.7545571886454229,1.7208661559260794,0.00860832137733142,0.14470539803718688,0.999,2/14,2.82%,PITX2;ACVR1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5801299932258837,1.7169872644659558,0.0,0.15026577500817645,0.999,23/73,17.39%,OAS3;OAS2;IFIH1;NOD2;WNT5A;CLU;TNFRSF8;STAT3;ADAM8;DHX9;TMEM106A;APP;HMGB1;SPHK2;HAVCR2;PTPN11;PSEN1;ARFGEF2;JAK2;TLR2;LGALS9;TLR3;PTPRC
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5827439014936955,1.715062245843517,0.0,0.15170421126399827,0.999,22/69,17.39%,OAS3;OAS2;IFIH1;NOD2;WNT5A;CLU;TNFRSF8;STAT3;DHX9;TMEM106A;APP;HMGB1;SPHK2;HAVCR2;PTPN11;PSEN1;ARFGEF2;JAK2;TLR2;LGALS9;TLR3;PTPRC
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.6343887887396416,-1.7091107065783002,0.009404388714733543,0.6892719071062825,1.0,7/12,20.91%,TGFB1;SIRT7;RBM4;AAAS;PTPN14;NEDD4;TPR
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.7480912496991662,1.7082292124927565,0.004143646408839779,0.16382879198191116,0.999,6/14,8.49%,ETNK1;ETNK2;SLC27A1;PCYT2;LPIN2;CEPT1
prerank,phospholipid homeostasis (GO:0055091),0.7984050779313228,1.7049422841995945,0.0029806259314456036,0.1680311351400789,0.999,3/11,4.69%,ABCA1;ABCG1;TLCD2
prerank,regulation of cytokine production (GO:0001817),0.5529649002494794,1.7030052088144483,0.0010449320794148381,0.17029026079626455,0.999,23/126,10.56%,IGF2BP1;ZBP1;EIF2AK2;IRF7;IFIH1;ISG15;IL15;AGT;ICOSLG;PIK3CD;IGF2BP3;TRIM21;CD47;PTGER4;CD276;BCL6;SNAI2;N4BP1;LYN;PPP1R11;MAPK14;TRAF3;CCDC88B
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.5705605108143548,1.6998451316134608,0.002157497303128371,0.1750254576444984,1.0,25/72,17.56%,USP18;STAT1;ZBP1;AXL;SPPL2A;SOCS1;BIRC2;RBCK1;RUNX1;HSP90AB1;CFLAR;CYLD;ABCE1;RNF31;PTPN11;RACK1;SHARPIN;BIRC3;JAK2;IFNAR2;PIAS1;IRAK1;ELF1;PTPRC;CDC37
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.6547010446376583,1.699145178085267,0.006435006435006435,0.17433390213298558,1.0,4/25,5.48%,CXCL10;CXCL9;THY1;CX3CL1
prerank,regulation of viral life cycle (GO:1903900),0.6883556675996004,1.6980067233986271,0.00651890482398957,0.1745432543821113,1.0,5/21,7.74%,AXL;TRIM14;TRIM25;TRIM21;PPIA
prerank,negative regulation of DNA binding (GO:0043392),0.6520652720022794,1.6939793833195846,0.0073439412484700125,0.18129551763509766,1.0,5/28,4.10%,SP100;ILRUN;PER2;MAD2L2;SUMO3
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.6382085479877917,1.6938550286805993,0.00375,0.1791875736436538,1.0,5/32,8.60%,CXCL10;CXCL9;GALP;RNASE7;FAM3A
prerank,water transport (GO:0006833),0.7748953878463269,1.6901165276552998,0.0014124293785310734,0.186108494436361,1.0,3/12,9.05%,AQP11;AQP4;PDPN
prerank,positive regulation of response to stimulus (GO:0048584),0.6116758581577844,1.6900713106019971,0.0023446658851113715,0.18383837696713307,1.0,12/40,14.60%,RSAD2;IFIH1;IL15;WNT5A;B2M;CGAS;DHX9;ECHDC3;YPEL3;IER5;FCGR2B;NSMCE1
prerank,cellular response to fluid shear stress (GO:0071498),-0.6315465663075395,-1.6876887522676292,0.028938906752411574,0.7508207963762432,1.0,9/12,31.24%,MTSS1;ASS1;MAPK7;KLF4;MAP2K5;MEF2C;SREBF2;HAS2;HDAC3
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.6501337183977587,1.6862150663582625,0.0049382716049382715,0.19093204714745016,1.0,5/29,2.94%,STAT1;STAT2;IL15;STAT3;NMI
prerank,pyroptosis (GO:0070269),0.7257540302288851,1.6820632845302703,0.004172461752433936,0.1987899726395703,1.0,4/15,7.25%,ZBP1;CASP4;AIM2;DHX9
prerank,myelin maintenance (GO:0043217),0.8024882921085907,1.6803346422128251,0.003110419906687403,0.20107243492738844,1.0,5/10,9.46%,CXCR4;CLU;DEGS1;EPB41L3;ABCD1
prerank,sensory perception of smell (GO:0007608),-0.6556389453964886,-1.6790265857887086,0.008823529411764706,0.7524318390031982,1.0,3/11,4.38%,ADCY3;UBR3;SYT10
prerank,thymus development (GO:0048538),-0.6047273537885228,-1.6785030219305093,0.014234875444839857,0.7085397085376437,1.0,3/13,6.69%,ZBTB1;FOXE1;FGF10
prerank,response to cytokine (GO:0034097),0.5406975647831718,1.676845808468031,0.0,0.20725546613395499,1.0,31/141,12.29%,STAT1;SP100;EIF2AK2;CD274;ISG15;PML;XAF1;BST2;CXCR4;KLHL20;ADAR;CD40;CXCL16;STAT3;ASAH2;PTPN18;TRIM21;IKBKE;IGBP1;SRF;PTPN7;APP;LDLRAP1;TIMP2;GCH1;ALDH1A2;COL3A1;RELB;GGT7;PTPN11;REL
prerank,cellular zinc ion homeostasis (GO:0006882),-0.49270712267432665,-1.6767644952824612,0.009569377990430622,0.6760015304640148,1.0,10/26,5.88%,MT1E;MT1F;MT1M;MT1G;MT1A;MT1H;MT1B;MT1X;SLC39A14;SLC39A7
prerank,regulation of response to external stimulus (GO:0032101),0.5471302308397417,1.6722903554446857,0.0,0.217319090298841,1.0,30/121,16.65%,USP18;ZBP1;SAMHD1;PIK3AP1;CNGB1;CASP4;NOD2;DHX58;CXCR4;WNT5A;BIRC2;CD55;HCK;CX3CL1;AREL1;ERAP1;BCL6;CYLD;N4BP1;P2RX4;TRAF3;CAMKMT;USP14;FCGR2B;BIRC3;JAK2;MYD88;ADAMTS12;LRP8;METAP2
prerank,innate immune response (GO:0045087),0.5253857962424016,1.6690361203711708,0.0,0.223579981497761,1.0,38/217,12.29%,CXCL10;SP100;NLRC5;IRF7;IFIH1;IFIT1;ISG15;IRGM;PML;TRIM14;NOD2;BST2;DHX58;ALPK1;TRIM25;PIK3CD;B2M;ADAR;CD40;CXCL16;TRIM21;CYBB;HCK;TLR8;SLPI;TRIM39;CYLD;ATAD3A;RNASE7;LYN;APP;HMGB1;SRPK1;GCH1;IRAK4;RELB;TRIM26;REL
prerank,cellular response to chemokine (GO:1990869),0.5907971735103319,1.6684433534890326,0.005868544600938967,0.22275749514157495,1.0,11/46,12.50%,CXCL10;CXCL9;CCL7;DOCK8;CCL5;CX3CL1;ACKR3;ZC3H12A;LRCH1;CCL14;GPR35
prerank,monocyte differentiation (GO:0030224),-0.6603467292060322,-1.665791654776475,0.01818181818181818,0.6957612290771121,1.0,4/10,6.24%,PPARG;MT1G;THOC5;PDE1B
prerank,zinc ion homeostasis (GO:0055069),-0.473160196171144,-1.6642935453320404,0.01015228426395939,0.6670100996171789,1.0,10/28,5.88%,MT1E;MT1F;MT1M;MT1G;MT1A;MT1H;MT1B;MT1X;SLC39A14;SLC39A7
prerank,positive regulation of viral genome replication (GO:0045070),0.6364867418915365,1.6630002607786758,0.0140485312899106,0.23554817029985478,1.0,12/29,11.58%,IFIT1;ADAR;PKN2;TARBP2;LARP1;CCL5;CNOT7;PPIA;VAPB;SRPK1;STAU1;HACD3
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.627609341955597,-1.656716338453538,0.03205128205128205,0.669409286185335,1.0,6/12,23.50%,ZBTB1;PRKCQ;CCR2;CARD9;CLEC6A;IL1B
prerank,fluid transport (GO:0042044),0.7618849449941748,1.6541548753134692,0.01167883211678832,0.2584463880276292,1.0,3/12,9.05%,AQP11;AQP4;PDPN
prerank,cellular response to copper ion (GO:0071280),-0.5705687291157302,-1.6469645466995981,0.040145985401459854,0.6823514847306552,1.0,8/16,1.99%,MT1E;MT1F;MT1M;MT1G;MT1A;MT1H;MT1B;MT1X
prerank,positive regulation of type 2 immune response (GO:0002830),0.7226979513525248,1.6464911670180575,0.015235457063711912,0.280504619378479,1.0,2/14,0.94%,RSAD2;NOD2
prerank,regulation of response to interferon-gamma (GO:0060330),0.7288890852068158,1.6451193396960306,0.014577259475218658,0.28186690547114784,1.0,4/14,4.85%,STAT1;PARP9;SOCS1;HSP90AB1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.65105362383925,1.6441661470130207,0.01948051948051948,0.2818151195917123,1.0,6/23,12.11%,AXL;CD274;HMGB1;PRNP;ZC3H12A;HAVCR2
prerank,cellular response to dsRNA (GO:0071359),0.7042800456024558,1.64281849567506,0.015942028985507246,0.2829012864900522,1.0,6/15,10.95%,IFIH1;IFIT1;CGAS;DHX9;NPM1;RIOK3
prerank,protein auto-ADP-ribosylation (GO:0070213),0.749939967369813,1.642476455408379,0.014858841010401188,0.281038066991804,1.0,3/12,0.46%,PARP12;PARP10;PARP11
prerank,regulation of RNA metabolic process (GO:0051252),0.5693844567296915,1.642461735328268,0.006593406593406593,0.27804855133180817,1.0,12/59,11.84%,OAS3;IGF2BP1;OASL;OAS2;FASTK;IGF2BP3;HNRNPH1;YTHDF2;CLK3;HNRNPL;MITF;HNRNPH3
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.6114470413243841,-1.6413198417894945,0.018808777429467086,0.6789178011190292,1.0,6/13,13.61%,CHST1;OGA;MGAT3;CHST7;PGM3;CHST3
prerank,protein heterooligomerization (GO:0051291),-0.5462357710355358,-1.6404168628894389,0.03557312252964427,0.653290816919859,1.0,7/17,14.30%,GRIN2B;KCNC2;GRIN1;MAT2A;TMEM120A;CPSF7;FARSA
prerank,nerve growth factor signaling pathway (GO:0038180),0.7695804130175141,1.6384752761956842,0.015197568389057751,0.2879657592527289,1.0,4/10,13.45%,BDNF;MAGI2;RAPGEF2;RAPGEF1
prerank,positive regulation of viral process (GO:0048524),0.558261163976069,1.6378058485625957,0.003303964757709251,0.2871441551832222,1.0,17/60,11.58%,AXL;IFIT1;POLR2G;ADAR;PKN2;TARBP2;LARP1;CCL5;CNOT7;DHX9;MDFIC;PPIA;POLR2K;VAPB;SRPK1;STAU1;HACD3
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.5461196433743011,-1.6367237301032318,0.022727272727272728,0.6416012386324217,1.0,9/17,19.51%,SYK;PRKCQ;PRKCZ;RARA;CEBPB;SLC7A5;CD86;IRF4;CD28
prerank,cellular response to exogenous dsRNA (GO:0071360),0.7380955291083331,1.63637515352081,0.01199400299850075,0.288400719221422,1.0,4/12,7.25%,IFIH1;IFIT1;CGAS;DHX9
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.5328659846904871,-1.6356733210902201,0.018315018315018316,0.6208939551230819,1.0,12/18,29.44%,CACNG7;TSHZ3;NLGN2;CACNG8;NRXN1;SHANK3;CCR2;CACNG2;CACNG3;CCL2;CACNG5;PTK2B
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.7123474219632456,1.6355515868443384,0.01694915254237288,0.28811964225065384,1.0,4/15,10.28%,RNF213;NPHP3;DACT1;SPEF1
prerank,mesenchyme development (GO:0060485),0.7176723818878048,1.6314906375808553,0.009485094850948509,0.2987796383582419,1.0,4/15,9.53%,WNT11;SFRP2;FGFR2;BMPR2
prerank,negative regulation of DNA replication (GO:0008156),-0.5922870082314411,-1.630558949735028,0.032679738562091505,0.618725748245937,1.0,6/13,17.60%,WAPL;CDAN1;RAD17;S100A11;TERF1;TSPYL2
prerank,lung development (GO:0030324),0.605980668652612,1.629105924035603,0.012091898428053204,0.30369517230996523,1.0,9/33,11.32%,WNT11;CCDC40;FGFR2;ITGA3;WNT7B;NPHP3;PDPN;PROX1;FGF9
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.6221057764284668,-1.6290490552700303,0.020833333333333332,0.6023665486230146,1.0,8/12,20.98%,DOCK4;DOCK7;TPM1;ADAMTS1;IGFBP5;DOCK5;PRKG1;MEF2C
prerank,monocyte chemotaxis (GO:0002548),0.6167717299391704,1.6276076721119708,0.007547169811320755,0.3060717759867761,1.0,5/32,5.48%,CALCA;FLT1;CCL7;CCL5;CX3CL1
prerank,response to zinc ion (GO:0010043),-0.4883118082438074,-1.6241252931377295,0.026905829596412557,0.6020335165554271,1.0,8/25,1.99%,MT1E;MT1F;MT1M;MT1G;MT1A;MT1H;MT1B;MT1X
prerank,monoacylglycerol metabolic process (GO:0046462),-0.5951641314199099,-1.622714229312148,0.01904761904761905,0.5866320394771692,1.0,8/13,26.13%,ABHD16A;MOGAT3;DGAT1;MGLL;ABHD12;FAAH;ABHD6;DGAT2
prerank,protein homotetramerization (GO:0051289),0.5822674690743053,1.6226832452985203,0.005636978579481398,0.3202150984267119,1.0,12/49,13.77%,SAMHD1;SYCP1;GBP5;TRPM2;B2M;SOD2;AQP4;TK1;ALDH1A2;HPRT1;ACOT13;SHMT1
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.7546575352543204,1.620751584879516,0.025073746312684365,0.3235056733760036,1.0,3/11,7.72%,AGT;ABCG1;LIPC
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.7550947077353495,1.617204123923191,0.013975155279503106,0.3334704100836482,1.0,8/11,17.07%,DHX36;NCBP2;BARD1;ZFP36L1;AHCYL1;PAPOLA;NCBP1;ZC3H3
prerank,regulation of interleukin-4 production (GO:0032673),-0.505814899270151,-1.6168098353438727,0.024691358024691357,0.5925826909124177,1.0,12/21,26.62%,SYK;PRKCQ;PRKCZ;RARA;CEBPB;SLC7A5;CD86;IRF4;CD28;ZFPM1;FCER1G;LEF1
prerank,reverse cholesterol transport (GO:0043691),0.7252879260756762,1.6151461550380424,0.015602836879432624,0.3377291385226734,1.0,5/13,12.34%,ABCA1;ABCG1;CLU;LIPC;APOE
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.7284664672535476,1.6146860956035776,0.01875901875901876,0.33605270484964284,1.0,3/12,8.80%,AGT;SOX9;GDNF
prerank,response to purine-containing compound (GO:0014074),0.6790078530822035,1.6119541792633987,0.020804438280166437,0.34299242468820645,1.0,3/17,8.96%,STAT1;TRPM2;P2RX4
prerank,microtubule nucleation (GO:0007020),-0.509505146506455,-1.611908299340963,0.03272727272727273,0.593263728061922,1.0,11/19,20.07%,NDE1;TPPP;TUBGCP3;CLASP2;TUBGCP4;TUBGCP6;TUBGCP2;CCDC57;GOLGA2;TPX2;CLASP1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.47789083299952373,-1.6100573518672485,0.02631578947368421,0.582069642578053,1.0,14/26,22.44%,DLG4;GRIN1;PRKCZ;NLGN2;SLC8A3;NRXN1;RIMS1;SHANK3;STX1B;CHRNA7;RIMS2;SLC8A2;CUX2;SHANK1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.6269853262668756,-1.608735231561883,0.03353658536585366,0.5700340546521663,1.0,7/11,30.05%,TGFB1;EFNB2;FZD7;MEF2C;SOX6;GREM1;BMP2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.6986059701358827,1.6083141498065847,0.01662049861495845,0.353247326070833,1.0,3/15,8.80%,AGT;SOX9;GDNF
prerank,ncRNA 3'-end processing (GO:0043628),-0.5596391272040757,-1.6074506193226754,0.03496503496503497,0.5580411435905765,1.0,9/14,30.79%,ERI1;TRNT1;INTS12;INTS2;ELAC2;INTS6;TOE1;INTS5;INTS6L
prerank,sprouting angiogenesis (GO:0002040),0.5590096042446062,1.6067292743901658,0.004618937644341801,0.3556307497560247,1.0,8/51,11.22%,RNF213;LOXL2;KDR;CDH13;YJEFN3;SRF;BMPER;VEGFD
prerank,vitamin transport (GO:0051180),0.6223967977169276,1.6056364080196177,0.012345679012345678,0.35593405727177824,1.0,8/29,9.47%,SLC27A1;SLC2A6;SLC46A1;SLC19A1;SLC52A2;SLC35F3;PDPN;AMN
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.6283450421201493,1.6021883292318255,0.012953367875647668,0.3654264027917316,1.0,5/26,3.46%,TRAFD1;ILRUN;DHX58;NMI;TRIM21
prerank,sarcomere organization (GO:0045214),0.6134765735938753,1.59731495781863,0.02369077306733167,0.38154304860189153,1.0,3/27,3.82%,MYOZ2;CSRP1;ACTN2
prerank,regulation of immune response (GO:0050776),0.5173006425826763,1.5967407281069452,0.0,0.3802079277852588,1.0,23/135,8.83%,RSAD2;IRF7;CLEC2D;SAMHD1;IL15;TREML2;DHX58;SPPL2A;PIANP;BIRC2;B2M;LAG3;CD40;GPR108;NPDC1;CD276;ERAP1;BCL6;N4BP1;SH2D1A;LAIR1;LYN;FCGR1A
prerank,positive regulation of defense response (GO:0031349),0.5317877487697379,1.5944342499684967,0.0010649627263045794,0.38584703476696325,1.0,20/89,11.17%,ZBP1;IL15;AGT;GBP5;IFI35;WNT5A;NMI;ADAM8;CD47;PTGER4;CCL5;TLR8;CX3CL1;LRSAM1;POLR3B;DHX9;APP;TNIP1;RIOK3;ABCC1
prerank,receptor signaling pathway via STAT (GO:0097696),0.6275381025833838,1.5922687550835575,0.017587939698492462,0.39127267660291115,1.0,4/25,2.94%,STAT1;STAT2;STAT3;NMI
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.5675576930032615,-1.5910926090028594,0.03691275167785235,0.605545964143265,1.0,6/15,13.61%,CHST1;OGA;MGAT3;GNPDA1;CHST7;CHST3
prerank,positive regulation of interleukin-10 production (GO:0032733),0.6016381086205826,1.5839763442803563,0.01597051597051597,0.4221673645573499,1.0,4/30,2.87%,CD274;ISG15;NOD2;STAT3
prerank,cytokine-mediated signaling pathway (GO:0019221),0.4901859108915403,1.5819654341917466,0.0,0.42742878874029383,1.0,117/532,14.86%,IFIT3;RSAD2;OAS3;STAT1;STAT2;CXCL10;SP100;OASL;IRF7;OAS2;SAMHD1;IFIT1;ISG15;CXCL9;EDAR;PML;IL15;CRLF1;XAF1;NOD2;IFIT2;PSMB10;BST2;CCL7;TNFSF9;CAMK2D;IL15RA;IFI35;NOD1;SKP1;AIM2;IRS1;PSME2;SOCS1;TRIM25;BIRC2;PIK3CD;B2M;TNFRSF8;CAMK2B;PSMA5;SLC27A1;ADAR;CD40;SOD2;STAT3;IL21R;BCL2L11;PSME4;GRB10;TRIM21;MAP3K8;GBP2;IL17RC;HCK;CCL5;TXNDC17;JUNB;CX3CL1;CCND1;IL27;PSMA3;NFKB1;BCL6;MT3;CSF1;IL10RA;CSNK2B;HNRNPA2B1;PPIA;TNFRSF17;IL12RB2;PSMB9;ACKR3;FCGR1A;LEPR;SOCS5;RBX1;IRF9;VAV1;HSPA8;TRAF3;RORA;COMMD7;BTRC;HNRNPDL;PSMD2;CCL14;TRAF5;PIM1;TNFSF8;IL10RB;IRAK4;SOS1;TRIM26;PTPN11;PSME3;SOCS2;GPR35;PIK3CB;LIMS1;RAPGEF1;ST18;NUMBL;BIRC3;STX4;JAK2;FYN;IFNAR2;AIP;PSMA4;IL1RAP;SOX2;IRS2;TNIP2;MYD88;HSP90AA1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5136533950609287,1.5795875936622856,0.0031380753138075313,0.4340252779275873,1.0,29/112,17.39%,OAS3;OAS2;IFIH1;NOD2;SLAMF1;ILRUN;WNT5A;CLU;ZFP36;TNFRSF8;STAT3;CD47;CX3CL1;DHX9;TMEM106A;APP;HMGB1;SPHK2;ZC3H12A;HAVCR2;PTPN11;PSEN1;ARFGEF2;JAK2;TLR2;DICER1;LGALS9;TLR3;PTPRC
prerank,cell differentiation in spinal cord (GO:0021515),-0.6263494853125784,-1.5780557384020142,0.06086956521739131,0.641068517414933,1.0,8/10,37.40%,SOX13;ZC4H2;MDGA2;SOX4;MDGA1;SOX6;LHX1;ISL1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.737357736947398,1.5774154317372215,0.03490136570561457,0.43973540553060547,1.0,2/10,1.74%,PARP14;SOCS1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.6752279762530874,1.5772253177585243,0.02401129943502825,0.4368250779965504,1.0,6/16,8.47%,TMEM161A;CLU;SFRP2;CDKN2D;SNAI2;ACKR3
prerank,positive regulation of lymphocyte migration (GO:2000403),0.7183740622232778,1.5760197990799727,0.023255813953488372,0.4387507538941061,1.0,4/12,9.06%,CXCL10;DOCK8;CCL5;APP
prerank,genitalia development (GO:0048806),0.717832969063876,1.57488969653267,0.01692524682651622,0.44005525924386246,1.0,3/12,12.25%,WNT5A;CHD7;PTPN11
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.7353158553143684,1.57445504605553,0.021103896103896104,0.43811122253875817,1.0,3/10,8.76%,AXL;RAPGEF2;LYN
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.594697733103966,1.5739795512350852,0.017135862913096694,0.43661524236875565,1.0,4/32,5.48%,CXCL10;CXCL9;THY1;CX3CL1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.7506743181865501,1.573557351764885,0.025525525525525526,0.4346493055688502,1.0,3/10,1.72%,NAMPT;NOD2;KDR
prerank,regulation of response to cytokine stimulus (GO:0060759),0.6511682695410094,1.569726556367592,0.02455661664392906,0.4478687613966764,1.0,5/19,7.25%,IFIH1;PARP9;WNT5A;RUNX1;DHX9
prerank,hyaluronan metabolic process (GO:0030212),0.6245892701852261,1.5691078856300624,0.02230971128608924,0.44678531696702156,1.0,6/23,3.12%,HAS3;SPAM1;HYAL1;STAB2;HYAL4;HAS1
prerank,regulation of activated T cell proliferation (GO:0046006),0.5977146289498774,1.5686558770771017,0.008816120906801008,0.44501508466884326,1.0,7/30,16.80%,CD274;ICOSLG;TNFSF9;HMGB1;PRNP;IL18;LGALS9
prerank,positive regulation of T cell cytokine production (GO:0002726),0.6349173655329388,1.5672056972534965,0.029333333333333333,0.44774509831530096,1.0,3/20,2.89%,RSAD2;B2M;CD55
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.6931869844269346,1.565813667714776,0.027181688125894134,0.4504016429066488,1.0,4/13,4.60%,PLXNA3;PLXNB2;NRP2;PLXNB3
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6931371268433963,1.56373588497689,0.020497803806734993,0.45635491702856124,1.0,4/13,12.93%,GPR37L1;GPR37;MET;RACK1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.7443555846717163,1.5632209512262276,0.03736920777279522,0.4550027032858248,1.0,1/10,0.46%,CNGB1
prerank,erythrocyte differentiation (GO:0030218),-0.42001628923970125,-1.561626211701851,0.0,0.6952178017506094,1.0,19/44,23.89%,RPS14;UBA5;NCKAP1L;TGFBR3;KMT2E;CASP3;ID2;DMTN;PTPN2;ABCB10;ALAS1;JAK3;SLC25A5;LYAR;CDK5RAP3;ZFPM1;INHBA;HIPK2;ALAS2
prerank,regulation of erythrocyte differentiation (GO:0045646),0.5830062578527749,1.5616004450393663,0.026570048309178744,0.4586091311334191,1.0,10/35,12.41%,STAT1;HSPA1B;ZFP36;STAT3;BRD1;LYN;MAPK14;ZFP36L1;LDB1;PRKDC
prerank,negative regulation of cartilage development (GO:0061037),0.7055006263229923,1.56110267992206,0.023448275862068966,0.4572225441753464,1.0,5/13,15.87%,WNT11;SOX9;SNAI2;PTPN11;ADAMTS12
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.584079464012433,1.560568991457629,0.01877346683354193,0.4560890068459466,1.0,5/32,8.96%,CXCL10;CXCL9;THY1;CX3CL1;P2RX4
prerank,autophagy of nucleus (GO:0044804),-0.5345351408482018,-1.5605137584129074,0.03806228373702422,0.681736498293346,1.0,6/16,12.58%,ATG5;ULK2;ATG2B;ATG2A;ATG9A;ATG3
prerank,protein heterotetramerization (GO:0051290),-0.5618572333375589,-1.559283353576186,0.050505050505050504,0.6696274181868155,1.0,4/13,14.30%,GRIN2B;GRIN1;CPSF7;FARSA
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6735596424487116,1.5582943005146284,0.036775106082036775,0.46273195246098103,1.0,4/15,8.96%,KDR;MET;SMOC2;P2RX4
prerank,pancreas development (GO:0031016),0.7126118688624186,1.5569703960873273,0.034782608695652174,0.46525234180803365,1.0,6/12,15.24%,CCDC40;TCF7L2;NPHP3;MET;PROX1;SELENOT
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6068194595400557,1.556496374815404,0.016270337922403004,0.46401170310866935,1.0,6/26,8.80%,HSPA1B;EYA4;UNC5B;SNAI2;RET;GDNF
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.6150874417938653,1.5561114594184011,0.02372034956304619,0.4622286352186218,1.0,7/26,7.74%,NOL3;GPR37L1;SOD2;FBXO7;NME5;GPR37;PPIA
prerank,folic acid metabolic process (GO:0046655),0.6487287606604853,1.5556757648354185,0.03278688524590164,0.46087586133726305,1.0,4/18,5.34%,MTHFR;DHFR;SLC46A1;SLC19A1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5423264588633473,1.553892057096299,0.021052631578947368,0.46517406001271683,1.0,17/51,19.90%,NOD2;GBP5;AIM2;WNT5A;USP50;STAT3;TLR8;TMEM106A;APP;HMGB1;TMED10;PANX1;JAK2;MYD88;LGALS9;RIPK2;TYROBP
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.6789325598488938,1.552638944140691,0.025210084033613446,0.46713899278428667,1.0,5/15,4.80%,TENT4A;POLR2G;ZFP36;AGO2;CNOT7
prerank,glycerol metabolic process (GO:0006071),0.7364870108208393,1.5486627323556075,0.0377643504531722,0.48099430533266224,1.0,4/10,6.32%,COQ2;TPI1;PDXP;COQ3
prerank,folic acid-containing compound metabolic process (GO:0006760),0.6344424145785952,1.5471671252652872,0.041278295605858856,0.4842188154451121,1.0,4/19,5.34%,MTHFR;DHFR;SLC46A1;SLC19A1
prerank,respiratory system development (GO:0060541),0.5825169546428408,1.5466798149507655,0.02195121951219512,0.48283005122501,1.0,9/32,11.32%,CHD7;CCDC40;FGFR2;ITGA3;WNT7B;NPHP3;PDPN;PROX1;FGF9
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.7130201622091786,1.5443386465752051,0.03863298662704309,0.49003568590885754,1.0,2/11,3.85%,SP100;MAD2L2
prerank,regulation of coagulation (GO:0050818),-0.6140402239451888,-1.5435818482626034,0.05099150141643059,0.7212881370577017,1.0,5/11,28.81%,EPHB2;HS3ST5;F2R;CAV1;PROCR
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.48285546599775653,-1.5411330041556244,0.029535864978902954,0.7138904084209947,1.0,12/23,22.31%,TECR;HACD1;ELOVL5;DGAT1;FAR1;ELOVL1;ACSL1;ACSL6;ELOVL7;ACSBG1;ACSL4;ELOVL6
prerank,myeloid cell activation involved in immune response (GO:0002275),0.648642438046227,1.540706436198397,0.030344827586206897,0.5030931627649554,1.0,4/18,3.81%,SLAMF1;IFI35;NMI;ENPP3
prerank,secondary palate development (GO:0062009),0.6770805635211614,1.5401598797190783,0.03244005641748942,0.501959631170376,1.0,4/14,7.84%,WNT11;WNT5A;CHD7;SMAD2
prerank,negative regulation of protein transport (GO:0051224),0.5972365097206738,1.5401391687504287,0.02295918367346939,0.4987037377440985,1.0,5/25,12.34%,RSAD2;RSC1A1;PPM1F;RHBDF2;APOE
prerank,cellular response to retinoic acid (GO:0071300),0.5462509921842172,1.5389203954965602,0.012987012987012988,0.5009785096397101,1.0,11/42,15.64%,WNT11;WNT5A;BRINP3;SOX9;WNT7B;RET;LTK;LYN;SNW1;ZNF35;ADNP2
prerank,inner ear morphogenesis (GO:0042472),0.611865371848991,1.5389101548376127,0.03038309114927345,0.49769221931966223,1.0,5/22,6.04%,CHD7;MYO3B;SOX9;FGFR2;TTC39C
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.6200965794223876,1.537707872854392,0.03280839895013123,0.49656195042949114,1.0,5/21,8.80%,HSPA1B;EYA4;UNC5B;SNAI2;GDNF
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.6200965794223876,1.537707872854392,0.03280839895013123,0.49656195042949114,1.0,5/21,8.80%,HSPA1B;EYA4;UNC5B;SNAI2;GDNF
prerank,regulation of endothelial cell migration (GO:0010594),0.502934534084461,1.5367696693167128,0.009594882729211088,0.49759650874727485,1.0,19/85,13.90%,SP100;AGT;WNT5A;KDR;PIK3CD;NRP2;SASH1;RHOJ;BCAR1;SMOC2;BMPER;BMPR2;PROX1;ZC3H12A;RIN2;APOE;PIK3CB;NRP1;RAC1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.593710168346048,1.5361994599622453,0.03722084367245657,0.4967588941767852,1.0,10/25,14.68%,CHMP4A;CHMP4B;CHMP1B;MVB12A;RILP;LEPROT;CHMP3;LEPROTL1;LYST;DENND10
prerank,regulation of mitochondrial fission (GO:0090140),0.5984605519733367,1.5344651249163401,0.030848329048843187,0.5007012260536041,1.0,3/24,2.15%,STAT2;KDR;FIS1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.6101892945801158,1.5339408446834724,0.02236842105263158,0.5001119789189943,1.0,5/23,8.80%,AGT;PIK3CD;SOX9;SIRT6;GDNF
prerank,development of primary male sexual characteristics (GO:0046546),0.5787767642939814,1.5318918117719422,0.019002375296912115,0.5062345691610045,1.0,6/34,5.41%,MSH2;WNT5A;TFAP2C;KITLG;LRP2;SOX9
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.5611983695353138,1.5312164301532796,0.029585798816568046,0.5060818041533476,1.0,9/42,5.34%,PARP10;ISG15;SYCP1;UBE2L6;TRIM25;POLD4;CDKN2D;RFC4;RFC1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.561472391304074,1.5304952644704424,0.030084235860409144,0.5062341668174545,1.0,3/35,1.39%,STAT1;FLT1;XDH
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.5646780985250655,1.5291724262195077,0.02603550295857988,0.50885788657577,1.0,6/40,3.63%,NOL3;TNFSF10;CLU;MLLT11;BCL2L11;FXN
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.5473709031248524,1.5281937345846197,0.0234192037470726,0.5099455773980839,1.0,12/44,10.96%,MOV10;ZC3HAV1;POLR2G;PNPT1;ZFP36;AGO2;YTHDF1;CNOT7;DHX36;YTHDF2;ZC3H12A;ZFP36L1
prerank,defense response to protozoan (GO:0042832),0.6994844685745645,1.5269268845630342,0.03333333333333333,0.5124519974518444,1.0,4/12,5.13%,GBP4;CD40;GBP2;GBP7
prerank,amide transport (GO:0042886),0.5949113161686129,1.5268893126488057,0.04114713216957606,0.5094683264570827,1.0,13/26,22.39%,SLC27A1;AQP11;SLC46A1;SLC19A1;SLC14A2;ABCB9;PDPN;PLEKHA3;TAP1;GLTP;ABCG2;SLC5A6;CERT1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.637708715091003,1.5266905935220978,0.04834254143646409,0.5073171888069429,1.0,5/17,16.08%,CXCL10;CCL5;HMGB1;CXCL17;AIF1
prerank,ruffle organization (GO:0031529),0.6593172172718393,1.524724545683299,0.031029619181946404,0.5133062193829786,1.0,9/16,16.08%,CYFIP1;CARMIL1;PIP5K1A;AIF1L;PLEKHA1;CORO1B;RAC1;INPP5K;AIF1
prerank,respiratory tube development (GO:0030323),0.5912143524522777,1.5239919990643342,0.024968789013732832,0.5133178801980531,1.0,8/28,11.32%,CCDC40;FGFR2;ITGA3;WNT7B;NPHP3;PDPN;PROX1;FGF9
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.540112511752609,1.5219968182055061,0.028169014084507043,0.5196082186862638,1.0,15/45,19.90%,NOD2;GBP5;AIM2;WNT5A;USP50;STAT3;TLR8;TMEM106A;APP;PANX1;JAK2;MYD88;LGALS9;RIPK2;TYROBP
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.5210720355403591,1.5214894151298968,0.012127894156560088,0.5185599233952161,1.0,10/63,7.21%,SP100;NOL3;TNFSF10;PML;AGT;ACVR1;FEM1B;CFLAR;TCF7L2;CYLD
prerank,protein autoubiquitination (GO:0051865),0.525584633242915,1.5212778815985883,0.013377926421404682,0.5165196637615359,1.0,14/61,8.77%,RNF213;DTX3L;NFX1;RNF4;TRIM21;RNFT1;BFAR;CNOT4;UBE2B;RNF11;UBE3A;LRSAM1;AMFR;RNF19B
prerank,multivesicular body assembly (GO:0036258),0.5753514356893487,1.5212238569275796,0.04119850187265917,0.5136408304188783,1.0,14/30,22.41%,CHMP4A;CHMP4B;CHMP1B;MVB12A;VPS37A;CHMP3;VPS28;HGS;RAB11A;IST1;CHMP5;CHMP1A;TSG101;VPS36
prerank,negative regulation of cell division (GO:0051782),-0.6030287635963114,-1.5204546368214324,0.0480225988700565,0.7875844144622806,1.0,8/11,32.37%,ZFYVE19;ORC6;MYC;VPS4A;E2F8;AURKB;CHMP4C;E2F7
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.6843574743118315,1.5204050459099585,0.04507042253521127,0.5141846828916058,1.0,3/13,1.72%,NAMPT;NOD2;KDR
prerank,male gonad development (GO:0008584),0.5779698891131958,1.5201151437426381,0.02497027348394768,0.512474057262528,1.0,6/34,5.41%,MSH2;WNT5A;TFAP2C;KITLG;LRP2;SOX9
prerank,lamellipodium assembly (GO:0030032),0.5933983601326209,1.519664228881115,0.04203821656050955,0.5114914918424336,1.0,11/26,13.90%,CDH13;SPATA13;PARVB;CYFIP1;CARMIL1;ARHGEF7;CCDC88A;SPEF1;SRGAP2;WHAMM;RAC1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6896977004887888,1.5191516142854453,0.036127167630057806,0.510791515677691,1.0,1/12,0.04%,OAS3
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.7050174627283178,1.518554678107301,0.056129985228951254,0.5103692843810659,1.0,3/11,5.47%,LMX1A;WNT5A;CTNNB1
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.6075575921160001,-1.5185228159443411,0.0683453237410072,0.7784629420442518,1.0,10/11,39.29%,ASAH1;SIRT1;EGR1;WNT4;BMP5;STAR;DGKQ;BMP2;NR1H4;FGFR4
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.6084652571387836,-1.5169010266927148,0.0423728813559322,0.768169094325992,1.0,6/10,19.26%,RCC2;CDC42;APC;RACGAP1;ECT2;KNSTRN
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.4988718124553062,1.516781825211729,0.0032119914346895075,0.515270447929792,1.0,23/95,16.67%,CXCL10;AXL;CD274;CXCL9;IRGM;NOD2;WNT5A;ZFP36;NFKB1;HMGB1;MAPK14;GIT1;ZC3H12A;XBP1;STAP1;FCGR2B;TNIP2;MYD88;TLR2;TNIP3;IRAK1;UPF1;ACOD1
prerank,positive regulation of endothelial cell migration (GO:0010595),0.49999485539070665,1.5166039483159892,0.0064516129032258064,0.513051593223386,1.0,21/84,13.90%,AGT;WNT5A;KDR;PIK3CD;CD40;NRP2;SASH1;MAP2K3;BCAR1;MET;SMOC2;P2RX4;HMGB1;BMPR2;MAPK14;PROX1;ZC3H12A;RIN2;PIK3CB;NRP1;RAC1
prerank,cochlea morphogenesis (GO:0090103),0.7055134408816861,1.5161194231155273,0.03840472673559823,0.5122795868362902,1.0,2/10,5.41%,MYO3B;SOX9
prerank,oxoacid metabolic process (GO:0043436),0.5907756600897803,1.5160722326824587,0.03431372549019608,0.5095635758780187,1.0,6/27,7.68%,TPST1;LIPT1;AGXT;GRHPR;THAP4;SULT6B1
prerank,cellular response to alkaloid (GO:0071312),0.6389628848548381,1.5145347034582595,0.03961748633879782,0.5136014433520523,1.0,4/17,4.27%,CASP7;SLC8A1;CASP6;CRHBP
prerank,neurotrophin signaling pathway (GO:0038179),0.6118564621180482,1.514446627456441,0.03871829105473965,0.5110857087027909,1.0,7/21,13.45%,BDNF;MAGI2;RAPGEF2;BCAR1;DDIT4;SOS1;RAPGEF1
prerank,regulation of cell projection organization (GO:0031344),0.6723768643884924,1.5141057975299221,0.05057803468208093,0.5095136934116249,1.0,3/13,2.58%,MOV10;SPRY2;SEMA4D
prerank,amino acid import across plasma membrane (GO:0089718),-0.4607903451586503,-1.5125868317006754,0.0391304347826087,0.7711399153999317,1.0,7/24,16.28%,SLC1A2;SLC7A2;SLC16A2;SLC3A2;SLC7A5;SLC1A4;SLC1A1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.7094537831283937,1.5122333401287757,0.05588235294117647,0.5148247991907741,1.0,1/10,0.10%,SP100
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.5325063352205591,-1.5120428022620684,0.03536977491961415,0.7567064368125596,1.0,4/15,13.42%,TGFB1;IRAK3;TGFB2;JAK3
prerank,positive regulation of chromosome organization (GO:2001252),0.6541108085226824,1.5105328092500188,0.035961272475795295,0.5195104880526348,1.0,7/15,12.58%,PML;DHX36;RTEL1;FEN1;SIRT6;PPP1R10;DDX11
prerank,mesoderm formation (GO:0001707),0.6280809068267604,1.5100861291714138,0.0395778364116095,0.5187707829699112,1.0,5/17,9.53%,ITGA2;ITGA3;SMAD2;SCX;BMPR2
prerank,endosome organization (GO:0007032),0.5433663107253435,1.508489451250994,0.027090694935217905,0.522747692016812,1.0,13/41,13.57%,DNAJC13;USP50;SNX33;WASHC4;RILP;SNX10;TMEM9;VPS11;HOOK2;RAB22A;HOOK1;ARFGEF2;HOOK3
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6673507261647499,1.5077653193100942,0.04419889502762431,0.5231963118630072,1.0,3/15,3.63%,NOL3;CLU;FXN
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5904045021660905,1.507702321810956,0.03656998738965952,0.5206697877030715,1.0,6/25,12.41%,STAT1;HSPA1B;STAT3;BRD1;MAPK14;PRKDC
prerank,mRNA stabilization (GO:0048255),0.5561392397876248,1.5076158671838704,0.030696576151121605,0.5182497111694897,1.0,11/40,15.56%,IGF2BP1;ZFP36;TARDBP;LARP1;DHX9;GDNF;MAPK14;TENT5A;TENT5C;MYD88;TAF15
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.5858164905871242,-1.507517215527016,0.07917888563049853,0.760694510744438,1.0,7/10,28.06%,TGFB1;CST3;DPP4;TNFRSF1B;FAP;EMILIN1;CHADL
prerank,cellular response to lipopolysaccharide (GO:0071222),0.4934704406601558,1.5069901611799579,0.003194888178913738,0.5183184592051786,1.0,26/101,16.67%,CXCL10;AXL;CD274;CXCL9;IRGM;NOD2;WNT5A;ZFP36;HCK;CCL5;NFKB1;LYN;HMGB1;MAPK14;GIT1;ZC3H12A;XBP1;STAP1;PRKCE;TNIP2;MYD88;TNIP3;IL18;IRAK1;UPF1;ACOD1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.600605709395427,1.505817678352436,0.04054054054054054,0.5204951389464105,1.0,10/22,21.15%,XDH;GADD45G;SASH1;ZC3H12A;MAP3K4;MINK1;PRMT1;RELL1;MFHAS1;GADD45A
prerank,response to exogenous dsRNA (GO:0043330),0.6362273734102956,1.5054647644324202,0.044630404463040445,0.5193954039667524,1.0,4/18,7.25%,IFIH1;IFIT1;CGAS;DHX9
prerank,regulation of superoxide anion generation (GO:0032928),-0.5391783233518714,-1.5039017493487856,0.04472843450479233,0.7606849200187549,1.0,2/14,0.30%,TGFB1;SYK
prerank,positive regulation of immune effector process (GO:0002699),0.5763428755374789,1.5028177602178467,0.047435897435897434,0.5286421907240498,1.0,2/27,1.27%,DDX60;DHX58
prerank,dendritic cell differentiation (GO:0097028),0.6047979980359348,1.5018972808612943,0.034106412005457026,0.5299347117943097,1.0,4/22,8.76%,AXL;TRPM2;BATF3;LYN
prerank,regulation of spindle assembly (GO:0090169),0.6007278109659209,1.501703977484433,0.04236200256739409,0.5281287569959774,1.0,5/25,4.21%,HSPA1B;CHMP4B;CHMP1B;RNF4;DYNC1H1
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.5556337810692211,-1.501510718470196,0.08653846153846154,0.7552966581596026,1.0,2/13,0.30%,TGFB1;SYK
prerank,negative regulation of viral release from host cell (GO:1902187),0.6679130625287895,1.5014548849419906,0.03932584269662921,0.5265103334544349,1.0,4/13,12.02%,PML;TRIM21;CHMP3;TRIM26
prerank,response to sterol (GO:0036314),-0.5576591530486653,-1.5008498997232882,0.0748502994011976,0.7431805203831782,1.0,6/11,11.37%,CCR5;TGFB1;ABCA2;INSIG1;CCL3;PMVK
prerank,retinoic acid metabolic process (GO:0042573),0.6639569403878712,1.499755197841506,0.05694444444444444,0.5312455597135824,1.0,3/14,10.65%,BCO2;CYP26B1;ALDH1A2
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.7116801086481829,1.4996369738053976,0.042134831460674156,0.5291204847778933,1.0,3/11,8.25%,STAT1;STAT3;IL12RB2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.6431228827532635,1.4976597459056857,0.05138888888888889,0.5352738008156804,1.0,5/17,10.04%,NOL3;SOD2;NME5;PPIA;UBQLN1
prerank,maintenance of protein localization in organelle (GO:0072595),0.6297011811788197,1.4965683749928855,0.05913978494623656,0.537383255833972,1.0,8/19,11.60%,PML;SKP1;CHCHD10;MORC3;SUPT7L;TAF8;HK1;TAF3
prerank,pyruvate metabolic process (GO:0006090),-0.37408356753353456,-1.4960580531699854,0.0234375,0.7487601604580449,1.0,17/52,11.13%,ENO1;VDAC1;SRR;PDHB;PFKL;GLO1;SLC16A1;PGAM1;PGAM4;PKM;PDHA1;HOGA1;PFKFB2;ME2;ENO2;PGK1;ME1
prerank,regulation of T cell migration (GO:2000404),0.6236309561707354,1.4958757354122179,0.04370860927152318,0.5377877771766092,1.0,5/18,10.85%,CXCL10;DOCK8;CCL5;APP;LRCH1
prerank,regulation of protein modification process (GO:0031399),0.5301658802316753,1.495404948546198,0.032073310423825885,0.5373032542667273,1.0,17/50,19.46%,STAT2;PML;PLXNB2;SOCS1;NOP53;KDM4D;MT3;CCDC88A;LYN;PHIP;PUM3;NDUFS4;SPRED3;CORO1C;FNIP2;SPRED1;PIN1
prerank,cellular response to purine-containing compound (GO:0071415),0.7064554131407632,1.4953206797917953,0.04154302670623145,0.5349631936676402,1.0,2/10,3.74%,TRPM2;SLC8A1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6180372054097639,-1.4952786602249442,0.09192200557103064,0.7372357298595899,1.0,4/10,10.24%,PTPN12;APOD;SNCA;PTPN2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.678391906680995,1.4952460866769304,0.04526748971193416,0.5300820968712754,1.0,3/13,2.87%,IL15;IL15RA;STAT3
prerank,cellular response to interleukin-15 (GO:0071350),0.678391906680995,1.4952460866769304,0.04526748971193416,0.5300820968712754,1.0,3/13,2.87%,IL15;IL15RA;STAT3
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.5066693180535982,-1.494962764016399,0.0683453237410072,0.7247359025918465,1.0,10/18,22.31%,TECR;HACD1;ELOVL5;ELOVL1;ACSL1;ACSL6;ELOVL7;ACSBG1;ACSL4;ELOVL6
prerank,modulation by symbiont of entry into host (GO:0052372),0.6424110344996943,1.4942206302367096,0.06527777777777778,0.5320870557292646,1.0,3/16,3.46%,TRIM14;TRIM25;TRIM21
prerank,response to retinoic acid (GO:0032526),0.5130702740713555,1.4939737618155102,0.01583710407239819,0.5306810740541261,1.0,14/59,12.98%,WNT11;TMEM161A;WNT5A;RARG;BRINP3;CDKN2D;SOX9;WNT7B;RET;CTSH;LTK;LYN;SNW1;ZNF35
prerank,cell proliferation in forebrain (GO:0021846),-0.5924282698297284,-1.4938036929120488,0.069164265129683,0.7163962082024031,1.0,5/10,7.87%,NUMB;DOCK7;PCM1;AKNA;CEP120
prerank,multivesicular body organization (GO:0036257),0.5622268416461419,1.4928204571591284,0.04962779156327544,0.5331708885685,1.0,14/31,22.41%,CHMP4A;CHMP4B;CHMP1B;MVB12A;VPS37A;CHMP3;VPS28;HGS;RAB11A;IST1;CHMP5;CHMP1A;TSG101;VPS36
prerank,response to peptide hormone (GO:0043434),0.5409927674566196,1.492652665540535,0.032825322391559206,0.5314848395166493,1.0,9/43,11.49%,STAT1;STAT2;IRS1;SLC27A1;STAT3;EIF2B2;ZFP36L1;XBP1;EIF6
prerank,regulation of mitochondrial depolarization (GO:0051900),0.7013806681034211,1.4917493732090574,0.0583596214511041,0.5328614376938134,1.0,5/10,12.93%,KDR;MLLT11;MYOC;ABCD1;RACK1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.5685995800841143,1.4912928107928105,0.05189873417721519,0.5324066490733134,1.0,10/26,15.31%,AIM2;PSME2;USP50;STAT3;EPHA4;LYN;PSME3;FYN;APH1A;APH1B
prerank,mRNA destabilization (GO:0061157),0.5426217742272481,1.4911459299803111,0.039285714285714285,0.5305443475114434,1.0,16/38,19.29%,MOV10;ZFP36;TARDBP;YTHDF1;PLEKHN1;DHX36;YTHDF2;ZC3H12A;ZFP36L1;DIS3L2;MEX3D;TUT7;UPF1;METTL14;DCPS;RC3H2
prerank,androgen receptor signaling pathway (GO:0030521),0.6893713616807435,1.4905276984593372,0.05625,0.5308308719371846,1.0,4/11,5.70%,DAXX;DDX5;PMEPA1;ARID1A
prerank,sympathetic nervous system development (GO:0048485),0.6439594344258341,1.490340821494634,0.05680119581464873,0.5291622979809513,1.0,6/15,18.18%,NRP2;CTNNB1;TFAP2B;GDNF;NRP1;NF1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5362945906914782,1.490175823018706,0.036686390532544376,0.5273971298992058,1.0,13/42,13.90%,KDR;UTRN;CDH13;THY1;CX3CL1;CSF1;MYOC;CIB1;PPM1F;RIN2;LIMS1;NRP1;RAC1
prerank,base conversion or substitution editing (GO:0016553),0.6891033439822158,1.4898812281982443,0.06408345752608048,0.5261783902407332,1.0,2/11,2.40%,APOBEC1;ADAR
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.5642581140098781,-1.4890852536872201,0.05921052631578947,0.7211272030954952,1.0,3/12,4.73%,TGFB1;PPARG;ESR1
prerank,potassium ion export across plasma membrane (GO:0097623),-0.5429743185973174,-1.4877220354293785,0.0594059405940594,0.7136942253727959,1.0,8/13,40.13%,KCND3;KCNT2;KCNK5;KCNH2;KCNQ1;KCNIP2;KCNE3;KCNE4
prerank,DNA dealkylation (GO:0035510),0.7043126607444877,1.4871167852242029,0.054093567251461985,0.5337859058383939,1.0,5/10,14.41%,ASCC3;ALKBH1;MPG;ALKBH2;ASCC2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.7043126607444877,1.4871167852242029,0.054093567251461985,0.5337859058383939,1.0,5/10,14.41%,ASCC3;ALKBH1;MPG;ALKBH2;ASCC2
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.6263826437545439,1.4847062209177588,0.05342465753424658,0.5416261237446557,1.0,4/18,8.80%,AGT;NOD2;FXN;GDNF
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.6964700765259239,1.4838516095012386,0.0658682634730539,0.5430127508277564,1.0,3/10,6.05%,ACTN2;PDXP;CARMIL1
prerank,connective tissue development (GO:0061448),0.549411054289771,1.4820857043229572,0.041617122473246136,0.5484997479584256,1.0,13/35,18.95%,NAMPT;HYAL1;DDRGK1;ARID5B;SOX9;ITGB8;SCX;XBP1;COL11A2;SOX5;SH3PXD2B;SPTLC2;CREB3L2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.6578090941505018,1.4818043467008652,0.052781740370898715,0.5472867532231628,1.0,5/13,13.47%,KDR;SFRP2;CTNNB1;NOTCH4;NRP1
prerank,regulation of lymphocyte migration (GO:2000401),-0.5861638776423577,-1.479941499251214,0.06542056074766354,0.7314715236993814,1.0,4/10,13.17%,STK10;WASL;JAM2;AKT1
prerank,negative regulation of chemokine production (GO:0032682),0.658995695859088,1.4784203108663243,0.05150214592274678,0.5593441256190119,1.0,1/14,0.04%,OAS3
prerank,organophosphate biosynthetic process (GO:0090407),0.5484774634786332,1.47793583680406,0.05200945626477541,0.5589858241088335,1.0,11/37,11.24%,TPI1;ITPKC;MOCS3;PCYT2;AGPAT5;PIP5K1A;PPIP5K1;NFS1;GNPAT;MOCOS;TPK1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.6100000423122729,1.4776548142872994,0.06481481481481481,0.5576486566347706,1.0,3/19,1.51%,HSPA1B;CHMP4B;CHMP1B
prerank,regulation of T cell proliferation (GO:0042129),0.5101037971509587,1.4768606948495804,0.037527593818984545,0.558812027431613,1.0,11/61,11.56%,CD274;IL15;TNFSF9;SDC4;CCL5;IL27;CD276;NCK1;NCK2;CCDC88B;TNFSF8
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.65162930704371,1.475220150321692,0.055964653902798235,0.5633543446369139,1.0,7/13,16.42%,PIK3AP1;UNC93B1;PIK3R4;IRAK4;TNIP2;MYD88;IRAK1
prerank,myelination (GO:0042552),0.5312741122634148,1.4743334365133207,0.04267589388696655,0.5648657320046239,1.0,18/46,19.93%,PMP22;CXCR4;CNTNAP1;DEGS1;MYOC;EPB41L3;EIF2B2;B4GALT5;ABCD1;ARHGEF10;SCN2A;PLLP;ACER3;MPZ;SCN8A;NF1;EIF2B5;PLP1
prerank,regulation of interleukin-10 production (GO:0032653),0.5263952019478801,1.474328195254513,0.047674418604651166,0.5624122271077137,1.0,5/44,3.99%,CD274;ISG15;NOD2;STAT3;CD47
prerank,regulation of lymphocyte activation (GO:0051249),0.664356152371667,1.4725171253289266,0.04815864022662889,0.568298862421837,1.0,3/12,7.99%,THEMIS2;CCL5;DCAF15
prerank,regulation of response to biotic stimulus (GO:0002831),0.5708445356910773,1.471831158164372,0.05541871921182266,0.5688474568754783,1.0,11/28,16.28%,SAMHD1;DHX58;BIRC2;CD55;CX3CL1;ERAP1;N4BP1;TRAF3;FCGR2B;BIRC3;LRP8
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6789375885267206,1.4694541688159146,0.06323529411764706,0.5765431305886376,1.0,6/11,18.04%,ARHGEF7;PDPN;KANK1;CORO1B;RREB1;CORO1C
prerank,response to UV-B (GO:0010224),0.6645154856383644,1.4678390395480538,0.059322033898305086,0.5811855000149153,1.0,2/12,1.26%,MSH2;HYAL1
prerank,chordate embryonic development (GO:0043009),0.5136778375679993,1.4677375709465654,0.02924634420697413,0.5791267271524689,1.0,10/55,10.65%,WNT11;EGFL8;WNT5A;CHD7;FGFR2;WNT7B;DACT1;PROX1;KIAA1217;ALDH1A2
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.6125750739093478,1.4672921885823265,0.0749665327978581,0.5785856201936468,1.0,8/16,22.41%,CHMP4A;CHMP4B;LEPROT;LEPROTL1;VPS28;CHMP5;TMEM50A;VPS36
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.5731681351027824,1.4672235079035783,0.075,0.5764148694024376,1.0,4/25,2.89%,NOD2;WNT5A;B2M;CD55
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.6198459333745777,1.4663363206298143,0.08531468531468532,0.5780595498535267,1.0,6/16,12.41%,PARP9;DTX3L;MAD2L2;KDM4D;SHLD1;PRKDC
prerank,cholesterol efflux (GO:0033344),0.5980340750061836,1.4658302475648735,0.05759162303664921,0.5778420306815795,1.0,7/20,17.01%,ABCA1;ABCG1;APOE;NPC1;NPC2;SOAT2;SOAT1
prerank,positive regulation of T cell activation (GO:0050870),0.5029990523219238,1.4655335512110237,0.029900332225913623,0.5766934021081319,1.0,22/62,21.27%,CD274;IL15;NOD2;DOCK8;THY1;CD47;CCL5;CD276;NCK1;NCK2;CCDC88B;XBP1;AIF1;LGALS9;MDK;FLOT2;PTPRC;SIRPA;LCK;VCAM1;CD46;RHOH
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.6132324234904708,1.464575920844259,0.07692307692307693,0.578546531672407,1.0,5/18,8.57%,NOL3;SOD2;NME5;PPIA;NONO
prerank,nuclear membrane organization (GO:0071763),0.6014234160562869,1.464445095549847,0.055916775032509754,0.5766751975821326,1.0,4/19,9.92%,CHMP4B;TOR1AIP1;TARDBP;UBXN2B
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6827260072001496,1.4634398900771746,0.08006042296072508,0.5787081508860294,1.0,4/10,16.64%,WNT5A;CCL5;OXSR1;STK39
prerank,response to interleukin-1 (GO:0070555),0.49115743298439285,1.463042600391415,0.022900763358778626,0.5779261884090218,1.0,21/73,16.80%,CCL7;HYAL1;GBP3;CD40;GBP2;CD47;RBMX;CCL5;SOX9;CX3CL1;IGBP1;NFKB1;APP;ZC3H12A;CCL14;MYD88;ADAMTS12;IRAK1;UPF1;ACOD1;LGALS9
prerank,regulation of interleukin-1 beta production (GO:0032651),0.4951966727207228,1.4628018787133874,0.027995520716685332,0.5765331947612938,1.0,20/66,19.95%,NOD2;GBP5;AIM2;WNT5A;USP50;STAT3;TLR8;CX3CL1;TMEM106A;APP;GIT1;ZC3H12A;PANX1;JAK2;MYD88;LGALS9;CD33;RIPK2;TYROBP;SIRPA
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.6180621006956223,1.4623201925967504,0.06630581867388363,0.5762584294498639,1.0,3/17,0.96%,EIF2AK2;NOD2;TAOK3
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5513327243395756,1.4612383595548046,0.0449438202247191,0.5787622058839099,1.0,5/29,7.21%,TNFSF10;PML;AGT;RET;CYLD
prerank,protein alkylation (GO:0008213),0.5795541965414591,1.4612283205931602,0.047244094488188976,0.5764678343720269,1.0,9/22,17.34%,PRMT2;METTL21A;GSPT1;EEF2KMT;CAMKMT;FAM98B;ETF1;PRMT1;PRMT3
prerank,positive regulation of chemokine production (GO:0032722),0.5201237023374571,1.459420093496032,0.04789719626168224,0.5822431270081478,1.0,10/44,17.33%,OAS3;EIF2AK2;WNT5A;APP;HMGB1;TLR2;AIF1;IL18;LGALS9;TLR3
prerank,neutrophil migration (GO:1990266),0.5010459627879317,1.4589396072862535,0.03859250851305335,0.5820668189855402,1.0,10/58,13.08%,CXCL10;CXCL9;CCL7;PIK3CD;CCL5;CX3CL1;PPIA;CCL14;IRAK4;PIP5K1C
prerank,histone monoubiquitination (GO:0010390),0.5765215550928934,1.4585852615816628,0.062111801242236024,0.581297334266307,1.0,7/24,11.44%,DTX3L;SKP1;RNF40;UBE2E1;RING1;WAC;RYBP
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.37588713595141354,-1.4579481328765127,0.021897810218978103,0.8133593200832865,1.0,22/46,24.87%,GRM3;CDH2;CACNG7;GRIK1;TSHZ3;DGKZ;HOMER1;NLGN2;CACNG8;NRXN1;SHANK3;CCR2;GRM8;CLN3;UNC13A;CACNG2;SYT1;MEF2C;CACNG3;MAPK8IP2;CCL2;DRD2
prerank,ribosomal subunit export from nucleus (GO:0000054),0.6454990427300658,1.4571366374921009,0.07492795389048991,0.5853277478494976,1.0,7/13,17.51%,LTV1;LSG1;RRS1;ABCE1;NPM1;EIF6;NUP88
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.5769661223847602,-1.4567288633674258,0.09792284866468842,0.8049910728020995,1.0,5/10,22.95%,MTMR1;MTMR4;MTMR9;ABCA3;PHB2
prerank,regulation of inflammatory response (GO:0050727),0.4606370218578185,1.4565510778220234,0.00101010101010101,0.5855318865857188,1.0,42/190,17.33%,USP18;ZBP1;PIK3AP1;IL15;CASP4;AGT;AOAH;NOD2;IFI35;WNT5A;BIRC2;NMI;ENPP3;CD47;PTGER4;HCK;CCL5;CX3CL1;AREL1;BCL6;CYLD;DHX9;APP;RORA;TNIP1;ABCC1;APOE;CXCL17;RB1;SHARPIN;VAMP2;BIRC3;JAK2;DAGLA;MYD88;TLR2;ADAMTS12;PPARD;IL18;ACOD1;MDK;TLR3
prerank,DNA geometric change (GO:0032392),0.5638669978079902,1.4556201550177765,0.06513409961685823,0.5874493836250373,1.0,11/24,15.29%,ASCC3;DHX36;MCM9;RTEL1;DHX9;HNRNPA2B1;HMGB1;HMGB3;ZRANB3;DDX11;RECQL5
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.5089317379987808,-1.4553031709360786,0.08076923076923077,0.7977869038890872,1.0,8/16,32.81%,SLC39A14;PRMT5;C3;CHGA;ACP3;GRP;PDE6G;NECAB2
prerank,neutrophil chemotaxis (GO:0030593),0.5069727596132706,1.455137828090472,0.046296296296296294,0.5872560491595012,1.0,7/53,7.74%,CXCL10;CXCL9;CCL7;PIK3CD;CCL5;CX3CL1;PPIA
prerank,positive regulation of catalytic activity (GO:0043085),0.5308623850788583,1.454419716575866,0.0498220640569395,0.5879149916861577,1.0,13/37,15.71%,NOD2;MSH2;AZIN2;FXN;MT3;MAPK14;CIB1;PSEN1;CHTOP;STX4;APH1A;PHACTR4;NHEJ1
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5361306409201763,-1.454115046019273,0.0738255033557047,0.7895452431266169,1.0,8/12,31.78%,WASL;AKT1;NBL1;BMP5;CCN3;GREM1;DUSP1;PLCB1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.3208822716454656,-1.4538625221790036,0.015625,0.7780479304200324,1.0,32/87,18.72%,RPS12;RPL13;RPS14;RPS28;RPL10;RPL23;RPL17;RPS26;RPLP0;RPL9;RPS17;RPL8;RPL21;RPL31;RPL36A;SEC61A1;RPLP2;RPL7;RPL39;RPS9;RPS18;RPL37;SEC61B;RPL13A;ZFAND2B;SRP19;UBA52;RPS25;RPS27A;RPL18;RPL38;RPL34
prerank,regulation of cholesterol esterification (GO:0010872),0.6858522042669307,1.4533975585645436,0.07027818448023426,0.5902165810903688,1.0,3/10,12.34%,AGT;ABCG1;APOE
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.4838089436149225,1.453023502538954,0.027114967462039046,0.5896551950573513,1.0,8/75,5.47%,STAT1;CXCL10;PML;SPRY2;MECP2;COL4A2;YJEFN3;CTNNB1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.620408551858409,1.4523841367571997,0.07240437158469945,0.5902465686455168,1.0,3/16,2.36%,NR1H2;PNPLA2;SLC27A1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.6803166747001048,1.4512257426098822,0.06296851574212893,0.5932337816512109,1.0,2/11,2.48%,IGF2BP1;IGF2BP3
prerank,regulation of postsynapse organization (GO:0099175),-0.4279653384257923,-1.4511413879510868,0.052132701421800945,0.7774841762874752,1.0,12/28,11.79%,PDLIM5;IL1RAPL1;CFL1;ARHGAP44;SRCIN1;HOMER1;PPFIA2;TANC2;SHANK3;ABHD17B;ABHD17C;ZDHHC15
prerank,in utero embryonic development (GO:0001701),0.5715609535139299,1.4504112641234073,0.06812339331619537,0.5945021756353823,1.0,4/25,6.44%,EGFL8;CHD7;FGFR2;WNT7B
prerank,"phototransduction, visible light (GO:0007603)",0.6413708918785742,1.4501444321884638,0.06767955801104972,0.5934481049428815,1.0,1/14,0.46%,CNGB1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.4598227179814304,1.449740569766921,0.009146341463414634,0.592862097478903,1.0,42/175,15.89%,STAT1;EDAR;PSMB10;CCL7;TNFSF9;HYAL1;AIM2;PSME2;BIRC2;ZFP36;TNFRSF8;PSMA5;GBP3;CD40;PSME4;GBP2;CRHBP;CCL5;TXNDC17;CX3CL1;PSMA3;DHX9;TNFRSF17;PSMB9;TRAF3;COMMD7;CIB1;ZC3H12A;ZFP36L1;PSMD2;CCL14;TRAF5;TNFSF8;PSME3;LIMS1;ST18;BIRC3;JAK2;PSMA4;INPP5K;ADAMTS12;CD27
prerank,lipid droplet formation (GO:0140042),0.6796474532047629,1.4495137812737617,0.06723891273247497,0.5915587746018431,1.0,2/10,2.72%,AUP1;CDS1
prerank,cellular response to gamma radiation (GO:0071480),-0.4904998720507916,-1.4490737652549754,0.0627177700348432,0.7748481331567972,1.0,7/17,22.40%,MAP3K20;XRCC5;KDM1A;TP53;HRAS;YAP1;CRYAB
prerank,determination of bilateral symmetry (GO:0009855),0.5629158391033239,1.4488848467820028,0.0707070707070707,0.5920419954030125,1.0,4/24,6.82%,PITX2;ODAD2;NPHP3;KIF3B
prerank,regulation of monocyte chemotaxis (GO:0090025),0.5748084483915316,1.4486251612300467,0.062095730918499355,0.5909524776906526,1.0,6/24,16.08%,CXCL10;CCL5;LYN;HMGB1;CXCL17;AIF1
prerank,protein homooligomerization (GO:0051260),0.4791409268860829,1.4486185893423895,0.011375387797311272,0.5887535068016817,1.0,20/114,11.63%,RNF213;SAMHD1;SYCP1;GBP5;PNPT1;TRPM2;B2M;ATL1;MLKL;SOD2;AQP11;RBMX;AQP4;TRMT61B;TK1;RS1;G3BP2;ALDH1A2;HPRT1;POLQ
prerank,negative regulation of myoblast differentiation (GO:0045662),0.6507915243317632,1.4471994304007254,0.07488986784140969,0.5927514579616125,1.0,4/13,5.43%,EID2B;PRICKLE1;SOX9;SRA1
prerank,regulation of interferon-gamma production (GO:0032649),0.4904578724386065,1.447100631618578,0.025527192008879023,0.5910193979920555,1.0,12/71,12.11%,AXL;CD274;ISG15;CD47;TLR8;IL27;CD276;IL12RB2;HMGB1;PRNP;ZC3H12A;HAVCR2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.4714600523796037,1.4466588525473028,0.011351909184726523,0.5907750344929252,1.0,24/121,16.37%,PARP14;PARP9;IL15;AGT;CRLF1;SEMA4D;CD40;ACVR1;STAT3;CCL5;EPHA4;DOK7;CSPG4;LYN;FCGR1A;PRNP;PTPN11;NRP1;JAK2;PIBF1;FGFR3;IL18;LRP8;ARL2BP
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.5439370937056982,-1.4461632858553537,0.07540983606557378,0.7751982633889426,1.0,7/12,34.89%,SIRT1;MIF;KDM1A;ING2;TAF9;TAF9B;TRIAP1
prerank,positive regulation of protein deacetylation (GO:0090312),-0.5253191491806658,-1.4459822196360355,0.06690140845070422,0.7642873075524026,1.0,5/14,15.54%,DYRK1A;NIPBL;SAP30BP;ZBTB7B;ING2
prerank,protein import (GO:0017038),0.4846535025703574,1.4459221216455072,0.02145922746781116,0.5918084032419156,1.0,29/84,17.51%,CLU;FIS1;RANBP6;RAB8B;SNX33;STAT3;LAMP2;NUP153;KPNB1;CSE1L;PRICKLE1;GDAP1;NXT1;RPAIN;ABCD1;PEX2;PPP1R10;SAMM50;HSPA4;IPO8;APOE;TNPO2;NUP155;HSP90AA1;RANBP17;PEX5;PEX13;ATAD1;NUP88
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5198761439033328,1.4450521240818937,0.03819444444444445,0.593397482446699,1.0,5/48,5.48%,CXCL10;CXCL9;CAMK2D;THY1;CX3CL1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.5580588278609202,-1.4443071473855253,0.07142857142857142,0.7598525048901645,1.0,7/11,34.89%,SIRT1;MIF;KDM1A;ING2;TAF9;TAF9B;TRIAP1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.48369708766704955,1.4419682900610518,0.03440621531631521,0.6049078031607665,1.0,19/68,17.70%,IFIH1;NOD2;WNT5A;STAT3;TLR8;DHX9;TMEM106A;APP;HMGB1;SPHK2;IL17D;XBP1;PTPN11;MYD88;TLR2;AIF1;LGALS9;TLR3;POU2F2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5714086712751,1.441279180007133,0.06140350877192982,0.6056536281098933,1.0,6/24,8.47%,TMEM161A;CLU;SFRP2;CDKN2D;SNAI2;ACKR3
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.31466968549963825,-1.4410837359285245,0.0,0.7620998854244829,1.0,33/91,18.72%,TRAM1;RPS12;RPL13;RPS14;RPS28;RPL10;RPL23;RPL17;RPS26;RPLP0;RPL9;RPS17;RPL8;RPL21;SSR1;RPL31;RPL36A;SEC61A1;RPLP2;RPL7;RPL39;RPS9;RPS18;RPL37;RPL13A;SIL1;SRP19;UBA52;RPS25;RPS27A;RPL18;RPL38;RPL34
prerank,protein targeting to lysosome (GO:0006622),0.5808594277729273,1.440998732050617,0.0728744939271255,0.6046895122021276,1.0,8/20,15.27%,CLU;LAMP2;GNPTAB;GGA3;NAGPA;HSPA8;SORL1;HGS
prerank,positive regulation of heart contraction (GO:0045823),-0.47854399440097267,-1.4406894789899434,0.08745247148288973,0.7526655949354207,1.0,14/19,49.39%,ATP2A2;TGFB2;TRPM4;SCN3B;CHGA;RYR2;KCNQ1;ATP1A2;APLN;ADM;EDN3;EDN2;NPPA;EDN1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.5071726987530161,1.4383230222873653,0.05304740406320542,0.6142691645508824,1.0,12/50,13.32%,HSPA1B;ISG15;DTX3L;SPRY2;PER2;UBXN1;CAMLG;N4BP1;ARRB2;PRR7;VPS28;HDAC8
prerank,regulation of tau-protein kinase activity (GO:1902947),0.6797206000540571,1.4380481448281144,0.07503828483920368,0.6132043998064834,1.0,5/10,14.86%,CLU;HSP90AB1;SORL1;RB1;HSP90AA1
prerank,gene silencing by miRNA (GO:0035195),0.5420878747067074,1.4376617084466266,0.06403940886699508,0.6127818528064893,1.0,12/32,17.16%,MOV10;ZFP36;ZC3H7A;ADAR;AGO2;TARBP2;CNOT7;NOTCH4;EIF6;ZC3H7B;DICER1;PRKRA
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.6370098184717395,1.437361179527271,0.06657018813314038,0.6119360303026115,1.0,4/13,9.04%,SP100;NUP153;MDFIC;BARD1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4656406944268726,1.4372441339323214,0.018691588785046728,0.6102034975277646,1.0,26/114,14.39%,STAT1;EDAR;PSMB10;TNFSF9;AIM2;PSME2;BIRC2;TNFRSF8;PSMA5;CD40;PSME4;TXNDC17;PSMA3;TNFRSF17;PSMB9;TRAF3;COMMD7;PSMD2;TRAF5;TNFSF8;PSME3;LIMS1;ST18;BIRC3;JAK2;PSMA4
prerank,regulation of phosphorylation (GO:0042325),0.46701283509147495,1.437198472622896,0.011235955056179775,0.6082609437275521,1.0,38/120,19.62%,STAT2;NLRC5;PML;NUP37;PLXNB2;SOCS1;ANKLE2;MCM7;SLC2A6;CCL5;NUP153;NOP53;CDKN2D;KDM4D;RAE1;CCDC88A;LYN;BARD1;APP;PRKAG1;PHIP;EIF6;STAP1;LDB2;LDB1;PSEN1;DYNLL1;NRP1;NUP155;DSCAM;NDUFS4;PTGES3;NUP88;CORO1C;FNIP2;TESK1;PIN1;NUP133
prerank,regulation of angiogenesis (GO:0045765),0.45538730299339847,1.4362497178162195,0.0020304568527918783,0.6102424686136301,1.0,29/192,11.45%,STAT1;CXCL10;SP100;PML;FLT1;HYAL1;WNT5A;SPRY2;KDR;PIK3CD;AGO2;CD40;MECP2;SASH1;SFRP2;RUNX1;COL4A2;YJEFN3;CTNNB1;RHOJ;MYDGF;ITGB8;HTATIP2;CTSH;SMOC2;BMPER;ZC3H12A;VEGFD;XBP1
prerank,lysine metabolic process (GO:0006553),0.6579313874366912,1.435973574811025,0.09261939218523878,0.6070548375799246,1.0,6/12,15.55%,HYKK;ALDH7A1;DLD;AASS;GCDH;PIPOX
prerank,lysine catabolic process (GO:0006554),0.6579313874366912,1.435973574811025,0.09261939218523878,0.6070548375799246,1.0,6/12,15.55%,HYKK;ALDH7A1;DLD;AASS;GCDH;PIPOX
prerank,regulation of endothelial cell proliferation (GO:0001936),0.47097452404384166,1.4359046648743492,0.031149301825993556,0.6051754861268148,1.0,26/88,23.82%,STAT1;XDH;WNT5A;KDR;PIK3CD;CDH13;NRP2;PLXNB3;MYDGF;EGFL7;BMPR2;PROX1;VEGFD;APOE;NRP1;AGGF1;NF1;ACVRL1;SPARC;F3;AKT3;FGF2;STAT5A;VASH1;PTPRM;ANG
prerank,insulin secretion (GO:0030073),0.5988877083270598,1.4357546132769763,0.06561679790026247,0.6037075470806017,1.0,4/19,8.15%,CLTRN;GAL;RAB11B;SNX19
prerank,lipid homeostasis (GO:0055088),0.4983038204433954,1.4354416008274402,0.037527593818984545,0.602945206560603,1.0,21/57,21.55%,ACOXL;ABCA1;USF2;ABCG1;PNPLA2;TLCD2;FBXW7;USF1;ABHD8;ABCD1;THADA;XBP1;APOE;IRS2;ACOX1;PNPLA3;NR1D2;DDX3X;ZBTB20;ADCK1;PNPLA8
prerank,regulation of vasoconstriction (GO:0019229),0.5529326333403441,1.434295421519705,0.07134220072551391,0.6059081977756605,1.0,4/27,9.53%,AGT;PER2;ZDHHC21;BMPR2
prerank,DNA double-strand break processing (GO:0000729),-0.4772312775325884,-1.4337761717155537,0.08171206225680934,0.768902876558433,1.0,10/18,24.24%,NBN;UBE2V2;EXD2;SLX4;DNA2;BRCA1;RNF138;SETMAR;MRE11;RAD50
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.6504978290754537,1.4334437104978268,0.08163265306122448,0.6075184271838328,1.0,2/12,5.41%,NOD2;SOX9
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.4071130995254932,-1.432968289899704,0.05188679245283019,0.7616886060395706,1.0,12/32,17.31%,APOD;RCC2;CLASP2;DMTN;JAG1;SRC;SEMA3E;NEXMIF;ACER2;HOXA7;MAP4K4;ITGB1BP1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.48576587767759416,1.4323032651362402,0.037694013303769404,0.6102191925638812,1.0,15/69,12.34%,CRLF1;MSH2;UNC5B;BDNF;SOD2;ADAM8;CX3CL1;MT3;NRBP2;AGAP2;NONO;GDNF;MAG;PPARGC1A;APOE
prerank,sterol transport (GO:0015918),0.5969876743468829,1.4322338958148395,0.07060333761232349,0.6084440062770616,1.0,8/19,20.82%,LDLRAP1;STARD3;NPC1;NPC2;OSBP;LDLR;OSBPL2;MSR1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.48993116323199287,-1.432029518908611,0.06007067137809187,0.7553577078438672,1.0,5/16,7.56%,GPR137C;GPR137B;RRAGD;RRAGB;LARS1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5504315006906855,1.4309263564145251,0.05520702634880803,0.6119651813476206,1.0,5/30,3.58%,PARP14;SOCS1;SEMA4D;THY1;SFRP2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4868489750992763,1.430879616486325,0.029347826086956522,0.6100689083698403,1.0,17/72,14.63%,PIK3AP1;AGT;FLT1;UNC5B;KDR;PIK3CD;SEMA4D;CCL5;SOX9;MYDGF;MYOC;LYN;INSR;ROR2;PIK3CB;JAK2;IRS2
prerank,RNA splicing (GO:0008380),0.470319567714659,1.4299750101431854,0.02127659574468085,0.612076228318918,1.0,35/95,17.94%,NOL3;TARDBP;MAGOHB;TXNL4A;PRPF18;NCBP2;RRAGC;CDK12;NONO;BCAS2;RNPC3;SRPK1;RSRC1;WDR83;RNPS1;HNRNPH3;PPARGC1A;USP39;SNRPD2;SNRPD1;DBR1;DDX39B;SNRPG;NCBP1;DHX16;GEMIN2;SRSF7;SF3B4;NRDE2;SRSF4;DDX47;SNRNP48;DDX23;SLU7;SCNM1
prerank,negative regulation of viral transcription (GO:0032897),0.6308981820249998,1.429790103856929,0.08603667136812412,0.61078348440334,1.0,4/13,7.01%,TRIM14;ZFP36;TRIM21;UBP1
prerank,T cell migration (GO:0072678),0.6326476306653638,1.42861390057527,0.09728183118741059,0.6138165944083913,1.0,3/13,2.73%,CXCL10;PIK3CD;CXCL16
prerank,cellular response to UV-A (GO:0071492),-0.5565375803474812,-1.4283263837440747,0.09615384615384616,0.7604497143389575,1.0,7/11,36.28%,MMP1;CERS1;MMP2;OPN3;PPID;MME;TIMP1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4548091808644307,1.4269784941540784,0.005112474437627812,0.6189058136866781,1.0,39/149,16.97%,EIF2AK2;HSPA1B;TRIM14;AGT;NOD2;NOD1;AIM2;WNT5A;CLU;TRIM25;DDRGK1;DHX33;CD40;NFKB2;STAT3;RBCK1;TRIM21;ADAM8;RHEBL1;CX3CL1;CFLAR;NFKB1;DHX9;PPIA;RNF31;APP;CIB1;NPM1;RTKN2;TRAF5;RNF25;IL1RAP;PRKCH;MYD88;TLR2;IL18;IRAK1;LGALS9;FLOT2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.5446584854099953,1.4257377637351984,0.04945717732207479,0.6221447796378958,1.0,12/30,12.65%,DDRGK1;NOP53;HSP90AB1;UBXN1;TRIM39;CAMLG;N4BP1;UCHL5;WAC;RYBP;USP14;SVIP
prerank,positive regulation of dendrite development (GO:1900006),-0.5673915346217323,-1.4246273212074902,0.0935483870967742,0.7644737750811853,1.0,5/10,12.11%,COBL;ALK;DAB2IP;ZDHHC15;VLDLR
prerank,negative regulation of neuron death (GO:1901215),0.4757469283633996,1.424425265697807,0.022532188841201718,0.6258743037740648,1.0,19/93,12.34%,CHMP4A;CHMP4B;CRLF1;MSH2;UNC5B;BDNF;SOD2;FBXO7;ADAM8;NENF;MT3;NRBP2;CSF1;AGAP2;GDNF;MAG;SORL1;PPARGC1A;APOE
prerank,regulation of viral release from host cell (GO:1902186),0.5720378866949574,1.4243837030154574,0.06734434561626429,0.6239490335614534,1.0,8/21,22.16%,PML;TRIM25;TRIM21;CHMP3;TRIM26;TRIM62;TRIM13;TSG101
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.5316215132934276,1.4240974604760634,0.053738317757009345,0.6231715368141861,1.0,14/36,16.35%,DDRGK1;AQP11;USP25;NOP53;HSP90AB1;UBXN1;TRIM39;CAMLG;N4BP1;UCHL5;WAC;RYBP;RPL11;OPHN1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.6723703340783689,1.4228716652061275,0.08882521489971347,0.626450054755389,1.0,2/10,1.16%,MTHFR;DHFR
prerank,positive regulation of binding (GO:0051099),0.47057020089656293,1.422165572186726,0.04081632653061224,0.6273555701464051,1.0,40/84,27.24%,PARP9;DTX3L;TRIB3;B2M;TRIM21;KDM4D;CDT1;TCF7L2;EDF1;AMFR;DHX9;RAPGEF2;DACT1;BAMBI;MET;APP;HMGB1;MEN1;PSEN1;APOE;DDX11;SPPL3;NCBP1;RPL11;HMBOX1;STK3;PIN1;RIPK2;PLAUR;USP33;IDE;CAPRIN2;SIRT2;ADD2;NVL;LRP1;TXN;TIAM1;MED25;FKBP1A
prerank,regulation of presynapse assembly (GO:1905606),-0.4717023878088525,-1.4217097960510967,0.08741258741258741,0.7554978976379433,1.0,11/18,29.96%,IL1RAPL1;IL1RAPL2;LRFN5;SNCA;SLITRK1;GPC4;SLITRK3;SLITRK2;MDGA1;PTPRD;WNT7A
prerank,regulation of presynapse organization (GO:0099174),-0.4717023878088525,-1.4217097960510967,0.08741258741258741,0.7554978976379433,1.0,11/18,29.96%,IL1RAPL1;IL1RAPL2;LRFN5;SNCA;SLITRK1;GPC4;SLITRK3;SLITRK2;MDGA1;PTPRD;WNT7A
prerank,translesion synthesis (GO:0019985),0.5157376671796762,1.4199875951848446,0.05680473372781065,0.6347918017474351,1.0,9/42,5.34%,PARP10;ISG15;UBE2L6;TRIM25;POLD4;POLE2;MAD2L2;RFC4;RFC1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.4587415996143803,1.419245531013033,0.01131687242798354,0.6361198510541977,1.0,33/132,16.56%,IRGM;TRIM14;MOV10;ZC3HAV1;DTX3L;IRS1;PNPT1;PNPLA2;SNX33;TRIM21;ADAM8;CNOT7;SH3GLB1;VPS11;DACT1;ENTPD5;APP;HMGB1;INSR;ABCD1;ZSWIM8;SNX9;ZC3H12A;PSEN1;APOE;SVIP;PIK3CB;BAD;IRS2;HSP90AA1;TMEM59;PHKG2;UPF1
prerank,nucleoside salvage (GO:0043174),0.6646395262831697,1.4190641230281973,0.1031390134529148,0.6348706385321593,1.0,5/10,14.95%,DCK;TK1;TK2;HPRT1;UCKL1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.6135367709797549,1.4187660650458136,0.09557774607703282,0.6341547516888612,1.0,6/14,21.02%,CCL7;WNT5A;CCL5;OXSR1;STK39;CCL4
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.4933362805061939,1.4185375789729888,0.04669703872437358,0.6330803849792287,1.0,14/50,17.33%,EIF2AK2;NOD2;IFI35;NOD1;SASH1;NMI;APP;RTKN2;LIMS1;TLR2;CD27;IRAK1;LGALS9;TLR3
prerank,inflammatory response (GO:0006954),0.4497887006201883,1.4180818729488005,0.006091370558375634,0.632948885094226,1.0,34/195,12.86%,CXCL10;TPST1;CXCL9;SIGLEC1;CCL7;HYAL1;NOD1;CXCR4;PIK3CD;NFX1;CD40;STAT3;FPR3;ADAM8;CYBB;PTGER4;CRHBP;CCL5;TACR1;CX3CL1;TAC1;NFKB1;TMIGD3;PTGER3;HMGB1;TAC4;C3AR1;IL17D;CCL14;ABCF1;IL10RB;RELB;REL;FCGR2B
prerank,renal system development (GO:0072001),0.504580706852935,1.4180469329603405,0.06292134831460675,0.6310695270538283,1.0,7/52,10.64%,STAT1;AGT;GREB1L;TFAP2B;NPHP3;PROX1;IFT27
prerank,regulation of phosphate metabolic process (GO:0019220),0.5942277555053916,1.4172609593969725,0.09264305177111716,0.6323676799987609,1.0,6/16,12.26%,MCM7;SMG7;IGBP1;BARD1;SMG5;PSEN1
prerank,granulocyte chemotaxis (GO:0071621),0.49412590499429443,1.4171810011081416,0.0640279394644936,0.630673439456729,1.0,7/55,7.74%,CXCL10;CXCL9;CCL7;PIK3CD;CCL5;CX3CL1;PPIA
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.5206238326318067,1.4170480312466345,0.054245283018867926,0.6292765624699721,1.0,12/37,11.44%,PML;DDRGK1;NOP53;HSP90AB1;UBXN1;TRIM39;CAMLG;CSNK2A2;N4BP1;UCHL5;WAC;RYBP
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.5506839255130688,1.4159723653303173,0.07593307593307594,0.631915718582497,1.0,6/27,6.88%,AGT;NR1H2;ABCA1;ABCG1;NFKB1;CSF1
prerank,regulation of leukocyte migration (GO:0002685),-0.4846564461823738,-1.4159560659764316,0.08812260536398467,0.7685107596822635,1.0,6/16,18.54%,CD81;NCKAP1L;HMOX1;RAC2;HOXA7;ANXA1
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.66505019507403,1.4151635696823774,0.08454810495626822,0.6334825164798417,1.0,3/10,16.80%,CD274;PRNP;LGALS9
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.6332861785251392,1.415121666853111,0.07932011331444759,0.6316436386212375,1.0,4/13,4.80%,POLR2G;ZFP36;AGO2;CNOT7
prerank,midbody abscission (GO:0061952),0.6009829345363381,1.4136633787527255,0.07883817427385892,0.6359252585092477,1.0,3/17,1.51%,CHMP4A;CHMP4B;CHMP1B
prerank,RNA metabolic process (GO:0016070),0.4564030326285045,1.413333672035008,0.017580144777662874,0.6353354421770958,1.0,46/127,19.34%,APOBEC1;TP53RK;POLR2G;PNPT1;XRN2;ADAR;AGO2;HNRNPH1;RBMX;DHX36;RNASEH2A;NCBP2;NOL9;HNRNPK;RBMS2;DDX20;ALKBH1;HNRNPM;DHX9;HNRNPA2B1;RNASEH2C;POLR2K;HNRNPL;DDX24;ZC3H12A;HNRNPH3;HNRNPA1;DDX54;ATXN1;PAPOLA;RNASE1;DUSP11;DDX39B;RBM39;NCBP1;RNASEH2B;RBM3;LAGE3;DICER1;METTL14;HNRNPA3;TBRG4;RBPMS;FASTKD2;WTAP;HNRNPF
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.653791041552712,1.413090886887923,0.09050445103857567,0.6343924365355254,1.0,5/11,11.24%,ENPP3;SLC25A19;DCK;NT5C3A;TPK1
prerank,regulation of osteoblast proliferation (GO:0033688),0.5976387973148835,1.4110841616988756,0.09905020352781546,0.6412667615759879,1.0,4/17,13.46%,EIF2AK2;FGFR2;HPSE;NELL1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.64303840554836,1.410509455393467,0.10339943342776203,0.6417454805442362,1.0,4/12,11.23%,APOBEC1;RESF1;DNMT1;SETDB2
prerank,positive regulation of translational initiation (GO:0045948),0.5890319175613236,1.409053239635704,0.0849933598937583,0.6461886355897989,1.0,8/18,20.50%,POLR2G;YTHDF1;LARP1;CCL5;YTHDF2;MTOR;EIF2B5;DDX3X
prerank,regulation of chromatin binding (GO:0035561),0.6665045072811766,1.4086955599603548,0.08970588235294118,0.6457819687546921,1.0,7/10,20.12%,PARP9;DTX3L;KDM4D;CDT1;DDX11;HMBOX1;BTAF1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6333561862349452,1.4081594380339313,0.10248901903367497,0.6461272107519377,1.0,3/13,12.26%,PER2;MAD2L2;PSEN1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.43420975407284124,1.4078839555027673,0.0,0.6454566516975667,1.0,114/509,17.39%,DDX60;OASL;EIF2AK2;AXL;PIK3AP1;EDAR;WNT11;TNFSF10;TRIM14;AGT;NOD2;BST2;FLT1;UNC5B;DHX58;IFI35;NOD1;TRIB3;WNT5A;SPRY2;ALPK1;IRS1;KDR;TRIM25;BIRC2;MIOS;PIK3CD;FIS1;GPR37L1;DHX33;SEMA4D;CD40;CDH13;CANT1;KITLG;SASH1;CGAS;NMI;BCL2L11;TGFA;RBCK1;LRP2;TRIM21;ADAM8;USP15;CCL5;SIAH1;OSBPL8;IKBKE;DHX36;HSP90AB1;RRAGC;SOX9;CX3CL1;MYDGF;FGFR2;CFLAR;TCF7L2;GPR37;RET;TSPAN6;TMEM106A;MYOC;RAPGEF2;TMEM9B;MET;LYN;RNF31;P2RX4;APP;HMGB1;INSR;VAV1;ROR2;SPHK2;HPSE;ADGRV1;FGF9;RTKN2;TRAF5;IRAK4;NEK6;PTPN11;REL;LAMTOR3;MIER1;RACK1;PIK3CB;LIMS1;BAD;SHARPIN;AKAP13;BIRC3;RAC1;JAK2;FYN;SOX2;IRS2;TNIP2;MYD88;HSP90AA1;TLR2;BMF;CD27;FGFR3;IL18;IRAK1;MIB2;ZDHHC13;LGALS9;BAX;RUNDC3A;TLR3;PTPRC
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.453998749125606,1.4078319125762888,0.015384615384615385,0.6436900474907701,1.0,29/136,13.52%,SP100;NLRC5;PARP10;AIM2;PRMT2;RBCK1;TRIM21;MAD2L2;ID3;BHLHE40;TCF7L2;TMIGD3;CYLD;PRNP;MEN1;TRAF3;PROX1;ARRB2;COMMD7;BTRC;ZC3H12A;SIK1;PIM1;TAF3;HAVCR2;PAXIP1;RB1;MDFI;PTCH1
prerank,B cell mediated immunity (GO:0019724),0.6718076977351896,1.4075926899233757,0.1021671826625387,0.6426182389702187,1.0,4/10,15.89%,MSH2;TLR8;FCGR2B;CD27
prerank,positive regulation of T cell proliferation (GO:0042102),0.48955457940544805,1.407561808987427,0.05454545454545454,0.6407636184453751,1.0,10/55,10.56%,CD274;IL15;ICOSLG;TNFSF9;CCL5;CD276;NCK1;HMGB1;NCK2;CCDC88B
prerank,negative regulation of lipid storage (GO:0010888),0.5767359460402813,1.4070354921526667,0.08125819134993446,0.6410790901001518,1.0,5/19,4.72%,NR1H2;ABCA1;ABCG1;PNPLA2;OSBPL8
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.6068472885615137,1.4066077941271131,0.10504201680672269,0.6411606314241733,1.0,5/14,13.47%,KDR;PIK3CD;MYO1C;VEGFD;NRP1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6117125493897477,1.404962881458304,0.07894736842105263,0.6444112053706881,1.0,5/15,10.96%,ZFP36;AGO2;CNOT7;DHX36;ZFP36L1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6117125493897477,1.404962881458304,0.07894736842105263,0.6444112053706881,1.0,5/15,10.96%,ZFP36;AGO2;CNOT7;DHX36;ZFP36L1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.5870033770694261,-1.404709841484579,0.10714285714285714,0.8042640373665778,1.0,5/10,12.65%,EMC2;EMC3;EMC8;EMC9;MMGT1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.6343739829407035,1.4044228155792362,0.08615819209039548,0.6428451886294397,1.0,4/12,12.03%,MYOZ2;RCAN1;PRNP;DYRK2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.6343739829407035,1.4044228155792362,0.08615819209039548,0.6428451886294397,1.0,4/12,12.03%,MYOZ2;RCAN1;PRNP;DYRK2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.4467372195317569,1.4043254789396533,0.00708502024291498,0.6412603043313256,1.0,66/186,24.14%,RNF213;WNT11;PSMB10;WNT5A;PSME2;PSMA5;PSME4;GRB10;TMEM170B;SFRP2;MAD2L2;PRICKLE1;PFDN5;SOX9;PSMA3;TCF7L2;HMGXB4;NPHP3;SNAI2;AMFR;BICC1;CYLD;FRZB;PSMB9;DACT1;RBX1;DKK3;APCDD1;PSMD2;SCYL2;PSME3;APOE;MDFI;LZTS2;RACK1;CXXC4;DAB2;LMBR1L;PSMA4;SOX2;MLLT3;MCC;PTPRU;MDK;TPBG;HDAC1;PSMD7;PSMD8;STK3;PSMD9;PSMF1;WWOX;STK11;PSMB6;PSMC2;PSMD12;GLI3;RUVBL2;PSMD4;CUL3;LIMD1;CHD8;AXIN1;PSMA2;TLE5;KREMEN1
prerank,regulation of p38MAPK cascade (GO:1900744),0.5188488708135155,1.403910056226541,0.07946210268948656,0.641040032274506,1.0,15/35,21.15%,XDH;GADD45G;SASH1;CYLD;ZC3H12A;DUSP10;MAP3K4;DLG1;MINK1;PRMT1;LGALS9;RELL1;MFHAS1;PER1;GADD45A
prerank,megakaryocyte differentiation (GO:0030219),-0.5464850197958422,-1.4038846759753225,0.11041009463722397,0.7973825129824131,1.0,3/11,32.96%,UBA5;ZFPM1;TAL1
prerank,dicarboxylic acid transport (GO:0006835),0.5427898762929809,1.4035298135247354,0.08690176322418136,0.6408390065430971,1.0,7/28,9.05%,SLC25A22;ABCC2;SLC26A1;SLC46A1;SLC19A1;SLC25A10;PDPN
prerank,positive regulation of interleukin-8 production (GO:0032757),0.49207802639686427,1.40321765612968,0.059770114942528735,0.6402368296957062,1.0,11/49,17.33%,HSPA1B;NOD2;NOD1;STAT3;TLR8;HMGB1;IL17D;MYD88;TLR2;LGALS9;TLR3
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.5293877503999955,1.4031538784096493,0.07186358099878197,0.6386041307260671,1.0,10/33,18.56%,STAT1;HSPA1B;STAT3;BRD1;MAPK14;PRKDC;MTURN;PRMT1;ACVR2A;HOXA5
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5001475890105976,1.4027770663711248,0.04914285714285714,0.6382491186156586,1.0,15/52,12.58%,ZBTB17;ATP6V0D1;YIF1A;KLHDC3;SRPRA;HYOU1;GOSR2;MYDGF;CUL7;GFPT1;VAPB;XBP1;PDIA6;EXTL3;DDX11
prerank,positive regulation of cytokine production (GO:0001819),0.43642259585916554,1.4027270563386902,0.002008032128514056,0.636605283696557,1.0,49/292,12.41%,ZBP1;EIF2AK2;IRF7;IFIH1;HSPA1B;CD274;ISG15;IL15;AGT;NOD2;GBP5;DHX58;NOD1;WNT5A;PIK3CD;DHX33;CD40;NFKB2;STAT3;CGAS;RUNX1;PTGER4;DHX36;TLR8;CTNNB1;IL27;CD276;NFKB1;POLR3B;DHX9;TMEM106A;IL12RB2;POLR3GL;APP;HMGB1;POLR2K;MAPK14;RORA;SPHK2;TMED10;CCDC88B;HPSE;IL17D;XBP1;SORL1;HAVCR2;PTPN11;CXCL17;PRKDC
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.6583792611159969,1.4025416309050018,0.10371517027863777,0.6355454366356107,1.0,3/10,8.57%,PCGF5;MECP2;DNMT3A
prerank,positive regulation of histone deacetylation (GO:0031065),-0.5342475739803834,-1.4025235453566995,0.10616438356164383,0.7933653177839306,1.0,4/12,15.54%,NIPBL;SAP30BP;ZBTB7B;ING2
prerank,postreplication repair (GO:0006301),0.5079613114813544,1.4024199473530117,0.07134502923976609,0.6342744676419773,1.0,10/45,5.97%,PARP10;ISG15;MSH2;UBE2L6;TRIM25;POLD4;UBE2B;RFC4;RFC1;WDR33
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.4443901451112043,1.401893322461719,0.010141987829614604,0.6346799795646829,1.0,34/182,12.93%,PARP14;PARP10;PARP9;MOV10;APOBEC1;ABCC2;XDH;KDR;DDRGK1;AGO2;TARDBP;MECP2;RBL1;SFRP2;RUNX1;CNOT7;HSP90AB1;FBXW7;NFKB1;WDR54;PTRH2;ITGB8;APP;DNMT1;LRPAP1;ZC3H12A;SETDB2;MAP2K2;HAVCR2;PSEN1;REL;APOE;RB1;RACK1
prerank,nucleocytoplasmic transport (GO:0006913),0.5078032162116495,1.4015853928921758,0.0757396449704142,0.6340992014216467,1.0,16/40,15.68%,PHAX;NCBP2;LSG1;DDX20;NXT1;HTATIP2;NPM1;RSRC1;HNRNPA1;ATXN1;GEMIN7;SNRPD2;SNRPD1;SNRPG;NCBP1;GEMIN2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.548624299239185,1.401431718964446,0.0741687979539642,0.6328842333701924,1.0,8/24,12.34%,PSME2;UBE3A;EPHA4;CTSC;UCHL5;USP14;PSME3;APOE
prerank,negative regulation of catalytic activity (GO:0043086),0.5632405531993522,1.4011581006613594,0.07964601769911504,0.6321233200803824,1.0,4/24,8.06%,IFIT1;PARP9;MT3;CAND1
prerank,cellular response to ionizing radiation (GO:0071479),-0.3545842722310746,-1.400855804862733,0.04132231404958678,0.7903579471501585,1.0,18/47,20.05%,MAP3K20;XRCC5;INO80;NIPBL;RHNO1;SPIDR;SIRT1;EEF1D;HUS1;KDM1A;TP53;CDKN1A;HRAS;RAD1;YAP1;NET1;ECT2;RAD51AP1
prerank,regulation of nuclear division (GO:0051783),0.5664185644946806,1.4007792839287379,0.10610079575596817,0.631994885640318,1.0,4/20,6.27%,PKMYT1;DAPK3;PDXP;CUL7
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.5472604150730394,-1.4005152212702596,0.1023391812865497,0.7820867200752027,1.0,7/11,24.95%,EXOSC10;LARP7;EXOSC5;EXOSC3;TENT4B;FBL;PARN
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.6042467223750189,1.4002840253508262,0.10167130919220056,0.632308765884455,1.0,7/15,21.97%,AGT;NFKB1;CSF1;PRKCH;IL18;MSR1;MAPK9
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.5976771782010182,1.4002595483587208,0.09497206703910614,0.6306264962377458,1.0,2/16,1.74%,PARP14;SOCS1
prerank,response to cholesterol (GO:0070723),-0.4671444729843912,-1.399834664477718,0.08480565371024736,0.7754959522740331,1.0,8/17,11.37%,CCR5;TGFB1;GRAMD1A;LRP6;GRAMD1B;ABCA2;CCL3;PMVK
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.595110303984559,1.3995235478123074,0.0811554332874828,0.6319152968478607,1.0,4/17,5.68%,SASH1;CD55;CX3CL1;LY86
prerank,actin filament bundle organization (GO:0061572),-0.38816016230626693,-1.3993117574620482,0.057803468208092484,0.768558656694825,1.0,7/33,7.63%,ADD1;PLS3;CALD1;DPYSL3;MICAL1;EPS8;DMTN
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.6263974017472889,1.3986923633657118,0.10230547550432277,0.6336345562613995,1.0,3/12,1.79%,NR1H2;ABCA1;ABCG1
prerank,negative regulation of cytokine production (GO:0001818),0.4444415377946931,1.398254858972689,0.013224821973550356,0.6336948256272774,1.0,39/163,20.30%,NLRC5;AXL;IFIH1;CD274;ISG15;SLAMF1;UBE2L6;ILRUN;DHX58;TRIM25;ZFP36;PTGER4;IKBKE;TLR8;CX3CL1;CYLD;N4BP1;HMGB1;PPP1R11;ABCD1;PRNP;ZC3H12A;HAVCR2;CHID1;FCGR2B;RAC1;CD84;PIBF1;NPTN;ACOD1;LGALS9;ANXA4;PTPRC;ASB1;PIN1;CD33;TYROBP;SIRPA;APPL2
prerank,positive regulation of neuron migration (GO:2001224),-0.5489387275490195,-1.3979190264864507,0.11267605633802817,0.7648854629762024,1.0,7/11,13.81%,NIPBL;SHTN1;KIF20B;SEMA6A;DAB2IP;NSMF;ARHGEF2
prerank,positive regulation of double-strand break repair (GO:2000781),0.5087176118366483,1.3974133451717448,0.07645631067961164,0.635504576967003,1.0,11/39,12.58%,PARP9;DTX3L;TIMELESS;ACTR2;MAD2L2;KDM4D;SLF2;ARID2;SHLD1;PRKDC;DDX11
prerank,response to organophosphorus (GO:0046683),0.6049211089956108,1.3962425919998576,0.08701657458563536,0.6386602872187727,1.0,1/16,0.06%,STAT1
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5120003094191143,1.3958714121589273,0.07701283547257877,0.6384823825419008,1.0,8/40,15.45%,GBP4;STAB2;GBP2;GBP7;RNASE7;PPP1R11;MYD88;TLR2
prerank,heterocycle biosynthetic process (GO:0018130),0.6213389713708477,1.3952246079676875,0.09167842031029619,0.6394424469706242,1.0,4/14,10.48%,MOCS3;NFS1;GCH1;MOCOS
prerank,gonad development (GO:0008406),0.5148602450099518,1.3951408263460812,0.07060185185185185,0.6380198420679966,1.0,6/41,5.41%,MSH2;WNT5A;TFAP2C;KITLG;LRP2;SOX9
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.5482730750095137,1.3951287152420864,0.08842652795838751,0.6362993848121904,1.0,8/23,21.13%,IFI35;NMI;CYLD;TSPAN6;ZC3H12A;UACA;DDX3X;ADIPOR1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.4182860174902675,-1.3946078178630197,0.05555555555555555,0.7686852681776424,1.0,17/25,29.76%,CACNG7;SHISA9;NLGN2;SHISA6;CACNG8;SHANK3;GSG1L;PRRT1;SHISA7;CACNG2;MEF2C;CACNG3;SHANK1;MAPK8IP2;CACNG5;ADRB2;SHISA8
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.5480395779305725,1.3936093034586075,0.08542713567839195,0.6410259937236971,1.0,6/27,8.49%,ETNK1;ETNK2;SLC27A1;PCYT2;LPIN2;CEPT1
prerank,mesonephric tubule development (GO:0072164),0.60170661758735,1.3935877398624887,0.09575923392612859,0.6393653324043946,1.0,2/15,5.98%,WNT11;FGFR2
prerank,error-free translesion synthesis (GO:0070987),-0.4418533166650158,-1.393475246039694,0.0794979079497908,0.7641680972100274,1.0,14/22,19.73%,RPA1;RFC2;POLH;UBB;RCHY1;NPLOC4;RFC3;UBC;UBA52;UFD1;RPS27A;RPA3;RFC5;POLD1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.4549253260233362,1.3915086281587148,0.035676810073452254,0.6465417569026459,1.0,27/104,15.27%,PKMYT1;IRGM;TRIB3;SLC27A1;CCNJ;THY1;SLC8A1;CCND2;CDKN2D;CCND1;CDK12;ETAA1;CCNT2;CAB39;CNPPD1;MTCP1;MNAT1;CIB1;MAP2K2;RB1;TELO2;CCNI;ACTB;SERTAD1;EZH2;CALM3;HGS
prerank,regulation of protein acetylation (GO:1901983),-0.5248079493780101,-1.3911731558841667,0.11501597444089456,0.7648498313554851,1.0,6/12,14.51%,TERF2IP;SIRT1;GSK3B;CAMK1;FAM161A;RAPGEF3
prerank,histone H2B ubiquitination (GO:0033523),0.6608116857672507,1.3911502797192898,0.11490683229813664,0.6463150008191705,1.0,4/10,9.77%,DTX3L;RNF40;UBE2E1;WAC
prerank,regulation of DNA metabolic process (GO:0051052),-0.3707439139117573,-1.3906146623757125,0.04827586206896552,0.7582892860562708,1.0,17/44,19.63%,XRCC5;MPV17;SIRT7;NBN;UBE2V2;KDM1B;POLH;TERF2IP;PARG;YLPM1;KPNA1;WDR18;THOC1;TOM1L1;KPNA2;MYC;RADX
prerank,epithelial cell migration (GO:0010631),0.5119727904435633,1.3894734513725693,0.09552599758162031,0.6516896188546883,1.0,4/37,3.98%,STAT1;LOXL2;CDH13;PKN2
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5615510632131938,1.388808774221086,0.08613728129205922,0.6527744104310099,1.0,7/22,16.88%,SOCS1;LAG3;RUNX1;BCL6;NFATC2;DUSP10;MDK
prerank,negative regulation of immune effector process (GO:0002698),0.6345377786678368,1.3872357234815136,0.10057471264367816,0.6574552321825877,1.0,5/13,15.41%,CD55;ENPP3;CD47;HAVCR2;CD300A
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.42554364545189194,-1.3859635155619223,0.07659574468085106,0.7670639151102228,1.0,12/24,21.82%,CDH2;CTNNA1;OLFM2;RBM4;CTNNA2;CDC42;CAMK1;BNIP2;BOC;ABL1;MEF2C;TCF3
prerank,regulation of translational initiation (GO:0006446),0.4797735495804054,1.385782307588509,0.05470459518599562,0.6619266155539044,1.0,24/63,20.50%,POLR2G;EIF4A2;AGO2;YTHDF1;LARP1;CCL5;NCBP2;EIF4EBP2;ALKBH1;YTHDF2;NCK1;EIF2B2;NCK2;EIF4H;NPM1;EIF4G3;EIF1B;NCBP1;EIF2B5;EIF4B;EIF5;CSDE1;GLE1;DDX3X
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.6321740455779283,1.3852494973887683,0.11731044349070101,0.6624218317824077,1.0,2/12,0.58%,CHMP4A;CHMP4B
prerank,eosinophil migration (GO:0072677),0.6047219541750951,1.3850170377181732,0.12573099415204678,0.6598793896821373,1.0,3/14,5.48%,CCL7;CCL5;CX3CL1
prerank,eosinophil chemotaxis (GO:0048245),0.6047219541750951,1.3850170377181732,0.12573099415204678,0.6598793896821373,1.0,3/14,5.48%,CCL7;CCL5;CX3CL1
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.5356289664219241,-1.38414491183966,0.14012738853503184,0.7653353105622936,1.0,6/11,20.43%,TGFB1;CASP8;ID2;RIPK1;PF4;IL34
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.45567636122994143,1.3840742891915498,0.042735042735042736,0.6620781240056002,1.0,24/93,15.92%,EIF2AK2;EDAR;NOD2;TAOK3;SLAMF1;XDH;GADD45G;SASH1;TRAF4;WNT7B;TPD52L1;APP;HMGB1;TRAF3;ZC3H12A;TRAF5;FCGR2B;MAP3K4;STK25;MINK1;TAOK2;MTURN;CD27;PRMT1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.4505174198047205,1.3833732500141338,0.049893842887473464,0.6633337294372967,1.0,24/92,17.24%,AGT;HYAL1;WNT5A;KDR;PIK3CD;NRP2;SASH1;SOX9;CTSH;BCAR1;SMOC2;BMPR2;PROX1;PPM1F;ZC3H12A;RIN2;PRKCE;PIK3CB;NRP1;RAC1;RREB1;RAB11A;MTOR;IQSEC1
prerank,regulation of extracellular matrix organization (GO:1903053),0.599432422338205,1.3832297096260016,0.09749303621169916,0.6621931551876467,1.0,8/15,23.22%,AGT;RUNX1;AEBP1;RB1;RIC1;ANGPTL7;DDR2;NOTCH1
prerank,positive regulation of vasculature development (GO:1904018),0.4604654637403033,1.381840864343169,0.027777777777777776,0.666400976737901,1.0,17/94,11.45%,FLT1;HYAL1;WNT5A;KDR;PIK3CD;AGO2;CD40;SASH1;SFRP2;RUNX1;MYDGF;ITGB8;CTSH;SMOC2;ZC3H12A;VEGFD;XBP1
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5011288116750274,1.3817394098495972,0.06973995271867613,0.6649763250277478,1.0,4/41,3.82%,CLTRN;KCNMB3;CTSS;ACTN2
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.5105398635897463,1.3811361403918325,0.0828258221680877,0.6657742425500804,1.0,13/38,17.43%,XDH;TRIB3;OTUD3;NOP53;PPP2R5C;MAGI2;ARRB2;CIB1;PLEKHA1;RACK1;PIK3CB;INPP5K;PHLDA3
prerank,stress granule assembly (GO:0034063),0.5656656228626232,1.380401389554628,0.11171662125340599,0.6670834569190613,1.0,9/20,23.99%,YTHDF1;DYNC1H1;YTHDF2;EIF2S1;OGFOD1;CSDE1;DDX3X;G3BP1;UBAP2L
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6297770002449079,1.3803234420948083,0.10044313146233383,0.6656550111079242,1.0,2/12,1.61%,RER1;GPAA1
prerank,regulation of fibroblast proliferation (GO:0048145),0.49055283737045813,1.3787849394249319,0.08505747126436781,0.6706031056956393,1.0,7/45,9.49%,PARP10;AGT;WNT5A;MORC3;CTNNB1;DHX9;PEX2
prerank,early endosome to late endosome transport (GO:0045022),0.5694615638212769,1.3762538079258695,0.09827357237715803,0.6800381297512891,1.0,12/20,26.19%,RILP;HOOK2;STX8;KIF16B;HOOK1;ANKRD27;HOOK3;WDR91;BECN1;EEA1;PTPN23;SNF8
prerank,nucleotide catabolic process (GO:0009166),0.59270107822841,1.375841878742804,0.11265646731571627,0.6800194189801635,1.0,2/16,1.39%,SAMHD1;XDH
prerank,regulation of ERAD pathway (GO:1904292),0.6358635590782568,1.3751535468825953,0.12797619047619047,0.6811158946076252,1.0,5/11,12.90%,AQP11;USP25;RNFT1;UBXN1;RNF185
prerank,lipoxygenase pathway (GO:0019372),-0.4908274921113477,-1.3744424893161196,0.08881578947368421,0.794260610131048,1.0,3/14,4.65%,HPGD;LTC4S;ALOX5AP
prerank,mesonephros development (GO:0001823),-0.5470438530004955,-1.3739037269717298,0.12962962962962962,0.7877400196672472,1.0,7/11,35.74%,FGF10;ZBTB16;PAX8;OSR1;BMP4;GATA3;BMP7
prerank,lamellipodium organization (GO:0097581),0.5249040031138289,1.3738029150173088,0.10850801479654747,0.6853301682748102,1.0,11/29,16.78%,CDH13;SPATA13;PARVB;CYFIP1;CARMIL1;ARHGEF7;CCDC88A;SPEF1;WHAMM;RAC1;SNX1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.43468151178031816,1.3732607070518228,0.022564102564102566,0.6858799543159361,1.0,32/150,16.22%,AXL;PIK3AP1;TRIB3;SPRY2;IRS1;PIK3CD;KITLG;TGFA;LRP2;ADAM8;OSBPL8;HSP90AB1;CX3CL1;MYDGF;FGFR2;TCF7L2;RET;MYOC;MET;P2RX4;INSR;VAV1;HPSE;FGF9;PTPN11;PIK3CB;RAC1;FYN;IRS2;HSP90AA1;FGFR3;IL18
prerank,negative regulation of viral life cycle (GO:1903901),0.5978221757108139,1.3729395229170132,0.1034965034965035,0.6855558996017601,1.0,5/15,12.02%,BST2;LY6E;PPIA;GSN;TRIM26
prerank,endothelial cell migration (GO:0043542),0.5104658477607141,1.3722055572690166,0.0876979293544458,0.6869996545955851,1.0,3/37,2.73%,STAT1;LOXL2;CDH13
prerank,embryonic eye morphogenesis (GO:0048048),0.6273243681114905,1.3707217857926077,0.12280701754385964,0.6915557214150222,1.0,3/11,7.88%,RARG;FBN1;MFAP5
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5661405731619892,1.3705023980098927,0.1121751025991792,0.6906978630471676,1.0,6/19,13.05%,XDH;SPRY2;ADAMTS3;MYO1C;SMOC2;PIK3CB
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6021728508478632,1.3699292274335062,0.11127167630057803,0.6914622910047675,1.0,9/13,28.75%,SIRT6;HMGB1;MDK;ITGA4;AKT3;FGF2;PDPK1;PLCG1;SP1
prerank,regulation of microtubule nucleation (GO:0010968),0.6449076065168029,1.3694351981412416,0.1111111111111111,0.6920343079577094,1.0,4/10,10.43%,HSPA1B;MECP2;ARHGEF7;GIT1
prerank,regulation of axon guidance (GO:1902667),0.645700843596218,1.3687724091410507,0.13757396449704143,0.6932266160785433,1.0,5/10,15.04%,TUBB2B;YTHDF1;ZSWIM8;NRP1;MYCBP2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.5145965126904335,1.368567165763052,0.08971291866028708,0.6923090423237482,1.0,11/35,14.25%,CLU;B2M;RAB21;HNRNPK;MKLN1;LDLRAP1;LRPAP1;PIK3CB;RAC1;SMAP1;SNAP91
prerank,protein methylation (GO:0006479),0.4926488979027865,1.3683397849848793,0.07639680729760548,0.6914832638098912,1.0,14/40,17.43%,PRMT2;METTL21A;GSPT1;NTMT1;NSD3;SETD3;EEF2KMT;CAMKMT;FAM98B;EZH2;ETF1;PRMT1;PRMT3;ATPSCKMT
prerank,blood circulation (GO:0008015),0.48379126250025756,1.368253679587838,0.07441860465116279,0.6900662214270282,1.0,5/49,10.19%,STAT1;CXCL10;TBC1D8;CYB5R3;C3AR1
prerank,positive regulation of inflammatory response (GO:0050729),0.45838294701221116,1.3674868241167797,0.042598509052183174,0.6916312453205856,1.0,14/86,11.17%,ZBP1;IL15;AGT;IFI35;WNT5A;NMI;ADAM8;CD47;PTGER4;CX3CL1;DHX9;APP;TNIP1;ABCC1
prerank,hyaluronan catabolic process (GO:0030214),0.5672242470757719,1.3667216888861746,0.12116991643454039,0.6930917220861894,1.0,4/18,2.88%,SPAM1;HYAL1;STAB2;HYAL4
prerank,cholesterol transport (GO:0030301),0.49661048264999,1.3659506982377019,0.06825938566552901,0.6945777944556358,1.0,16/45,22.58%,ABCA1;ABCG1;CLU;LIPC;LDLRAP1;STARD3;APOE;NPC1;NPC2;SOAT2;OSBP;SOAT1;LDLR;OSBPL2;MSR1;ABCA5
prerank,cellular response to lipid (GO:0071396),0.4314377372671808,1.3658904773651306,0.010183299389002037,0.6931469955923023,1.0,39/191,16.67%,CXCL10;AXL;CD274;CXCL9;WNT11;IRGM;NOD2;WNT5A;IRS1;ZFP36;CRHBP;BRINP3;ADCY5;SOX9;NFKB1;WNT7B;RET;LTK;LYN;HMGB1;MAPK14;RORA;SPHK2;GIT1;ZC3H12A;SNW1;XBP1;STAP1;NR3C1;LCOR;UBE2L3;ZNF35;TNIP2;MYD88;ADNP2;TNIP3;IRAK1;UPF1;ACOD1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5054878633533227,1.3657557753279657,0.10072815533980582,0.6920564943788763,1.0,9/35,12.51%,ESR2;DAXX;DDX5;EGLN2;PMEPA1;UBE3A;ARID1A;NR3C1;DDX54
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.4760034688341978,-1.3656596903863307,0.10862619808306709,0.802658607071531,1.0,8/16,25.10%,APOD;RCC2;CLASP2;DMTN;SRC;ITGB1BP1;DUSP22;ARHGAP6
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.4760034688341978,-1.3656596903863307,0.10862619808306709,0.802658607071531,1.0,8/16,25.10%,APOD;RCC2;CLASP2;DMTN;SRC;ITGB1BP1;DUSP22;ARHGAP6
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.5042399416590273,-1.3654220589204675,0.11221122112211221,0.7952605759615349,1.0,6/13,18.35%,DYRK1A;PTTG1IP;SIRT1;MIF;KDM1A;PSMD10
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.6124366338451523,1.365304261038729,0.11299435028248588,0.6922552408007888,1.0,5/12,19.13%,IRGM;FYCO1;INSR;JMJD4;UVRAG
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.48508724791116375,1.365283857119356,0.07568807339449542,0.690589886762051,1.0,13/47,14.47%,TRIB3;SLC27A1;ACADL;FBXW7;NFKB1;SNAI2;RAPGEF2;PROX1;ZC3H12A;SIK1;CLK2;FYN;ERLIN2
prerank,positive regulation of peptidase activity (GO:0010952),0.5497699202355972,1.3651439484604968,0.12384716732542819,0.6894663321286582,1.0,12/20,27.53%,PSME2;DDRGK1;CTSH;PSME3;APH1A;APH1B;TANK;VCP;PSENEN;GRN;VSIR;PRELID1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.47870461140757914,1.3632340608617208,0.0834272829763247,0.6959461031167294,1.0,13/54,13.32%,HSPA1B;ISG15;SPRY2;PER2;TRIM21;CTNNB1;UBXN1;CAMLG;N4BP1;ARRB2;PRR7;VPS28;HDAC8
prerank,lipid droplet organization (GO:0034389),0.5510872043762423,1.3624822269328096,0.10935441370223979,0.6974989693336844,1.0,7/22,24.22%,AUP1;CDS1;PPIA;FAF2;PNPLA3;ZFYVE1;BSCL2
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.40268658464615953,-1.3616221172394063,0.07655502392344497,0.8005063591002042,1.0,11/26,22.22%,GPR137B;MAFB;RARA;PTPN2;CCL3;TMEM178A;CEACAM1;HOXA7;MYC;ZFPM1;INHBA
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.45094256580274805,1.361195459202741,0.05177993527508091,0.7012691761452043,1.0,12/88,6.29%,IGF2BP1;EIF2AK2;TM4SF20;DAPK3;DHFR;RGP1;IGF2BP3;LARP1;CNOT7;ILF3;DHX36;NFKB1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.58540711450897,1.361074816646291,0.10857142857142857,0.7000485121597531,1.0,11/15,34.14%,MET;SMOC2;P2RX4;FGF2;NOTCH1;SEMA5A;PRKD1;FGF1;LGMN;PRKD2;TMSB4X
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.44073402713497206,1.3610321231642892,0.03225806451612903,0.6984998958354398,1.0,24/113,14.88%,NOD2;HYAL1;WNT5A;KDR;PIK3CD;CDH13;NRP2;TGFA;LAMC1;PLXNB3;SOX9;MYDGF;FGFR2;TCF7L2;EGFL7;BMPR2;PROX1;VEGFD;FGF9;XBP1;BAD;NRP1;RREB1;AGGF1
prerank,regulation of stem cell proliferation (GO:0072091),0.5747605653174989,1.360885472696978,0.12121212121212122,0.6974746470917121,1.0,1/17,0.13%,EIF2AK2
prerank,regulation of cellular component biogenesis (GO:0044087),0.4985157407609759,1.3601234274959646,0.09079754601226994,0.6990810490960843,1.0,10/39,14.86%,PARP10;IRGM;AGT;VPS11;RAPGEF2;HSPA8;PTPN11;APOE;RAPGEF1;HSP90AA1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.6026931260458149,1.3593928215926625,0.13675213675213677,0.7004512182569681,1.0,3/13,3.32%,NR1H2;CLU;AQP11
prerank,natural killer cell activation (GO:0030101),0.5408323215809999,1.3584258545537193,0.10154241645244216,0.7031277339814057,1.0,4/23,9.29%,AXL;PIK3CD;IL21R;ELF4
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.49203892602684207,1.358099181347035,0.10781990521327015,0.7028783073343241,1.0,17/41,25.43%,THY1;CD47;CCL5;CX3CL1;PODXL;MEGF10;PTPRU;MDK;LCK;PLAUR;CITED2;GCNT2;PIEZO1;JAK1;MAGI1;PTPN23;TNF
prerank,embryonic hemopoiesis (GO:0035162),0.6173127959555005,1.3579424843829624,0.13353115727002968,0.7019523853876408,1.0,3/12,5.60%,KDR;KITLG;KMT2A
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.523478493418808,1.3574480862719405,0.11508951406649616,0.7024925126819659,1.0,11/29,17.16%,ZC3H7A;ADAR;AGO2;TARBP2;SRRT;HNRNPA2B1;SMAD2;ZC3H7B;TUT7;DICER1;PRKRA
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5919366642117541,1.3574400617726075,0.1332378223495702,0.7008320610886785,1.0,3/14,3.82%,GAL;ATP1B3;ACTN2
prerank,positive regulation of protein binding (GO:0032092),0.4701621511746523,1.3572047165544792,0.07789232531500573,0.7000774944324867,1.0,27/56,27.24%,DTX3L;TRIB3;BDNF;B2M;TRIM21;TCF7L2;AMFR;RAPGEF2;DACT1;BAMBI;APP;MEN1;PSEN1;APOE;SPPL3;RPL11;STK3;PIN1;RIPK2;USP33;IDE;CAPRIN2;ADD2;NVL;LRP1;TIAM1;FKBP1A
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.5550205120987812,1.3567593155817912,0.10904255319148937,0.7003212682988603,1.0,6/19,12.03%,PML;MSH2;AEN;SNW1;DDIT4;DYRK2
prerank,mitotic cytokinetic process (GO:1902410),0.5614785361046639,1.3559252492340919,0.10591471801925723,0.7023943798327558,1.0,3/20,1.51%,CHMP4A;CHMP4B;CHMP1B
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5511483858075368,1.355254007392379,0.11711711711711711,0.7035517167494257,1.0,8/21,14.60%,AIM2;BIRC2;USP50;MT3;PSMB9;BIRC3;FYN;SOX2
prerank,negative regulation of epithelial cell migration (GO:0010633),0.50604257487836,1.3543214791338845,0.09820359281437126,0.70591165010766,1.0,14/33,26.52%,SP100;EVL;APOE;DUSP10;MCC;CORO1C;SVBP;ACVRL1;ADIPOR1;VASH1;PTPRM;PTPN23;PFN2;PTEN
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.4782029467360029,1.3538314110106988,0.08873720136518772,0.7064237830291361,1.0,14/50,17.56%,PKMYT1;CCNJ;CCND2;HSP90AB1;CDKN2D;CCND1;CCNT2;CNPPD1;MNAT1;CCNI;ACTB;SERTAD1;CCNK;CDC37
prerank,regulation of protein kinase B signaling (GO:0051896),0.4241658724409003,1.3535840367774585,0.018218623481781375,0.7057382586155065,1.0,42/193,16.22%,AXL;PIK3AP1;XDH;TRIB3;SPRY2;IRS1;PIK3CD;KITLG;TGFA;LRP2;ADAM8;OTUD3;NOP53;OSBPL8;HSP90AB1;CX3CL1;PPP2R5C;MYDGF;FGFR2;TCF7L2;RET;MAGI2;MYOC;MET;P2RX4;INSR;VAV1;ARRB2;CIB1;HPSE;PLEKHA1;FGF9;PTPN11;RACK1;PIK3CB;RAC1;FYN;IRS2;HSP90AA1;INPP5K;FGFR3;IL18
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5607182309196443,1.3534357934160564,0.10863509749303621,0.7047370598925938,1.0,3/18,9.13%,ICOSLG;TNFSF9;HMGB1
prerank,neuron fate commitment (GO:0048663),-0.48176801954043535,-1.3523397568822308,0.11036789297658862,0.8296902980700106,1.0,9/14,44.56%,MYT1L;ID2;POU3F2;ISL1;SHH;PAX6;DLL4;EPOP;DLL1
prerank,regulation of feeding behavior (GO:0060259),0.6193190437583384,1.3522063296215245,0.1456752655538695,0.708468020682067,1.0,3/11,14.62%,STAT3;LEPR;CFAP20
prerank,central nervous system neuron development (GO:0021954),0.5869193246957429,1.3514675740930358,0.13661971830985917,0.7099949823679296,1.0,5/15,19.08%,HSP90AB1;RAPGEF2;B4GALT5;HSP90AA1;GBA2
prerank,release of cytochrome c from mitochondria (GO:0001836),0.5730673480408168,1.3508352944854591,0.1409028727770178,0.7110681090139334,1.0,6/17,17.12%,CLU;FIS1;SOD2;TIMM50;BAD;BAX
prerank,plasma membrane tubulation (GO:0097320),0.6112321627039616,1.350431394436184,0.12156295224312591,0.7112921493070091,1.0,5/13,13.43%,CHMP4A;SNX33;FNBP1L;SNX9;WHAMM
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.620309105695145,1.3497009207864996,0.13421828908554573,0.7127970647303642,1.0,3/12,8.76%,BST2;CSF1;LYN
prerank,regulation of chemokine production (GO:0032642),0.501594805189192,1.3491584078406957,0.11097560975609756,0.7134665770862388,1.0,9/36,17.33%,EIF2AK2;WNT5A;SNAI2;APP;TLR2;AIF1;IL18;LGALS9;TLR3
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.45627234239640435,1.3487636605731033,0.06702702702702702,0.713580447500689,1.0,28/73,21.78%,EIF2AK2;PSMB10;PSME2;PSMA5;KITLG;PSME4;RUNX1;DHX36;KMT2A;PSMA3;PSMB9;YTHDF2;LMO2;PSMD2;LDB1;PSME3;PRKDC;PSMA4;MYB;PUS7;METTL14;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.5028489953343831,1.3485544302103187,0.1055753262158956,0.7128225555268946,1.0,7/36,9.28%,WNT11;MOV10;WNT5A;AGO2;CTNNB1;TCF7L2;PLCB3
prerank,sterol homeostasis (GO:0055092),0.4664692223367561,1.3481666155542373,0.07932960893854749,0.7129024369104154,1.0,20/65,20.65%,NR1H2;ABCA1;ABCG1;LIPC;ABCD1;LDLRAP1;RORA;RALY;XBP1;EPHX2;APOE;NPC1;NPC2;IL18;SOAT2;SOAT1;MTTP;LDLR;TTC39B;CYP39A1
prerank,protein K11-linked ubiquitination (GO:0070979),0.516853348978294,1.3479098861208587,0.11323155216284987,0.7122891190263937,1.0,10/27,12.63%,UBE2W;CDC26;RNF4;ANAPC5;UBE2B;ANAPC4;UBE2E3;CDC16;CDC27;UBE2L3
prerank,positive regulation of heart rate (GO:0010460),-0.46096329066176467,-1.3474669978853206,0.10486891385767791,0.8407508079908356,1.0,4/17,13.22%,ATP2A2;TPM1;TRPM4;SCN3B
prerank,regulation of mRNA metabolic process (GO:1903311),0.627893717191417,1.3474474694809229,0.1217008797653959,0.7127317150186157,1.0,5/11,15.32%,SRPK3;DHX9;SLTM;SRPK1;NCBP1
prerank,sphingoid metabolic process (GO:0046519),0.6124302600360799,1.3469182380132243,0.1339031339031339,0.713278725382733,1.0,3/12,9.98%,SGPP2;ASAH2;SPHK2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4512681342647529,1.346616619333752,0.06482465462274177,0.713026651284481,1.0,21/85,15.90%,NOD2;HYAL1;ZFP36;B2M;SGPP2;TGFA;AQP11;SFRP2;LAMC1;SOX9;FGFR2;TCF7L2;PEX2;ZFP36L1;FGF9;PRKDC;DUSP10;LIMS1;BAD;SOX2;MCC
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5347889126904938,1.3461615356571452,0.12109375,0.713261793381766,1.0,10/24,19.18%,KDR;THY1;DUSP3;MYOC;PPM1F;LIMS1;NRP1;RAC1;IQSEC1;TSC1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.5748491557238696,1.3459855129325697,0.11659807956104253,0.7124271358701615,1.0,6/16,16.98%,ESR2;DDX5;EGLN2;ARID1A;DDX54;TRIP4
prerank,epidermal cell differentiation (GO:0009913),0.4927950708677721,1.345213343519284,0.10324825986078887,0.714118680503522,1.0,5/41,6.59%,PITX2;CLIC4;WNT5A;CTNNB1;PIP5K1A
prerank,protein targeting to peroxisome (GO:0006625),0.5143259309024035,1.3451985626347904,0.11220715166461159,0.7125674858252318,1.0,10/29,17.40%,FIS1;RAB8B;PEX7;LONP2;GDAP1;ABCD1;PEX2;PEX5;PEX13;ATAD1
prerank,mRNA catabolic process (GO:0006402),0.48577086666161395,1.3441476428781234,0.0869047619047619,0.7155361599714716,1.0,20/44,24.00%,HSPA1B;PNPT1;ZFP36;XRN2;DDX5;XRN1;DCP2;YTHDF2;DIS3L2;EXOSC9;NUDT16;TUT7;UPF1;LSM5;ERN1;EXOSC4;AGO4;RNH1;ZFP36L2;PDE12
prerank,response to cAMP (GO:0051591),0.4945514282349819,1.3423607934082726,0.10978520286396182,0.7214703191032545,1.0,8/37,16.24%,STAT1;CRHBP;RAPGEF2;ZFP36L1;AKAP9;RAPGEF1;INPP5K;NDUFS4
prerank,relaxation of muscle (GO:0090075),0.5867986733937461,1.3421904211897793,0.1452513966480447,0.7205197325469563,1.0,5/13,16.74%,CAMK2D;SLC8A1;P2RX4;GSN;KCNJ2
prerank,cellular response to interleukin-1 (GO:0071347),0.42822269007614966,1.3420756057230174,0.03494347379239465,0.7194306038919146,1.0,50/143,21.78%,NOD2;PSMB10;CCL7;HYAL1;NOD1;SKP1;PSME2;PSMA5;GBP3;CD40;PSME4;MAP3K8;GBP2;CD47;RBMX;CCL5;SOX9;CX3CL1;PSMA3;NFKB1;PSMB9;RBX1;BTRC;ZC3H12A;PSMD2;CCL14;IRAK4;PSME3;ST18;PSMA4;IL1RAP;TNIP2;MYD88;ADAMTS12;IRAK1;UPF1;ACOD1;PSMD7;UBE2V1;PSMD8;PSMD9;TAB3;TANK;RIPK2;SIRPA;PSMF1;CCL4;PSMB6;PSMC2;PSMD12
prerank,positive regulation of DNA metabolic process (GO:0051054),0.4631578143278348,1.34104121230431,0.08156424581005586,0.7223435031825777,1.0,12/61,9.62%,PML;EYA4;TMEM161A;MECP2;APLF;DHX36;RTEL1;DHX9;SIRT6;SMOC2;HMGB1;PPP1R10
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5083376876456218,1.3408317326999326,0.13059701492537312,0.7215779237991218,1.0,6/29,16.80%,CXCL10;CCL5;HMGB1;CXCL17;AIF1;LGALS9
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.6287802899881768,1.3408088131155953,0.14912280701754385,0.7200748855852388,1.0,4/11,12.90%,AUP1;RNF5;POMT2;RNF185
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.584233599859143,1.340703300032298,0.13783783783783785,0.7189425723142782,1.0,5/15,12.63%,ZFP36;BCL2L11;ZFP36L1;NR3C1;UBE2L3
prerank,coenzyme A biosynthetic process (GO:0015937),0.6118994226224755,1.3401258853366782,0.13464235624123422,0.7165623422557259,1.0,6/11,22.32%,PPCS;SLC25A16;PANK2;ACAT1;DCAKD;PPCDC
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.6118994226224755,1.3401258853366782,0.13464235624123422,0.7165623422557259,1.0,6/11,22.32%,PPCS;SLC25A16;PANK2;ACAT1;DCAKD;PPCDC
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.6118994226224755,1.3401258853366782,0.13464235624123422,0.7165623422557259,1.0,6/11,22.32%,PPCS;SLC25A16;PANK2;ACAT1;DCAKD;PPCDC
prerank,regulation of monocyte differentiation (GO:0045655),0.5791814997209078,1.3400209604765732,0.1320754716981132,0.7154434060490784,1.0,3/14,10.96%,IRF7;CSF1;ZFP36L1
prerank,negative regulation of angiogenesis (GO:0016525),0.437624522877045,1.338931006783254,0.07537154989384288,0.7187068750955756,1.0,8/84,5.47%,STAT1;CXCL10;PML;SPRY2;MECP2;COL4A2;YJEFN3;CTNNB1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5921385704410909,1.3373292309033935,0.1478770131771596,0.7240555795618445,1.0,5/13,12.93%,DDRGK1;BFAR;ATF6B;NCK1;RACK1
prerank,muscle tissue development (GO:0060537),0.587269421149004,1.3371846297968495,0.12960235640648013,0.7230823911208324,1.0,4/13,18.18%,SRPK3;CSRP1;PTCH1;NF1
prerank,cellular response to cytokine stimulus (GO:0071345),0.4162334213439254,1.3368896882012626,0.001001001001001001,0.7226454655283072,1.0,91/416,16.80%,STAT1;STAT2;CXCL10;GBP4;AXL;IFIT1;IRGM;CRLF1;GBP5;CCL7;DAPK3;HYAL1;DOCK8;CXCR4;AIM2;WNT5A;SOCS1;PNPT1;PIK3CD;ZFP36;GBP3;CD40;STAT3;BCL2L11;ASAH2;PTPN18;GRB10;GBP2;CD47;HCK;CRHBP;RBMX;CCL5;JUNB;GBP7;SOX9;CX3CL1;CCND1;NFKB1;BCL6;CSF1;IL10RA;AQP4;DHX9;RO60;IL12RB2;LEPR;SOCS5;PTPN7;LDLRAP1;VAV1;HSPA8;RORA;CIB1;ZC3H12A;LRCH1;ZFP36L1;CCL14;XBP1;PIM1;IL10RB;IRAK4;SOS1;PTPN11;SOCS2;PIK3CB;RAPGEF1;NUMBL;SHMT1;STX4;JAK2;FYN;IFNAR2;IL1RAP;SOX2;HSP90AA1;INPP5K;CRK;TLR2;ADAMTS12;OXSR1;AIF1;IL18;LRP8;IRAK1;UPF1;PTPN9;STK39;ACOD1;CSK;LGALS9
prerank,regulation of myotube differentiation (GO:0010830),0.5156560859588094,1.336862191306655,0.11795543905635648,0.7211862629759024,1.0,11/24,23.49%,BDNF;MMP14;MAPK14;SIK1;XBP1;ATP11A;SMYD1;HDAC1;PIEZO1;NOTCH1;HDAC4
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.4390844289911846,-1.3361400215407229,0.0916030534351145,0.8797767971161263,1.0,8/20,20.14%,ITGAV;CASP3;GSK3B;CASP9;APPL1;DCC;BAK1;FAS
prerank,regulation of programmed cell death (GO:0043067),0.4253848264535331,1.3358183542647528,0.024415055951169887,0.7239904816278275,1.0,23/161,8.35%,STAT1;CXCL10;AGT;DAPK3;TNFSF9;DAXX;CLU;BIRC2;RARG;TMEM219;ACTN1;TARDBP;BCL2L11;ACTN2;CASP6;RSL1D1;NOP53;OSGIN1;SOX9;SRA1;BCL6;HTATIP2;BCAR1
prerank,negative regulation of cell growth (GO:0030308),0.4333106294514351,1.3352200639571496,0.04149377593360996,0.7248570464009907,1.0,26/121,13.19%,HSPA1B;WNT11;PML;ESR2;BST2;HYAL1;SFRP2;GNG4;CDKN2D;OSGIN1;SERTAD3;BCL6;MT3;FRZB;ST7L;BMPR2;SPHK2;EI24;SLIT3;MAG;SERTAD2;RB1;ENPP1;RACK1;FGF13;APBB1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5186928848354667,1.334804480771394,0.13154533844189017,0.7250633841790213,1.0,8/26,20.50%,RSAD2;IFI35;HMGB1;WDFY1;TLR2;TLR3;MFHAS1;DDX3X
prerank,neuron projection regeneration (GO:0031102),0.6337415171358284,1.3344897729008762,0.138763197586727,0.7248736269951133,1.0,3/10,7.92%,DHFR;GAP43;MAPK8IP3
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.4849110184642576,1.33354354960999,0.10144927536231885,0.7275845124489022,1.0,10/43,16.22%,STAT1;CDH13;CCL5;CX3CL1;DNMT1;LDLRAP1;FGF9;BMPR1A;AIF1;IL18
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.558877046846712,1.3323038664669347,0.14634146341463414,0.7312554232496815,1.0,8/18,19.75%,BCL2L11;RNFT1;NCK1;XBP1;FCGR2B;RNF185;BAX;ERN1
prerank,protein tetramerization (GO:0051262),0.45741294544071454,1.331969948106926,0.07483731019522777,0.7312964796626122,1.0,12/67,13.77%,SAMHD1;SYCP1;GBP5;TRPM2;B2M;SOD2;AQP4;TK1;ALDH1A2;HPRT1;ACOT13;SHMT1
prerank,protein polyubiquitination (GO:0000209),0.41750133999694283,1.331806376924599,0.006006006006006006,0.7303957620419348,1.0,101/297,22.66%,RNF213;HERC6;TRIM14;IRF2BP1;PSMB10;UBE2L6;DTX3L;SKP1;FBXL16;PSME2;UBE2W;BIRC2;KLHL20;PSMA5;CDC26;RNF4;TMEM129;SASH1;FBXO7;PSME4;ANAPC5;RBCK1;TRIM21;RNF5;BFAR;SIAH1;UBE2B;FBXW7;CTNNB1;UBE3A;AREL1;PSMA3;LRSAM1;RNF114;AMFR;SPSB1;FBXW8;DCAF15;PSMB9;ANAPC4;RNF19B;RNF31;RBX1;UBE2E3;BARD1;UBE2E1;TRAF3;ARIH1;BTRC;PSMD2;CDC16;TRAF5;CDC27;SMURF1;PSME3;NPEPPS;FBXL14;UBE2L3;FBXL19;SHARPIN;MYLIP;UBE4B;LONRF1;PSMA4;RUSC1;UBE2Q1;DZIP3;NHLRC3;HECTD2;ANAPC2;LMO7;RNF166;MIB2;FBXL5;UBE2K;HECTD1;TRIM2;TRIM62;WWP1;PSMD7;RFFL;UBE2V1;PSMD8;RC3H2;PSMD9;SPOP;FBXO30;PSMF1;MKRN1;PSMB6;RNF216;ANKRD39;UNKL;PSMC2;PSMD12;HUWE1;SMURF2;STUB1;UBR2;FBXW2;PSMD4
prerank,Golgi to endosome transport (GO:0006895),0.5698714278225994,1.3317849017642036,0.14125874125874127,0.7289394950715552,1.0,9/16,19.65%,KLHL20;AP2A1;DOP1B;KIF16B;RAB14;CORO7;VPS13A;GBF1;VPS13C
prerank,myofibril assembly (GO:0030239),0.47974754914404216,1.3317398550206316,0.11940298507462686,0.7275821561112948,1.0,4/42,6.12%,MYOZ2;CSRP1;ACTN2;CFLAR
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.4585662502756314,1.3312975515887082,0.08946772366930918,0.7279382745813304,1.0,11/54,13.78%,HSPA1B;CASP4;SPPL2A;BIRC2;RBCK1;CFLAR;CYLD;RNF31;RACK1;SHARPIN;BIRC3
prerank,carboxylic acid metabolic process (GO:0019752),0.4992269654625387,1.3312974605566266,0.10853658536585366,0.726382850917695,1.0,8/33,15.77%,LIPT1;AGXT;GRHPR;ST6GAL1;CYB5R3;ST3GAL1;GNE;GLUD1
prerank,regulation of blood circulation (GO:1903522),0.49893268622922426,1.3311946692165464,0.10972568578553615,0.7252687875925511,1.0,4/34,7.01%,AGT;CAMK2D;PER2;TMIGD3
prerank,adipose tissue development (GO:0060612),0.6052365818715506,1.329855361176292,0.1414141414141414,0.729591611895883,1.0,5/11,18.29%,NAMPT;ARID5B;XBP1;SH3PXD2B;SPTLC2
prerank,skeletal muscle organ development (GO:0060538),0.5190814686922681,1.3298429725415815,0.13043478260869565,0.7281129550059429,1.0,2/26,6.12%,MYOZ2;CFLAR
prerank,positive regulation of endocytosis (GO:0045807),0.48068473785677746,1.3288819750656382,0.1145475372279496,0.7307410326435733,1.0,12/45,14.72%,AXL;CLU;B2M;RAB21;HNRNPK;LDLRAP1;ANKFY1;STAP1;APOE;VPS28;DAB2;TFR2
prerank,negative regulation of translation (GO:0017148),0.4446723394511526,1.3288150042449345,0.07841031149301826,0.7294742915528521,1.0,12/87,5.65%,IGF2BP1;EIF2AK2;DAPK3;DHFR;IGF2BP3;AGO2;YTHDF1;LARP1;CNOT7;ILF3;DHX36;EIF4EBP2
prerank,regulation of RNA export from nucleus (GO:0046831),0.6155176538250018,1.328504325701242,0.14658925979680695,0.7292575251304549,1.0,4/11,16.14%,NUP153;NCBP2;DHX9;NRDE2
prerank,visual perception (GO:0007601),0.4378656097301554,1.327988166538726,0.07822410147991543,0.7299403184334734,1.0,12/84,15.23%,CABP4;CNGB1;EYA4;CACNA2D4;CRYGN;IMPG2;RS1;ATXN7;ADGRV1;RGS16;CHRNB2;BBS2
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5670056435181239,1.3278689967339639,0.14184397163120568,0.7288963553429474,1.0,2/15,1.21%,AGT;CAMK2D
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.5105616500452675,1.3269275508395444,0.12407862407862408,0.7314531306899981,1.0,6/29,7.70%,DTX3L;TRIB3;ARRDC4;FEM1B;FBXW7;DCUN1D4
prerank,RNA processing (GO:0006396),0.4200318560707007,1.3267298308177804,0.028629856850715747,0.7307591687873368,1.0,56/176,18.72%,NOL3;APOBEC1;TENT4A;XRN2;ADAR;TARDBP;MAGOHB;PRPF18;HNRNPH1;NCBP2;NOL9;RRAGC;HNRNPK;CDK12;RBMS2;DDX20;HNRNPA2B1;NONO;BCAS2;RNPC3;SRPK1;HNRNPL;TSEN2;RSRC1;RNPS1;HNRNPH3;PPARGC1A;DDX54;USP39;ATXN1;SNRPD2;SNRPD1;DUSP11;AURKAIP1;DDX39B;SNRPG;RBM39;NCBP1;RBM3;DHX16;GEMIN2;SRSF7;SF3B4;NRDE2;SRSF4;TUT7;DDX47;DICER1;SNRNP48;TSEN34;DDX23;SLU7;SCNM1;LSM5;RBPMS;FASTKD2
prerank,ether lipid biosynthetic process (GO:0008611),0.6331674834168943,1.3267001822874993,0.13893129770992366,0.7293782551658194,1.0,5/10,15.97%,PEX7;LPCAT2;GNPAT;CHPT1;PEDS1
prerank,neuromuscular process controlling balance (GO:0050885),-0.5042035068731637,-1.3266677591780691,0.1245674740484429,0.910756097966934,1.0,7/12,29.72%,CDH23;NRXN1;MYO7A;CLN3;SHANK1;CLRN1;TIFAB
prerank,secondary alcohol metabolic process (GO:1902652),0.4847829127010872,1.3259742908907097,0.11254396248534584,0.731012021087403,1.0,16/42,23.26%,ABCA1;ABCG1;CH25H;IDH1;LDLRAP1;STARD3;CYP27A1;APOE;PPARD;SOAT2;SOAT1;EBP;GBA2;IDH3A;ABCA5;CLN6
prerank,lipid translocation (GO:0034204),0.5412030241587393,1.3254044634627578,0.13534822601839686,0.7318413442859181,1.0,6/21,15.76%,ATP10A;ABCA1;ATP8A1;ABCC1;ATP11A;ATP9B
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.49482097852096574,1.325283867379521,0.1323529411764706,0.7308418563948939,1.0,8/32,12.03%,PML;MSH2;MYBBP1A;DDX5;AEN;SNW1;DDIT4;DYRK2
prerank,retinal metabolic process (GO:0042574),0.6070867215431166,1.3251335067356151,0.1633587786259542,0.7299463203580666,1.0,2/12,7.89%,BCO2;RDH11
prerank,regulation of necroptotic process (GO:0060544),0.5371611334107819,1.3250755577706375,0.13671875,0.7286602073239279,1.0,9/23,17.56%,ZBP1;BIRC2;MLKL;CFLAR;CYLD;BIRC3;HSP90AA1;FLOT2;CDC37
prerank,histone H2A monoubiquitination (GO:0035518),0.5690160029057064,1.3249171788765097,0.14304461942257218,0.7277728624647184,1.0,5/17,11.44%,PCGF5;SKP1;PCGF6;RING1;RYBP
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.5177580634878328,-1.3248237286754647,0.16614420062695925,0.9097046412240603,1.0,7/11,36.04%,ALG10B;TREM2;NOS1AP;AKAP6;LRRC55;RNF207;KCNIP2
prerank,protein localization to nucleus (GO:0034504),0.4372877784866388,1.3246787803412627,0.060669456066945605,0.7273004236967174,1.0,28/102,17.51%,PML;TOR1AIP2;TOR1AIP1;SKP1;RANBP6;STAT3;GBP2;CHCHD10;NUP153;NOP53;MORC3;KPNB1;CSE1L;PRICKLE1;NXT1;RRS1;RPAIN;SUPT7L;TAF8;PPP1R10;TAF3;IPO8;TNPO2;NUP155;RPL11;ARL2BP;RANBP17;NUP88
prerank,positive regulation of angiogenesis (GO:0045766),0.43753437820402713,1.3245532787993899,0.04867724867724868,0.7263432077405781,1.0,19/108,11.45%,FLT1;HYAL1;WNT5A;KDR;PIK3CD;AGO2;CD40;SASH1;SFRP2;RUNX1;MYDGF;ITGB8;CTSH;SIRT6;SMOC2;BMPER;ZC3H12A;VEGFD;XBP1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5226972099368943,1.3241012667068448,0.132,0.726766807559914,1.0,6/21,18.26%,AGXT;LPIN2;LDHD;CYP26B1;PPARD;ACOX1
prerank,regulation of mRNA catabolic process (GO:0061013),0.42966097942467624,1.3235153530413377,0.055842812823164424,0.7279157649510295,1.0,42/121,23.76%,IGF2BP1;MOV10;ZC3HAV1;PSMB10;PSME2;PNPT1;ZFP36;PSMA5;IGF2BP3;PSME4;YTHDF1;CNOT7;DHX36;XRN1;PSMA3;DCP2;PSMB9;YTHDF2;HSPA8;ZC3H12A;ZFP36L1;PSMD2;PSME3;EXOSC9;PSMA4;UPF1;PCBP4;PSMD7;PSMD8;SET;RC3H2;PSMD9;PSMF1;PSMB6;PRKCD;PSMC2;PSMD12;EXOSC4;PSMD4;ZC3H14;ZFP36L2;PSMA2
prerank,positive regulation of cartilage development (GO:0061036),0.5585785378451859,1.3233975802081186,0.1285140562248996,0.7269037113840661,1.0,8/17,22.86%,LOXL2;SOX9;SCX;BMPR2;SOX5;MDK;ACVRL1;PKDCC
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.522977828736079,-1.3233566626683857,0.17088607594936708,0.9076805673911662,1.0,4/11,23.47%,PRKCQ;NFKBID;CARD9;CLEC6A
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.5234949497721957,-1.3218589407869565,0.14501510574018128,0.8966014210618701,1.0,4/10,16.92%,CDC42;APC;CDC42EP1;CDC42EP2
prerank,regulation of pseudopodium assembly (GO:0031272),-0.5234949497721957,-1.3218589407869565,0.14501510574018128,0.8966014210618701,1.0,4/10,16.92%,CDC42;APC;CDC42EP1;CDC42EP2
prerank,regulation of endopeptidase activity (GO:0052548),0.4539398251945627,1.3216734842152538,0.09427609427609428,0.7325663530158605,1.0,11/59,15.31%,AGT;PSME2;BIRC2;SERPINC1;PSMA3;PSMB9;TIMP2;PSME3;BIRC3;APH1A;APH1B
prerank,protein localization to synapse (GO:0035418),-0.49375852652928,-1.3216666977992269,0.13719512195121952,0.8889686736357101,1.0,7/12,22.44%,DLG4;NRXN2;NLGN2;NRXN1;ZDHHC15;ZDHHC12;SHANK1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.4812038573277055,1.3215204571898456,0.12690951821386603,0.7317796395954999,1.0,10/40,13.94%,CLU;B2M;RAB21;HNRNPK;MAGI2;INSR;LDLRAP1;ARRB2;SCYL2;DAB2
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.5595179483176643,1.321488225739048,0.14402173913043478,0.7304542059977747,1.0,7/18,14.68%,DNAJC13;RAB21;VPS11;CHMP3;MAP2K2;DAB2;DENND10
prerank,negative regulation of protein secretion (GO:0050709),0.48433297500380335,1.321324112543466,0.11842105263157894,0.7297156160145397,1.0,2/38,1.64%,RSAD2;IRS1
prerank,epithelial structure maintenance (GO:0010669),0.6137462537422839,1.3210814885540922,0.1762917933130699,0.729266103564112,1.0,1/11,0.94%,NOD2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.4414326058469297,1.3209951385721077,0.08867521367521368,0.728154223367651,1.0,18/76,17.26%,NLRC5;PARP10;AIM2;PRMT2;RBCK1;TRIM21;TMIGD3;CYLD;TRAF3;ARRB2;COMMD7;G3BP2;ZC3H12A;HAVCR2;MTURN;IRAK1;ACOD1;ANXA4
prerank,regulation of transferase activity (GO:0051338),0.5630473565355703,1.3204455727402344,0.1548731642189586,0.7290939543927412,1.0,4/17,12.24%,NLRC5;FEM1B;LDB2;LDB1
prerank,sensory perception (GO:0007600),-0.3425697692430395,-1.3196472886604498,0.09523809523809523,0.8890799248851774,1.0,25/45,32.74%,GNAL;OPRM1;CDH23;GNAS;WHRN;PENK;CHRNA7;MYO7A;CCR2;KCNA2;PTGES;SCN9A;NTSR2;CHRNA4;CCL2;P2RX7;OPRL1;OPRK1;CLRN1;TTC8;USH2A;PNOC;ALOXE3;PDYN;KCNK4
prerank,protein insertion into ER membrane (GO:0045048),-0.3573056669127329,-1.3196014523889452,0.08125,0.8810662556528169,1.0,19/37,23.59%,TRAM1;EMC2;CCDC47;EMC3;EMC8;CYB5A;HMOX1;GET3;UBE2J2;SEC61G;EMC9;MMGT1;SEC61B;UBL4A;WDR83OS;OTOF;EMC6;STX1A;ALDH3A2
prerank,nuclear body organization (GO:0030575),0.6079050776143637,1.3194557782964567,0.13997113997113997,0.7317825172356671,1.0,2/12,2.06%,PML;USP50
prerank,positive regulation of kinase activity (GO:0033674),0.42894235421024585,1.319094074959929,0.07045215562565721,0.7319242191912027,1.0,21/107,10.39%,AXL;FLT1;KDR;DAXX;LCP2;CACUL1;EPHA4;TRAF4;FGFR2;MAP2K3;CSF1;RET;EPHA6;AGAP2;RAPGEF2;LTK;MET;INSR;PRKAG1;ROR2;SNX9
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4346445170705491,1.3174392227630207,0.06360792492179354,0.7373382979102576,1.0,22/100,14.63%,PIK3AP1;AGT;FLT1;UNC5B;KDR;PIK3CD;SEMA4D;CCL5;NOP53;SOX9;PPP2R5C;MYDGF;PIP5K1A;MYOC;ENTPD5;LYN;INSR;ROR2;PIK3CB;PIP5K1C;JAK2;IRS2
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5127180856776803,1.3173219509097935,0.1282051282051282,0.7363577238625245,1.0,6/26,9.62%,CDC25B;PKN2;DUSP3;SMOC2;APP;PPP1R10
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.5221070112417547,-1.3172803141158165,0.18769230769230769,0.8821592677579537,1.0,5/10,14.73%,UBAC2;UBE2J1;INSIG1;UBE2G2;YOD1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.5871543028276285,1.3171569074155425,0.15351506456241032,0.7355511191682594,1.0,5/13,12.84%,ENTPD3;ENPP3;ENTPD6;ENTPD5;ENPP1
prerank,positive regulation of protein kinase activity (GO:0045860),0.4184788968668137,1.3166476056916865,0.0449438202247191,0.7363091878516631,1.0,38/148,16.28%,IRGM;CALCA;AGT;TAOK3;DAXX;CLU;SLC27A1;LCP2;CCL5;HSP90AB1;CACUL1;ETAA1;EPHA4;TRAF4;PAK3;CAB39;DOK7;MAP2K3;CSF1;AGAP2;MTCP1;RAPGEF2;CCDC88A;FCGR1A;INSR;PRNP;PRKAG1;TNIK;SNX9;CIB1;MAP2K2;TELO2;EZH2;HSP90AA1;MINK1;CALM3;TAOK2;LRP8
prerank,cholesterol homeostasis (GO:0042632),0.4555020922628197,1.3163555693740445,0.09832402234636871,0.7360658565160124,1.0,19/64,20.65%,NR1H2;ABCA1;ABCG1;LIPC;LDLRAP1;RORA;RALY;XBP1;EPHX2;APOE;NPC1;NPC2;IL18;SOAT2;SOAT1;MTTP;LDLR;TTC39B;CYP39A1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.567405129037254,1.3162797675220481,0.14172185430463577,0.7349086169997705,1.0,5/18,14.27%,STAT1;STAT3;PTPN11;ST18;JAK2
prerank,carbohydrate derivative catabolic process (GO:1901136),0.5498489352888518,1.3159298025766757,0.16421895861148197,0.7349349948357955,1.0,2/18,0.67%,SAMHD1;AOAH
prerank,retina homeostasis (GO:0001895),0.5294756272399149,1.3157092059953313,0.14210526315789473,0.7343966818161389,1.0,5/23,15.47%,CNGB1;B2M;POTEF;ACTB;CCDC66
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.40554471389082936,-1.3152666076755626,0.12552301255230125,0.8819002313396829,1.0,11/21,24.14%,CHSY1;VCAN;CSGALNACT1;CHST7;CHST15;CHST3;BGN;DCN;BCAN;UGDH;CSPG5
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.46077467225206026,1.3151169045200037,0.09655172413793103,0.7354461277132136,1.0,18/55,20.60%,TNFSF10;PML;AGT;FIS1;BCL2L11;SIAH1;TRIM39;CYLD;TPD52L1;RACK1;BAD;BMF;BAX;CRADD;BECN1;BCAP31;WWOX;LCK
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.5064436027985869,1.314927589723765,0.1457286432160804,0.7348181574514644,1.0,11/29,18.40%,TRAPPC3;COG3;GOLGA5;COPE;GOSR2;COG8;COG2;VTI1B;NAPA;GOSR1;COPB2
prerank,regulation of vasculogenesis (GO:2001212),0.5690601725700439,1.314922200515279,0.15877437325905291,0.733397031068306,1.0,4/14,11.71%,XDH;KDR;RAPGEF2;RIN2
prerank,protein import into peroxisome membrane (GO:0045046),0.5367831204051339,1.3148972735190063,0.13691275167785236,0.7320758107958353,1.0,8/22,17.40%,FIS1;RAB8B;GDAP1;ABCD1;PEX2;PEX5;PEX13;ATAD1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.47149428865563126,1.31460708624164,0.12124711316397228,0.7318818213774078,1.0,13/45,16.04%,PARP9;ZC3H7A;TDRD7;LARP1;TCOF1;CYFIP1;NOLC1;APP;PUM3;MATR3;ZC3H7B;RBM3;MEX3D
prerank,intracellular sterol transport (GO:0032366),0.6002289535297262,1.3145811740359319,0.16056338028169015,0.7305491273197425,1.0,6/13,19.16%,ABCA1;ABCG1;NPC1;NPC2;OSBP;OSBPL2
prerank,regulation of viral transcription (GO:0046782),0.4781571047241036,1.314544480696957,0.10785463071512309,0.7292606993947557,1.0,9/39,9.30%,TRIM14;POLR2G;ZFP36;TRIM21;TARBP2;UBP1;DHX9;MDFIC;POLR2K
prerank,T cell homeostasis (GO:0043029),-0.5319299760632163,-1.3135034267186232,0.17117117117117117,0.8813534747153299,1.0,8/10,42.41%,NCKAP1L;AKT1;JAK3;FAS;PMAIP1;FOXP3;FADD;RIPK3
prerank,homocysteine metabolic process (GO:0050667),0.6204928549703803,1.313290025289147,0.13994169096209913,0.7329172162906359,1.0,1/11,0.30%,MTHFR
prerank,negative regulation of defense response to virus (GO:0050687),0.6232190152917386,1.3113388781328819,0.16174183514774496,0.7396446900463056,1.0,3/10,7.35%,ILRUN;TARBP2;TSPAN6
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.4715754018316827,-1.3108174660118979,0.1482758620689655,0.8844079592606907,1.0,7/14,25.50%,CD81;CARD11;IKBKG;CD226;TESPA1;NECTIN2;RPS3
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.6222342171504294,1.3100086913730538,0.1598240469208211,0.7437701331673495,1.0,3/10,9.68%,PFKM;GFPT1;HK1
prerank,cellular response to heat (GO:0034605),0.4841739567214597,1.3096455758061214,0.1395631067961165,0.7438582892430786,1.0,13/35,24.82%,HSPA1B;DAXX;DHX36;HSP90AB1;IER5;TRPV4;HSP90AA1;SLU7;HSBP1;STUB1;SUMO1;VCP;YWHAE
prerank,regulation of viral entry into host cell (GO:0046596),0.5007209705973812,1.3084721199700895,0.1268472906403941,0.7473520623650565,1.0,8/30,18.07%,TRIM14;TRIM25;TRIM21;LY6E;GSN;TRIM26;LGALS9;TRIM62
prerank,macrophage activation (GO:0042116),0.4898740602344381,1.3080934349723614,0.1375921375921376,0.7474851410449408,1.0,9/34,16.08%,IFI35;CLU;NMI;CX3CL1;TMEM106A;APP;JAK2;CRTC3;AIF1
prerank,intracellular cholesterol transport (GO:0032367),0.5810414520715542,1.307834009184407,0.16371077762619374,0.747133837616226,1.0,8/15,19.16%,ABCA1;ABCG1;LDLRAP1;NPC1;NPC2;OSBP;LDLR;OSBPL2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5074878747191839,1.3072946964154686,0.1529709228824273,0.748015291922107,1.0,7/26,14.16%,MYOZ2;RCAN1;CHERP;PRNP;CIB1;DYRK2;SPPL3
prerank,histone H2A ubiquitination (GO:0033522),0.5563523683864566,1.3063648273124935,0.1513157894736842,0.7504546622266366,1.0,5/17,11.44%,DTX3L;SKP1;UBE2B;RING1;RYBP
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.6025921170683746,1.3059852581156213,0.16366366366366367,0.7505079680394683,1.0,3/11,9.13%,CD274;RUNX1;HMGB1
prerank,import into cell (GO:0098657),0.47287818828383393,1.3055947154183958,0.13058823529411764,0.7507810756843794,1.0,8/41,6.94%,SLC27A1;SLC38A1;LRP2;SLC46A1;SLC19A1;LRSAM1;IL10RA;SLC11A2
prerank,AMP metabolic process (GO:0046033),0.5820125189974833,1.305437046275035,0.17114568599717114,0.749991491221401,1.0,5/13,18.84%,XDH;ADSL;AK4;AK3;AMPD3
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.4639851014242102,1.3053852033554436,0.12254335260115606,0.7487932449080391,1.0,13/49,15.92%,MOV10;DPY30;MYL9;RBBP5;RUNX1;CNOT4;KMT2A;WDR5;CIB1;EIF6;RBM15;MTURN;PRMT1
prerank,histone exchange (GO:0043486),-0.3599887691154106,-1.3049289395726122,0.09937888198757763,0.8998977754140386,1.0,21/37,32.56%,CENPO;ZNHIT1;KNL1;CENPA;ITGB3BP;SPTY2D1;CENPL;MIS18BP1;CENPK;CENPU;CENPC;DMAP1;CENPX;CENPQ;VPS72;CENPH;ANP32E;CENPI;MIS18A;CENPW;RNF8
prerank,regulation of fatty acid oxidation (GO:0046320),0.5510453076356542,1.3046030289730495,0.15811373092926492,0.7507210743475131,1.0,5/16,12.32%,LONP2;ACADL;SOX9;ABCD1;PPARGC1A
prerank,membrane lipid catabolic process (GO:0046466),-0.5166492920910399,-1.3044994636467768,0.17166212534059946,0.8937293481289936,1.0,5/10,25.45%,PDXDC1;FUCA1;SMPDL3B;SMPD2;PPT1
prerank,regulation of vasculature development (GO:1901342),0.5203002978087556,1.3040019534305902,0.1446862996158771,0.7517891346366959,1.0,4/26,9.40%,SP100;CTNNB1;HTATIP2;BMPER
prerank,negative regulation of autophagosome assembly (GO:1902902),0.5756791579996502,1.3037079504806754,0.15275813295615276,0.7515702237018591,1.0,2/13,0.58%,CHMP4A;CHMP4B
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.444645674339896,1.303238849666753,0.11610076670317634,0.7519536245311698,1.0,15/66,15.90%,STAT1;XDH;B2M;AQP11;SFRP2;FBXW7;SOX9;FGFR2;SNAI2;NFIB;PEX2;APOE;DUSP10;SOX2;MCC
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.6234794589314953,1.303117799522208,0.1676829268292683,0.7510876729045677,1.0,4/10,14.78%,NR1H2;SLC45A3;ABCD1;LPGAT1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.6040060840769278,1.3028821951107141,0.16494845360824742,0.7492432446448005,1.0,4/11,11.49%,ZFP36;AGO2;NOTCH4;EIF6
prerank,miRNA mediated inhibition of translation (GO:0035278),0.6040060840769278,1.3028821951107141,0.16494845360824742,0.7492432446448005,1.0,4/11,11.49%,ZFP36;AGO2;NOTCH4;EIF6
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.5616574260431688,1.3023815692382668,0.1678520625889047,0.7500561590858246,1.0,4/16,9.69%,GPR37L1;PLCB3;BMPR2;KLK1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.4373231002261385,1.302199212336248,0.10086767895878525,0.7494494285582756,1.0,11/74,10.20%,NOL3;HSPA1B;TNFSF10;EYA4;UNC5B;ACVR1;CFLAR;TCF7L2;SNAI2;GDNF;PHIP
prerank,relaxation of cardiac muscle (GO:0055119),0.569468964617544,1.301969526063109,0.1669024045261669,0.7489871032384806,1.0,5/13,16.74%,CAMK2D;SLC8A1;P2RX4;GSN;KCNJ2
prerank,protein targeting to membrane (GO:0006612),0.4400125792565571,1.3013206650838471,0.09277238403451996,0.7502234715360365,1.0,16/83,9.49%,CHMP4A;CHMP4B;GOLGA7;FIS1;RAB8B;MYO1C;AQP11;RTP4;ZDHHC21;SRPRA;ZDHHC20;GDAP1;VPS37A;NACA;ABCD1;PEX2
prerank,negative regulation of inclusion body assembly (GO:0090084),0.6083136573018647,1.300801691671689,0.17771084337349397,0.7509931300985215,1.0,3/10,11.64%,HSPA1B;DNAJB6;SORL1
prerank,tRNA wobble base modification (GO:0002097),0.5732140489223377,1.3002910432439667,0.16457461645746166,0.751694840004956,1.0,4/14,6.87%,TRMT9B;MOCS3;ADAT2;ALKBH1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.5198294153286813,-1.2998856177423965,0.1875,0.9046098015621407,1.0,6/10,22.86%,APOD;WASL;AKT1;RIPOR2;CD200R1;CD200
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5404006726851263,1.2995031990836696,0.1509433962264151,0.7535468465415411,1.0,7/18,17.85%,CABYR;CCDC40;ADCY10;NPHP3;AQP4;ODAD4;SPAG17
prerank,negative regulation of gene expression (GO:0010629),0.4078496338957677,1.2992030546721633,0.014084507042253521,0.7534221934102403,1.0,70/302,19.18%,PARP14;IGF2BP1;EIF2AK2;HSPA1B;PARP10;PARP9;MOV10;ABCC2;DAPK3;DHFR;XDH;KDR;PNPT1;ZFP36;DDRGK1;IGF2BP3;AGO2;TARDBP;MECP2;RBL1;SFRP2;RUNX1;PTGER4;LARP1;CNOT7;ILF3;DHX36;FBXW7;NFKB1;PTRH2;ITGB8;DCP2;N4BP1;YTHDF2;DNMT3A;APP;DNMT1;PPP1R11;ZC3H12A;SETDB2;MAP2K2;HAVCR2;PSEN1;REL;APOE;RB1;FCGR2B;RACK1;SHMT1;DIS3L2;PATL2;EZH2;NPTN;BMPR1A;NUDT16;SLC24A3;TIPARP;ENC1;PUS7;DICER1;LGALS9;FLOT2;MRPL13;LSM5;HDAC1;CAPRIN1;HINFP;ASB1;TERF2;TSC1
prerank,response to gamma radiation (GO:0010332),-0.40195146067843496,-1.2990976808387114,0.13304721030042918,0.8999314636129051,1.0,12/24,28.32%,MAP3K20;XRCC5;DCUN1D3;FANCD2;KDM1A;TP53;HRAS;YAP1;MYC;CRYAB;LIG4;TSPYL5
prerank,regulation of cell population proliferation (GO:0042127),0.40105089175664044,1.2989315268666277,0.001,0.7531851696045647,1.0,115/691,13.10%,IFIT3;STAT1;STAT2;CXCL10;EIF2AK2;HSPA1B;CXCL9;NAMPT;PML;IL15;AGT;CRLF1;FLT1;SLAMF1;IFI35;TFAP2C;SGK3;SGK2;IRS1;KDR;ZBTB17;CLU;BIRC2;RARG;GAREM1;DDRGK1;TIMELESS;TNFRSF8;GDF9;SOD2;CDH13;MECP2;KITLG;STAT3;NMI;TGFA;CDC25B;ECRG4;AQP11;S1PR2;SFRP2;FXN;RUNX1;CD47;HCK;NACC1;CCND2;TMEM115;CNOT7;TIPIN;JUNB;CDKN2D;OSGIN1;CACUL1;SOX9;CHERP;CTNNB1;CX3CL1;P3H1;PPP2R5C;FGFR2;TCF7L2;BCL6;TFAP2B;CSF1;TMIGD3;CSNK2B;MAGI2;TBC1D8;FRZB;MEIS3;RAPGEF2;CTSH;CCDC88A;IL12RB2;ARID2;BAMBI;LTK;LYN;GDNF;PDPN;APP;SCX;NCK2;INSR;BMPR2;MEN1;ROR2;PROX1;PHIP;CIB1;NPM1;ALDH1A2;CDK10;FAM98B;ZFP36L1;DNAJA3;CTCF;CCL14;CEP131;VEGFD;FGF9;RTKN2;XBP1;IER5;KLF10;THAP12;NOP2;CAPNS1;PRKDC;TSPO;RPS6;CAPN1;CGREF1;LIMS1
prerank,cellular response to peptide (GO:1901653),0.45377917916447186,1.2987152646296596,0.10348706411698538,0.7526019186835348,1.0,15/56,14.33%,CASP4;NOD2;NOD1;TIMELESS;EPHA4;CACNA1A;APP;PRNP;ZFP36L1;ABCC1;XBP1;PSEN1;DDX11;FCGR2B;FYN
prerank,response to copper ion (GO:0046688),-0.411224224569898,-1.2985415020786608,0.1506276150627615,0.8945177290774543,1.0,8/20,1.99%,MT1E;MT1F;MT1M;MT1G;MT1A;MT1H;MT1B;MT1X
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4770853450270963,1.297859272921381,0.13885647607934656,0.7547224718377367,1.0,14/40,22.93%,SLC27A1;SLC38A2;SLC38A1;SLC19A1;SLC38A3;SLC25A10;SLC38A6;SLC7A6;ABCC1;SLC36A4;ABCC5;SLC7A7;SLC5A6;SLC25A30
prerank,ether lipid metabolic process (GO:0046485),0.5756801848388846,1.2976045664044844,0.15524475524475526,0.754453097298582,1.0,7/14,20.99%,TMEM86B;PEX7;GNPAT;PEDS1;PAFAH1B1;PLA2G6;NCEH1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5683547549170858,1.2973236835151225,0.17114568599717114,0.7542673341090823,1.0,3/14,4.06%,DDRGK1;BCL2L11;BFAR
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.44022828995079427,1.2965938930512613,0.12101210121012101,0.7557116012805185,1.0,20/67,16.07%,AXL;FLT1;KDR;NRP2;ELMO2;CYBB;CYFIP1;BCAR1;NCK1;NCK2;VAV1;MAPK14;VEGFD;PIK3CB;NRP1;RAC1;FYN;HSP90AA1;CRK;BAIAP2
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.43408684659157853,1.2964393817810893,0.09110867178924259,0.7549424561192599,1.0,19/76,17.33%,EIF2AK2;NOD2;IFI35;NOD1;SASH1;NMI;CYLD;TSPAN6;APP;ZC3H12A;RTKN2;LIMS1;DLG1;UACA;TLR2;CD27;IRAK1;LGALS9;TLR3
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.5137207075213964,1.2962826601841066,0.14507772020725387,0.7542089781470844,1.0,7/24,12.93%,NR1H2;CLU;AQP11;USP25;UBXN1;XBP1;RACK1
prerank,determination of left/right symmetry (GO:0007368),0.4755628974539094,1.2959343958196217,0.14251497005988023,0.7543203023350222,1.0,5/36,6.82%,PITX2;ODAD2;CCDC40;NPHP3;KIF3B
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5405708472928452,1.2952739486138536,0.16260162601626016,0.7556539347272279,1.0,7/19,13.90%,KDR;THY1;MYOC;PPM1F;LIMS1;NRP1;RAC1
prerank,regulation of establishment of planar polarity (GO:0090175),0.42897448001856636,1.2946906160257126,0.09872611464968153,0.7565995212282178,1.0,22/88,14.39%,WNT11;PSMB10;WNT5A;PSME2;DAAM1;PSMA5;PSME4;PRICKLE1;AP2A1;PSMA3;NPHP3;PSMB9;DACT1;ROR2;ARRB2;SPEF1;AP2S1;PSMD2;SMURF1;PSME3;RAC1;PSMA4
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5451947197041518,1.2945443603421687,0.1638418079096045,0.7558139597554249,1.0,2/16,1.21%,AGT;CAMK2D
prerank,positive regulation of leukocyte migration (GO:0002687),0.5078087807059881,1.2943934577082805,0.14543114543114544,0.7550294194587425,1.0,6/27,16.88%,THY1;ADAM8;CSF1;AIF1;JAM3;MDK
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.4941736249278197,1.2941366269910484,0.1560549313358302,0.7548582716253108,1.0,6/31,15.41%,CD274;SDC4;LST1;LYN;FCGR2B;CD300A
prerank,peroxisomal membrane transport (GO:0015919),0.4990489896728129,1.2939517868495851,0.15894868585732166,0.7543234963492323,1.0,10/27,20.44%,FIS1;RAB8B;PEX7;GDAP1;ABCD1;PEX2;PEX5;PEX13;ATAD1;ABCD4
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.40646304455349475,1.2939173574904221,0.025100401606425703,0.7530922585487361,1.0,52/234,16.97%,EIF2AK2;HSPA1B;TRIM14;AGT;NOD2;ESR2;NOD1;AIM2;WNT5A;CLU;TRIM25;DDRGK1;DHX33;CD40;NFKB2;STAT3;ARID5B;RBCK1;TRIM21;ADAM8;IKBKE;RHEBL1;CTNNB1;CX3CL1;CFLAR;LPAR5;NFKB1;DHX9;SRF;PPIA;TFDP1;RNF31;APP;CRTC1;CIB1;NPM1;RTKN2;TRAF5;TRIM26;PPARGC1A;RNF25;BUD31;IL1RAP;PRKCH;MYD88;CRTC3;TLR2;IL18;LRP8;IRAK1;LGALS9;FLOT2
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.555708279158061,1.2935175361962405,0.17119565217391305,0.7534195944550687,1.0,4/17,11.00%,STAT1;MAML2;SNW1;NOTCH4
prerank,presynapse organization (GO:0099172),0.5926916772260112,1.2930693912090379,0.1901081916537867,0.7538426112885562,1.0,3/10,16.19%,WNT5A;LRRTM3;NLGN3
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4760910788616524,1.2928000310180845,0.14354066985645933,0.7535658947650877,1.0,17/37,25.28%,IRGM;SPRY2;S1PR2;TNKS1BP1;CAB39;APP;DDIT4;INPP5K;CALM3;UBE2K;SPRED3;SPRED1;RIPK2;AXIN1;CALM2;WNK3;SIRT2
prerank,regulation of anoikis (GO:2000209),0.5306126666655024,1.2921085609792988,0.15940054495912806,0.7551291255245907,1.0,8/19,24.62%,MYBBP1A;PTRH2;SNAI2;SIK1;MCL1;NOTCH1;TLE5;PIK3CA
prerank,positive regulation of vasoconstriction (GO:0045907),-0.4741038357712349,-1.2916820590045937,0.14715719063545152,0.9147246980869547,1.0,10/13,52.62%,TRPM4;F2R;CAV1;SMTNL2;AVPR2;TBXA2R;OXTR;AVPR1A;ADRA1A;ADRA1B
prerank,regulation of smooth muscle contraction (GO:0006940),0.5338143313651974,1.291475535418614,0.17245989304812834,0.7564548880992844,1.0,4/20,7.26%,DAPK3;ZDHHC21;SETD3;SRF
prerank,regulation of protein ubiquitination (GO:0031396),0.4235932403161639,1.291140018621263,0.08722741433021806,0.7564599394932098,1.0,25/108,15.96%,HSPA1B;ISG15;SPRY2;PER2;DAXX;BIRC2;SASH1;HSP90AB1;FBXW7;PRICKLE1;UBE3A;UBXN1;CAMLG;N4BP1;UBQLN1;ARRB2;PRR7;VPS28;PAXIP1;UBE2L3;HDAC8;BIRC3;HSP90AA1;MYCBP2;SPRTN
prerank,positive regulation of cell motility (GO:2000147),0.40828919949226417,1.2909514960533703,0.03771661569826707,0.7558676838227922,1.0,47/205,17.33%,WNT11;FLT1;CCL7;SPRY2;KDR;CPNE3;PIK3CD;DDRGK1;SEMA4D;SOD2;CXCL16;CDH13;ACVR1;STAT3;MYO1C;MMP14;RUFY3;CCL5;FAM83H;CARMIL1;PODXL;CSF1;SNAI2;RET;ELP6;MAPRE1;MYOC;CTSH;BCAR1;PDPN;INSR;ROR2;CIB1;PPM1F;SUN2;XBP1;RACK1;DAB2;STX4;CFAP20;MIEN1;SPAG9;AIF1;SEMA3D;MGAT5;MDK;CBLL1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.4339860176417353,-1.2905903925081195,0.13380281690140844,0.9115586625782681,1.0,7/17,18.54%,ARRB1;BCL3;PTPN22;CACTIN;KLF4;MAP2K5;ANXA1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.502380576628799,1.2904316445279427,0.15858453473132372,0.7567361645818487,1.0,7/27,16.16%,CAMK2D;FXYD4;UTRN;FXYD6;FXYD5;DLG1;SCN1B
prerank,aspartate family amino acid catabolic process (GO:0009068),0.5350070672789171,1.2902424261402046,0.17066666666666666,0.7562252227481775,1.0,6/19,15.55%,HYKK;ALDH7A1;DLD;AASS;GCDH;PIPOX
prerank,ribonucleoprotein complex assembly (GO:0022618),0.4101279822482595,1.289540854114233,0.06172839506172839,0.7578326841150927,1.0,54/132,23.56%,NOL3;SRPK3;PWP2;TXNL4A;PRPF18;ERAL1;TARBP2;MDN1;NOP53;HSP90AB1;DDX20;RRS1;PPAN;DHX9;SRPK1;TGS1;EIF4H;EIF6;EIF3A;CELF6;NOP2;PRKDC;USP39;DENR;SART1;CLNS1A;GEMIN7;SNRPD2;SNRPD1;DDX39B;HSP90AA1;SNRPG;NCBP1;GEMIN2;RPL23A;RPL11;DICER1;PTGES3;DDX23;RSL24D1;RPL24;EIF4B;RPL3;MRPS11;SNUPN;EIF5;RPL5;SRSF5;SF3A2;RPL6;SRSF10;SART3;LSM4;SNRPD3
prerank,response to muramyl dipeptide (GO:0032495),0.5803220799376602,1.2894548081283865,0.1816860465116279,0.7568450206804311,1.0,2/12,1.42%,NOD2;NOD1
prerank,regulation of cell division (GO:0051302),0.43383474886639695,1.2890741439665705,0.09368191721132897,0.7570995459831855,1.0,23/72,19.51%,ESRRB;SFRP2;PDXP;PRPF40A;FGFR2;SH3GLB1;KLHL13;ZFYVE26;PLK3;PIK3R4;GIT1;CIB1;KLHL9;RACK1;AHCTF1;MLLT3;CALM3;RAB11A;BIRC6;UVRAG;BECN1;PIN1;SMYD5
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5567037194755552,1.2883974021696267,0.1755829903978052,0.7585387235923047,1.0,1/16,0.24%,CD274
prerank,negative regulation of defense response (GO:0031348),0.4305697275116059,1.288243613970391,0.10416666666666667,0.7578499957260166,1.0,21/77,21.65%,TRAFD1;AOAH;ILRUN;DHX58;NMI;TRIM21;ENPP3;PTGER4;RORA;APOE;CXCL17;RB1;SHARPIN;PPARD;ACOD1;MFHAS1;SIRPA;TNFAIP8L2;MAPKBP1;PRKCD;VPS35
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.4152661420989312,1.2878755240134312,0.07157676348547717,0.7579471857252604,1.0,30/122,16.70%,NLRC5;NAMPT;NOD2;IRS1;PLXNB2;KDR;PPP1R3E;YTHDF1;ZCCHC4;CDT1;NFKB1;DHX9;TMEM106A;SMOC2;INSR;NPM1;XBP1;EIF6;DYRK2;LDB1;PRKDC;UPF3A;STN1;JAK2;IRS2;RBM3;TLR2;PRMT1;MTOR;METTL14
prerank,myeloid cell development (GO:0061515),-0.43375449705532654,-1.2877353371157736,0.14028776978417265,0.9158215342625196,1.0,7/18,16.97%,NCKAP1L;DMTN;SRC;ABCB10;ALAS1;FOXP1;LYAR
prerank,proteoglycan biosynthetic process (GO:0030166),0.4881321570478511,1.2872066593160434,0.1548780487804878,0.7593721154542723,1.0,7/31,12.37%,EXT1;XYLT2;CANT1;FAM20B;BMPR2;CSGALNACT2;EXTL3
prerank,response to tumor necrosis factor (GO:0034612),0.4262775774527279,1.2869905131609563,0.10649627263045794,0.758949287922855,1.0,22/91,16.67%,CCL7;HYAL1;ZFP36;GBP3;CD40;CXCL16;GBP2;CRHBP;CCL5;CX3CL1;IGBP1;DHX9;GCH1;CIB1;ZC3H12A;ZFP36L1;CCL14;GGT7;JAK2;INPP5K;ADAMTS12;ACOD1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.5000163705423886,1.2864585034436236,0.14883148831488316,0.7597973408838375,1.0,13/27,28.83%,NAA50;KAT8;SGF29;KAT7;RUVBL2;KAT6A;KAT5;KAT2B;RUVBL1;EP300;BRD8;ATAT1;NAT8
prerank,male meiosis I (GO:0007141),-0.4471312043981091,-1.2853834848860832,0.17073170731707318,0.917908798984469,1.0,9/16,45.38%,ING2;FOXJ3;DDX4;SYCP3;BRDT;HSF2BP;SLC25A31;TDRD9;MOV10L1
prerank,regulation of cell growth (GO:0001558),0.4081940253664885,1.285325327981182,0.038267875125881166,0.7631072519090041,1.0,47/204,15.75%,HSPA1B;WNT11;PML;AGT;ESR2;BST2;CAMK2D;HYAL1;SGK3;SGK2;CXCL16;KIF26A;MMP14;SFRP2;FXN;MAD2L2;DDX49;EGLN2;GNG4;CDKN2D;OSGIN1;SERTAD3;BCL6;MT3;ATAD3A;FRZB;BCAR1;ST7L;BMPR2;SPHK2;OGFR;CIB1;EI24;SLIT3;ARHGEF11;SOCS2;SERTAD2;RB1;ENPP1;RACK1;APBB1;EXOSC9;PRDM11;NCBP1;TAOK2;ADNP2;CHPT1
prerank,regulation of translation (GO:0006417),0.4077611614636927,1.285217636284977,0.05685279187817259,0.7622162003320058,1.0,52/173,21.12%,IGF2BP1;EIF2AK2;DAPK3;DHFR;PLXNB2;EIF4A2;IGF2BP3;YTHDF1;LARP1;CNOT7;ILF3;DHX36;NCBP2;GSPT1;TCOF1;CYFIP1;ZCCHC4;ALKBH1;DHX9;NOLC1;EIF2B2;APP;EIF4H;NPM1;PUM3;EIF6;PRKDC;UPF3A;RACK1;EIF4G3;SHMT1;EIF1B;PATL2;ETF1;NCBP1;RBM3;MTOR;ENC1;UPF1;PUS7;METTL14;MRPL13;CAPRIN1;EIF4B;OGFOD1;TSC1;EIF5;CSDE1;GLE1;DDX3X;MTG2;RPL5
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.5976241743204939,1.2851969087842896,0.2,0.7609778246132681,1.0,6/11,25.06%,RAB21;VPS11;SORL1;DAB2;MSN;PTPN23
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5061803261708726,1.2850702452184741,0.18053777208706787,0.7602008807657558,1.0,12/25,23.75%,AUP1;UBE2W;RNF5;POMT2;NGLY1;LONP1;RNF185;KLHL15;STUB1;CUL3;VCP;HDAC6
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.4920831997330153,1.2848558323673103,0.15844155844155844,0.7598000089522763,1.0,6/28,12.19%,CLU;DDRGK1;OSBPL7;FBXW7;CTSC;SMURF1
prerank,T cell receptor signaling pathway (GO:0050852),0.4122373409867155,1.284577972977284,0.08188331627430911,0.7596731787811836,1.0,45/138,21.78%,THEMIS2;PSMB10;ICOSLG;SKP1;PSME2;PIK3CD;PSMA5;PSME4;LCP2;RBCK1;THY1;CD276;PAK3;PSMA3;NFKB1;PSMB9;BCAR1;NCK1;EIF2B2;RNF31;BTRC;ZC3H12A;PSMD2;PSME3;PIK3CB;SPPL3;FYN;PSMA4;CSK;PTPRC;PAG1;PSMD7;EIF2B5;EIF2B3;PSMD8;DENND1B;RC3H2;PSMD9;PDE4B;RIPK2;PSMF1;LCK;PSMB6;PSMC2;PSMD12
prerank,protein stabilization (GO:0050821),0.40552762557995375,1.2842118712476105,0.06288032454361055,0.7598430987566458,1.0,44/168,19.90%,HSPA1B;IRGM;ZSWIM7;CLU;FKBPL;GOLGA7;CHEK2;RAB21;ATP1B3;LAMP2;COG3;OTUD3;NOP53;UBE2B;HSP90AB1;MORC3;SEC16A;FBXW7;P3H1;EPHA4;MT3;TRIM39;CDC37L1;CAMLG;CCT4;CCT7;CCT3;BAG1;PPARGC1A;TELO2;TNIP2;HSP90AA1;RPL11;FLOT2;PRKRA;PTGES3;LAMP1;CDC37;IFT46;STK3;TSC1;PIN1;AAK1;TYROBP
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.4669207471412712,-1.2841945796411387,0.17096774193548386,0.915245953506978,1.0,3/14,6.20%,ATP1B1;DMD;ANK3
prerank,DNA modification (GO:0006304),-0.39496808404922834,-1.2841457950406732,0.14644351464435146,0.9079648458076683,1.0,10/22,17.51%,PARP2;PARP1;TERF2IP;EXOSC5;OGG1;EXOSC3;NEIL1;PARP3;NEIL3;TERF1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5080840137575255,1.2841153961369547,0.1483375959079284,0.7589065977027163,1.0,11/23,24.70%,IRGM;S1PR2;TNKS1BP1;CAB39;APP;CALM3;UBE2K;RIPK2;AXIN1;CALM2;WNK3
prerank,negative regulation of phagocytosis (GO:0050765),0.5403724709835852,1.2837947341659521,0.1917024320457797,0.7588179994564924,1.0,8/17,19.95%,CD47;HMGB1;FCGR2B;RACK1;CD300A;TLR2;CD300LF;SIRPA
prerank,C-terminal protein amino acid modification (GO:0018410),-0.5015612981592719,-1.2837851152152644,0.1855072463768116,0.9021098453176872,1.0,5/11,22.82%,AGBL4;ATG5;AGTPBP1;ICMT;LCMT1
prerank,regulation of mitotic spindle organization (GO:0060236),0.48056957480400087,1.2837297758986839,0.16444981862152358,0.7578093165633566,1.0,6/35,11.28%,HSPA1B;CHMP4B;CHMP1B;DYNC1H1;RAE1;CHMP3
prerank,regulation of macrophage differentiation (GO:0045649),-0.4415455313196828,-1.2830719900308403,0.1708185053380783,0.8980794590068323,1.0,7/15,22.22%,CASP8;ID2;RIPK1;PTPN2;PF4;IL34;INHBA
prerank,ncRNA metabolic process (GO:0034660),0.47284658980578487,1.2821049937844864,0.15096618357487923,0.7630818119402392,1.0,9/37,17.16%,AGO2;DTD1;TARBP2;BCDIN3D;MEPCE;DTD2;TUT7;DICER1;PRKRA
prerank,outflow tract septum morphogenesis (GO:0003148),0.5002386892490119,1.2811859479689258,0.17002518891687657,0.7654462471538023,1.0,7/24,15.33%,NRP2;ACVR1;LRP2;FGFR2;BMPR2;NRP1;BMPR1A
prerank,cAMP-mediated signaling (GO:0019933),0.5128818992577634,1.28078078306587,0.15223097112860892,0.7657819768287507,1.0,4/24,8.10%,PDE7B;GAL;SOX9;RAPGEF2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4926532201222185,1.2806619162006063,0.17258883248730963,0.7650083565677732,1.0,5/27,9.52%,NOD2;FLT1;IRS1;AGAP2;PIK3R4
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.49049914853968307,1.2805004277664285,0.14512195121951219,0.764359714132878,1.0,6/31,11.73%,MOCS3;FDFT1;NFS1;GCH1;MOCOS;DHRS11
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5419626578135877,1.2801081345302276,0.17813765182186234,0.7646650395516149,1.0,3/17,2.89%,MSH2;STAT3;CD55
prerank,actin filament bundle assembly (GO:0051017),-0.3510407165135031,-1.2800730264460003,0.11173184357541899,0.9031673564194018,1.0,7/33,7.63%,ADD1;PLS3;CALD1;DPYSL3;MICAL1;EPS8;DMTN
prerank,regulation of cartilage development (GO:0061035),0.5426185198828849,1.2799871269912735,0.16843501326259946,0.7639039914303952,1.0,6/18,16.88%,WNT11;SOX9;SCX;BMPR2;SOX5;MDK
prerank,mononuclear cell differentiation (GO:1903131),0.5053092106355823,1.2799622215194257,0.17380025940337224,0.7627227910284113,1.0,6/24,14.15%,AXL;TRPM2;BATF3;LYN;RELB;IKZF1
prerank,Rac protein signal transduction (GO:0016601),0.5442643633536863,1.2797940304696782,0.1723202170963365,0.7621161108445418,1.0,13/18,29.06%,CDH13;CYFIP1;HACD3;RAC1;DBNL;AIF1;NCKAP1;RHOH;BRK1;FARP2;TIAM1;WASF1;HACE1
prerank,protein complex oligomerization (GO:0051259),0.4290701759796094,1.2788600989491337,0.10319148936170212,0.7647908363275822,1.0,13/85,11.63%,RNF213;NOL3;PNPT1;ATL1;AQP11;RBMX;TRMT61B;TMEM120B;TWNK;RS1;G3BP2;ZC3H12A;POLQ
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5159077141310249,1.27869339318377,0.17825537294563842,0.7642096423050754,1.0,9/24,22.86%,LOXL2;SOX9;SNAI2;PTPN11;SOX5;ADAMTS12;MDK;ACVRL1;PKDCC
prerank,cellular response to misfolded protein (GO:0071218),0.5176208055073077,1.2786584101517289,0.20318725099601595,0.7630711023128217,1.0,9/20,23.55%,AUP1;UBE2W;RNF5;POMT2;RNF185;KLHL15;STUB1;CUL3;VCP
prerank,pre-miRNA processing (GO:0031054),0.5611071933947018,1.2786487108561564,0.1896551724137931,0.7618290521150995,1.0,6/14,17.16%,ADAR;AGO2;TARBP2;TUT7;DICER1;PRKRA
prerank,ureteric bud development (GO:0001657),0.5419293005622015,1.2783288255648444,0.16102841677943167,0.7618432569391043,1.0,2/17,5.98%,WNT11;FGFR2
prerank,regulation of cholesterol storage (GO:0010885),0.5509491851777755,1.2781802657769337,0.1934156378600823,0.7611688944856999,1.0,3/15,1.79%,NR1H2;ABCA1;ABCG1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.556699776794016,1.2779880394659517,0.18244170096021947,0.7607620462970017,1.0,5/15,14.71%,NOD2;GBP5;STAT3;IL17D;MYD88
prerank,negative regulation of DNA recombination (GO:0045910),0.46041035981328293,1.2776092129801595,0.16071428571428573,0.7609545059020627,1.0,10/43,12.48%,MSH2;POLR2G;DAXX;CGAS;MAD2L2;RTEL1;POLR2K;POLQ;SHLD1;ZRANB3
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.4276163739905455,1.277357436262333,0.12286324786324786,0.7607056691109525,1.0,23/84,19.46%,IGF2BP1;EIF2AK2;DAPK3;DHFR;CLU;IGF2BP3;LARP1;CNOT7;ILF3;DHX36;GGA3;PRNP;SORL1;APOE;RACK1;SHMT1;PATL2;ENC1;PUS7;MRPL13;CAPRIN1;TSC1;PIN1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.43926952274677317,1.2773549796485961,0.11208791208791209,0.7594599251808988,1.0,14/62,12.61%,NOL3;TMEM161A;CLU;SOD2;SFRP2;HYOU1;CDKN2D;NME5;SNAI2;PPIA;ACKR3;RTKN2;XBP1;ARMC10
prerank,negative regulation of cellular component movement (GO:0051271),0.5604444054468606,1.2767999566919788,0.17891816920943135,0.7606115443903336,1.0,2/15,2.31%,SP100;ACTN1
prerank,protein monoubiquitination (GO:0006513),0.4722497302969011,1.2763811762833632,0.1519903498190591,0.7611107478527956,1.0,9/36,9.77%,DTX3L;TRIM25;UBE2W;RNF40;TRIM21;UBE2B;RBX1;UBE2E1;WAC
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5445153382849969,1.275940395040054,0.19008264462809918,0.7617041208299138,1.0,6/15,18.10%,NR1H2;SLC27A1;FBXW7;SIK1;SREBF1;LDLR
prerank,regulation of macromolecule metabolic process (GO:0060255),0.4052768329756091,1.2752289002237884,0.05858585858585859,0.7632867216341074,1.0,41/170,18.44%,IGF2BP1;ZUP1;TRIM14;IGF2BP3;TARDBP;TRIM21;CGGBP1;SLC8A1;TAPBP;HNRNPK;AFF1;TRIM39;RO60;GDNF;APP;KIF16B;MKLN1;PROX1;ZC3H12A;MARF1;ZFP36L1;HNRNPDL;CTCF;NKAP;TRIM26;PSEN1;APOE;PRDM4;NELL1;POGZ;SOX2;PRDM11;ADNP2;NPAT;AIF1;PCBP4;PTPRC;ZNF445;ZNF513;LDLR;HINFP
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.4559819911368332,-1.2750279806977696,0.17064846416382254,0.9157332529026739,1.0,7/15,21.67%,ABHD16A;HOGA1;ABHD12;SARDH;GGT5;PRODH;ALDH4A1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.4964412547994484,1.27461057710297,0.16624040920716113,0.7644903761466103,1.0,7/28,12.41%,PARP9;DTX3L;ACTR2;MAD2L2;KDM4D;SHLD1;PRKDC
prerank,regulation of stem cell population maintenance (GO:2000036),0.5363745180118917,1.2744339246062868,0.1773981603153745,0.763936141433643,1.0,4/18,15.14%,LOXL2;ESRRB;WDR43;ZC3H13
prerank,SNARE complex assembly (GO:0035493),0.5948587521310444,1.274168451077858,0.1917024320457797,0.7636725564352858,1.0,5/10,19.13%,CLTRN;VAMP1;VAMP2;VAMP4;UVRAG
prerank,protein localization to mitochondrion (GO:0070585),0.5890449309835126,1.2737497473163413,0.17751479289940827,0.764135665026484,1.0,2/11,9.68%,ISG15;HK1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.503753148329157,1.2735283229786931,0.18275418275418276,0.763800639242174,1.0,9/25,21.70%,HSPA1B;DNAJB4;HSPA8;SDF2;BAG1;PTGES3;HSPA14;ERO1A;DNAJC7
prerank,endothelial cell differentiation (GO:0045446),0.5698034126601507,1.2735202611121028,0.19327731092436976,0.7626060475294516,1.0,4/12,10.07%,KDR;EDF1;BMPR2;PROX1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.48657954579303775,1.2733948447453922,0.17245657568238212,0.7618816490988527,1.0,10/30,21.70%,HSPA1B;DNAJB4;ENTPD5;HSPA8;SDF2;BAG1;PTGES3;HSPA14;ERO1A;DNAJC7
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4317856111464389,1.2728947877025634,0.12459016393442623,0.7625448808797942,1.0,33/78,25.86%,HSPA1B;TRIB3;CLU;DDRGK1;SUMO2;UBQLN2;NOP53;PRICKLE1;DET1;SIRT6;RNF19B;SOCS5;RBX1;PLK3;UBQLN1;ARIH1;RACK1;DAB2;PIAS1;HECTD1;BCAP31;RNF180;HSPBP1;USP5;NUB1;STUB1;DNAJB2;SUMO1;VCP;BBS7;SIRT2;RAD23A;DDA1
prerank,cytosolic transport (GO:0016482),0.41797967489882426,1.2728824292910557,0.0948905109489051,0.7613386177933692,1.0,50/108,26.19%,VPS51;RGP1;KLHL20;RILP;AP2A1;GOSR2;VPS53;TBC1D23;HOOK2;VPS54;DOP1B;BAIAP3;STX8;KIF16B;HOOK1;STX16;RAB14;ARL1;ANKFY1;ANKRD27;CORO7;VPS50;TMEM87A;VPS52;RIC1;VTI1B;HOOK3;PREPL;SPAG9;VPS26A;SNX1;VPS13A;LAMP1;GBF1;GOSR1;WDR91;BECN1;VPS13C;VPS35;SNX2;STX6;RAB29;EEA1;DENND2A;RBSN;PTPN23;CCDC91;DCTN1;TBC1D17;SNF8
prerank,somite development (GO:0061053),0.5884241066766744,1.2724549292503118,0.18958031837916064,0.7618285916197273,1.0,4/11,22.44%,SFRP2;PTCH1;MTHFD1;PPP2R3A
prerank,response to lipopolysaccharide (GO:0032496),0.4086573529034686,1.2720387355816312,0.07810894141829394,0.762284585846514,1.0,26/138,16.80%,CXCL10;AXL;CD274;CXCL9;IRGM;NOD2;WNT5A;ZFP36;SLPI;NFKB1;HMGB1;MAPK14;GCH1;GIT1;ZC3H12A;XBP1;STAP1;GGT7;JAK2;TNIP2;MYD88;TNIP3;IRAK1;UPF1;ACOD1;LGALS9
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.46451697265308983,-1.272032219952486,0.17956656346749225,0.9206344655697545,1.0,3/12,4.99%,TGFB1;AR;SELENOS
prerank,negative regulation of apoptotic process (GO:0043066),0.39511850123364756,1.2717481805558664,0.009,0.7622296483458709,1.0,74/444,12.74%,RNF213;IFIT3;NOL3;AXL;HSPA1B;WNT11;CRLF1;MSH2;UNC5B;WNT5A;SPRY2;COMP;KDR;BDNF;BIRC2;DDRGK1;KLHL20;SEMA4D;SOD2;ASAH2;LRP2;ANKLE2;FXN;ADAM8;BFAR;HCK;CCND2;CDKN2D;SOX9;HNRNPK;CTNNB1;CX3CL1;AREL1;MYDGF;CFLAR;IGBP1;NFKB1;TMBIM4;MT3;NRBP2;PTRH2;TFAP2B;SNAI2;CSNK2A2;ATAD3A;AGAP2;HTATIP2;CTSH;LTK;GDNF;BARD1;PDPN;SCX;PLK3;DNAJB6;PHIP;CIB1;ZC3H12A;NPM1;NUAK2;MAG;XBP1;PIM1;CBX4;BAG1;NAA35;ARHGAP10;PSEN1;PPARGC1A;APOE;PRKDC;SOCS2;DFFA;RB1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.5570975521662102,1.2715995913459512,0.1952247191011236,0.7616081126673734,1.0,6/14,20.32%,XDH;SPRY2;NOTCH4;SPRED3;SPRED1;ZEB1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.5827963971414134,1.2714070107756261,0.18352601156069365,0.761112707931203,1.0,4/12,12.41%,CCND1;PLK3;WAC;PRKDC
prerank,regulation of protein localization to cell surface (GO:2000008),0.4736819153763155,1.2714033248546779,0.16769420468557336,0.7599074621361795,1.0,16/33,25.73%,BDNF;SNX33;ACTN2;HSP90AB1;CTNNB1;RAB11B;LEPROT;LEPROTL1;STX4;GBF1;TYROBP;TM9SF4;RAB11FIP5;COMMD1;TNF;TMEM35A
prerank,cellular response to nitrogen compound (GO:1901699),0.519945966877839,1.271190154558711,0.19404915912031048,0.7595674210147065,1.0,6/20,18.94%,DAXX;TIMELESS;RIOK3;DDX11;RTF2;DDI2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.41780021197098044,1.2708037228677544,0.1142263759086189,0.7598862806374977,1.0,10/110,8.39%,CXCL10;CXCL9;CALCA;ABCA1;RXFP2;S1PR2;PTGER4;ADCY5;RAPGEF2;PTGER3
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.4625608918960349,1.270393897812325,0.16183574879227053,0.7602329567585787,1.0,4/38,6.12%,SP100;TNFSF10;FEM1B;CFLAR
prerank,ERK1 and ERK2 cascade (GO:0070371),0.5093522974215812,1.2702863649694958,0.19921875,0.7594558092562589,1.0,7/21,11.82%,KDR;PTGER4;SOX9;MT3;CTSH;ZFP36L1;MAP2K2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5310454518339098,1.2695783211213219,0.17989417989417988,0.7610874696911893,1.0,5/18,12.63%,ZFP36;BCL2L11;ZFP36L1;NR3C1;UBE2L3
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.567469737030549,1.269124421923337,0.18857142857142858,0.7617303051471074,1.0,5/14,15.54%,ENTPD3;ENTPD6;NUDT5;ENTPD5;NUDT16
prerank,regulation of multicellular organismal development (GO:2000026),0.4996357225255552,1.269088548368005,0.17906683480453972,0.7606520542459698,1.0,6/25,10.98%,OAS2;DHX36;SCX;INSR;HPSE;RAB14
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.4435877913413865,1.268762985323657,0.1197339246119734,0.7607134887842447,1.0,16/63,17.88%,PML;CHEK2;CNOT4;CNOT7;CCND1;TNKS1BP1;TFDP1;PLK3;WAC;TFDP2;PRKDC;E2F4;PRMT1;PCBP4;BAX;CRADD
prerank,negative regulation of T cell differentiation (GO:0045581),0.5799916893128536,1.2684165570491626,0.2003012048192771,0.7608699301837636,1.0,4/10,23.80%,LAG3;MDK;GLI3;IRF1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.42691097290777946,1.2678092208799203,0.11513859275053305,0.762117378188648,1.0,28/80,19.78%,RER1;ARF3;KIF26A;KIF3C;COG3;ERGIC3;COPE;TMEM115;TAPBP;KIF2C;ARF5;KIF3B;TMED10;KDELR1;SCFD1;RINT1;NAPA;KIF2A;ATP9B;ARF4;KLC2;ERGIC2;TMED3;GBF1;COPB2;GOLPH3L;UVRAG;RAB1A
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.5425711981946864,1.2670626525476265,0.17679558011049723,0.7639208138411374,1.0,4/15,11.93%,BDNF;BCAR1;DDIT4;SOS1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.4268173162363538,1.266699943964691,0.12567132116004295,0.7642483445702157,1.0,28/72,22.66%,PSMB10;SKP1;PSME2;BIRC2;PSMA5;NFKB2;PSME4;PSMA3;PSMB9;BTRC;PSMD2;RELB;PSME3;REL;BIRC3;PSMA4;IRAK1;DICER1;TLR3;COPS8;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.4299217892035837,1.266384661803442,0.13355048859934854,0.7643068046616972,1.0,25/70,21.78%,EIF2AK2;PSMB10;PSME2;PSMA5;PSME4;RUNX1;KMT2A;PSMA3;PSMB9;YTHDF2;LMO2;PSMD2;LDB1;PSME3;PRKDC;PSMA4;MYB;PUS7;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12
prerank,regulation of mitotic nuclear division (GO:0007088),0.4445113012624707,1.2661723404445624,0.1433370660694289,0.7639636482606714,1.0,11/55,14.38%,PKMYT1;DAPK3;TGFA;CHEK1;PDXP;CUL7;CDK5RAP2;INSR;PHIP;ANAPC15;AURKAIP1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.36566587969694525,-1.265782700408043,0.13705583756345177,0.9381153930701134,1.0,14/33,23.36%,APOD;PPARG;PDCD4;HMOX1;TPM1;IGFBP5;TRIB1;PRKG1;CDKN1A;CDKN1B;MEF2C;TNFAIP3;EFEMP2;IGFBP3
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.41975182750382595,1.26568278278871,0.12351029252437704,0.7646007875559441,1.0,24/75,24.65%,WNT5A;KDR;PIK3CD;CDH13;NRP2;PLXNB3;MYDGF;SIRT6;EGFL7;HMGB1;BMPR2;PROX1;VEGFD;NRP1;AGGF1;MDK;ITGA4;F3;AKT3;FGF2;STAT5A;PDPK1;ANG;SCG2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.6038897514889401,1.2656339035607944,0.2012288786482335,0.7636085421946447,1.0,2/10,1.57%,XDH;SPRY2
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.4434126812545069,-1.265610255076226,0.1794871794871795,0.9314286898366634,1.0,7/15,21.62%,TGFB1;CST3;CLASP2;DPP4;FAP;CLASP1;DDR1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5565286365386325,1.2655389756523472,0.17812061711079943,0.7627698132612907,1.0,4/15,8.31%,ACVR1;CSNK2B;MAGI2;DACT1
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.42981165867445054,-1.2653589279835087,0.1780821917808219,0.9254972280513557,1.0,9/15,23.50%,ANP32B;GSK3B;CAMK1;RAPGEF3;TP53;BAG3;TPR;RBM22;IL1B
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5991102926933607,1.2650610116859704,0.18294573643410852,0.763515345596124,1.0,4/10,13.46%,RGP1;EPHA4;RIC1;NELL1
prerank,positive regulation of glucose metabolic process (GO:0010907),0.5536543276407928,1.2650315658598579,0.20457796852646637,0.7624450694214875,1.0,5/14,14.63%,IRS1;ARPP19;SLC45A3;PPARGC1A;IRS2
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5740038422959131,1.2648038812137763,0.18016759776536312,0.762178182170818,1.0,1/13,0.17%,AXL
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5453244946980146,1.2637882843341328,0.19127988748241911,0.7648956469906754,1.0,5/16,17.01%,PPCS;SLC25A1;SCD5;GCDH;ACAT1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.5024240212516105,1.2630324115594138,0.1664564943253468,0.7667620226770296,1.0,7/24,8.69%,B2M;TAPBPL;TAPBP;ERAP1;ABCB9;SEC24D;SEC23A
prerank,B cell receptor signaling pathway (GO:0050853),-0.34959179090927683,-1.26297932489367,0.09090909090909091,0.9284026957709323,1.0,6/32,3.83%,NFAM1;SYK;CD38;SH2B2;NCKAP1L;LAT2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.43400909672933086,1.2629760137524026,0.14481185860889395,0.7657973527331351,1.0,15/59,20.65%,MCAT;PER2;OSBPL7;CH25H;LIPC;OSBPL3;ALDH1A2;XBP1;CYP27A1;OSBPL9;OSBP;OXSM;OSBPL2;ELOVL4;CYP39A1
prerank,regulation of stem cell differentiation (GO:2000736),0.42141591607248047,1.262735715060263,0.12659574468085105,0.7655811880485661,1.0,33/89,23.76%,EIF2AK2;PSMB10;PSME2;ESRRB;PSMA5;PSME4;RUNX1;KMT2A;PSMA3;PSMB9;YTHDF2;LMO2;GDNF;PSMD2;LDB1;PSME3;PRKDC;PSMA4;MYB;BMPR1A;PUS7;PSMD7;PSMD8;PSMD9;SMYD5;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4;NOTCH1;ZFP36L2;PSMA2
prerank,RNA catabolic process (GO:0006401),0.4532675688660561,1.2627235458565516,0.16200466200466201,0.7644650062154662,1.0,20/46,24.23%,HSPA1B;PNPT1;ZFP36;XRN2;RNASEH2A;DCP2;FEN1;RNASEH2C;YTHDF2;DIS3L2;NCBP1;RNASEH2B;NUDT16;LSM5;ERN1;RNASEH1;AGO4;RNH1;ZFP36L2;RNASE3
prerank,histone H3-K4 methylation (GO:0051568),0.49237904766074847,1.2618644356784603,0.17369093231162197,0.7666898582353611,1.0,7/26,14.84%,DPY30;RBBP5;KMT2A;MEN1;WDR5;PAXIP1;TET2
prerank,myeloid dendritic cell activation (GO:0001773),0.5659676699801383,1.2617084998289516,0.19184290030211482,0.766123100543463,1.0,3/12,9.13%,SLAMF1;BATF3;HMGB1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.40451640366579,1.2613035211814456,0.08012170385395538,0.7664746462055565,1.0,58/161,24.14%,WNT11;PSMB10;WNT5A;PSME2;PSMA5;PSME4;TMEM170B;SFRP2;MAD2L2;PRICKLE1;PFDN5;SOX9;PSMA3;TCF7L2;NPHP3;SNAI2;AMFR;BICC1;CYLD;FRZB;PSMB9;DACT1;RBX1;DKK3;PSMD2;SCYL2;PSME3;APOE;LZTS2;DAB2;LMBR1L;PSMA4;SOX2;MLLT3;MCC;PTPRU;MDK;TPBG;HDAC1;PSMD7;PSMD8;STK3;PSMD9;PSMF1;STK11;PSMB6;PSMC2;PSMD12;GLI3;RUVBL2;PSMD4;CUL3;LIMD1;CHD8;AXIN1;PSMA2;TLE5;KREMEN1
prerank,peripheral nervous system development (GO:0007422),0.4922686379344843,1.2611126578493135,0.17783505154639176,0.7660606863810583,1.0,5/23,18.18%,PMP22;BDNF;GDNF;SCN8A;NF1
prerank,positive regulation of cell population proliferation (GO:0008284),0.3909431121080454,1.2606331399749187,0.01,0.7668197577268208,1.0,88/423,17.39%,STAT1;NAMPT;IL15;AGT;CRLF1;NOD2;BST2;FLT1;SLAMF1;HYAL1;WNT5A;IRS1;KDR;GAREM1;DDRGK1;GDF9;CDH13;MECP2;KITLG;TGFA;CDC25B;AQP11;S1PR2;SFRP2;FXN;LAMC1;CD47;HCK;NACC1;CCL5;CCND2;CNOT7;TIPIN;CACUL1;SOX9;CX3CL1;FGFR2;TCF7L2;TFAP2B;CSF1;TBC1D8;DHX9;MEGF10;MEIS3;CTSH;IL12RB2;SIRT6;BAMBI;LYN;GDNF;SCX;INSR;PROX1;PHIP;CIB1;NPM1;HPSE;FAM98B;CCL14;CEP131;VEGFD;FGF9;RTKN2;XBP1;PIM1;NOP2;CAPNS1;RPS6;CAPN1;BAD;CHTOP;STX4;PRKCH;SERTAD1;IRS2;EZH2;BMPR1A;PRMT1;ACER3;FGFR3;AIF1;IL18;NDUFS4;TCIRG1;RBPJ;MDK;RPS15A;PTPRC
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3972449267984997,1.2603916770572363,0.054490413723511606,0.766619676171777,1.0,63/208,22.03%,STAT1;EDAR;TNFSF10;TRIM14;NOD2;BST2;NOD1;WNT5A;ALPK1;TRIM25;BIRC2;CD40;CANT1;RBCK1;TRIM21;IKBKE;DHX36;CX3CL1;TRAF4;CFLAR;TRIM39;TSPAN6;TMEM106A;TMEM9B;RNF31;TRAF3;RORA;SPHK2;TNIP1;ZC3H12A;RIOK3;TRAF5;IRAK4;NEK6;REL;MIER1;SHARPIN;AKAP13;BIRC3;TNIP2;MYD88;TNIP3;IRAK1;MIB2;ZDHHC13;LGALS9;CXXC5;TRIM62;TFG;UBE2V1;TAB3;TANK;RIPK2;PER1;TRIM13;ZFAND6;MAPKBP1;RHOH;OPTN;LITAF;ROR1;S100A13;GOLT1B
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4481109146189471,1.2597636406467272,0.14482758620689656,0.7679344151882734,1.0,13/48,18.22%,PML;MSH2;CHEK2;BCL2L11;AEN;IKBKE;SNW1;DDIT4;DYRK2;PRKDC;BAX;PHLDA3;FNIP2
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5971913831329669,1.2596151239206503,0.1993911719939117,0.7673770539499748,1.0,3/11,7.25%,ZFP36;STAT3;DHX9
prerank,B cell proliferation (GO:0042100),0.5377946553426036,1.2584411809047555,0.2028169014084507,0.770747283725858,1.0,2/17,2.63%,GAPT;CD40
prerank,cellular response to growth factor stimulus (GO:0071363),0.404505968054288,1.2579301093946695,0.0856269113149847,0.7716397960208112,1.0,44/151,20.36%,FLT1;HYAL1;WNT5A;SPRY2;KDR;CPNE3;ZFP36;GAREM1;ACVR1;HAS1;LRP2;CCL5;DUSP3;SOX9;CTNNB1;MAP2K3;SNAI2;MAGI2;RAPGEF2;BCAR1;BMPR2;MAPK14;CIB1;ZFP36L1;PTPN11;GAS1;NR3C1;RACK1;LIMS1;RAPGEF1;NRP1;CORO1B;INPP5K;BMPR1A;SOX5;ADAMTS12;PDE3A;STMN2;ACVR2A;DSTYK;ERN1;ACVRL1;APPL2;WWOX
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.543534323369424,1.257361579473213,0.21067415730337077,0.7727776527379958,1.0,3/15,7.13%,SAT1;DDC;SMOX
prerank,endochondral bone morphogenesis (GO:0060350),0.5827227184451329,1.257107810675332,0.21255349500713266,0.7725582181310406,1.0,5/11,16.05%,COL13A1;SCX;BMPR2;TRPV4;FGFR3
prerank,positive regulation of cell adhesion (GO:0045785),0.4258183949669264,1.2570528523873257,0.12795698924731183,0.771635477020351,1.0,16/74,14.27%,FBLN2;HYAL1;SFRP2;ADAM8;CD47;CCL5;EPHA4;RET;MEGF10;CIB1;DUSP26;PPM1F;LIMS1;RAC1;STX4;JAK2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.40392044204445876,1.2570039434001088,0.08478038815117467,0.7706852216987112,1.0,24/140,15.24%,CHRNA9;CALCA;CXCR4;FIS1;CD55;FPR3;SLC8A1;PTGER4;ADCY5;TACR1;GNA15;TAC1;PTGER3;CACNA1A;ACKR3;P2RX4;HMGB1;TAC4;C3AR1;GPR35;TRPV4;SPPL3;NPTN;SELENOT
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.39520849378029177,-1.2566768084256237,0.13584905660377358,0.9467488201390951,1.0,11/22,20.67%,PARP1;ERCC3;XPC;ERCC2;UBB;UBC;UBA52;RPS27A;GTF2H3;XPA;GTF2H4
prerank,regulation of interleukin-6 production (GO:0032675),0.4070787361513385,1.2558100712595912,0.13107822410147993,0.7739806876617786,1.0,23/96,17.70%,IFIH1;NOD2;SLAMF1;WNT5A;STAT3;CD47;TLR8;CX3CL1;DHX9;TMEM106A;APP;HMGB1;SPHK2;ZC3H12A;IL17D;XBP1;PTPN11;MYD88;TLR2;AIF1;LGALS9;TLR3;POU2F2
prerank,replicative senescence (GO:0090399),0.5753097431915863,1.2556908702620426,0.21220930232558138,0.77328047858657,1.0,2/12,4.45%,CHEK2;CHEK1
prerank,regulation of B cell activation (GO:0050864),0.4929185219989055,1.255050563126286,0.19612903225806452,0.7747102496556347,1.0,5/25,14.67%,THEMIS2;NOD2;ZFP36L1;FCGR2B;TNIP2
prerank,regulation of amyloid fibril formation (GO:1905906),0.5481431304721281,1.2546225303455143,0.18844566712517194,0.7751810548303736,1.0,6/15,12.34%,CLU;PFDN5;APP;PSEN1;PFDN4;APOE
prerank,contractile actin filament bundle assembly (GO:0030038),-0.43927870389541196,-1.2536480192664563,0.18771331058020477,0.9444300295935053,1.0,7/15,18.29%,SORBS1;ARRB1;PDLIM1;SRC;RHOA;FAM171A1;KCTD13
prerank,stress fiber assembly (GO:0043149),-0.43927870389541196,-1.2536480192664563,0.18771331058020477,0.9444300295935053,1.0,7/15,18.29%,SORBS1;ARRB1;PDLIM1;SRC;RHOA;FAM171A1;KCTD13
prerank,extracellular transport (GO:0006858),0.567427776420053,1.252931654365704,0.20224719101123595,0.7806632801398481,1.0,3/12,6.16%,CABYR;CCDC40;ADCY10
prerank,regulation of histone modification (GO:0031056),0.5571991816292109,1.2526883266629691,0.2028169014084507,0.7805067448142814,1.0,2/13,10.81%,MTHFR;SETD5
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.3808129276646482,-1.2524504746357112,0.15450643776824036,0.9424320438025439,1.0,6/22,12.68%,STIM1;GRM3;CAP2;EDNRB;PALM;CCR2
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.3812681365690014,-1.2517767493076841,0.13839285714285715,0.9386182933631232,1.0,14/25,25.50%,CARD11;TRAF2;PNP;TRAF6;CCR2;CD86;GLMN;ANXA1;IRF4;CD28;IL1B;IL1A;CD80;RPS3
prerank,fatty acid beta-oxidation (GO:0006635),0.4406698680770562,1.2510147847945383,0.15977011494252874,0.7860635944414655,1.0,16/51,21.16%,MCAT;ACOXL;ACADL;ECI2;AUH;ABCD1;PEX2;ACADS;GCDH;PPARD;HADHA;ACAT1;ACOX1;HADH;ABCD4;DECR2
prerank,endocrine system development (GO:0035270),0.5105897376893304,1.250992687084229,0.18863049095607234,0.7849774327532243,1.0,6/21,18.18%,WNT11;TG;DKK3;SOX2;MDK;NF1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.4742408899251231,-1.2503486038901115,0.20216606498194944,0.9373755416226933,1.0,7/12,20.45%,SYT2;RIMS1;RIMS3;UNC13A;SYT8;RIMS2;SYT1
prerank,chemical homeostasis (GO:0048878),0.4285434857556693,1.2491677286622147,0.16207276736493936,0.7911896390551885,1.0,19/61,21.55%,ACOXL;USF2;PNPLA2;AQP11;TLCD2;FBXW7;USF1;ABHD8;AQP4;THADA;IRS2;SLC4A2;ACOX1;PNPLA3;NR1D2;DDX3X;ZBTB20;ADCK1;PNPLA8
prerank,autonomic nervous system development (GO:0048483),0.5256764259114639,1.2489648312189598,0.2148876404494382,0.790867663004178,1.0,6/17,18.18%,KIF26A;TFAP2B;GDNF;NRP1;PHACTR4;NF1
prerank,positive regulation of mRNA processing (GO:0050685),0.5082541265067239,1.248251041633161,0.21456436931079323,0.7925106778746213,1.0,8/21,15.91%,RBMX;DHX36;NCBP2;SNW1;DAZAP1;NCBP1;RBM3;SF3B4
prerank,mitochondrial fission (GO:0000266),0.538080984919392,1.24709723096347,0.21389645776566757,0.7959775223021831,1.0,8/16,23.67%,MTFR2;FIS1;GDAP1;DNM2;MTFP1;SLC25A46;OPA1;DNM3
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5195223297354901,1.247055140398657,0.21287779237844942,0.7949456447248107,1.0,6/19,16.80%,PIK3AP1;NMI;PRKCE;TNIP3;IRAK1;LGALS9
prerank,protein kinase A signaling (GO:0010737),0.5550013973675934,1.2467453063386278,0.22406639004149378,0.7950161335822489,1.0,1/12,0.59%,GAL
prerank,cytoplasmic translation (GO:0002181),-0.27144311643178654,-1.246658833587164,0.06451612903225806,0.9457803368625092,1.0,31/91,18.72%,RPS12;RPL13;RPS14;DRG1;RPS28;RPL10;RPL23;RPL17;RPS26;RPLP0;RPL9;RPS17;RPL8;RPL21;TMA7;FTSJ1;RPL22L1;RPL31;RPL36A;RPL7;RPL39;RPS9;RPS18;RPL37;RPL13A;UBA52;RPS25;RPS27A;RPL18;RPL38;RPL34
prerank,microtubule-based transport (GO:0099111),0.5672449509033497,1.2466561666167184,0.21137026239067055,0.7942227746422169,1.0,3/12,6.16%,CABYR;CCDC40;ADCY10
prerank,modification-dependent protein catabolic process (GO:0019941),0.39683891631895524,1.2466487422494097,0.06633165829145729,0.7930752676884891,1.0,53/193,19.30%,RNF213;ISG15;UBE2L6;DTX3L;TRIM25;CDC26;FBXO7;ANAPC5;RNF40;RNF5;BFAR;CNOT4;SIAH1;UBQLN2;UBE2B;RNF11;AREL1;RNF114;AMFR;SPSB1;ANAPC4;RNF19B;RBX1;PPP1R11;UBE2E1;UBQLN1;ARIH1;ELOC;BTRC;CDC16;XBP1;CDC27;LONP1;RNF149;SMURF1;FBXL14;UBE2L3;RNF185;ANAPC15;MYLIP;UBE4B;UBR4;UBA1;ANAPC2;RNF166;UBE2K;KLHL15;BIRC6;RFFL;WDR91;PTTG1;RC3H2;PSMD9
prerank,alcohol catabolic process (GO:0046164),0.5902454364938908,1.2465921961288666,0.20178041543026706,0.792155642036122,1.0,3/10,12.34%,MT3;CYP27A1;APOE
prerank,regulation of autophagosome assembly (GO:2000785),0.462233792066288,1.2463940618541716,0.18888888888888888,0.7917726114868037,1.0,5/33,6.35%,CHMP4A;CHMP4B;UBQLN2;LRSAM1;SH3GLB1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5170087979294798,1.2459500545427973,0.21552878179384202,0.7924613451595587,1.0,4/20,10.04%,HSPA1B;DAXX;HSP90AB1;UBQLN1
prerank,autophagy of peroxisome (GO:0030242),0.5687830467410846,1.2457095825617557,0.22972972972972974,0.7922980972140192,1.0,5/12,16.90%,NBR1;PIK3R4;MAP1LC3B;RB1CC1;PEX5
prerank,synaptonemal complex organization (GO:0070193),0.5503067996721587,1.2454323150358584,0.2165087956698241,0.791102088310471,1.0,2/15,10.05%,SYCP1;TEX11
prerank,synaptonemal complex assembly (GO:0007130),0.5503067996721587,1.2454323150358584,0.2165087956698241,0.791102088310471,1.0,2/15,10.05%,SYCP1;TEX11
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5973166534326657,1.2454021828181205,0.20516717325227962,0.7900762546653445,1.0,5/10,22.86%,LOXL2;SOX9;SOX5;ACVRL1;PKDCC
prerank,regulation of centrosome cycle (GO:0046605),0.5014699679098331,1.2446934458000132,0.21767810026385223,0.7917638912176368,1.0,8/21,18.08%,CHMP4B;CHMP1B;XRCC3;NPM1;CEP131;CHMP3;GEN1;CHMP5
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.5911082033238779,1.2445098790804725,0.20647149460708783,0.791299196602365,1.0,2/10,5.47%,WNT5A;CTNNB1
prerank,positive regulation of protein depolymerization (GO:1901881),0.5817293882978061,1.244364749446486,0.21637426900584794,0.7907338103687273,1.0,4/11,18.71%,PDXP;TRPV4;STMN2;CFL2
prerank,cytoplasmic translational initiation (GO:0002183),0.528743978719694,1.2441412303645731,0.18724559023066487,0.7905164978757196,1.0,8/17,21.49%,EIF4A2;EIF4H;EIF3A;DENR;EIF2B3;EIF4B;EIF5;EIF3I
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.4436847610797948,-1.243722121895179,0.2,0.9509108856650207,1.0,4/14,12.53%,XRCC5;TERF2IP;PINX1;NABP2
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.4993773508497118,1.2436639865935084,0.22721268163804492,0.7911995323889383,1.0,7/20,17.23%,CLU;HSP90AB1;HSPA4;LONP1;PSMG2;HSP90AA1;PTGES3
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5319598212488709,1.243314909253243,0.20168067226890757,0.7913856647220808,1.0,6/15,16.02%,IRS1;SLC45A3;LDLRAP1;PRKCE;IRS2;PPARD
prerank,negative regulation of DNA metabolic process (GO:0051053),0.48685542534599613,1.2432671160576918,0.18240620957309184,0.7904422492144831,1.0,10/24,20.16%,MSH2;KMT2A;RTEL1;ERCC4;BMPR2;ZRANB3;DFFA;DACH1;TERF2;ACVRL1
prerank,tRNA modification (GO:0006400),0.42651730515627667,1.2431067115949228,0.15703380588876772,0.7898995377949735,1.0,21/62,21.53%,TPRKB;TRMT9B;OSGEP;MOCS3;BCDIN3D;ADAT2;TRMT1;TRMT13;ALKBH1;AARS1;TRMT61B;THADA;WDR4;DUS2;PUS7;THUMPD3;TYW3;GTPBP3;METTL1;TARBP1;PUS10
prerank,double-strand break repair (GO:0006302),0.39758258328312196,1.2427126716470744,0.09887869520897044,0.7903988867636162,1.0,39/158,15.71%,SAMHD1;PARP9;TENT4A;DTX3L;ZSWIM7;SEM1;CHEK2;APLF;POLM;MAD2L2;AP5Z1;HELQ;POLB;TNKS1BP1;KDM4D;HERC2;MCM9;BRIP1;UBXN1;RAD51C;FEN1;ERCC4;XRCC3;ACTR8;BARD1;HMGB1;ZFYVE26;CIB1;POLQ;PRKDC;PAXIP1;APBB1;NSMCE2;NSMCE1;DCLRE1A;GEN1;RMI1;RECQL5;NHEJ1
prerank,regulation of receptor binding (GO:1900120),0.5909465052276506,1.242426058357875,0.21513353115727002,0.7904162616289672,1.0,2/10,2.20%,BDNF;B2M
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.43763721658218274,1.2418662711393316,0.19679633867276888,0.7914653356569866,1.0,9/51,16.88%,CXCL10;CCL5;CSF1;HMGB1;VEGFD;CXCL17;AIF1;LGALS9;MDK
prerank,icosanoid biosynthetic process (GO:0046456),-0.49967839270997927,-1.2416646099755901,0.24022346368715083,0.9526624760174408,1.0,2/10,4.65%,LTC4S;ALOX5AP
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.41797800906190113,1.2414108683668368,0.14778856526429343,0.7909264485951385,1.0,22/78,16.48%,CTSS;LAG3;KIF26A;KIF3C;DYNC1H1;RILP;KIF2C;AP2A1;DYNC1LI2;ACTR1A;KIF3B;SEC24D;AP1S1;SEC23A;AP2S1;DNM2;CAPZB;FCGR2B;DYNLL1;KIF2A;SEC24A;KLC2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.41797800906190113,1.2414108683668368,0.14778856526429343,0.7909264485951385,1.0,22/78,16.48%,CTSS;LAG3;KIF26A;KIF3C;DYNC1H1;RILP;KIF2C;AP2A1;DYNC1LI2;ACTR1A;KIF3B;SEC24D;AP1S1;SEC23A;AP2S1;DNM2;CAPZB;FCGR2B;DYNLL1;KIF2A;SEC24A;KLC2
prerank,regulation of cytoplasmic transport (GO:1903649),0.582620891080645,1.2412303021668711,0.2213855421686747,0.7905412224341593,1.0,4/11,14.68%,DNAJC13;CHMP3;MAP2K2;DENND10
prerank,diol metabolic process (GO:0034311),0.5162920536285894,1.2407821663354768,0.19787516600265603,0.7912388350126824,1.0,7/19,21.47%,SGPP2;ASAH2;SPHK2;GCH1;HSP90AA1;PRKG2;PLPP2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3575293240695465,-1.240501866546281,0.15384615384615385,0.950483158596789,1.0,13/29,20.67%,RPA1;PARP1;ERCC3;XPC;ERCC2;UBB;UBC;UBA52;RPS27A;RPA3;GTF2H3;XPA;GTF2H4
prerank,cellular defense response (GO:0006968),0.4478805337058095,1.2401438755831444,0.1990521327014218,0.7925654106037918,1.0,2/40,0.33%,LGALS3BP;CXCL9
prerank,protein modification by small protein conjugation (GO:0032446),0.3882533817195997,1.2397029708059848,0.033,0.7931910106461588,1.0,91/361,18.77%,RNF213;IFIH1;ISG15;TRIM14;DTX3L;NUP37;SKP1;UBE2W;NFX1;DDRGK1;KLHL20;TMEM129;UVSSA;HLTF;CUL5;ARRDC4;FBXO7;RNF40;MOCS3;TRIM21;SUMO2;SUMO3;CNOT4;NUP153;UBE2B;TNFAIP1;FBXW7;AREL1;HERC2;CUL7;TRIM39;UBE2M;VPS11;DET1;AMFR;KLHL13;SPSB1;FBXW8;DCUN1D4;DCAF15;CAND1;RAE1;UCHL3;RBX1;UBE2E3;BARD1;UBA2;PEX2;UBE2E1;WAC;ZSWIM8;VCPIP1;ARRB2;ARIH1;ELOC;BTRC;RNF103-CHMP3;CDC16;CDC27;TRIM26;SMURF1;KLHL9;PRKDC;UBE2L3;RACK1;MYLIP;RNF25;NSMCE2;NUP155;MYCBP2;RNF103;LZTR1;PIAS1;UBA1;PIAS2;LMO7;ENC1;MIB2;PEX5;FBXL5;PEX13;UBE2K;CBLL1;NUP88;BIRC6;CAND2;TRIM62;WWP1;PCNP;MGRN1;ASB1
prerank,regulation of T cell mediated immunity (GO:0002709),-0.4900173593935739,-1.239305903714046,0.20738636363636365,0.9484993816141203,1.0,5/10,14.68%,ZBTB1;TRPM4;TNFRSF1B;CCR2;WAS
prerank,angiogenesis involved in wound healing (GO:0060055),0.5774037111932793,1.23920204227824,0.21812596006144394,0.7940174194511573,1.0,3/11,10.66%,KDR;SRF;HPSE
prerank,positive regulation of cell migration (GO:0030335),0.387255106417834,1.2390734485832022,0.06350806451612903,0.7933783800048296,1.0,59/253,17.39%,WNT11;FLT1;CCL7;HYAL1;SPRY2;KDR;CPNE3;PIK3CD;DDRGK1;AGO2;SEMA4D;SOD2;CXCL16;CDH13;ACVR1;STAT3;MYO1C;MMP14;RUFY3;CCL5;SYDE1;SOX9;FAM83H;CARMIL1;ARHGEF7;PODXL;CSF1;SNAI2;RET;ELP6;MAPRE1;MYOC;RAPGEF2;CTSH;BCAR1;PDPN;INSR;BMPR2;ROR2;CIB1;PPM1F;SUN2;XBP1;PRKCE;RACK1;NRP1;DAB2;STX4;RREB1;MIEN1;SPAG9;AIF1;SEMA3D;RAB11A;MTOR;MGAT5;MDK;CBLL1;PTPRC
prerank,regulation of trans-synaptic signaling (GO:0099177),0.4679894538425729,1.2389656318381181,0.19230769230769232,0.7926401447998676,1.0,14/33,25.14%,BDNF;GRIK3;EIF4EBP2;ABR;CACNA1A;IQSEC2;GRID1;NLGN3;LRP8;BCR;LRRC4;GRIK4;GRIK5;GRIK2
prerank,diterpenoid metabolic process (GO:0016101),0.43302346228359123,1.2383194050984818,0.16179775280898875,0.7940150221743265,1.0,9/55,13.22%,BCO2;SDC3;SDC4;LRP2;RDH11;AGRN;AKR1B10;APOE;ALDH1A1
prerank,response to glucocorticoid (GO:0051384),0.4801623551447778,1.238301695227322,0.20395550061804696,0.7929644621291696,1.0,6/26,12.63%,ZFP36;BCL2L11;ZFP36L1;SLIT3;NR3C1;UBE2L3
prerank,ribosomal large subunit assembly (GO:0000027),0.4844198246499486,1.2379909527256914,0.20052770448548812,0.7930373970790843,1.0,14/24,22.08%,MDN1;NOP53;RRS1;PPAN;DHX30;NOP2;RPL23A;RPL11;RSL24D1;RPL24;FASTKD2;RPL3;RPL5;RPL6
prerank,vitamin D metabolic process (GO:0042359),0.5454741839732514,1.2378590893513548,0.22566995768688294,0.7925131628796817,1.0,1/13,3.42%,LRP2
prerank,miRNA metabolic process (GO:0010586),0.5098382765949975,1.2376555321132297,0.2074966532797858,0.7921782812900393,1.0,7/20,17.16%,AGO2;TARBP2;BCDIN3D;DIS3L2;TUT7;DICER1;PRKRA
prerank,regulation of cardiac conduction (GO:1903779),0.4366082272068532,1.237621045470677,0.16856492027334852,0.7912081452076242,1.0,9/54,10.97%,AGT;ASPH;FXYD4;ATP1B3;SLC8A1;ITPR1;NPPC;FXYD6;AHCYL1
prerank,positive regulation of chemotaxis (GO:0050921),0.4434353526217471,1.236952792680666,0.18427230046948356,0.7927115092796201,1.0,11/43,16.88%,KDR;CDH13;MET;SMOC2;P2RX4;PPM1F;NRP1;STX4;DSCAM;AIF1;MDK
prerank,regulation of cholesterol transport (GO:0032374),0.5050965328513513,1.2368190711943996,0.20877659574468085,0.7920922007249128,1.0,4/20,12.95%,NR1H2;YJEFN3;NFKB1;TSPO
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.43957316896793197,1.2366620763867506,0.17591499409681227,0.7916122864318949,1.0,6/46,6.23%,STAT1;CDH13;CCL5;CTNNB1;CX3CL1;TCF7L2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4179790104281391,1.2365457950186283,0.15460526315789475,0.790962576976433,1.0,31/76,25.86%,HSPA1B;TRIB3;CLU;DDRGK1;SUMO2;NOP53;FBXW7;PRICKLE1;DET1;RNF19B;SOCS5;RBX1;ARIH1;SMURF1;RACK1;DAB2;PIAS1;HECTD1;RNF180;HSPBP1;USP5;NUB1;STUB1;DNAJB2;SUMO1;VCP;AXIN1;BBS7;SIRT2;RAD23A;DDA1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.5657122212554091,1.2361142354251236,0.24522760646108663,0.7915515820385447,1.0,2/11,2.36%,NR1H2;SLC27A1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.37459728661455494,-1.2360550877840577,0.16822429906542055,0.9551554834389457,1.0,9/24,18.66%,TGFB1;NUMB;RHOQ;DMTN;TMBIM1;GDI1;ABI3;ITGB1BP1;PICALM
prerank,regulation of cellular component movement (GO:0051270),0.43974501396504767,1.2358117426271005,0.18337129840546698,0.7916521486032485,1.0,9/49,9.79%,SP100;DAPK3;ACTN1;YTHDF1;PKN2;IGBP1;LYN;PDPN;ZSWIM8
prerank,regulation of glycogen metabolic process (GO:0070873),0.5570005713071471,1.2356429889449927,0.22096317280453256,0.7912677115602473,1.0,5/12,20.61%,PPP1R3E;PPP1R3D;RUBCNL;INPP5K;PPP1R3B
prerank,regulation of cell aging (GO:0090342),0.5722082675120962,1.2354123400753003,0.22998544395924309,0.7910322080112974,1.0,3/11,11.86%,PNPT1;RSL1D1;NEK6
prerank,lymphocyte mediated immunity (GO:0002449),0.5639729800529839,1.2350226374398385,0.2077922077922078,0.7913907858965076,1.0,2/12,2.89%,MSH2;CD55
prerank,mRNA metabolic process (GO:0016071),0.40683872186327785,1.234909921250602,0.14331550802139037,0.7907147873033376,1.0,36/90,24.21%,HSPA1B;PNPT1;ZFP36;DDX5;PRPF18;NCBP2;DCP2;HNRNPA2B1;YTHDF2;NONO;PPARGC1A;USP39;DIS3L2;PCF11;AURKAIP1;SNRPG;NCBP1;NUDT16;GEMIN2;SRSF7;SF3B4;SRSF4;LSM5;TBRG4;ERN1;PCBP3;SRSF5;SF3A2;TCERG1;AGO4;SRSF2;RNH1;ZFP36L2;SNRPD3;RNASE4;SON
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.36693925029359353,-1.2347900584482712,0.1722488038277512,0.9536551973010632,1.0,7/26,12.68%,TGFB1;SULF1;CCBE1;NOX1;C3;BRCA1;CCR2
prerank,regulation of neuron apoptotic process (GO:0043523),0.40807128495231043,1.2346792809552625,0.13326226012793177,0.7904976957562582,1.0,24/96,19.22%,CRLF1;MSH2;UNC5B;BDNF;SOD2;ADAM8;EGLN2;CTNNB1;MT3;NRBP2;TFAP2B;AGAP2;GDNF;PRNP;MAG;PPARGC1A;APOE;AKT1S1;MDK;BAX;TRIM2;RETREG1;NF1;SET
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.41980935842093614,1.2344348288997722,0.15460526315789475,0.7903366939761081,1.0,19/67,18.85%,FBLN2;UTRN;CDH13;CX3CL1;CARMIL1;ARHGEF7;CSF1;MYOC;CIB1;PPM1F;LIMS1;NRP1;RAC1;JAK2;RREB1;CRK;MDK;VIT;TESK1
prerank,retinoid metabolic process (GO:0001523),0.41843674984997775,1.2344055202639235,0.15376344086021507,0.7893490894259354,1.0,11/71,13.22%,BCO2;SDC3;SDC4;LRP2;RDH11;CYP26B1;AGRN;ALDH1A2;AKR1B10;APOE;ALDH1A1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.48009197636631173,1.2333592828460525,0.1987012987012987,0.7922391930723004,1.0,4/26,1.58%,IFIH1;NOD2;NOD1;ALPK1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.5627694775244447,1.233114601427911,0.23605150214592274,0.7921261951922476,1.0,3/12,13.96%,CLTRN;BAIAP3;STX4
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.43226254985816237,1.2325492047249178,0.17869415807560138,0.7931792945899354,1.0,19/54,23.42%,KDR;CD40;MECP2;MAP2K3;CSNK2B;P2RX4;HMGB1;MAPK14;APOE;SH3BP1;NF1;ACVRL1;GADD45A;AKT3;FGF2;ATP5F1B;STAT5A;VASH1;PDPK1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.48699184663995454,1.2324017901461493,0.22597402597402597,0.7926891949657575,1.0,6/25,17.12%,TNFSF10;MLLT11;BCL2L11;BAD;BMF;BAX
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.4453453084420529,-1.2318666504963869,0.19745222929936307,0.959484240954009,1.0,7/14,21.66%,NFKBIA;FAF1;KEAP1;NFKBIE;NFKBIB;PSMD10;CCDC22
prerank,phospholipid transport (GO:0015914),0.43504365133898215,1.231705013134245,0.18623024830699775,0.794216057736379,1.0,15/52,19.72%,ATP10A;ABCA1;ABCG1;ATP8A1;OSBPL8;PITPNM1;ABCC1;APOE;ATP11A;NPC2;ATP9B;MTTP;LDLR;OSBPL2;PCTP
prerank,regulation of mitotic cell cycle (GO:0007346),0.39271553342620497,1.2307358238348478,0.08704453441295547,0.7968337950994746,1.0,36/171,13.12%,PKMYT1;PSMB10;DAPK3;SKP1;PSME2;PSMA5;CDC26;ASAH2;PSME4;ANAPC5;CDC25B;RNF40;PKN2;BRINP3;DUSP3;SRA1;PDXP;PSMA3;CUL7;CYLD;PSMB9;ANAPC4;SMOC2;APP;UBE2E1;BTRC;CDK10;PSMD2;SIK1;CDC16;CDC27;NEK6;GAS1;PSME3;RB1;ANAPC15
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.4080973925593948,1.2304745117555456,0.14790996784565916,0.7967345015503372,1.0,28/86,19.81%,CLU;HCK;EVL;CX3CL1;PDXP;CARMIL1;MAPRE1;CDK5RAP2;NCK1;MET;APP;NCK2;PROX1;SNX9;PSEN1;APOE;AKAP9;RB1;SYNPO;PRKCE;TRPV4;RAC1;BAIAP2;BAIAP2L1;STMN2;CFL2;NUMA1;NCKAP1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.42636280113266084,-1.2303112317262894,0.19784172661870503,0.9590855220177822,1.0,8/15,29.29%,PTTG1IP;SIRT1;MIF;KDM1A;ING2;TAF9;TAF9B;PRKN
prerank,focal adhesion assembly (GO:0048041),0.5051315984767669,1.230062389651844,0.22015915119363394,0.7972274133426109,1.0,9/21,17.12%,ACTN1;THY1;ACTN2;PEAK1;ARHGEF7;PIP5K1A;WHAMM;TAOK2;BCR
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.38591708737717284,1.2299817446749237,0.039,0.7964436781951393,1.0,119/341,23.58%,RNF213;PML;PSMB10;UBE2L6;DTX3L;PSME2;TRIM25;UBE2W;BIRC2;KLHL20;PSMA5;UBAP1;CDC26;RNF4;FBXO7;PSME4;ANAPC5;RBCK1;RNF40;FEM1B;RNF5;MVB12A;BFAR;CNOT4;SIAH1;UBQLN2;UBE2B;TNFAIP1;RNF11;KCTD17;FBXW7;CTNNB1;PPP2R5C;AREL1;PSMA3;UBXN1;RNF114;AMFR;SPSB1;PSMB9;ANAPC4;RNF19B;RBX1;VPS37A;PPP1R11;UBE2E1;ZSWIM8;UBXN2B;UBQLN1;ARRB2;ARIH1;ELOC;BTRC;UBXN11;RNF122;PSMD2;CDC16;XBP1;CDC27;RNF149;SMURF1;PSME3;FBXL14;VPS28;UBE2L3;FBXL19;RNF185;ANAPC15;SHARPIN;ZRANB1;MYLIP;UBE4B;PSMA4;NHLRC3;APPBP2;UBR4;UBA1;ATE1;ANAPC2;GID4;RNF166;UBE2K;KLHL15;BIRC6;TRIM2;WWP1;PSMD7;PCNP;RFFL;WDR91;PSMD8;PTTG1;RC3H2;PSMD9;ZFAND2A;SPOP;PSMF1;TRIM13;PSMB6;RNF216;PSMC2;NUB1;PSMD12;USP33;HUWE1;UBQLN4;SMURF2;TSG101;STUB1;ADRM1;PSMD4;CUL3;PELI1;KCTD21;KAT5;FEM1C;FEM1A;VCP;MAEA
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5636302480174968,1.2290798193006989,0.25401459854014596,0.7988350656111151,1.0,4/12,15.87%,XDH;SPRY2;PIK3CB;ADAMTS12
prerank,response to iron ion (GO:0010039),0.5661993921408861,1.228805731373093,0.2303206997084548,0.7988550449585086,1.0,4/12,14.72%,B2M;FXN;SLC11A2;TFR2
prerank,positive regulation of mitochondrion organization (GO:0010822),0.42588314520999115,1.2287692202457479,0.18312985571587126,0.7979060322112139,1.0,7/57,4.40%,TNFSF10;KDR;FIS1;MLLT11;BCL2L11;FBXO7;CHCHD10
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.46385509518326706,1.228450871223035,0.19672131147540983,0.7981054987827776,1.0,12/32,21.57%,SLC27A1;CSNK2B;CSNK2A2;LPIN2;CEPT1;ABHD3;CHPT1;PCYT1A;PCTP;SLC44A1;CHKA;PCYT1B
prerank,apoptotic mitochondrial changes (GO:0008637),0.46914228716005113,1.228314088581406,0.23057953144266338,0.7975446921781363,1.0,7/32,13.25%,IFIT2;CLU;FIS1;SOD2;TIMM50;BAD;NDUFS1
prerank,regulation of histone methylation (GO:0031060),0.5500565601331965,1.2283033832404264,0.2275449101796407,0.7965171475908015,1.0,3/13,13.37%,MTHFR;AASS;CHTOP
prerank,positive regulation of T cell differentiation (GO:0045582),0.4505418736444887,1.2281401813114374,0.19951923076923078,0.7960630104867137,1.0,12/36,21.80%,TNFSF9;SOCS1;ADAM8;BCL6;XBP1;NKAP;DUSP10;SART1;MDK;CD46;RHOH;GLI3
prerank,myelination in peripheral nervous system (GO:0022011),0.5457976528829435,1.2277263000702836,0.24375917767988253,0.7964791078101435,1.0,5/13,18.18%,CNTNAP1;MYOC;ARHGEF10;DICER1;NF1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.4080947444114367,1.227612272093628,0.15658747300215983,0.7958437544697704,1.0,34/85,25.86%,HSPA1B;TRIB3;CLU;DDRGK1;RNFT1;SUMO2;NOP53;OSBPL7;FBXW7;PRICKLE1;DET1;RNF19B;SOCS5;RBX1;ARIH1;RNF185;RACK1;DAB2;PIAS1;HECTD1;RNF180;HSPBP1;USP5;PSMC2;NUB1;STUB1;DNAJB2;SUMO1;TMTC3;VCP;BBS7;SIRT2;RAD23A;DDA1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.40785603224075373,1.2272655414501292,0.15417558886509636,0.7961834301936603,1.0,20/85,14.39%,WNT11;PSMB10;WNT5A;PSME2;DAAM1;PSMA5;PSME4;PRICKLE1;AP2A1;PSMA3;MAGI2;PSMB9;ROR2;ARRB2;AP2S1;PSMD2;SMURF1;PSME3;RAC1;PSMA4
prerank,positive regulation of lipid catabolic process (GO:0050996),0.5116050739379663,1.2269655550887146,0.2198100407055631,0.7962633496348278,1.0,4/19,14.63%,IRS1;PNPLA2;ABCD1;IRS2
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5553445247274047,1.2266538360228287,0.2433234421364985,0.7964386450084434,1.0,4/11,11.69%,SNX33;ACTN2;LEPROT;LEPROTL1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.4961281823746626,1.2257086778900217,0.22529644268774704,0.7989529679112771,1.0,9/21,22.00%,PGD;PGM2L1;PGLS;HK1;RPIA;DERA;RPE;TKT;TALDO1
prerank,receptor catabolic process (GO:0032801),0.48071972375757854,1.2247915987662834,0.2013157894736842,0.8014471406164552,1.0,11/24,19.25%,MVB12A;AP2A1;SH3GLB1;KIF16B;PIK3R4;AP2S1;SMURF1;MYLIP;SNX25;UVRAG;BECN1
prerank,negative regulation of T cell proliferation (GO:0042130),0.47495263263592086,1.2243797873180065,0.2201722017220172,0.8019098215278434,1.0,3/28,9.50%,CD274;SDC4;PRNP
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.4497868211711228,-1.2240246450018701,0.21476510067114093,0.9782688652716113,1.0,4/12,11.57%,DPYSL3;CTPS1;UMPS;CRMP1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.5056217875219485,1.2237249833250001,0.24093264248704663,0.8034010828727028,1.0,8/20,17.34%,TRIB3;SLC27A1;ACADL;FBXW7;ASXL3;SIK1;ERLIN2;PRMT3
prerank,positive regulation of acute inflammatory response (GO:0002675),0.5442973139110783,1.223057163247373,0.23687752355316286,0.8049405305228469,1.0,2/14,8.39%,ADAM8;PTGER3
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.46809917043409977,1.2230340778860107,0.21072319201995013,0.8039569447951093,1.0,7/30,8.47%,TMEM161A;CLU;SFRP2;CDKN2D;RTEL1;SNAI2;ACKR3
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5682359668757229,1.2227466842029115,0.2594268476621418,0.8039630019922902,1.0,3/10,16.64%,CAMK2D;PRKCE;STK39
prerank,positive regulation of synaptic transmission (GO:0050806),-0.28614768284436987,-1.2226372117085493,0.06097560975609756,0.977326990313779,1.0,28/72,21.52%,GRIN2A;GRIN2B;CACNG7;DLG4;PRKCZ;TSHZ3;RGS14;EPHB2;NLGN2;SLC8A3;FLOT1;CACNG8;NRXN1;RIMS1;SHANK3;STX1B;CHRNA7;RIMS3;CCR2;SHISA7;ZDHHC12;RIMS2;CACNG2;KCTD13;PLK2;SYT1;CACNG3;SLC8A2
prerank,mitochondrial genome maintenance (GO:0000002),-0.4725609377411809,-1.2225031868143288,0.20238095238095238,0.971336002551471,1.0,4/11,6.41%,MPV17;SLC25A4;PARP1;SLC25A36
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.572955378828275,1.2220894282689008,0.24420401854714066,0.8054649419809442,1.0,3/10,10.95%,DHX58;TSPAN6;RIOK3
prerank,proteasomal protein catabolic process (GO:0010498),0.3869283171728485,1.2219146639548326,0.09576612903225806,0.8050898526619148,1.0,74/201,23.76%,PML;PSMB10;PSME2;UBE2W;BIRC2;KLHL20;PSMA5;RNF4;PSME4;RBCK1;FEM1B;RNF5;BFAR;SIAH1;UBE2B;TNFAIP1;KCTD17;FBXW7;CTNNB1;PPP2R5C;AREL1;PSMA3;UBXN1;SPSB1;PSMB9;RBX1;ZSWIM8;UBXN2B;ARRB2;BTRC;UBXN11;RNF122;PSMD2;SMURF1;PSME3;FBXL19;RNF185;SHARPIN;UBE4B;PSMA4;NHLRC3;APPBP2;ATE1;ENC1;GID4;UBE2K;TRIM2;WWP1;PSMD7;PCNP;RFFL;SOCS6;DDI2;PSMD8;PSMD9;ZFAND2A;SPOP;PSMF1;TRIM13;PSMB6;RNF216;PSMC2;PSMD12;HUWE1;SMURF2;STUB1;PSMD4;CUL3;PELI1;KAT5;FEM1C;VCP;MAEA;PSMA2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.5448729798657965,1.2217571241274723,0.21467391304347827,0.8046081445493787,1.0,4/14,15.87%,SOX9;SNAI2;PTPN11;ADAMTS12
prerank,central nervous system myelination (GO:0022010),0.5609837443796247,1.221562360780449,0.22321428571428573,0.8042643671465436,1.0,5/11,21.68%,CLU;CNTNAP1;B4GALT5;PLP1;TENM4
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.464124487738768,1.2215226030777095,0.2111111111111111,0.8033504103200325,1.0,5/33,8.22%,AGT;TGFA;DOK1;FBXW7;CCDC88A
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.4017421960339807,1.2210327715011988,0.1463157894736842,0.8042941016354876,1.0,20/101,15.21%,IRGM;NOD2;FLT1;WNT5A;SLC27A1;CD40;ADAM8;CCND2;CCND1;ETAA1;CAB39;MTCP1;TPD52L1;RAPGEF2;PROX1;CIB1;MAP2K2;TELO2;EZH2;CALM3
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.45514304105413955,1.2209552236601497,0.22088835534213686,0.8035199509673803,1.0,11/37,15.54%,PNPT1;XRN2;ENTPD3;ENTPD6;RNASEH2A;NUDT5;RNASEH2C;ENTPD5;NCBP1;RNASEH2B;NUDT16
prerank,cellular response to interleukin-6 (GO:0071354),0.48905070867616807,1.2208936245418875,0.2200488997555012,0.8026963625376143,1.0,6/26,14.27%,STAT1;STAT3;NFKB1;PTPN11;ST18;JAK2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.503079050485365,1.2208556338193415,0.2391891891891892,0.801815622556243,1.0,9/20,20.10%,PML;CAMK2D;FIS1;KCTD17;THADA;PSEN1;BAX;BCAP31;TGM2
prerank,negative regulation of growth (GO:0045926),0.3981959848004351,1.2204739318820421,0.14791666666666667,0.802178503259532,1.0,25/121,13.19%,HSPA1B;WNT11;PML;ESR2;BST2;HYAL1;PNPT1;SFRP2;GNG4;CDKN2D;OSGIN1;SERTAD3;BCL6;MT3;FRZB;ST7L;BMPR2;SPHK2;EI24;SLIT3;SERTAD2;RB1;ENPP1;RACK1;APBB1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.4433005525911434,1.220376419337498,0.20971563981042654,0.8015308053265271,1.0,15/42,19.18%,FBLN2;THY1;CX3CL1;PDPN;PPM1F;PIK3CB;LIMS1;RAC1;JAK2;MINK1;TBCD;CORO1C;VIT;NF1;TSC1
prerank,RNA methylation (GO:0001510),0.41868697394843934,1.2201395914880282,0.1821155943293348,0.8014073358080112,1.0,23/60,20.91%,BCDIN3D;MRM2;ZCCHC4;MEPCE;TFB2M;TRMT13;TRMT61B;THADA;TGS1;DIMT1;NOP2;TRMT10C;RBM15;ZC3H13;METTL14;CBLL1;THUMPD3;TYW3;GTPBP3;BUD23;WTAP;METTL1;TARBP1
prerank,regulation of cellular component organization (GO:0051128),0.3913719730626182,1.2200347241288958,0.12744090441932168,0.8007584021735773,1.0,35/135,17.69%,IRGM;AGT;CAMK2D;WNT5A;SGK3;SGK2;SEMA4D;CDH13;STK38L;MAD2L2;EGLN2;ATAD3A;RAPGEF2;BCAR1;RAB5C;HSPA8;SSRP1;OGFR;AP2S1;SETD5;ARHGEF11;PTPN11;APOE;SOCS2;RAPGEF1;STON1;HSP90AA1;MLLT3;TAOK2;CHPT1;MTOR;OPHN1;CAMSAP2;PLCE1;STON2
prerank,negative regulation of blood pressure (GO:0045776),0.5396185827189369,1.219388836647177,0.23795620437956205,0.8021565664870163,1.0,2/13,9.53%,GPR37L1;BMPR2
prerank,regulation of telomere maintenance (GO:0032204),0.4700494064652088,1.2190943323328678,0.22509702457956016,0.80227339483952,1.0,10/26,18.99%,PML;DHX36;RTEL1;ERCC4;SIRT6;PPP1R10;SMG5;HDAC8;UPF1;TERF2
prerank,nucleic acid metabolic process (GO:0090304),0.4155472815990592,1.2189477041985997,0.16757344940152338,0.8018061046771703,1.0,23/69,19.34%,POLR2G;XRN2;HNRNPH1;RBMX;NCBP2;HNRNPK;HNRNPM;FEN1;HNRNPA2B1;POLR2K;HNRNPL;DDX24;HNRNPA1;DDX54;ENPP1;DNASE2;DUSP11;RECQL5;NCBP1;METTL14;HNRNPA3;WTAP;HNRNPF
prerank,regulation of DNA binding (GO:0051101),0.44441602042570966,1.2187774923503962,0.20327102803738317,0.8014443784065737,1.0,9/44,14.27%,SP100;ILRUN;SUMO3;CDT1;EDF1;CSNK2B;HMGB1;MDFI;JAK2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.47264144868628055,1.2186049904808522,0.22556390977443608,0.8010757743555841,1.0,9/26,14.33%,ANAPC5;CDK5RAP2;ANAPC4;CDC16;CDC27;NEK6;RB1;ANAPC15;NSMCE2
prerank,ribosome assembly (GO:0042255),0.42830577990525137,1.2185478937396685,0.1943127962085308,0.8002436690678726,1.0,22/47,22.08%,PWP2;SBDS;ERAL1;MDN1;NOP53;RRS1;PPAN;NPM1;EIF6;NOP2;MRPS2;RPL23A;RPL11;DHX37;RSL24D1;RPL24;RPL3;MRPS11;MRPL22;DDX3X;RPL5;RPL6
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.3359271827032285,-1.2184840127224712,0.16129032258064516,0.9814532224669907,1.0,17/38,24.84%,CENPO;ASF1A;HAT1;KNL1;CENPA;ITGB3BP;CENPL;MIS18BP1;HIRA;CENPK;CENPU;CENPC;CENPX;ATRX;ASF1B;CENPQ;CENPH
prerank,positive regulation of ossification (GO:0045778),0.4465244710428047,1.2183627961485004,0.19626168224299065,0.7998632795643549,1.0,9/39,15.33%,ISG15;WNT5A;ACVR1;SLC8A1;BMPR2;ADGRV1;PTPN11;NELL1;BMPR1A
prerank,zinc ion transport (GO:0006829),0.5005940161607841,1.218136206148237,0.21842105263157896,0.799731721440661,1.0,5/21,11.36%,TRPM2;SLC30A1;SLC30A5;MT3;SLC30A6
prerank,rRNA catabolic process (GO:0016075),-0.41737378032806494,-1.2180344280629283,0.2277580071174377,0.9769244422318737,1.0,7/16,14.40%,EXOSC7;EXOSC10;DIS3;DIS3L;EXOSC5;EXOSC3;DEDD2
prerank,protein ubiquitination (GO:0016567),0.37892835856435814,1.217870345145526,0.032,0.7997158434000755,1.0,141/471,22.33%,RNF213;HERC6;ISG15;TRIM14;IRF2BP1;PSMB10;UBE2L6;DTX3L;SKP1;FBXL16;PSME2;TRIM25;UBE2W;BIRC2;NFX1;KLHL20;PSMA5;RNF4;TMEM129;UVSSA;HLTF;CUL5;SASH1;ARRDC4;FBXO7;PSME4;RBCK1;RNF40;TRIM21;RNFT1;BFAR;CNOT4;SIAH1;UBE2B;TNFAIP1;RNF11;FBXW7;CTNNB1;UBE3A;AREL1;PSMA3;LRSAM1;HERC2;CUL7;TRIM39;VPS11;DET1;RNF114;AMFR;KLHL13;SPSB1;FBXW8;DCAF15;CAND1;PSMB9;UCHL3;RNF19B;RNF31;RBX1;UBE2E3;BARD1;PEX2;UBE2E1;WAC;ZSWIM8;VCPIP1;ARRB2;ARIH1;ELOC;BTRC;RNF122;PSMD2;RNF103-CHMP3;CDC16;CDC27;TRIM26;SMURF1;PSME3;NPEPPS;FBXL14;KLHL9;PRKDC;UBE2L3;FBXL19;RNF185;RACK1;MYLIP;RNF25;UBE4B;LONRF1;PSMA4;RUSC1;UBE2Q1;DZIP3;MYCBP2;NHLRC3;RNF103;HECTD2;LZTR1;UBA1;LMO7;ENC1;RNF166;MIB2;PEX5;FBXL5;PEX13;UBE2K;CBLL1;BIRC6;TRIM2;CAND2;TRIM62;WWP1;PSMD7;PCNP;MGRN1;ASB1;UBE2V1;PSMD8;RC3H2;PSMD9;SPOP;VPS18;FBXO30;PSMF1;MKRN2;TRIM13;MKRN1;USP5;PSMB6;UNKL;PSMC2;NUB1;PSMD12;HUWE1;FBH1;SMURF2;STUB1;RRAGA;UBR2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.4631336799007682,1.2175700131139269,0.21595092024539878,0.799803549602282,1.0,7/31,12.63%,TRIB3;SKP1;ARRDC4;FBXW7;DCUN1D4;BTRC;UBE2L3
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4465365873964633,-1.217563398707579,0.21630094043887146,0.9724162936864473,1.0,6/13,21.54%,GOPC;NFKBIA;KEAP1;NFKBIE;DBN1;YWHAB
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5733555307310167,1.2172139614392843,0.2481089258698941,0.8001909192213977,1.0,2/10,5.26%,TGFA;FBXW7
prerank,skeletal system development (GO:0001501),0.39205109752222367,1.216789084999172,0.12207527975584945,0.8007941750295169,1.0,19/148,7.77%,WNT11;EXT1;COL13A1;HYAL1;WNT5A;COMP;DDRGK1;CHD7;MMP14;PTGER4;TCOF1;SOX9;P3H1;FGFR2;ITGB8;ANKH;FBN1;FRZB;MYOC
prerank,immunoglobulin mediated immune response (GO:0016064),0.5791397724593388,1.2166627977881548,0.24772036474164133,0.800238084297371,1.0,4/10,15.89%,GAPT;TLR8;FCGR2B;CD27
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.3790879495262266,-1.2166412711326564,0.1652892561983471,0.9701763413708948,1.0,7/23,16.78%,MPP1;NCKAP1L;C5AR2;RAC2;DPP4;RIPOR2;C1QBP
prerank,metal ion homeostasis (GO:0055065),-0.32355444375548315,-1.2160544410216807,0.16666666666666666,0.9662330884812571,1.0,11/40,11.99%,SLC12A6;SLC12A2;GRIN1;ANK3;TMTC2;SNCA;COX11;LETM1;FAM20A;WFS1;SELENON
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.4565732801984517,-1.2159826401713933,0.23104693140794225,0.9603103755355924,1.0,5/13,10.62%,CD81;SAR1A;GCC2;SAR1B;INSIG1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.40077539480558444,1.215897275225308,0.1382198952879581,0.8020707301547133,1.0,29/94,23.60%,PML;CASP4;TRIB3;MYBBP1A;CHEK2;CUL5;MLLT11;BCL2L11;DDX5;ITPR1;IKBKE;PPM1F;DIABLO;SCN2A;PRKDC;BAD;BAX;FNIP2;STK24;ERO1A;ERN1;DDX3X;JMY;MCL1;STK11;PRKCD;BCL2L2;CUL3;ARL6IP5
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.48952782477778767,-1.2157765440295274,0.24522292993630573,0.9549391932304405,1.0,6/10,27.43%,VDAC1;BIN1;FKBP1B;CBARP;ADRA2A;SESTD1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.4798661737517014,1.2156191046093683,0.23285899094437257,0.8020661252662075,1.0,8/24,21.95%,TRPM2;ITPR1;CHERP;HTR2A;PTPRC;ERO1A;LCK;FGF2
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.4770508405401612,1.215220015182825,0.23362175525339926,0.8025996793614362,1.0,6/26,14.08%,TPI1;GBGT1;B4GALT5;SCCPDH;TNIP1;ALG11
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.5479745199014634,1.2151293974467012,0.23120567375886525,0.8019376577629544,1.0,6/13,16.50%,IRS1;PPP1R3E;INSR;DYRK2;IRS2;PHKG2
prerank,histone ubiquitination (GO:0016574),0.49313327502073034,1.2149384240370837,0.225201072386059,0.8016321853860583,1.0,5/21,9.77%,DTX3L;RNF40;UBE2B;UBE2E1;WAC
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.4087616969076795,1.214899444265407,0.16017316017316016,0.8007670910924405,1.0,23/87,19.34%,HYAL1;POLR2G;ZFP36;HNRNPH1;CCL5;NCBP2;FGFR2;HNRNPM;POLR2K;KIF16B;ZFP36L1;RAB14;FGF9;HNRNPA1;PTPN11;TIAL1;NCBP1;FGFR3;FLRT2;FIBP;DSTYK;SPRED1;HNRNPF
prerank,vasodilation (GO:0042311),0.540016228749676,1.21474582992616,0.24599708879184862,0.8003437697489314,1.0,1/13,2.68%,SOD2
prerank,monosaccharide transmembrane transport (GO:0015749),0.523947013584418,1.2147455205757003,0.25102880658436216,0.7993268145141804,1.0,3/16,15.48%,SLC2A6;SLC45A3;SLC2A9
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.4623436409306443,1.213576059026942,0.23850931677018633,0.8027237668768136,1.0,6/26,14.86%,CLU;HSP90AB1;TMEM106A;P2RX4;INSR;HSP90AA1
prerank,negative regulation of cell death (GO:0060548),0.3999482298449907,1.2134285212325016,0.18704284221525602,0.8022524754327921,1.0,16/88,14.33%,HSPA1B;WNT11;CHMP4A;CHMP4B;CLU;NENF;MT3;CSF1;NCK1;LRPAP1;SPEF1;SRGAP2;SORL1;PPARGC1A;DUS2;FYN
prerank,endoderm development (GO:0007492),0.5410286875590807,1.2133473875172276,0.2600574712643678,0.8015090358735986,1.0,2/13,9.39%,LAMC1;KIF16B
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5771248881579814,1.2127869359224983,0.2404870624048706,0.8025679778927649,1.0,5/10,14.89%,CAMK2B;NETO1;APP;SYNGR1;NPTN
prerank,positive regulation of JNK cascade (GO:0046330),0.40931878041985287,1.2127127442802237,0.19094922737306844,0.801833626209686,1.0,17/70,15.89%,EDAR;NOD2;TAOK3;SLAMF1;GADD45G;TRAF4;WNT7B;TPD52L1;APP;HMGB1;TRAF3;TRAF5;FCGR2B;MINK1;TAOK2;MTURN;CD27
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.33960136312526623,-1.2126216891523343,0.1511627906976744,0.96197936385745,1.0,8/37,10.55%,IL1RAPL1;CD164;ADGRL1;FAT4;CADM3;NECTIN1;ALCAM;TENM3
prerank,regulation of kinase activity (GO:0043549),0.40294689182779464,1.2123894675941127,0.18384697130712008,0.8020067063037478,1.0,22/89,19.24%,NLRC5;AXL;FLT1;KDR;RBL1;EPHA4;FGFR2;RET;EPHA6;LTK;MET;INSR;ROR2;LDB2;LDB1;RB1;IRS2;FGFR3;PLCE1;DSTYK;NPRL2;CAMKK2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3862595237448776,1.2115379028192714,0.12757201646090535,0.8040413566499455,1.0,46/158,22.03%,EDAR;TNFSF10;TRIM14;NOD2;BST2;NOD1;ALPK1;TRIM25;BIRC2;CD40;CANT1;RBCK1;TRIM21;IKBKE;DHX36;CX3CL1;CFLAR;TSPAN6;TMEM106A;TMEM9B;RNF31;TRAF5;IRAK4;NEK6;REL;MIER1;SHARPIN;AKAP13;BIRC3;TNIP2;MYD88;IRAK1;MIB2;ZDHHC13;LGALS9;CXXC5;TRIM62;TFG;UBE2V1;TAB3;RIPK2;TRIM13;LITAF;ROR1;S100A13;GOLT1B
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5503729641734856,1.2111822373583314,0.2533136966126657,0.8024439058864071,1.0,6/12,14.33%,ANAPC5;ANAPC4;CDC16;CDC27;RB1;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5503729641734856,1.2111822373583314,0.2533136966126657,0.8024439058864071,1.0,6/12,14.33%,ANAPC5;ANAPC4;CDC16;CDC27;RB1;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5503729641734856,1.2111822373583314,0.2533136966126657,0.8024439058864071,1.0,6/12,14.33%,ANAPC5;ANAPC4;CDC16;CDC27;RB1;NSMCE2
prerank,double-strand break repair via break-induced replication (GO:0000727),0.5534240998384983,1.2108240297222002,0.2535410764872521,0.8028026695396904,1.0,5/12,18.16%,MCM2;MCM7;MCM4;GINS2;GINS4
prerank,lymphocyte migration (GO:0072676),0.4556523049433014,1.2096872640924943,0.2109181141439206,0.8061459910244477,1.0,6/32,11.08%,CCL7;ADAM8;CCL5;CX3CL1;RET;CCL14
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5578145560915142,1.2091400306378306,0.24324324324324326,0.8071696472733888,1.0,6/12,13.32%,CTNNB1;FEN1;CTCF;DDX11;RB1;HDAC8
prerank,regulation of actin filament depolymerization (GO:0030834),0.5517134604812439,1.2089775295620186,0.25,0.8067851308491027,1.0,6/12,28.43%,PDXP;PLEKHH2;SH3BP1;CFL2;PIK3CA;SEMA5A
prerank,amino sugar metabolic process (GO:0006040),0.5774364229681124,1.2088235696700564,0.26533742331288346,0.8063364520585289,1.0,5/10,14.58%,ST6GAL1;GFPT1;ST3GAL1;GNE;SLC35A3
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.4112649798591255,1.2085864383884213,0.18796992481203006,0.8062153423599131,1.0,16/72,17.88%,SP100;PML;CHEK2;CNOT4;CNOT7;TNKS1BP1;TFDP1;PLK3;TFDP2;PAXIP1;E2F4;MYO6;PRMT1;PCBP4;BAX;CRADD
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.4981685797985402,1.2084752674546626,0.22709163346613545,0.8056110870772475,1.0,7/18,23.22%,CXCR4;TMEM98;SLC45A3;MDK;NF1;TENM4;NOTCH1
prerank,telomere maintenance via recombination (GO:0000722),0.5499842739155134,1.2084618751509615,0.2576219512195122,0.8046527485677578,1.0,4/11,14.33%,TPRKB;ERCC4;XRCC3;NSMCE2
prerank,peptide catabolic process (GO:0043171),0.48349985988357824,1.2080507332802128,0.26666666666666666,0.8051435297653882,1.0,9/23,24.77%,ERAP1;CPQ;CTSH;GGT7;NPEPPS;CHAC2;IDE;TRHDE;ECE1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.5147966073814547,1.2079767657686606,0.22237380627557982,0.8044084350730614,1.0,8/16,22.11%,CGAS;MAD2L2;POLQ;SHLD1;KLHL15;SMCHD1;FBH1;UBQLN4
prerank,negative regulation of translational initiation (GO:0045947),0.5320640869932302,1.2078295977276627,0.26425591098748263,0.8040070495810687,1.0,3/13,5.65%,AGO2;LARP1;EIF4EBP2
prerank,neuron cell-cell adhesion (GO:0007158),-0.42899473700008894,-1.2078158954299276,0.22413793103448276,0.9745473604811756,1.0,4/14,8.56%,ASTN1;NRXN2;NLGN2;NRXN1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4066745941995935,1.2078108171707889,0.18142548596112312,0.8030666056616544,1.0,22/79,16.48%,CTSS;LAG3;KIF26A;KIF3C;DYNC1H1;RILP;KIF2C;AP2A1;DYNC1LI2;ACTR1A;KIF3B;SEC24D;AP1S1;SEC23A;AP2S1;DNM2;CAPZB;FCGR2B;DYNLL1;KIF2A;SEC24A;KLC2
prerank,activation of protein kinase B activity (GO:0032148),0.4568104690494131,1.2077949040436082,0.23124231242312424,0.8021421234213555,1.0,8/29,16.31%,WNT5A;OSBPL8;MT3;PPIA;CCDC88A;INSR;IL18;MTOR
prerank,bile acid metabolic process (GO:0008206),0.46578798969475055,1.2077220759802134,0.23558897243107768,0.8014428392096783,1.0,10/27,20.65%,OSBPL7;CH25H;OSBPL3;CYP27A1;NPC1;OSBPL9;OSBP;GBA2;OSBPL2;CYP39A1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4009831510684232,1.2076258998326264,0.1663135593220339,0.8008108335561771,1.0,40/100,25.86%,HSPA1B;TRIB3;CLU;DDRGK1;SUMO2;NOP53;HSP90AB1;PRICKLE1;UBXN1;TRIM39;CAMLG;DET1;N4BP1;UCHL5;RNF19B;SOCS5;RBX1;WAC;ARIH1;RYBP;RACK1;DAB2;PIAS1;RPL11;HECTD1;TLK2;RNF180;HSPBP1;USP5;NUB1;UBQLN4;STUB1;DNAJB2;SUMO1;VCP;BBS7;COMMD1;SIRT2;RAD23A;DDA1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5077293028649087,1.2068734202425988,0.2388663967611336,0.8025869179012314,1.0,9/16,26.35%,CLU;SRF;LRPAP1;APOE;HDAC1;IFNGR1;HMGCR;TNF;LRP1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.45833071817735366,1.206509134727336,0.21549636803874092,0.8029088411179486,1.0,11/32,22.44%,DHFR;ESRRB;CDT1;BACH1;TFDP1;TFDP2;RB1;NPAT;HINFP;ORC1;CDK16
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.3798596065631531,-1.2057810612249646,0.16883116883116883,0.976766890470993,1.0,9/20,21.54%,RPGRIP1L;RNF157;GRK3;SNCA;RGS14;GRK2;CRY1;GPRASP1;YWHAB
prerank,fatty acid oxidation (GO:0019395),0.417085774916445,1.205335578849653,0.19681456200227532,0.8062899144822239,1.0,16/57,21.13%,MCAT;ACADL;ECI2;AUH;ABCD1;PEX2;PPARGC1A;ACADS;PPARD;HADHA;ACAT1;PEX13;ACOX1;HADH;ABCD4;ADIPOR1
prerank,negative chemotaxis (GO:0050919),-0.34434016524865757,-1.2051786485886997,0.19642857142857142,0.9730640453166273,1.0,19/33,29.01%,SEMA4C;UNC5C;ITGAV;SEMA4G;SEMA4A;EPHA7;SEMA6A;SEMA4B;SEMA3E;RHOA;ITGB3;NTN1;SEMA6D;SEMA4F;ROBO1;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,regulation of gene expression (GO:0010468),0.3723335215484342,1.2049936544882747,0.009,0.806505581326701,1.0,179/903,17.49%,PARP14;IGF2BP1;HSPA1B;PARP10;PARP9;WNT11;ZUP1;PML;TRIM14;MOV10;THAP7;ABCC2;ESR2;DAPK3;ICOSLG;XDH;WNT5A;MYBBP1A;TFAP2C;SPRY2;KDR;FASTK;DAXX;CLU;ESRRB;PIK3CD;NFX1;DDRGK1;ZC3H7A;SAP30L;IGF2BP3;AGO2;ZFPL1;TARDBP;TEAD2;NFKB2;CHEK2;MECP2;STAT3;ZFP37;CHD7;TDRD7;SLC38A2;TRIM21;RBL1;SFRP2;CGGBP1;SLC8A1;RUNX1;HNRNPH1;BHLHE40;LARP1;NKX6-2;SRRT;CNOT7;DHX36;MZF1;NFXL1;SERTAD3;FBXW7;PFDN5;SOX9;TAPBP;HNRNPK;ZNF2;NSD3;CD276;ZSCAN26;NFKB1;BCL6;EDF1;AFF1;ZBTB38;BACH1;MT3;PTRH2;TRIM39;NFATC2;ITGB8;CSF1;SNAI2;SAP30;RO60;CTSH;YTHDF2;NONO;ACTR8;LYN;GDNF;POU3F1;CLK3;APP;SCX;DNMT1;INSR;HNRNPL;MAPK14;PRKAG1;TRAF3;RORA;PROX1;PPM1F;ZC3H12A;DNM2;FAM98B;MARF1;ZFP36L1;HNRNPDL;CTCF;NAB1;SETDB2;HCFC2;FGF9;MITF;RYBP;GSN;MAP2K2;HNRNPH3;ZNF423;NKAP;STAP1;TRIM26;HAVCR2;LDB1;PSEN1;REL;EPHX2;PPARGC1A;APOE;NR3C1;UBE2L3;RB1;RACK1;PRDM4;ZNF35;ATXN1;PIK3CB;LIMS1;MATR3;APBB1;CLK2;NELL1;ZC3H7B;POGZ;ASCC2;CASZ1;SOX2;MYD88;RREB1;EZH2;MYB;PRDM11;MBNL2;HGS;BMPR1A;TLR2;TDG;MYCBP;GTF2IRD1;ADNP2;NPAT;SLC24A3;TIPARP;AIF1;RPL11;DENND4A;MTOR;ZNHIT3;ZBTB4;DICER1;RBPJ;LGALS9;FLOT2;TRIP4;PCBP4;RRP1B;TLR3;PTPRC;TULP3
prerank,regulation of T cell activation (GO:0050863),0.43013977677041637,1.2041293625675578,0.20933014354066987,0.8085942333086399,1.0,12/42,20.60%,TNFSF9;THY1;CD47;CCL5;DUSP3;IL27;CCDC88B;TNFSF8;PAG1;SIRPA;TNFAIP8L2;LCK
prerank,regulation of cellular senescence (GO:2000772),0.4600867844237434,1.2034555921360774,0.24344569288389514,0.8101473532219723,1.0,12/28,23.03%,PNPT1;B2M;CGAS;RBL1;RSL1D1;YPEL3;NEK6;EEF1E1;ZKSCAN3;TERF2;AKT3;VASH1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.37573762619931145,1.2024237483177045,0.03403403403403404,0.8130983838842909,1.0,113/476,20.46%,STAT1;SP100;IRF7;PARP9;WNT11;PML;AGT;LHX2;NR1H2;HAS3;ESR2;DTX3L;WNT5A;TRIM45;ESRRB;PRMT2;RNF4;TEAD2;CHEK2;ACVR1;STAT3;MLLT11;ARID1B;RUNX1;MAD2L2;USP21;ILF3;NCOA1;MRPL12;SERTAD3;SOX9;CTNNB1;KMT2A;ARID1A;NSD3;TCF4;SMARCC2;ZXDC;NFKB1;EDF1;SETD3;MT3;NFATC2;TFAP2B;MAP2K3;RET;MDFIC;RAI1;SMAD2;CDK5RAP2;BAMBI;NFIB;POU3F1;SCX;ELF4;WAC;RORA;MED12;PHIP;BTRC;RGMB;NPM1;FOXK1;DNM2;NOTCH4;CTCF;MITF;RYBP;ARHGEF11;MAP2K2;ZNF423;ILF2;PSEN1;PPARGC1A;APOE;BRPF1;APBB1;SMARCA1;KDM8;CASZ1;SOX2;RREB1;CREB5;MYB;INPP5K;PRDM11;MLLT3;TAF15;NPAT;PPARD;KAT8;BRD7;MED16;ELF1;TRIP4;TNNI2;ENY2;CAND2;HDAC1;HINFP;ZKSCAN3;CREB3L2;UBE2V1;CAMKK2;PSMD9;SS18L1;SEC14L2;POU3F3;MED24;ACVRL1;NR1D2;SPIN1;ZFP90
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5657507432111175,1.2022242221902084,0.2629310344827586,0.8128037354235944,1.0,4/11,11.23%,RESF1;SIRT6;DNMT1;SETDB2
prerank,t-circle formation (GO:0090656),-0.48254218120994047,-1.201963303337278,0.2345679012345679,0.9678455091888812,1.0,6/10,17.83%,NBN;SLX4;DNA2;SMARCAL1;TERF1;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.48254218120994047,-1.201963303337278,0.2345679012345679,0.9678455091888812,1.0,6/10,17.83%,NBN;SLX4;DNA2;SMARCAL1;TERF1;ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.48254218120994047,-1.201963303337278,0.2345679012345679,0.9678455091888812,1.0,6/10,17.83%,NBN;SLX4;DNA2;SMARCAL1;TERF1;ERCC1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.48313497823431706,-1.201791406874892,0.23636363636363636,0.9626890803672926,1.0,2/10,4.99%,SIRT7;SELENOS
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.43393906131003945,1.2017360493000344,0.23104265402843602,0.8138469260980552,1.0,10/43,19.95%,CD274;SLAMF1;ILRUN;CX3CL1;ZC3H12A;HAVCR2;DICER1;LGALS9;CD33;SIRPA
prerank,amyloid precursor protein metabolic process (GO:0042982),0.5126507331951051,1.2017000849955912,0.2452054794520548,0.8129826964203432,1.0,6/18,15.31%,ABCG1;LDLRAP1;PSEN1;APOE;APH1A;APH1B
prerank,regulation of microtubule polymerization (GO:0031113),-0.3212857795963017,-1.2015711719604636,0.14375,0.9577014201811611,1.0,9/40,9.55%,PAK1;DYRK1A;FES;DRG1;PRUNE1;CLIP1;TUBB4A;SNCA;ARL2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.38366076505976215,1.2012224432436551,0.11122345803842265,0.8138718078145494,1.0,71/173,27.54%,TRAPPC3;YIF1A;CD55;TGFA;DYNC1H1;COG3;ERGIC3;COPE;TMEM115;HYOU1;SEC16A;ANK1;GOSR2;CNIH3;COG8;DYNC1LI2;ACTR1A;NRBP2;TMED5;SEC24D;CTSC;SEC23A;VAPB;TMED10;TRAPPC12;COG2;CAPZB;KDELR1;SCFD1;DYNLL1;WHAMM;VTI1B;NAPA;MIA2;VAMP4;SEC24A;NRBP1;ARF4;ERGIC2;TMED1;TMED3;DCTN3;GBF1;GOSR1;COPB2;CNIH1;TFG;BCAP31;RAB1A;TMED7;ERGIC1;GOLT1A;TRAPPC6A;RAB2A;F8;CUL3;RAB29;CNIH4;ANK2;BCAP29;TBC1D20;DCTN1;SEC22B;ARCN1;DYNC1LI1;KDELR2;CAPZA2;COG7;COPB1;SPTBN1;COG1
prerank,cellular response to superoxide (GO:0071451),0.5623634241664872,1.2012220631197055,0.2697466467958271,0.8128853182057987,1.0,3/10,14.25%,SOD2;MT3;PRDX2
prerank,negative regulation of response to external stimulus (GO:0032102),0.3904662782803612,1.2006933417112167,0.1655982905982906,0.8138746553606928,1.0,27/105,21.95%,TRAFD1;AOAH;ILRUN;DHX58;NMI;TRIM21;ENPP3;PTGER4;DUSP3;EPHA4;RORA;APOE;CXCL17;RB1;SHARPIN;CRK;PPARD;ACOD1;CERS2;MFHAS1;RTN4RL1;SIRPA;TNFAIP8L2;MAPKBP1;PRKCD;VPS35;FGF2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5634568349465068,1.2005810465714273,0.23922734026745915,0.813323427161529,1.0,4/11,18.08%,SLC18A2;ABCD1;FYN;ABCB7
prerank,sulfur amino acid metabolic process (GO:0000096),0.4747956757708746,1.2004365514096322,0.2417721518987342,0.8128864781466169,1.0,8/24,23.02%,MTHFR;SMS;MSRA;GCLC;MTHFD1;GADL1;MMUT;TXN2
prerank,plasma membrane invagination (GO:0099024),0.46495850707011066,1.2002385418319248,0.24368686868686867,0.8126337486955255,1.0,11/29,20.82%,SNX33;GULP1;FCGR1A;SNX9;ARHGAP25;GSN;FCGR2B;SH3BP1;AIF1;MYH9;MSR1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.3885489901693476,1.1986025172594907,0.1601642710472279,0.8177003083333941,1.0,24/124,12.28%,WNT11;MOV10;PSMB10;WNT5A;PSME2;DAAM1;PSMA5;AGO2;PSME4;SFRP2;PRICKLE1;CTNNB1;AP2A1;PSMA3;TCF7L2;FRZB;PSMB9;PLCB3;ROR2;ARRB2;AP2S1;PSMD2;SMURF1;PSME3
prerank,cation transmembrane transport (GO:0098655),0.4299620199528207,1.1981771545168507,0.2222222222222222,0.8183172792271878,1.0,11/44,22.40%,TRPM5;TRPM2;TRPM6;SLC25A19;TRPM3;SFXN2;TRPM7;SLC36A4;SFXN1;MFSD12;ABCC9
prerank,vesicle organization (GO:0016050),0.4292287244377649,1.1980274339634323,0.22247706422018348,0.8178667549804604,1.0,12/46,13.57%,DNAJC13;USP50;SNX33;WASHC4;SNX10;VPS11;HOOK2;RAB22A;HOOK1;FNBP1L;ARFGEF2;HOOK3
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.5130630118623575,1.1979751268477263,0.26258503401360545,0.817059989709803,1.0,9/17,24.43%,HSP90AB1;MAGI2;CALM3;CD300A;MTOR;PTPRC;CD33;PPP1R12A;CALM2
prerank,protein autoprocessing (GO:0016540),0.5120466094703622,1.1975160203625288,0.25135135135135134,0.8178009028691007,1.0,2/17,3.63%,CASP4;FXN
prerank,DNA replication initiation (GO:0006270),0.4426963603818029,1.1973712383522936,0.23662306777645659,0.8173514140886733,1.0,6/37,5.99%,MCM2;LRWD1;POLE2;MCM7;MCM4;CDT1
prerank,carnitine shuttle (GO:0006853),-0.45351282782475555,-1.197132939417955,0.2116564417177914,0.9696046365103811,1.0,8/11,38.54%,CPT2;THRSP;CPT1A;ACACB;PRKAG2;PRKAA2;CPT1B;MID1IP1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.5196701112535443,1.1970713838940215,0.2387005649717514,0.8174719445706217,1.0,5/15,17.73%,SNX33;ADAM8;SNX9;APOE;SH3D19
prerank,positive regulation of cell junction assembly (GO:1901890),0.41348728724507766,1.1969354873364115,0.20930232558139536,0.8170191190139299,1.0,13/56,16.19%,AGT;KDR;BDNF;CLSTN1;THY1;MYOC;PPM1F;LIMS1;NRP1;RAC1;IL1RAP;CLSTN3;NLGN3
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5660301753489839,1.1968881095520987,0.26666666666666666,0.8162361853028671,1.0,3/10,15.32%,DHX36;NCBP2;NCBP1
prerank,tRNA metabolic process (GO:0006399),0.5083911129541274,1.196751380722026,0.25205479452054796,0.8157763268687873,1.0,7/17,17.02%,TRPT1;DTD1;AARS1;ADAT1;DTD2;YARS2;RPP30
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.47045645727995444,1.1963591621747622,0.22613065326633167,0.8162967956621131,1.0,7/26,14.78%,NR1H2;TRIB3;ACADL;SLC45A3;EIF6;ERLIN2;LPGAT1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.4873470692299105,1.1963150220819405,0.24283765347885403,0.8154900174388974,1.0,8/20,19.77%,KPNB1;ACADL;LDLRAP1;EPHX2;APOE;SREBF1;TTC39B;SEC14L2
prerank,peptidyl-lysine modification (GO:0018205),0.3964270526812496,1.1961506873238739,0.17793964620187305,0.8151700262065223,1.0,41/99,27.29%,IFIH1;LIPT1;LOXL2;NUP37;METTL21A;SENP3;SUMO2;SUMO3;NUP153;SENP5;RAE1;UBA2;VIPAS39;USPL1;NSMCE2;NUP155;GCSH;PIAS1;PIAS2;ATPSCKMT;NUP88;NUP133;NUP43;SENP7;SENP2;SUMO1;HDAC4;KAT5;HDAC6;PLOD3;KAT2B;LOX;TRIM28;NUP205;EEF1AKMT1;SIRT2;PIAS4;SEH1L;EYA1;NUP188;EP300
prerank,protein oxidation (GO:0018158),0.552552802823781,1.1958633303768205,0.26676384839650147,0.8152169965360387,1.0,1/11,0.54%,LOXL2
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.401278395733661,-1.1957230179127725,0.20866141732283464,0.9693301608156429,1.0,4/18,4.73%,TGFB1;TMBIM6;RPS26;ESR1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.4250059775499306,1.1956263074491842,0.20782122905027933,0.8151304159717064,1.0,13/54,17.88%,PML;CHEK2;CNOT4;CNOT7;TNKS1BP1;TFDP1;PLK3;TFDP2;E2F4;PRMT1;PCBP4;BAX;CRADD
prerank,ureteric bud morphogenesis (GO:0060675),0.5064328624462432,1.1951126592826347,0.24033149171270718,0.8161019613227091,1.0,2/16,8.80%,WNT11;GDNF
prerank,endothelial cell proliferation (GO:0001935),0.4981811934968078,1.1948898730619752,0.2427055702917772,0.8159360905369257,1.0,6/17,20.16%,LOXL2;BMPER;BMPR2;DLG1;ERN1;ACVRL1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.46344616444392833,1.1939275956880877,0.24812967581047382,0.8184524940213013,1.0,11/29,18.99%,HSP90AB1;RFC1;TNKS1BP1;RTEL1;GAR1;PPIA;PPP6R3;TELO2;HSP90AA1;PTGES3;TERF2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.5470716470505375,1.193806900336568,0.258493353028065,0.817908342071627,1.0,5/12,14.63%,IRS1;PPP1R3E;INSR;DYRK2;IRS2
prerank,negative regulation of secretion by cell (GO:1903531),0.4318477753368868,1.1935796808937336,0.22037914691943128,0.8177894882787388,1.0,4/38,12.34%,RSAD2;SLC30A1;RHBDF2;APOE
prerank,ganglion development (GO:0061548),0.5416741469860549,1.1929861027601791,0.26572327044025157,0.8189816826527407,1.0,3/11,13.47%,NRP2;CTNNB1;NRP1
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.44976948599649624,-1.1927578037716187,0.23692307692307693,0.9754312199245768,1.0,7/12,24.14%,UST;VCAN;BGN;DSEL;DCN;BCAN;CSPG5
prerank,establishment of protein localization to organelle (GO:0072594),0.40534663622391276,1.1927058445876346,0.21513513513513513,0.8190615381910193,1.0,24/72,20.30%,RANBP6;STAT3;LAMP2;NUP153;KPNB1;CSE1L;PRICKLE1;LRSAM1;NXT1;IL10RA;RPAIN;PPP1R10;HK1;IPO8;NEURL1B;TNPO2;NUP155;RAB11A;RANBP17;LAMP1;NUP88;CD68;NUP133;APPL2
prerank,import into nucleus (GO:0051170),0.4027979816716105,1.1926448031969141,0.21274298056155508,0.8183067880355838,1.0,25/73,20.30%,RANBP6;STAT3;NUP153;KPNB1;CSE1L;PRICKLE1;DDX20;NXT1;RPAIN;HTATIP2;PPP1R10;IPO8;HNRNPA1;TNPO2;GEMIN7;SNRPD2;SNRPD1;NUP155;SNRPG;GEMIN2;RANBP17;NUP88;SNUPN;NUP133;APPL2
prerank,positive regulation of lymphocyte activation (GO:0051251),0.4572106677914539,1.1924570588127366,0.24159402241594022,0.8180100200037212,1.0,9/28,20.60%,NOD2;THY1;CD47;CCDC88B;PRKDC;TNIP2;TYROBP;SIRPA;LCK
prerank,positive regulation of microtubule polymerization (GO:0031116),0.45397686351329947,1.1922064541732602,0.23193916349809887,0.8179882951062206,1.0,8/28,13.90%,HSPA1B;MECP2;MAPRE1;CDK5RAP2;MET;GIT1;AKAP9;RAC1
prerank,mitotic metaphase plate congression (GO:0007080),0.4255375551761856,1.1919581052637769,0.24277456647398843,0.8179478038463429,1.0,16/51,19.25%,CHMP4A;CHMP4B;CHMP1B;KPNB1;KIF2C;CDT1;RRS1;CHMP3;PIBF1;MIS12;RAB11A;CHAMP1;RMDN1;CHMP5;NDC80;BECN1
prerank,lipid catabolic process (GO:0016042),0.5051011932619665,1.1912976418994297,0.2493150684931507,0.8194286463838736,1.0,4/18,8.32%,ACADL;MT3;LIPC;HSD11B1
prerank,negative regulation of cell junction assembly (GO:1901889),-0.35785506593347816,-1.1910866853312958,0.18775510204081633,0.9763810894263818,1.0,6/25,10.34%,APOD;RCC2;ROCK1;CLASP2;DMTN;SRC
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.4632885541452943,1.1910569136220341,0.25572519083969464,0.8193748337796051,1.0,8/26,21.95%,TRPM2;ITPR1;CHERP;HTR2A;PTPRC;ERO1A;LCK;FGF2
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.5168687972887002,1.1908925793622556,0.2582781456953642,0.8189988576036803,1.0,5/15,12.14%,ENTPD3;ENTPD6;ENTPD5;CMPK2;AK4
prerank,regulation of protein localization to nucleus (GO:1900180),0.4282894138482654,1.1906655873733618,0.23433874709976799,0.818890653407801,1.0,4/43,4.10%,PARP9;ILRUN;DTX3L;SUMO3
prerank,protein polymerization (GO:0051258),0.414272273342254,1.1904675172978316,0.2125984251968504,0.8186856548946387,1.0,17/55,21.20%,CHMP4A;CHMP4B;GAS7;TPPP3;CHMP3;CORO7;GSN;TRPV4;FGF13;RAC1;JAK2;AIF1;UBE2K;TTC17;PIN1;GPX4;MSRB1
prerank,regulation of MAP kinase activity (GO:0043405),0.3948611897116361,1.1903862812492088,0.20233050847457626,0.8180163199347424,1.0,19/92,16.42%,AGT;NOD2;FLT1;TRIB3;SPRY2;CD40;ADAM8;CDK12;TPD52L1;PAQR3;LYN;SORL1;APOE;PIK3CB;EZH2;INPP5K;HGS;CD300A;IRAK1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.45672187087842564,1.1899762704161674,0.24621212121212122,0.8185045570330902,1.0,3/27,7.25%,AGT;WNT5A;DHX9
prerank,neurogenesis (GO:0022008),-0.31156536415139896,-1.1898815549837842,0.1532258064516129,0.9754966630983614,1.0,12/43,13.32%,BTBD1;LPAR1;TRAK2;FAT4;SPOCK1;WDR62;CIT;RYK;TGFB2;EPHB1;METTL3;CLN5
prerank,cellular response to glucose starvation (GO:0042149),0.43217072451261096,1.1895269732825011,0.24187725631768953,0.8192782913425787,1.0,10/41,12.05%,MYBBP1A;KPTN;SH3GLB1;PIK3R4;PRKAG1;ZC3H12A;NUAK2;SIK1;XBP1;HNRNPA1
prerank,positive regulation of viral life cycle (GO:1903902),0.4731246804242505,1.1894532232654398,0.2607052896725441,0.8185861563758994,1.0,1/22,0.17%,AXL
prerank,cell-substrate junction assembly (GO:0007044),0.4456687852640354,1.189331558001034,0.2433734939759036,0.8180990550384386,1.0,7/33,6.59%,ACTN1;THY1;LAMC1;ACTN2;PEAK1;ARHGEF7;PIP5K1A
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.49642929402268676,1.188981355333124,0.2646276595744681,0.8184281873263287,1.0,5/18,18.18%,PARP10;MORC3;PEX2;CD300A;NF1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4304209529362134,1.1886437008643742,0.21585365853658536,0.8187298845342311,1.0,11/39,18.91%,CAMK2D;FXYD4;UTRN;NETO1;FXYD6;FXYD5;PRKCE;FGF13;SCN1B;STK39;GLRX
prerank,regulation of centrosome duplication (GO:0010824),0.45532509217750566,1.1883598844521635,0.26433915211970077,0.8188721790750373,1.0,9/29,15.00%,CHMP4B;CHMP1B;XRCC3;NPM1;CEP131;CHMP3;CEP295;TMEM67;GEN1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.38190229985440005,1.188032474287391,0.15869786368260427,0.8191610985315513,1.0,24/142,15.85%,CHRNA9;CALCA;CXCR4;WNT5A;FIS1;CD55;FPR3;SLC8A1;PTGER4;ADCY5;TACR1;TAC1;PTGER3;CACNA1A;ACKR3;HMGB1;TAC4;C3AR1;GPR35;TRPV4;SPPL3;NPTN;SELENOT;HCRTR1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.404914037378316,1.1874023875007862,0.2004381161007667,0.8205323160804656,1.0,20/70,21.57%,NR1H2;TMEM86B;SLC27A1;PLA2G12A;CSNK2B;CSNK2A2;LIPC;LPIN2;CEPT1;LPCAT2;ABHD3;CHPT1;PCYT1A;PLA2G4E;PCTP;SLC44A1;PLA2G6;CHKA;PNPLA8;PCYT1B
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.40810080472677157,1.1871208794359487,0.21624713958810068,0.8206247158011162,1.0,15/56,19.67%,NOD2;NOD1;ALPK1;CTSS;TLR8;UNC93B1;HMGB1;TRAF3;IRAK4;MYD88;TLR2;IRAK1;TLR3;LACC1;TAB3
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.46719783857730723,1.1870677200960638,0.2620253164556962,0.8198601329028669,1.0,8/24,14.94%,IRS1;PPP1R3E;PPP1R3D;INSR;DYRK2;ENPP1;IRS2;INPP5K
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3653576875015244,1.1868654908004381,0.006,0.8196616859745582,1.0,237/1082,18.56%,STAT1;CXCL10;SP100;NLRC5;IRF7;HELZ2;PARP9;WNT11;PITX2;NAMPT;PML;GAL;AGT;LHX2;LMX1A;NR1H2;HAS3;NOD2;ESR2;DTX3L;USF2;PCGF5;MEF2B;WNT5A;TFAP2C;ZBTB17;TRIM45;ESRRB;PRMT2;RARG;DDRGK1;DHX33;AGO2;RBM14;RNF4;TEAD2;CD40;NFKB2;CHEK2;CDH13;ACVR1;STAT3;MLLT11;ARID1B;ACTR2;RBL1;SFRP2;ELK3;RUNX1;MAD2L2;USP21;RBMX;CHCHD10;KLF15;CHEK1;ILF3;DHX36;MZF1;JUNB;UBTF;NCOA1;MRPL12;SERTAD3;SOX9;CTNNB1;CX3CL1;PFKM;KMT2A;PAXBP1;ARID1A;CCNT2;ZNF76;MYDGF;FGFR2;NSD3;TCF7L2;TCF4;SMARCC2;ZXDC;NFKB1;CREBRF;ASXL3;EDF1;ZBTB38;SETD3;THAP3;MT3;USF1;ACTR3;NFATC2;TFAP2B;MAP2K3;RET;UBP1;DHX9;SRF;MDFIC;RAI1;HTATIP2;SMAD2;MRTFA;GLIS3;MEIS3;ATF6B;TFDP1;CDK5RAP2;LPIN2;BAMBI;NCK1;LMO2;MET;GDNF;ATF1;NFIB;METTL23;POU3F1;APP;SCX;HMGB1;NCK2;ELF4;CRTC1;MAML2;AGRN;BMPR2;MEN1;BPTF;WAC;RORA;MED12;PROX1;TNIP1;PHIP;BTRC;RGMB;ZC3H12A;NPM1;FOXK1;DNM2;MAX;SNW1;NOTCH4;CTCF;MITF;GALR1;RYBP;XBP1;TFDP2;IER5;ARHGEF11;ECD;MAP2K2;KLF10;ICE2;ZNF423;ILF2;LDB2;LDB1;PSEN1;REL;PPARGC1A;APOE;PRKDC;SERTAD2;NR3C1;BRPF1;PRDM4;E2F4;APBB1;HDAC8;ST18;MYO6;POGZ;DAB2;WDR43;BCL11B;SMARCA1;KDM8;CASZ1;SERTAD1;SOX2;TNIP2;TFR2;RREB1;DDX39B;TET2;CREB5;MYB;INPP5K;CRTC3;PRDM11;MLLT3;CAMTA2;BMPR1A;TLR2;SMARCD2;TAF15;NPAT;ARF4;MEF2A;PPARD;TNIP3;LAGE3;IL18;MTOR;LMO7;SREBF1;CCNK;ZBED4;KAT8;RBPJ;BRD7;MED16;CHCHD2;ELOF1;ELF1;TRIP4;MPND;IER2;RRP1B;TLR3;TNNI2;PELP1;ENY2;ZBTB49;POU2F2;ZNF513;PTOV1;CAND2;ACVR2A;FOSL2;HDAC1;HINFP;GABPB1;GABPB2;MED10;HOXA5
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4106041933157294,1.1865060082837295,0.2265625,0.8199906141290889,1.0,31/60,29.23%,MOV10;MECP2;DHX36;SOX9;CTNNB1;CCND1;TCF7L2;NFKB1;SRF;MED12;PAXIP1;MED27;MED16;BAX;MED10;MED7;MED24;CDK8;AGO4;MED8;TRIM28;ATF7IP;CDKN2A;PTEN;AGO1;MED25;AGO3;SUB1;MED26;CSF1R;MED13
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.4409702186141502,1.1860154759559451,0.23894862604540024,0.8209071620641367,1.0,9/36,14.43%,TAOK3;DUSP3;IGBP1;CYLD;PPIA;DACT1;MEN1;DUSP10;DLG1
prerank,mitochondrion morphogenesis (GO:0070584),0.5533924775371195,1.185859279839809,0.2662807525325615,0.8205704567211263,1.0,3/11,9.74%,PNPT1;FIS1;SLIRP
prerank,regulation of secretion (GO:0051046),0.5269617576244824,1.1856619048432109,0.25611510791366904,0.8203549069513042,1.0,1/13,0.18%,OAS2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4998524728070091,1.185651859814049,0.2567204301075269,0.8194721773303643,1.0,7/19,20.63%,KDR;TRPM2;FIS1;PRNP;PTPRC;BCAP31;VCAM1
prerank,macromolecule catabolic process (GO:0009057),0.4594121289369204,1.185651684119363,0.23341836734693877,0.8185388377206485,1.0,14/26,23.26%,MVB12A;SIAH1;LRSAM1;SH3GLB1;UCHL3;KIF16B;PIK3R4;SMURF1;MTOR;SNX25;UVRAG;BECN1;IDE;CLN6
prerank,regulation of GTPase activity (GO:0043087),0.3745768883561522,1.1851095076366138,0.16279069767441862,0.8195272371576322,1.0,51/177,21.06%,WNT11;CCL7;PLXNA3;RASA4;DOCK8;RGP1;PLXNB2;SEMA4D;CD40;THY1;CCL5;PLXNB3;CX3CL1;EPHA4;ARHGEF7;RAPGEF6;RAPGEF2;RAP1GAP;AGRN;VAV1;SNX9;STMN3;LRCH1;CCL14;SRGAP2;RGS16;CHN1;ARHGAP11A;RACK1;SIPA1L1;RIC1;FGD6;LIMS1;RAPGEF1;ASAP3;EZH2;CRK;SH3BP1;OCRL;TBC1D2;RRP1B;NF1;CPEB2;ARAP1;PIN1;SGSM3;TGM2;RGS10;DOCK10;CCL4;MMUT
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5387562089583051,1.1851029696411954,0.2767203513909224,0.8186142174827543,1.0,6/13,16.92%,ARID1B;CHEK1;ARID1A;SERTAD2;SERTAD1;ELOF1
prerank,negative regulation of macrophage activation (GO:0043031),0.503996429359435,1.1850082343644184,0.26600284495021337,0.818057821159538,1.0,6/16,18.10%,CX3CL1;CST7;ZC3H12A;FCGR2B;PTPRC;LDLR
prerank,positive regulation of MAPK cascade (GO:0043410),0.3726755875127959,1.1849293280405544,0.11693548387096774,0.8174332232605832,1.0,45/245,16.80%,EIF2AK2;NOD2;TAOK3;FLT1;CCL7;SLAMF1;SPRY2;KDR;GAREM1;GPR37L1;DHX33;CD40;ADAM8;CCL5;FBXW7;CX3CL1;MYDGF;FGFR2;MT3;GPR37;RET;TMEM106A;TPD52L1;RAPGEF2;ACKR3;APP;HMGB1;INSR;BMPER;ROR2;ARRB2;CIB1;CCL14;HTR2A;PTPN11;APOE;NRP1;SOX2;EZH2;STK25;TAOK2;MTURN;FGFR3;IRAK1;LGALS9
prerank,regulation of osteoclast differentiation (GO:0045670),-0.3284940314959336,-1.1843162653517356,0.2214765100671141,0.9925654100333293,1.0,9/33,15.71%,GPR137B;MAFB;TRAF6;CAMK4;CCL3;UBASH3B;TMEM178A;CEBPB;CCR1
prerank,regulation of platelet aggregation (GO:0090330),-0.40622719255470613,-1.1840631898683207,0.2332155477031802,0.9878399474769392,1.0,7/17,17.79%,SYK;PRKCQ;DMTN;CEACAM1;CD9;PRKG1;F11R
prerank,pinocytosis (GO:0006907),0.5590597403924921,1.183858064998792,0.2823179791976226,0.8204601238674522,1.0,2/10,6.05%,SNX33;CARMIL1
prerank,regulation of apoptotic process (GO:0042981),0.3652687244513676,1.183855601555046,0.026,0.8195490440362231,1.0,110/676,13.37%,IFIT3;STAT1;ZBP1;CXCL10;NOL3;AXL;HSPA1B;WNT11;TNFSF10;AGT;IFIT2;DAPK3;TNFSF9;WNT5A;SPRY2;COMP;KDR;DAXX;CLU;BIRC2;PRMT2;RARG;GADD45G;DDRGK1;KLHL20;TNFRSF8;TMEM219;ACTN1;SEMA4D;TARDBP;MLLT11;BCL2L11;LRP2;ANKLE2;SFRP2;PLEKHN1;FXN;ACTN2;CASP6;BFAR;EGLN2;HCK;SIAH1;CCND2;RSL1D1;NOP53;OSGIN1;SOX9;SRA1;HNRNPK;CTNNB1;CX3CL1;AREL1;MYDGF;ARHGEF7;CFLAR;NFKB1;BCL6;TMBIM4;DDX20;MT3;TFAP2B;ATAD3A;FRZB;PPIA;HTATIP2;CTSH;ABR;BCAR1;LTK;GDNF;BARD1;PDPN;SCX;HMGB1;PLK3;VAV1;SPHK2;PHIP;PRR7;CIB1;DIABLO;NPM1;DNM2;PHLDA1;NUAK2;DNAJA3;RNF122;RNPS1;RYBP;XBP1;ARHGEF11;PIM1;CBX4;BAG1;SOS1;NAA35;ARHGAP10;GAS1;PSEN1;PRKDC;SOCS2;AKT1S1;DFFA;RACK1;RPS6;BAD;APBB1;AKAP13;TIAM2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.46198758730553247,1.183145852919596,0.2586427656850192,0.8211651346724598,1.0,8/24,16.24%,COQ10B;SDHAF4;MT3;GFPT1;LEPR;PPARGC1A;NDUFS1;NDUFS4
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.48410524530430654,1.182732216636653,0.273224043715847,0.8217664054404137,1.0,6/19,16.88%,AXL;MMP14;XBP1;PRKDC;CD27;MDK
prerank,negative regulation of proteolysis (GO:0045861),0.44496850395921494,1.1826544616523942,0.24907521578298397,0.8211343534084142,1.0,8/34,15.01%,TM4SF20;TRIM21;EPHA4;CST7;PRNP;TIMP2;GAS1;TMEM59
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5529317360156369,1.1819872012695616,0.29464285714285715,0.8226493220759367,1.0,6/11,16.92%,ARID1B;CHEK1;ARID1A;SERTAD2;SERTAD1;ELOF1
prerank,cellular lipid catabolic process (GO:0044242),0.45318944329199756,1.1819796452604407,0.25487646293888166,0.8217555909664179,1.0,4/27,8.33%,AOAH;ACADL;MT3;LPIN2
prerank,glycogen biosynthetic process (GO:0005978),0.5404167077398722,1.1813780262060214,0.2780203784570597,0.8220888480397297,1.0,3/12,7.78%,PER2;PGM2L1;PGM1
prerank,glucan biosynthetic process (GO:0009250),0.5404167077398722,1.1813780262060214,0.2780203784570597,0.8220888480397297,1.0,3/12,7.78%,PER2;PGM2L1;PGM1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5621911517759487,1.1813563631817605,0.2893175074183976,0.8212471680357486,1.0,3/10,11.00%,MAD2L2;PPM1F;NOTCH4
prerank,modified amino acid transport (GO:0072337),0.5082858414808774,1.1813476887017744,0.2824858757062147,0.8203657586504212,1.0,6/15,21.83%,SLC46A1;SLC19A1;PDPN;CTNS;SLC5A6;MGST1
prerank,inorganic anion transport (GO:0015698),0.41480199728067596,1.1813376650170286,0.23111612175873733,0.8194818272717539,1.0,16/53,23.23%,CLIC4;SLC26A1;ENPP3;CLCN2;CLCN6;SLC25A10;TTYH1;ANO10;ENPP1;SLC13A4;ANO5;CLCN1;GLRA1;CLIC1;SLC25A30;SLC26A7
prerank,carbohydrate derivative transport (GO:1901264),0.49748220795434156,1.1808858317054918,0.27595628415300544,0.8202169632973493,1.0,4/18,4.39%,ABCG1;SLC15A3;SLC15A2;SLC25A19
prerank,Rho protein signal transduction (GO:0007266),-0.29530557461490375,-1.1804591377970555,0.16129032258064516,0.996988465057024,1.0,20/53,20.93%,CFL1;ARHGAP5;ROCK1;PLEKHG5;ARHGDIB;SHTN1;ARHGEF1;EPS8;CDC42;COL1A2;RHOU;RIPOR1;RHOA;WAS;CDC42EP1;ARHGEF3;CDC42EP2;NTN1;RTKN;TAX1BP3
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.4480412161715235,1.1803602307041503,0.2512437810945274,0.8211544710920169,1.0,13/30,22.79%,BLZF1;GOLGA7;SEC16A;GGA3;AMN;VAMP2;VAMP4;BBS2;PREPL;VAMP5;GOLPH3L;OPTN;RAB10
prerank,positive regulation of neuron projection development (GO:0010976),0.39120142846004335,1.1800689585009796,0.21574973031283712,0.8213385703888951,1.0,25/85,18.43%,WNT5A;PLXNB2;BDNF;CAMK2B;RETREG3;PLXNB3;DHX36;CX3CL1;P3H1;RET;MAGI2;RAPGEF2;LTK;LYN;ROR2;APOE;RAPGEF1;NPTN;DBNL;SCN1B;LRP8;MDK;STMN2;FUT9;CAPRIN1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.4082128954215427,-1.179708321345726,0.24232081911262798,0.9942193644230628,1.0,8/17,21.48%,EMC2;EMC3;EMC8;GET3;EMC9;MMGT1;UBL4A;EMC6
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.3591796976700651,-1.1796212354493734,0.2577777777777778,0.9889671376822852,1.0,6/24,11.40%,TGFB1;SULF1;CCBE1;NOX1;C3;BRCA1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.45087276548014193,1.1794094884566335,0.26097560975609757,0.8228207828353566,1.0,10/30,19.72%,IRF7;BIRC2;CD40;IKBKE;TRAF3;BIRC3;TNIP3;TLR3;CD300LF;TANK
prerank,steroid metabolic process (GO:0008202),0.4017276721697239,1.1793039691603195,0.2235294117647059,0.8222987778620481,1.0,11/72,13.69%,LRP2;HSD17B7;DHRS4;HSD11B1;FDFT1;CYP26B1;STARD3;DHRS11;CYP27A1;TSPO;NPC1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.44269751299411764,-1.1791226702664754,0.24489795918367346,0.9853244977157646,1.0,6/13,22.31%,TECR;HACD1;ELOVL5;ELOVL1;ELOVL7;ELOVL6
prerank,regulation of cell migration (GO:0030334),0.3650513957716582,1.1786106491816282,0.08517034068136273,0.8239060817655156,1.0,80/382,16.88%,WNT11;BST2;FLT1;CCL7;PLXNA3;CLIC4;SPRY2;SGK3;PLXNB2;KDR;CPNE3;PIK3CD;DDRGK1;CAMK2B;SEMA4D;SOD2;CXCL16;CDH13;ACVR1;SASH1;STAT3;MYO1C;SPATA13;THY1;MMP14;SFRP2;RUFY3;CCL5;PLXNB3;OSGIN1;DUSP3;CX3CL1;FAM83H;EPHA4;CARMIL1;PODXL;ARHGAP4;CSF1;SNAI2;RET;TMIGD3;MAGI2;ELP6;MAPRE1;MYOC;CTSH;BCAR1;ARID2;PDPN;KANK1;INSR;TBCCD1;ROR2;CIB1;PPM1F;SUN2;FGF9;MITF;XBP1;SRGAP2;SRGAP3;SORL1;LDB2;LDB1;DUSP10;RACK1;RAC1;DAB2;STX4;KIF2A;AMOTL2;IGSF10;MINK1;MIEN1;SPAG9;AIF1;SEMA3D;MGAT5;PTPRU;MDK
prerank,regulation of protein transport (GO:0051223),0.4516111974984306,1.1785994066040737,0.2707808564231738,0.8230250884518158,1.0,14/27,26.65%,P3H1;GAPVD1;HSPA8;PPM1F;SCFD1;RHBDF2;STXBP5L;LLGL1;SNX12;TNF;CHP1;NDFIP1;PTPN1;DNAJA1
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.27945818546825685,-1.1785519793733676,0.17721518987341772,0.9821592769659631,1.0,26/68,20.67%,CSTF3;CSTF2;POLR1A;FIP1L1;PABPN1;ERCC3;TBP;TTF1;ERCC2;PRMT5;MAZ;SNRPE;SYMPK;TAF1D;SNRPF;CPSF7;POLR2F;CPSF4;POLR1C;TAF1A;POLR1H;GTF2H3;POLR2A;CLP1;MTERF2;GTF2H4
prerank,B cell activation (GO:0042113),-0.27852245583783136,-1.1784963400581339,0.13131313131313133,0.9769031155506949,1.0,25/68,23.12%,NFAM1;GPR183;CASP8;KLF6;LAT2;DCAF1;ZBTB7A;CTPS1;BANK1;EPHB2;LYL1;PTPN2;FCRL1;DNAJB9;JAK3;SLC25A5;CD86;ADGRG3;BTK;MEF2C;CHRNA4;RASGRP1;TCF3;PHB2;CLCF1
prerank,sulfur compound transport (GO:0072348),0.4624668697409843,1.1779704938135591,0.2742138364779874,0.8243652390442457,1.0,14/27,26.33%,SLC27A1;SLC26A1;SLC25A19;SLC25A10;SLC35F3;SLC13A4;ABCG2;SLC5A6;MGST1;SLC6A6;SLC25A30;SLC26A7;SLC36A1;SLC25A26
prerank,regulation of neuron death (GO:1901214),0.3965574534159242,1.1779151836313908,0.22008547008547008,0.8236647622667619,1.0,18/82,14.33%,CHMP4A;CHMP4B;WNT5A;DAXX;CLU;NENF;EGLN2;CCL5;RILPL1;CSF1;PRNP;SORL1;DDIT4;PPARGC1A;AKT1S1;FCGR2B;EIF2S1;FYN
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.5524746189853414,1.1779027844576204,0.2992481203007519,0.8227925146947216,1.0,5/11,16.80%,PIK3CD;RAPGEF2;LYN;PIK3CB;LGALS9
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.4793799462519899,1.1776581328547362,0.24324324324324326,0.8228011573953482,1.0,4/21,5.80%,ZFP36;CNOT4;CNOT7;TNKS1BP1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.4401293384699768,-1.177640565515959,0.2578616352201258,0.9747760156646087,1.0,3/12,8.41%,FBXW4;LRP6;TGFB2
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.40078251183025143,-1.177476012655717,0.24,0.9700208128026659,1.0,10/16,29.95%,NAPEPLD;SIRT1;ZBTB7B;VSTM2A;SOX13;FLCN;FTO;FNDC5;TFE3;METRNL
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.4502481564976175,1.1768884674540376,0.25759416767922233,0.824765309758855,1.0,4/29,9.05%,NR1H2;TMEM86B;PLA2G12A;LPCAT2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5501049792123671,1.1764006070440136,0.27769347496206376,0.8255790194917835,1.0,3/10,16.64%,CAMK2D;PRKCE;STK39
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.43034508469188115,1.1761892657175326,0.259927797833935,0.8255004985708158,1.0,13/37,23.06%,FIS1;BCL2L11;SIAH1;NCK1;RACK1;BAD;BMF;BAX;BECN1;BCAP31;LCK;FBH1;NACC2
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5317260881239173,1.1761605932014536,0.29493087557603687,0.8246929047204297,1.0,4/12,14.63%,IRS1;ABCD1;PPARGC1A;IRS2
prerank,intracellular pH reduction (GO:0051452),-0.332389672301518,-1.1756889043424676,0.19047619047619047,0.971478157609744,1.0,10/33,13.24%,ATP6V0A1;ATP6V1H;ATP6V1E1;DMXL1;ATP6V1C1;ATP6V1D;GPR89B;GPR89A;DMXL2;ATP6V1A
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.43051954667181164,1.1756482726467241,0.2497027348394768,0.8256971595759418,1.0,9/38,14.86%,CLU;CD47;HSP90AB1;P2RX4;INSR;ZC3H12A;RAC1;JAK2;HSP90AA1
prerank,canonical Wnt signaling pathway (GO:0060070),0.3976655908562954,1.1754117354762985,0.2229580573951435,0.8256286899771642,1.0,8/68,7.60%,WNT11;WNT5A;RARG;SFRP2;CTNNB1;TCF7L2;WNT7B;FRZB
prerank,regulation of autophagosome maturation (GO:1901096),0.5172032668736931,1.1751897886636387,0.2855072463768116,0.8254975973932611,1.0,2/13,3.92%,IRGM;FYCO1
prerank,skeletal muscle contraction (GO:0003009),0.4883190063478316,1.174780641177908,0.28344370860927154,0.8261555471110915,1.0,5/19,22.05%,TNNC1;STAC3;TNNI2;RCSD1;MYH14
prerank,high-density lipoprotein particle assembly (GO:0034380),0.5529979572442537,1.1747366259158423,0.27340267459138184,0.8253956094192113,1.0,3/10,17.35%,ABCA1;APOE;ZDHHC8
prerank,negative regulation of signal transduction (GO:0009968),0.3669507519252844,1.1746718533007985,0.12663316582914572,0.8247416116669701,1.0,53/249,15.87%,AGT;SLAMF1;XDH;SPRY2;IRS1;SOCS1;BDNF;DLK2;ACVR1;KIF26A;ASAH2;PTPN18;GRB10;KIF7;MMP14;SFRP2;CD47;CRHBP;CCL5;SIAH1;GPR108;FBXW7;CX3CL1;HMGXB4;SNAI2;CSNK2A2;FRZB;DACT1;YTHDF2;NCK1;LYN;LEPROT;SOCS5;EGFL7;KANK1;CYP26B1;LRPAP1;BTRC;DKK3;APCDD1;DDIT4;RB1;MDFI;ENPP1;RACK1;PIK3CB;CXXC4;PTCH1;EZH2;INPP5K;HGS;PHACTR4;ADAMTS12
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3314208194054108,-1.174310709823308,0.18947368421052632,0.9716620037525087,1.0,14/30,24.14%,ARSB;CHSY1;VCAN;CSGALNACT1;CHST7;CHST15;CHST3;BGN;DSEL;NDNF;DCN;BCAN;UGDH;CSPG5
prerank,heme catabolic process (GO:0042167),0.5231934779236773,1.174174833737426,0.29322268326417705,0.8247051323158324,1.0,6/14,20.00%,ABCC2;SLCO1B1;ABCC1;BLVRB;HMOX2;ABCG2
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.5231934779236773,1.174174833737426,0.29322268326417705,0.8247051323158324,1.0,6/14,20.00%,ABCC2;SLCO1B1;ABCC1;BLVRB;HMOX2;ABCG2
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.32526500874949016,-1.1741138358216379,0.16477272727272727,0.9671295360443063,1.0,10/33,13.52%,CSTF3;CSTF2;FIP1L1;PABPN1;MAZ;SNRPE;SYMPK;SNRPF;CPSF7;CPSF4
prerank,regulation of nervous system development (GO:0051960),0.4361721105863925,1.173857405658439,0.26610978520286394,0.824988372716785,1.0,7/37,8.45%,PER2;BHLHE40;NKX6-2;CTNNB1;CX3CL1;NPHP3;YTHDF2
prerank,endothelial tube morphogenesis (GO:0061154),0.5573126418728196,1.1738501605167626,0.2875722543352601,0.8241136212495036,1.0,4/10,20.16%,CTNNB1;CSNK2B;RBPJ;ACVRL1
prerank,RNA modification (GO:0009451),0.41165983610418294,1.1736985630130983,0.2291196388261851,0.823737497984162,1.0,12/54,12.15%,TRMT9B;ADAR;BCDIN3D;ADAT2;MRM2;MEPCE;TRMT1;ALKBH1;PUS7L;AARS1;WDR4;NOP2
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.44191037728246657,1.1734801519319293,0.24731182795698925,0.8236206450607245,1.0,9/34,14.33%,TGFA;ANAPC5;ANAPC4;INSR;PHIP;CDC16;CDC27;RB1;NSMCE2
prerank,regulation of mRNA processing (GO:0050684),0.4410486410061344,1.1728852444698086,0.26353790613718414,0.8249354365559296,1.0,11/32,17.54%,SRPK3;HNRNPK;DHX9;SLTM;SRPK1;ZFP36L1;AHCYL1;PAPOLA;RBM39;NCBP1;CWC22
prerank,regulation of steroid metabolic process (GO:0019218),0.4733865022063771,1.1728351355503328,0.2828282828282828,0.82423210974028,1.0,9/23,24.91%,ABCG1;ACADL;RORA;EPHX2;APOE;PANK2;TTC39B;STUB1;ACADVL
prerank,positive regulation of dendritic spine development (GO:0060999),0.47984200696183404,1.1723716941277047,0.2724795640326976,0.8250825137742366,1.0,7/20,18.43%,CAMK2B;DHX36;PSEN1;APOE;DBNL;LRP8;CAPRIN1
prerank,mesenchyme morphogenesis (GO:0072132),0.49129416938481696,1.171932070590126,0.2918340026773762,0.825834442396053,1.0,6/17,23.22%,ACVR1;SOX9;SMAD2;BMPR1A;ACVRL1;NOTCH1
prerank,muscle organ development (GO:0007517),0.4145059778005587,1.1719014630825821,0.26013513513513514,0.8250836148411205,1.0,5/54,4.99%,CXCL10;MEF2B;UTRN;ITGB1BP2;COPRS
prerank,tRNA wobble uridine modification (GO:0002098),0.5180173391575733,1.1716252129721865,0.2861150070126227,0.8252130956902943,1.0,3/14,6.10%,TRMT9B;MOCS3;TRMU
prerank,amino acid transmembrane transport (GO:0003333),0.4249430613113116,1.1715492482259364,0.26450116009280744,0.824559797854945,1.0,13/45,21.95%,SLC25A22;SLC38A2;SLC38A1;SLC38A3;SLC38A6;SLC7A6;SFXN2;SLC25A12;SLC36A4;SFXN1;SLC7A7;MFSD12;SLC6A6
prerank,maturation of LSU-rRNA (GO:0000470),0.4606399292417793,1.171207306813884,0.2786259541984733,0.824911195547091,1.0,9/26,17.84%,DDX18;RSL1D1;LAS1L;RPL7L1;EIF6;NOP2;ZNHIT3;RPL10A;WDR12
prerank,sensory perception of light stimulus (GO:0050953),0.3871506136772417,1.1711642438940753,0.22866174920969443,0.8241872694237219,1.0,11/87,15.23%,CABP4;CNGB1;EYA4;CRYGN;IMPG2;RS1;ATXN7;ADGRV1;RGS16;CHRNB2;BBS2
prerank,negative regulation of binding (GO:0051100),0.39718489432665194,1.1711161793614624,0.2077922077922078,0.8234551891869373,1.0,15/81,14.27%,SP100;IFIT1;IFIT2;ILRUN;SUMO3;SLPI;DACT1;LRPAP1;SORL1;DDX11;MDFI;RACK1;DAB2;ACTB;JAK2
prerank,positive regulation of axonogenesis (GO:0050772),0.42734741551086725,1.1708096924440266,0.2629757785467128,0.8237452148983535,1.0,6/43,4.60%,PLXNA3;PLXNB2;BDNF;SEMA4D;RUFY3;PLXNB3
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5551657899926654,1.1705617498372027,0.29057187017001546,0.8237558065966123,1.0,2/10,6.59%,GPR37L1;GPR37
prerank,positive regulation of GTPase activity (GO:0043547),0.37137763664699525,1.1705163756271273,0.1670061099796334,0.8230200876899274,1.0,59/188,21.06%,WNT11;CCL7;DOCK8;RGP1;TBC1D1;SEMA4D;CD40;THY1;CCL5;SYDE1;CX3CL1;ARHGEF7;PIP5K1A;TBC1D8;RAPGEF6;RAPGEF2;ABR;RAP1GAP;SYDE2;AGRN;SIPA1L2;TBC1D8B;SNX9;ARHGAP25;CCL14;SRGAP2;ARHGEF10;RGS16;ARHGAP11A;RACK1;SIPA1L1;RIC1;LIMS1;TIAM2;RAPGEF1;ASAP3;EZH2;SH3BP1;TBCK;BCR;TBC1D2;RALGAPB;ARHGAP29;CORO1C;NF1;ARAP1;SIPA1L3;TSC1;ARHGAP24;PIN1;ARHGAP42;SGSM1;SGSM3;TBC1D4;TGM2;RGS10;DOCK10;CCL4;MMUT
prerank,negative regulation of cell cycle (GO:0045786),-0.2715143210351129,-1.1703424635699624,0.18032786885245902,0.9766700371020337,1.0,28/73,25.94%,TGFB1;PTPRK;HPGD;PDCD4;BTG2;BRINP1;RPS6KA2;NUDT6;RUNX3;APC;NR2F2;CEBPA;SIPA1;BTG1;PPP1R13B;INCA1;SCRIB;BRINP2;TSPYL2;HEXIM1;CDKN1B;NLRP2B;INHBA;NR4A1;CDK5RAP1;FOXC1;NUPR1;HTRA2
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.39252994068537783,-1.1702521768330962,0.20930232558139536,0.9718262646982259,1.0,6/17,15.21%,COX15;COX10;NDUFA4;COX8A;COX6C;COX7B
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.4258353820619175,1.1701386009536825,0.2487864077669903,0.8234578867837219,1.0,16/40,26.72%,PML;CLU;FBXW7;UBE3A;TRIM39;CSNK2A2;SMURF1;RPL11;RPL5;NUB1;UBQLN4;AXIN1;COMMD1;RAD23A;PTEN;UFL1
prerank,camera-type eye development (GO:0043010),0.46298085626295216,1.1700953520837194,0.26533166458072593,0.822742299982908,1.0,2/25,7.48%,PITX2;FBN1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5271608952781774,1.1697810395444852,0.28029197080291973,0.8230047413886095,1.0,2/13,3.74%,CAMK2D;SLC8A1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.49712820270797764,1.1691333760220775,0.2849162011173184,0.8245376119514686,1.0,4/16,11.56%,TNFSF9;IL27;LST1;TNFSF8
prerank,regulation of protein processing (GO:0070613),0.479837786374897,1.1687418662964022,0.2713375796178344,0.8250414550736201,1.0,5/21,15.01%,ADAM8;RUNX1;PRNP;GAS1;TMEM59
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.4774826542574155,1.1685906760852824,0.2797297297297297,0.8247353876311748,1.0,5/20,16.64%,CAMK2D;ACTN2;CAB39;PRKCE;STK39
prerank,histone lysine methylation (GO:0034968),0.44120795735333346,1.168499487380504,0.254278728606357,0.8242100979494599,1.0,10/33,16.10%,DPY30;RBBP5;KMT2A;SETD3;MEN1;WDR5;SETDB2;PAXIP1;EZH2;SMYD1
prerank,regulation of interleukin-8 production (GO:0032677),0.39268921449977545,1.1684833223524784,0.2439824945295405,0.8233969805119717,1.0,17/69,21.45%,HSPA1B;NOD2;NOD1;STAT3;TLR8;HMGB1;IL17D;MYD88;TLR2;LGALS9;ANXA4;TLR3;PTPRC;CD33;RAB1A;MAPKBP1;F3
prerank,aspartate family amino acid metabolic process (GO:0009066),0.4879627382340135,1.1684786286728137,0.26344086021505375,0.8225408542582635,1.0,7/18,17.63%,MTHFR;SMS;SLC25A12;MSRA;FOLH1;MTHFD1;GADL1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.40452575065546514,1.168286003253816,0.24242424242424243,0.8223408719960884,1.0,12/55,16.67%,AGT;BCO2;XDH;MT3;DHRS4;MAPK14;SPHK2;ZC3H12A;EIF6;RAC1;ARF4;ACOD1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.4179911543054102,1.1678814398709416,0.2520138089758343,0.8228895422081843,1.0,11/41,16.28%,AGT;BDNF;TGFA;FBXW7;EPHA4;DOK7;FCGR1A;PRNP;STAP1;FYN;LRP8
prerank,positive regulation of protein acetylation (GO:1901985),-0.4444700095053479,-1.1676340349137584,0.2686084142394822,0.9775423384085768,1.0,5/12,14.51%,DIP2B;TERF2IP;CAMK1;FAM161A;RAPGEF3
prerank,COPII vesicle coating (GO:0048208),0.40029343535532375,1.1672635770092705,0.25248070562293273,0.8223959101616368,1.0,20/61,22.98%,TRAPPC3;TGFA;SEC16A;GOSR2;CNIH3;SEC24D;CTSC;PPP6R3;SEC23A;TMED10;SCFD1;NAPA;SEC24A;CNIH1;TFG;RAB1A;TRAPPC9;TRAPPC6A;F8;CUL3
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.40029343535532375,1.1672635770092705,0.25248070562293273,0.8223959101616368,1.0,20/61,22.98%,TRAPPC3;TGFA;SEC16A;GOSR2;CNIH3;SEC24D;CTSC;PPP6R3;SEC23A;TMED10;SCFD1;NAPA;SEC24A;CNIH1;TFG;RAB1A;TRAPPC9;TRAPPC6A;F8;CUL3
prerank,vesicle coating (GO:0006901),0.40029343535532375,1.1672635770092705,0.25248070562293273,0.8223959101616368,1.0,20/61,22.98%,TRAPPC3;TGFA;SEC16A;GOSR2;CNIH3;SEC24D;CTSC;PPP6R3;SEC23A;TMED10;SCFD1;NAPA;SEC24A;CNIH1;TFG;RAB1A;TRAPPC9;TRAPPC6A;F8;CUL3
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.45801399893077777,1.1670797999626084,0.2535031847133758,0.8222204178888161,1.0,13/25,25.38%,PLXNB3;EVL;KANK1;RAP1GAP;CDK10;ODF2L;CAPZB;STAP1;TESK1;ARHGAP24;PRKCD;EVI5L;PFN2
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3147179770057937,-1.1666205567237682,0.17142857142857143,0.976375981210991,1.0,13/39,16.09%,TRAK2;WASL;MYO1G;BICDL1;NDE1;HTT;PPFIA2;TANC2;FBXW11;MYO7A;MYO1B;MYO5B;CLN3
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.4572995671298731,1.1665753655385975,0.26572528883183566,0.8231987349603954,1.0,11/25,23.33%,TXNL4A;BCAS2;WDR83;DBR1;GEMIN2;SF3B4;SRSF4;DDX23;SLU7;SRSF10;TRA2B
prerank,B cell activation involved in immune response (GO:0002312),0.5265583478701346,1.1663842990702349,0.2956521739130435,0.8230185430860293,1.0,2/13,0.99%,GAPT;MSH2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.45764361063713077,1.1660460966300046,0.28214731585518105,0.8234105455754784,1.0,7/26,17.33%,IRF7;BIRC2;GPR108;BIRC3;TLR2;FLOT2;TLR3
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4015915931661674,1.1659743534462788,0.2505592841163311,0.822808948130816,1.0,15/56,16.20%,HYAL1;MECP2;ANAPC5;CDC25B;CCND2;CCND1;RAD51C;TFDP1;ANAPC4;CDC16;CDC27;RB1;NSMCE2;AIF1;RAB11A
prerank,negative regulation of intracellular protein transport (GO:0090317),0.46264309509993573,1.165761341684066,0.28401585204755614,0.8226971106123332,1.0,3/22,9.04%,SP100;MDFIC;BARD1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4845693863214564,1.1657128820270186,0.2691256830601093,0.8220102292963777,1.0,9/19,19.75%,CAMK2B;DHX36;CUL7;FBXW8;CUX1;DBNL;LRP8;CAPRIN1;SS18L1
prerank,epithelial to mesenchymal transition (GO:0001837),0.42135389293419795,1.16543356694578,0.2399540757749713,0.8220948721668359,1.0,9/47,13.10%,LOXL2;WNT5A;DDX5;SOX9;CTNNB1;CUL7;SNAI2;NOTCH4;LIMS1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.47568157567797287,1.1654126201542416,0.2802721088435374,0.8213156007596699,1.0,8/21,14.94%,PAQR3;CNKSR3;NCK1;NCK2;PPM1F;DDIT4;RACK1;INPP5K
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.4756096228652631,-1.1653616177557464,0.29819277108433734,0.9762106553682633,1.0,4/10,16.70%,IRAK3;MAPK7;KLF4;MAP2K5
prerank,cell part morphogenesis (GO:0032990),0.5241408261732904,1.1646476096331821,0.2957142857142857,0.823162109272743,1.0,3/13,9.74%,PNPT1;FIS1;SLIRP
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5356660138045554,1.1644283842767822,0.2944693572496263,0.8230860951258857,1.0,6/11,25.64%,PRR7;GSN;ST18;LGALS9;PLAUR;PIH1D1
prerank,regulation of peptide hormone secretion (GO:0090276),0.40028577156973244,1.1641126936550197,0.24606741573033708,0.8233565378184441,1.0,9/67,8.44%,PER2;CHD7;CRHBP;CCL5;ITPR1;TFAP2B;SYT7;KCNS3;CACNA1A
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.4780171389651997,1.164099254762156,0.3010899182561308,0.8225541140024121,1.0,5/19,12.84%,TPST1;SLC26A1;SULT6B1;SLC26A2;ENPP1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.39684598558975487,1.1636851100393995,0.24478594950603733,0.8231220999422646,1.0,28/67,25.95%,PSMB10;PSME2;B2M;PSMA5;PSME4;CYBB;TAPBP;PSMA3;PSMB9;FCGR1A;PSMD2;PSME3;SNAP23;PSMA4;PSMD7;PSMD8;PSMD9;TAP1;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4;PSMA2;CYBA;PSMD1;SEC22B;PSMD11
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.44653594541858443,-1.1636532632752112,0.26973684210526316,0.9775067690688047,1.0,7/12,39.59%,GRIN1;RAB27A;TLR4;ZNF205;ADGRB1;MMP8;SLC5A3
prerank,nitrogen compound transport (GO:0071705),0.37546707922263745,1.163362947858464,0.2,0.8233812331489097,1.0,34/141,22.39%,ZG16;ABCC2;CHMP1B;SLC18A2;ARRDC4;SLC38A2;SLC38A1;LRP2;SLC15A3;SLC15A2;RILP;SLC52A2;ARRDC2;SLC38A3;SLC35F3;PDPN;SLC7A6;AMN;ABCC1;CHMP3;CMTM6;VAMP2;DENND10;SLC25A47;SLC25A45;MYH9;FLVCR1;ABCG2;SLC44A1;SLC7A7;SLC6A6;CHMP1A;HSP90B1;CERT1
prerank,negative regulation of immune system process (GO:0002683),0.4963744754848837,1.1629784718685896,0.2712100139082058,0.823905507575081,1.0,5/16,12.86%,SOX9;LYN;IL17D;COL3A1;FCGR2B
prerank,response to progesterone (GO:0032570),0.49073397154838894,1.1629620465484343,0.2892561983471074,0.8231089633819705,1.0,3/18,5.55%,CATSPER4;ABHD2;UBE3A
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3657284439204848,1.1629483749273621,0.12124248496993988,0.8223088697451397,1.0,108/314,23.90%,PML;PSMB10;SKP1;AUP1;FBXL16;PSME2;TRIM25;UBE2W;BIRC2;KLHL20;PSMA5;CDC26;RNF4;TMEM129;CUL5;PSME4;ANAPC5;RBCK1;ECRG4;FEM1B;RNF5;BFAR;SIAH1;UBQLN2;UBE2B;TNFAIP1;KCTD17;FBXW7;CTNNB1;PPP2R5C;AREL1;PSMA3;UBXN1;AMFR;SPSB1;PSMB9;ANAPC4;RBX1;TMUB2;UBE2E1;ZSWIM8;UBXN2B;UBQLN1;ARRB2;FAM8A1;BTRC;UBXN11;RNF122;PSMD2;RNF103-CHMP3;CDC16;CDC27;FAF2;SMURF1;PSME3;FBXL14;FBXL19;RB1;RNF185;ANAPC15;SHARPIN;UBE4B;ANKZF1;PSMA4;ERLIN2;TMEM67;NHLRC3;RNF103;APPBP2;AMN1;ANAPC2;GID4;FBXL5;UBE2K;KLHL15;TRIM2;WWP1;STT3B;PSMD7;PCNP;RFFL;PSMD8;PTTG1;PSMD9;ZFAND2A;SPOP;PSMF1;TRIM13;PSMB6;RNF216;PSMC2;PSMD12;HUWE1;SMURF2;HSP90B1;STUB1;UBR2;PSMD4;DNAJB2;CUL3;PELI1;KAT5;FEM1C;FEM1A;VCP;MAEA;PSMA2;UBR1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.4528418264336871,1.162094538755465,0.2844155844155844,0.8244664160132132,1.0,13/26,27.95%,ATP1B3;ACTN2;CAB39;NETO1;AKAP9;VAMP2;DLG1;STK39;KCNS1;ANK2;YWHAE;ITGB1;CACNA1D
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.4372218737318317,1.1617363364119477,0.26715686274509803,0.8248877959970711,1.0,8/34,13.47%,FLT1;SPRY2;KDR;MAP2K3;MAPK14;VEGFD;GAS1;NRP1
prerank,regulation of chemotaxis (GO:0050920),0.4432606366416986,1.1616222853259555,0.2860696517412935,0.824472885842184,1.0,10/30,16.08%,CXCR4;YTHDF1;DUSP3;P2RX4;ZSWIM8;PPM1F;USP14;STX4;MYCBP2;AIF1
prerank,positive regulation of phospholipase activity (GO:0010518),0.47054525005319914,1.161241602506877,0.2844387755102041,0.8250062525502135,1.0,9/22,23.42%,FLT1;CCL5;FGFR2;ARL1;ARF4;FGFR3;ABL2;FGF2;PDPK1
prerank,receptor internalization (GO:0031623),-0.30341067348511247,-1.160829571992203,0.19424460431654678,0.983639798729383,1.0,15/44,21.20%,SYK;CALCRL;CD81;ARRB1;GRK3;SNCA;TFRC;GRK2;RAB31;CEACAM1;CD9;SAG;PICALM;NEDD4;CAV1
prerank,microtubule polymerization (GO:0046785),-0.3344536423912068,-1.1604450997568179,0.22885572139303484,0.9801660616241231,1.0,16/28,28.08%,NDE1;TPPP;TUBGCP3;CLASP2;TUBGCP4;TUBGCP6;TUBGCP2;HDGFL3;CCDC57;GOLGA2;TPX2;CLASP1;CKAP5;CSNK1D;NDEL1;MAP7D3
prerank,dermatan sulfate metabolic process (GO:0030205),-0.42854761906991445,-1.160281536706381,0.28205128205128205,0.9757601238066224,1.0,7/13,24.14%,UST;VCAN;BGN;DSEL;DCN;BCAN;CSPG5
prerank,ncRNA transcription (GO:0098781),0.5123065764820495,1.1600205803321886,0.2991202346041056,0.8284616413625394,1.0,9/13,23.82%,SNAPC2;RPAP2;USPL1;POLR1G;CAVIN1;BRF1;SPIN1;GTF3C1;ANG
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.5316175737513951,1.160015549834637,0.3068017366136035,0.8276299806245958,1.0,5/12,18.10%,CLU;PFDN5;PFDN4;APOE;LDLR
prerank,diol biosynthetic process (GO:0034312),0.4957913948754864,1.1597389159373328,0.30779944289693595,0.8277373039223838,1.0,6/15,18.29%,DHFR;ASAH2;SPHK2;GCH1;ACER3;SPTLC2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3941439611021031,1.1596015291780895,0.24,0.8274082173198483,1.0,11/76,12.50%,CALCA;AGT;FPR3;ACTN2;TACR1;GNA15;GNA14;PTGER3;C3AR1;HTR2A;GPR35
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.4205982107025108,1.1592263530050548,0.25886524822695034,0.8278760910670024,1.0,11/42,12.36%,TIMELESS;CGAS;ACTR2;MAD2L2;CHEK1;RTEL1;ARID2;SIRT6;POLQ;SHLD1;PPP4R2
prerank,cholesterol metabolic process (GO:0008203),0.3998909531732881,1.1589116749864272,0.26043956043956046,0.8281526285075517,1.0,22/68,23.71%,ABCA1;ABCG1;HSD17B7;CH25H;MT3;FDFT1;LDLRAP1;STARD3;CYP27A1;APOE;GGPS1;PPARD;SOAT2;IDI1;SOAT1;EBP;GBA2;HMGCS1;ABCA5;HMGCR;CLN6;SNX17
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.45606981123437895,-1.1588847635303636,0.2626582278481013,0.9765603712266079,1.0,8/11,37.40%,ZFPM2;TGFB2;JAG1;SOX4;BMP4;HEY2;GATA3;ISL1
prerank,positive regulation of tissue remodeling (GO:0034105),0.5490253202766769,1.1583847822113487,0.30652503793626706,0.8292078348731778,1.0,1/10,0.61%,IL15
prerank,mitochondrial RNA metabolic process (GO:0000959),0.49352041417644005,1.1580341073337879,0.3058321479374111,0.8296046537407175,1.0,4/14,9.88%,PNPT1;MRPL12;TFB2M;TWNK
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.4207069983391233,1.1562493449285853,0.27208480565371024,0.8350461089983046,1.0,15/36,22.79%,BLZF1;GOLGA7;RILPL1;GGA3;AMN;NECTIN3;VAMP2;VAMP4;BBS2;PREPL;VAMP5;GOLPH3L;GORASP2;OPTN;RAB10
prerank,renal absorption (GO:0070293),0.5391476441837105,1.1561831021248237,0.327217125382263,0.8343907957025721,1.0,3/10,11.77%,MAGED2;SLC15A2;GSN
prerank,chromatin remodeling at centromere (GO:0031055),-0.3284729575801998,-1.1559040124510984,0.22777777777777777,0.9826481011901033,1.0,13/31,24.84%,CENPV;CENPO;KNL1;CENPA;ITGB3BP;CENPL;MIS18BP1;CENPK;CENPU;CENPC;CENPX;CENPQ;CENPH
prerank,spliceosomal complex assembly (GO:0000245),0.41412394492524085,1.1554596290337031,0.27494199535962877,0.8360424674487825,1.0,11/46,15.32%,NOL3;SRPK3;TXNL4A;SRPK1;CELF6;USP39;SNRPD2;SNRPD1;DDX39B;SNRPG;NCBP1
prerank,negative regulation of cell motility (GO:2000146),0.37865802577862545,1.1548555931433724,0.24307036247334754,0.837333824994676,1.0,29/108,21.53%,WNT11;BST2;CLIC4;THY1;SFRP2;PLXNB3;DUSP3;CX3CL1;EPHA4;ARHGAP4;TMIGD3;MAGI2;ARID2;KANK1;MITF;SRGAP2;SRGAP3;DUSP10;CRK;PTPRU;DACH1;NF1;STK24;SINHCAF;PIN1;RAP2A;ACVRL1;MCTP1;CITED2
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.4867844580038753,1.1548144449861162,0.2865013774104683,0.8366199451905602,1.0,6/17,19.77%,ABCG1;KPNB1;APOE;ERLIN2;SREBF1;SEC14L2
prerank,negative regulation of endocytosis (GO:0045806),0.45940672679535616,1.154494295800488,0.2805194805194805,0.836912907267148,1.0,6/24,15.41%,NR1H2;SNX33;LRSAM1;RUBCN;RAC1;CD300A
prerank,dopaminergic neuron differentiation (GO:0071542),0.47601376068916723,1.1544743041778824,0.2898550724637681,0.8361325867256344,1.0,2/19,5.47%,LMX1A;CTNNB1
prerank,vasculature development (GO:0001944),0.49735400131355073,1.154110856563605,0.30926430517711173,0.8366016720066998,1.0,6/16,24.62%,FBXW7;BMPR2;NOTCH4;ACVRL1;STK11;PIK3CA
prerank,photoreceptor cell development (GO:0042461),-0.40841587158980547,-1.1539940407989666,0.24555160142348753,0.985462330808356,1.0,10/14,50.63%,MYO7A;DCX;MFSD2A;CEP290;RP1;RORB;AHI1;TH;CDHR1;TOPORS
prerank,gland development (GO:0048732),0.39939062366009015,1.1533270534596602,0.25192519251925194,0.8384557765860169,1.0,11/59,11.45%,WNT11;GFER;ARID5B;SOX9;FGFR2;MET;TG;PROX1;DKK3;NOTCH4;XBP1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.2755796819817929,-1.1533092815305235,0.17777777777777778,0.9831608243606267,1.0,20/70,14.90%,TGFB1;CASP8;CASP8AP2;TRAF2;BLOC1S2;ITGAV;CASP3;TGFB2;RIPK1;GSK3B;DAB2IP;CASP9;ACVR1B;TRADD;RNF41;TNFRSF1B;APPL1;HIPK1;DEDD2;DCC
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.46842756075707565,1.1531464039674442,0.30066225165562915,0.8382567247477694,1.0,8/21,18.17%,SPPL2A;RBMX;ERAP1;PSEN1;SPPL3;APH1A;HM13;MYH9
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.4323339747705315,1.153132841584905,0.2770935960591133,0.8374721081935775,1.0,7/35,16.99%,PDE7B;GAL;SOX9;RAPGEF2;APOE;PDE3A;NUDT4
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.46409820438016847,1.15312127577781,0.29328165374677,0.8366677719008232,1.0,4/21,10.07%,LRP2;CTNNB1;CX3CL1;PROX1
prerank,quinone biosynthetic process (GO:1901663),0.5031842130680177,1.1525691186960612,0.28492392807745504,0.837779544576852,1.0,3/14,6.32%,COQ2;COQ10B;COQ3
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.2594783804206448,-1.1523600162376821,0.15151515151515152,0.9818660507773681,1.0,24/107,12.68%,STIM1;ATP1B1;MT1E;MT1F;MT1M;MT1G;MT1A;MT1H;MT1B;MT1X;TPT1;TMCO1;SLC39A14;SLC39A7;ATP2A2;CCL13;SLC10A7;SLC8A3;ATP2C1;CCL15;SLC39A12;CCL3;CHRNA7;CCR2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.45862395842264114,1.1520289241018813,0.30062111801242236,0.8388252901679937,1.0,5/25,11.70%,EXT1;HAS3;HAS1;CSGALNACT2;B3GALNT1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.529821439566216,1.1519240991278958,0.3134978229317852,0.8383568112412507,1.0,5/11,23.29%,TIMELESS;TIPIN;ZRANB3;FBH1;LIG3
prerank,negative regulation of complement activation (GO:0045916),0.5399277098349082,1.1517180616267413,0.30895522388059704,0.8382681872283687,1.0,2/10,4.99%,CD55;SUSD4
prerank,regulation of tissue remodeling (GO:0034103),0.4843746076812543,1.1516748279350797,0.3048780487804878,0.8375670250588619,1.0,7/18,20.47%,IL15;RUNX1;SYT7;LEPR;IL18;MDK;DDR2
prerank,bile acid and bile salt transport (GO:0015721),0.46238231143616854,1.1514412464075519,0.28272251308900526,0.8375671030961426,1.0,4/24,6.49%,ABCC2;SLCO1C1;NCOA1;SLCO1B1
prerank,endomembrane system organization (GO:0010256),0.36713739128058753,1.151431177722992,0.2006079027355623,0.8367703336033426,1.0,49/178,19.97%,DNAJC13;VPS51;TOR1AIP2;BLZF1;USP50;TJAP1;ATL1;SNX33;COG3;GOLGA5;GOLGA8B;TLCD2;WASHC4;SEC16A;SNX10;ARHGEF7;CUL7;VPS11;TMED5;HOOK2;RAB22A;FBXW8;DOP1B;RAB43;VAPB;HOOK1;UBXN2B;TMED10;TRAPPC12;COG2;ARL1;SUN2;ARHGAP21;ARFGEF2;REEP3;HOOK3;PLEKHM2;NUP155;SYNGR1;DYNC2H1;TMED1;TMED3;GBF1;GOLPH3L;SERP1;OSBPL2;GORASP2;RAB1A;VPS18
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4215095762455216,1.151216516146575,0.29044117647058826,0.8366766097730869,1.0,12/36,23.30%,SP100;MECP2;CSNK2B;HMGB1;APOE;SVBP;ACVRL1;GADD45A;FGF2;VASH1;NOTCH1;PTPRM
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.49423448828704475,1.1512001335141466,0.28924418604651164,0.8358953966816501,1.0,5/15,16.02%,NR1H2;SLC45A3;PPARGC1A;LPGAT1;PPARD
prerank,regulation of microtubule-based process (GO:0032886),-0.3070636087513129,-1.1508513474091355,0.21212121212121213,0.9825413763685116,1.0,9/36,11.76%,MACF1;ROCK1;MAP6;TPPP;MARK4;KLHL42;CLASP2;GSK3B;APC
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5497820527354099,1.1502927048455611,0.3264094955489614,0.8383176782269552,1.0,5/10,20.30%,GRB10;RSC1A1;ENPP1;INPP5K;APPL2
prerank,membrane protein proteolysis (GO:0033619),0.42404592600497387,1.150214379780341,0.27951807228915665,0.8377480969744663,1.0,13/37,18.17%,SPPL2A;RBMX;ERAP1;NFKB1;RET;CTSH;PSEN1;NAPSA;SPPL3;APH1A;APH1B;HM13;MYH9
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.37281966718059706,1.150081415158414,0.2034587995930824,0.8373801257053284,1.0,12/152,6.59%,CXCL10;CXCL9;CALCA;ABCA1;RXFP2;GPR37L1;S1PR2;PTGER4;ADCY5;GNA15;GNA14;GPR37
prerank,regulation of double-strand break repair (GO:2000779),0.41812410953359685,1.1495650739879704,0.28502994011976046,0.8384678731291564,1.0,9/39,12.58%,PML;TIMELESS;ACTR2;CHEK1;RTEL1;SLF2;SIRT6;PPP4R2;DDX11
prerank,negative regulation of response to stimulus (GO:0048585),0.3918062850686362,1.1495560394595017,0.2750556792873051,0.8376687590397315,1.0,20/60,22.52%,NR1H2;CLU;ACVR1;KIF26A;AQP11;RBL1;THY1;LYN;SOCS5;COL3A1;GGT7;FCGR2B;ZKSCAN3;TERF2;VPS13C;APPL2;MCTP1;AKT3;PIM3;ERBB3
prerank,alpha-amino acid catabolic process (GO:1901606),-0.3309179137319598,-1.1487512872726833,0.22926829268292684,0.9857080014282139,1.0,13/29,36.29%,BLMH;HOGA1;SARDH;KMO;PRODH;IL4I1;ALDH4A1;DDO;GOT2;CBS;IDO2;THNSL2;DAO
prerank,regulation of mitochondrial fusion (GO:0010635),-0.4594395607956551,-1.1484513311648317,0.2774390243902439,0.9819978642032033,1.0,7/11,31.84%,VAT1;TFRC;ZDHHC6;MUL1;PRKN;BNIP3;PID1
prerank,regulation of heart contraction (GO:0008016),0.3799400772494201,1.148328286377066,0.25874867444326616,0.8411475537377422,1.0,12/90,10.97%,AGT;ASPH;CAMK2D;FXYD4;ATP1B3;SLC8A1;ITPR1;TMIGD3;NPPC;FXYD6;P2RX4;AHCYL1
prerank,positive regulation of cell cycle (GO:0045787),0.393067045184545,1.1480775339642697,0.26850828729281767,0.8411550540048367,1.0,11/62,10.07%,CDC25B;TRIM21;PKN2;CCND2;CHEK1;DUSP3;CCND1;FGFR2;SMOC2;APP;PROX1
prerank,protein destabilization (GO:0031648),0.4298415456639349,1.147676511025727,0.2775061124694376,0.8417031239343636,1.0,9/32,14.37%,IRGM;TRIM21;GGA3;CTSH;PEX2;PRNP;BTRC;GSN;KDM8
prerank,glycerolipid metabolic process (GO:0046486),0.5259780116053815,1.1463265166519798,0.31843575418994413,0.8456916686108957,1.0,5/11,20.00%,PDXP;PIP5K1A;DGKB;DGKA;PNPLA3
prerank,regulation of protein phosphorylation (GO:0001932),0.3568965574425164,1.1457556183934932,0.1691842900302115,0.8468622606854173,1.0,47/256,14.94%,STAT2;IRGM;PML;XDH;PLXNB2;KDR;SOCS1;DAXX;SEMA4D;TARDBP;CD40;CCND2;NOP53;SOX9;CCND1;PPP2R5C;KDM4D;MYDGF;MT3;PPIA;PAQR3;CCDC88A;LYN;LEPR;APP;INSR;BMPER;PRNP;MEN1;TNIK;PHIP;MOB1B;CIB1;ZC3H12A;NPM1;VEGFD;FGF9;PPP2R5D;PRKDC;RACK1;RAC1;DAB2;FYN;RB1CC1;HSP90AA1;NPTN;INPP5K
prerank,mitotic nuclear membrane organization (GO:0101024),0.40818342740574626,1.1457411742668588,0.2925714285714286,0.8452326627704976,1.0,13/51,17.06%,CHMP4A;CHMP4B;CC2D1B;NUP37;ANKLE2;KPNB1;BANF1;CHMP3;REEP3;AHCTF1;NUP155;IST1;PPP2R2A
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.40818342740574626,1.1457411742668588,0.2925714285714286,0.8452326627704976,1.0,13/51,17.06%,CHMP4A;CHMP4B;CC2D1B;NUP37;ANKLE2;KPNB1;BANF1;CHMP3;REEP3;AHCTF1;NUP155;IST1;PPP2R2A
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5423566492594801,1.1451946141259564,0.312874251497006,0.8462910675991394,1.0,1/11,3.51%,RTP4
prerank,dendritic spine morphogenesis (GO:0060997),-0.41278090583912963,-1.1442778646685665,0.2762237762237762,0.9935003211921108,1.0,6/15,10.44%,WASL;DLG4;CDC42;EPHB2;SHANK3;EPHB1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.5079049311019632,1.144246045274605,0.3128491620111732,0.8487969279348748,1.0,7/14,14.90%,CTNNB1;KMT2A;DNMT1;WDR5;SNW1;PAXIP1;MYB
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.37271579018737766,1.1442326734974873,0.24922760041194644,0.848004422738867,1.0,37/119,21.19%,PIGW;SOCS1;ARF3;PIK3CD;SLC27A1;ITPKC;CDS1;SYNJ1;PITPNM1;SBF1;PIP5K1A;PIGV;SOCS5;PI4KB;PIK3R4;EFR3A;CDIPT;RAB14;PLEKHA1;SOCS2;PIK3CB;PIP5K1C;INPP4B;PLEKHA4;PLEKHA3;INPP5K;MTMR14;PGAP2;OCRL;PIGQ;SOCS6;PIGB;PGAP3;SOCS4;PI4KA;SACM1L;SOCS7
prerank,protein K48-linked ubiquitination (GO:0070936),0.39672098332471517,1.144014985515185,0.2798216276477146,0.8479585931823203,1.0,10/54,9.59%,DTX3L;RNF4;RNF5;BFAR;UBE2B;UBE3A;AMFR;RBX1;UBE2E3;UBE2E1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4442773490408443,1.1438791655677496,0.2828282828282828,0.847636058903308,1.0,7/27,14.94%,IRS1;SOCS1;GRB10;NCK1;KANK1;ENPP1;INPP5K
prerank,cellular response to interleukin-2 (GO:0071352),-0.44206445785318055,-1.1434064414301721,0.2706270627062706,0.9872890987176943,1.0,3/11,13.42%,SYK;STAT5B;JAK3
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.44206445785318055,-1.1434064414301721,0.2706270627062706,0.9872890987176943,1.0,3/11,13.42%,SYK;STAT5B;JAK3
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.4707535651036656,1.1433326592295805,0.32858990944372574,0.8487264001998814,1.0,4/21,10.31%,TUBD1;KIF7;UCHL5;PDCL
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.45301745541390065,1.1433200963801633,0.29833546734955185,0.8479321451978801,1.0,7/22,17.00%,THY1;DUSP3;SH2D1A;PRNP;FCGR2B;CD300A;UBASH3A
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.5005492890504726,1.1433080724520703,0.31824611032531824,0.8471493055168257,1.0,4/14,14.63%,IRS1;LONP2;ABCD1;IRS2
prerank,positive regulation of hydrolase activity (GO:0051345),0.3680254752345976,1.143098021916905,0.2198364008179959,0.8470395503049224,1.0,39/137,21.06%,WNT11;CCL7;DOCK8;RGP1;SEMA4D;CD40;THY1;CCL5;CX3CL1;ARHGEF7;RAPGEF6;RAPGEF2;CTSH;RAP1GAP;AGRN;SNX9;CCL14;SRGAP2;RGS16;ARHGAP11A;RACK1;RIC1;LIMS1;RAPGEF1;ASAP3;EZH2;CALM3;SH3BP1;TBC1D2;NF1;FNTA;ARAP1;PIN1;SGSM3;TGM2;RGS10;DOCK10;CCL4;MMUT
prerank,regulation of JNK cascade (GO:0046328),0.37584750561950364,1.142994474154215,0.25026737967914436,0.8465453786000069,1.0,23/101,15.89%,EDAR;NOD2;TAOK3;SLAMF1;GADD45G;DUSP3;TRAF4;WNT7B;CYLD;MAPK8IP3;TPD52L1;DACT1;APP;HMGB1;MEN1;TRAF3;TRAF5;DUSP10;FCGR2B;MINK1;TAOK2;MTURN;CD27
prerank,ganglioside biosynthetic process (GO:0001574),0.4922631139230036,1.1427738815431916,0.3045897079276773,0.8464914630835718,1.0,4/15,9.70%,ST6GALNAC4;ST6GALNAC6;B4GALT5;ST3GAL1
prerank,protein mannosylation (GO:0035268),0.4639943092705955,1.1418913947250449,0.3151750972762646,0.8487487844111267,1.0,7/22,18.09%,DPY19L4;TMTC1;POMT1;POMT2;CRPPA;TMTC4;DPY19L1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3889204769469199,1.1418794199485054,0.2744656917885264,0.8479738738416076,1.0,6/57,2.15%,TNFSF10;ASPH;NOD1;AIM2;USP50;FIS1
prerank,superoxide anion generation (GO:0042554),0.511419560492725,1.1417543638037184,0.3124108416547789,0.8475591089460659,1.0,2/13,4.67%,CYBB;TAFA4
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4625456366665704,1.141696044416476,0.2987179487179487,0.8469190224254287,1.0,9/23,25.43%,CCL5;IL10RA;IL10RB;JAK2;PIBF1;NOTCH1;CRLF3;OCIAD1;TNF
prerank,sensory perception of taste (GO:0050909),-0.4590760733115742,-1.141586436343774,0.29178470254957506,0.9896309085009993,1.0,7/10,54.11%,PKD2L1;PKD1L3;ASIC3;TAS1R3;TAS1R1;ASIC1;CD36
prerank,water-soluble vitamin metabolic process (GO:0006767),0.3896348951922024,1.1412987208470073,0.2834051724137931,0.8474664541429339,1.0,18/68,21.06%,MTHFR;DHFR;SLC25A19;SLC46A1;SLC19A1;SLC52A2;CYB5R3;AMN;ABCC1;TPK1;ENPP1;SHMT1;PANK2;MCCC1;MTHFD1;ABCD4;SLC5A6;MMUT
prerank,regulation of adaptive immune response (GO:0002819),0.46834225196564494,1.1412813700818525,0.3016759776536313,0.8467016682755264,1.0,1/18,0.14%,IRF7
prerank,regulation of transmembrane transport (GO:0034762),0.4287143472472417,1.1412440207723156,0.3037974683544304,0.8460096215690825,1.0,5/31,16.74%,CLTRN;TRIB3;PIM1;ACTB;KCNJ2
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.42257147088477787,1.1411823268465504,0.2926829268292683,0.8454310570634932,1.0,10/35,16.09%,PLXNA3;PLXNB2;SEMA4D;NRP2;PLXNB3;MET;NRP1;RAC1;SH3BP1;SEMA3D
prerank,positive regulation of lipid localization (GO:1905954),0.5185122091534345,1.1410404661819897,0.3220588235294118,0.8451244344063437,1.0,3/11,10.58%,IKBKE;NFKB1;ZC3H12A
prerank,positive regulation of cell death (GO:0010942),0.39428363106760117,1.141016929917279,0.288268156424581,0.844395052259413,1.0,13/59,14.33%,WNT5A;DAXX;CLU;RARG;MT3;HTATIP2;PRNP;PRR7;ZC3H12A;DDIT4;FCGR2B;EIF2S1;FYN
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.44047820106712987,1.140937104309098,0.2899628252788104,0.843851816388442,1.0,9/29,19.72%,IRF7;BIRC2;CD40;IKBKE;TRAF3;BIRC3;TLR3;CD300LF;TANK
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.35604328046319134,-1.1400002501335673,0.2556053811659193,0.9910381099514685,1.0,10/23,19.06%,PARP1;XPC;COPS2;UBB;UBC;GPS1;UBA52;COPS6;RPS27A;XPA
prerank,nuclear membrane reassembly (GO:0031468),0.4032940488804583,1.1396064489268496,0.296127562642369,0.8476301715614005,1.0,14/54,17.06%,CHMP4A;CHMP4B;CC2D1B;NUP37;ANKLE2;KPNB1;BANF1;UBXN2B;CHMP3;REEP3;AHCTF1;NUP155;IST1;PPP2R2A
prerank,response to thyroid hormone (GO:0097066),0.5021939601573298,1.139367381060243,0.32994186046511625,0.8476311982772203,1.0,3/13,8.64%,CTSS;CTSH;LMO2
prerank,negative regulation of protein metabolic process (GO:0051248),0.4066820040308894,1.1385574286531799,0.2941860465116279,0.849648719173565,1.0,16/48,19.46%,CLU;AZIN2;MAD2L2;HSP90AB1;RILP;PFDN5;NFKB1;AGAP2;PRNP;AZIN1;PFDN4;APOE;CD84;FLOT2;LDLR;PIN1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.38170692348143037,1.1384846669059765,0.26931330472103004,0.8491015439644702,1.0,29/84,22.98%,PSMB10;PSME2;PSMA5;CDC26;PSME4;ANAPC5;ECRG4;PSMA3;PSMB9;ANAPC4;UBE2E1;PSMD2;CDC16;CDC27;PSME3;RB1;ANAPC15;PSMA4;ANAPC2;PSMD7;PSMD8;PTTG1;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4;CUL3
prerank,myelin assembly (GO:0032288),0.536481489747785,1.1383425290689668,0.3108728943338438,0.8487837769620975,1.0,3/10,8.27%,PMP22;CNTNAP1;EPB41L3
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.477219329504293,1.1382488379292381,0.3226256983240223,0.848295521035649,1.0,5/17,10.49%,SFRP2;CCL5;PODXL;RET;CIB1
prerank,regulation of dendrite development (GO:0050773),-0.3057389581711904,-1.1373524268831994,0.2111801242236025,0.9962943894985291,1.0,12/37,14.90%,SDC2;COBL;ALK;CSMD3;BCL11A;GSK3B;DAB2IP;NSMF;ZDHHC15;VLDLR;ADGRB3;DCC
prerank,negative regulation of transport (GO:0051051),0.39890480308444815,1.1373105069280964,0.2857142857142857,0.850661967479263,1.0,25/51,30.59%,NR1H2;BST2;SNX33;LRSAM1;RSC1A1;PPM1F;FCGR2B;RACK1;RUBCN;TLR2;SIRPA;MCTP1;ERBB3;ARL6IP5;SNX12;SYT11;NDFIP1;PTEN;PIP4P2;CTTNBP2NL;MTMR2;LILRB1;RAB7A;PRKD1;LGALS3
prerank,tyrosine metabolic process (GO:0006570),0.5139883217693102,1.137198948979497,0.3217391304347826,0.8502239804693863,1.0,1/11,4.38%,THAP4
prerank,positive regulation of B cell proliferation (GO:0030890),-0.33023962631119097,-1.1370406973732605,0.24271844660194175,0.992696042923045,1.0,7/29,8.84%,GPR183;CD38;CD81;NCKAP1L;SASH3;EPHB2;TFRC
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.5036624298275675,1.1369864963059682,0.33905579399141633,0.8501463639586804,1.0,1/13,0.31%,CLTRN
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.5093194825356222,1.1365814972290291,0.3249258160237389,0.8507448961692353,1.0,3/12,8.64%,CTSS;CTSH;LMO2
prerank,autophagosome maturation (GO:0097352),0.43331215815447627,1.1365593732603962,0.29818181818181816,0.8500127418985268,1.0,9/32,13.50%,LAMP2;VPS33A;LIX1;RUBCNL;UBQLN1;VIPAS39;CHMP3;MAP1LC3B;VTI1B
prerank,positive regulation of vasculogenesis (GO:2001214),0.5342218152860713,1.1365132057902636,0.330804248861912,0.8493483061470738,1.0,3/10,11.71%,KDR;RAPGEF2;RIN2
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.3604690635220276,-1.13541258208628,0.26199261992619927,0.9946189431496102,1.0,7/21,16.64%,TGFB1;ROCK1;SRGN;TRPM4;CCL3;CCR1;ECM1
prerank,positive regulation of ATPase activity (GO:0032781),0.41262157203581096,1.135362519331082,0.3159144893111639,0.8524875366285082,1.0,7/41,13.37%,MSH2;TOR1AIP2;TOR1AIP1;ATP1B3;DHX9;DYNLL1;CHTOP
prerank,regulation of protein binding (GO:0043393),0.3682673806049227,1.1353266495112186,0.25696594427244585,0.8517913093109071,1.0,25/114,16.10%,IFIT1;IFIT2;DTX3L;TRIB3;B2M;TRIM21;SLPI;TCF7L2;AMFR;RAPGEF2;DACT1;BAMBI;APP;LDLRAP1;MEN1;LRPAP1;SORL1;PSEN1;DDX11;RACK1;DAB2;ACTB;SPPL3;CRK;RPL11
prerank,nucleosome assembly (GO:0006334),0.425291703092586,1.1350534165661783,0.30599755201958384,0.851850646692957,1.0,6/31,10.60%,DAXX;BRD2;NAP1L2;SOX9;CHAF1B;NPM1
prerank,aminoglycan biosynthetic process (GO:0006023),0.4062826043163725,1.134825177259386,0.2982456140350877,0.8518304021858729,1.0,5/49,3.12%,EXT1;XYLT2;SDC3;SDC4;HAS1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.41406752160537486,1.1347250259267456,0.31030444964871196,0.8513520121180906,1.0,2/42,0.60%,IRGM;GALP
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5297951047946979,1.134690950399861,0.3343328335832084,0.8506528255639076,1.0,3/11,10.00%,ATL1;VAPB;VCPIP1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5400042002962998,1.1345466183137896,0.3165137614678899,0.8503597714618458,1.0,4/10,14.63%,IRS1;SLC45A3;PRKCE;IRS2
prerank,cardiac muscle cell differentiation (GO:0055007),0.463147277240837,1.1345102632255848,0.31895424836601305,0.8496752548282871,1.0,4/21,13.31%,ACVR1;SLC8A1;SIK1;AKAP13
prerank,rRNA methylation (GO:0031167),0.449836763903886,1.1344684506417175,0.30140485312899107,0.8490177657362623,1.0,9/22,20.56%,MRM2;MRM3;ZCCHC4;TFB2M;DIMT1;NOP2;METTL15;BUD23;EMG1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.4837180836079088,1.134020496225347,0.3360544217687075,0.8497447931226171,1.0,2/17,7.72%,NR1H2;LIPC
prerank,programmed necrotic cell death (GO:0097300),0.46712071015369555,1.133782148137324,0.32887700534759357,0.8497314325323324,1.0,6/18,17.33%,ALKBH7;MLKL;CYLD;ITPK1;TRPM7;TLR3
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.47423639198219264,1.1333515128937786,0.31020408163265306,0.8504450065941676,1.0,5/18,9.11%,TNFAIP1;ITGA3;MYOC;MET;KANK1
prerank,regulation of protein export from nucleus (GO:0046825),0.4547275986699044,1.1331428820544183,0.32858990944372574,0.8503683549587419,1.0,3/23,9.04%,SP100;TCF7L2;BARD1
prerank,protein sumoylation (GO:0016925),0.4027539556388659,1.1328255067700612,0.3221099887766554,0.8506702651879929,1.0,21/49,26.89%,IFIH1;NUP37;SUMO2;SUMO3;NUP153;RAE1;UBA2;NSMCE2;NUP155;PIAS1;PIAS2;NUP88;NUP133;NUP43;SUMO1;TRIM28;NUP205;PIAS4;SEH1L;EYA1;NUP188
prerank,aminoglycan metabolic process (GO:0006022),0.5279635146607262,1.1326102562206635,0.33435114503816793,0.850610601013275,1.0,1/10,0.90%,XYLT2
prerank,regulation of cellular protein catabolic process (GO:1903362),0.4714877640647477,1.1324919295709686,0.3055555555555556,0.8502254099565129,1.0,9/18,23.04%,RGP1;VPS11;DACT1;RIC1;NELL1;HSP90AA1;WDR91;VPS35;MSN
prerank,positive regulation of phagocytosis (GO:0050766),0.4077869459733483,1.1324157810648803,0.29411764705882354,0.8496782779459034,1.0,11/47,20.30%,IL15;IL15RA;C4B;CD47;TUB;STAP1;FCGR2B;PTPRC;CD300LF;SIRPA;APPL2
prerank,negative regulation of cell population proliferation (GO:0008285),0.3528950291993808,1.1323640858025341,0.156,0.8490386356942959,1.0,65/351,16.82%,IFIT3;EIF2AK2;HSPA1B;PARP10;PML;IFI35;WNT5A;PER2;ZBTB17;RARG;B2M;TNFRSF8;SOD2;CDH13;NMI;AQP11;SFRP2;TMEM115;CNOT7;MORC3;CDKN2D;SOX9;CHERP;CTNNB1;P3H1;PPP2R5C;TFAP2B;TMIGD3;CSNK2B;MAGI2;FRZB;RAPGEF2;TFDP1;ARID2;LYN;PDPN;APP;NCK2;PEX2;BMPR2;MEN1;ROR2;PROX1;CIB1;NPM1;ALDH1A2;CDK10;DNAJA3;CTCF;KLF10;THAP12;DUSP10;CGREF1;NELL1;ST18;DIS3L2;JAK2;SOX2;HGS;CD300A;MCC;AIF1;EEF1E1;BRD7;PTPRU
prerank,response to amino acid (GO:0043200),-0.3212767265214368,-1.1322410967931336,0.23655913978494625,1.0,1.0,11/31,16.48%,TMBIM6;GRIN1;RRAGD;GLRB;RRAGB;LARS1;NSMF;GLRA3;SLC38A9;CAPN2;LAMTOR2
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.42284922045794926,-1.1322260452637818,0.3111111111111111,0.9973799679719596,1.0,6/12,33.53%,ANXA6;UBASH3B;FKBP1B;MTLN;PTK2B;RYR2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.4404589357167219,-1.1320375493412993,0.31384615384615383,0.9934315158018512,1.0,3/11,8.85%,EPN1;E2F2;SEMA6A
prerank,COPII-coated vesicle budding (GO:0090114),0.3829896312182391,1.131848946765222,0.2870967741935484,0.8499699962000787,1.0,21/68,22.98%,TRAPPC3;TGFA;SEC16A;GOSR2;CNIH3;SEC24D;CTSC;PPP6R3;SEC23A;VAPB;TMED10;SCFD1;NAPA;SEC24A;CNIH1;TFG;RAB1A;TRAPPC9;TRAPPC6A;F8;CUL3
prerank,cellular response to oxygen-containing compound (GO:1901701),0.35194607586127263,1.1317476611458785,0.17552657973921765,0.8495095215867972,1.0,53/291,16.84%,CXCL10;AXL;CD274;CXCL9;WNT11;IRGM;NOD2;WNT5A;IRS1;ZFP36;CRHBP;BRINP3;DHX36;RRAGC;SOX9;PDXP;NFKB1;WNT7B;MT3;RET;RAPGEF2;LTK;LYN;P2RX4;HMGB1;MAPK14;RORA;GIT1;ZC3H12A;SNW1;ZFP36L1;GLRA2;XBP1;STAP1;LCOR;AKAP9;LAMTOR3;ZNF35;RAPGEF1;SHMT1;ACTB;TNIP2;MYD88;INPP5K;ERCC6L2;TLR2;ADNP2;TNIP3;MTOR;IRAK1;UPF1;ACOD1;PDE3A
prerank,mesenchymal cell differentiation (GO:0048762),0.4037722929069094,1.1314902528592021,0.29035874439461884,0.8496255865081407,1.0,11/51,14.36%,LOXL2;WNT5A;DDX5;SOX9;CTNNB1;FGFR2;CUL7;SNAI2;NOTCH4;LIMS1;RANBP3L
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3483578072848438,1.1310771947090257,0.017,0.8502497374466843,1.0,330/1668,17.70%,STAT1;STAT2;CXCL10;SP100;NLRC5;IRF7;HELZ2;PARP9;PITX2;MYOZ2;SIM1;NAMPT;LOXL2;GAL;MOV10;THAP7;SP110;LHX2;LMX1A;NR1H2;NOD2;CC2D1B;IRF2BP1;ESR2;USF2;CAMK2D;ETV3;PCGF5;VRTN;MEF2B;TCF24;TRIB3;WNT5A;ZNF483;TFAP2C;PER2;GMEB2;CCNL1;ZBTB17;ESRRB;ZFP36;RARG;BRD2;NFX1;HTATSF1;DDRGK1;BBX;AGO2;RBM14;RNF4;SEMA4D;TEAD2;ZBTB2;CD40;NFKB2;SOD2;CDH13;MECP2;ACVR1;STAT3;ARID1B;ARID5B;ZFP37;TGFA;BATF3;ACTR2;RBL1;SFRP2;DDX5;ZNF471;MTA3;ELK3;CGGBP1;PCGF6;RUNX1;MAD2L2;ID3;BHLHE40;ZHX3;NACC1;NKX6-2;RBMX;KLF15;CIC;CCNL2;GATAD2A;NOP53;DHX36;MZF1;BRWD3;JUNB;ZSCAN12;NCOA1;ZNF23;SOX9;SRA1;HNRNPK;CTNNB1;CX3CL1;CCND1;CDK12;PFKM;KMT2A;ZNF2;PAXBP1;ARID1A;CCNT2;TRAK1;ZNF76;MYDGF;MBD2;ZSCAN22;FGFR2;ZSCAN26;IGBP1;SMARCE1;TCF7L2;TCF4;SMARCC2;ZXDC;ZBTB43;NFKB1;BCL6;CREBRF;ASXL3;ZBTB38;SETD3;BRIP1;BACH1;DDX20;THAP3;USF1;ZSCAN29;ACTR3;NFATC2;TFAP2B;SNAI2;SAP30;UBP1;DHX9;SRF;ETV6;MTA2;RAI1;IKZF2;TADA2A;HTATIP2;SMAD2;MRTFA;GLIS3;MED13L;MEIS3;ATF6B;TFDP1;DACT1;LPIN2;SIRT6;RPAP2;NCK1;DNMT3A;AEBP1;LMO2;AASS;SLTM;MET;ELP2;GDNF;ATF1;HOXA9;NFIB;METTL23;POU3F1;APP;SCX;HMGB1;DACH2;LCORL;NCK2;ELF4;TADA2B;CRTC1;MAML2;HR;PLK3;PEX2;IRF9;AGRN;BMPR2;MEN1;MAPK14;BPTF;ZSCAN20;MNAT1;LIN9;NR2C1;RORA;MED12;PROX1;TNIP1;PHIP;ELOC;NCOA5;KDM3B;DUSP26;ZC3H12A;NPM1;FOXK1;MAX;SNW1;NOTCH4;DNAJA3;CTCF;HCFC2;ZBTB5;MITF;GALR1;XBP1;SKIL;TFDP2;IER5;CBX4;TAF3;HMGB3;ECD;KLF10;NKAP;CUX1;RELB;UXT;TEF;NOP2;LDB2;LDB1;PSEN1;REL;PPARGC1A;APOE;PRKDC;HOXB6;NR3C1;LCOR;FBXL19;RB1;MIER1;MDFI;PRDM4;E2F4;ZNF35;ATXN1;APBB1;HDAC8;PTCH1;PGBD1;BUD31;ST18;ZBTB21;TIAL1;DBX2;MYO6;POGZ;MED29;DAB2;BCL11B;SMARCA1;IKZF1;ZNF418;CASZ1;DLG1;MYPOP;SOX2;TNIP2;TFR2;RREB1;EZH2;TET2;CREB5;MYB;POU6F1;CRTC3;ZBTB24;ZBTB34;CAMTA2;ERF;BMPR1A;CRK;KLF16;TLR2;SOX5;SMARCD2;GTF2IRD1;PIAS1;NPAT;ARF4;RCOR3;MEF2A;KDM7A;CARF;PROX2;PIAS2;PPARD;MED27;TNIP3;LAGE3;IL18;LMO7;SREBF1;CCNK;ZBED4;ZBTB4;DICER1;KAT8;RBPJ;BRD7;MED16;CHCHD2;ELF1;ID4;HMBOX1;MPND;BAX;IER2;ANXA4;RRP1B;TLR3;LRRFIP1;ZNF445;PELP1;ENY2;ZBTB49;POU2F2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.35461306969323503,1.1304062110203745,0.1921921921921922,0.8517943326718445,1.0,63/259,17.08%,CNGB1;PMP22;CEP19;ATP6V0D1;BBIP1;RAB8B;CDH13;SPATA13;B9D2;ACTR2;S1PR2;CEP162;ACTN2;PARVB;RILP;CYFIP1;RILPL1;SNX10;TTC39C;CARMIL1;ARHGEF7;PIP5K1A;ACTR3;NPHP3;KIF3B;AIF1L;RAPGEF6;RAPGEF2;CCDC88A;MKS1;CFAP54;TNIK;FNBP1L;SPEF1;WDR35;TMEM138;CEP131;EXOC6;SRGAP2;FXYD5;GSN;DYNLT2B;DYNLL1;FGD6;WHAMM;NRP1;RAC1;PIBF1;DZIP1;CFAP20;INPP5K;TMEM67;MINK1;BBS2;CCDC66;ARF4;AIF1;RAB11A;OPHN1;WDR19;DYNC2H1;OCRL;CEP89
prerank,nucleosome organization (GO:0034728),0.39235393104959293,1.1303828499855897,0.2905788876276958,0.8510839563632404,1.0,12/55,11.05%,DAXX;BRD2;NAP1L2;SOX9;ARID1A;SMARCE1;SMARCC2;ARID2;BPTF;CHAF1B;NPM1;CTCF
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.43794422228431407,1.1303342864485755,0.2949367088607595,0.8504453076414792,1.0,5/26,9.24%,TGFA;FBXW7;SOCS5;APP;NCK2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.38615121113980916,1.129944645729745,0.2893289328932893,0.8510738644033141,1.0,16/64,19.18%,DAPK3;UTRN;CDH13;THY1;PEAK1;DUSP3;CX3CL1;CSF1;MYOC;CIB1;LDB1;PIK3CB;MINK1;CORO1C;NF1;TSC1
prerank,epithelium development (GO:0060429),0.36965223300085126,1.12982007834203,0.2719665271966527,0.8506772031179786,1.0,14/107,14.27%,STAT1;KDR;TIMELESS;CASP6;SOX9;FGFR2;WNT7B;SNAI2;DACT1;PROX1;ALDH1A2;HNRNPH3;PTCH1;JAK2
prerank,xenobiotic transport (GO:0042908),0.47885944640672834,1.1296337972691588,0.308843537414966,0.8505405640778402,1.0,5/17,20.39%,ABCC2;SLC15A2;ABCC1;ABCG2;ABCC5
prerank,glial cell development (GO:0021782),0.4416542998901631,1.1293454916490695,0.30980392156862746,0.8507193310310448,1.0,9/25,18.89%,MT3;EIF2B2;MXRA8;APP;TLR2;MDK;NF1;EIF2B5;EIF2B3
prerank,positive regulation of interleukin-17 production (GO:0032740),0.4577770022824519,1.1291414402454718,0.32625994694960214,0.8506090673545168,1.0,2/22,0.94%,IL15;NOD2
prerank,keratinocyte differentiation (GO:0030216),0.4311874586656146,1.1288742929182343,0.3176178660049628,0.8506875613997118,1.0,3/29,6.59%,CLIC4;WNT5A;PIP5K1A
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.44381069867093986,1.1288468248355394,0.320253164556962,0.8499974778810816,1.0,5/25,7.32%,PML;HSP90AB1;EPHA4;TRIM39;CSNK2A2
prerank,centromere complex assembly (GO:0034508),-0.31127298977317774,-1.1288423400438317,0.23493975903614459,1.0,1.0,16/36,24.84%,CENPV;CENPO;CENPE;KNL1;CENPA;ITGB3BP;CENPL;MIS18BP1;CENPK;CENPU;CENPC;CENPF;DLGAP5;CENPX;CENPQ;CENPH
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.48743202308691563,1.1288131411928952,0.33101529902642557,0.8493114697591578,1.0,3/15,12.34%,ABCG1;LIPC;APOE
prerank,regulation of interleukin-12 production (GO:0032655),0.4019520362312336,1.128359659968214,0.3116883116883117,0.8500732496941021,1.0,15/47,24.19%,SLAMF1;CD40;CD47;TLR8;HMGB1;MAPK14;PIBF1;TLR2;LGALS9;MDK;TLR3;RIPK2;LTB;IRF5;LILRA5
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.46532916514260725,1.128257185791113,0.3414965986394558,0.8496451141839867,1.0,8/18,23.42%,FLT1;SIRT6;HMGB1;MDK;ITGA4;AKT3;FGF2;PDPK1
prerank,eye morphogenesis (GO:0048592),0.4716528621400946,1.1281817628242392,0.31886024423337855,0.8490793330777695,1.0,4/19,7.88%,RARG;STAT3;FBN1;MFAP5
prerank,response to ethanol (GO:0045471),-0.4003899212643576,-1.128153054133617,0.2961672473867596,0.9991016009169317,1.0,3/14,3.94%,GRIN2A;GRIN2B;GRIN1
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.4002527053778433,-1.1280995766720592,0.3231939163498099,0.994678759893621,1.0,3/15,11.40%,UBR3;TGFB2;BRCA1
prerank,RNA interference (GO:0016246),0.47901877526186043,1.127316268834961,0.33379120879120877,0.8513309186641086,1.0,10/17,28.16%,AGO2;TARBP2;DHX9;NRDE2;DICER1;PRKRA;AGO4;TSN;AGO1;AGO3
prerank,telomere maintenance via telomerase (GO:0007004),0.4394786404798448,1.1270975751172905,0.31,0.8513071526337093,1.0,10/28,18.99%,HSP90AB1;RFC1;TNKS1BP1;RTEL1;GAR1;PPP6R3;TELO2;HSP90AA1;PTGES3;TERF2
prerank,cellular response to interleukin-7 (GO:0098761),0.4714157641338921,1.1270255278038304,0.324,0.8499961894831716,1.0,5/17,14.63%,IRS1;SOCS1;STAT3;SOCS2;IRS2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4714157641338921,1.1270255278038304,0.324,0.8499961894831716,1.0,5/17,14.63%,IRS1;SOCS1;STAT3;SOCS2;IRS2
prerank,filopodium assembly (GO:0046847),0.48069695754605346,1.1268281657748205,0.3202170963364993,0.8498904830374003,1.0,5/16,13.02%,SPATA13;S1PR2;SPEF1;SRGAP2;FGD6
prerank,homotypic cell-cell adhesion (GO:0034109),0.4106909465600783,1.126727889781089,0.30260047281323876,0.8494560329120011,1.0,11/39,18.17%,CSRP1;ACTN1;MYL9;MEGF10;PPIA;MEGF11;TJP2;PIK3CB;ACTB;FIBP;MYH9
prerank,organelle transport along microtubule (GO:0072384),-0.3209329921870547,-1.1266232960740568,0.25133689839572193,0.9959018268176372,1.0,8/31,9.60%,TRAK2;BICDL1;NDE1;HTT;CDC42;TMEM201;FBXW11;UBB
prerank,regulation of neuron differentiation (GO:0045664),-0.2547490905191353,-1.1258303901646374,0.22535211267605634,0.9944713542113,1.0,24/76,22.52%,IMPACT;ZFHX3;ZFHX2;ROCK1;ALK;MOSMO;BIN1;REST;BRINP1;MMD2;ID2;RHOA;ARHGEF2;BRINP2;HOXD3;NRCAM;ZC4H2;ECT2;CDK5RAP3;NREP;NBL1;MEF2C;TCF3;DISP3
prerank,cellular response to topologically incorrect protein (GO:0035967),0.4195245365442718,1.12576274017847,0.3184634448574969,0.8519514867918859,1.0,3/31,1.94%,HSPA1B;DAXX;UBE2W
prerank,receptor recycling (GO:0001881),0.5389071387262736,1.125290439060846,0.3318452380952381,0.8527997650600174,1.0,3/10,12.80%,RAB11B;SORL1;ARFGEF2
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.366074411354554,-1.1252096049851616,0.2967479674796748,0.9923727837205538,1.0,13/20,29.01%,SEMA4C;SEMA4G;SEMA4A;SEMA6A;SEMA4B;SEMA3E;SEMA5B;SEMA6D;SEMA4F;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,negative regulation of transferase activity (GO:0051348),0.43650946430055226,1.1249442831484817,0.2962962962962963,0.853238288688757,1.0,7/28,14.94%,DTX3L;ZFP36;EIF4A2;ERCC4;MEN1;IRS2;INPP5K
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.33928735632380963,-1.1248984519737286,0.25,0.9890449356989595,1.0,7/23,12.18%,INPP5F;MTMR1;MTMR4;INPP5B;MTMR9;SYNJ2;MTMR10
prerank,regulation of response to stress (GO:0080134),0.5407237709179687,1.1246848459111358,0.33487654320987653,0.8533197377838295,1.0,3/10,9.93%,SLC38A2;CRHBP;MLC1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.4108963996424504,1.12458036836429,0.3106332138590203,0.8528767785322839,1.0,14/37,23.07%,NOD2;GBP5;STAT3;ABCD1;MAPK14;ZC3H12A;IL17D;CHID1;MYD88;SIRPA;PER1;APPL2;PLD3;ADCY7
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.44961194358694234,1.1243474649427054,0.3109919571045576,0.852854572347308,1.0,7/23,17.12%,BCL2L11;SAMM50;HSPA4;BAD;HSP90AA1;BMF;BAX
prerank,cation transport (GO:0006812),0.35935807428221456,1.1243084354012463,0.2548223350253807,0.8522182169355044,1.0,20/167,13.04%,TRPM5;CATSPER4;CNGB1;KCNMB3;TRPM2;TRPM6;SLC18A2;LRP2;SLC8A1;PANX2;SLC11A2;KCNS3;SLC7A6;KCNA4;TRPM3;PANX1;ANO10;KCNK3;SCN2A;FGF13
prerank,negative regulation of cellular component organization (GO:0051129),0.3753700713775675,1.1242969079021714,0.3213507625272331,0.8514738730821848,1.0,15/74,13.23%,HSPA1B;SPRY2;CLU;SNX33;NOP53;CARMIL1;LRSAM1;RTEL1;HSPA8;DNAJB6;DNM2;RIOK3;SORL1;SVIP;RUBCN
prerank,negative regulation of B cell proliferation (GO:0030889),0.5177321116141049,1.1240440835989052,0.3394495412844037,0.8515235702089954,1.0,4/11,19.90%,LYN;FCGR2B;CD300A;TYROBP
prerank,DNA damage checkpoint signaling (GO:0000077),-0.3303197035615103,-1.123991851378445,0.24390243902439024,0.9879467716580185,1.0,12/28,17.59%,MAP3K20;NBN;USP28;CEP63;RHNO1;DONSON;HUS1;RAD17;CLSPN;E2F1;STK33;RAD1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.5340646775242079,1.1238554778700864,0.3261538461538461,0.8513818245218558,1.0,3/10,16.28%,ISG15;DIS3L2;TUT7
prerank,negative regulation of telomere maintenance (GO:0032205),-0.3872395372888628,-1.123793007418854,0.28368794326241137,0.9841617488902787,1.0,7/15,17.83%,PARP1;NBN;TERF2IP;SLX4;PINX1;TERF1;ERCC1
prerank,regulation of intracellular protein transport (GO:0033157),-0.32058547063201587,-1.123764701535114,0.2871287128712871,0.979826050368886,1.0,9/32,12.34%,TGFB1;OAZ2;SIRT7;OAZ1;PCM1;GCC2;KIF20B;ZFAND1;RIPOR1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.4422908563506881,1.123699659923249,0.32951653944020354,0.8510793450783039,1.0,4/27,12.50%,CALCA;GNA15;C3AR1;GPR35
prerank,negative regulation of cellular catabolic process (GO:0031330),0.38698047751247017,1.1236664604664683,0.311804008908686,0.8504255666632522,1.0,21/63,22.24%,RGP1;STAT3;MT3;IL10RA;MET;LEPR;TIMP2;FOXK1;SORL1;RIC1;RUBCN;NELL1;EIF4G3;BMF;NRDE2;MTOR;ZKSCAN3;TAB3;TLK2;MCL1;RRAGA
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4491590930393484,1.1234015129694332,0.31968295904887717,0.8505107325043049,1.0,7/21,19.97%,DHX36;SRF;MED12;MITF;PAXIP1;MED16;MED24
prerank,negative regulation of programmed cell death (GO:0043069),0.3497162932309734,1.122763520415374,0.18218218218218218,0.8517916830918126,1.0,53/355,12.42%,IFIT3;NOL3;AXL;HSPA1B;WNT11;WNT5A;SPRY2;COMP;KDR;BIRC2;DDRGK1;KLHL20;SEMA4D;LRP2;ANKLE2;FXN;BFAR;HCK;CCND2;SOX9;HNRNPK;CTNNB1;CX3CL1;AREL1;MYDGF;CFLAR;NFKB1;TMBIM4;MT3;TFAP2B;ATAD3A;HTATIP2;CTSH;LTK;MET;GDNF;BARD1;PDPN;SCX;PLK3;PHIP;CIB1;NPM1;NUAK2;XBP1;PIM1;CBX4;BAG1;NAA35;ARHGAP10;PSEN1;PRKDC;SOCS2
prerank,positive regulation of bone mineralization (GO:0030501),0.4173284433035049,1.1224596481668883,0.32660332541567694,0.8520768755816743,1.0,8/35,18.18%,ISG15;ACVR1;SLC8A1;BMPR2;ADGRV1;NELL1;BMPR1A;ACVR2A
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.38967638303392205,1.1223729781456322,0.30666666666666664,0.8515884681728679,1.0,14/63,17.39%,CD274;IL15;CD40;CCL5;CD276;NFATC2;NCK1;NCK2;CCDC88B;IRS2;CHRNB2;AIF1;IL18;PTPRC
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.35351072735304756,1.121987253277948,0.22722722722722724,0.8521289694102674,1.0,79/248,24.14%,WNT11;PSMB10;DAPK3;WNT5A;PSME2;PSMA5;PSME4;TMEM170B;SFRP2;MAD2L2;UBE2B;PRICKLE1;PFDN5;SOX9;CTNNB1;FGFR2;PSMA3;TCF7L2;NFKB1;TMEM9;NPHP3;SNAI2;AMFR;BICC1;CYLD;FRZB;PSMB9;DACT1;BAMBI;RBX1;USP34;KANK1;BTRC;DKK3;PSMD2;SCYL2;PSEN1;PSME3;APOE;LZTS2;PLEKHA4;DAB2;CTNND2;LMBR1L;PSMA4;SOX2;MLLT3;MCC;PTPRU;MDK;TPBG;HDAC1;PSMD7;PSMD8;STK3;PSMD9;PIN1;PSMF1;DDX3X;STK11;PSMB6;USP8;PSMC2;PSMD12;GLI3;SMURF2;RUVBL2;PSMD4;GPRC5B;CUL3;LIMD1;XIAP;VCP;CHD8;AXIN1;PSMA2;CAPRIN2;TLE5;KREMEN1
prerank,oligodendrocyte development (GO:0014003),0.4791805687891447,1.1219446206920554,0.32083333333333336,0.8514914250216586,1.0,6/15,19.93%,CNTNAP1;EIF2B2;B4GALT5;EIF2B5;EIF2B3;PLP1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5380504735015651,1.1216579351679081,0.36936936936936937,0.8517404412458353,1.0,2/10,4.41%,THAP7;KLF15
prerank,microglial cell activation (GO:0001774),0.45640807272663053,1.1212133779101143,0.32972972972972975,0.8524290433024627,1.0,7/21,20.32%,CLU;CX3CL1;APP;JAK2;AIF1;TYROBP;IFNGR1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.4495140944529575,1.1210775424424,0.3237221494102228,0.8521065933632042,1.0,9/21,24.94%,EXT1;XYLT2;HPSE;EXTL3;HS3ST4;HS6ST1;XYLT1;HS6ST2;EXT2
prerank,regulation of oxidoreductase activity (GO:0051341),0.5084578706891871,1.1210212889111995,0.32581100141043723,0.8515392927247364,1.0,2/13,6.57%,NOD2;MT3
prerank,anion transmembrane transport (GO:0098656),0.3869665465955922,1.1209617344131142,0.2938643702906351,0.8509739190876029,1.0,22/67,23.60%,SLC25A22;SLC27A1;SLC25A19;SLC25A1;SLC19A1;SLC35B1;SLC25A10;ABCC1;SFXN2;SLC35B4;SLC13A4;SLC35A3;SLC25A12;SLC36A4;SFXN1;SLC35C2;ABCC5;SLC5A6;MFSD12;SLC1A3;SLC25A30;ARL6IP5
prerank,fatty acid biosynthetic process (GO:0006633),0.3788192764972848,1.1204574446524416,0.2906458797327394,0.8518758894813134,1.0,16/63,21.16%,MCAT;ABHD2;ASAH2;DEGS1;FADS3;LIPC;SCD5;ABCD1;XBP1;HACD3;EPHX2;ABHD3;OXSM;GPX4;ELOVL4;DECR2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.4253167533101049,1.120134915414823,0.3333333333333333,0.8522198598871719,1.0,5/27,11.39%,PML;PER2;BHLHE40;CRTC1;SIK1
prerank,stress-activated MAPK cascade (GO:0051403),0.38418747511038553,1.119845022210344,0.3194600674915636,0.8524233403357601,1.0,21/61,21.97%,NOD2;NOD1;SKP1;ZFP36;MAP3K8;PTGER4;NFKB1;MAP2K3;MAPK14;BTRC;ZFP36L1;TNIP2;MINK1;TAOK2;IRAK1;LGALS9;UBE2V1;TAB3;RIPK2;MAP4K2;MAPK9
prerank,response to ketone (GO:1901654),0.4435853052145794,1.119840543731125,0.3333333333333333,0.85167527901937,1.0,4/24,11.12%,CATSPER4;ABHD2;UBE3A;SLIT3
prerank,cell-matrix adhesion (GO:0007160),0.37016286392873743,1.1198292570516784,0.2876712328767123,0.8509555829305626,1.0,21/95,17.59%,SIGLEC1;COL13A1;ITGA2;ACTN1;THY1;ACTN2;PEAK1;ARHGEF7;ITGA3;PIP5K1A;ITGB8;MKLN1;HPSE;COL3A1;WHAMM;RAC1;TAOK2;NID2;ADAMTS12;BCR;ITGA4
prerank,gliogenesis (GO:0042063),-0.3920191126003312,-1.1197119045835884,0.3120567375886525,0.9909430541187982,1.0,6/15,22.45%,CDH2;TGFB2;METTL3;CD9;ANXA1;METRN
prerank,calcium ion import across plasma membrane (GO:0098703),0.4950657872023497,1.1195108761831567,0.3402777777777778,0.8513054449281378,1.0,3/14,12.83%,TRPM2;SLC8A1;TRPV4
prerank,lipid biosynthetic process (GO:0008610),0.37036338916114403,1.1194091531094932,0.28555917480998916,0.8509011780492566,1.0,20/77,23.13%,MCAT;PCYT2;AGPAT5;PIP5K1A;ACSL5;LIPC;FDFT1;SCD5;GNPAT;XBP1;DHRS11;GGPS1;PAM;SREBF1;ACSS2;OXSM;ELOVL4;SRD5A1;DOLPP1;HMGCR
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.5151300368329916,1.1186455802900264,0.353030303030303,0.8518845475874539,1.0,6/10,25.43%,NSMAF;SPHK2;RACK1;PLA2G6;PRKCD;TNF
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.5151300368329916,1.1186455802900264,0.353030303030303,0.8518845475874539,1.0,6/10,25.43%,NSMAF;SPHK2;RACK1;PLA2G6;PRKCD;TNF
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.47859435002081957,1.118507105782443,0.33943661971830985,0.8516063927858464,1.0,7/16,17.94%,DDX5;HNRNPM;DHX9;RBM17;RSRC1;SLU7;SCNM1
prerank,regulation of amyloid-beta formation (GO:1902003),0.4143186015511774,1.1183467701325691,0.3239263803680982,0.8513663645303353,1.0,9/34,12.34%,ABCG1;CLU;EPHA4;GGA3;PRNP;TMED10;SORL1;LRRTM3;APOE
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3568014691655528,1.1183352089390437,0.26809378185524974,0.850639796761009,1.0,48/163,21.78%,THEMIS2;PSMB10;ICOSLG;SKP1;PSME2;PIK3CD;PSMA5;PSME4;LCP2;RBCK1;THY1;CD276;PAK3;PSMA3;NFKB1;NFATC2;PSMB9;BCAR1;NCK1;EIF2B2;RNF31;BTRC;ZC3H12A;PSMD2;PLEKHA1;PSME3;PIK3CB;SPPL3;FYN;PSMA4;BLNK;CSK;PTPRC;PAG1;PSMD7;EIF2B5;EIF2B3;PSMD8;DENND1B;RC3H2;PSMD9;PDE4B;RIPK2;PSMF1;LCK;PSMB6;PSMC2;PSMD12
prerank,negative regulation of nervous system development (GO:0051961),0.4748834623765829,1.1181272030000249,0.3575268817204301,0.850601394131719,1.0,8/17,25.43%,B2M;SLIT1;SORL1;HOOK3;TLR2;APPL2;NOTCH1;TNF
prerank,regulation of cilium movement (GO:0003352),0.5231182837602577,1.1180460370609189,0.3551263001485884,0.850124318046079,1.0,2/10,5.16%,ODAD2;CCDC40
prerank,nuclear migration (GO:0007097),-0.4143086830887447,-1.1179821236342224,0.31683168316831684,0.9932016327344868,1.0,7/13,12.16%,DOCK7;PCM1;TMEM201;CEP120;FBXW11;SYNE3;CLMN
prerank,glycosaminoglycan metabolic process (GO:0030203),0.39283584307614205,1.1179463905919291,0.30324074074074076,0.8497195119768802,1.0,6/54,3.12%,EXT1;XYLT2;SDC3;HYAL4;SDC4;HAS1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.41994137637766293,1.117227712709237,0.3208685162846803,0.8514303110284422,1.0,3/33,3.63%,NOL3;CLU;FXN
prerank,neutrophil activation (GO:0042119),0.5138412809613369,1.117105902977653,0.3518248175182482,0.8511230953244638,1.0,2/12,4.35%,IL15;CCL5
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.4462056433894197,1.1170150702083295,0.32597402597402597,0.8506766316677988,1.0,7/22,16.52%,PSMB10;PSMA5;PSME4;PSMA3;PSMB9;PSMA4;ENC1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.46133174342822075,1.1161932467725746,0.34579439252336447,0.8527183097453052,1.0,10/20,23.13%,BIRC2;MLKL;CFLAR;CYLD;BIRC3;HSP90AA1;FLOT2;CDC37;STUB1;PELI1
prerank,ribosomal large subunit biogenesis (GO:0042273),0.39204294550824925,1.1156172430837836,0.3299319727891156,0.8538000004814584,1.0,21/54,22.58%,PAK1IP1;MDN1;RSL1D1;NOP53;LAS1L;RRS1;PPAN;NPM1;EIF6;NOP2;NOP16;RPL23A;RPL11;RPL10A;WDR12;RSL24D1;RPL24;RPL3;RPL5;RPL6;LTO1
prerank,apoptotic DNA fragmentation (GO:0006309),0.4757054705337564,1.1152714458852957,0.34349030470914127,0.8542137504266998,1.0,5/16,16.68%,KPNB1;HMGB1;DFFA;DNASE2;DICER1
prerank,skeletal muscle tissue development (GO:0007519),0.425170683152469,1.1152114879988377,0.3566084788029925,0.8536507912514801,1.0,2/32,6.12%,MYOZ2;CFLAR
prerank,negative regulation of organelle assembly (GO:1902116),0.4168847063205112,1.11520374405922,0.32075471698113206,0.8529239424561319,1.0,7/35,11.95%,CHMP4A;CHMP4B;RBM14;CDK5RAP2;CDK10;ODF2L;SCFD1
prerank,photoperiodism (GO:0009648),0.42221342369025516,1.1151349256967482,0.3452088452088452,0.8523772845592068,1.0,5/28,11.39%,PML;PER2;BHLHE40;CRTC1;SIK1
prerank,rRNA modification (GO:0000154),0.4581944239027276,1.1146742676619248,0.33025099075297226,0.8530987777178015,1.0,5/21,9.95%,MRM2;ZCCHC4;TFB2M;GAR1;DIMT1
prerank,granulocyte differentiation (GO:0030851),-0.3699516354218302,-1.1145864158234413,0.2727272727272727,1.0,1.0,9/18,17.39%,CBFA2T3;LBR;RXRA;JAGN1;RARA;CDK4;CEBPA;E2F1;CDKN1A
prerank,positive regulation of lipid kinase activity (GO:0090218),0.4223001378764602,1.1141438766844545,0.3429286608260325,0.8541081107271111,1.0,3/29,1.64%,NOD2;FLT1;IRS1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.42590372952754024,-1.1140954160532068,0.31736526946107785,0.9994691369717807,1.0,4/12,6.20%,ATP1B1;DMD;ATP1B2;ANK3
prerank,regulation of glucose import (GO:0046324),0.4282943280453444,1.1136751311785715,0.3246268656716418,0.8549063140931646,1.0,8/30,14.63%,IRS1;ARPP19;GRB10;OSBPL8;INSR;PTPN11;ENPP1;IRS2
prerank,long-term synaptic potentiation (GO:0060291),-0.35134642635998603,-1.113608730145062,0.2754237288135593,0.9967298824681357,1.0,6/21,8.19%,GRIN2A;GRIN2B;PRKCZ;TSHZ3;RGS14;SLC8A3
prerank,bone morphogenesis (GO:0060349),0.4859433660758258,1.1133641879267846,0.33516483516483514,0.8552071075634214,1.0,4/14,16.05%,FGFR2;CYP26B1;BMPR2;FGFR3
prerank,protein transport (GO:0015031),0.3481464311701785,1.1131716111679173,0.20841683366733466,0.8550761726607827,1.0,92/332,19.99%,ZG16;ABCA1;BLZF1;CHMP1B;ABCG1;CLU;ARF3;GOLGA7;TBC1D1;ATP6V0D1;RAB8B;SNX33;ARRDC4;RAB21;LRP2;LAMP2;RAB12;RILP;AP2A1;STX7;LRSAM1;ARRDC2;HERC2;ARF5;GGA3;TMED5;KIF3B;VPS33A;IL10RA;TBC1D8;UNC93B1;RAB22A;RAB43;RAB11B;RAB5C;STX8;AMN;STX16;TMED10;TBC1D8B;SNX9;NPM1;DNM2;IFT27;TMEM167A;VIPAS39;RAB14;ARL1;CHMP3;RAB24;SCFD1;APOE;NEURL1B;CMTM6;ARL5C;RIC1;VAMP2;MYO6;NAPB;NAPA;STX4;FAM91A1;MIA2;VAMP4;DENND10;TFR2;BBS2;PREPL;ARF4;VPS26A;RAB32;TCIRG1;TBCK;SNX1;MTTP;TBC1D2;ATP6V1B2;TMED1;VAMP5;ATP6V1G1;SLU7;TMED3;MYH9;SVBP;COPB2;GOLPH3L;ATP6V1G2;RAB5B;SGSM1;RAB1A;SGSM3;TBC1D4
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.43039925930977874,-1.1124913999186563,0.31952662721893493,0.9967796306051591,1.0,5/11,22.36%,ASF1A;HAT1;HIRA;ATRX;ASF1B
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3608009496591436,1.1122027748579038,0.2934443288241415,0.8576361223835999,1.0,22/118,13.35%,STAT2;SP100;FMNL2;SEMA4D;RUFY3;CTNNB1;EPHA4;FGFR2;PAK3;BCL6;HTATIP2;GDNF;ZMYM3;BMPER;TNIK;PHIP;INF2;PHLDB1;CAPZB;CHN1;SIPA1L1;ZRANB1
prerank,regulation of inclusion body assembly (GO:0090083),0.5035649023473096,1.111737526689405,0.35014409221902015,0.8583624163803057,1.0,2/11,9.80%,HSPA1B;DNAJB6
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3478478315228929,1.1116084824256218,0.25529767911200807,0.8580628400830284,1.0,52/190,21.27%,STAT1;IFI35;XDH;TRIB3;NMI;OTUD3;NOP53;ITPR1;UBE2B;DUSP3;PPP2R5C;TRIM39;MAP2K3;MAGI2;CYLD;TSPAN6;LYN;MAPK14;RORA;ARRB2;TNIP1;CIB1;ZC3H12A;ARHGAP25;RIOK3;PLEKHA1;RTKN2;DDIT4;AKT1S1;RACK1;PIK3CB;INPP5K;UACA;SH3BP1;TNIP3;PDE3A;PHLDA3;NF1;RFFL;MGRN1;SPRED1;NPRL2;TSC1;NPRL3;TANK;PER1;DDX3X;PLAUR;MCL1;ADIPOR1;MAPKBP1;RHOH
prerank,phosphate ion homeostasis (GO:0055062),0.5227569700235581,1.111306546970419,0.35021707670043417,0.8582918951464138,1.0,2/10,12.84%,TFAP2B;ENPP1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4911105336564788,1.1110824943531818,0.3412256267409471,0.8582562880231293,1.0,3/14,9.46%,ACOXL;ECI2;ABCD1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.45424445430200255,1.1110541175423752,0.34595300261096606,0.8575944371343811,1.0,2/19,0.90%,EXT1;XYLT2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.245981428594479,-1.11096662036313,0.23404255319148937,0.9983836241187294,1.0,23/87,17.79%,TGFB1;ZMIZ2;PTPRK;HPGD;USP9X;PXN;TGFBR3;PRKCZ;TWSG1;SIRT1;TGFB2;COL1A2;UBB;SRC;RHOA;UBC;APPL1;CBL;SMAD6;UBA52;SMAD4;RPS27A;F11R
prerank,negative regulation of cell projection organization (GO:0031345),0.39615835845533304,1.1109057709676518,0.3265073947667804,0.857350914272607,1.0,16/48,17.78%,SPRY2;EPHA4;MT3;PAQR3;RAPGEF2;KANK1;PRNP;CIB1;MAG;APOE;TRPV4;MYLIP;FYN;PTPN9;STMN2;ITM2C
prerank,negative regulation of cell migration (GO:0030336),0.35672438341464635,1.1107131761002405,0.2932098765432099,0.8572680599313802,1.0,36/137,21.95%,WNT11;BST2;CLIC4;HAS1;THY1;SFRP2;PLXNB3;EVL;DUSP3;CX3CL1;EPHA4;ARHGAP4;TMIGD3;MAGI2;ARID2;KANK1;COL3A1;MITF;SRGAP2;SRGAP3;DUSP10;RAC1;BMPR1A;MCC;PTPRU;DACH1;CORO1C;NF1;STK24;SINHCAF;RAP2A;ACVRL1;ADIPOR1;MCTP1;CITED2;FGF2
prerank,ubiquinone metabolic process (GO:0006743),0.47746273160529845,1.1106610824075183,0.34010840108401086,0.8566595428863548,1.0,3/15,6.32%,COQ2;COQ10B;COQ3
prerank,pre-replicative complex assembly (GO:0036388),0.38281020868692317,1.1106519106963904,0.3180327868852459,0.8559367004863716,1.0,23/64,22.66%,PSMB10;PSME2;MCM2;PSMA5;PSME4;MCM7;MCM4;CDT1;PSMA3;PSMB9;PSMD2;PSME3;ORC3;PSMA4;PSMD7;PSMD8;PSMD9;ORC1;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4
prerank,cellular potassium ion homeostasis (GO:0030007),-0.4126370363854506,-1.1101905511646102,0.34185303514376997,0.9970916302592392,1.0,3/13,3.63%,ATP1B1;SLC12A2;ATP1B2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5388471592771074,1.1101700782521355,0.35968992248062015,0.8568168673377409,1.0,3/10,15.69%,CD40;LYN;BTLA
prerank,cellular response to UV (GO:0034644),-0.26005615550562483,-1.1100737144701895,0.27710843373493976,0.9931626498881522,1.0,29/76,21.13%,ZBTB1;PTPRK;IMPACT;MMP1;PARP1;INO80;USP28;YY1;RHNO1;XPC;SIRT1;ACTR5;NSMCE3;CASP9;TAF1;METTL3;KDM1A;TP53;CERS1;CDKN1A;ERCC1;BAK1;XPA;MYC;USP47;POLD1;NEDD4;SMPD1;COPS9
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.38031867247802204,-1.1100279700203366,0.28716216216216217,0.9890598211542935,1.0,8/17,22.64%,PPARG;PDCD4;TPM1;PRKG1;CDKN1A;CDKN1B;MEF2C;EFEMP2
prerank,protein K48-linked deubiquitination (GO:0071108),0.438952091505021,1.109603675063562,0.34974093264248707,0.857941579857089,1.0,9/23,21.85%,USP50;USP25;OTUD3;USP34;VCPIP1;USP37;USP5;USP8;USP33
prerank,negative regulation of histone modification (GO:0031057),0.48803775297679,1.1093079253397735,0.35294117647058826,0.8581907469167912,1.0,5/14,19.22%,THAP7;AASS;SPHK2;CTBP1;SET
prerank,primary neural tube formation (GO:0014020),0.42171207555822243,1.1089968790348648,0.32616487455197135,0.858497844999523,1.0,4/30,5.36%,MTHFR;PLXNB2;LRP2;PRICKLE1
prerank,negative regulation of ATPase activity (GO:0032780),0.48221669521404487,1.1089643294694633,0.36451169188445665,0.8578618346531665,1.0,2/16,9.66%,IFIT1;THADA
prerank,regulation of vesicle-mediated transport (GO:0060627),0.367535286459987,1.1086960411667166,0.3144385026737968,0.8579791162957354,1.0,26/91,17.69%,DNAJC13;RAB8B;CDH13;RAB21;HCK;RAB12;CPLX1;SYT7;RAB11B;RAB5C;AP2S1;CHMP3;MAP2K2;SCFD1;RINT1;GAS1;VAMP2;NRP1;STON1;STX4;DENND10;RAB11A;OPHN1;STXBP5L;PTPRC;STON2
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.48138021159554706,1.1084945485771793,0.3603238866396761,0.8578763804427043,1.0,7/16,14.90%,CTNNB1;KMT2A;DNMT1;WDR5;SNW1;PAXIP1;MYB
prerank,DNA replication (GO:0006260),0.36346037812561766,1.1083723344981007,0.3024948024948025,0.8575585379873379,1.0,20/105,9.91%,MCM2;TIMELESS;POLD4;POLE2;MCM7;CHEK1;TIPIN;RNASEH2A;MCM4;RFC4;POLG2;POLB;RFC1;MCM9;BRIP1;RPAIN;FEN1;BARD1;WDHD1;PTMS
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.4610944241827567,1.1078833131472616,0.341688654353562,0.858418213711442,1.0,5/20,16.14%,MOV10;AGO2;CNOT7;EIF6;NRDE2
prerank,O-glycan processing (GO:0016266),0.3893633718669835,1.107772673392427,0.3321995464852608,0.8580371916415331,1.0,12/54,19.14%,ST6GALNAC4;GALNT7;GALNT15;ST6GAL1;GCNT4;B4GALT5;ST3GAL1;XXYLT1;GALNT1;GXYLT1;GALNT13;GALNT14
prerank,protein processing (GO:0016485),0.36622283072289785,1.106957512502102,0.3181336161187699,0.8600508641047101,1.0,22/102,18.94%,CASP4;CTSS;PRSS12;ADAMTS3;MMP14;FXN;LONP2;CTSH;AEBP1;PCSK7;KLK1;SPCS1;PSEN1;PITRM1;PTCH1;SPPL3;APH1A;APH1B;SPRTN;METAP2;HM13;DDI2
prerank,negative regulation of cellular process (GO:0048523),0.34384876570807865,1.1069185669718111,0.165,0.8594657958640787,1.0,79/521,13.19%,IFIT3;SP100;EIF2AK2;HSPA1B;WNT11;PML;CHMP4B;NR1H2;ESR2;BST2;PLXNA3;HYAL1;IFI35;PLXNB2;ZBTB17;CLU;RARG;TNFRSF8;ACTN1;SEMA4D;SOD2;CDH13;NMI;AQP11;SFRP2;GNG4;PLXNB3;TMEM115;CNOT7;CDKN2D;OSGIN1;SERTAD3;CHERP;CTNNB1;P3H1;PPP2R5C;BCL6;PODXL;MT3;TFAP2B;TMIGD3;CSNK2B;MAGI2;TMEM98;FRZB;RAPGEF2;ST7L;ARID2;NCK1;LYN;PDPN;APP;NCK2;BMPR2;MEN1;ROR2;SPHK2;LRPAP1;PROX1;SPEF1;CIB1;NPM1;ALDH1A2;CDK10;EI24;NOTCH4;DNAJA3;CTCF;SLIT3;SRGAP2;KLF10;THAP12;SERTAD2;RB1;ENPP1;FCGR2B;RACK1;CGREF1;APBB1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3690732336079908,1.106899081684192,0.3074468085106383,0.8587849278589259,1.0,22/95,15.29%,SAMHD1;ZSWIM7;MCM2;SEM1;MCM7;AP5Z1;MCM4;HELQ;KDM4D;MCM9;RAD51C;FEN1;ERCC4;XRCC3;ZFYVE26;POLQ;GINS2;NSMCE2;NSMCE1;GEN1;RMI1;RECQL5
prerank,postsynaptic membrane organization (GO:0001941),-0.37438472282868296,-1.1063084524802844,0.35507246376811596,0.9992421946234359,1.0,5/17,8.89%,DLG4;NRXN2;NLGN2;NRXN1;SHANK3
prerank,response to chemokine (GO:1990868),0.49122354606462515,1.1060581086063115,0.3546099290780142,0.860870487308138,1.0,5/13,16.64%,DOCK8;ZC3H12A;LRCH1;OXSR1;STK39
prerank,positive regulation of lamellipodium organization (GO:1902745),0.42494947976956876,1.105913736301745,0.3403726708074534,0.8605985785137179,1.0,11/32,19.81%,ACTR2;CYFIP1;CARMIL1;ARHGEF7;ACTR3;CORO1B;RAC1;RREB1;PLCE1;CORO1C;NCKAP1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.4437051032445724,1.1057448365050058,0.3337730870712401,0.8604193833926231,1.0,3/22,6.11%,B2M;CD55;STX7
prerank,muscle cell differentiation (GO:0042692),-0.3057995116396258,-1.1052181694722976,0.26666666666666666,0.9991160165697045,1.0,13/32,21.96%,SEMA4C;DMD;NINJ1;NEBL;SPEG;MRTFB;KDM1A;WNT5B;GLMN;TMEM204;MTLN;MEF2C;NEB
prerank,embryonic organ development (GO:0048568),0.3831805223358959,1.1050546530276206,0.33816964285714285,0.8619615348049451,1.0,9/61,8.80%,COL13A1;KDR;TEAD2;KITLG;KMT2A;FGFR2;WNT7B;TBC1D23;GDNF
prerank,cellular response to amyloid-beta (GO:1904646),0.4157543620782491,1.1048821849238668,0.3337453646477132,0.8617926672302116,1.0,9/35,14.33%,CASP4;EPHA4;CACNA1A;APP;PRNP;ABCC1;PSEN1;FCGR2B;FYN
prerank,response to axon injury (GO:0048678),0.4610167229798985,1.1048363827164687,0.3460490463215259,0.8612147735578879,1.0,4/18,8.96%,DHFR;GAP43;MAPK8IP3;P2RX4
prerank,collagen fibril organization (GO:0030199),0.3656294657971157,1.1046640295330084,0.32199787460148777,0.8610485520368796,1.0,15/88,12.53%,LOXL2;COL13A1;P4HA1;ADAMTS3;COL9A1;COL4A2;COL14A1;P3H1;COL5A3;COL8A1;COL22A1;SCX;COL3A1;ADAMTS2;COL11A2
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.3518402745988765,1.1045930772901067,0.2978723404255319,0.8605400986625552,1.0,38/172,16.96%,ETNK1;ETNK2;CPNE3;ARF3;PIK3CD;SLC27A1;CDS1;SYNJ1;PLA2G12A;PCYT2;PITPNM1;SBF1;AGPAT5;PIP5K1A;ABHD8;CSNK2B;CSNK2A2;LPIN2;CEPT1;LPCAT2;PI4KB;PIK3R4;GNPAT;DGKB;CDIPT;RAB14;PLEKHA1;PIK3CB;PIP5K1C;INPP4B;PLEKHA4;PLEKHA3;ABHD3;INPP5K;MTMR14;CHPT1;DGKA;OCRL
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.505124715425133,1.1045450464579014,0.3515509601181684,0.8599544627247625,1.0,5/12,17.39%,RUNX1;LYN;CD300A;ELF1;PTPRC
prerank,response to hydroxyurea (GO:0072710),0.5168223042023977,1.1044232070540614,0.36,0.8595917816971476,1.0,5/11,19.71%,TIMELESS;DDX11;RTF2;DDI2;KAT7
prerank,basement membrane organization (GO:0071711),0.4864187938208886,1.103847712026703,0.3651452282157676,0.8606930342081537,1.0,6/14,25.01%,CTSS;LAMB2;NID2;FLRT2;NTN4;NTNG2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4268153054744866,1.10331417249713,0.3404255319148936,0.8617291028178627,1.0,7/28,14.94%,IRS1;SOCS1;GRB10;NCK1;KANK1;ENPP1;INPP5K
prerank,regulation of cell cycle process (GO:0010564),0.36633486928364317,1.1030030655933445,0.3036649214659686,0.8620334230943878,1.0,28/104,19.46%,PKMYT1;DAPK3;DYNC1H1;CHEK1;TIPIN;SOX9;CTNNB1;PDXP;PRPF40A;CUL7;SH3GLB1;CSNK2A2;KLHL13;YTHDF2;ZFYVE26;PLK3;PIK3R4;GIT1;KLHL9;AHCTF1;CALM3;NUDT16;RAB11A;BIRC6;NUMA1;UVRAG;BECN1;PIN1
prerank,cellular response to calcium ion (GO:0071277),0.3795653777248521,1.1028892757317372,0.33406352683461116,0.861666791627083,1.0,10/67,10.83%,CAMK2D;RASA4;CLIC4;WNT5A;CPNE3;TRPM2;CRHBP;SYT7;SYT3;ADGRV1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.4463050102542214,1.1024968884260549,0.36766623207301175,0.8622641934846075,1.0,4/19,8.03%,NANS;GMPPB;MPI;GFPT1
prerank,RNA stabilization (GO:0043489),0.41428659511399335,1.1019990964189033,0.3570552147239264,0.8630959004122565,1.0,7/33,15.56%,PHAX;LARP1;DHX36;GDNF;TENT5A;TENT5C;TAF15
prerank,macroautophagy (GO:0016236),0.3565351651555154,1.1016019022677195,0.30403309203722856,0.8636459269234571,1.0,28/118,17.17%,CHMP4A;CHMP4B;ILRUN;MVB12A;LAMP2;VPS33A;NBR1;CSNK2B;LIX1;RUBCNL;CSNK2A2;TOMM5;VPS37A;PIK3R4;PRKAG1;UBQLN1;EI24;VIPAS39;CHMP3;VPS28;MAP1LC3B;DYNLL1;VTI1B;RB1CC1;MTMR14;HGS;TCIRG1;TOMM40
prerank,cartilage development (GO:0051216),0.3896043450748092,1.100720389964139,0.3231638418079096,0.8657356229400267,1.0,12/49,16.05%,HYAL1;DDRGK1;RUNX1;SOX9;ITGB8;SNX19;NFIB;SCX;COL11A2;TRPV4;SOX5;FGFR3
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.49625915316647273,1.1006487064196409,0.3652694610778443,0.865233889724587,1.0,7/13,25.73%,SNX33;HSP90AB1;STX4;TYROBP;TM9SF4;TNF;TMEM35A
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.5030346709893067,1.1006162905022439,0.36335403726708076,0.8645995992709007,1.0,3/11,13.88%,UQCRQ;UQCR10;CYC1
prerank,positive regulation of autophagy (GO:0010508),0.3672981390748834,1.1001162269359352,0.33153928955866524,0.8655268481375686,1.0,14/81,13.10%,IRGM;TRIM14;KDR;FBXO7;TRIM21;LARP1;SH3GLB1;HMGB1;PLK3;WAC;ZC3H12A;SVIP;PIK3CB;BAD
prerank,organic acid transport (GO:0015849),0.36502027896950856,1.0999559556551661,0.3245521601685985,0.8653209176546115,1.0,14/94,9.33%,ABCC2;SLC27A1;SLCO1C1;SLC38A2;SLC26A1;SLC38A1;SLC46A1;NCOA1;SLC19A1;SLCO1B1;SLC38A3;SLC25A10;PDPN;SLC7A6
prerank,positive regulation of transport (GO:0051050),0.3673605783413728,1.0999409811952692,0.3265524625267666,0.864636457800911,1.0,27/85,26.35%,IL15;IL15RA;SGK2;CD47;DYNC1H1;CHCHD10;KMT2A;TUB;MLC1;APOE;FCGR2B;DAB2;ACTB;TFR2;INPP5K;BAX;CBLL1;NUMA1;SIRPA;C2CD5;CYBA;ACSL3;TNF;ANXA2;CHP1;CALY;LRP1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.3431637879354009,-1.0998816546214643,0.3045267489711934,1.0,1.0,5/22,8.69%,ROCK1;NCKAP1L;CRY2;PTPA;GSK3B
prerank,dendrite morphogenesis (GO:0048813),-0.30454572966432286,-1.099500272992925,0.31868131868131866,1.0,1.0,10/35,11.87%,SDC2;WASL;DLG4;MAP6;CTNNA2;CDC42;EPHB2;SHANK3;EPHB1;CHRNA7
prerank,protein-containing complex assembly (GO:0065003),0.3465636497837606,1.0993429583124388,0.26626626626626626,0.865849260853289,1.0,46/259,13.82%,NOL3;PML;TRAPPC3;SKP1;AIM2;GPAA1;TEAD2;CD40;TGFA;RBBP5;LAMC1;MDN1;CHCHD10;SEC16A;TSPAN4;SOX9;TAPBP;CTNNB1;CX3CL1;KMT2A;GOSR2;CNIH3;TCF7L2;SKAP2;SEC24D;DET1;CSNK2B;DHX9;CTSC;PPP6R3;CAND1;SEC23A;RBX1;MEN1;MNAT1;TMED10;SNX9;SAMM50;ZC3H12A;MITF;SCFD1;PPARGC1A;BAD;VAMP2;PYGO1;NAPA
prerank,regulation of monooxygenase activity (GO:0032768),-0.33778511858870386,-1.0992579106440181,0.2916666666666667,1.0,1.0,13/23,24.21%,WASL;LYPLA1;EGFR;SNCA;DDAH1;NOSTRIN;AKT1;POR;CAV1;SPR;IL1B;IL1A;NOS1AP
prerank,mitotic sister chromatid segregation (GO:0000070),0.36178901688971266,1.0992056118408655,0.32601880877742945,0.8655767340203839,1.0,25/98,19.35%,CHMP4A;CHMP4B;TENT4A;CHMP1B;HASPIN;NAA50;KPNB1;KIF2C;WRAP73;CSNK2B;RRS1;CSNK2A2;CHMP3;NCAPG2;RB1;POGZ;DIS3L2;PIBF1;MIS12;RAB11A;CHMP5;NDC80;SET;BECN1;PDS5B
prerank,DNA replication checkpoint signaling (GO:0000076),0.4776932898376681,1.0990714441484422,0.365034965034965,0.8652700033788082,1.0,3/16,5.99%,TIMELESS;TIPIN;CDT1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.4028586951947576,1.0987963332505524,0.3220536756126021,0.8654613278351951,1.0,7/47,7.92%,EIF2AK2;NOD2;TAOK3;IGBP1;NBR1;PPIA;MAPK8IP3
prerank,regulation of blood coagulation (GO:0030193),-0.3182674844728493,-1.0987571385770043,0.32558139534883723,1.0,1.0,10/27,28.22%,DMTN;EPHB2;VTN;ENPP4;FAP;F2R;CAV1;THBD;CD34;ST3GAL4
prerank,tube closure (GO:0060606),0.4181431736266471,1.0986923811341593,0.3588516746411483,0.865080092924129,1.0,4/31,5.36%,MTHFR;PLXNB2;LRP2;PRICKLE1
prerank,bile acid biosynthetic process (GO:0006699),0.43392147393672403,1.0984062523779834,0.36,0.8653049875481938,1.0,8/24,20.65%,OSBPL7;CH25H;OSBPL3;CYP27A1;OSBPL9;OSBP;OSBPL2;CYP39A1
prerank,protein targeting to ER (GO:0045047),-0.24382693094935248,-1.0983892154309263,0.2,1.0,1.0,36/99,18.72%,RPS12;RPL13;RPS14;RPS28;RPL10;RPL23;RPL17;RPS26;RPLP0;RPL9;RPS17;SGTB;RPL8;RPL21;GET3;RPL31;SPCS3;RPL36A;SEC61G;SEC61A1;RPLP2;RPL7;RPL39;RPS9;RPS18;RPL37;RPL13A;ZFAND2B;SRP19;UBA52;RPS25;RPS27A;RPL18;RPL38;SRPRB;RPL34
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3757561221694755,1.0977442024128878,0.3388704318936877,0.8666720601986547,1.0,10/65,8.22%,AGT;SPRY2;CDH13;TGFA;MVB12A;DOK1;DUSP3;ARHGEF7;WDR54;CCDC88A
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.4224294827983361,1.097703042823883,0.355,0.8660946096252439,1.0,5/25,14.86%,CLU;HSP90AB1;P2RX4;INSR;HSP90AA1
prerank,nitric oxide metabolic process (GO:0046209),0.47738083040975154,1.0976267136016096,0.35864978902953587,0.8656325269319836,1.0,3/14,10.23%,CYB5B;CYB5R3;GCH1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.3806879148222722,1.097181408001689,0.3367003367003367,0.8663983142498709,1.0,12/51,13.90%,WNT11;CD47;EVL;CX3CL1;CARMIL1;MYOC;CCDC88A;PPM1F;ARHGEF10;SYNPO;NRP1;RAC1
prerank,response to unfolded protein (GO:0006986),0.39234758111284607,1.0970813663234884,0.33605600933488916,0.8659972140946159,1.0,15/48,21.28%,HSPA1B;DAXX;ERP44;HSP90AB1;DNAJB4;HSPA8;HSPA4;HSPB3;HSP90AA1;DNAJC4;BAX;STT3B;HSPA14;ERN1;OPTN
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.36169642593953344,1.0970504752393442,0.329073482428115,0.8653861768291609,1.0,32/94,21.78%,NOD2;PSMB10;NOD1;SKP1;PSME2;PSMA5;PSME4;MAP3K8;PSMA3;NFKB1;PSMB9;RBX1;BTRC;PSMD2;IRAK4;PSME3;ST18;PSMA4;IL1RAP;TNIP2;MYD88;IRAK1;PSMD7;UBE2V1;PSMD8;PSMD9;TAB3;RIPK2;PSMF1;PSMB6;PSMC2;PSMD12
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.36508729647471305,1.0970131500507,0.33192389006342493,0.8647837050114247,1.0,30/87,23.76%,PSMB10;SKP1;PSME2;PRMT2;PSMA5;PSME4;RBL1;CDKN2D;PSMA3;PSMB9;DACT1;RBX1;ZFP36L1;PSMD2;PSME3;RB1;PSMA4;DLG1;BRD7;PSMD7;PSMD8;PSMD9;WEE1;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4;ZFP36L2;PSMA2
prerank,histone H3 deacetylation (GO:0070932),0.46396284874572363,1.0969473194848798,0.35753424657534244,0.8642877849779651,1.0,9/15,25.35%,PER2;SIRT6;HDAC8;HDAC1;PER1;HDAC2;HDAC4;SIRT2;SMARCAD1
prerank,intestinal lipid absorption (GO:0098856),0.5015315700225396,1.0966870273193734,0.36731634182908546,0.8644497169863873,1.0,2/11,18.10%,SOAT2;LDLR
prerank,nuclear export (GO:0051168),0.36876054808292885,1.0964483574812551,0.338411316648531,0.8644909552617518,1.0,22/80,17.87%,PHAX;MAGOHB;NUP153;WASHC4;NCBP2;CSE1L;LSG1;RAE1;RNPS1;HNRNPA1;SMURF1;ZC3H11A;ATXN1;CHTOP;RANBP3L;NUP155;DDX39B;NCBP1;SRSF7;SRSF4;RANBP17;SLU7
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.413642022264116,1.096196189093145,0.3635265700483092,0.8645914512808249,1.0,16/33,28.72%,IRS1;PIK3CD;LTK;ZFP36L1;PLEKHA1;HTR2A;PIK3CB;NYAP2;NF1;ERBB3;PIK3CA;SIRT2;PTEN;PIK3R5;HTR2B;PIK3R1
prerank,regulation of protein secretion (GO:0050708),0.3558380067576107,1.0961284461124836,0.32633788037775446,0.8641056888831969,1.0,16/119,13.19%,RSAD2;PER2;ABCG1;ADAM8;CCL5;ITPR1;P3H1;TFAP2B;SYT7;KCNS3;PPIA;CACNA1A;TMED10;RHBDF2;APOE;APBB1
prerank,regulation of cell cycle phase transition (GO:1901987),0.36420685996551005,1.095624930008884,0.3393617021276596,0.8650263511688285,1.0,28/91,21.78%,PSMB10;SKP1;PSME2;PSMA5;CDC26;PSME4;ANAPC5;FBXW7;PSMA3;TRIM39;PSMB9;ANAPC4;UBE2E1;BTRC;PSMD2;CDC16;CDC27;PSME3;ANAPC15;PSMA4;ANAPC2;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3398328493938232,1.095450741138956,0.133,0.864861932467028,1.0,146/807,15.00%,STAT1;SP100;IRF7;PARP9;WNT11;MYOZ2;PML;LOXL2;CALCA;THAP7;CIART;NR1H2;IRF2BP1;ESR2;TRIB3;WNT5A;MYBBP1A;TFAP2C;PER2;DAXX;PRMT2;ZFP36;RARG;NFX1;TIMELESS;SEMA4D;ZBTB2;MECP2;STAT3;ARID5B;ZFP37;BATF3;SFRP2;DDX5;MTA3;ELK3;CGGBP1;PCGF6;RUNX1;MAD2L2;ID3;BHLHE40;ZHX3;NACC1;EID2B;NKX6-2;CIC;GATAD2A;NOP53;CNOT7;ILF3;MZF1;PRICKLE1;PFDN5;SOX9;CTNNB1;CCND1;MBD2;FGFR2;IGBP1;SMARCE1;TCF7L2;SMARCC2;NFKB1;BCL6;ZBTB38;BACH1;DDX20;MT3;TFAP2B;SNAI2;SAP30;ETV6;MDFIC;MTA2;SMAD2;GLIS3;DACT1;SIRT6;NONO;DNMT3A;AEBP1;AASS;HMGB1;PLK3;PEX2;MEN1;HSPA8;BPTF;RING1;NR2C1;PROX1;COMMD7;NCOA5;BTRC;DUSP26;PPM1F;FOXK1;DKK3;MAX;SNW1;NOTCH4;DNAJA3;CTCF;NAB1;SETDB2;HCFC2;ZBTB5;MITF;SKIL;TFDP2;CBX4;TAF3;KLF10;ZNF423;NKAP;CUX1;UXT;LDB2;LDB1;PSEN1;NR3C1;LCOR;RB1;MIER1;MDFI;ATXN1;LIMS1;APBB1;HDAC8;PTCH1;ZBTB21;DAB2;IKZF1;ZMYND15;KDM8;DLG1;MYPOP;SOX2;RREB1;EZH2;RBM15;MYB;INPP5K;POU6F1;PRDM11
prerank,organic substance transport (GO:0071702),0.35595028287476527,1.0953153036109924,0.33470648815653964,0.864562871032512,1.0,19/121,13.36%,ZG16;ABCA1;CHMP1B;ABCG1;SLC18A2;ARRDC4;LRP2;ATP8A1;SLC19A1;RILP;ARRDC2;SLCO1B1;ABCB9;SLC35F3;ABCD1;AMN;CHMP3;CMTM6;VAMP2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.44293009996203925,1.0951876109334635,0.35667107001321,0.8642451663570476,1.0,6/22,17.73%,SNX33;ADAM8;TIMP2;SNX9;APOE;SH3D19
prerank,cellular response to hormone stimulus (GO:0032870),0.3709728747778054,1.094950326466118,0.3395196506550218,0.8643087836706668,1.0,13/69,12.63%,CTSS;STAT3;CRHBP;NCOA1;SRA1;CTSH;LMO2;ZFP36L1;SLIT3;XBP1;SOCS2;NR3C1;UBE2L3
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.38133475096468805,-1.094653555286394,0.3063973063973064,1.0,1.0,8/15,24.14%,UST;VCAN;CSGALNACT1;BGN;DSEL;DCN;BCAN;CSPG5
prerank,negative regulation of neurogenesis (GO:0050768),0.4128700564402111,1.0946055951400078,0.3629719853836784,0.8646489336917519,1.0,14/34,26.52%,B2M;THY1;RUFY3;RAPGEF2;MAG;SORL1;HOOK3;NF1;APPL2;NOTCH1;LINGO1;LRP4;TNF;PTEN
prerank,positive regulation of cellular component movement (GO:0051272),0.4309259373495867,1.0946032517630102,0.34491634491634493,0.863940988260298,1.0,7/24,21.17%,TUBB2B;LYN;PDPN;CFAP20;CAVIN1;CCDC25;STK11
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.4373588781547407,1.0944285182445612,0.362565445026178,0.8637600342410985,1.0,13/24,27.46%,FBXW7;CTNNB1;TFAP2B;PRNP;BAX;NF1;TYROBP;MCL1;TNF;CDK5R1;GRN;SRPK2;CDK5
prerank,regulation of cell junction assembly (GO:1901888),0.42601915264023527,1.0942758641588892,0.3596938775510204,0.8635545181772756,1.0,8/27,15.10%,MYO1C;RUNX1;SNAI2;RAPGEF2;SETD5;RAPGEF1;PRKCH;CHRNB2
prerank,calcium ion import into cytosol (GO:1902656),0.48020501922739445,1.0935041577203208,0.3638928067700987,0.865238020635794,1.0,3/15,12.83%,TRPM2;SLC8A1;TRPV4
prerank,regulation of mRNA stability (GO:0043488),0.3510358490456709,1.093084989024353,0.3115423901940756,0.8658862504257868,1.0,46/145,24.00%,IGF2BP1;PSMB10;PSME2;ZFP36;PSMA5;IGF2BP3;PSME4;YTHDF1;LARP1;DHX36;XRN1;PSMA3;DCP2;PSMB9;YTHDF2;GDNF;HSPA8;NPM1;ZFP36L1;PSMD2;TENT5A;PSME3;TENT5C;EXOSC9;PSMA4;TAF15;MEX3D;METTL14;PCBP4;TBRG4;PSMD7;PSMD8;SET;RC3H2;PSMD9;PSMF1;PSMB6;PRKCD;PSMC2;PSMD12;EXOSC4;PSMD4;ZC3H14;ZFP36L2;PSMA2;PDE12
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.4394979385720264,1.0929224939699038,0.3724966622162884,0.8657084243118809,1.0,5/21,10.60%,MECP2;CDC25B;CCND1;RAD51C;NPM1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.37187532013391034,1.0927747630677482,0.3542795232936078,0.8654846367841593,1.0,19/72,20.54%,POLR2G;HNRNPH1;NCBP2;FGFR2;HNRNPM;POLR2K;KIF16B;RAB14;FGF9;HNRNPA1;PTPN11;TIAL1;NCBP1;FGFR3;FLRT2;FIBP;SPRED1;HNRNPF;FGFRL1
prerank,regulation of membrane depolarization (GO:0003254),0.45544374990431175,1.0925767071180232,0.37637362637362637,0.8654386530106936,1.0,3/18,16.16%,CAMK2D;ABCD1;SCN1B
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.34181841806666863,1.0924216357476848,0.1881881881881882,0.8652319465588653,1.0,121/497,20.50%,IGF2BP1;EIF2AK2;WNT11;PML;LOXL2;CALCA;THAP7;CIART;NR1H2;DAPK3;DHFR;TRIB3;WNT5A;MYBBP1A;PER2;DAXX;PRMT2;TIMELESS;IGF2BP3;MECP2;ARID5B;SFRP2;MTA3;ELK3;PCGF6;ID3;BHLHE40;LARP1;ZHX3;NACC1;EID2B;NKX6-2;CIC;GATAD2A;CNOT7;ILF3;DHX36;PRICKLE1;PFDN5;SOX9;CTNNB1;MBD2;SMARCE1;TCF7L2;SMARCC2;BCL6;ZBTB38;MT3;TFAP2B;MDFIC;SMAD2;NONO;BMPR2;MEN1;HSPA8;RING1;PROX1;COMMD7;BTRC;PPM1F;FOXK1;DKK3;SNW1;CTCF;NAB1;SETDB2;TFDP2;CBX4;KLF10;ZNF423;NKAP;LDB1;NR3C1;RB1;ENPP1;RACK1;ATXN1;LIMS1;ZBTB21;SHMT1;IKZF1;ZMYND15;KDM8;PATL2;EZH2;RBM15;MYB;INPP5K;PRDM11;RCOR3;PPARD;GCLC;ENC1;ZBTB4;PUS7;KAT8;BAHD1;RBPJ;BRD7;ID4;HMBOX1;MRPL13;DACH1;HDAC1;WWP1;CAPRIN1;HINFP;CTBP1;ZKSCAN3;TSC1;SET;KAT7;POU3F3;PER1;BTAF1;ACVRL1;NR1D2;SFMBT1;ZEB1;BCOR;DDX3X
prerank,regulation of filopodium assembly (GO:0051489),-0.30035729422638896,-1.0922668218356144,0.2802547770700637,1.0,1.0,11/38,11.17%,MYO10;WASL;DPYSL3;ARHGAP44;PPP1R16B;FXR2;CDC42;RHOQ;DMTN;PALM;GPM6A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.37175107808504215,1.092248564109371,0.3424507658643326,0.8650758389547412,1.0,28/70,25.95%,PSMB10;PSME2;B2M;PSMA5;PSME4;CYBB;TAPBP;PSMA3;PSMB9;FCGR1A;PSMD2;PSME3;SNAP23;PSMA4;PSMD7;PSMD8;PSMD9;TAP1;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4;PSMA2;CYBA;PSMD1;SEC22B;PSMD11
prerank,positive regulation of cellular protein localization (GO:1903829),0.3729019439211822,1.0917313568466127,0.3443708609271523,0.8659556411308812,1.0,18/69,21.05%,PARP9;DTX3L;DDRGK1;SNX33;HSP90AB1;CDT1;CCDC88A;TRAPPC12;VPS28;STX4;FYN;TESK1;NUMA1;NDC80;KAT7;TYROBP;TM9SF4;ENTR1
prerank,regulation of histone acetylation (GO:0035065),0.4168683299588992,1.0917100640420538,0.37761377613776137,0.8653138743131927,1.0,11/33,19.22%,THAP7;CHEK1;KMT2A;TADA2A;TADA2B;SETD5;PPARGC1A;PAXIP1;BRD7;CTBP1;SET
prerank,stem cell differentiation (GO:0048863),-0.29347578332823543,-1.0912857223079306,0.2620689655172414,1.0,1.0,11/39,17.40%,LRP6;BATF;FBXL17;JARID2;TGFB2;NELFB;GPM6A;HMGA2;TP53;EEF1AKMT4-ECE2;FOXO4
prerank,regulation of JUN kinase activity (GO:0043506),-0.30862085930761973,-1.0910507758920807,0.29292929292929293,1.0,1.0,9/33,10.48%,PAK1;TRAF2;PDCD4;MAP3K11;TRAF6;PTPN22;DVL3;DAB2IP;MAPK8IP1
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.436864246465525,1.0910164796739639,0.35877862595419846,0.86683477293767,1.0,3/22,9.98%,NOD2;WNT5A;SPHK2
prerank,bicellular tight junction assembly (GO:0070830),-0.28012932867330853,-1.0909740416939926,0.2698412698412698,1.0,1.0,22/46,35.32%,PAK2;ARL2;APC;PRKCI;F11R;ECT2;MARVELD2;STRN;CLDN14;PECAM1;ESAM;FRMPD2;RAMP2;OCLN;RAB13;PARD6A;CLDN18;PARD3;CLDN1;CDH5;MPP7;CLDN5
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.35217560891520133,1.0909552106224156,0.32395833333333335,0.8663115946001237,1.0,14/113,8.97%,ISG15;CLTRN;ABCA1;GBP5;CLU;USP50;DHX33;BCL2L11;CHD1L;CDT1;SH3GLB1;SLF2;ERCC4;RBX1
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.37011652326745315,-1.090851044582048,0.32978723404255317,1.0,1.0,8/17,32.99%,PDE3B;ALK;AKT1;IL1B;ADRA2A;APOC1;MFSD2A;HCAR2
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.4585082269444044,1.0907473010021753,0.36551724137931035,0.8662832505922526,1.0,4/18,6.82%,MECP2;CDC25B;CCND1;RAD51C
prerank,positive regulation of cellular respiration (GO:1901857),-0.42746189874308727,-1.0900235140571772,0.35014836795252224,1.0,1.0,3/11,6.65%,PINK1;ISCU;IFNAR1
prerank,regulation of hormone secretion (GO:0046883),-0.3894223178052276,-1.089906881101629,0.3345323741007194,1.0,1.0,4/15,21.03%,SCG5;VAMP3;ANXA1;OSM
prerank,RNA transport (GO:0050658),0.37297232855431717,1.0898932386185987,0.34577387486278816,0.868289929877855,1.0,19/71,17.87%,PNPT1;ZFP36;MAGOHB;NUP153;NCBP2;HNRNPA2B1;RAE1;ZFP36L1;RNPS1;RBFOX1;HNRNPA1;ZC3H11A;CHTOP;NUP155;DDX39B;NCBP1;SRSF7;SRSF4;SLU7
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3363485701757563,1.0897154957106128,0.064,0.8681395923404084,1.0,302/1646,17.09%,STAT1;STAT2;SP100;IRF7;PARP9;WNT11;PITX2;SIM1;PML;LOXL2;CALCA;AGT;THAP7;SP110;LHX2;LMX1A;CIART;NR1H2;HAS3;CC2D1B;IRF2BP1;ESR2;DAPK3;DHFR;DTX3L;USF2;CAMK2D;ETV3;PCGF5;VRTN;MEF2B;TCF24;TRIB3;WNT5A;MYBBP1A;ZNF483;TFAP2C;PER2;GMEB2;DAXX;CCNL1;ZBTB17;TRIM45;ESRRB;PRMT2;BRD2;NFX1;HTATSF1;TIMELESS;SAP30L;BBX;ZFPL1;RNF4;TEAD2;ZBTB2;NFKB2;SOD2;CHEK2;MECP2;ACVR1;STAT3;MLLT11;ARID1B;ARID5B;ZFP37;TGFA;BATF3;CHD7;SFRP2;DDX5;ZNF471;MTA3;ELK3;PCGF6;RUNX1;MAD2L2;ID3;USP21;BHLHE40;ZHX3;NACC1;EID2B;NKX6-2;KLF15;SRRT;CIC;CCNL2;GATAD2A;CNOT7;ILF3;DHX36;MZF1;BRWD3;NFXL1;JUNB;ZSCAN12;NCOA1;MRPL12;SERTAD3;PRICKLE1;ZNF23;PFDN5;SOX9;SRA1;HNRNPK;CTNNB1;KMT2A;ZNF2;ARID1A;CCNT2;TRAK1;ZNF76;MBD2;ZSCAN22;CDT1;NSD3;ZSCAN26;SMARCE1;TCF7L2;TCF4;SMARCC2;ZXDC;ZBTB43;NFKB1;BCL6;CREBRF;EDF1;ZBTB38;SETD3;BRIP1;BACH1;MT3;USF1;ZSCAN29;NFATC2;TFAP2B;MAP2K3;SNAI2;RET;SAP30;UBP1;DHX9;SRF;ETV6;MDFIC;RAI1;IKZF2;TADA2A;HTATIP2;SMAD2;GLIS3;MED13L;MEIS3;ATF6B;TFDP1;CDK5RAP2;BAMBI;NONO;SLTM;ACTR8;ELP2;ATF1;HOXA9;NFIB;POU3F1;SCX;HMGB1;DACH2;LCORL;ELF4;POLR2K;INSR;TADA2B;HR;IRF9;MEN1;MAPK14;HSPA8;BPTF;ZSCAN20;MNAT1;RING1;WAC;LIN9;NR2C1;RORA;MED12;PROX1;PHIP;ELOC;COMMD7;BTRC;RGMB;KDM3B;PPM1F;NPM1;FOXK1;DNM2;DKK3;SETD5;MAX;SNW1;NOTCH4;CTCF;NAB1;SETDB2;HCFC2;ZBTB5;MITF;RYBP;TFDP2;ARHGEF11;CBX4;HMGB3;MAP2K2;KLF10;ZNF423;NKAP;CUX1;RELB;UXT;TEF;ILF2;NOP2;LDB1;PSEN1;REL;PPARGC1A;APOE;HOXB6;NR3C1;LCOR;BRPF1;UBE2L3;FBXL19;RB1;E2F4;ZNF35;ATXN1;LIMS1;APBB1;PGBD1;ST18;ZBTB21;TIAL1;DBX2;MED29;BCL11B;SMARCA1;IKZF1;ZNF418;ZMYND15;KDM8;ASCC2;CASZ1;MYPOP;SOX2;RREB1;EZH2;CREB5;RBM15;MYB;INPP5K;POU6F1;PRDM11;ZBTB24;MLLT3;ZBTB34;CAMTA2;ERF;CRK;KLF16;SOX5;SMARCD2;TAF15;MYCBP;GTF2IRD1;PIAS1;NPAT;RCOR3;MEF2A;KDM7A;CARF;PROX2;PIAS2;PPARD;MED27;GCLC;DENND4A;ZNHIT3;SREBF1;CCNK;ZBTB4;KAT8;BAHD1;RBPJ;BRD7;MED16;ELF1;TRIP4;ID4;HMBOX1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.39860059227683725,1.0896716329966727,0.3532163742690059,0.8675916808468894,1.0,10/40,16.88%,LOXL2;CTNNB1;TCF7L2;SMAD2;BAMBI;PDPN;DAB2;EZH2;MTOR;MDK
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.42353068116945336,1.0896625511251217,0.36503856041131105,0.866915434932153,1.0,7/26,18.29%,ASAH2;CYB5B;CYB5R3;SPHK2;GCH1;ACER3;SPTLC2
prerank,B cell homeostasis (GO:0001782),0.5105907290778737,1.0895248994950728,0.3805970149253731,0.8666448161474748,1.0,3/10,8.76%,GAPT;CAMLG;LYN
prerank,negative regulation of reproductive process (GO:2000242),-0.36447327799503476,-1.0894316977441723,0.328,1.0,1.0,4/17,7.97%,SULF1;PAEP;ARHGDIB;WDR77
prerank,negative regulation of peptidase activity (GO:0010466),0.38496850891992357,1.0894250983826466,0.35106382978723405,0.8662652182003775,1.0,5/47,10.22%,AGT;SERPINC1;UBXN1;CST7;TIMP2
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.3447242221892221,-1.089382407155394,0.359504132231405,0.9962390358922847,1.0,3/22,3.11%,PDE3B;APOD;ALK
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.34158217877394315,1.0893675877947133,0.221,0.8657760907799622,1.0,103/417,20.37%,WNT11;PML;LOXL2;CALCA;THAP7;CIART;NR1H2;TRIB3;WNT5A;MYBBP1A;PER2;DAXX;PRMT2;TIMELESS;EIF4A2;MECP2;ARID5B;SFRP2;MTA3;ELK3;PCGF6;ID3;BHLHE40;ZHX3;NACC1;EID2B;NKX6-2;CIC;GATAD2A;CNOT7;ILF3;PRICKLE1;PFDN5;SOX9;CTNNB1;MBD2;SMARCE1;TCF7L2;SMARCC2;BCL6;ZBTB38;MT3;TFAP2B;MDFIC;SMAD2;NONO;MEN1;HSPA8;RING1;PROX1;COMMD7;BTRC;PPM1F;FOXK1;DKK3;SNW1;CTCF;NAB1;SETDB2;TFDP2;CBX4;KLF10;ZNF423;NKAP;LDB1;NR3C1;RB1;ATXN1;LIMS1;ZBTB21;IKZF1;ZMYND15;KDM8;EZH2;RBM15;MYB;INPP5K;PRDM11;RCOR3;PPARD;GCLC;ZBTB4;KAT8;BAHD1;RBPJ;BRD7;ID4;HMBOX1;DACH1;HDAC1;WWP1;HINFP;CTBP1;ZKSCAN3;SET;KAT7;POU3F3;PER1;BTAF1;NR1D2;SFMBT1;ZEB1;BCOR
prerank,cellular protein catabolic process (GO:0044257),0.37498652246104097,1.0891921567412535,0.3536036036036036,0.8656407543929892,1.0,14/59,16.38%,CTSS;CHEK2;RNF5;RAB12;AP2A1;RSPRY1;CTSC;CTSH;AP2S1;LONP1;MYLIP;AFG1L;ADAMTS12;TCIRG1
prerank,protein-DNA complex assembly (GO:0065004),0.353711951893945,1.087911888731134,0.33505687693898656,0.8690490360599147,1.0,23/116,12.45%,PSMB10;PSME2;DAXX;MCM2;BRD2;PSMA5;PSME4;NAP1L2;MCM7;CHD1L;MCM4;SOX9;CDT1;PSMA3;TCF4;PSMB9;RBX1;MNAT1;CHAF1B;NPM1;PSMD2;PSME3;ORC3
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.33830857054602037,1.0878059344118112,0.198,0.8686801150615474,1.0,102/572,14.95%,STAT1;SP100;IRF7;PARP9;MYOZ2;LOXL2;THAP7;NR1H2;IRF2BP1;ESR2;TRIB3;TFAP2C;PER2;ZFP36;RARG;NFX1;SEMA4D;ZBTB2;MECP2;STAT3;ARID5B;ZFP37;BATF3;DDX5;MTA3;CGGBP1;RUNX1;MAD2L2;ID3;BHLHE40;GATAD2A;NOP53;MZF1;SOX9;CCND1;MBD2;FGFR2;IGBP1;TCF7L2;NFKB1;BCL6;BACH1;DDX20;TFAP2B;SNAI2;SAP30;SRF;ETV6;MTA2;SMAD2;GLIS3;DACT1;SIRT6;DNMT3A;AEBP1;AASS;NFIB;HMGB1;PLK3;PEX2;MEN1;BPTF;NR2C1;PROX1;NCOA5;DUSP26;MAX;SNW1;NOTCH4;DNAJA3;CTCF;HCFC2;ZBTB5;MITF;SKIL;CBX4;TAF3;KLF10;NKAP;CUX1;UXT;LDB2;LDB1;PSEN1;NR3C1;LCOR;RB1;MIER1;MDFI;ATXN1;APBB1;HDAC8;PTCH1;ZBTB21;DAB2;DLG1;MYPOP;SOX2;RREB1;EZH2;MYB;POU6F1
prerank,endocardial cushion development (GO:0003197),0.44770985530956364,1.0877453255682477,0.35496688741721855,0.8681727248624529,1.0,6/21,23.22%,ACVR1;SOX9;BMPR2;BMPR1A;ACVRL1;NOTCH1
prerank,cellular protein-containing complex assembly (GO:0034622),0.34682997629522355,1.0877203521893266,0.2976554536187564,0.8675434534979735,1.0,32/159,15.36%,CLTRN;CHMP4A;CHMP4B;CLU;NUP153;HSP90AB1;CCDC40;NSG2;TCF4;CSNK2B;DHX9;FMOD;SMAD2;NCK1;NCK2;EIF4H;SNX9;SAMM50;AP2S1;VAMP1;HSPA4;CHMP3;LONP1;VAMP2;POGZ;AHCTF1;TBCC;PSMG2;VAMP4;MIS12;HSP90AA1;TBCD
prerank,DNA-dependent DNA replication (GO:0006261),0.35239798592257054,1.087684011078794,0.33572895277207393,0.8669679756710793,1.0,43/128,24.11%,PSMB10;PSME2;MCM2;LRWD1;PSMA5;PSME4;POLD4;POLE2;MCM7;MCM4;RFC4;POLG2;POLB;RFC1;CDT1;PSMA3;RPAIN;PSMB9;WDHD1;TWNK;PSMD2;PSME3;ORC3;GINS2;PSMA4;RECQL5;DDX23;GINS4;PSMD7;PSMD8;PSMD9;PRIM1;ORC1;PSMF1;GINS3;PSMB6;PSMC2;PSMD12;PSMD4;SSBP1;TEFM;PSMA2;POLG
prerank,response to estrogen (GO:0043627),0.4049274082167861,1.0876517812214321,0.3576555023923445,0.8663544858779969,1.0,4/31,5.43%,TRIM25;RBBP5;CRHBP;SRA1
prerank,negative regulation of leukocyte activation (GO:0002695),0.47547924442498796,1.0874832190557382,0.3779310344827586,0.8661829689425395,1.0,6/15,18.64%,ZC3H12A;HAVCR2;FCGR2B;CD84;CD300A;CD300LF
prerank,inhibitory synapse assembly (GO:1904862),0.5021759027346235,1.0874483231207714,0.37392550143266473,0.8655962109741672,1.0,5/11,21.79%,WNT5A;FGF13;LGI2;CBLN4;GABRB2
prerank,macrophage activation involved in immune response (GO:0002281),0.48618885409021956,1.087370391451548,0.37553956834532376,0.8651552674960967,1.0,2/13,2.94%,IFI35;NMI
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3677928975171779,1.0872664703056119,0.3380281690140845,0.8648120746713627,1.0,32/74,26.40%,PSMB10;PSME2;PSMA5;PSME4;EGLN2;PSMA3;BACH1;PSMB9;RBX1;ELOC;PSMD2;PSME3;PSMA4;RBPJ;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;CITED2;PSMC2;PSMD12;PSMD4;LIMD1;NOTCH1;PSMA2;CUL2;SIRT2;EPAS1;PSMD1;PSMD11;HIGD1A
prerank,histone H3 acetylation (GO:0043966),0.3996811497819316,1.087111024946595,0.3767605633802817,0.8645890211675064,1.0,17/40,24.79%,JADE3;BRD1;KAT14;TADA2A;SUPT7L;WDR5;LDB1;BRPF1;SGF29;KAT7;PER1;ING5;TADA1;KAT6A;JADE2;KAT2B;YEATS2
prerank,fatty acid catabolic process (GO:0009062),0.36544182056880997,1.0870595318694085,0.34691629955947134,0.8640651766836595,1.0,19/67,21.06%,MCAT;ABHD2;ACADL;ECI2;MCEE;AUH;LPIN2;ABCD1;PEX2;ABHD3;ACADS;PPARD;HADHA;ACAT1;PEX13;ACOX1;HADH;ABCD4;MMUT
prerank,mitochondrial transcription (GO:0006390),0.5052473150239708,1.087002628851272,0.39469578783151327,0.8635405602709446,1.0,6/10,25.99%,MRPL12;TFB2M;TWNK;TEFM;TFAM;SLC25A33
prerank,regulation of sensory perception of pain (GO:0051930),-0.42660008596546733,-1.086970741189631,0.33540372670807456,1.0,1.0,6/11,29.53%,ZFHX2;CCL3;MGLL;F2R;ACP3;CCN3
prerank,regulation of protein localization (GO:0032880),0.37602148003612096,1.0867986021281808,0.34894091415830547,0.8635165528143659,1.0,13/58,14.86%,TRIM14;TRIM25;TRIM21;RSL1D1;HSP90AB1;FBXW7;DNAJB6;PPM1F;RAB14;RACK1;PLEKHM2;DLG1;HSP90AA1
prerank,snRNA processing (GO:0016180),-0.3778832337794751,-1.0867366907897558,0.33454545454545453,0.9981788304401673,1.0,8/16,30.79%,INTS10;INTS12;INTS2;TUT1;INTS6;TOE1;INTS5;INTS6L
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.4949818815306427,1.0866089652193247,0.3828016643550624,0.8634362038185961,1.0,7/13,27.38%,CDK5RAP2;XRCC3;ANAPC15;GEN1;NDC80;DYNC1LI1;MAD2L1
prerank,body fluid secretion (GO:0007589),-0.3734803716124662,-1.086594473348005,0.31141868512110726,0.9947212541561694,1.0,10/15,48.74%,ZBTB7B;GUCA1B;GPAT4;NPR1;APLN;VIP;PRLR;OXTR;CSN3;SLC22A2
prerank,axon guidance (GO:0007411),0.3423128516422951,1.0864026289833184,0.31048387096774194,0.8633688601283204,1.0,42/201,16.35%,PLXNA3;UNC5B;CXCR4;WNT5A;PLXNB2;BDNF;PIK3CD;SEMA4D;NRP2;GRB10;DOK1;SIAH1;GAP43;PLXNB3;EVL;CYFIP1;EPHA4;RET;DOK6;DOK5;EPHA6;GDNF;NFIB;RAP1GAP;GFRA2;LYPLA2;SLIT3;SLIT1;SOS1;PTPN11;CHN1;PIK3CB;NRP1;RAC1;FYN;IRS2;NPTN;DSCAM;DSCAML1;SEMA3D;SCN1B;OPHN1
prerank,striated muscle tissue development (GO:0014706),0.42229918542692446,1.0859689934692225,0.37375,0.8640752064490062,1.0,3/29,9.53%,MYOZ2;CFLAR;BMPR2
prerank,phosphorylation (GO:0016310),0.3397125611468816,1.0856422459941275,0.249,0.8644445612193398,1.0,98/384,19.24%,EIF2AK2;WNT11;TAOK3;DAPK3;GLYCTK;CAMK2D;TP53RK;RSKR;SGK3;SGK2;FASTK;PIK3CD;BRD2;CAMK2B;CHEK2;ACVR1;MAPK6;STAT3;HASPIN;CDC25B;STK38L;PKN2;HCK;CHEK1;GNPTAB;IKBKE;ILF3;PEAK1;MORC3;CDK12;MKNK1;PAK3;NRBP2;RET;FAM20B;GMFB;LTK;LYN;CLK3;NADK;APP;INSR;SRPK1;PIK3R4;BMPR2;HK1;PRKAG1;DGKB;CERKL;CDK19;SPHK2;DGKK;TNIK;CDK10;NUAK2;CDK20;BCKDK;SIK1;PIM1;FGGY;NEK6;DYRK2;PRKDC;PRKCE;PIK3CB;CLK2;JAK2;FYN;PRKCH;PANK2;FAM20C;STK25;MINK1;BMPR1A;NRBP1;TAOK2;OXSR1;MTOR;TBCK;IRAK1;STK39;CSK;DGKA;BCR;SNRK;PRKG2;BIRC6;ACVR2A;FNIP2;COPS8;DGKI;MARK1;CTBP1;BRSK1;NEK7;STK24;STK3;CAMKK2
prerank,regulation of cellular protein metabolic process (GO:0032268),0.38992951098340495,1.084800653074623,0.35805330243337197,0.8664318789168151,1.0,10/47,12.34%,AGT;NR1H2;TCOF1;CYFIP1;NFKB1;CSF1;NOLC1;APP;PUM3;APOE
prerank,zinc ion transmembrane transport (GO:0071577),0.43840416474499305,1.0845952540504527,0.3761467889908257,0.866400863876266,1.0,6/22,19.42%,TRPM2;SLC30A1;SLC30A5;SLC30A6;SLC39A10;SLC39A3
prerank,positive regulation of macrophage migration (GO:1905523),0.4473826801857426,1.0845167564922107,0.37733333333333335,0.865950675981252,1.0,6/19,16.88%,CCL5;CX3CL1;CSF1;P2RX4;CXCL17;MDK
prerank,positive regulation of histone methylation (GO:0031062),0.4302428121406853,1.0844217925288988,0.3836317135549872,0.8655540676789478,1.0,8/24,14.90%,CTNNB1;KMT2A;DNMT1;WDR5;SNW1;PAXIP1;CHTOP;MYB
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.33443612066475836,1.0835543141609634,0.167,0.8676173979054854,1.0,170/834,18.56%,STAT1;CXCL10;NLRC5;IRF7;HELZ2;PITX2;NAMPT;GAL;LMX1A;NR1H2;NOD2;USF2;PCGF5;MEF2B;WNT5A;TFAP2C;ZBTB17;ESRRB;RARG;DDRGK1;AGO2;RBM14;RNF4;CD40;NFKB2;CDH13;ACVR1;STAT3;ACTR2;RBL1;SFRP2;ELK3;RUNX1;RBMX;KLF15;DHX36;MZF1;JUNB;NCOA1;SOX9;CTNNB1;CX3CL1;CDK12;PFKM;KMT2A;PAXBP1;CCNT2;ZNF76;MYDGF;MEPCE;FGFR2;TCF7L2;TCF4;NFKB1;CREBRF;ASXL3;ZBTB38;SETD3;THAP3;USF1;ACTR3;TFAP2B;UBP1;DHX9;SRF;HTATIP2;SMAD2;MRTFA;GLIS3;MEIS3;ATF6B;TFDP1;LPIN2;NCK1;LMO2;MET;GDNF;ATF1;NFIB;METTL23;APP;SCX;HMGB1;NCK2;ELF4;CRTC1;MAML2;AGRN;BMPR2;MEN1;BPTF;RORA;MED12;PROX1;TNIP1;PHIP;ZC3H12A;NPM1;MAX;SNW1;NOTCH4;MITF;GALR1;XBP1;TFDP2;IER5;ECD;KLF10;LDB2;LDB1;REL;PPARGC1A;PRKDC;NR3C1;PAXIP1;PRDM4;E2F4;APBB1;HDAC8;ST18;MYO6;POGZ;DAB2;BCL11B;SMARCA1;CASZ1;SOX2;TNIP2;TFR2;RREB1;TET2;MYB;CRTC3;CAMTA2;BMPR1A;TLR2;SMARCD2;NPAT;ARF4;MEF2A;PPARD;TNIP3;LAGE3;IL18;LMO7;SREBF1;CCNK;ZBED4;KAT8;RBPJ;MED16;CHCHD2;ELF1;MPND;IER2;RRP1B;TLR3;PELP1;ZBTB49;POU2F2;ZNF513;PTOV1;ACVR2A;FOSL2;HDAC1;HINFP;GABPB1;GABPB2;MED10;HOXA5
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.4986578665231136,1.0835536926299554,0.38945827232796487,0.8669274193802455,1.0,3/12,7.11%,KLF15;PODXL;MAGI2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.41814625492922786,1.083430005050555,0.3822784810126582,0.8666076866714959,1.0,3/28,4.64%,CASP4;TRIB3;ITPR1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.46362248479467083,1.0834203336639263,0.3700564971751412,0.8659419625453008,1.0,6/15,16.77%,CDH13;PTPN18;MVB12A;WDR54;RHBDF2;RBPJ
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.42988714475771084,1.0831351117759542,0.375,0.8661037673942157,1.0,5/22,11.89%,ABCG1;CLU;EPHA4;LYN;LRRTM3
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3341268900269738,-1.0830398612660055,0.3130081300813008,1.0,1.0,8/23,17.04%,CASP8;PPP3R1;PPP3CC;YWHAQ;YWHAZ;PPP1R13B;TP53;E2F1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3341268900269738,-1.0830398612660055,0.3130081300813008,1.0,1.0,8/23,17.04%,CASP8;PPP3R1;PPP3CC;YWHAQ;YWHAZ;PPP1R13B;TP53;E2F1
prerank,regulation of osteoblast differentiation (GO:0045667),0.36356312484443754,1.0828812288199074,0.34227467811158796,0.866205531469319,1.0,16/82,15.33%,SEMA4D;ACVR1;DDX5;ZHX3;SOX9;FGFR2;WNT7B;SNAI2;NBR1;BAMBI;BMPR2;MEN1;NELL1;PTCH1;RANBP3L;BMPR1A
prerank,positive regulation of cellular senescence (GO:2000774),0.5198231435187817,1.0828344030768122,0.3830104321907601,0.8656826882738933,1.0,4/10,16.66%,B2M;CGAS;YPEL3;EEF1E1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.492586814764305,1.0827922918983397,0.3943452380952381,0.8651415731303639,1.0,7/12,28.72%,BCL2L11;XBP1;BAX;ERN1;ATF6;PTPN1;PIK3R1
prerank,triglyceride catabolic process (GO:0019433),0.44919362927049167,1.0826754715199758,0.3564875491480996,0.8648064831198004,1.0,2/19,7.72%,PNPLA2;LIPC
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.45477000075434865,1.0823921429494825,0.3795620437956204,0.8649756976103431,1.0,5/16,11.57%,DHX36;RTEL1;HNRNPA2B1;ERCC4;SMG5
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3446110207691116,1.0822161125300995,0.3384615384615385,0.8648754892327759,1.0,23/151,12.34%,NOD2;CCL7;SLAMF1;SPRY2;KDR;GAREM1;CCL5;FBXW7;CX3CL1;FGFR2;MT3;RAPGEF2;ACKR3;APP;HMGB1;BMPER;ROR2;ARRB2;CIB1;CCL14;HTR2A;PTPN11;APOE
prerank,protein targeting to mitochondrion (GO:0006626),0.3771899725937905,1.081988957078023,0.35443037974683544,0.8649388674893259,1.0,14/52,17.51%,FIS1;FBXO7;TOMM40L;GDAP1;TOMM5;TIMM50;SAMM50;HSPA4;TSPO;PITRM1;AIP;HSP90AA1;TOMM40;MIPEP
prerank,telomere maintenance (GO:0000723),0.3764445008565401,1.0816096607526149,0.3630057803468208,0.8654809457038415,1.0,9/50,14.33%,SP100;TPRKB;POLD4;RTEL1;ERCC4;XRCC3;PRKDC;STN1;NSMCE2
prerank,proteoglycan metabolic process (GO:0006029),0.4203875313787166,1.0814930582245887,0.37361282367447596,0.8651556223728709,1.0,10/26,23.62%,CANT1;FAM20B;BMPR2;CSGALNACT2;HPSE;HS3ST4;ADAMTS12;XYLT1;CHST11;CHST12
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3792891633819983,1.081321628610191,0.36152954808806487,0.8650168062480608,1.0,5/47,11.64%,AGT;SERPINC1;MT3;TIMP2;SORL1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.4550579785044646,1.0813056650767157,0.39207650273224043,0.864402912280421,1.0,6/18,13.99%,MMP14;STX7;STX8;LDLRAP1;VTI1B;ACTB
prerank,protein trimerization (GO:0070206),0.4796406854342419,1.0807568271891408,0.36657303370786515,0.8648101216530094,1.0,2/14,2.61%,PNPT1;MLKL
prerank,protein homotrimerization (GO:0070207),0.4796406854342419,1.0807568271891408,0.36657303370786515,0.8648101216530094,1.0,2/14,2.61%,PNPT1;MLKL
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.42544274793099723,1.0805837076193128,0.3694829760403531,0.8646854257628325,1.0,8/26,14.94%,ZFP36;GAREM1;DUSP3;SOX9;SNAI2;ZFP36L1;PTPN11;INPP5K
prerank,positive regulation of cellular process (GO:0048522),0.3342592807104064,1.0805820893042364,0.227,0.864013015665399,1.0,99/565,16.08%,NAMPT;IL15;CRLF1;FLT1;SLAMF1;IL15RA;HYAL1;WNT5A;IRS1;KDR;ZFP36;GAREM1;DDRGK1;GDF9;CXCL16;MECP2;KITLG;TGFA;CDC25B;AQP11;TRIM21;S1PR2;MMP14;SFRP2;FXN;ADAM8;DDX49;CD47;DYNC1H1;HCK;NACC1;CCL5;CCND2;CHEK1;CNOT7;DHX36;TIPIN;HSP90AB1;CACUL1;SOX9;CX3CL1;CCND1;EPHA4;FGFR2;MT3;TFAP2B;CSF1;TBC1D8;SRF;TUB;MEIS3;CTSH;IL12RB2;BAMBI;LYN;CST7;GDNF;P2RX4;PDPN;SCX;INSR;MLC1;PROX1;PHIP;ECHDC3;PRR7;CIB1;DUSP26;ZC3H12A;NPM1;FAM98B;ZFP36L1;CCL14;CEP131;VEGFD;FGF9;RTKN2;XBP1;IER5;NOP2;CAPNS1;FCGR2B;RPS6;CAPN1;CHTOP;RAC1;STX4;EXOSC9;SERTAD1;NSMCE1;IRS2;EZH2;NCBP1;TLR2;ADNP2;PRMT1;ACER3;FGFR3;AIF1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.33895977443346076,1.080412971642023,0.27955911823647295,0.8638922915231312,1.0,51/308,16.31%,EIF2AK2;LOXL2;IL15;AGT;ABCA1;CXCR4;WNT5A;PER2;ESRRB;PIK3CD;GADD45G;SLC27A1;AGO2;ACVR1;GRB10;MAD2L2;PTGER4;DYNC1H1;ACADL;SYDE1;SOX9;CTNNB1;SMAD2;SIRT6;BAMBI;GDNF;LEPR;B4GALT5;PDPN;SCX;BMPR2;LRPAP1;CCDC88B;XBP1;SORL1;SHLD1;PTPN11;PPARGC1A;APOE;PAXIP1;BAD;DAB2;JAK2;PRKCH;RREB1;EZH2;INPP5K;BMPR1A;SOX5;IL18;MTOR
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.339164731793046,-1.0802114036333241,0.29583333333333334,1.0,1.0,8/22,24.66%,SORBS1;PPARG;AKT1;CREB1;CREBL2;DISP3;IL1B;EEF1A2
prerank,positive regulation of cation channel activity (GO:2001259),0.39144521031002333,1.0801633763273368,0.37631887456037516,0.8639787702115481,1.0,7/40,17.43%,GAL;CTSS;ACTN2;CALM3;NLGN3;STAC3;ATPSCKMT
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3920452910215005,1.0801130943303963,0.36971830985915494,0.8634595026082602,1.0,8/38,9.50%,AGT;THY1;EPHA4;DOK7;FCGR1A;APP;NCK2;PRNP
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.40801858350355635,1.080014087106852,0.3668280871670702,0.8630832941146299,1.0,14/35,26.46%,SOCS1;CCL5;IL10RA;LEPROT;IL10RB;JAK2;HGS;PTPRC;ADIPOR1;NOTCH1;CRLF3;OCIAD1;TNF;DOT1L
prerank,apical protein localization (GO:0045176),-0.42495255302357104,-1.0799482490903534,0.3525835866261398,1.0,1.0,2/10,1.44%,ATP8B1;GOPC
prerank,positive regulation of ERAD pathway (GO:1904294),0.4741079702449943,1.0798845445564187,0.37590711175616837,0.8628042630659467,1.0,4/13,12.90%,RNFT1;UBQLN2;UBQLN1;RNF185
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4665450302221292,1.0797064329233506,0.38303693570451436,0.8627069254385419,1.0,3/16,5.41%,TRIB3;ACADL;SOX9
prerank,nitric oxide biosynthetic process (GO:0006809),0.47738724700493956,1.07961289876174,0.37714285714285717,0.8623368897972731,1.0,3/13,10.23%,CYB5B;CYB5R3;GCH1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.395750043771852,1.079349649589961,0.36524822695035464,0.8624390623729541,1.0,7/40,15.33%,ISG15;ACVR1;SLC8A1;BMPR2;ADGRV1;NELL1;BMPR1A
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3625801182312217,1.0789308706726384,0.3732470334412082,0.863090621961965,1.0,14/77,12.74%,NOL3;CLU;BDNF;ACVR1;ASAH2;FXN;CX3CL1;CFLAR;TCF7L2;CSNK2A2;PHIP;RTKN2;PSME3;RB1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.36955421946641115,1.0788164286511068,0.36017897091722595,0.8627923340613272,1.0,11/62,11.49%,MOV10;DPY30;MYL9;RBBP5;RUNX1;CNOT4;KMT2A;LYN;HOXA9;WDR5;EIF6
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.4329888530025881,1.078743556779082,0.3680649526387009,0.8623288088786192,1.0,3/22,8.96%,AGT;CAMK2D;P2RX4
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.47815851130069814,1.0787262045203305,0.3869625520110957,0.8616988698753009,1.0,4/14,14.71%,ZFP36;TARDBP;MAPK14;MYD88
prerank,regulation of protein-containing complex assembly (GO:0043254),0.3490853204343377,1.078647266845946,0.3481404958677686,0.8612462793911164,1.0,25/110,17.12%,EIF2AK2;IRGM;ABCA1;CLU;BCL2L11;HCK;NOP53;CDT1;SH3GLB1;SLF2;HSPA8;RIOK3;SORL1;GSN;PTPN11;APOE;SVIP;RB1;RACK1;NAPB;NAPA;HSP90AA1;BMF;PEX5;BAX
prerank,cellular senescence (GO:0090398),0.41898519023671404,1.0785816261233934,0.3627329192546584,0.8607702181807227,1.0,9/27,22.92%,PML;ECRG4;SRF;MAPK14;NSMCE2;TERF2;PRKCD;OPA1;KAT6A
prerank,regulation of TORC1 signaling (GO:1903432),-0.295799978754507,-1.0785680668754034,0.3113207547169811,1.0,1.0,6/33,7.56%,GPR137C;GPR137B;RRAGD;RRAGB;CASTOR2;LARS1
prerank,recombinational repair (GO:0000725),0.36359313401011106,1.0785506642045728,0.3438177874186551,0.8602068476525335,1.0,18/77,15.29%,SAMHD1;ZSWIM7;SEM1;AP5Z1;HELQ;KDM4D;MCM9;RAD51C;FEN1;ERCC4;XRCC3;ZFYVE26;POLQ;NSMCE2;NSMCE1;GEN1;RMI1;RECQL5
prerank,calcium-mediated signaling (GO:0019722),0.3557831247990875,1.0784381074997524,0.3739406779661017,0.859874810706871,1.0,12/93,9.50%,IRGM;CXCR4;KDR;TRPM2;FIS1;RCAN1;SLC8A1;PPP1R9A;SAMD14;ACKR3;P2RX4;PRNP
prerank,negative regulation of centrosome duplication (GO:0010826),0.5005596280819413,1.0783222278310565,0.39481268011527376,0.8595759632441381,1.0,6/11,23.96%,RBM14;CDK5RAP2;NPM1;TMEM67;MDM1;KAT2B
prerank,ubiquinone biosynthetic process (GO:0006744),0.4658942148174027,1.077512051276808,0.38820301783264743,0.8615723932870751,1.0,3/15,6.32%,COQ2;COQ10B;COQ3
prerank,regulation of epithelial cell migration (GO:0010632),0.3815517527913103,1.077344095203769,0.3710045662100457,0.8613954256422753,1.0,15/51,18.04%,HYAL1;SASH1;EVL;SOX9;RHOJ;CTSH;BMPER;BMPR2;PPM1F;DUSP10;PRKCE;RREB1;MCC;RAB11A;CORO1C
prerank,hemopoiesis (GO:0030097),0.3576088091970229,1.0772608876286134,0.35306553911205074,0.8610029549206282,1.0,16/87,11.37%,FLT1;WNT5A;KDR;KITLG;SBDS;SFRP2;RUNX1;YJEFN3;KMT2A;FGFR2;ETV6;MFAP5;YTHDF2;FUT10;NOTCH4;RTKN2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.3938461693715594,-1.0769507005417585,0.3711340206185567,1.0,1.0,4/14,13.97%,TMBIM6;SELENOS;HERPUD1;CREB3
prerank,embryonic skeletal system development (GO:0048706),0.40270989758858294,1.076747878468878,0.3764988009592326,0.8619171593843777,1.0,4/35,10.11%,WNT11;WNT5A;HOXA9;KIAA1217
prerank,generation of neurons (GO:0048699),0.34261534476566163,1.0767119304124844,0.32795156407669024,0.8613598216521098,1.0,39/190,19.80%,WNT11;LHX2;LMX1A;WNT5A;PER2;PLXNB2;TUBB2B;RUNX1;BHLHE40;CTNNB1;CX3CL1;NGRN;WNT7B;NRBP2;RAPGEF2;DTNB;YTHDF2;MET;DDIT4;LDB1;FGF13;NRP1;RAC1;SMARCA1;DNER;LRP12;ADNP2;OPHN1;PEX13;IER2;ITM2C;DCDC2;FUT9;PAFAH1B1;MARK1;BRSK1;MAP1B;PIN1;CCK
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.44729582888599495,1.0763160363148465,0.37771739130434784,0.8618464325245759,1.0,4/17,9.50%,THY1;DUSP3;SH2D1A;PRNP
prerank,regulation of protein localization to Cajal body (GO:1904869),0.4989836854331542,1.0760424294574626,0.38023952095808383,0.8613568559779656,1.0,4/11,10.73%,MEPCE;CCT4;CCT7;CCT3
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.4989836854331542,1.0760424294574626,0.38023952095808383,0.8613568559779656,1.0,4/11,10.73%,MEPCE;CCT4;CCT7;CCT3
prerank,negative regulation of macroautophagy (GO:0016242),0.4133535946106459,1.0757329460351555,0.3877038895859473,0.8616406995502747,1.0,8/26,19.18%,CHMP4A;CHMP4B;NRBP2;SCFD1;RUBCN;MTOR;FEZ2;TSC1
prerank,protein targeting (GO:0006605),0.3529606397880656,1.0750481155676272,0.36438923395445133,0.8631261086264919,1.0,26/118,17.56%,GOLGA7;FIS1;MYO1C;FBXO7;AQP11;RTP4;LAMP2;ZDHHC21;LONP2;SRPRA;ZDHHC20;TRAK1;GDAP1;TOMM5;VPS37A;NACA;SPCS1;FUT10;SORL1;TSPO;PITRM1;AIP;TAOK2;RPL11;TOMM40;CDC37
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.3813976284970041,-1.0749880204580002,0.3669064748201439,1.0,1.0,7/15,20.33%,FLOT1;EHD1;CAMK1;TREM2;RIPOR2;RAPGEF3;ADAM9
prerank,protein localization to organelle (GO:0033365),0.34480986029929195,1.074683289791165,0.3585291113381001,0.8635508673662039,1.0,30/133,19.09%,ISG15;GBP5;TOR1AIP1;AUP1;DDRGK1;GBP2;LAMP2;COG3;FAM83H;SNX10;DHX9;TUB;CNTLN;PAQR3;APP;TRAM2;PRNP;WDR35;ARL1;SORL1;ZNF423;VAMP2;BBS2;RPL11;RAB11A;LAMP1;TULP3;GBF1;SERP1;CD68
prerank,response to UV-A (GO:0070141),-0.38411572437847563,-1.074465484310356,0.3626760563380282,1.0,1.0,7/14,26.24%,MMP1;EGFR;AKT1;CERS1;MMP2;OPN3;PPID
prerank,regulation of defense response to virus (GO:0050688),0.4763370088081618,1.0744643756053345,0.37660485021398005,0.8635741510302498,1.0,3/14,9.90%,ILRUN;DHX9;TRAF3
prerank,regulation of calcium-mediated signaling (GO:0050848),0.4234243233513822,1.074454812737728,0.370757180156658,0.8629442502614925,1.0,4/25,8.96%,CDH13;ITPR1;TMBIM4;P2RX4
prerank,ribosomal small subunit biogenesis (GO:0042274),0.387389047042023,1.0743941433787014,0.3793103448275862,0.8624823250757387,1.0,7/39,13.00%,PWP2;LTV1;NOB1;ERAL1;NPM1;RIOK3;RPS6
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.4587753879901114,1.074363900407677,0.40324763193504737,0.8619288221150108,1.0,5/16,15.29%,MCM2;MCM7;MCM4;TWNK;RECQL5
prerank,transition metal ion transport (GO:0000041),0.4054863934367012,1.0743241389872695,0.3708530805687204,0.8613946090477939,1.0,14/35,25.59%,SLC30A1;SLC30A5;MT3;SLC11A2;TTYH1;TFR2;TRPC4;SLC31A1;SLC31A2;COX17;TRPC1;SLC30A9;CP;ATP7B
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3538259862935337,1.0742355792154425,0.3634453781512605,0.8610017325046431,1.0,15/95,10.06%,EXT1;XYLT2;HAS3;HYAL1;SDC3;SDC4;HAS1;FMOD;B4GALT4;B4GALT1;CSPG4;B4GALT5;AGRN;ST3GAL1;CSGALNACT2
prerank,protein localization to Golgi apparatus (GO:0034067),0.4144036755995915,1.074059300177799,0.38246505717916135,0.8608971864271994,1.0,11/27,21.28%,GBP5;PAQR3;TMED10;ARL1;SORL1;ARL5C;VPS13D;VPS13A;GBF1;VPS13C;OPTN
prerank,Golgi organization (GO:0007030),0.35073704663865596,1.0738799586297743,0.3596673596673597,0.8607858997087774,1.0,39/112,23.12%,VPS51;BLZF1;TJAP1;COG3;GOLGA5;GOLGA8B;SEC16A;GOSR2;ARHGEF7;CUL7;TMED5;FBXW8;RAB43;PLK3;UBXN2B;STX16;VCPIP1;TMED10;TRAPPC12;COG2;ARL1;ARHGAP21;VTI1B;PLEKHM2;VAMP4;STK25;DYNC2H1;TMED1;TMED3;GBF1;GOLPH3L;GORASP2;RAB1A;TMED7;OPTN;HUWE1;RAB2A;STX6;RAB29
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.4843998027508492,1.073799211389764,0.40559440559440557,0.8603844270758597,1.0,4/13,14.47%,NFKB1;DKK3;APOE;ERLIN2
prerank,liver development (GO:0001889),0.40214722253677443,1.0735185517397554,0.38405797101449274,0.8606067046650264,1.0,7/32,11.45%,GFER;ARID5B;CCDC40;NPHP3;MET;PROX1;XBP1
prerank,synapse assembly (GO:0007416),0.3631421144935232,1.0731241696916547,0.37102085620197583,0.8612111151916296,1.0,14/67,16.19%,SLITRK6;PCDHB13;WNT5A;PLXNB2;BDNF;SDK1;LRRTM3;PCDHB16;FGF13;DNER;LGI2;DBNL;DSCAM;NLGN3
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.29057694125038613,-1.0730470529217067,0.3125,1.0,1.0,13/39,17.31%,RCC2;SPOCK1;CORO2B;DMTN;JAG1;SEMA3E;RHOA;NEXMIF;ACER2;HOXA7;FZD7;MAP4K4;ITGB1BP1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.4335839648828815,1.0730173771107383,0.38571428571428573,0.860865269542813,1.0,6/22,16.95%,BDNF;MAGI2;RAPGEF2;CIB1;RAPGEF1;STMN2
prerank,response to organonitrogen compound (GO:0010243),0.3918492858136878,1.0730089799657487,0.3918757467144564,0.8602426978918835,1.0,13/38,25.00%,DHFR;TRPM2;RNF5;RRAGC;GLRA2;RNF185;MTOR;KAT7;GLRA1;KYNU;IRF5;VCP;HLCS
prerank,regulation of neuron projection arborization (GO:0150011),0.46285806139629765,1.0727955955447719,0.3838526912181303,0.8602003406240751,1.0,2/15,1.52%,MOV10;WNT5A
prerank,regulation of phagocytosis (GO:0050764),0.37464230751796496,1.0724504963157129,0.3658256880733945,0.8605904530755079,1.0,12/53,20.10%,IL15;IL15RA;CD47;HCK;SYT7;TUB;FCGR2B;RACK1;TLR2;PTPRC;SIRPA;TGM2
prerank,piRNA metabolic process (GO:0034587),-0.3498333890859035,-1.0723671464941575,0.3522727272727273,1.0,1.0,10/19,48.35%,TEX15;EXD1;DDX4;PIWIL2;TDRD12;GPAT2;TDRD9;MOV10L1;PIWIL4;PIWIL1
prerank,positive regulation of cell aging (GO:0090343),0.5026990721193192,1.0720567142566686,0.39826839826839827,0.8611712458731602,1.0,4/11,16.66%,B2M;CGAS;YPEL3;EEF1E1
prerank,skin development (GO:0043588),0.3629834702989524,1.0720300043149438,0.3691275167785235,0.8605906878166879,1.0,7/65,11.27%,CLIC4;WNT5A;ITGA3;PIP5K1A;COL5A3;MET;COL3A1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.34348989001459534,1.071598579650833,0.3611111111111111,0.8612664721487157,1.0,37/138,21.64%,AXL;FLT1;KDR;BDNF;LCP2;HCK;EPHA4;FGFR2;CSF1;RET;NPPC;EPHA6;BCAR1;LTK;MET;LYN;INSR;BMPR2;GFRA2;ROR2;STAP1;PIK3CB;RAPGEF1;JAK2;FYN;FGFR3;BLNK;PTPRU;MPZL1;ACVR2A;POLR1G;NPR2;PTPRF;DDR2;LCK;YES1;ROR1
prerank,cellular component assembly (GO:0022607),0.33996551345499476,1.0715453899724163,0.3256513026052104,0.860774156683693,1.0,52/253,16.61%,SYCP1;PML;HAS3;WNT5A;GPAA1;TEAD2;CD40;HAS1;YTHDF1;LAMC1;PARVB;MDN1;CHCHD10;TLCD2;TSPAN4;CCDC40;SOX9;CYFIP1;TAPBP;RHOJ;KMT2A;STX7;SKAP2;DET1;AIF1L;YTHDF2;MNAT1;VCPIP1;TEX11;CHAF1B;SPEF1;SNX9;MITF;GSN;LRRTM3;PPARGC1A;LIMS1;VAMP2;CORO1B;BSN;RAC1;ACTB;IL1RAP;STK25;SH3BP1;BAIAP2;AIF1;NLGN3;OPHN1;BAIAP2L1;LLGL1;WDR19
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.35211641505753044,-1.0711420874469864,0.3305439330543933,1.0,1.0,4/20,7.77%,TGFB1;NUMB;RHOQ;TMBIM1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.2632369204945258,-1.0708377316712239,0.3211009174311927,1.0,1.0,16/57,11.41%,DLGAP1;GRIN2A;GRIN2B;LRRC7;CACNG7;DLG4;SHISA9;GRIN1;OPRM1;DAPK1;DLG3;NLGN2;SHISA6;CACNG8;GSG1L;PRRT1
prerank,regulation of cell death (GO:0010941),0.3522460449040365,1.070830259702744,0.3777544596012592,0.8623976893873896,1.0,17/94,15.93%,HSPA1B;WNT11;CHMP4B;CLU;CCL5;RILPL1;MT3;NCK1;LRPAP1;SPEF1;PRR7;ZC3H12A;SRGAP2;DUS2;NOA1;ADNP2;ACER3
prerank,negative regulation of T cell activation (GO:0050868),0.4014936827700307,1.0706731941477827,0.3985419198055893,0.8622294249358416,1.0,5/35,12.86%,CD274;SDC4;DUSP3;HAVCR2;FCGR2B
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5114676632338864,1.0706632433158838,0.37613293051359514,0.8616039862364476,1.0,2/10,6.57%,GRB10;MT3
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.37289850136609803,-1.0705347945823247,0.35714285714285715,1.0,1.0,3/15,19.09%,QDPR;KMO;IL4I1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.4610375850785239,1.0704496918474584,0.38545953360768176,0.8616253205870629,1.0,7/15,22.76%,ACTR2;ACTR3;ARPC5;WHAMM;ARPC1B;JMY;IQGAP2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.35276331712720604,1.070085840837481,0.3602550478214665,0.8621003314712632,1.0,19/93,14.94%,IRGM;SPRY2;BDNF;SFRP2;MAD2L2;HSP90AB1;TNKS1BP1;MTCP1;PAQR3;CNKSR3;NCK1;APP;NCK2;PPM1F;DDIT4;AKAP9;RACK1;HSP90AA1;INPP5K
prerank,positive regulation of translation (GO:0045727),0.3523097098036738,1.0700735752608208,0.3818565400843882,0.8614854864809961,1.0,23/94,18.72%,POLR2G;PLXNB2;AGO2;YTHDF1;LARP1;CCL5;DHX36;ZCCHC4;NGRN;RCC1L;DHX9;YTHDF2;NPM1;EIF6;PRKDC;TRMT10C;UPF3A;RBM3;MTOR;METTL14;JMJD4;EIF2B5;FASTKD2
prerank,negative regulation of cellular protein localization (GO:1903828),0.4012764193427955,1.0700269226240458,0.3713235294117647,0.860974424651673,1.0,7/34,11.69%,ILRUN;SNX33;ACTN2;CDT1;LEPROT;UBXN2B;LEPROTL1
prerank,protein localization to microtubule organizing center (GO:1905508),0.4755249362126064,1.0698986837738855,0.39628040057224606,0.8607097453956981,1.0,9/15,27.47%,SNX10;NEDD1;CEP131;HOOK3;PIBF1;CEP83;BBS4;CEP192;CCDC14
prerank,regulation of protein import into nucleus (GO:0042306),-0.2949793535785162,-1.0698528602776236,0.32941176470588235,1.0,1.0,13/36,22.88%,TGFB1;APOD;EFCAB7;UFM1;CABP1;PIK3R2;ZIC1;UBR5;DMAP1;BAG3;ECT2;TPR;RBM22
prerank,positive regulation of glucose import (GO:0046326),0.4366370871748744,1.069826173132836,0.3880794701986755,0.8602672450798379,1.0,6/21,14.63%,IRS1;ARPP19;OSBPL8;INSR;PTPN11;IRS2
prerank,neural tube closure (GO:0001843),0.3997381427022863,1.0696545199840073,0.39401197604790417,0.8601363041364092,1.0,4/34,5.36%,MTHFR;PLXNB2;LRP2;PRICKLE1
prerank,negative regulation of JNK cascade (GO:0046329),0.40436897725301457,1.0694040975024117,0.3884093711467324,0.8602770112075079,1.0,6/31,12.72%,TAOK3;DUSP3;CYLD;DACT1;MEN1;DUSP10
prerank,respiratory electron transport chain (GO:0022904),0.47118555951173446,1.0693468095406335,0.38050734312416556,0.8597966511651094,1.0,4/14,14.79%,SLC25A22;NDUFA5;PPARGC1A;SLC25A12
prerank,phospholipid translocation (GO:0045332),0.4179840053979724,1.0690068057134645,0.3969658659924147,0.8602039289191675,1.0,6/28,15.76%,ATP10A;ABCA1;ATP8A1;ABCC1;ATP11A;ATP9B
prerank,production of siRNA involved in RNA interference (GO:0030422),0.5072370390613875,1.0688665764960428,0.39819004524886875,0.8599477874183276,1.0,4/10,17.16%,AGO2;TARBP2;DICER1;PRKRA
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5036910122346833,1.0688089747820484,0.4100609756097561,0.8594695042278154,1.0,4/11,21.13%,SOCS1;LEPROT;HGS;ADIPOR1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.46148432976600995,1.0685762446063503,0.4,0.859539569911757,1.0,3/16,15.46%,DHX36;SOX9;SOX5
prerank,negative regulation of immune response (GO:0050777),0.34051386086822766,1.0681945330590112,0.36446700507614216,0.8600253911724431,1.0,19/154,12.86%,TRAFD1;CALCA;RXFP2;ILRUN;DHX58;NMI;TRIM21;ENPP3;PTGER4;HCK;ADCY5;PRKAR2B;LYN;FCGR1A;MAPK14;COL3A1;HAVCR2;RHBDF2;FCGR2B
prerank,positive regulation of actin filament polymerization (GO:0030838),0.3824694076896676,1.0680859039116093,0.3744131455399061,0.8597281431535466,1.0,11/44,16.35%,HCK;EVL;CARMIL1;NCK1;NCK2;SNX9;GSN;PRKCE;WHAMM;BAIAP2;BAIAP2L1
prerank,axon extension (GO:0048675),0.41583383058094386,1.0676065738717824,0.37516170763260026,0.8605249030628355,1.0,9/23,19.01%,NRP2;HSP90AB1;CYFIP1;SLIT3;SLIT1;NRP1;HSP90AA1;NLGN3;MAP1B
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.4800105395894858,1.0668399271730125,0.3873239436619718,0.8621817913948361,1.0,3/13,12.84%,TPST1;SULT6B1;ENPP1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.3088560070518868,-1.0663649095076513,0.3553299492385787,1.0,1.0,15/27,29.29%,PAK2;RHPN2;CLASP2;SHANK3;WAS;WASF2;F11R;CLASP1;SHANK1;ARHGAP6;PPFIA1;ARHGEF18;TJP1;ARHGAP28;PRKN
prerank,organic anion transport (GO:0015711),0.3616743558833091,1.0663533345959573,0.3879310344827586,0.8629620640971705,1.0,16/76,20.39%,CA4;CYB5R2;SLCO1C1;SLC2A6;SLC25A19;SLC19A1;SLC52A2;SLCO1B1;SLC35B1;SLC35B4;CA2;SLC35A3;SLC4A2;SLC35C2;ABCG2;ABCC5
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3565053332963345,1.065334841821098,0.3850267379679144,0.865409640879821,1.0,17/83,15.73%,DHFR;ACVR1;CUL5;GSPT1;CDKN2D;CACUL1;CCND1;CDT1;BACH1;TFDP1;PLK3;MNAT1;MAX;TFDP2;RB1;USP37;NPAT
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.4349131079369129,1.0641133736891328,0.4,0.8685395961548571,1.0,6/20,17.16%,ZC3H7A;AGO2;TARBP2;ZC3H7B;DICER1;PRKRA
prerank,coenzyme A metabolic process (GO:0015936),0.46685682234546577,1.0640672035035854,0.4016393442622951,0.8680290024082257,1.0,6/14,22.32%,PPCS;SLC25A16;PANK2;ACAT1;DCAKD;PPCDC
prerank,regulation of cell morphogenesis (GO:0022604),0.40301359414927757,1.0639685684795557,0.38854296388542964,0.8676833288936804,1.0,9/30,17.73%,MOV10;FMNL2;PDPN;ZMYM3;PHIP;CAPZB;ZRANB1;ZMYM6;SH3D19
prerank,activation of protein kinase A activity (GO:0034199),-0.36396466138020134,-1.0639681492972308,0.3473282442748092,1.0,1.0,4/16,6.48%,ADCY9;PRRC1;ADCY3;PRKACB
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.48684265770462604,1.0636213642917198,0.3869047619047619,0.8681106463802043,1.0,3/11,16.64%,ACTN2;CAB39;STK39
prerank,positive regulation of receptor internalization (GO:0002092),0.42877912809900787,1.0634629717207886,0.38350785340314136,0.8679308333169642,1.0,5/22,17.40%,MAGI2;INSR;ARRB2;SCYL2;ATAD1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.4911815961174041,1.063174864899936,0.4199706314243759,0.8681890701470648,1.0,4/11,17.82%,DHFR;GCH1;HSP90AA1;PRKG2
prerank,extracellular matrix assembly (GO:0085029),0.4259236938769816,1.0630323659913392,0.4059662775616083,0.8679625947723457,1.0,3/23,3.80%,HAS3;HAS1;LAMB2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.44556351045906784,1.0624356139805626,0.3949579831932773,0.8690835448310207,1.0,4/18,10.19%,FPR3;BCAR1;LYN;C3AR1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.42246174719490454,-1.0621060407885605,0.3560371517027864,1.0,1.0,6/10,26.12%,HMOX1;HOXA7;CD200R1;CD200;BMP5;EMILIN1
prerank,cellular response to fatty acid (GO:0071398),0.48415988638105195,1.0618776261067722,0.41595441595441596,0.87008694780985,1.0,2/12,10.58%,IRS1;ZC3H12A
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.407711945830752,-1.0618692151804923,0.38924050632911394,1.0,1.0,4/11,16.91%,ARRB1;GRK3;GRK2;SAG
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.4728888238792811,1.0615790433923034,0.39859154929577467,0.8703361466549914,1.0,2/13,2.75%,ESR2;ABHD2
prerank,acylglycerol homeostasis (GO:0055090),0.44346408272541116,1.0614590539498812,0.4,0.870070923824278,1.0,6/20,21.55%,LIPC;RORA;APOE;APOC4;IL18;PNPLA8
prerank,snRNA 3'-end processing (GO:0034472),-0.3526349581416651,-1.0614571303491467,0.3547008547008547,1.0,1.0,12/19,35.10%,EXOSC7;EXOSC5;INTS12;EXOSC3;INTS2;TUT1;INTS6;TOE1;INTS5;INTS6L;USB1;EXOSC8
prerank,supramolecular fiber organization (GO:0097435),0.3336439347887026,1.0614098736038664,0.327,0.869581498981631,1.0,64/333,14.70%,LOXL2;CALCA;COL13A1;UBE2L6;B2M;ACTN1;P4HA1;KATNAL1;ADAMTS3;COL9A1;MYO1C;ELMO2;MAD2L2;COL4A2;RHOF;RUFY3;DYNC1H1;PPP1R9A;SIAH1;EVL;HSP90AB1;COL14A1;KIF2C;P3H1;CARMIL1;GGA3;COL5A3;HOOK2;COL8A1;COL22A1;SAMD14;STMN4;CCDC88A;BCAR1;APP;SCX;BFSP1;PLK3;HOOK1;DNAJB6;TPPP3;STMN3;CIB1;CCDC88B;ARHGAP25;COL3A1;SORL1;CORO7;GSN;FAT1;TMOD3;ADAMTS2;COL11A2;TRPV4;FGF13;CLIP2;WHAMM;CORO1B;HOOK3;MYO6;RAC1;APH1A;DLG1;KIF2A
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.33591642257770327,1.061395427949684,0.366497461928934,0.8689876185937832,1.0,33/166,16.70%,NR1H2;IRS1;PLXNB2;CLU;SLC27A1;PPP1R3E;ARPP19;YTHDF1;CCL5;HSP90AB1;ZCCHC4;CDT1;DHX9;SLC45A3;SMOC2;P2RX4;INSR;NPM1;EIF6;DYRK2;LDB1;PPARGC1A;PRKDC;UPF3A;STN1;IRS2;LPGAT1;HSP90AA1;RBM3;PRMT1;MTOR;SREBF1;METTL14
prerank,cellular response to glucose stimulus (GO:0071333),0.3950437872088411,1.061066549698118,0.37682926829268293,0.8693271900982698,1.0,11/30,27.04%,CLTRN;RAB11B;XBP1;RACK1;SELENOT;ERN1;ZBTB20;RAB11FIP5;TRA2B;KCNB1;PTPRN
prerank,positive regulation of transferase activity (GO:0051347),0.34036559554492934,1.060852577045234,0.38109756097560976,0.8693201309705683,1.0,22/142,9.96%,AXL;FLT1;DTX3L;TRIB3;KDR;ARRDC4;HSP90AB1;RFC4;POLG2;FBXW7;CTNNB1;EPHA4;FGFR2;RET;CCT4;EPHA6;HNRNPA2B1;DCUN1D4;LTK;MET;INSR;ROR2
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3493779697106452,1.0608048056504635,0.3792016806722689,0.8688260476734603,1.0,21/98,17.81%,AGT;NR1H2;XDH;SLCO1C1;CCL5;MT3;CSF1;MAGI2;DHRS4;INSR;MAPK14;ARRB2;ZC3H12A;SCYL2;IL10RB;APOE;PPARD;ACOD1;CHCHD2;ATAD1;GHITM
prerank,mRNA transport (GO:0051028),0.35050919271995223,1.0607460851275616,0.3812038014783527,0.8683651852995677,1.0,31/101,21.85%,NUP37;ZFP36;MAGOHB;SMG7;NUP153;NCBP2;WDR33;NXT1;HNRNPA2B1;RAE1;ZFP36L1;RNPS1;SMG5;UPF2;ZC3H11A;CHTOP;NUP155;DDX39B;NCBP1;DDX19B;SRSF7;SRSF4;UPF1;NUP88;SLU7;NUP133;GLE1;NUP43;THOC7;SRSF5;MCM3AP
prerank,blood vessel diameter maintenance (GO:0097746),0.3949408233728977,1.0607075999309203,0.3886838868388684,0.8678592463438206,1.0,2/34,1.59%,AGT;PER2
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3322024933761244,1.0604477779476262,0.33133133133133136,0.8679823347682313,1.0,62/327,16.58%,PML;THAP7;ESR2;DAPK3;MYBBP1A;DAXX;ESRRB;NFX1;SAP30L;ZFPL1;TEAD2;NFKB2;CHEK2;STAT3;ZFP37;CHD7;BHLHE40;NKX6-2;SRRT;MZF1;NFXL1;SERTAD3;PFDN5;ZNF2;NSD3;ZSCAN26;EDF1;ZBTB38;BACH1;NFATC2;SNAI2;SAP30;NONO;ACTR8;INSR;RORA;DNM2;NAB1;HCFC2;RALY;MITF;RYBP;ZNF423;LDB1;PPARGC1A;NR3C1;UBE2L3;RB1;ZNF35;ATXN1;APBB1;ASCC2;CASZ1;SOX2;RREB1;EZH2;MYB;MYCBP;GTF2IRD1;DENND4A;ZNHIT3;ZBTB4
prerank,sodium ion homeostasis (GO:0055078),0.4375366608708443,1.0603985805578693,0.40710382513661203,0.8674958411415702,1.0,3/21,6.71%,ATP1B3;SLC8A1;TFAP2B
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.454393144866275,1.059913386983875,0.41289437585733885,0.8682728870216724,1.0,2/16,3.74%,CAMK2D;SLC8A1
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.3493676198281637,-1.0598232021275236,0.3511450381679389,1.0,1.0,6/18,8.69%,APOD;CTNNA1;POLR1A;UFM1;CABP1;GSK3B
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3443515057415509,1.0596463206428013,0.381294964028777,0.868489584589064,1.0,34/128,18.82%,PKMYT1;SKP1;CHEK2;ARPP19;CDC25B;DYNC1H1;BACH1;ACTR1A;MAPRE1;TPD52L1;CDK5RAP2;PRKAR2B;TAF2;PLK3;MNAT1;BTRC;DNM2;PHLDA1;NEDD1;CEP131;CEP152;CEP70;AKAP9;DYNLL1;KDM8;HSP90AA1;MASTL;TUBB4B;PPME1;PPP2R2A;DCTN3;PAFAH1B1;BRSK1;CEP135
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.311670229544404,-1.0594682740712917,0.3532608695652174,1.0,1.0,8/29,11.62%,PAK1;UBA5;CBFB;ESR1;KANK2;UFM1;BRCA1;GPAM
prerank,calcineurin-mediated signaling (GO:0097720),-0.43182080056908484,-1.0589102012130964,0.4,1.0,1.0,2/10,1.84%,PPP3R1;PPP3CC
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.43182080056908484,-1.0589102012130964,0.4,1.0,1.0,2/10,1.84%,PPP3R1;PPP3CC
prerank,negative regulation of interleukin-12 production (GO:0032695),0.45981921176571644,1.0584268885668424,0.39705882352941174,0.8715102606067991,1.0,2/14,5.01%,SLAMF1;TLR8
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3519051445302459,1.058389738301822,0.37912673056443025,0.8709733831066896,1.0,26/88,18.52%,BLOC1S4;GOLGA7;KLHL20;AP2A1;AP1S1;DOP1B;APP;KIF16B;HSPA8;DNM2;RAB14;EXOC6;SORL1;CORO7;SCFD1;ARFGEF2;VAMP2;NAPA;STX4;SNAP23;HGS;LLGL1;VPS13A;SH3D19;GBF1;DTNBP1
prerank,brain development (GO:0007420),0.34087468845753816,1.058333157275601,0.3890608875128999,0.8705231905984482,1.0,30/136,16.48%,VPS51;CXCR4;PLXNB2;GRIN2D;PAFAH1B3;SYNJ1;PHGDH;CIC;PITPNM1;UBE3A;TBC1D23;MEIS3;RAPGEF2;CDK5RAP2;NFIB;BPTF;PROX1;DNAJC30;SCYL2;DDIT4;PTPN11;ATXN1;PTCH1;SMARCA1;CTNS;POU6F1;BBS2;DSCAML1;NDUFS4;DHX37
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.439851469548213,1.0582279990541172,0.39804469273743015,0.8702027786168188,1.0,4/18,11.89%,ABCG1;CLU;EPHA4;LRRTM3
prerank,protein neddylation (GO:0045116),0.4826504199372563,1.0574869068300192,0.4077669902912621,0.8717654786848263,1.0,3/13,8.97%,UBE2M;DCUN1D4;RBX1
prerank,regulation of cellular response to stress (GO:0080135),0.347593929068602,1.0572223996099461,0.39334027055150883,0.8719259345076811,1.0,26/115,17.51%,HSPA1B;CAMK2D;NUP37;PNPT1;CAMK2B;SLC38A2;CRHBP;NUP153;RSL1D1;HSP90AB1;AMFR;RAE1;ABCD1;HSPA8;DNAJB6;NPM1;CHORDC1;NEK6;BAG1;AKT1S1;NUP155;HSP90AA1;MTOR;CHCHD2;PTGES3;NUP88
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.47748229924205643,1.0569434521679753,0.4046920821114369,0.8721557010140201,1.0,4/12,14.95%,DCK;TK1;TK2;UCKL1
prerank,regulation of humoral immune response (GO:0002920),0.3803337851312322,1.0568260647779304,0.413472706155633,0.8718613680308303,1.0,7/44,16.22%,CLU;C4B;CD55;SUSD4;C3AR1;FCGR2B;C1QB
prerank,negative regulation of cell differentiation (GO:0045596),0.3372650947436715,1.056757772486947,0.3856998992950655,0.8714278457878077,1.0,31/181,14.90%,NR1H2;ABCA1;XDH;TRIB3;WNT5A;SPRY2;ABCG1;ESRRB;SEMA4D;SFRP2;MAD2L2;EID2B;SOX9;SRA1;NPHP3;SNAI2;NBR1;YTHDF2;BAMBI;HOXA9;MEN1;RORA;ADGRV1;NOTCH4;PTPN11;RB1;ENPP1;PTCH1;RANBP3L;SOX2;MYB
prerank,cellular copper ion homeostasis (GO:0006878),0.4686859930918734,1.0565567483446123,0.3974358974358974,0.8714251897954618,1.0,6/14,25.59%,APP;PRNP;COX19;SLC31A1;SLC31A2;ATP7B
prerank,"phagocytosis, engulfment (GO:0006911)",0.3916243368986244,1.0563787035187178,0.40625,0.8713225385952873,1.0,13/36,21.27%,GULP1;XKR7;MEGF10;FCGR1A;ARHGAP25;GSN;FCGR2B;RAC1;SH3BP1;AIF1;MYH9;MSR1;RHOH
prerank,positive regulation of signaling (GO:0023056),-0.2967242511062738,-1.056353761081078,0.32051282051282054,1.0,1.0,15/37,24.11%,INPP5F;DLG4;HOMER1;SNCA;RIMS1;NSF;VAMP3;RIMS3;SCRIB;CDKN2AIP;RIMS2;KCTD13;SYT1;NMU;CD80
prerank,plasma membrane organization (GO:0007009),0.36216989180884396,1.0562776713233994,0.4097452934662237,0.8709902785992666,1.0,12/61,13.96%,CHMP4A;CXCR4;SNX33;TLCD2;DEGS1;SYT7;EPB41L3;ABCD1;FNBP1L;SNX9;WHAMM;STX4
prerank,positive regulation of neuron differentiation (GO:0045666),-0.2791329677163709,-1.0556799742848495,0.3565217391304348,1.0,1.0,14/40,21.82%,IMPACT;REST;BRINP1;MMD2;RHOA;ARHGEF2;BRINP2;HOXD3;NRCAM;ZC4H2;ECT2;NBL1;MEF2C;TCF3
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3621664753603859,1.0556077800681964,0.4268558951965066,0.8723501867916543,1.0,17/69,15.32%,AUP1;TRIM25;TMEM129;RNF5;UBQLN2;AMFR;TMUB2;UBQLN1;FAM8A1;RNF103-CHMP3;FAF2;RNF185;UBE4B;ANKZF1;ERLIN2;TMEM67;RNF103
prerank,glutamate receptor signaling pathway (GO:0007215),-0.2927309921835066,-1.0550756450143177,0.3815789473684211,1.0,1.0,7/37,6.13%,GRM3;GRIN2A;GRIN2B;GRIK1;GRIN1;HOMER1;HOMER3
prerank,regulation of cellular response to heat (GO:1900034),0.35876608248533004,1.0549788268288158,0.38675213675213677,0.8735981445002144,1.0,21/77,20.34%,HSPA1B;CAMK2D;NUP37;CAMK2B;NUP153;HSP90AB1;RAE1;HSPA8;DNAJB6;CHORDC1;IER5;BAG1;AKT1S1;NUP155;HSP90AA1;MTOR;PTGES3;NUP88;HSBP1;NUP133;NUP43
prerank,peroxisome organization (GO:0007031),0.41704469482642803,1.0547344003700878,0.4213197969543147,0.8737140131925931,1.0,5/25,9.49%,FIS1;PEX7;LONP2;ABCD1;PEX2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.41161504739569466,1.0546881023042252,0.42857142857142855,0.8732246192150467,1.0,8/26,24.80%,CLTRN;ADCY5;BAIAP3;STX4;PLA2G6;PIM3;CDK16;CFTR
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.38671312845218486,1.0546429216401478,0.392226148409894,0.8727221252042713,1.0,12/39,21.19%,SOCS1;PIK3CD;ITPKC;SOCS5;PI4KB;EFR3A;SOCS2;PIK3CB;SOCS6;SOCS4;PI4KA;SOCS7
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.451156299098521,1.0541548735559363,0.41815680880330125,0.8735827573618601,1.0,8/17,25.28%,SPRY2;DDIT4;INPP5K;CALM3;SPRED3;SPRED1;CALM2;SIRT2
prerank,anterograde axonal transport (GO:0008089),0.3888483108009555,1.0539392035510635,0.418331374853114,0.8736104924687453,1.0,7/37,12.09%,BLOC1S4;RAB21;TRAK1;KIF3B;MAPK8IP3;AP3M2;AP3S2
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.38904671819632763,1.0538935364550939,0.41127098321342925,0.8731240370016986,1.0,5/33,8.17%,HYAL1;DDRGK1;CCND2;CCND1;TFDP1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.4549616108795884,1.053876713968031,0.39628040057224606,0.8725455278007511,1.0,7/15,23.55%,DAXX;DHX36;ZC3H12A;HNRNPA1;CPEB2;DDX3X;VCP
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.37160760060324816,1.0538675951081051,0.40162980209545984,0.8719497495034089,1.0,17/49,22.67%,FIS1;BCL2L11;SIAH1;CYLD;UBQLN1;RTKN2;RACK1;BAD;BMF;BAX;BECN1;BCAP31;DDX3X;LCK;PLAUR;MCL1;BCL2L2
prerank,microtubule polymerization or depolymerization (GO:0031109),0.4164823733416432,1.0538246838999183,0.4186046511627907,0.8714756724889726,1.0,9/24,19.46%,KIF2C;STMN4;TPPP3;STMN3;TRPV4;FGF13;KIF2A;STMN2;PIN1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.36930464661950263,1.053703426197731,0.4131185270425777,0.8712257124990754,1.0,17/51,19.81%,TAOK3;BDNF;CNTNAP1;GAS7;EPB41L3;TNIK;DNM2;ANKRD27;SRGAP2;MINK1;DBNL;TAOK2;NYAP2;DICER1;SNX1;DTNBP1;NCKAP1
prerank,cellular response to chemical stress (GO:0062197),0.3479706464717695,1.053677019144972,0.38308977035490605,0.8706841944930185,1.0,20/96,16.91%,HSPA1B;TMEM161A;PNPT1;SOD2;CYBB;SRXN1;MT3;PPIA;GSR;ZC3H12A;LONP1;PPARGC1A;TRPV4;STX4;EIF2S1;PRDX2;ADNP2;MSRA;AIF1;CHCHD2
prerank,positive regulation of positive chemotaxis (GO:0050927),0.46326905190860657,1.0530747304454715,0.4197707736389685,0.8718438805607105,1.0,3/15,11.22%,KDR;CDH13;VEGFD
prerank,pulmonary valve morphogenesis (GO:0003184),-0.3461819177893051,-1.0530400929625925,0.358974358974359,1.0,1.0,8/17,37.02%,TGFB2;JAG1;SMAD6;ROBO1;BMP4;HEY1;HEY2;HEYL
prerank,protein modification by small protein removal (GO:0070646),0.33011410699463933,1.0526514240302667,0.3678391959798995,0.8724867277650135,1.0,81/252,24.13%,USP18;IFIH1;PSMB10;PSME2;BIRC2;INO80E;USP50;PSMA5;PSME4;SENP3;USP25;USP21;USP15;OTUD3;POLB;USP40;PSMA3;SENP5;CYLD;SMAD2;UCHL5;PSMB9;UCHL3;ACTR8;USP34;BARD1;TADA2B;COPS7B;TRAF3;VCPIP1;JOSD2;ARRB2;TNIP1;ZC3H12A;FOXK1;OTUD1;ATXN7;PSMD2;USP14;PSME3;USPL1;ZRANB1;USP45;BIRC3;ACTB;PSMA4;TNIP2;USP37;HGS;TNIP3;OTULINL;INO80C;BABAM2;COPS8;PSMD7;OTUD6B;PSMD8;BECN1;PSMD9;MBD6;NFRKB;PSMF1;USP5;PSMB6;USP8;PSMC2;PSMD12;SENP8;USP33;COPS7A;SENP7;SMURF2;ADRM1;PSMD4;SENP2;VCP;PSMA2;KAT2B;ACTL6A;USP32;USP10
prerank,dendritic cell chemotaxis (GO:0002407),0.4605915994471338,1.0526233844309487,0.41414141414141414,0.8719418656726189,1.0,4/14,9.13%,CXCR4;TRPM2;CCL5;HMGB1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.21532816797103999,-1.0524903860494872,0.3333333333333333,1.0,1.0,30/128,18.25%,TGFB1;ZMIZ2;PTPRK;HPGD;USP9X;PXN;TGFBR3;RUNX2;PRKCZ;PDCD4;MAPK3;TWSG1;SIRT1;TGFB2;COL1A2;UBB;BMP6;ACVR1B;SRC;RHOA;UBC;APPL1;CBL;SMAD6;UBA52;SMAD4;GDF1;RPS27A;F11R;ACVR1C
prerank,histone modification (GO:0016570),0.341914833799903,1.0521242459013167,0.4139004149377593,0.8728236451570031,1.0,42/109,28.74%,EYA4;PRMT2;RBM14;MTA3;NAA50;USP21;UBE2B;NTMT1;NSD3;MT3;MTA2;ATXN7;MIER1;EZH2;RCOR3;PRMT1;KAT8;EYA2;ENY2;HDAC1;SGF29;PRKCD;HUWE1;RUVBL2;HDAC2;KAT6A;HDAC4;KAT5;HDAC6;HLCS;SIRT2;EYA3;EHMT2;RUVBL1;EYA1;UFL1;EP300;UBE2N;BRD8;USP22;HDAC5;NEK11
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.32947232938130505,1.0520840274687764,0.348,0.872323961386791,1.0,70/366,16.58%,PML;THAP7;ESR2;DAPK3;MYBBP1A;DAXX;ESRRB;NFX1;SAP30L;ZFPL1;TEAD2;NFKB2;CHEK2;STAT3;ZFP37;CHD7;BHLHE40;NKX6-2;SRRT;MZF1;NFXL1;TCOF1;SERTAD3;PFDN5;CYFIP1;ZNF2;NSD3;ZSCAN26;EDF1;ZBTB38;BACH1;NFATC2;SNAI2;SAP30;CCDC88A;NOLC1;NONO;ACTR8;APP;INSR;RORA;DNM2;PUM3;NAB1;HCFC2;MITF;RYBP;ZNF423;LDB1;PPARGC1A;ORC3;NR3C1;UBE2L3;RB1;ZNF35;ATXN1;APBB1;ASCC2;CASZ1;SOX2;RREB1;EZH2;MYB;USP37;RBM3;MYCBP;GTF2IRD1;DENND4A;ZNHIT3;ZBTB4
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.36206158760341384,1.0520734306939228,0.40625,0.8717249881532377,1.0,29/59,29.23%,MOV10;MECP2;SOX9;CTNNB1;CCND1;TCF7L2;NFKB1;MED12;MITF;MED27;MED16;BAX;MED10;MED7;MED24;CDK8;AGO4;MED8;TRIM28;CDKN2A;PTEN;AGO1;MED25;SETX;AGO3;MED26;JUN;CSF1R;MED13
prerank,microvillus assembly (GO:0030033),0.45477172418097894,1.0520310673319142,0.4315937940761636,0.8712203356591228,1.0,6/14,19.48%,RAPGEF6;RAPGEF2;TNIK;FXYD5;MINK1;RAP2A
prerank,cognition (GO:0050890),0.3825934129974382,1.0518881382452068,0.4028605482717521,0.8710131182145553,1.0,13/42,18.37%,CHD7;CYFIP1;PTCHD1;DOP1B;METTL23;APP;LINS1;SETD5;CTNS;CHRNB2;MAGT1;NF1;SOBP
prerank,N-terminal protein amino acid modification (GO:0031365),0.4772761867670381,1.0517561825593513,0.43342776203966005,0.8707638397212738,1.0,4/14,16.65%,NAA50;NTMT1;NAA35;METAP2
prerank,cellular response to mechanical stimulus (GO:0071260),0.37231395018165,1.0515513110884578,0.41440377804014167,0.870769596927585,1.0,16/46,24.71%,TNFRSF8;CD40;PTGER4;CHEK1;TLR8;SOX9;NFKB1;BAD;MYD88;TLR3;CRADD;GADD45A;PIEZO1;TLR7;IRF1;MAP2K4
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.378434934166283,1.0514879873128993,0.41828571428571426,0.8703172498692208,1.0,10/43,16.18%,IRS1;SOCS1;GRB10;NCK1;KANK1;SORL1;PTPN11;ENPP1;INPP5K;GKAP1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.40762399454375525,1.0509779616861923,0.4094387755102041,0.8711915746666634,1.0,6/25,15.21%,CAMK2D;CTNNA3;AKAP9;FGF13;DLG1;CALM3
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.4570536809883836,1.0507040263303322,0.4217032967032967,0.8713623814172188,1.0,2/15,3.85%,DTX3L;MAD2L2
prerank,positive regulation of interleukin-12 production (GO:0032735),0.3986032701128267,1.0506771714084153,0.4245742092457421,0.8708125739163535,1.0,10/31,23.40%,CD40;HMGB1;MAPK14;TLR2;LGALS9;MDK;TLR3;RIPK2;LTB;IRF5
prerank,cellular component maintenance (GO:0043954),0.4853527353221144,1.0505449450867905,0.42330383480825956,0.8705909523005158,1.0,4/12,14.33%,ITGA3;INSR;PRNP;FYN
prerank,positive regulation of cell projection organization (GO:0031346),0.33997689262063036,1.0496442991214685,0.41770833333333335,0.8726162634976339,1.0,28/115,18.43%,PLXNA3;WNT5A;PLXNB2;BDNF;CAMK2B;RETREG3;PLXNB3;CX3CL1;P3H1;CARMIL1;CUL7;RET;MAGI2;FBXW8;RAPGEF2;LTK;LYN;ROR2;CUX1;APOE;TIAM2;RAPGEF1;NPTN;SCN1B;MDK;STMN2;FUT9;CAPRIN1
prerank,positive regulation of neuron death (GO:1901216),0.3749718003753139,1.049458245993041,0.4009163802978236,0.8725428671314762,1.0,13/46,19.90%,WNT5A;DAXX;CLU;CTNNB1;TFAP2B;PRNP;DDIT4;FCGR2B;EIF2S1;FYN;BAX;NF1;TYROBP
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3900498722617093,1.049287579792731,0.4,0.8724032352282124,1.0,9/34,21.95%,NOD2;FLT1;IRS1;PIK3R4;RUBCN;FGFR3;WDR91;TNFAIP8L3;FGF2
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.3973791528273043,1.0490776393261039,0.4094775212636695,0.872441294910909,1.0,11/33,18.99%,HSP90AB1;RFC1;TNKS1BP1;RTEL1;GAR1;PPP6R3;TELO2;STN1;HSP90AA1;PTGES3;TERF2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.36199070817373524,-1.0490554951556021,0.3674911660777385,1.0,1.0,3/16,14.95%,PPP1R16B;HMOX1;JCAD
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.4061712727041581,1.049033274641713,0.39751552795031053,0.871940787222231,1.0,6/27,11.82%,ZFP36;AGO2;STAT3;DDX5;DHX9;MAP2K2
prerank,negative regulation of protein processing (GO:0010955),0.4874864798137148,1.048831895044371,0.42196531791907516,0.8719314291338209,1.0,4/12,23.73%,PRNP;GAS1;TMEM59;SNX12
prerank,regulation of smoothened signaling pathway (GO:0008589),0.3722635076401286,1.0485930969530919,0.42598870056497173,0.8720351826450022,1.0,18/50,23.55%,TUBD1;KIF7;FGFR2;UCHL5;RORA;PDCL;BTRC;GAS1;RACK1;PTCH1;TULP3;DCDC2;MGRN1;GLI3;HERC4;KCTD21;TTC23;VCP
prerank,peptidyl-tyrosine modification (GO:0018212),0.3679372726313898,1.048039668020853,0.4172259507829978,0.8731040651229903,1.0,8/56,9.33%,TPST1;FLT1;KDR;HCK;EPHA4;FGFR2;LYN;INSR
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.375149100611226,1.0478954605467847,0.4055619930475087,0.8728992808397081,1.0,16/48,23.07%,PPCS;SLC26A1;ADCY5;ADCY10;SLC25A16;NPPC;SLC26A2;ADSL;PANK2;ACAT1;AMPD3;NPR2;AK5;DCAKD;PPCDC;ADCY7
prerank,cellular response to hydroxyurea (GO:0072711),0.49921379272341637,1.0478195465921236,0.4232488822652757,0.8725066884041214,1.0,4/10,18.94%,TIMELESS;DDX11;RTF2;DDI2
prerank,microvillus organization (GO:0032528),0.46200958567343314,1.0478055335490652,0.42257597684515197,0.8719309415208075,1.0,6/13,19.48%,RAPGEF6;RAPGEF2;TNIK;FXYD5;MINK1;RAP2A
prerank,mitotic cell cycle phase transition (GO:0044772),0.33175179842764724,1.0474194272778292,0.3949748743718593,0.872453939125753,1.0,49/203,18.82%,PKMYT1;CHMP4B;SKP1;CHEK2;ACVR1;CUL5;ARPP19;CDC25B;CCNJ;DYNC1H1;CCND2;GSPT1;CDKN2D;CACUL1;CCND1;ACTR1A;MAPRE1;TPD52L1;CDK5RAP2;PRKAR2B;TAF2;PLK3;MNAT1;BTRC;DNM2;PHLDA1;NEDD1;MAX;CEP131;CEP152;CDC16;CDC27;CEP70;AKAP9;RB1;DYNLL1;CCNI;KDM8;HSP90AA1;MASTL;USP37;TUBB4B;PPME1;PPP2R2A;DCTN3;PAFAH1B1;HINFP;BRSK1;CEP135
prerank,actin nucleation (GO:0045010),0.42520744811300853,1.046828203403899,0.40850515463917525,0.8735789628579547,1.0,7/21,22.76%,ACTR2;ACTR3;ARPC5;WHAMM;ARPC1B;JMY;IQGAP2
prerank,copper ion homeostasis (GO:0055070),0.4446212055489659,1.0468014933129721,0.4174757281553398,0.8730411910183418,1.0,8/17,25.59%,APP;PRNP;COX19;SLC31A1;SLC31A2;XIAP;COMMD1;ATP7B
prerank,intraciliary retrograde transport (GO:0035721),0.4821631463138002,1.046688051893054,0.42525399129172714,0.8727489034282256,1.0,7/12,26.75%,WDR35;DYNC2LI1;DYNLT2B;WDR19;DYNC2H1;IFT140;IFT43
prerank,signal transduction in response to DNA damage (GO:0042770),-0.2659917179583497,-1.045973954321384,0.37142857142857144,1.0,1.0,18/49,17.59%,MAP3K20;NBN;USP28;CEP63;BCL3;RHNO1;BATF;NDRG1;CASP9;DONSON;HUS1;RAD17;TP53;CLSPN;ACER2;E2F1;STK33;RAD1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4732166970422178,1.045775552543455,0.4172661870503597,0.8748022069093749,1.0,6/13,21.63%,BCL2L11;BAD;BMF;BAX;RHOT2;VDAC2
prerank,regulation of primary metabolic process (GO:0080090),0.33700357549874693,1.0452402315875364,0.40965092402464065,0.8757599637571553,1.0,44/126,25.95%,HELZ2;PSMB10;PSME2;PSMA5;PSME4;NCOA1;PSMA3;EDF1;RUBCNL;PSMB9;FDFT1;TGS1;PSMD2;AZIN1;PSME3;APOE;GGPS1;PSMA4;IRS2;PPARD;SREBF1;IDI1;LDLR;PSMD7;CERS2;PSMD8;PSMD9;NR1D2;PSMF1;ADIPOR1;PSMB6;TNFAIP8L3;PSMC2;PSMD12;HMGCS1;PSMD4;HMGCR;PSMA2;NCOR2;PRKAB2;BBS4;PLPP1;PSMD1;PSMD11
prerank,protein deacylation (GO:0035601),-0.32502078172009463,-1.0450440843225963,0.40310077519379844,1.0,1.0,7/23,10.91%,SIRT7;LYPLA1;SIRT1;LYPLAL1;ABHD17B;SIRT5;ABHD17C
prerank,endocytic recycling (GO:0032456),0.3697270409243928,1.04476739017329,0.41485714285714287,0.8765138065063675,1.0,21/50,26.19%,VPS51;VPS53;DENND1A;RAB11B;RAB14;ANKRD27;VPS50;VPS52;CMTM6;VPS26A;DENND1B;ENTR1;VPS35;ACAP2;STX6;VPS39;SNX17;SNX12;ARL4C;PTPN23;SNF8
prerank,lymphocyte differentiation (GO:0030098),0.35382210185580776,1.0444360629929512,0.3940724478594951,0.8768483380080312,1.0,17/68,21.27%,AXL;MSH2;PIK3CD;CHD7;LEPR;RELB;LMBR1L;IKZF1;NHEJ1;BLNK;PTPRC;ITGA4;KAT7;LCK;VCAM1;TPD52;RHOH
prerank,vasculogenesis (GO:0001570),0.3975413558078973,1.0444359011926836,0.41097560975609754,0.8762330058410082,1.0,5/32,9.08%,KDR;CUL7;WNT7B;ITGB8;EGFL7
prerank,cellular polysaccharide catabolic process (GO:0044247),0.44458283738188786,1.044173582693785,0.42075736325385693,0.8763918876630433,1.0,2/16,4.55%,AOAH;PGM2L1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3253990807518013,1.044152063483448,0.3863863863863864,0.8758382674457249,1.0,60/336,12.58%,IRF7;SAMHD1;PML;TAOK3;MSH2;DTX3L;MACROD1;ALKBH7;TIMELESS;CHEK2;CGAS;BCL2L11;PSME4;POLE2;APLF;RBBP5;MCM7;CHEK1;NOP53;UBE2B;IKBKE;CHD1L;RFC4;POLB;CCND1;ETAA1;HERC2;BCL6;MCM9;ZBTB38;BACH1;RTEL1;NFATC2;SLF2;RAD51C;ALKBH1;CHCHD6;RPAIN;FEN1;ERCC4;XRCC3;LYN;BARD1;POLK;PLK3;WDHD1;MEN1;MAPK14;MNAT1;WAC;VCPIP1;CIB1;ZC3H12A;NPM1;POLQ;DYRK2;PSEN1;PRKDC;ZRANB3;DDX11
prerank,glycosaminoglycan catabolic process (GO:0006027),0.359985271068372,1.0441131283259648,0.42454954954954954,0.875340283164227,1.0,10/55,10.66%,SPAM1;HYAL1;SDC3;STAB2;HYAL4;SDC4;FMOD;CSPG4;AGRN;HPSE
prerank,tRNA aminoacylation (GO:0043039),0.384636103925018,1.04388416109729,0.4121863799283154,0.8754291713241239,1.0,10/37,18.71%,VARS1;RARS1;HARS2;IARS2;AARS1;IARS1;NARS1;EEF1E1;YARS2;PPA1
prerank,pentose-phosphate shunt (GO:0006098),0.4842940975598639,1.0434462106798326,0.4223512336719884,0.8760685828851866,1.0,7/11,22.00%,PGD;PGLS;RPIA;DERA;RPE;TKT;TALDO1
prerank,membrane organization (GO:0061024),0.3302896227737417,1.0433183664045944,0.39354187689202824,0.8758122216766442,1.0,53/227,18.10%,CHMP4A;CHMP4B;TOR1AIP2;TOR1AIP1;CHMP1B;WNT5A;AZIN2;TGFA;ACTR2;LRP2;RTP4;SYNJ1;TLCD2;AP2A1;SH3GLB1;ACTR3;GAPVD1;CCDC88A;TIMM50;LPCAT2;VAPB;LDLRAP1;HSPA8;UBXN2B;ARRB2;FNBP1L;SNX9;AP2S1;NECAP1;DNM2;SUN2;CHMP3;ARPC5;PIP5K1C;VAMP2;REEP3;VTI1B;NPC1;NAPA;DAB2;ACTB;SNAP23;VAMP4;PLEKHA3;NUP155;SYNGR1;HGS;OCRL;EPN2;STON2;CORO1C;CHMP5;LDLR
prerank,toxin transport (GO:1901998),0.49711214969795914,1.0432706468148636,0.4333821376281113,0.8753444030105525,1.0,5/10,31.15%,ANTXR1;ANTXR2;RAB29;ADAM10;RAB40B
prerank,myotube differentiation (GO:0014902),-0.35145277309158063,-1.0432460150897873,0.3584905660377358,1.0,1.0,5/17,25.18%,KCNH1;JAM2;ADGRB3;MEF2C;NOS1
prerank,tRNA methylation (GO:0030488),0.3884877642241199,1.0427700478194113,0.4233490566037736,0.8761899974844092,1.0,12/34,22.65%,BCDIN3D;TRMT1;TRMT13;TRMT61B;THADA;TRMT10C;THUMPD3;TYW3;GTPBP3;METTL1;TARBP1;TRDMT1
prerank,toll-like receptor signaling pathway (GO:0002224),0.3438819357006063,1.0418861601230023,0.4200863930885529,0.8781501460350636,1.0,19/84,17.33%,PIK3AP1;CTSS;BIRC2;NMI;TLR8;UNC93B1;HMGB1;PIK3R4;TRAF3;TNIP1;IRAK4;BIRC3;TNIP2;MYD88;TLR2;TNIP3;IRAK1;LGALS9;TLR3
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3577428784505604,1.0418730370377518,0.41325966850828727,0.8775738901008281,1.0,17/66,20.50%,HYAL1;PSME2;PRMT2;RBL1;CCND2;CDKN2D;CCND1;TFDP1;DACT1;PSME3;RB1;DLG1;AIF1;BRD7;WEE1;APPL2;DDX3X
prerank,regulation of lipid storage (GO:0010883),0.4195047981821177,1.041833358945019,0.40878828229027964,0.8770655812776363,1.0,5/22,10.58%,ALKBH7;IKBKE;FBXW7;NFKB1;ZC3H12A
prerank,CENP-A containing chromatin organization (GO:0061641),-0.3072366414655436,-1.0417717657251122,0.37988826815642457,1.0,1.0,15/29,32.18%,CENPO;KNL1;CENPA;ITGB3BP;CENPL;MIS18BP1;CENPK;CENPU;CENPC;CENPX;CENPQ;CENPH;CENPI;MIS18A;CENPW
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.3072366414655436,-1.0417717657251122,0.37988826815642457,1.0,1.0,15/29,32.18%,CENPO;KNL1;CENPA;ITGB3BP;CENPL;MIS18BP1;CENPK;CENPU;CENPC;CENPX;CENPQ;CENPH;CENPI;MIS18A;CENPW
prerank,regulation of neutrophil migration (GO:1902622),-0.4264451577633343,-1.0415387518303867,0.3942307692307692,1.0,1.0,3/10,6.52%,MPP1;NCKAP1L;RAC2
prerank,sphingosine metabolic process (GO:0006670),0.4472700212593737,1.0414021397225754,0.43496503496503497,0.8777112233621369,1.0,6/17,21.47%,SGPP2;ASAH2;SPHK2;ACER3;SPTLC2;PLPP2
prerank,tight junction assembly (GO:0120192),-0.26824233781582624,-1.040313190229373,0.34782608695652173,1.0,1.0,23/49,35.32%,PAK2;ARL2;APC;PRKCI;F11R;ECT2;MARVELD2;LSR;STRN;CLDN14;PECAM1;ESAM;FRMPD2;RAMP2;OCLN;RAB13;PARD6A;CLDN18;PARD3;CLDN1;CDH5;MPP7;CLDN5
prerank,external encapsulating structure organization (GO:0045229),0.32795030522713203,1.0402508738773268,0.40483383685800606,0.8804974132640883,1.0,38/205,18.18%,COL13A1;ITGA2;COMP;KDR;ADAMTS3;COL9A1;MMP14;LAMC1;LAMB2;COL4A2;CD47;ITGAD;COL14A1;TNC;ITGA3;ITGB8;COL5A3;COL8A1;ADAMTS19;COL22A1;FBN1;MFAP5;SMOC2;APP;AGRN;GFOD2;COL3A1;ADAMTS2;COL11A2;ST7;ADAMTS6;NID2;ADAMTS12;JAM3;ITGA4;COL15A1;VIT;NF1
prerank,atrioventricular valve development (GO:0003171),0.46965761636961756,1.0399877318317143,0.42917847025495753,0.8806407288634867,1.0,4/14,15.33%,ACVR1;BMPR2;SLIT3;BMPR1A
prerank,mitotic recombination (GO:0006312),0.4454620341428641,1.0399601951289077,0.4169054441260745,0.8801142652773981,1.0,4/15,15.00%,TPRKB;XRCC3;NSMCE2;GEN1
prerank,embryonic organ morphogenesis (GO:0048562),0.3807555813432829,1.0398609192241586,0.4255813953488372,0.8797781151005238,1.0,6/42,8.81%,RARG;ACVR1;FGFR2;FBN1;MFAP5;HOXA9
prerank,homeostasis of number of cells (GO:0048872),-0.3923938027602488,-1.0398008583954124,0.4012738853503185,1.0,1.0,5/12,21.16%,NAPEPLD;CX3CR1;CARD9;OCIAD2;F2R
prerank,apical junction assembly (GO:0043297),-0.26217112642185614,-1.0396923964289888,0.4067796610169492,1.0,1.0,27/53,35.32%,CTNNA1;PAK2;ARL2;APC;PRKCI;RHOA;F11R;ECT2;MARVELD2;VCL;STRN;CLDN14;PECAM1;WDR1;ESAM;FRMPD2;RAMP2;OCLN;RAB13;PARD6A;CLDN18;PARD3;CLDN1;CDH5;RHOC;MPP7;CLDN5
prerank,protein O-linked glycosylation (GO:0006493),0.3445412175263805,1.0388878977839002,0.4281217208814271,0.8820961416073122,1.0,22/96,19.14%,ST6GALNAC4;TMTC1;POMT1;TRAK1;POMT2;GALNT7;GALNT15;ST6GAL1;GCNT4;GALNTL6;B4GALT5;ST3GAL1;XXYLT1;B3GLCT;GALNT18;CRPPA;TET2;GALNT1;TMTC4;GXYLT1;GALNT13;GALNT14
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3679305180189253,1.0384754471661959,0.41762013729977115,0.8827300446935665,1.0,12/47,16.02%,ZFP36;CDS1;SFRP2;MEDAG;AAMDC;FRZB;ZC3H12A;ZFP36L1;XBP1;PIM1;RREB1;PPARD
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.3778018096909503,1.038276242098862,0.42303172737955347,0.8826849112457933,1.0,11/41,21.95%,TRPM2;GRIN2D;SLC8A1;ITPR1;CHERP;HTR2A;TRPV4;PTPRC;ERO1A;LCK;FGF2
prerank,global genome nucleotide-excision repair (GO:0070911),-0.31031512879856493,-1.0382662931629507,0.3684210526315789,1.0,1.0,12/26,20.67%,PARP1;ERCC3;XPC;ERCC2;UBB;UBC;UBA52;RPS27A;ERCC1;GTF2H3;XPA;GTF2H4
prerank,regulation of ossification (GO:0030278),0.3878061062473599,1.0382260981497653,0.4241338112305854,0.8822234958012453,1.0,10/36,16.88%,WNT5A;ACVR1;SOX9;NBR1;ANKH;BMPR2;PTPN11;ENPP1;RBPJ;MDK
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.36229109347589383,1.0382235566638722,0.42841163310961966,0.8816189394152365,1.0,20/53,23.76%,PSMB10;PSME2;PSMA5;PSME4;PSMA3;PSMB9;PSMD2;BCKDK;AZIN1;PSME3;PSMA4;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4;PSMA2
prerank,regulation of lipid kinase activity (GO:0043550),0.47911680161803333,1.0381126066720092,0.446064139941691,0.88132895417298,1.0,4/11,20.37%,RBL1;RB1;WDR91;PPP2R5A
prerank,regulation of protein localization to membrane (GO:1905475),0.40273519905764354,1.038076790519297,0.42493638676844786,0.8808250390808811,1.0,8/28,14.33%,MMP14;STX7;STX8;LDLRAP1;GSN;VTI1B;ACTB;FYN
prerank,cellular protein modification process (GO:0006464),0.32173527048965794,1.0377603030839284,0.318,0.8811501303545806,1.0,259/982,22.55%,PARP14;EIF2AK2;PARP10;PARP9;ISG15;WNT11;LIPT1;LOXL2;ZC3HAV1;TAOK3;PSMB10;DAPK3;GLYCTK;UBE2L6;MACROD1;CAMK2D;TP53RK;RSKR;SKP1;FBXL16;GPAA1;SGK3;SGK2;PSME2;FASTK;PNPLA2;DCAF17;PIK3CD;BRD2;KLHL20;CAMK2B;PSMA5;CHEK2;ACVR1;CUL5;MAPK6;HASPIN;RCN1;FBXO7;PSME4;CDC25B;PTPN18;USP25;RBBP5;SERPINC1;STK38L;LAMC1;LAMB2;FEM1B;PKN2;ART4;HCK;COG3;CHEK1;IKBKE;ILF3;PEAK1;MORC3;FBXW7;TNC;CDK12;P3H1;PPP2R5C;PDXP;SBF1;MPI;MKNK1;PAK3;PTAR1;PSMA3;CUL7;SETD3;MT3;NRBP2;UBE2M;DUSP29;CSF1;RET;NAGPA;KLHL13;FBN1;SPSB1;FBXW8;FAM20B;GMFB;CAND1;RAB11B;SEPHS1;PSMB9;SIRT6;TIMM50;LTK;NGLY1;UCHL3;LYN;SOCS5;CLK3;MXRA8;B4GALT5;PTPN7;RBX1;APP;INSR;LRRC41;SRPK1;PIK3R4;BMPR2;UBE2E1;MEN1;ST3GAL1;WDR5;PRKAG1;CDK19;COPS7B;WSB2;TNIK;ELOC;BTRC;DAD1;DUSP26;PPM1F;FUT10;CDK10;ASB7;NUAK2;CDK20;PSMD2;BCKDK;COL3A1;SIK1;PDIA6;PIM1;PPP2R5D;B3GALNT1;NEK6;ASB10;DYRK2;PSME3;APOE;FBXL14;PPP4R2;KLHL9;PRKDC;SOCS2;UBE2L3;KTN1;FBXL19;DUSP10;PRKCE;GGCX;DUSP16;CLK2;NPC1;DCAF4;RPN1;DUSP11;JAK2;FYN;PSMA4;PRKCH;FAM20C;STK25;MINK1;BMPR1A;NRBP1;TAOK2;ARF4;ATE1;OXSR1;TIPARP;MSRA;RAB11A;MTOR;LMO7;TBCK;IRAK1;PTPN9;STK39;METAP2;CSK;PTPRU;ASB3;FBXL5;PPP2R2A;SPARCL1;BCR;JMJD4;ST8SIA1;PTPRC;SNRK;PRKG2;BIRC6;GAD1;ACVR2A;FUT9;FNIP2;COPS8;DUSP8;STT3B;PSMD7;MARK1;CTBP1;ASB1;SERP1;BRSK1;SOCS6;GLRX;NEK7;PSMD8;STK24;STK3;OGFOD1;CAMKK2;PTPRB;PSMD9;UBL5;PIGK;ERO1A;AAK1;ERN1;RAB1A;TGM2;FBXO30;ACVRL1;PSMF1;PTPRF;APLP2;PPP2R5A;TLK2;LCK;DDOST;LHPP;MAP4K2;YES1;STK11;SUMF1;PSMB6;PRKCD;CDK9;ABL2;PSMC2;NUB1;PSMD12;GCNT2;SENP8;AKT3;DCAF5;MAPK9;ASB13;COPS7A;HSP90B1;PIM3;MMP15;CDK8;CDK16;PPP2R3A;PTP4A2;RAB2A;FBXW2
prerank,regulation of axonogenesis (GO:0050770),0.37246118898000563,1.037710913555057,0.42214532871972316,0.8806816670998651,1.0,11/51,13.37%,PLXNA3;PLXNB2;THY1;RUFY3;PLXNB3;EPHA4;PAK3;MAG;CHN1;SIPA1L1;TIAM2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.4649298597173495,1.037643228152223,0.4222539229671897,0.8802629951690627,1.0,4/13,18.75%,DDX5;EEF1E1;SPRED3;SPRED1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.47239020589137204,1.0374512331830332,0.4272863568215892,0.880219117745327,1.0,5/12,15.10%,HSP90AB1;B4GALT5;HSP90AA1;MYCBP2;CHRNB2
prerank,mesenchymal to epithelial transition (GO:0060231),-0.4143392099935416,-1.0373992972905683,0.4006024096385542,1.0,1.0,5/10,33.97%,SALL1;FZD7;PAX8;BMP4;GATA3
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.39301815630543424,1.0372429181099838,0.44189016602809705,0.8802547931972383,1.0,7/31,14.36%,SEMA4D;SOX9;NBR1;BAMBI;MEN1;PTCH1;RANBP3L
prerank,negative regulation of nuclear division (GO:0051784),0.4690069389519014,1.0371581176006812,0.43434343434343436,0.8799098088600548,1.0,5/11,29.31%,CHEK1;AURKAIP1;TOM1L2;FBXO5;NME6
prerank,response to fatty acid (GO:0070542),0.4339686389810725,1.0368194040309822,0.44246575342465755,0.880276986480992,1.0,2/17,5.41%,IRS1;SOX9
prerank,DNA recombination (GO:0006310),0.379683650393253,1.036794880139915,0.4227053140096618,0.8797462108115922,1.0,9/37,15.29%,MSH2;RTEL1;RAD51C;RPAIN;XRCC3;HMGB1;HMGB3;GEN1;RECQL5
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.38279653097653304,-1.0367746950386565,0.3881578947368421,1.0,1.0,4/12,13.06%,SMARCA4;ZBTB7A;SIRT1;FOXP1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.37159830202826877,1.0360554287742592,0.4254335260115607,0.8812628179062336,1.0,10/44,15.41%,AGT;SPRY2;PAQR3;LYN;SORL1;APOE;DUSP10;PIK3CB;INPP5K;CD300A
prerank,chromatin assembly (GO:0031497),0.3819199981325128,1.0356689172163391,0.4141656662665066,0.8817839962982336,1.0,7/38,11.05%,DAXX;BRD2;NAP1L2;SOX9;CHAF1B;NPM1;CTCF
prerank,negative regulation of anoikis (GO:2000811),0.45529354792676335,1.0356469587252313,0.43686502177068215,0.8812463951423021,1.0,6/14,27.50%,PTRH2;SNAI2;MCL1;NOTCH1;PIK3CA;ITGB1
prerank,morphogenesis of an epithelium (GO:0002009),0.41023374155068404,1.035367265152675,0.4316069057104914,0.8814834458232784,1.0,3/25,5.98%,TIMELESS;SOX9;FGFR2
prerank,negative regulation of response to wounding (GO:1903035),0.42863370366451253,1.0352628440405867,0.42955801104972374,0.8811640217633575,1.0,9/19,26.88%,EPHA4;GIT1;CRK;MDK;CERS2;RTN4RL1;FGF2;PTPRS;AJAP1
prerank,ncRNA catabolic process (GO:0034661),-0.3011034772718393,-1.0352030611602259,0.36574074074074076,1.0,1.0,10/28,18.88%,EXOSC7;EXOSC10;RBM7;DIS3;DIS3L;EXOSC5;EXOSC3;DEDD2;TENT4B;NUDT16L1
prerank,cellular amide metabolic process (GO:0043603),0.3381179439546974,1.0351784901341268,0.41631799163179917,0.8808099985021455,1.0,26/102,21.98%,MTHFR;DHFR;ACOT9;ASAH2;NSMAF;SLC46A1;SLC19A1;ACBD6;ABCB9;ST6GAL1;NLN;AEBP1;ST3GAL1;ACOT13;GNE;SHMT1;PANK2;MCCC1;MIPEP;MTHFD1;SGPL1;OXSM;PLA2G4E;SLC5A6;PLPP2;NIT1
prerank,DNA duplex unwinding (GO:0032508),0.36580014182695614,1.0347706631474667,0.42482915717539865,0.8814017891968597,1.0,10/50,9.88%,ASCC3;MCM2;MCM7;CHD1L;MCM4;MCM9;RTEL1;DHX9;RBX1;TWNK
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.42653759079778775,1.0340822333233752,0.4381868131868132,0.8827927001624418,1.0,4/19,9.06%,SLCO1C1;NFKB1;TMEM106A;APP
prerank,reticulophagy (GO:0061709),-0.3802621248758158,-1.0339419364066402,0.40268456375838924,1.0,1.0,5/12,8.91%,UBA5;ULK2;UFM1;ATG2B;ATG2A
prerank,Wnt signaling pathway (GO:0016055),0.34034536989595626,1.0337000592452206,0.4247881355932203,0.8832986891862032,1.0,12/92,10.35%,WNT11;SKP1;WNT5A;RARG;SFRP2;CTNNB1;TCF7L2;WNT7B;FRZB;RBX1;USP34;BTRC
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.39868688886856557,1.033662821997348,0.44165621079046424,0.8828133198926896,1.0,5/26,10.66%,HYAL1;CCND2;CCND1;TFDP1;CDK10
prerank,phosphatidylinositol metabolic process (GO:0046488),0.33971875086565945,1.0336259683973494,0.44780793319415446,0.8823032805521661,1.0,24/109,15.22%,PIGW;ARF3;PIK3CD;SLC27A1;CDS1;SYNJ1;PLA2G12A;PITPNM1;SBF1;PIP5K1A;PLCB3;PI4KB;PIK3R4;CDIPT;RAB14;PLEKHA1;PIK3CB;PIP5K1C;INPP4B;PLEKHA4;PLEKHA3;LPGAT1;INPP5K;MTMR14
prerank,extracellular structure organization (GO:0043062),0.3259392688304073,1.0334606443382341,0.4305835010060362,0.8821777587614801,1.0,38/204,18.18%,COL13A1;ITGA2;COMP;KDR;ADAMTS3;COL9A1;MMP14;LAMC1;LAMB2;COL4A2;CD47;ITGAD;COL14A1;TNC;ITGA3;ITGB8;COL5A3;COL8A1;ADAMTS19;COL22A1;FBN1;MFAP5;SMOC2;APP;AGRN;GFOD2;COL3A1;ADAMTS2;COL11A2;ST7;ADAMTS6;NID2;ADAMTS12;JAM3;ITGA4;COL15A1;VIT;NF1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.37749714578959137,1.0331538506998046,0.4294330518697226,0.8824913497785486,1.0,8/36,7.97%,BDNF;ASAH2;CX3CL1;TRIM39;CYLD;CSNK2A2;PPIA;TPD52L1
prerank,proteolysis (GO:0006508),0.3246327613869192,1.0331277001446388,0.4088176352705411,0.8819641227459338,1.0,46/252,18.40%,CASP4;CASP7;ADAM33;SPPL2A;LAP3;CTSS;ADAMTS3;USP25;MMP14;TMPRSS5;CASP6;LONP2;UBE3A;ERAP1;CUL7;RET;CPQ;RSPRY1;CTSC;NLN;CTSH;DPP3;AEBP1;PCSK7;SPCS1;ADGRV1;LONP1;PSEN1;NPEPPS;CAPN1;PITRM1;PTCH1;NAPSA;SPPL3;APH1A;APH1B;CAPN5;HTRA3;ADAMTS12;SPRTN;LRP8;METAP2;MIPEP;FOLH1;HM13;SVBP
prerank,regulation of cellular biosynthetic process (GO:0031326),0.3993498857214925,1.0330699670651609,0.42909987669543775,0.8815236428919577,1.0,10/28,21.20%,CD47;CCL5;MITF;EIF6;RAC1;CTNS;JAK2;SIRPA;ADIPOR1;MFSD12
prerank,atrial septum morphogenesis (GO:0060413),0.49733849249161804,1.0326696740154955,0.4652173913043478,0.8820526512509439,1.0,2/10,9.53%,ACVR1;BMPR2
prerank,response to organic cyclic compound (GO:0014070),0.36221909926873497,1.0321654667340523,0.4231651376146789,0.8828714109271152,1.0,12/52,17.33%,DHFR;TRPM2;STAT3;CCL5;CDKN2D;CTNNB1;GGT7;SOCS2;CHRNB2;TIPARP;IL18;TLR3
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.48060025051988564,1.0321543597038723,0.41363636363636364,0.8823106058528278,1.0,2/10,5.48%,CTNNB1;CX3CL1
prerank,regulation of neurogenesis (GO:0050767),0.3598270133073105,1.032137537093835,0.43626373626373627,0.881755327694864,1.0,11/55,13.62%,PER2;B2M;LRP2;BHLHE40;CTNNB1;CX3CL1;YTHDF2;SNW1;SORL1;HOOK3;NUMBL
prerank,positive regulation of DNA repair (GO:0045739),0.3705070590191661,1.0321045728934317,0.4297520661157025,0.8812531979529088,1.0,20/46,28.16%,EYA4;TMEM161A;TIMELESS;SLF2;DHX9;HMGB1;DDX11;ZCWPW1;EYA2;BABAM2;SLF1;SMCHD1;TIGAR;XRCC1;TRIM28;EYA3;FMN2;EYA1;UBE2N;BABAM1
prerank,thyroid hormone generation (GO:0006590),0.4881455015775747,1.0318163175964967,0.4311111111111111,0.8814705154453346,1.0,2/10,9.77%,CPQ;TG
prerank,response to growth factor (GO:0070848),0.3767737771816571,1.0318044556198218,0.45539906103286387,0.8809135350369385,1.0,11/41,20.16%,CPNE3;ACVR1;LRP2;CTNNB1;BMPR2;CIB1;RACK1;SOX2;BMPR1A;ACVR2A;ACVRL1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.32065176458676414,1.03167862233994,0.4044044044044044,0.8806574644263878,1.0,60/348,15.60%,IRGM;IL15;AGT;SPRY2;KDR;DAXX;BDNF;DDRGK1;GDF9;SEMA4D;CD40;ACVR1;LCP2;S1PR2;SFRP2;MAD2L2;CCND2;HSP90AB1;CACUL1;SOX9;CX3CL1;CCND1;TNKS1BP1;TRAF4;MYDGF;CAB39;MT3;MAP2K3;CSF1;CSNK2B;AGAP2;PPIA;MTCP1;RAPGEF2;CSPG4;LYN;LEPR;APP;INSR;PRNP;BMPR2;PRKAG1;TNIK;SNX9;CIB1;VEGFD;FGF9;PTPN11;AKAP9;RACK1;NRP1;RAC1;DAB2;JAK2;RB1CC1;HSP90AA1;NPTN;CALM3;BMPR1A;TAOK2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.3596565866000296,1.0314954908871834,0.4176931690929451,0.8805747901288491,1.0,19/55,22.66%,PSMB10;SKP1;PSME2;PSMA5;PSME4;PSMA3;PSMB9;RBX1;PSMD2;PSME3;PSMA4;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4
prerank,ion transport (GO:0006811),0.3395837943269052,1.0314001779884068,0.4439746300211416,0.8802385917882819,1.0,20/111,16.45%,CNGB1;SLC25A22;AQP11;SLC26A1;SLC8A1;SLC15A3;SLC15A2;PANX2;SLC12A5;LASP1;SLC25A10;TRPM3;PANX1;SLC26A2;ANO10;TSPO;CTNS;CHRNB2;SLC24A3;SLC4A2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4526678449691445,1.031377834335293,0.4410029498525074,0.8797090213278216,1.0,4/13,16.02%,SOX9;SRF;NFIB;PPARD
prerank,macrophage migration (GO:1905517),0.4600906403956315,1.0310032294070208,0.42574257425742573,0.880163540332785,1.0,4/13,12.39%,CCL5;TAFA4;P2RX4;CXCL17
prerank,mitochondrial translation (GO:0032543),0.3375230754631314,1.0309342221389013,0.4328042328042328,0.8797606188280744,1.0,27/104,19.21%,MRPL36;IARS2;ERAL1;MTIF3;MRPS30;MRPL12;MRPL16;MRPS35;MRPS28;GFM1;TUFM;MRPL42;MRPL4;MRPS23;MRPS2;MRPS22;AURKAIP1;NOA1;MRPL24;MRPS10;MRPL13;MTRF1L;MRPL57;FASTKD2;MRPS11;MRPL40;MRPL22
prerank,regulation of immune effector process (GO:0002697),0.37163159853949695,1.0306939142097327,0.4372093023255814,0.8798824062467038,1.0,7/41,16.22%,CLU;C4B;CD55;SUSD4;C3AR1;FCGR2B;C1QB
prerank,motile cilium assembly (GO:0044458),0.470278857927824,1.0302998278439572,0.45894428152492667,0.8803690095033936,1.0,3/12,12.97%,CCDC40;SPATA6;E2F4
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.3882879312350376,1.0302399017459323,0.43200962695547535,0.8799546048996046,1.0,16/35,27.24%,HSP90AB1;CSNK2B;MAGI2;PPP6R3;PPP1R11;MASTL;CALM3;CD300A;MTOR;TSC1;HSP90B1;PPP1R12A;CALM2;TIPRL;BOD1;FKBP1A
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.4461378156330865,1.0300523084795308,0.44,0.8798924218586687,1.0,6/16,15.91%,RBMX;SNW1;DAZAP1;NCBP1;RBM3;SF3B4
prerank,regulation of macrophage cytokine production (GO:0010935),-0.37958366121539944,-1.0300283163206425,0.40634920634920635,1.0,1.0,4/13,8.41%,TGFB1;IRAK3;SIRT1;TGFB2
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.4281932887378769,1.0299712910121235,0.4355263157894737,0.8795267853417439,1.0,7/19,23.22%,RUNX1;FGFR2;PIM1;BMPR1A;RBPJ;FGF2;NOTCH1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.4542781441333728,1.0299536220079017,0.4391304347826087,0.8789830100120384,1.0,5/14,17.84%,DDX18;NOL9;RPL7L1;ZNHIT3;WDR12
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.35313325376522114,1.0293699877838574,0.4433551198257081,0.8800229754805973,1.0,18/74,21.81%,LOXL2;SPRY2;SFRP2;MAD2L2;CTNNB1;SMAD2;BAMBI;PDPN;PHLDB1;DAB2;EZH2;MTOR;MDK;SPRED3;SPRED1;ADIPOR1;USF3;GCNT2
prerank,organelle organization (GO:0006996),0.3209259496454996,1.0286083774265957,0.40681362725450904,0.8816532636558827,1.0,115/388,23.27%,CHMP4A;CHMP4B;VPS51;TOR1AIP2;MTFR2;CCL7;FMNL2;BLZF1;CHMP1B;AUP1;KLHL20;TJAP1;ATL1;YTHDF1;CNTNAP1;THY1;PEX7;COG3;GOLGA5;GOLGA8B;CHCHD10;LONP2;BRWD3;SEC16A;POLG2;SPRYD3;PRPF40A;ANK1;ARHGEF7;STX7;CUL7;TFB2M;ARHGAP4;VPS11;TMED5;ATAD3A;FBXW8;PPIA;DOP1B;RAB43;YTHDF2;ZMYM3;VAPB;ABCD1;PEX2;MAST3;TWNK;UBXN2B;TNIK;TMED10;PHIP;FNBP1L;TRAPPC12;ATXN7;COG2;RAB14;DNAJA3;ARL1;CHMP3;FAF2;LONP1;CAPZB;ARHGAP21;ARHGAP10;PPARGC1A;APOE;FGD6;NCKIPSD;ZRANB1;AFG1L;PLEKHM2;VPS13D;STX4;ZMYM6;RAB32;DYNC2H1;MDK;CHCHD2;TMED1;PLCE1;SH3D19;TMED3;RHOT2;CHMP5;GBF1;FMNL3;GABPB1;GOLPH3L;MARK1;NUMA1;SIPA1L3;TTC17;RANBP9;VPS13C;GORASP2;RAB1A;VPS18;PNPLA3;ABCD4;TMED7;OPTN;ADCK1;MTX1;HUWE1;CHMP1A;ATP5F1B;RAB2A;PRDX3;PTCD2;SSBP1;OPA1;PAK5;RAB29;LIMD1;PCLO
prerank,negative regulation of bone mineralization (GO:0030502),-0.3833623440377948,-1.0284708793190676,0.421875,1.0,1.0,5/13,16.64%,SRGN;TRPM4;CCL3;CCR1;ECM1
prerank,sterol metabolic process (GO:0016125),0.35722146786163034,1.0283013838692145,0.43937708565072303,0.8819581286779555,1.0,17/60,23.26%,ABCA1;ABCG1;CH25H;CYP26B1;LDLRAP1;STARD3;CYP27A1;APOE;PPARD;SOAT2;SOAT1;EBP;GBA2;CYP39A1;ABCA5;HMGCR;CLN6
prerank,myoblast differentiation (GO:0045445),0.4459598583073964,1.0282913450679212,0.44490358126721763,0.8814014087191371,1.0,4/14,18.44%,DDX5;TCF7L2;RB1;HINFP
prerank,cell cycle G2/M phase transition (GO:0044839),0.33443392454362125,1.0281612837332275,0.4492307692307692,0.8811739532885497,1.0,33/129,18.82%,PKMYT1;SKP1;CHEK2;ARPP19;CDC25B;DYNC1H1;ACTR1A;MAPRE1;TPD52L1;CDK5RAP2;PRKAR2B;TAF2;PLK3;MNAT1;BTRC;DNM2;PHLDA1;NEDD1;CEP131;CEP152;CEP70;AKAP9;DYNLL1;KDM8;HSP90AA1;MASTL;TUBB4B;PPME1;PPP2R2A;DCTN3;PAFAH1B1;BRSK1;CEP135
prerank,regulated exocytosis (GO:0045055),0.32576162079475995,1.0279672024861677,0.4475806451612903,0.8811562695254286,1.0,23/173,13.50%,LGALS3BP;CLTRN;CLU;ACTN1;ACTN2;LAMP2;MAGED2;CRHBP;CPLX1;CDC37L1;SYT7;ISLR;RAB11B;SYT3;LYN;APP;SCCPDH;TMED10;VEGFD;CHID1;PIP5K1C;VAMP2;VTI1B
prerank,extracellular matrix organization (GO:0030198),0.32181788619264445,1.027871942832838,0.4126506024096386,0.880846758326608,1.0,41/276,13.03%,LOXL2;HAS3;COL13A1;CTSS;ITGA2;COMP;KDR;P4HA1;ADAMTS3;COL9A1;HAS1;MMP14;ADAM8;LAMC1;LAMB2;COL4A2;CD47;ITGAD;COL14A1;TNC;P3H1;ITGA3;ITGB8;COL5A3;COL8A1;ADAMTS19;COL22A1;FBN1;MFAP5;SMOC2;APP;SCX;AGRN;GFOD2;TIMP2;COL3A1;GSN;CAPNS1;ADAMTS2;COL11A2;CAPN1
prerank,regulation of complement activation (GO:0030449),0.374410846605791,1.0277755081907403,0.43617021276595747,0.8805088299739976,1.0,5/40,10.19%,CLU;C4B;CD55;SUSD4;C3AR1
prerank,positive regulation of insulin secretion (GO:0032024),0.38328657465117894,1.0276326115757994,0.46033653846153844,0.880310718071788,1.0,10/36,20.53%,CLTRN;TCF7L2;BAIAP3;MYRIP;BAD;STX4;IRS2;GLUD1;PSMD9;PLA2G6
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.45789463124210084,1.027424649574912,0.4556040756914119,0.8803103964589142,1.0,2/13,4.97%,RGPD1;KPNB1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.46517696129056496,1.0272988686599192,0.4578488372093023,0.8800825696987009,1.0,4/13,13.86%,NOL9;RPS21;RRS1;KRI1
prerank,limb morphogenesis (GO:0035108),-0.3273871928574764,-1.0272448911908685,0.4083333333333333,1.0,1.0,4/20,8.41%,FBXW4;LRP6;NIPBL;TGFB2
prerank,antibacterial humoral response (GO:0019731),0.43957595776054903,1.0268627556393466,0.43351800554016623,0.880761119290038,1.0,6/16,24.23%,SLPI;RNASE7;PLA2G6;ANG;CAMP;RNASE3
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.39756573923772387,-1.0267759649386512,0.37770897832817335,1.0,1.0,3/11,12.51%,TGFB1;TGFB2;EFNB2
prerank,pseudouridine synthesis (GO:0001522),0.46294201659225576,1.0264795976605383,0.4514285714285714,0.8811928522917019,1.0,5/13,24.55%,PUS7L;GAR1;PUS7;PUS10;NHP2
prerank,positive regulation of telomere maintenance (GO:0032206),0.3869438825744384,1.0263771843007026,0.45724907063197023,0.8808660589319184,1.0,6/31,9.62%,PML;DHX36;RTEL1;HNRNPA2B1;SIRT6;PPP1R10
prerank,apoptotic cell clearance (GO:0043277),-0.28815854658697276,-1.0262282979651738,0.41578947368421054,1.0,1.0,13/30,21.01%,ITGAV;XKR6;RAC2;RHOBTB2;SCARB1;RARA;XKR4;TREM2;RHOBTB1;TYRO3;ITGB3;ANXA1;NR1H3
prerank,dopamine metabolic process (GO:0042417),-0.3421741530570934,-1.0256624315171228,0.3978102189781022,1.0,1.0,11/18,36.29%,SNCAIP;SNCA;TGFB2;MAOA;MAOB;DRD2;MOXD1;PRKN;DRD3;LRTOMT;DAO
prerank,homologous chromosome segregation (GO:0045143),0.4210615666797379,1.0254708122453986,0.4427994616419919,0.882918822624767,1.0,1/20,0.40%,SYCP1
prerank,protein autophosphorylation (GO:0046777),0.3292753343402748,1.0253952737163505,0.4462474645030426,0.882531295067122,1.0,32/157,16.64%,EIF2AK2;TAOK3;FLT1;DAPK3;CAMK2D;KDR;CAMK2B;CHEK2;HCK;PEAK1;CDK12;EPHA4;MKNK1;FGFR2;HTATIP2;LYN;INSR;TNIK;SIK1;PIM1;MAP2K2;NEK6;CLK2;JAK2;STK25;MINK1;TAOK2;OXSR1;FGFR3;MTOR;IRAK1;STK39
prerank,response to amyloid-beta (GO:1904645),0.37172810560245817,1.0252260707382435,0.44565217391304346,0.882421533309083,1.0,9/44,14.33%,CASP4;EPHA4;CACNA1A;APP;PRNP;ABCC1;PSEN1;FCGR2B;FYN
prerank,protein localization to cell junction (GO:1902414),-0.3188924686287363,-1.0246499706049306,0.3829787234042553,1.0,1.0,5/22,8.00%,KIF3A;DLG4;NECTIN1;PAK2;NLGN2
prerank,regulation of cell killing (GO:0031341),0.43108541989666627,1.0245268049565077,0.44521497919556174,0.8837492055191398,1.0,2/16,2.89%,WNT5A;CD55
prerank,positive regulation of interferon-gamma production (GO:0032729),0.36460426048936573,1.0241885299252538,0.46449359720605354,0.8841219980230063,1.0,10/48,20.86%,ISG15;TLR8;IL27;CD276;IL12RB2;IL18;LGALS9;TLR3;PDE4B;EBI3
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.32094238114273177,-1.0240969955329369,0.4109090909090909,1.0,1.0,11/21,21.20%,PPARG;NFKBIA;RXRA;SIRT1;EEPD1;TREM2;PLTP;ABCA7;ABCA3;NR1H3;CAV1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.3887136320696869,1.0240849359144033,0.47395171537484115,0.8838058708273925,1.0,8/29,18.10%,NR1H2;SLC27A1;SLC45A3;APOE;LPGAT1;MTOR;SREBF1;LDLR
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.41725272514298706,1.024082047149099,0.4325032765399738,0.883225609226202,1.0,8/22,25.43%,CCL5;IL10RA;IL10RB;MGAT5;NOTCH1;CRLF3;OCIAD1;TNF
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.4116651873124799,1.0239239153197603,0.469281045751634,0.8830865235301025,1.0,6/25,20.62%,AGT;DOK1;CCDC88A;RBPJ;ARAP1;PLAUR
prerank,regulation of muscle contraction (GO:0006937),0.4030268233750513,1.0236576891525595,0.43147208121827413,0.8832443523433282,1.0,3/26,5.30%,DAPK3;MYL9;TNNC1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.4724104571354539,1.0235381510682984,0.45252225519287836,0.8829973056729963,1.0,6/12,22.12%,PCGF5;CDYL;RBM15;LRIF1;SMCHD1;PCGF3
prerank,regulation of chromosome organization (GO:0033044),-0.31380531743873863,-1.0234017361706325,0.3547008547008547,1.0,1.0,5/22,7.70%,WAPL;XRCC5;CENPV;TERF2IP;YLPM1
prerank,positive regulation of cell differentiation (GO:0045597),0.32212146748718407,1.0225201599909242,0.44332998996990974,0.8852764270362146,1.0,48/237,16.89%,LOXL2;AGT;KDR;ZFP36;CDS1;ACVR1;KITLG;SFRP2;MEDAG;ZHX3;BRINP3;AAMDC;DHX36;HSP90AB1;SOX9;CTNNB1;TCF4;NFKB1;WNT7B;CSF1;SRF;FRZB;SMAD2;RAPGEF2;BAMBI;GDNF;PDPN;BMPR2;MAPK14;ZC3H12A;ZFP36L1;XBP1;RIN2;NELL1;DAB2;RANBP3L;PRKCH;EZH2;BMPR1A;SOX5;SPAG9;MEF2A;PPARD;SMYD1;IL18;MTOR;MDK;PCP4
prerank,peptidyl-asparagine modification (GO:0018196),-0.2848238010412642,-1.0223476272150045,0.4327485380116959,1.0,1.0,11/31,20.10%,ALG5;DPM1;UBE2J1;TUSC3;UGGT2;HIF1AN;STT3A;RPN2;FUT8;DPM3;MGAT2
prerank,glycolytic process (GO:0006096),-0.2977012889282373,-1.022084161086413,0.42328042328042326,1.0,1.0,8/28,10.78%,ENO1;PFKL;PGAM1;PGAM4;PKM;PFKFB2;ENO2;PGK1
prerank,regulation of leukocyte activation (GO:0002694),-0.3630872586906578,-1.0220331224843344,0.4124087591240876,1.0,1.0,6/14,17.02%,GPR137B;MYO18A;PLSCR1;MIF;PJA2;SHPK
prerank,cellular biogenic amine catabolic process (GO:0042402),0.48123197720502686,1.0219669670269107,0.4382530120481928,0.886207639588761,1.0,4/10,20.20%,SMOX;ALDH7A1;COMT;SLC44A1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.32472352633897483,1.021767838264958,0.46808510638297873,0.8861736409071457,1.0,49/168,21.12%,HELZ2;POLR2G;ZFP36;XRN2;RPL36;DDX5;MAGOHB;SMG7;CNOT4;CNOT7;NCBP2;GSPT1;RPL22;XRN1;TNKS1BP1;RPS21;DCP2;ZC3H12A;ZFP36L1;RNPS1;SMG5;UPF2;UPF3A;RPS6;DIS3L2;EXOSC9;PATL2;RPS11;RPL30;ETF1;NCBP1;RPL32;RPL23A;RPL11;TUT7;UPF1;RPL10A;PPP2R2A;RPS15A;DCPS;RPL24;PAN3;RPL37A;RPL3;RC3H2;CSDE1;RPL29;MTPAP;RPL5
prerank,dorsal/ventral pattern formation (GO:0009953),0.42256374288835363,1.0217594742155676,0.45225464190981435,0.8856176527040255,1.0,7/20,23.94%,ACVR1;MDFI;PTCH1;BMPR1A;DSCAML1;ACVRL1;LMX1B
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.28886877222545865,-1.0216554443674448,0.4117647058823529,1.0,1.0,13/32,18.28%,POLR1A;MAPK3;ERCC3;TBP;ERCC2;RRN3;TAF1D;TAF1;POLR2F;POLR1C;TAF1A;POLR1H;GTF2H3
prerank,protein localization to cell surface (GO:0034394),0.3967007687662402,1.0215540741178,0.43908629441624364,0.8856085517721127,1.0,7/26,19.58%,WNT11;CTNNB1;GGA3;SMURF1;JAM3;PTPRU;PIGK
prerank,negative regulation of biosynthetic process (GO:0009890),0.4401219700552298,1.0214978402216492,0.46354883081155435,0.885175248557867,1.0,3/16,9.46%,SLC18A2;ASXL3;ABCD1
prerank,synaptic vesicle cycle (GO:0099504),0.3930597670983243,1.0213410883010836,0.45633456334563344,0.8850409867234148,1.0,14/30,28.33%,SLC18A2;CPLX1;SYT7;PIP5K1C;VAMP2;SLC32A1;BRSK1;PCLO;RAB3A;DNAJC5;PLD2;CDK5;CPLX2;SYNDIG1
prerank,negative regulation of MAPK cascade (GO:0043409),0.33912576958710144,1.020935135933679,0.45483528161530284,0.8856446712830582,1.0,25/87,19.95%,AGT;SPRY2;DUSP3;IGBP1;DUSP29;PPIA;PAQR3;CNKSR3;LYN;TNIP1;DUSP26;SORL1;APOE;DUSP10;PIK3CB;DLG1;INPP5K;CD300A;SPRED3;PTPRC;NF1;SPRED1;PIN1;RANBP9;SIRPA
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3378516231425638,1.0209333147358495,0.45454545454545453,0.8850690932532183,1.0,23/80,22.47%,PLXNB2;ABCG1;CLU;YTHDF1;NSMAF;ZCCHC4;EPHA4;SPHK2;NPM1;EIF6;LRRTM3;PRKDC;UPF3A;RACK1;RBM3;MTOR;METTL14;IFNGR1;DDX3X;PLA2G6;RPL5;PRKCD;PYM1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.4714205610425923,1.020645127282377,0.4563253012048193,0.8852923626467262,1.0,1/12,1.21%,CAMK2D
prerank,polyol metabolic process (GO:0019751),0.36008856903502867,1.0204827459444994,0.4471264367816092,0.8851695724363514,1.0,11/46,18.98%,PLCB4;ITPKC;SYNJ1;PPIP5K1;ITPK1;PLCB3;INPP4B;OCRL;NUDT4;PLCE1;MINPP1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.34406459001202194,1.0198010682179537,0.4503735325506937,0.8865028192324068,1.0,15/78,17.56%,PKMYT1;CCNJ;CCND2;CDKN2D;CCND1;CCNT2;CNPPD1;MEN1;MNAT1;PROX1;CCNI;ACTB;SERTAD1;CCNK;CDC37
prerank,chromatin organization (GO:0006325),0.32979461423332956,1.0197057361293782,0.46098562628336753,0.8861761552373424,1.0,30/132,17.11%,LOXL2;GATAD1;HMGN3;DAXX;LRWD1;CHD1L;SOX9;ARID1A;KDM4D;SMARCE1;SMARCC2;NUDT5;MTA2;TADA2A;TADA2B;BPTF;NPM1;SETD5;SETDB2;HCFC2;DDX11;RB1;HDAC8;SMARCA1;SOX2;EZH2;MYB;SMARCD2;INO80C;MPND
prerank,regulation of ruffle assembly (GO:1900027),0.41022660420403884,1.0196766934374941,0.463768115942029,0.8856895350892664,1.0,5/23,12.01%,EVL;P2RX4;KANK1;DEF8;STAP1
prerank,negative regulation of mRNA processing (GO:0050686),0.4370232702196786,1.0191317486930873,0.4380053908355795,0.8866421196417783,1.0,6/15,17.10%,RBMX;BARD1;RNPS1;SRSF7;SRSF4;PCBP4
prerank,regulation of microtubule-based movement (GO:0060632),0.4702238577124801,1.0187636074931647,0.450229709035222,0.8870879916281231,1.0,4/11,23.75%,IGBP1;DYNLT2B;LAMP1;HDAC6
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.37749152112500556,1.01866849802293,0.4367396593673966,0.8867453983244258,1.0,7/34,18.54%,NOD2;WNT5A;SPHK2;XBP1;STX4;PTPRC;LACC1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.4647879384790071,1.0183717778576555,0.4535928143712575,0.8870273778803089,1.0,3/11,20.64%,BMPR1A;LGALS9;CD46
prerank,vascular transport (GO:0010232),0.3397321033086386,1.0179923850600536,0.44994617868675996,0.8875324013243031,1.0,13/81,11.17%,ABCC2;SLC27A1;SLCO1C1;SLC38A2;SLC38A1;LRP2;SLC15A2;ATP8A1;SLC19A1;SLC38A3;LEPR;INSR;ABCC1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.3554520597236467,1.017767082361807,0.44685714285714284,0.887577794025183,1.0,5/52,6.99%,MTHFR;DHFR;SLC46A1;SLC19A1;IDH1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.36231326351606197,1.0175016179494447,0.45359628770301624,0.8877304348876687,1.0,15/46,19.95%,SPRY2;DUSP3;DUSP29;CNKSR3;LYN;TNIP1;DUSP26;DUSP10;DLG1;SPRED3;PTPRC;SPRED1;PIN1;RANBP9;SIRPA
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.37152556550011906,1.0172162642383153,0.4617253948967193,0.8879691900634432,1.0,6/38,10.95%,STAT1;TRIM39;RORA;TNIP1;ZC3H12A;RIOK3
prerank,transport across blood-brain barrier (GO:0150104),0.33914994549691957,1.0171450127521875,0.4536637931034483,0.8875953412108764,1.0,13/83,11.17%,ABCC2;SLC27A1;SLCO1C1;SLC38A2;SLC38A1;LRP2;SLC15A2;ATP8A1;SLC19A1;SLC38A3;LEPR;INSR;ABCC1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3471788816867138,1.0170704778925261,0.46304347826086956,0.8872154481422266,1.0,23/70,16.07%,MYO1C;ELMO2;ACTR2;HCK;HSP90AB1;CYFIP1;ACTR3;NCK1;LYN;FCGR1A;VAV1;ARPC5;PRKCE;FCGR2B;PIK3CB;NCKIPSD;RAC1;ACTB;FYN;MYH2;HSP90AA1;CRK;BAIAP2
prerank,barbed-end actin filament capping (GO:0051016),-0.345465841661437,-1.0170104097732984,0.4185022026431718,1.0,1.0,3/18,13.01%,ADD1;EPS8;CAPG
prerank,actin filament capping (GO:0051693),-0.345465841661437,-1.0170104097732984,0.4185022026431718,1.0,1.0,3/18,13.01%,ADD1;EPS8;CAPG
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.38023669862222376,1.0169426351467068,0.4411764705882353,0.8869907178575279,1.0,3/30,2.85%,FLT1;KDR;SBDS
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.3758302680436264,-1.0167933304261556,0.43812709030100333,1.0,1.0,8/13,30.68%,SHISA9;SHISA6;CLN3;SHISA7;SLC8A2;PPFIA3;SHISA8;SLC4A10
prerank,regulation of lipase activity (GO:0060191),-0.37763834517434053,-1.0167383367353409,0.4019607843137255,1.0,1.0,4/13,14.63%,SNCA;PCSK6;RHOA;LPL
prerank,bone development (GO:0060348),0.3724183166259347,1.0166498376009812,0.45595238095238094,0.887201289122622,1.0,11/39,17.39%,SBDS;PTGER4;P3H1;FGFR2;MYOC;CYP26B1;AKAP13;RANBP3L;FGFR3;SH3PXD2B;PTPRC
prerank,regulation of calcium ion import (GO:0090279),0.40899518618257213,1.0166351363147612,0.46,0.8866633606234094,1.0,5/21,14.33%,SLC30A1;CTNNB1;PRNP;SPHK2;FYN
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.4289323063382807,1.0157912660006219,0.4581005586592179,0.8883432998489929,1.0,2/17,7.88%,CLTRN;UNC13D
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.395477750842292,1.0157093451129222,0.44095477386934673,0.8880116702486528,1.0,14/27,24.55%,ZC3H12C;XRN1;ZC3H12A;RNASE1;PCF11;NUDT16;DICER1;RPP30;TRIR;ERN1;RNASEH1;RNASE4;PDE12;NHP2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.4640358592386209,1.0153405690396842,0.4569343065693431,0.8884584668291823,1.0,2/11,8.96%,CDH13;P2RX4
prerank,Notch signaling pathway (GO:0007219),0.35347150843879765,1.0152184759459488,0.4467849223946785,0.8882227534179802,1.0,12/59,16.88%,STAT1;DTX3L;SNAI2;MAML2;SNW1;NOTCH4;ZNF423;PSEN1;APH1A;APH1B;RBPJ;MDK
prerank,response to reactive oxygen species (GO:0000302),-0.2467007198864784,-1.0151966995578747,0.4426229508196721,1.0,1.0,10/54,7.83%,PTPRK;APOD;MPV17;PXN;EGFR;APTX;MAPK3;HMOX1;TPM1;SIRT1
prerank,cellular response to pH (GO:0071467),0.43155404092823946,1.0147155034099586,0.4872881355932203,0.8890378408132433,1.0,2/17,8.07%,HYAL1;RAB11B
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3413366583109047,1.0142633832779415,0.45701849836779107,0.8896889158646084,1.0,20/76,19.81%,DYNC1H1;HCK;EVL;CX3CL1;PDXP;CARMIL1;KATNBL1;NCK1;NCK2;PROX1;SNX9;STAP1;SYNPO;PRKCE;NRP1;BAIAP2;BAIAP2L1;CFL2;NUMA1;NCKAP1
prerank,positive regulation of apoptotic process (GO:0043065),0.3153515040156006,1.0141408455182295,0.4764292878635908,0.889437292767554,1.0,48/293,13.37%,ZBP1;TNFSF10;IFIT2;DAPK3;MYBBP1A;CLU;PRMT2;RARG;GADD45G;TNFRSF8;MLLT11;BCL2L11;SFRP2;PLEKHN1;SIAH1;CTNNB1;ARHGEF7;BCL6;DDX20;PTRH2;TRIM39;TFAP2B;FRZB;TPD52L1;ABR;BARD1;HMGB1;PRNP;VAV1;SPHK2;PRR7;ZC3H12A;DIABLO;DNM2;PHLDA1;RNF122;RNPS1;SIK1;RYBP;ARHGEF11;SOS1;PSEN1;RACK1;RPS6;BAD;APBB1;AKAP13;TIAM2
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.38874887343808606,1.0140050442906086,0.4794007490636704,0.8892203597073037,1.0,11/29,29.22%,LARP1;GDNF;TENT5A;TENT5C;TAF15;FUS;NOCT;EIF4ENIF1;HNRNPU;SLC11A1;PABPC1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.4574302076839518,1.013690613783589,0.4631268436578171,0.8895460664708745,1.0,3/11,12.93%,FBXO7;NONO;RACK1
prerank,chromatin remodeling (GO:0006338),0.33432792344703655,1.0133696828712977,0.47564766839378236,0.88983638483693,1.0,26/100,17.11%,GATAD1;DAXX;ARID1B;CHD1L;SOX9;ARID1A;KDM4D;MBD2;SMARCE1;SMARCC2;NUDT5;MTA2;TADA2A;ACTR8;TADA2B;BPTF;NPM1;HCFC2;RB1;ACTB;SMARCA1;MYB;SMARCD2;BAHD1;INO80C;MPND
prerank,carbohydrate catabolic process (GO:0016052),-0.27928777245548697,-1.0132174856141014,0.41044776119402987,1.0,1.0,10/38,10.78%,ENO1;PFKL;PGAM1;PGAM4;MANBA;MAN2B1;PKM;PFKFB2;ENO2;PGK1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.3920505456085536,1.0131567772157717,0.4440203562340967,0.8898338192023608,1.0,5/26,13.05%,DHFR;GDNF;GCH1;APOE;PIK3CB
prerank,entry into host (GO:0044409),0.45514435019831945,1.0130512487798355,0.4711673699015471,0.8895609241318416,1.0,4/13,8.66%,CXCR4;CTNNB1;PPIA;MET
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3440113742708857,1.0129513023900607,0.4621295279912184,0.8892819171489031,1.0,6/66,3.66%,NOD2;TAOK3;FLT1;CD40;SASH1;ADAM8
prerank,regulation of organelle assembly (GO:1902115),0.3446675905257858,1.012429545560316,0.460196292257361,0.8901775101948753,1.0,30/72,28.47%,TBC1D1;RNF4;HCK;UBQLN2;RABEP2;VPS11;TBC1D8;CYLD;TRAPPC12;NPM1;GSN;DYNC2LI1;DYNLT2B;CEP295;TBC1D2;DCDC2;NPRL2;NPRL3;SGSM3;TSG101;MSN;IFT140;TBC1D2B;TBC1D20;TBC1D17;STX18;TBC1D15;PDCD6IP;CEP76;TBC1D9B
prerank,negative regulation of cyclase activity (GO:0031280),-0.35617083697909424,-1.0120516652254044,0.4155844155844156,1.0,1.0,4/14,12.68%,GRM3;EDNRB;PALM;CCR2
prerank,non-motile cilium assembly (GO:1905515),-0.29167419281173473,-1.0120393960299716,0.43,1.0,1.0,17/30,33.36%,RPGRIP1L;PCM1;IFT88;VANGL2;IFT57;BBS1;TMEM216;RPGRIP1;BBS10;FUZ;TMEM17;TTC8;CSNK1D;CEP250;TMEM107;CCDC13;CEP290
prerank,regulation of endocytosis (GO:0030100),0.34943794897302366,1.0119768933191409,0.4598870056497175,0.8908279598454565,1.0,25/61,26.35%,CDH13;SNX33;LRSAM1;RAB5C;LRPAP1;AP2S1;APOE;RUBCN;STON1;DAB2;TFR2;OPHN1;CBLL1;STON2;RAB5B;MCTP1;ABL2;CD22;SNX17;SNX12;PACSIN1;SYT11;PTPN1;CALY;LRP1
prerank,heterochromatin assembly (GO:0031507),0.4249528067603556,1.0117398395206367,0.4741721854304636,0.8909279764111535,1.0,10/20,25.96%,ZNFX1;MBD2;NRDE2;BAHD1;HDAC1;SMCHD1;SIRT2;CDKN2A;EZH1;HELLS
prerank,positive regulation of vacuole organization (GO:0044090),0.4734689282099097,1.0114495828517627,0.45339652448657186,0.8911316538046576,1.0,2/10,6.35%,LRSAM1;SH3GLB1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.419772155778518,1.0114257110360139,0.46875,0.8906173865143158,1.0,4/18,13.97%,DHX33;UBTF;POLR2K;WDR43
prerank,positive regulation of proteolysis (GO:0045862),0.3558014632653684,1.0110215775840559,0.46906636670416196,0.8911339018272333,1.0,18/55,23.26%,ASPH;SNX33;ADAM8;CTSC;CTSH;TNIP1;BTRC;SNX9;ZC3H12A;APOE;BAD;AURKAIP1;IST1;SH3D19;TANK;STUB1;HDAC2;CLN6
prerank,calcium ion transport into cytosol (GO:0060402),0.409869864446033,1.011009387460887,0.4577373211963589,0.8906035632116208,1.0,3/21,3.74%,TRPM2;GRIN2D;SLC8A1
prerank,regulation of small molecule metabolic process (GO:0062012),0.39000105340112434,1.0107288901612683,0.4689054726368159,0.8908596529357001,1.0,11/28,24.91%,ACADL;RORA;FOXK1;BCKDK;EPHX2;APOE;PANK2;TTC39B;ADIPOR1;NCOR2;ACADVL
prerank,protein deubiquitination (GO:0016579),0.31770825598989955,1.0106988120982565,0.47183098591549294,0.890373864607995,1.0,74/242,24.13%,USP18;IFIH1;PSMB10;PSME2;BIRC2;INO80E;USP50;PSMA5;PSME4;USP25;USP21;USP15;OTUD3;POLB;USP40;PSMA3;CYLD;SMAD2;UCHL5;PSMB9;UCHL3;ACTR8;USP34;BARD1;TADA2B;TRAF3;VCPIP1;JOSD2;ARRB2;TNIP1;ZC3H12A;FOXK1;OTUD1;ATXN7;PSMD2;USP14;PSME3;ZRANB1;USP45;BIRC3;ACTB;PSMA4;TNIP2;USP37;HGS;TNIP3;OTULINL;INO80C;ENY2;BABAM2;PSMD7;OTUD6B;PSMD8;BECN1;PSMD9;MBD6;NFRKB;PSMF1;USP5;PSMB6;USP8;PSMC2;PSMD12;SENP8;USP33;SMURF2;ADRM1;PSMD4;VCP;PSMA2;KAT2B;ACTL6A;USP32;USP10
prerank,mitotic sister chromatid cohesion (GO:0007064),0.44134142667959236,1.0106457244095755,0.4574175824175824,0.8899619060628466,1.0,7/16,22.85%,HASPIN;NAA50;MAU2;RB1;POGZ;PDS5B;PDS5A
prerank,ncRNA export from nucleus (GO:0097064),0.37759617118114136,1.0105012294876985,0.4676258992805755,0.8897802276775357,1.0,11/36,20.34%,NUP37;PHAX;NUP153;NCBP2;RAE1;NPM1;NUP155;NUP88;TSC1;NUP133;NUP43
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.34747319663808496,-1.0104255324285814,0.4230769230769231,1.0,1.0,6/17,18.35%,DYRK1A;PTTG1IP;SIRT1;MIF;KDM1A;PSMD10
prerank,platelet degranulation (GO:0002576),0.32696013808045027,1.0101759341668404,0.46839378238341967,0.8900990423419957,1.0,14/118,13.50%,LGALS3BP;CLU;ACTN1;ACTN2;LAMP2;MAGED2;CDC37L1;ISLR;LYN;APP;SCCPDH;VEGFD;CHID1;VTI1B
prerank,phospholipid metabolic process (GO:0006644),-0.23222495691122122,-1.0101270138450287,0.43956043956043955,1.0,1.0,23/71,22.66%,PLCB2;MBOAT1;PLAAT3;CLN8;SMPD3;ABCA2;PLBD1;GPAM;AGPAT4;PLPPR4;PLCD1;ABHD12;LPL;ACP6;AGPAT2;PLPP3;PIP4K2A;PLA2G15;SMPD1;FITM2;SMPD2;LGALS13;PLA2G3
prerank,protein K63-linked ubiquitination (GO:0070534),0.3650089425390551,1.0099461619172918,0.4627039627039627,0.8901815801306262,1.0,8/41,11.44%,RNF4;TRIM21;RNF5;BFAR;UBE2B;UBE2E3;TRAF3;TRAF5
prerank,regulation of T cell cytokine production (GO:0002724),0.43571125044625064,1.0098251818653454,0.45839210155148097,0.8899354144815892,1.0,2/15,2.89%,B2M;CD55
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.38911824719486715,1.0097376804224079,0.4587378640776699,0.8896101860065445,1.0,3/29,3.85%,SPRY2;SFRP2;MAD2L2
prerank,regulation of cellular respiration (GO:0043457),0.4256193295357495,1.00963244599365,0.4767932489451477,0.8893339910298816,1.0,8/17,27.53%,PNPT1;NOP53;IL10RB;NOA1;IDE;VCP;TRAP1;PRELID1
prerank,regulation of trophoblast cell migration (GO:1901163),0.4425207837774716,1.0094328621043442,0.4652777777777778,0.8893343334931354,1.0,2/14,5.32%,AGO2;SYDE1
prerank,cilium movement (GO:0003341),0.35762017448318467,1.009411033728884,0.473928157589803,0.888836323892714,1.0,8/47,14.21%,ODAD2;CABYR;CCDC40;ADCY10;CFAP54;SPEF1;ODAD4;CFAP73
prerank,positive regulation of reproductive process (GO:2000243),0.3887615412536256,1.0092823376239448,0.45355850422195415,0.8886166976730742,1.0,8/31,22.14%,AGO2;TACR1;SYDE1;TAC4;PDE3A;GLRA1;LHFPL2;SMURF2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.3595037925192171,1.0090773153961956,0.46651532349602726,0.8885957997799295,1.0,14/48,18.68%,MYBBP1A;MYO1C;ARID1B;CHEK1;ARID1A;POLR2K;SPHK2;SERTAD2;TAF1B;ACTB;SERTAD1;ELOF1;POLR1G;TAF1C
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3573685606354924,1.0089633249577576,0.4676674364896074,0.8883255895350368,1.0,17/48,19.75%,CARMIL1;ARHGEF7;CUL7;FBXW8;MYOC;CIB1;CUX1;PRKDC;LIMS1;NRP1;RAC1;RREB1;CRK;MDK;CAPRIN1;TESK1;SS18L1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3438389200137553,1.0089241721348525,0.47122692725298587,0.8878664468471763,1.0,23/71,16.07%,MYO1C;ELMO2;ACTR2;HCK;HSP90AB1;CYFIP1;ACTR3;NCK1;LYN;FCGR1A;VAV1;ARPC5;PRKCE;FCGR2B;PIK3CB;NCKIPSD;RAC1;ACTB;FYN;MYH2;HSP90AA1;CRK;BAIAP2
prerank,regulation of cellular amine metabolic process (GO:0033238),0.3561761624407738,1.008837041802613,0.4685714285714286,0.8875530966082075,1.0,19/50,23.76%,PSMB10;PSME2;PSMA5;PSME4;PSMA3;PSMB9;PSMD2;AZIN1;PSME3;PSMA4;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4;PSMA2
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.47928259570169574,1.0083868520111057,0.4671641791044776,0.8882572433822767,1.0,3/10,9.98%,CHEK1;KMT2A;SPHK2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3520978555508133,1.007950405275947,0.4650112866817156,0.8889204252314541,1.0,9/53,12.34%,PSME2;DDRGK1;OSBPL7;HSP90AB1;FBXW7;UCHL5;USP14;PSME3;APOE
prerank,regulation of mitochondrion organization (GO:0010821),0.3571249476970202,1.0078614859417276,0.4794841735052755,0.8885930179847911,1.0,6/47,12.32%,STAT2;FIS1;FBXW7;CSNK2A2;INF2;PPARGC1A
prerank,arachidonic acid secretion (GO:0050482),-0.3963229270870119,-1.0076466714846055,0.4101694915254237,1.0,1.0,7/10,40.65%,ANXA1;DRD2;NMUR2;BDKRB2;PLA2G5;DRD3;ACE
prerank,arachidonate transport (GO:1903963),-0.3963229270870119,-1.0076466714846055,0.4101694915254237,1.0,1.0,7/10,40.65%,ANXA1;DRD2;NMUR2;BDKRB2;PLA2G5;DRD3;ACE
prerank,cellular response to organic substance (GO:0071310),0.326210235759259,1.0072050504976564,0.49741468459152016,0.889849130891843,1.0,25/116,18.18%,CXCR4;CPNE3;ACVR1;STAT3;ASAH2;PTPN18;LRP2;CCL5;NCOA1;CTNNB1;PTPN7;BMPR2;LDLRAP1;CIB1;SLIT3;PTPN11;SOCS2;RACK1;INPP5K;BMPR1A;TIPARP;IL18;PTPN9;DCPS;ACVR2A
prerank,negative regulation by host of viral transcription (GO:0043922),0.45828944842351,1.0070868431154196,0.4774774774774775,0.8895812286439256,1.0,6/12,24.43%,TARDBP;CCL5;INPP5K;HDAC1;CCL4;TFAP4
prerank,regulation of neuron migration (GO:2001222),0.3863573100030888,1.0069515507475228,0.47619047619047616,0.889375208717101,1.0,8/26,16.88%,PLXNB2;CAMK2B;CX3CL1;RAPGEF2;COL3A1;SRGAP2;IGSF10;MDK
prerank,regulation of receptor internalization (GO:0002090),0.3743112540522345,1.0068092321579498,0.4594272076372315,0.8891960799445846,1.0,7/35,11.09%,WDR54;MAGI2;INSR;MKLN1;LRPAP1;ARRB2;SCYL2
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.38925928834164336,1.006700467162795,0.4640102827763496,0.88894937429239,1.0,3/28,1.42%,IRGM;NOD2;NOD1
prerank,histone acetylation (GO:0016573),0.34308288490385835,1.0062559816987635,0.48253275109170307,0.8895382661877781,1.0,30/69,28.86%,JADE3;NAA50;EP400;BRD1;KAT14;TADA2A;SUPT7L;WDR5;BRPF1;APBB1;KAT8;SGF29;KAT7;PER1;RUVBL2;ING5;TADA1;KAT6A;KAT5;JADE2;KAT2B;ACTL6A;YEATS2;ZZZ3;RUVBL1;EP300;BRD8;CHD5;BRPF3;YEATS4
prerank,carnitine metabolic process (GO:0009437),-0.3735528074995228,-1.0060992014557304,0.45396825396825397,1.0,1.0,6/12,18.15%,ACADM;TMLHE;CROT;CPT2;CPT1C;CRAT
prerank,cellular response to inorganic substance (GO:0071241),0.4155905251266534,1.0059018979270502,0.47244094488188976,0.8899213649326257,1.0,6/21,18.94%,TIMELESS;ADCY10;MT3;DDX11;RTF2;DDI2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.37115786697419634,1.0055614936744337,0.46875,0.8902641352641576,1.0,4/35,12.29%,PCDHB13;CDH13;CDH9;PCDHB16
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.37108963282560387,1.0055144355000802,0.46079613992762364,0.8898524064175188,1.0,7/35,10.48%,SPRY2;TNFAIP1;ITGA3;MYOC;MET;KANK1;STMN3
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.35856751619513516,1.005398441696937,0.47502903600464574,0.8896130122584266,1.0,8/48,10.49%,KDR;CD40;RHOJ;MAP2K3;P2RX4;HMGB1;MAPK14;CIB1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3407723195416801,1.0051932495002613,0.49075081610446136,0.8895929740070206,1.0,23/73,16.07%,MYO1C;ELMO2;ACTR2;HCK;HSP90AB1;CYFIP1;ACTR3;NCK1;LYN;FCGR1A;VAV1;ARPC5;PRKCE;FCGR2B;PIK3CB;NCKIPSD;RAC1;ACTB;FYN;MYH2;HSP90AA1;CRK;BAIAP2
prerank,calcium ion transmembrane transport (GO:0070588),0.3380566534042219,1.0051277587420744,0.47853403141361256,0.8892127251337438,1.0,15/86,15.79%,TRPM5;TRPM2;CACNA2D4;GRIN2D;TRPM6;SLC8A1;CACNA1A;P2RX4;MCUR1;TRPM3;MCOLN2;TRPV4;MICU2;TRPM7;SLC24A3
prerank,wound healing (GO:0042060),-0.24450307361955834,-1.0050393623984128,0.4,1.0,1.0,12/62,10.63%,PAK1;DST;MACF1;AHNAK2;MYOF;HMOX1;FGF10;TPM1;SCARB1;TGFB2;ANXA6;PLEC
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.31212119068435684,1.0050034765598144,0.4869215291750503,0.8890000334493082,1.0,70/264,18.22%,SRPK3;POLR2G;RBM14;DDX5;MAGOHB;TXNL4A;HNRNPH1;RBMX;SRRT;NCBP2;CHERP;HNRNPK;GPATCH1;PRPF40A;WDR33;DDX20;HNRNPM;DHX9;HNRNPA2B1;SF3B6;NONO;BCAS2;POLR2K;RNPC3;SRPK1;HNRNPL;HSPA8;TGS1;RBM17;RSRC1;SNW1;WDR83;RNPS1;RALY;HNRNPH3;HNRNPA1;USP39;RBM41;PAPOLA;SART1;BUD31;CLNS1A;GEMIN7;SNRPD2;SNRPD1;DBR1;EFTUD2;PCF11;DDX39B;RBM15;SNRPG;NCBP1;PRPF40B;DHX16;GEMIN2;SRSF7;SF3B4;SRSF4;METTL14;HNRNPA3;CWF19L1;DDX46;CWC22;SNRPB2;SNRNP48;DDX23;SLU7;SCNM1;DCPS;LSM5
prerank,negative regulation of kinase activity (GO:0033673),-0.24326603527905682,-1.0049743497618007,0.4329896907216495,1.0,1.0,17/62,13.67%,CEP85;TAB1;PPM1E;DEPTOR;LRP6;PRKRIP1;PAK2;GSKIP;SNCA;QARS1;TSC2;DBNDD2;CEP43;UBASH3B;AKT1;CEACAM1;TRIB1
prerank,regulation of tube diameter (GO:0035296),-0.37265632278483996,-1.0047911590010252,0.4512987012987013,1.0,1.0,2/13,3.78%,ROCK1;GCLM
prerank,vascular process in circulatory system (GO:0003018),-0.37265632278483996,-1.0047911590010252,0.4512987012987013,1.0,1.0,2/13,3.78%,ROCK1;GCLM
prerank,establishment of spindle localization (GO:0051293),0.4445322926528239,1.0046514439722698,0.4616477272727273,0.8894183329553605,1.0,4/14,16.50%,DYNC1H1;KPNB1;MAP4;LLGL1
prerank,respiratory chain complex IV assembly (GO:0008535),-0.3148513754547749,-1.004486644441705,0.42231075697211157,1.0,1.0,10/21,25.69%,COX16;PET100;COX15;COX10;TIMM21;SCO1;SURF1;COA3;COA6;COX18
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.42683944105992566,1.0043608196678742,0.47107438016528924,0.8896522357851752,1.0,7/15,19.61%,UBQLN2;SCYL2;PIK3CB;DAB2;SMAP1;SNAP91;AAK1
prerank,regulation of spindle organization (GO:0090224),0.4192949840962671,1.004108737594894,0.4614343707713126,0.8898071824237819,1.0,3/18,8.13%,RNF4;DYNC1H1;RAE1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.343863546859863,1.003903641841379,0.4771739130434783,0.8898084808325396,1.0,22/73,24.15%,MYBBP1A;TFAP2C;MECP2;MYO1C;CGGBP1;DNMT3A;DNMT1;POLR2K;SPHK2;CTCF;TAF1B;ACTB;EZH2;TDG;POLR1G;TAF1C;SMYD5;TASOR;HDAC4;HDAC6;KAT2B;POLR1F
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.37142942045006483,1.0038797727840165,0.4719904648390942,0.8893151347185082,1.0,7/39,11.00%,NOD2;STAT3;TM2D3;ENHO;MAML2;SNW1;NOTCH4
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3418949317842755,1.0038761318350418,0.4928806133625411,0.8887671307647462,1.0,31/76,27.24%,BIRC2;FBXW7;PRICKLE1;UBE3A;DCUN1D4;UBA2;UBQLN1;TNIP1;ZC3H12A;PAXIP1;UBE2L3;BIRC3;MYCBP2;PIAS1;SPRTN;TANK;RIPK2;HSPBP1;HUWE1;STUB1;DCUN1D5;CUL3;SENP2;XIAP;HDAC4;AXIN1;COMMD1;NDFIP1;PIAS4;GNL3;FKBP1A
prerank,regulation of myoblast differentiation (GO:0045661),0.3824010783550581,1.0038619193349705,0.48370927318295737,0.8882518261161808,1.0,9/32,16.98%,EID2B;SOX9;SRA1;MAPK14;ZFP36L1;RANBP3L;SMYD1;FLOT2;TRIP4
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.39399581831916425,-1.0037919727695588,0.43564356435643564,1.0,1.0,3/12,11.67%,GPR183;MFNG;LFNG
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.36498830364582985,-1.0034847239189952,0.4383116883116883,1.0,1.0,4/13,12.68%,GRM3;EDNRB;PALM;CCR2
prerank,regulation of fat cell differentiation (GO:0045598),0.33973016181519206,1.0025056713740303,0.4854054054054054,0.8913111171339837,1.0,14/74,12.84%,TRIB3;WNT5A;ZFP36;CDS1;SFRP2;MEDAG;AAMDC;FRZB;TAF8;RORA;ZC3H12A;ZFP36L1;XBP1;ENPP1
prerank,primary miRNA processing (GO:0031053),0.47480117201869176,1.0018315278293142,0.4766214177978884,0.8925753992535036,1.0,3/10,7.84%,SRRT;HNRNPA2B1;SMAD2
prerank,regulation of fibroblast migration (GO:0010762),0.4095011643315875,1.0015831504763124,0.47114093959731546,0.8927178208058947,1.0,9/20,21.95%,HAS1;ARHGEF7;PRKCE;RAC1;CORO1C;RFFL;APPL2;DDR2;FGF2
prerank,organelle fission (GO:0048285),0.39977797911486856,1.001406706826688,0.4776500638569604,0.8926302618670161,1.0,10/24,26.73%,MTFR2;FIS1;GDAP1;DNM2;MTFP1;CORO1C;OPA1;DNM3;WASHC5;DNM1
prerank,isotype switching (GO:0045190),0.4777689439149081,1.0012878342895206,0.49165402124430957,0.8924095217844692,1.0,1/10,0.99%,MSH2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.40803657185273756,1.0012507702226525,0.4633152173913043,0.891960165254523,1.0,6/20,16.22%,HSP90AB1;ENTPD5;P2RX4;APP;C3AR1;IL18
prerank,regulation of receptor recycling (GO:0001919),-0.35325136230034065,-1.0011265288570244,0.46785714285714286,1.0,1.0,5/16,15.65%,INPP5F;SNCA;NSF;VAMP3;SCRIB
prerank,regulation of microglial cell activation (GO:1903978),0.4317386610292985,1.0010941903945205,0.4740532959326788,0.8918488663619477,1.0,5/15,18.10%,CX3CL1;CST7;STAP1;PTPRC;LDLR
prerank,superoxide metabolic process (GO:0006801),0.3861001666211142,1.0010344768585835,0.493099121706399,0.8914472630246555,1.0,4/29,6.57%,SOD2;CYBB;TAFA4;MT3
prerank,regulation of macrophage migration (GO:1905521),-0.3998955300896806,-1.0009163891204627,0.4467455621301775,1.0,1.0,6/10,29.44%,CD81;CX3CR1;CD200R1;CD200;EMILIN1;PTK2B
prerank,motor neuron axon guidance (GO:0008045),0.4270304809767565,1.000876290124647,0.4583333333333333,0.8913545236323492,1.0,4/15,13.90%,EPHA4;SLIT1;CHN1;RAC1
prerank,axonogenesis (GO:0007409),0.3132977412367076,1.0008394904519398,0.5140562248995983,0.8908925906487252,1.0,49/237,16.50%,SLITRK6;UNC5B;CXCR4;WNT5A;BDNF;PIK3CD;ATL1;SEMA4D;NRP2;GRB10;DOK1;SIAH1;EVL;HSP90AB1;CYFIP1;EPHA4;FGFR2;PAK3;RET;DOK6;DOK5;EPHA6;GDNF;B4GALT5;APP;RAP1GAP;GFRA2;LYPLA2;SLIT3;SLIT1;SOS1;PTPN11;PIK3CB;APBB1;NRP1;ACTB;FYN;IRS2;HSP90AA1;NPTN;TAOK2;DSCAM;BAIAP2;DSCAML1;SEMA3D;SCN1B;NLGN3;OPHN1;LLGL1
prerank,response to muscle stretch (GO:0035994),0.4316835595766821,1.0006640840985543,0.4606741573033708,0.8907772432201747,1.0,3/15,11.77%,SLC8A1;CTNNB1;GSN
prerank,acylglycerol catabolic process (GO:0046464),0.38341164562269636,1.000537142340695,0.47297297297297297,0.890549265325074,1.0,5/30,14.69%,PNPLA2;ABHD2;LIPC;LYPLA2;DAGLA
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.3483731331301908,1.000230022501769,0.4994438264738598,0.8908415013643716,1.0,10/57,12.41%,TAOK3;CHEK2;CHEK1;NOP53;TIPIN;CCND1;TRIM39;WAC;RINT1;PRKDC
prerank,negative regulation of bone remodeling (GO:0046851),0.4626672867805493,1.0000424249486464,0.4762589928057554,0.8907631148860129,1.0,1/11,0.60%,CALCA
prerank,cellular response to radiation (GO:0071478),-0.26491797982341847,-1.0000153208429627,0.43790849673202614,1.0,1.0,13/40,20.05%,INO80;RHNO1;SPIDR;SIRT1;EEF1D;NSMCE3;HUS1;TP53;CDKN1A;RAD1;NET1;ECT2;RAD51AP1
prerank,axon development (GO:0061564),0.3349049887215837,0.999671455706388,0.468682505399568,0.8911823463248113,1.0,21/78,19.93%,SLITRK6;DHFR;ATL1;GAP43;FGFR2;PAK3;MAPK8IP3;APP;APBB1;ACTB;TAOK2;BAIAP2;DSCAML1;LLGL1;CAMSAP2;SVBP;BRSK1;MAP1B;RTN4RL1;CCK;PLP1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3110676530337288,0.9996515173927568,0.4934934934934935,0.890679971881616,1.0,87/390,18.27%,AXL;NAMPT;FLT1;POLR2G;IRS1;KDR;BDNF;ATP6V0D1;NRP2;STAT3;ELMO2;LCP2;ACTR2;ZNF106;GRB10;CYBB;COL4A2;HNRNPH1;HCK;NCBP2;CYFIP1;AP2A1;EPHA4;FGFR2;PAK3;ARHGEF7;ACTR3;CSF1;RET;HNRNPM;EPHA6;RAPGEF2;BCAR1;LTK;NCK1;MET;LYN;NCK2;POLR2K;INSR;KIF16B;VAV1;MAPK14;GFRA2;ROR2;PHIP;GIT1;AP2S1;RAB14;VEGFD;FGF9;ARPC5;DDIT4;SOS1;STAP1;HNRNPA1;PTPN11;PSEN1;SOCS2;CHN1;SIPA1L1;PIK3CB;RAPGEF1;NRP1;TIAL1;RAC1;ACTB;JAK2;FYN;APH1A;IRS2;HSP90AA1;APH1B;NCBP1;CRK;FGFR3;BAIAP2;TCIRG1;BLNK;ATP6V1B2;FLRT2;FIBP;GIGYF1;MPZL1;ATP6V1G1;ARPC1B;POLR1G
prerank,positive regulation of mitochondrial fission (GO:0090141),0.4150191963586064,0.9995718735982958,0.49195710455764075,0.89033163837181,1.0,2/18,2.15%,KDR;FIS1
prerank,RNA export from nucleus (GO:0006405),0.32996923352101637,0.999525885280021,0.49157894736842106,0.8899030381997611,1.0,30/100,21.85%,NUP37;MAGOHB;SMG7;NUP153;NCBP2;WDR33;NXT1;HNRNPA2B1;RAE1;RNPS1;SMG5;HNRNPA1;UPF2;ZC3H11A;CHTOP;NUP155;DDX39B;NCBP1;DDX19B;SRSF7;SRSF4;UPF1;NUP88;SLU7;NUP133;GLE1;NUP43;THOC7;SRSF5;MCM3AP
prerank,positive regulation of cholesterol transport (GO:0032376),-0.2888294508846834,-0.9994831726413775,0.4425531914893617,1.0,1.0,12/27,21.20%,PPARG;NFKBIA;RXRA;SIRT1;EEPD1;TREM2;ABCA13;PLTP;ABCA7;ABCA3;NR1H3;CAV1
prerank,cellular response to hypoxia (GO:0071456),0.32633583308413255,0.9991027315283743,0.4850976361767729,0.8905072540993048,1.0,47/126,26.82%,PSMB10;PSME2;PSMA5;PSME4;ADAM8;EGLN2;NOP53;HYOU1;PSMA3;BACH1;MT3;PSMB9;RBX1;PLK3;RORA;UBQLN1;ELOC;ZFP36L1;PSMD2;AK4;SCN2A;PSME3;NPEPPS;BAD;PSMA4;MTOR;CPEB2;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12;STUB1;PSMD4;LIMD1;TIGAR;PSMA2;CUL2;SIRT2;EPAS1;PSMD1;PSMD11;HIGD1A;FMN2;BNIP3L
prerank,neuron projection organization (GO:0106027),0.4379901045090943,0.9986005562624956,0.4925775978407557,0.8913122180757138,1.0,5/15,12.26%,APP;INSR;ABCD1;PRNP;PSEN1
prerank,response to calcium ion (GO:0051592),0.32803178910565867,0.9984557666458189,0.4957983193277311,0.8911725393940453,1.0,16/102,15.98%,KCNMB3;CAMK2D;RASA4;CLIC4;WNT5A;CPNE3;TRPM2;CRHBP;SYT7;SYT3;ADGRV1;AHCYL1;SLC25A12;CALM3;MEF2A;CARF
prerank,lipid oxidation (GO:0034440),0.4473244293849561,0.9983528772540913,0.45132743362831856,0.8909172393370396,1.0,3/12,21.13%,PPARGC1A;ACOX1;ADIPOR1
prerank,lytic vacuole organization (GO:0080171),0.37912932647491193,0.9983092866896376,0.47896039603960394,0.8904654641569418,1.0,9/32,19.97%,ABCA1;GNPTAB;NAGPA;HOOK2;HOOK1;HOOK3;MTOR;ZKSCAN3;VPS18
prerank,inositol phosphate metabolic process (GO:0043647),0.3536985443741285,0.9981123709250007,0.4873271889400922,0.8904261360866147,1.0,11/46,18.98%,PLCB4;ITPKC;SYNJ1;PPIP5K1;ITPK1;PLCB3;INPP4B;OCRL;NUDT4;PLCE1;MINPP1
prerank,MAPK cascade (GO:0000165),0.3120173591832416,0.9978817100368671,0.5100200400801603,0.8904610252966741,1.0,70/295,19.55%,TAOK3;RGL3;PSMB10;RASA4;SKP1;IRS1;KDR;PSME2;GOLGA7;ZFP36;CAMK2B;PSMA5;KITLG;TGFA;PSME4;MAP3K8;ACTN2;PTGER4;CCL5;SOX9;FGFR2;PSMA3;NFKB1;MT3;RET;PAQR3;RAPGEF2;CTSH;PSMB9;MET;GDNF;PTPN7;RBX1;MEN1;GFRA2;TNIK;BTRC;ZFP36L1;WDR83;PSMD2;FGF9;MAP2K2;SOS1;PSME3;LAMTOR3;FGF13;PIK3CB;RASAL1;JAK2;FYN;PSMA4;DLG1;IRS2;TNIP2;MINK1;TAOK2;MEF2A;FGFR3;IL18;LGALS9;CSF2RA;PRKG2;NF1;PSMD7;FNTA;SPRED1;PSMD8;CAMKK2;PSMD9;RANBP9
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.2869804093492457,-0.9978716612421316,0.4563106796116505,1.0,1.0,10/27,22.36%,CMPK1;CTPS1;DTYMK;TYMS;TXNRD1;RRM2B;NME1;DUT;RRM1;GUK1
prerank,mitochondrion localization (GO:0051646),-0.32093598664524464,-0.9977671570213328,0.44841269841269843,1.0,1.0,8/19,24.80%,MFN1;TRAK2;BRAT1;ATCAY;MTM1;MUL1;MSTO1;NECTIN2
prerank,positive regulation of nervous system process (GO:0031646),-0.32926366595141177,-0.9977450033268316,0.4728682170542636,1.0,1.0,8/18,21.85%,TPPP;NLGN2;RIMS1;RNF10;TNFRSF1B;RIMS2;EGR2;NCMAP
prerank,intracellular protein transmembrane transport (GO:0065002),-0.25674686415310444,-0.9975594515172896,0.5347222222222222,1.0,1.0,23/42,31.28%,TOMM20;DNAJC15;TIMM21;AIFM1;SEC61G;SEC61A1;AKT2;SEC61B;PEX26;GRPEL1;PAM16;CHCHD4;ZFAND2B;TIMM17A;GRPEL2;ROMO1;PEX12;PEX1;HSPD1;SEC62;RTN2;SEC63;PEX6
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.33016493478286024,0.9975193799314802,0.48468848996832103,0.8908516632515806,1.0,29/96,21.85%,NUP37;MAGOHB;SMG7;NUP153;NCBP2;WDR33;NXT1;HNRNPA2B1;RAE1;RNPS1;SMG5;UPF2;ZC3H11A;CHTOP;NUP155;DDX39B;NCBP1;DDX19B;SRSF7;SRSF4;UPF1;NUP88;SLU7;NUP133;GLE1;NUP43;THOC7;SRSF5;MCM3AP
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.29707643637968095,-0.9973141982258944,0.4372093023255814,1.0,1.0,11/28,25.91%,TGFB1;EFCAB7;PIK3R2;ZIC1;UBR5;DMAP1;BAG3;ECT2;TPR;RBM22;JUP
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.24446019426997248,-0.9972593678059919,0.38317757009345793,1.0,1.0,17/59,13.17%,TAB1;NFKBIA;CARD11;TRAF2;ROCK1;NKIRAS1;TICAM2;BCL3;TRAF6;IKBKG;RIPK1;DAB2IP;UBB;IRAK1BP1;TRADD;UBC;AKT1
prerank,lipoprotein transport (GO:0042953),-0.39728719521129274,-0.9970373376857232,0.4540229885057471,1.0,1.0,1/10,1.69%,PPARG
prerank,negative regulation of cell development (GO:0010721),0.395809425911453,0.9966892067408764,0.4839948783610755,0.8925239826065691,1.0,5/25,13.57%,B2M;FBXW7;FBN1;SORL1;HOOK3
prerank,dendritic cell migration (GO:0036336),0.4251009854687004,0.996560018331332,0.4964838255977497,0.8923021078248394,1.0,4/16,9.13%,CXCR4;TRPM2;CCL5;HMGB1
prerank,regulation of neuron projection development (GO:0010975),0.31752668416977164,0.9964077328906945,0.5010204081632653,0.8921625074364208,1.0,43/163,18.79%,WNT5A;PLXNB2;BDNF;CAMK2B;FBXO7;RETREG3;RUFY3;PLXNB3;CX3CL1;P3H1;EPHA4;PAK3;MT3;RET;MAGI2;EFHC2;PAQR3;RAPGEF2;CCDC88A;LTK;LYN;KANK1;ROR2;CIB1;MAG;PSEN1;APOE;CHN1;TRPV4;SIPA1L1;MYLIP;RAPGEF1;RTN4IP1;NPTN;SCN1B;PTPN9;MDK;STMN2;CAMSAP2;ITM2C;FUT9;MARK1;BRSK1
prerank,electron transport chain (GO:0022900),0.43924330617470847,0.9962712704358259,0.4843110504774898,0.8919559149305384,1.0,8/15,29.64%,NDUFA5;ENOX2;PPARGC1A;SDHB;NDOR1;UQCRFS1;SDHA;ETFDH
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.4403303323909538,0.9959340433574726,0.48337950138504154,0.892341975595301,1.0,5/14,12.84%,ENPP3;CMPK2;AK4;AK3;ENPP1
prerank,epithelial cell morphogenesis (GO:0003382),0.4164371245994544,0.9958542383325124,0.4925575101488498,0.8919909019122724,1.0,5/17,19.10%,RILPL1;COL22A1;MET;COL15A1;SIPA1L3
prerank,activin receptor signaling pathway (GO:0032924),0.4331685732818669,0.9957924414828813,0.4805013927576602,0.8916131961768171,1.0,2/15,7.84%,ACVR1;SMAD2
prerank,cytoskeleton organization (GO:0007010),0.3262175512026582,0.9957453688724224,0.4865702479338843,0.8911892378562714,1.0,32/114,19.55%,CCL7;FMNL2;LRCH3;KLHL20;CNTNAP1;THY1;RHOF;BRWD3;SPRYD3;PRPF40A;ANK1;ARHGAP4;EPB41L3;ZMYM3;MAST3;TNIK;PHIP;CAPZB;ARHGAP10;APOE;FGD6;NCKIPSD;ZRANB1;RAC1;ZMYM6;MDK;PLCE1;SH3D19;FMNL3;MARK1;SIPA1L3;RANBP9
prerank,regulation of hydrolase activity (GO:0051336),0.33590991834265016,0.9948112383248908,0.5082872928176796,0.8931068714405163,1.0,17/71,18.30%,PLXNA3;PLXNB2;PLXNB3;EPHA4;RAPGEF6;RAP1GAP;VAV1;STMN3;CHN1;SIPA1L1;FGD6;CFAP73;CRK;TDG;OCRL;NF1;PAFAH1B1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.36895197479072117,-0.9946742855746793,0.4840764331210191,1.0,1.0,6/13,23.37%,CSTF2;FIP1L1;CPSF7;CPSF4;TUT1;CPSF2
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.43056401237202857,0.9945456251429083,0.48652482269503544,0.8932847721734943,1.0,6/15,19.75%,TRPT1;TSEN2;FAM98B;RTCB;TSEN34;ERN1
prerank,response to nitric oxide (GO:0071731),-0.3620342925018397,-0.9945073580178742,0.44086021505376344,1.0,1.0,4/13,14.19%,KCNC2;EGLN1;MTR;FOXO1
prerank,regulation of B cell apoptotic process (GO:0002902),0.452442273999044,0.9942952722787377,0.4864457831325301,0.8933869897442451,1.0,3/12,14.63%,BCL6;LYN;IRS2
prerank,lysosome organization (GO:0007040),0.3735335338440731,0.994269957036716,0.4838709677419355,0.8929035064724907,1.0,12/36,23.70%,ABCA1;GNPTAB;VPS33A;NAGPA;HOOK2;HOOK1;HOOK3;MTOR;ZKSCAN3;VPS18;CLN6;TMEM165
prerank,organelle assembly (GO:0070925),0.30804519323835844,0.9937390323601214,0.53,0.8937399597571094,1.0,109/384,24.46%,IRGM;CNGB1;CHMP4A;CHMP4B;CHMP1B;AUP1;CEP19;ATP6V0D1;BBIP1;RAB8B;RBM14;CDS1;B9D2;ACTR2;YTHDF1;CEP162;MVB12A;DYNC1H1;GOLGA8B;UBQLN2;RILP;RILPL1;SNX10;TTC39C;STX7;ACTR3;NPHP3;KIF3B;MAPRE1;RAB43;YTHDF2;MKS1;VPS37A;UBXN2B;UBQLN1;CFAP54;FNBP1L;WDR35;NPM1;TMEM138;CEP131;CHMP3;EXOC6;GSN;NEK6;TMOD3;DYNLT2B;VPS28;MAP1LC3B;SYNPO;DYNLL1;E2F4;POGZ;CCDC61;EIF2S1;PATL2;RB1CC1;PIBF1;DZIP1;CFAP20;MIS12;TMEM67;DBNL;BBS2;HGS;CCDC66;ARF4;RAB11A;RAB32;DHX37;WDR19;DYNC2H1;SH3PXD2B;OCRL;IST1;CEP89;DCDC2;CHMP5;GBF1;IFT46;NEK7;OGFOD1;MRPL22;BECN1;GORASP2;RAB1A;CSDE1;DDX3X;STARD9;G3BP1;TRAPPC14;HAUS3;CHMP1A;TSG101;TRAPPC6A;VPS36;FARP2;MAPRE3;IFT140;ZFYVE1;LIMD1;NOTCH1;LSM4;HDAC6;UBAP2L;EXOC2;BSCL2;BBS7;FLNA
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.40902949718554843,0.99352743082324,0.4973544973544973,0.8937743464969196,1.0,7/20,20.94%,ATIC;HPRT1;ADSL;AK4;AK3;AMPD3;LHPP
prerank,positive regulation of stress fiber assembly (GO:0051496),0.35229075179121294,0.9931349651445306,0.4804597701149425,0.8942365126390219,1.0,10/44,13.90%,WNT11;CD47;EVL;CARMIL1;MYOC;CCDC88A;PPM1F;ARHGEF10;NRP1;RAC1
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.266466106478309,-0.9929856057777046,0.4430379746835443,1.0,1.0,13/40,20.41%,SIRT7;UBE2V2;POLH;FXR2;PARG;CASP9;HMGA2;CRY1;ING2;BCLAF1;MYC;RADX;ABL1
prerank,negative regulation of myotube differentiation (GO:0010832),0.4378978037895858,0.992819131172143,0.47032640949554894,0.8944987098293524,1.0,5/12,23.49%,BDNF;XBP1;HDAC1;NOTCH1;HDAC4
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.30385923226961153,-0.9923910193149509,0.4481132075471698,1.0,1.0,4/23,7.16%,TGFB1;TGFBR3;TPM1;ID2
prerank,regulation of gene silencing by miRNA (GO:0060964),0.34614124015147796,0.992284050537284,0.49888641425389757,0.89534682706309,1.0,9/62,9.30%,NUP37;POLR2G;ZFP36;AGO2;STAT3;NUP153;DHX9;RAE1;POLR2K
prerank,peptide hormone secretion (GO:0030072),0.39215563425797306,0.9919521451049699,0.4822085889570552,0.8956422420287385,1.0,2/26,8.15%,GAL;SNX19
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.40067732700043984,0.9918528647231012,0.49869451697127937,0.8953450552145243,1.0,11/21,31.05%,SKP1;MAD2L2;BTRC;RPL11;RAB1A;RPL5;PTEN;MAD2L1;FBXO5;UBE2S;FZR1
prerank,microtubule depolymerization (GO:0007019),0.4148022047767745,0.9918311961354993,0.4733969986357435,0.8948511386297849,1.0,6/17,18.38%,KIF2C;STMN4;STMN3;KIF2A;STMN2;KIF19
prerank,substrate-dependent cell migration (GO:0006929),0.43257753078105426,0.991734443621541,0.47788873038516405,0.8945541832101204,1.0,4/14,17.39%,ITGA2;NRP1;OPHN1;PTPRC
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.40427837320099075,0.9916169710801709,0.49345549738219896,0.8943477864682718,1.0,11/22,26.02%,RNF5;AMFR;MAN1A2;RNF185;RNF103;MAN1C1;TRIM13;EDEM2;EDEM3;DERL2;EDEM1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.3925094613277842,0.9908606099978947,0.49744245524296676,0.8952572512230454,1.0,8/23,27.29%,HSP90AB1;MEN1;SNW1;DAB2;STK11;CITED2;SDCBP;EP300
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.3925094613277842,0.9908606099978947,0.49744245524296676,0.8952572512230454,1.0,8/23,27.29%,HSP90AB1;MEN1;SNW1;DAB2;STK11;CITED2;SDCBP;EP300
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.28712713726217387,-0.9907316891880897,0.45263157894736844,1.0,1.0,13/32,20.07%,DYRK1A;FKBP4;TUBB4A;SNCA;CLASP2;APC;HDGFL3;ARHGEF2;CLIP3;TTBK2;TPX2;APC2;CLASP1
prerank,polyol biosynthetic process (GO:0046173),0.4264548534157354,0.9905927887542155,0.4958791208791209,0.8953829576027186,1.0,4/16,15.93%,ITPKC;PPIP5K1;CYP27A1;ACER3
prerank,positive regulation of transmembrane transport (GO:0034764),0.4445140601108486,0.9905376622058358,0.4683357879234168,0.8949838317191549,1.0,4/13,13.27%,AZIN2;ACSL5;AZIN1;CA2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.3551792161544049,0.9903453444616811,0.4945321992709599,0.8949406373668344,1.0,15/39,27.95%,FXYD4;UTRN;FXYD6;SPHK2;AHCYL1;FXYD5;SCN1B;STK39;FXYD7;ANK2;WNK3;YWHAE;CHRM3;SCN4B;CACNA1D
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.42356148962928125,0.9902339784085645,0.4755244755244755,0.8947013576534446,1.0,6/16,24.97%,DDRGK1;SEC16A;GBF1;BCAP31;ANK2;BCAP29
prerank,fatty acid elongation (GO:0030497),-0.3663758453037156,-0.9901168414668952,0.4414715719063545,1.0,1.0,6/13,22.31%,TECR;HACD1;ELOVL5;ELOVL1;ELOVL7;ELOVL6
prerank,regulation of DNA recombination at telomere (GO:0072695),0.4107406334014603,0.9900505759648668,0.5006784260515604,0.8940938733804155,1.0,3/19,9.30%,POLR2G;DAXX;POLR2K
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.4107406334014603,0.9900505759648668,0.5006784260515604,0.8940938733804155,1.0,3/19,9.30%,POLR2G;DAXX;POLR2K
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.41618350141001437,0.9896938064360473,0.4904632152588556,0.8944695554170827,1.0,4/16,13.05%,DHFR;GCH1;APOE;PIK3CB
prerank,microtubule anchoring (GO:0034453),-0.37782654991226783,-0.9896709262750589,0.46325878594249204,1.0,1.0,7/12,30.99%,PCM1;GCC2;CLASP2;BCCIP;CLASP1;DAG1;CAMSAP3
prerank,DNA integrity checkpoint signaling (GO:0031570),0.3695060108734226,0.9894938203464223,0.5180722891566265,0.8944201380103709,1.0,6/36,6.50%,TIMELESS;CHEK2;CHEK1;TIPIN;CDT1;BRIP1
prerank,platelet aggregation (GO:0070527),0.36950718485962625,0.9894311433447508,0.49522673031026254,0.894031146854613,1.0,11/33,24.46%,CSRP1;ACTN1;MYL9;PPIA;PIK3CB;ACTB;FIBP;MYH9;STXBP3;CLIC1;FLNA
prerank,mRNA export from nucleus (GO:0006406),0.32660406397977004,0.9885963317325812,0.5079365079365079,0.8956737513358177,1.0,31/102,21.85%,NUP37;MAGOHB;SMG7;NUP153;NCBP2;WDR33;NXT1;HNRNPA2B1;RAE1;RNPS1;SMG5;UPF2;ZC3H11A;CHTOP;NUP155;DDX39B;NCBP1;DDX19B;SRSF7;SRSF4;UPF1;NUP88;ENY2;SLU7;DDX19A;NUP133;GLE1;NUP43;THOC7;SRSF5;MCM3AP
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.35556414680146303,0.9884723822057386,0.48009367681498827,0.8954634585240631,1.0,12/42,18.71%,VARS1;RARS1;HARS2;IARS2;AARS1;IARS1;NARS1;PARS2;EEF1E1;YARS2;TARS2;PPA1
prerank,cardiac muscle cell contraction (GO:0086003),0.40241854695421336,0.9880119602166748,0.47203274215552526,0.8960873723712934,1.0,4/19,16.74%,CAMK2D;GSN;SCN1B;KCNJ2
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.405763872717375,0.9878472455387083,0.47883597883597884,0.8959785474842958,1.0,2/21,3.74%,CAMK2D;SLC8A1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.4135568158709291,0.9876484741009073,0.4575342465753425,0.8959609951637575,1.0,6/17,17.31%,HASPIN;CTCF;RB1;MIS12;CHAMP1;ZWILCH
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.3580793166811188,-0.9876150555447302,0.46325878594249204,1.0,1.0,3/13,13.19%,ENO1;PINK1;TREM2
prerank,positive regulation of gene expression (GO:0010628),0.30531162027281894,0.9875518459698418,0.5545545545545546,0.8956768383233656,1.0,68/442,16.80%,EIF2AK2;HSPA1B;WNT11;MOV10;IL15;AGT;TENT4A;WNT5A;MYBBP1A;SPRY2;PLXNB2;CLU;PIK3CD;DDRGK1;AGO2;STAT3;MYO1C;SLC38A2;YTHDF1;DDX5;PTGER4;DHX36;SOX9;ZCCHC4;MT3;ITGB8;CSF1;CTSH;POU3F1;APP;SCX;DNMT1;POLR2K;MAPK14;PRKAG1;SPHK2;PPM1F;CCDC88B;ZC3H12A;NPM1;FAM98B;CTCF;FGF9;MITF;EIF6;GSN;MAP2K2;STAP1;PSEN1;EPHX2;PPARGC1A;PRKDC;UPF3A;TAF1B;PIK3CB;LIMS1;ACTB;MYD88;TFR2;HGS;RBM3;TLR2;SLC24A3;RPL11;MTOR;METTL14;RBPJ;LGALS9
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3341809916741307,0.9875260891278244,0.49349240780911063,0.8952091493109695,1.0,9/73,9.06%,IRGM;SPRY2;BDNF;SFRP2;MAD2L2;HSP90AB1;TNKS1BP1;MTCP1;APP
prerank,positive regulation of TOR signaling (GO:0032008),-0.2634007727266312,-0.9868874437699238,0.4722222222222222,1.0,1.0,13/40,19.55%,GPR137C;GPR137B;NCKAP1L;RRAGD;RRAGB;LARS1;SEC13;GOLPH3;TREM2;SLC38A9;LAMTOR2;FLCN;MLST8
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.3761341887232348,0.986379869609244,0.48891625615763545,0.8975840215646799,1.0,8/33,16.79%,PRMT2;RBL1;CDKN2D;DACT1;PLK3;RB1;DLG1;BRD7
prerank,positive regulation of B cell activation (GO:0050871),0.34722414441921107,0.9863478324794447,0.4948805460750853,0.8971314055859104,1.0,13/50,17.39%,NOD2;CD40;MMP14;MAD2L2;NFATC2;XBP1;SHLD1;PAXIP1;IRS2;TNIP2;CHRNB2;CD27;PTPRC
prerank,mitochondrial gene expression (GO:0140053),0.34939898168517364,0.9862384589257751,0.4970344009489917,0.8969068046874852,1.0,11/42,19.03%,IARS2;MRPL12;TFB2M;MRPL16;MRPS28;TWNK;MRPS2;NOA1;MRPL57;FASTKD2;MRPS11
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.40280048882077935,0.986003844188681,0.4914586070959264,0.8969681469320103,1.0,3/20,13.42%,BCKDK;SIK1;CLK2
prerank,histone deacetylation (GO:0016575),0.35130593815605243,0.9857297072687814,0.5112692763938316,0.8971177714838418,1.0,15/43,25.35%,PER2;RBM14;MTA3;MTA2;SIRT6;MIER1;HDAC8;RCOR3;HDAC1;PER1;HDAC2;HDAC4;HDAC6;SIRT2;SMARCAD1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.30619377570644163,0.9854534106078767,0.5498489425981873,0.8972894429546007,1.0,62/241,18.22%,POLR2G;RBM14;DDX5;MAGOHB;TXNL4A;HNRNPH1;RBMX;SRRT;NCBP2;CHERP;HNRNPK;GPATCH1;PRPF40A;WDR33;HNRNPM;DHX9;HNRNPA2B1;SF3B6;NONO;BCAS2;POLR2K;RNPC3;HNRNPL;HSPA8;RBM17;RSRC1;SNW1;WDR83;RNPS1;RALY;HNRNPH3;HNRNPA1;USP39;RBM41;PAPOLA;SART1;BUD31;GEMIN7;SNRPD2;SNRPD1;DBR1;EFTUD2;PCF11;DDX39B;RBM15;SNRPG;NCBP1;PRPF40B;DHX16;SRSF7;SF3B4;SRSF4;METTL14;HNRNPA3;CWF19L1;DDX46;CWC22;SNRPB2;SNRNP48;DDX23;SLU7;LSM5
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.4176476881375742,0.9853722502655592,0.5013812154696132,0.8969614256311433,1.0,2/18,4.27%,IRS1;CRHBP
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.4144659720476582,0.985372129831395,0.48501362397820164,0.8964256063804676,1.0,9/18,26.66%,GRIK3;GRIA2;NAPB;NAPA;GRID1;GRIK4;GRIK5;GRIK2;CDH8
prerank,transcription by RNA polymerase III (GO:0006383),0.38016724791703405,0.9853186889189796,0.491183879093199,0.8960277408105277,1.0,10/27,20.42%,SNAPC2;RO60;GTF3C5;POLR3GL;POLR2K;ICE2;SNAPC5;GTF3C3;BRF1;SNAPC4
prerank,positive regulation of synapse assembly (GO:0051965),0.37989809052008733,0.9852190348465482,0.49745547073791346,0.8957388172084131,1.0,7/27,16.19%,BDNF;CLSTN1;SEMA4D;AGRN;IL1RAP;CLSTN3;NLGN3
prerank,response to laminar fluid shear stress (GO:0034616),0.4640666333186457,0.9851456254945772,0.495398773006135,0.8953867538362171,1.0,1/10,1.02%,ABCA1
prerank,negative regulation of hydrolase activity (GO:0051346),-0.24657251504555458,-0.9851220138665596,0.5075757575757576,1.0,1.0,16/49,19.42%,CST3;RCC2;SLC39A14;GMIP;DAB2IP;ARL2;URI1;EGLN1;MAPK7;NEIL1;ZCCHC9;TMED2;ECM1;HRAS;F11R;CAMK2A
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.44674042736747227,0.9850327812553291,0.4950071326676177,0.8951464407528772,1.0,3/12,10.58%,STAT3;BCDIN3D;ZC3H12A
prerank,organelle fusion (GO:0048284),0.402671154613383,0.9848755392467792,0.49736842105263157,0.8950266512175918,1.0,9/22,23.45%,FIS1;GDAP1;VPS11;STX4;MIGA2;BAX;VPS18;OPA1;EEA1
prerank,cyclooxygenase pathway (GO:0019371),-0.39151823547620707,-0.9848526229189924,0.46938775510204084,1.0,1.0,6/10,26.63%,PTGDS;PTGS1;PTGES;CBR1;HPGDS;PTGIS
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.3897923107310217,0.9846401802742486,0.4888888888888889,0.8950708122864639,1.0,11/23,23.55%,KIF7;BTRC;ENPP1;RACK1;PTCH1;TULP3;MGRN1;GLI3;HERC4;KCTD21;VCP
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.32775470775654625,0.9844909515667668,0.5239107332624867,0.8949219335587563,1.0,25/88,21.78%,PSMB10;SKP1;FBXL16;PSME2;PSMA5;CUL5;PSME4;FBXW7;PSMA3;PSMB9;RBX1;BTRC;PSMD2;PSME3;FBXL14;PSMA4;AMN1;FBXL5;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.41399341337424,0.9844374932420517,0.48601864181091875,0.8945290062840764,1.0,5/17,12.34%,CLU;GGA3;PRNP;SORL1;APOE
prerank,iron ion homeostasis (GO:0055072),0.3415745546463805,0.9844246588731586,0.5061315496098104,0.8940249492568055,1.0,14/58,20.00%,SKP1;ATP6V0D1;B2M;FXN;SLC46A1;SLC11A2;CAND1;TFR2;HMOX2;FBXL5;ATP6V1G1;ABCB7;FLVCR1;ABCG2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3129354863392323,-0.9843995692094406,0.4448979591836735,1.0,1.0,9/21,20.67%,RPA1;PARP1;ERCC3;ERCC2;ERCC1;RPA3;GTF2H3;XPA;GTF2H4
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3129354863392323,-0.9843995692094406,0.4448979591836735,1.0,1.0,9/21,20.67%,RPA1;PARP1;ERCC3;ERCC2;ERCC1;RPA3;GTF2H3;XPA;GTF2H4
prerank,regulation of exocytosis (GO:0017157),0.3484378412300265,0.9843293790374635,0.4965753424657534,0.8937678120682122,1.0,11/46,16.46%,RAB8B;RAB21;RAB12;CPLX1;UNC13D;CADPS2;CHMP3;RAB2B;VAMP2;STX4;STXBP5L
prerank,positive regulation of filopodium assembly (GO:0051491),-0.3018325414160365,-0.9843083036379093,0.49145299145299143,1.0,1.0,7/24,14.28%,WASL;DPYSL3;CDC42;RHOQ;PALM;GPM6A;RIPOR2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.31921863247513926,-0.9843003547628906,0.4479638009049774,1.0,1.0,4/20,7.77%,TGFB1;NUMB;RHOQ;TMBIM1
prerank,negative regulation of histone acetylation (GO:0035067),0.46341232796179155,0.9841260437915736,0.5007256894049347,0.893757751163809,1.0,1/11,0.68%,THAP7
prerank,protein-containing complex disassembly (GO:0032984),0.3466490287257016,0.9838815042786908,0.5118376550169109,0.8938281232957981,1.0,11/54,13.50%,LAMP2;CTNNB1;VPS33A;LIX1;RUBCNL;HSPA8;UBQLN1;VIPAS39;CHMP3;MAP1LC3B;VTI1B
prerank,tryptophan catabolic process (GO:0006569),-0.3901404842924939,-0.9833786495865294,0.48264984227129337,1.0,1.0,5/11,39.99%,KMO;IL4I1;AFMID;IDO2;KYAT1
prerank,carbohydrate homeostasis (GO:0033500),0.33411059351286104,0.9831807498016799,0.5141304347826087,0.8951427117776581,1.0,15/67,21.74%,IRS1;STAT3;TCF7L2;USF1;TFAP2B;LEPR;INSR;RPS6;BAD;INPP5K;SELENOT;APPL2;ADIPOR1;STK11;CRTC2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.2939524327288249,-0.9826037392868634,0.4784688995215311,1.0,1.0,8/26,15.46%,SMARCA4;CRY2;ZBTB7A;SIRT1;KANK2;BRCA1;FOXP1;CRY1
prerank,mismatch repair (GO:0006298),0.3837961028943734,0.9821830960777045,0.4927007299270073,0.897223895494402,1.0,4/27,6.35%,MSH2;POLD4;RNASEH2A;MCM9
prerank,transcription by RNA polymerase I (GO:0006360),-0.2722200223834642,-0.9821734772924041,0.4888888888888889,1.0,1.0,14/34,18.28%,POLR1A;MAPK3;ERCC3;TBP;TTF1;ERCC2;RRN3;TAF1D;TAF1;POLR2F;POLR1C;TAF1A;POLR1H;GTF2H3
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.27622553952668605,-0.9820177868466343,0.5,1.0,1.0,5/33,8.54%,CASP8;FES;ID2;TRAF6;RIPK1
prerank,rRNA transcription (GO:0009303),0.42453467049216415,0.9819241828646152,0.5196629213483146,0.8973462039365412,1.0,10/17,23.82%,TCOF1;GTF3C5;TAF1B;GTF3C3;POLR1G;CAVIN1;BRF1;SPIN1;GTF3C1;ANG
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.40483253587844675,0.9811429163900338,0.499330655957162,0.8987716716926628,1.0,5/18,21.74%,LPAR5;CRTC1;CRTC3;LRP8;CRTC2
prerank,mitochondrion organization (GO:0007005),0.31139934259065266,0.9810192986269453,0.5416666666666666,0.8985543684201954,1.0,66/165,28.21%,IFIT2;MTFR2;PNPT1;FIS1;FBXO7;CHCHD10;POLG2;TRAK1;GDAP1;TFB2M;ATAD3A;TOMM5;TIMM50;SLIRP;TWNK;SAMM50;DNM2;DNAJA3;LONP1;PPARGC1A;TSPO;PITRM1;NDUFS1;AFG1L;VPS13D;AIP;MEF2A;RAB32;MIGA2;MTFP1;CHCHD2;BAX;TOMM40;RHOT2;GABPB1;COX7A2;BCAP31;VPS13C;HIGD2A;ADCK1;AKT3;MTX1;MYH14;ATP5F1B;PRDX3;PTCD2;SSBP1;OPA1;RAB29;DNM3;TFAM;BCS1L;CAV2;SLC25A33;COX7A2L;STOML2;HIGD1A;CYCS;DNM1;BNIP3L;BCL2L1;ESRRA;WASF1;PYROXD2;BID;HSD17B10
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.4271151670930028,0.9809227506608115,0.49860335195530725,0.898278555665661,1.0,1/14,1.52%,WNT5A
prerank,cellular macromolecule catabolic process (GO:0044265),0.34844973590668327,0.9809165500668514,0.5142207053469852,0.8977651759729571,1.0,8/49,8.62%,PNPT1;XRN2;CHEK2;RNF5;RNASEH2A;RAB12;RNASEH2C;NGLY1
prerank,regulation of interleukin-17 production (GO:0032660),0.3747078734127192,0.9803758270962899,0.5069356872635561,0.8986451211732486,1.0,2/31,0.94%,IL15;NOD2
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.3505849737412968,-0.9802749152695106,0.45054945054945056,1.0,1.0,6/16,20.18%,TOP2B;SLX4;FANCM;TOP2A;EME2;CENPX
prerank,anterograde synaptic vesicle transport (GO:0048490),0.42401277925591807,0.9801354809094971,0.5042857142857143,0.8981935869499161,1.0,4/15,18.52%,BLOC1S4;AP3M2;AP3S2;DTNBP1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.42401277925591807,0.9801354809094971,0.5042857142857143,0.8981935869499161,1.0,4/15,18.52%,BLOC1S4;AP3M2;AP3S2;DTNBP1
prerank,regulation of platelet activation (GO:0010543),-0.3122191782193175,-0.9800637900918252,0.48846153846153845,1.0,1.0,2/21,1.83%,SYK;PRKCQ
prerank,sulfur compound biosynthetic process (GO:0044272),-0.21733501803196803,-0.9795390473508346,0.5918367346938775,1.0,1.0,39/104,25.48%,CHSY1;CHST1;UST;ST3GAL6;METTL16;VCAN;GCLM;CSGALNACT1;B3GNT2;GSS;MAT2A;SLC10A7;CHST7;CHST15;ST3GAL3;B4GALT3;PAPSS2;CHST3;BGN;GSTO1;GSTA3;SLC35B2;GGT5;DSEL;HAGH;GGCT;GSTM1;CDO1;DCN;SLC35B3;BCAN;GSTA4;ACAN;GSTO2;UGDH;CSPG5;HPGDS;ST3GAL2;B3GNT7
prerank,neural tube development (GO:0021915),0.415135068442075,0.9793624097022932,0.49514563106796117,0.8996623908520808,1.0,4/15,13.52%,DACT1;PROX1;ALDH1A2;PTCH1
prerank,response to interleukin-6 (GO:0070741),-0.38697174044641247,-0.9792416985184598,0.4935897435897436,1.0,1.0,2/10,3.14%,ST3GAL6;SELPLG
prerank,receptor-mediated endocytosis (GO:0006898),0.3185163669791522,0.9786298442062068,0.5504587155963303,0.9010212198689992,1.0,29/132,14.86%,DNAJC13;STAB2;CXCL16;LRP2;HYOU1;AP2A1;AP1S1;ACKR3;FCGR1A;INSR;PI4KB;AMN;LDLRAP1;ARRB2;FNBP1L;SNX9;AP2S1;DNM2;SORL1;RABEPK;APOE;FCGR2B;PIP5K1C;MASP1;DAB2;LMBR1L;SNAP91;TFR2;HSP90AA1
prerank,bicarbonate transport (GO:0015701),0.38498733230197146,0.9785764469407886,0.5136186770428015,0.9006126731015881,1.0,2/25,1.70%,CA4;CYB5R2
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3633594954004079,0.9785543398622959,0.5053635280095352,0.9001478896012032,1.0,11/35,19.00%,DHX36;CTNNB1;RTEL1;CCT4;HNRNPA2B1;CCT7;CCT3;HNRNPA1;MAP3K4;HMBOX1;NEK7
prerank,carbohydrate transport (GO:0008643),0.4503121161891103,0.9785288249042902,0.5129310344827587,0.8996919190049085,1.0,1/11,3.32%,AQP11
prerank,calcium ion import (GO:0070509),0.3801192200255294,0.9785274166821752,0.5074441687344913,0.8991650806921044,1.0,10/28,27.95%,SLC8A1;CACNA1A;MCUR1;TRPV4;MICU2;TRPC4;SMDT1;MICU3;SLC25A23;CACNA1D
prerank,regulation of B cell proliferation (GO:0030888),-0.25535215962964997,-0.978264724013851,0.5214723926380368,1.0,1.0,8/44,8.84%,GPR183;CD38;CD81;NCKAP1L;TNFRSF13B;SASH3;EPHB2;TFRC
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.3585336514295342,0.9780580467336079,0.49129353233830847,0.899844931013439,1.0,4/33,3.81%,PRMT2;DDRGK1;DDX5;RUNX1
prerank,neuron projection development (GO:0031175),0.3107030849321492,0.9778270733787326,0.5531697341513292,0.8999003779447837,1.0,46/168,20.51%,BLOC1S4;TAOK3;BDNF;CNTNAP1;PPP1R9A;GAS7;EPHA4;PAK3;TBC1D23;MYOC;MAPK8IP3;SAMD14;STMN4;RAPGEF2;EPB41L3;LYN;GDNF;APP;HMGB1;TNIK;STMN3;DNM2;ADGRV1;ANKRD27;SRGAP2;APOE;RB1;CTNND2;MAP4;LRP12;MINK1;DBNL;TAOK2;PRMT1;RAB11A;OPHN1;NYAP2;DICER1;STMN2;CAMSAP2;SVBP;DTNBP1;NCKAP1;PLP1;LGI1;DOCK10
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.32985046434975235,0.9772826049454716,0.5393743257820928,0.9007392275022535,1.0,31/80,26.17%,VPS51;RGP1;GOSR2;VPS53;TBC1D23;VPS54;BAIAP3;STX16;ARL1;ANKFY1;VPS50;TMEM87A;VPS52;RIC1;VTI1B;PREPL;SPAG9;VPS26A;SNX1;GBF1;GOSR1;VPS35;SNX2;STX6;RAB29;SNX12;DENND2A;RBSN;DCTN1;TBC1D17;RAB7B
prerank,cytoplasmic microtubule organization (GO:0031122),0.34826504634138516,0.9772368324364873,0.5234899328859061,0.9003189816170492,1.0,20/54,21.34%,KATNAL1;DYNC1H1;KPNB1;HOOK2;CCDC88A;PLK3;HOOK1;STMN3;CIB1;CCDC88B;TRPV4;CLIP2;HOOK3;DLG1;RAB11A;CLIP4;CAMSAP2;NUMA1;FIGN;CRIPT
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.35247957222781745,0.9770512288454095,0.5045662100456622,0.9002610838087464,1.0,13/48,20.34%,NUP37;PNPT1;SLC2A6;NUP153;RUBCNL;RAE1;PRKAG1;EIF6;NUP155;NOA1;NUP88;NUP133;NUP43
prerank,negative regulation of metabolic process (GO:0009892),0.3414729465673635,0.976667640907033,0.49888641425389757,0.9006883857744304,1.0,15/54,24.01%,IL15;NR1H2;FIS1;ZNF423;RB1;ACOT13;ALDH1A1;RBPJ;PCTP;CCDC3;STK11;PGAM5;RHEB;NOTCH1;ACOT11
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3137012057254111,0.9766523158213934,0.5313463514902363,0.9002042609289783,1.0,38/129,23.79%,PSMB10;DAPK3;PSME2;PSMA5;PSME4;SFRP2;UBE2B;FGFR2;PSMA3;NFKB1;TMEM9;PSMB9;DACT1;BAMBI;USP34;KANK1;PSMD2;PSME3;PLEKHA4;PSMA4;PSMD7;PSMD8;PSMD9;PIN1;PSMF1;DDX3X;PSMB6;USP8;PSMC2;PSMD12;SMURF2;PSMD4;GPRC5B;XIAP;VCP;AXIN1;PSMA2;CAPRIN2
prerank,nuclear transport (GO:0051169),0.42595543094749433,0.976538664978065,0.5013966480446927,0.8999626909219859,1.0,4/16,10.71%,NXT1;BANF1;NPM1;RSRC1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.31048870199978934,0.976359347176956,0.5471887550200804,0.8998928095412942,1.0,42/199,21.69%,WNT11;LOXL2;IL15;NR1H2;SPRY2;SFRP2;MAD2L2;PTGER4;CRHBP;EVL;SOX9;SRF;N4BP1;NFIB;PPP1R11;BMPR2;LRPAP1;IL17D;ZNF423;DUSP10;RB1;ACOT13;FCGR2B;ALDH1A1;PTCH1;NPTN;BBS2;MCC;RBPJ;MDK;SPRED3;CORO1C;SPRED1;ASB1;PCTP;SFMBT1;IFNGR1;ADIPOR1;USF3;STK11;PGAM5;RHEB
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.40002132302430465,0.9761099296525179,0.5301204819277109,0.8999972492548599,1.0,3/19,6.89%,MYO1C;RUNX1;SNAI2
prerank,cellular sodium ion homeostasis (GO:0006883),0.42804438364492137,0.9759862743670145,0.5095447870778267,0.8998013699819057,1.0,2/15,3.74%,ATP1B3;SLC8A1
prerank,organophosphate ester transport (GO:0015748),0.3899790888150841,0.9756396645251157,0.4884910485933504,0.9001635725017263,1.0,10/24,23.36%,SLC25A19;OSBPL8;PITPNM1;NPC2;MTTP;LDLR;OSBPL2;PCTP;TNFAIP8L3;PITPNA
prerank,DNA repair (GO:0006281),0.3071740904526765,0.9755894778052363,0.5777331995987964,0.8997669506371132,1.0,59/284,16.63%,PARP9;TENT4A;MSH2;ASCC3;DTX3L;EXO5;TIMELESS;CHEK2;PSME4;POLD4;POLE2;APLF;MAD2L2;CHEK1;NOP53;UBE2B;RNASEH2A;CHD1L;CDKN2D;RFC4;POLB;TNKS1BP1;WDR33;HERC2;BRIP1;BACH1;UBXN1;RAD51C;ALKBH1;RPAIN;FEN1;ERCC4;XRCC3;MPG;ACTR8;BARD1;POLK;WDHD1;MEN1;MNAT1;VCPIP1;CIB1;NPM1;POLQ;PRKDC;ZRANB3;APBB1;USP45;MLH3;ALKBH2;ASCC2;NSMCE1;DCLRE1A;RECQL5;ERCC6L2;TDG;SPRTN;UPF1;NEIL2
prerank,regulation of DNA damage checkpoint (GO:2000001),0.46137869198552073,0.9755847587202181,0.4836309523809524,0.8992508050847938,1.0,3/10,14.75%,FEM1B;ETAA1;DDX39B
prerank,ERAD pathway (GO:0036503),0.32905557915660216,0.9755364673500394,0.5252960172228203,0.8988499122122072,1.0,18/83,15.32%,AUP1;TRIM25;TMEM129;RNF5;UBQLN2;POMT2;AMFR;TMUB2;UBQLN1;FAM8A1;RNF103-CHMP3;FAF2;RNF185;UBE4B;ANKZF1;ERLIN2;TMEM67;RNF103
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.45772377558443245,0.975529681546463,0.5029940119760479,0.898348347477247,1.0,2/10,6.37%,CCL5;PODXL
prerank,cellular response to unfolded protein (GO:0034620),0.3823133125036805,0.975515499050032,0.5142857142857142,0.8978567147101371,1.0,2/26,1.77%,HSPA1B;DAXX
prerank,positive chemotaxis (GO:0050918),0.4046398411324301,0.9754322066829603,0.4931693989071038,0.8975338272246,1.0,4/17,13.47%,PLXNB3;CX3CL1;MET;NRP1
prerank,cell-cell junction maintenance (GO:0045217),-0.3756815629418203,-0.9751478789532849,0.45288753799392095,1.0,1.0,7/11,41.90%,NLGN2;F2R;TJP1;PARD6A;INAVA;PRTN3;CD177
prerank,mitotic DNA replication (GO:1902969),0.46000725237224793,0.9748646462960312,0.5120481927710844,0.8984310324185903,1.0,2/10,5.06%,MCM2;MCM4
prerank,interstrand cross-link repair (GO:0036297),-0.24324339945019027,-0.9746181149848295,0.488,1.0,1.0,19/53,20.18%,RPA1;FANCC;FAAP20;SLX4;FANCM;DCLRE1B;UBB;FAAP100;UBC;FANCD2;UBA52;NEIL3;FANCG;RPS27A;ERCC1;RPA3;XPA;RAD51AP1;CENPX
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.438162945470987,0.9744501957637336,0.5256222547584187,0.8989177484757389,1.0,3/14,8.41%,TIMELESS;ACTR2;ARID2
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.3466552782546925,0.9744302176968068,0.5236447520184544,0.8984525750348327,1.0,10/46,14.38%,FIS1;FBXO7;TOMM40L;GDAP1;TOMM5;TIMM50;HK1;TSPO;PITRM1;AIP
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.389607889510753,0.9743861855302657,0.4869109947643979,0.8980357129069282,1.0,10/22,29.26%,DHX33;UBTF;DDX11;WDR43;MTOR;UTP15;PIH1D1;NCL;SMARCB1;ATF4
prerank,aminoglycan catabolic process (GO:0006026),0.3738849087198772,0.9741447018855253,0.5012315270935961,0.898113658910912,1.0,6/28,13.14%,SDC3;HYAL4;SDC4;AGRN;HPSE;HPSE2
prerank,hexose biosynthetic process (GO:0019319),0.3542770084413269,0.9739620917280479,0.5354239256678281,0.8980291627486487,1.0,6/42,8.02%,SORD;PER2;TPI1;SLC25A1;PGM1;SLC25A10
prerank,cardiac muscle cell development (GO:0055013),-0.3210368142506752,-0.9737454114135657,0.47161572052401746,1.0,1.0,10/20,34.59%,PDLIM5;SORBS2;CXADR;FHOD3;PDGFRA;PDGFRB;MYH11;HEY2;OBSL1;MYL2
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.2742031219085257,-0.9734225752079873,0.5,1.0,1.0,13/34,19.15%,TGFB1;ASXL1;ZFPM2;RUNX1T1;SIRT1;TRIO;ANKRD26;FOXO1;CCDC85B;E2F1;BBS12;YAP1;FLCN
prerank,neutrophil degranulation (GO:0043312),0.30355792091741685,0.9731953688368074,0.608,0.8993917088909823,1.0,111/425,21.92%,HSPA1B;DNAJC13;BST2;CTSS;CPNE3;TRPM2;GOLGA7;B2M;PSMA5;CANT1;CD55;ACTR2;ADAM8;CYBB;RHOF;CD47;LAMP2;DYNC1H1;ATP8A1;ERP44;HSP90AB1;KPNB1;FGL2;NAPRT;CYFIP1;SLPI;DEGS1;CAB39;NFKB1;CPPED1;IDH1;CSNK2B;CTSC;B4GALT1;PPIA;PGM1;UNC13D;CYB5R3;CAND1;CTSH;LAIR1;RAB5C;NEU1;HMGB1;MAPK14;HSPA8;C3AR1;TIMP2;HPSE;CRACR2A;RAB14;PSMD2;FAF2;ARPC5;GSN;RAB24;ILF2;PSEN1;SVIP;LAMTOR3;DYNLL1;CMTM6;CAPN1;KCMF1;GHDC;VAMP2;RAC1;SNAP23;ATP11A;HSP90AA1;SYNGR1;NPC2;DBNL;NHLRC3;PTGES2;CD300A;TLR2;TUBB4B;UBR4;PGRMC1;HMOX2;TCIRG1;IST1;PTPRC;LAMP1;MAGT1;GLB1;BRI3;DERA;GYG1;PSMD7;AMPD3;CD68;PTPRB;CD53;CD33;RAB5B;TYROBP;SIRPA;DDX3X;PLAUR;STXBP3;DDOST;PRKCD;PSMC2;TMC6;ARSA;ALDOC;PSMD12;MGST1;HUWE1
prerank,protein catabolic process (GO:0030163),0.33616231371720007,0.9731775808682768,0.5287610619469026,0.8989217948278241,1.0,16/59,18.94%,CHEK2;RNF5;LAMP2;SIAH1;RAB12;LRSAM1;NGLY1;UCHL3;HSPA8;APOE;HSP90AA1;ATE1;MTOR;STT3B;SOCS6;DDI2
prerank,protein import into peroxisome matrix (GO:0016558),0.439595579202154,0.9729830650610879,0.49264705882352944,0.89887473615303,1.0,4/12,17.02%,PEX7;PEX2;PEX5;PEX13
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.3951124861962475,0.9726244672874504,0.5046357615894039,0.8993183057671288,1.0,5/23,12.26%,NFKB1;ENTPD5;APP;INSR;PSEN1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.3234081335056217,-0.9725937189195247,0.48523206751054854,1.0,1.0,5/18,11.66%,ROCK1;SELPLG;JAM2;CX3CR1;GOLPH3
prerank,peptidyl-serine modification (GO:0018209),-0.20243583621968442,-0.9724637314068293,0.6,1.0,1.0,45/166,17.03%,CSNK2A1;DYRK1A;STK32A;STK38;PARP2;PRKCQ;SGK1;RPS6KA3;PARP1;ROCK1;PRKCZ;VRK1;PAK2;CSNK1E;PINK1;VRK2;ULK2;RPS6KA2;GSK3B;TTBK1;MKNK2;CAMK4;TAF1;AKT2;RPS6KA6;MAP3K13;CAMK1;GRK2;GALNT2;PRKCI;MAST1;AKT1;ULK3;HIPK1;TTBK2;RPS6KA4;CSNK1G2;MAP3K12;CLSPN;DYRK4;NDNF;DYRK1B;MAST4;MAP4K1;NAA10
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.3686501990542269,0.9722503664006759,0.5100250626566416,0.8997242284532736,1.0,13/32,21.60%,ANKLE2;HSP90AB1;MAGI2;PPIA;DUSP26;SPPL3;CALM3;CD300A;MTOR;PPP1R7;PIN1;PPP2R5A;PRKCD
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.34275388636632753,0.9721904970534617,0.5137614678899083,0.8993561085888438,1.0,21/53,28.16%,EYA4;TMEM161A;DDX5;DHX9;NSMCE1;EEF1E1;EYA2;SPRED3;BABAM2;SPRED1;PRKCD;SMCHD1;FBH1;NACC2;TIGAR;TRIM28;EYA3;EYA1;ATR;UBE2N;BABAM1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.3787502101581475,-0.9720719329779524,0.4778761061946903,1.0,1.0,3/11,6.20%,SYK;PRKCQ;ANK3
prerank,sphingosine biosynthetic process (GO:0046512),0.4472213846068998,0.9718677260717808,0.539039039039039,0.8991175355174644,1.0,4/11,18.29%,ASAH2;SPHK2;ACER3;SPTLC2
prerank,sphingoid biosynthetic process (GO:0046520),0.4472213846068998,0.9718677260717808,0.539039039039039,0.8991175355174644,1.0,4/11,18.29%,ASAH2;SPHK2;ACER3;SPTLC2
prerank,protein phosphorylation (GO:0006468),0.30246056460759024,0.9714722661061372,0.589,0.8996077345721986,1.0,104/478,19.24%,EIF2AK2;WNT11;TAOK3;FLT1;DAPK3;GLYCTK;CAMK2D;TP53RK;RSKR;SGK3;SGK2;KDR;FASTK;PIK3CD;BRD2;CAMK2B;CHEK2;ACVR1;MAPK6;HASPIN;CDC25B;STK38L;PKN2;PNCK;HCK;USP15;CHEK1;IKBKE;ILF3;PEAK1;MORC3;CDK12;EPHA4;MKNK1;FGFR2;PAK3;CAB39;NRBP2;RET;CSNK2B;CSNK2A2;HTATIP2;SMAD2;FAM20B;GMFB;VRK3;LTK;LYN;CLK3;APP;INSR;SRPK1;PIK3R4;BMPR2;MAST3;MAPK14;PRKAG1;CDK19;TNIK;CDK10;NUAK2;CDK20;BCKDK;SIK1;PIM1;NEK6;DYRK2;PRKDC;PRKCE;CLK2;JAK2;FYN;PRKCH;FAM20C;MASTL;STK25;MINK1;BMPR1A;TLR2;NRBP1;TAOK2;OXSR1;FGFR3;MTOR;TBCK;IRAK1;STK39;CSK;BCR;TLR3;SNRK;PRKG2;BIRC6;ACVR2A;FNIP2;COPS8;MARK1;CTBP1;BRSK1;NEK7;STK16;STK24;STK3;CAMKK2
prerank,intracellular protein transport (GO:0006886),0.30641006063656084,0.9712155187058805,0.5801603206412825,0.8997386652371689,1.0,77/304,20.30%,ARF3;TBC1D1;RANBP6;STAT3;MYO1C;RAB21;LAMP2;SRPRA;NUP153;KPNB1;SEC16A;CSE1L;PRICKLE1;AP2A1;TRAK1;STX7;HERC2;ARF5;GGA3;NXT1;TMED5;VPS33A;TBC1D8;UNC93B1;RPAIN;RAB22A;RAB43;RAB5C;STX8;PPP1R10;STX16;TMED10;TBC1D8B;SNX9;NPM1;IFT27;FUT10;VIPAS39;RAB14;ARL1;SORL1;RAB24;SCFD1;IPO8;SMURF1;VPS28;ARL5C;RIC1;TNPO2;MYO6;NAPB;NAPA;STX4;FAM91A1;RANBP3L;NUP155;ARF4;VPS26A;RPL11;RAB32;TBCK;RANBP17;SNX1;TBC1D2;TMED1;NUP88;CDC37;SLU7;TMED3;COPB2;NUP133;RAB5B;SGSM1;RAB1A;SGSM3;TBC1D4;APPL2
prerank,positive regulation of macroautophagy (GO:0016239),0.33720272651702876,0.9710663171270283,0.5232018561484919,0.8995855385437481,1.0,6/48,6.35%,IRGM;KDR;FYCO1;LARP1;LRSAM1;SH3GLB1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.3701926660063287,0.9709618474334737,0.5288343558282208,0.8993158545845996,1.0,10/30,20.16%,XRN1;DCP2;ERCC4;BMPR2;MEN1;HNRNPA1;STN1;DACH1;TERF2;ACVRL1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.34240415137740565,-0.9707963321021175,0.45263157894736844,1.0,1.0,7/15,21.62%,DYRK1A;EGFR;MAPK3;IGF1R;TXK;ABL1;DDR1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.36755378417923107,0.970685231792516,0.490613266583229,0.8994750274738323,1.0,8/30,12.63%,FBXW7;SH3GLB1;VPS11;CSNK2A2;RNF31;LEPROT;NPEPPS;UBE2L3
prerank,regulation of cellular localization (GO:0060341),0.3441638144139218,0.9705591061300256,0.5028901734104047,0.899267480003663,1.0,12/46,18.92%,CAMK2D;DYNC1H1;ADCY5;HSP90AB1;UNC13D;LYN;PPM1F;GSN;HSP90AA1;GOSR1;BRSK1;NUMA1
prerank,protein localization to centrosome (GO:0071539),0.4134573057027499,0.9705449216691199,0.5159059474412172,0.8987867238133403,1.0,9/17,27.47%,SNX10;NEDD1;CEP131;HOOK3;PIBF1;CEP83;BBS4;CEP192;CCDC14
prerank,negative regulation of protein catabolic process (GO:0042177),0.3550276241424307,0.9703421508432487,0.5299647473560517,0.8987648860068365,1.0,9/40,13.46%,RGP1;AZIN2;MAD2L2;RILP;AGAP2;TIMP2;AZIN1;RIC1;NELL1
prerank,regulation of protein localization to centrosome (GO:1904779),-0.38912774773626385,-0.9702854732948806,0.50997150997151,1.0,1.0,8/10,36.67%,MARK4;GSK3B;APC;CEP72;CEP250;NUP62;PARD6A;NSFL1C
prerank,chromatin assembly or disassembly (GO:0006333),0.44446379933204494,0.9700629961990903,0.5052005943536404,0.8989286195608157,1.0,3/11,13.32%,MTA2;CHAF1B;HDAC8
prerank,negative regulation of protein binding (GO:0032091),0.33330970986886777,0.9700168661042925,0.5445544554455446,0.8985352697120202,1.0,21/71,24.09%,IFIT1;IFIT2;B2M;SLPI;DACT1;LRPAP1;ARRB2;SORL1;DDX11;RACK1;DAB2;ACTB;BAX;ITGA4;PIN1;PTPRF;PRKCD;USP33;DNAJB2;TLE5;ADAM15
prerank,DNA metabolic process (GO:0006259),0.304327727167675,0.9698534982500965,0.5921843687374749,0.8984497252435507,1.0,47/270,13.64%,SP100;SAMHD1;MSH2;MCM2;LRWD1;TIMELESS;PSME4;POLD4;POLE2;MCM7;CHEK1;NOP53;UBE2B;RNASEH2A;CHD1L;MCM4;RFC4;POLB;RFC1;CDT1;TCF7L2;BACH1;RTEL1;RAD51C;ALKBH1;RPAIN;FEN1;ERCC4;XRCC3;MPG;BARD1;POLK;DNMT1;HMGB1;WDHD1;MEN1;MNAT1;NPM1;LONP1;POLQ;HMGB3;PRKDC;ORC3;ZRANB3;DNASE2;STN1;USP45
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3359565892423001,0.9697574682214479,0.5423162583518931,0.8981594930868165,1.0,13/56,20.16%,GDF9;ACVR1;PMEPA1;CSNK2B;BMPER;BMPR2;DAB2;BMPR1A;ACVR2A;RBPMS;SNX25;PIN1;ACVRL1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.4555744666439273,0.9687260062896793,0.5258358662613982,0.9002330539313557,1.0,2/10,10.06%,XYLT2;CSGALNACT2
prerank,T cell activation (GO:0042110),0.3241305378745102,0.9687184698085597,0.5300668151447662,0.8997410297632956,1.0,17/69,23.12%,TREML2;ICOSLG;PIK3CD;CHD7;CD276;NCK1;LEPR;NCK2;LMBR1L;NHEJ1;MDK;PTPRC;LCK;DDOST;RHOH;MSN;RAB29
prerank,regulation of cellular metabolic process (GO:0031323),0.35030669646252593,0.9684852501184396,0.5308219178082192,0.8998048718248908,1.0,8/45,15.79%,BCO2;ABCG1;KIF16B;MKLN1;EIF6;PANK2;NPC2;ARF4
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.333834837175882,-0.9684122963629385,0.5097276264591439,1.0,1.0,7/16,30.05%,IGFBP5;IGFBP4;ZFAND2B;IGFBP6;IGFBP3;BMP5;BMP2
prerank,regulation of vacuole organization (GO:0044088),-0.3150874956796613,-0.9684077767643905,0.47560975609756095,1.0,1.0,6/20,16.27%,ENO1;LAPTM4B;IFT88;ENO2;RAB1B;MTM1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.31808337909498574,-0.9683682747323858,0.5068493150684932,1.0,1.0,9/21,25.50%,NFAM1;CD81;CARD11;IKBKG;FOXP1;CD226;TESPA1;NECTIN2;RPS3
prerank,leukocyte tethering or rolling (GO:0050901),-0.32805319487039275,-0.9682089925513305,0.5039370078740157,1.0,1.0,5/17,11.66%,ROCK1;SELPLG;JAM2;CX3CR1;GOLPH3
prerank,amyloid fibril formation (GO:1990000),0.34228354968276925,0.9680156098461385,0.547105561861521,0.9004351057192227,1.0,10/51,15.31%,CALCA;UBE2L6;B2M;SIAH1;GGA3;APP;SORL1;GSN;APH1A;APH1B
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.3103557363160019,-0.9679001136128701,0.46236559139784944,1.0,1.0,4/19,16.78%,NCKAP1L;RAC2;RIPOR2;C1QBP
prerank,neutrophil mediated immunity (GO:0002446),0.3016802923649519,0.9675499370986156,0.633,0.9010508534041395,1.0,112/432,21.92%,HSPA1B;DNAJC13;BST2;CTSS;CPNE3;TRPM2;GOLGA7;B2M;PSMA5;CANT1;CD55;ACTR2;ADAM8;CYBB;RHOF;CD47;LAMP2;DYNC1H1;ATP8A1;ERP44;HSP90AB1;KPNB1;FGL2;NAPRT;CYFIP1;SLPI;DEGS1;CAB39;NFKB1;CPPED1;IDH1;CSNK2B;CTSC;B4GALT1;PPIA;PGM1;UNC13D;CYB5R3;CAND1;CTSH;LAIR1;RAB5C;NEU1;HMGB1;MAPK14;HSPA8;C3AR1;TIMP2;HPSE;CRACR2A;RAB14;PSMD2;FAF2;ARPC5;IRAK4;GSN;RAB24;ILF2;PSEN1;SVIP;LAMTOR3;DYNLL1;CMTM6;CAPN1;KCMF1;GHDC;VAMP2;RAC1;SNAP23;ATP11A;HSP90AA1;SYNGR1;NPC2;DBNL;NHLRC3;PTGES2;CD300A;TLR2;TUBB4B;UBR4;PGRMC1;HMOX2;TCIRG1;IST1;PTPRC;LAMP1;MAGT1;GLB1;BRI3;DERA;GYG1;PSMD7;AMPD3;CD68;PTPRB;CD53;CD33;RAB5B;TYROBP;SIRPA;DDX3X;PLAUR;STXBP3;DDOST;PRKCD;PSMC2;TMC6;ARSA;ALDOC;PSMD12;MGST1;HUWE1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.28178017044659437,-0.9672282783813388,0.49222797927461137,1.0,1.0,10/29,17.62%,ITGAV;MMD2;FGF10;RASGRF1;SRC;SHOC2;CRKL;RASGRP4;RASGEF1A;LRRC59
prerank,protein import into nucleus (GO:0006606),0.3302956726855328,0.9669509630511254,0.5350109409190372,0.9020465499019151,1.0,15/66,17.51%,RGPD1;RANBP6;STAT3;NUP153;KPNB1;CSE1L;PRICKLE1;NXT1;RPAIN;PPP1R10;IPO8;TNPO2;NUP155;RANBP17;NUP88
prerank,cellular respiration (GO:0045333),0.34927484321633534,0.966615752835167,0.5095465393794749,0.9023444109398286,1.0,18/41,29.64%,MTFR2;NDUFA5;COQ10B;SDHAF4;PPARGC1A;NDUFS1;UQCR10;NDUFS4;NDUFS8;NDUFS7;SDHB;UQCRFS1;LYRM7;CYCS;SDHA;SDHC;SIRT3;ETFDH
prerank,phagosome acidification (GO:0090383),-0.28812330528114205,-0.966364989886637,0.5,1.0,1.0,6/26,13.24%,ATP6V0A1;ATP6V1H;ATP6V1E1;ATP6V1C1;ATP6V1D;ATP6V1A
prerank,regulation of transport (GO:0051049),0.3577834498735287,0.9663321880982783,0.5301932367149759,0.9025337077299402,1.0,10/36,16.20%,GAPVD1;LEPR;RSC1A1;SCFD1;VAMP2;NRP1;MYO6;ACTB;CLDN10;RAB11A
prerank,regulation of Wnt signaling pathway (GO:0030111),0.31567837066100335,0.9661159617667194,0.5402542372881356,0.9025402280592675,1.0,21/108,15.45%,GRB10;SFRP2;RUNX1;CTNNB1;FGFR2;ITGA3;HMGXB4;MDFIC;FRZB;DACT1;APP;KANK1;BTRC;APCDD1;PSEN1;MDFI;RACK1;CXXC4;ZRANB1;CTNND2;TLR2
prerank,protein-containing complex subunit organization (GO:0043933),0.3193426820999401,0.9658946821260331,0.5617860851505712,0.9025747672378774,1.0,21/109,16.61%,PML;GPAA1;TEAD2;CD40;LAMC1;MDN1;CHCHD10;TSPAN4;SOX9;TAPBP;KMT2A;SKAP2;DET1;MNAT1;SNX9;MITF;PPARGC1A;VAMP2;IL1RAP;LLGL1;WDR19
prerank,macrophage differentiation (GO:0030225),0.4372403822382025,0.9655023677293938,0.5384615384615384,0.9030151309848022,1.0,2/13,6.88%,IL15;CSF1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.3922346874581579,-0.9650439707165122,0.47468354430379744,1.0,1.0,3/10,6.13%,STIM1;HOMER1;HOMER3
prerank,exit from mitosis (GO:0010458),0.4328115152250952,0.9646604283209048,0.5309859154929577,0.9045410618707678,1.0,1/12,0.58%,CHMP4B
prerank,protein kinase B signaling (GO:0043491),0.380302367754435,0.9646488882602934,0.5297157622739018,0.9040542333931806,1.0,5/23,10.96%,KDR;CCL5;MT3;PLK3;ZFP36L1
prerank,axonal transport (GO:0098930),0.3570754946593548,0.9646183002119797,0.5386416861826698,0.9036096166666459,1.0,6/36,12.09%,BLOC1S4;RAB21;DYNC1H1;KIF3B;AP3M2;AP3S2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.42655141411938685,0.9646083818863951,0.5347826086956522,0.9031244403596227,1.0,5/14,17.83%,TRPT1;TSEN2;FAM98B;RTCB;TSEN34
prerank,long-term memory (GO:0007616),-0.31170141684996205,-0.9643700136312565,0.49433962264150944,1.0,1.0,6/19,16.64%,SGK1;RASGRF1;RGS14;CAMK4;CALB1;PJA2
prerank,potassium ion import across plasma membrane (GO:1990573),-0.26353711794979706,-0.9642918332057698,0.49044585987261147,1.0,1.0,5/41,3.69%,SLC12A6;ATP1B1;SLC12A2;ATP1B2;KCNJ10
prerank,endocardial cushion morphogenesis (GO:0003203),0.40283657594445077,0.9640985490671017,0.5164835164835165,0.9038875822871699,1.0,5/18,23.22%,ACVR1;SOX9;BMPR1A;ACVRL1;NOTCH1
prerank,positive regulation of DNA binding (GO:0043388),-0.27977008878982745,-0.9636267242138704,0.5157894736842106,1.0,1.0,5/31,8.81%,TGFB1;PPARG;NIBAN2;TRAF6;PINX1
prerank,organic hydroxy compound transport (GO:0015850),0.3629260073778149,0.9636256757402659,0.5425,0.9044960411523502,1.0,4/36,6.49%,ABCC2;SLCO1C1;NCOA1;SLCO1B1
prerank,positive regulation of protein import (GO:1904591),-0.27852779908582453,-0.9636212157634269,0.5362318840579711,1.0,1.0,10/30,22.88%,TGFB1;EFCAB7;PIK3R2;ZIC1;UBR5;DMAP1;BAG3;ECT2;TPR;RBM22
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.4503415424778842,0.9634746086075201,0.5411061285500748,0.9043499631309587,1.0,6/12,19.17%,KIF2C;CDT1;MIS12;CHAMP1;RMDN1;NDC80
prerank,regulation of autophagy (GO:0010506),0.301207496218763,0.9633998330723821,0.5985844287158746,0.9040265075755018,1.0,56/216,21.85%,IRGM;TRIM14;DAPK3;TRIB3;ATP6V0D1;STAT3;TRIM21;UBQLN2;ITPR1;OSBPL7;FBXW7;RRAGC;SH3GLB1;MT3;IL10RA;CSNK2A2;CISD2;MET;LEPR;HMGB1;PRKAG1;UBQLN1;ZC3H12A;FOXK1;CAPNS1;SVIP;LAMTOR3;CAPN1;PIK3CB;BAD;RUBCN;EIF4G3;RB1CC1;TMEM59;BMF;VPS26A;MTOR;SREBF1;KAT8;WDR41;ATP6V1B2;ATP6V1G1;ZKSCAN3;NPRL2;ATP6V1G2;TAB3;ERN1;LAMTOR4;TLK2;MCL1;STK11;OPTN;VPS35;ABL2;RHEB;USP33
prerank,cellular protein localization (GO:0034613),0.3022977517929276,0.9627791364356515,0.6098294884653962,0.9050609674154096,1.0,71/285,19.99%,WNT11;WNT5A;ARF3;TBC1D1;RAB21;CNTNAP1;RTP4;COG3;RRAGC;CTNNB1;TM9SF1;AP2A1;STX7;HERC2;ARF5;GGA3;TMED5;VPS33A;TBC1D8;UNC93B1;RAB22A;CNTLN;RAB43;EPB41L3;RAB5C;STX8;STX16;TMED10;TBC1D8B;SNX9;NPM1;IFT27;VIPAS39;RAB14;ARL1;RAB24;SCFD1;SMURF1;LAMTOR3;ARL5C;RIC1;CORO1B;MYO6;SEPTIN9;NAPB;NAPA;STX4;FAM91A1;BBS2;HGS;ARF4;VPS26A;RAB32;TBCK;JAM3;SNX1;PTPRU;SH3PXD2B;TBC1D2;TMED1;SLU7;TMED3;COPB2;ARMCX3;RAP2A;PIGK;RAB5B;SGSM1;RAB1A;SGSM3;TBC1D4
prerank,regulation of cell adhesion (GO:0030155),0.3107383848847243,0.9627056619661085,0.5837669094693028,0.904738612396022,1.0,22/129,17.33%,PLXNA3;HYAL1;CXCR4;PLXNB2;SEMA4D;CDH13;ADAM8;CCL5;PLXNB3;EPHA4;PODXL;RET;YTHDF2;LYN;DUSP26;PTPN11;STX4;MINK1;DSCAM;IL18;MDK;CBLL1
prerank,regulation of ATP metabolic process (GO:1903578),0.3403133729995259,0.9625070410131753,0.5388888888888889,0.9047205462732487,1.0,15/54,20.34%,NUP37;FIS1;SLC2A6;NUP153;RAE1;ABCD1;PRKAG1;SPHK2;EIF6;AK4;NUP155;NUP88;COX7A2;NUP133;NUP43
prerank,presynapse assembly (GO:0099054),0.3990035959608445,0.9624073341686011,0.5083333333333333,0.9044572275807125,1.0,7/16,26.52%,WNT5A;LRRTM3;BSN;NLGN3;PCLO;LRP4;PTEN
prerank,rRNA 3'-end processing (GO:0031125),-0.3779655029159797,-0.962228350933725,0.5273224043715847,1.0,1.0,4/10,13.21%,EXOSC7;EXOSC10;ERI1;EXOSC3
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.28350027049282417,-0.962109205507292,0.5044642857142857,1.0,1.0,4/26,3.76%,PAK1;FES;DRG1;CLIP1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.28471217571136026,-0.9619896038179716,0.48095238095238096,1.0,1.0,11/29,22.31%,TECR;HACD1;ELOVL5;ELOVL1;ACSL1;ACSL6;ELOVL7;ACSBG1;SCD;ACSL4;ELOVL6
prerank,neutrophil activation involved in immune response (GO:0002283),0.3000273548345874,0.9619854503881168,0.641,0.9049704654285974,1.0,111/428,21.92%,HSPA1B;DNAJC13;BST2;CTSS;CPNE3;TRPM2;GOLGA7;B2M;PSMA5;CANT1;CD55;ACTR2;ADAM8;CYBB;RHOF;CD47;LAMP2;DYNC1H1;ATP8A1;ERP44;HSP90AB1;KPNB1;FGL2;NAPRT;CYFIP1;SLPI;DEGS1;CAB39;NFKB1;CPPED1;IDH1;CSNK2B;CTSC;B4GALT1;PPIA;PGM1;UNC13D;CYB5R3;CAND1;CTSH;LAIR1;RAB5C;NEU1;HMGB1;MAPK14;HSPA8;C3AR1;TIMP2;HPSE;CRACR2A;RAB14;PSMD2;FAF2;ARPC5;GSN;RAB24;ILF2;PSEN1;SVIP;LAMTOR3;DYNLL1;CMTM6;CAPN1;KCMF1;GHDC;VAMP2;RAC1;SNAP23;ATP11A;HSP90AA1;SYNGR1;NPC2;DBNL;NHLRC3;PTGES2;CD300A;TLR2;TUBB4B;UBR4;PGRMC1;HMOX2;TCIRG1;IST1;PTPRC;LAMP1;MAGT1;GLB1;BRI3;DERA;GYG1;PSMD7;AMPD3;CD68;PTPRB;CD53;CD33;RAB5B;TYROBP;SIRPA;DDX3X;PLAUR;STXBP3;DDOST;PRKCD;PSMC2;TMC6;ARSA;ALDOC;PSMD12;MGST1;HUWE1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.3943425982925789,0.9618934621702713,0.5243243243243243,0.9046659031975705,1.0,7/20,18.56%,ZFP36;HOXA9;CIB1;ZFP36L1;LDB1;PRMT1;HOXA5
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.314660584492489,-0.9618680224080903,0.5245283018867924,1.0,1.0,4/18,8.54%,TGFB1;EGFR;ESR1;RIPK1
prerank,sodium ion transmembrane transport (GO:0035725),-0.2198660030600274,-0.9617998250156607,0.6060606060606061,1.0,1.0,11/84,9.79%,SLC9A9;ATP1B1;SLC12A2;ATP1B2;NALCN;SLC6A15;SLC8A3;SLC6A8;SCN3A;SLC4A8;TRPM4
prerank,ameboidal-type cell migration (GO:0001667),-0.2392329314378359,-0.961724574742473,0.5390625,1.0,1.0,15/51,16.19%,PDXDC1;CENPV;SEMA4C;SEMA4G;SEMA4A;SEMA6A;PDLIM1;ANXA6;SEMA4B;SEMA3E;SEMA5B;AKT1;SOX10;AMOTL1;AMOT
prerank,T-helper cell differentiation (GO:0042093),0.42690569326720385,0.9614955992857287,0.5416058394160584,0.9051240311747428,1.0,3/14,9.13%,PTGER4;TMEM98;HMGB1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3485014297226698,0.9609206662351618,0.5518474374255066,0.9060144335906921,1.0,9/41,19.95%,SLAMF1;ILRUN;CX3CL1;ZC3H12A;HAVCR2;DICER1;LGALS9;CD33;SIRPA
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.34200878155140996,0.9606552742774765,0.5283893395133256,0.9061564992117158,1.0,14/47,18.85%,CARMIL1;ARHGEF7;MYOC;PDPN;KANK1;CIB1;LIMS1;NRP1;RAC1;RREB1;CRK;MDK;CORO1C;TESK1
prerank,response to ionizing radiation (GO:0010212),-0.22392923150613578,-0.9603074844195181,0.5866666666666667,1.0,1.0,26/70,20.74%,INO80;BRAT1;USP28;NABP1;XRCC4;RHNO1;SPIDR;SIRT1;EEF1D;DCUN1D3;MRNIP;BRCA1;INIP;NABP2;HUS1;FANCD2;TP53;CDKN1A;RAD1;ANXA1;NET1;ECT2;MYC;RAD51AP1;SMPD1;ABRAXAS1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.45014340836389316,0.9600691026837557,0.5073529411764706,0.9070758721731024,1.0,2/11,6.66%,ITPKC;PPIP5K1
prerank,response to hexose (GO:0009746),0.3738202254081939,0.9600650418337325,0.5227272727272727,0.9065781383006476,1.0,7/25,18.89%,TCF7L2;EIF2B2;VAMP2;IRS2;SELENOT;EIF2B5;EIF2B3
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.3240937533719637,0.959491670807685,0.5506465517241379,0.9074470663589581,1.0,22/75,19.80%,SLITRK6;ATL1;FGFR2;PAK3;BTBD3;APP;RB1;APBB1;ACTB;MINK1;TBCD;TAOK2;MEF2A;BAIAP2;DSCAML1;OPHN1;LLGL1;DCDC2;ABITRAM;BRSK1;MAP1B;CCK
prerank,sodium ion import across plasma membrane (GO:0098719),-0.3229851659053297,-0.9594721665952056,0.5,1.0,1.0,3/17,9.79%,SLC9A9;SLC12A2;TRPM4
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.43239715085633157,0.9592792043091437,0.5408895265423243,0.9074513038108952,1.0,3/12,14.82%,CYP26B1;SNW1;EZH2
prerank,negative regulation of lyase activity (GO:0051350),-0.32519623735681563,-0.9591951225002523,0.4861111111111111,1.0,1.0,4/16,12.68%,GRM3;EDNRB;PALM;CCR2
prerank,hepaticobiliary system development (GO:0061008),0.3882951855097017,0.9590453455805981,0.5214007782101168,0.9074978792563124,1.0,5/20,11.45%,GFER;ARID5B;MET;PROX1;XBP1
prerank,cellular response to BMP stimulus (GO:0071773),0.33025862472790646,0.9588269611277951,0.549171270718232,0.9075235250115943,1.0,12/66,15.87%,GDF9;ACVR1;DDX5;USP15;SOX9;SMAD2;SCX;BMPR2;RGMB;SMURF1;BMPR1A;ADAMTS12
prerank,regulation of neuroblast proliferation (GO:1902692),0.41074806949578674,0.9586159837094224,0.5344585091420534,0.9075491419675998,1.0,2/15,5.48%,CTNNB1;CX3CL1
prerank,embryonic digestive tract development (GO:0048566),-0.31647913775407,-0.9581804141421532,0.5204918032786885,1.0,1.0,4/18,8.41%,NIPBL;SALL1;ID2;TGFB2
prerank,necroptotic process (GO:0070266),0.4053630869953434,0.9581143872436719,0.5294924554183813,0.9082476920267153,1.0,6/16,21.41%,MLKL;CYLD;ITPK1;TRPM7;TLR3;PGAM5
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.34463525494252256,0.9574755885213598,0.5441696113074205,0.9092485158209226,1.0,7/39,13.47%,KDR;SFRP2;CTNNB1;MET;GDNF;NOTCH4;NRP1
prerank,membrane lipid metabolic process (GO:0006643),0.3879880318960084,0.9573089212768336,0.5254237288135594,0.9091520804027403,1.0,4/22,9.98%,ST6GALNAC4;B4GALT4;CERKL;SPHK2
prerank,embryonic heart tube morphogenesis (GO:0003143),0.3483557686451525,0.9571090449092834,0.5395348837209303,0.9091249617385839,1.0,5/43,11.23%,ACVR1;CCDC40;NPHP3;SRF;SETDB2
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.30795152497187417,-0.9568770381251949,0.4538152610441767,0.997717372931648,1.0,11/20,32.49%,MAD1L1;APC;TEX14;BUB1;CENPF;TPR;TRIP13;BUB3;KNTC1;TTK;PLK1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.30795152497187417,-0.9568770381251949,0.4538152610441767,0.997717372931648,1.0,11/20,32.49%,MAD1L1;APC;TEX14;BUB1;CENPF;TPR;TRIP13;BUB3;KNTC1;TTK;PLK1
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.30795152497187417,-0.9568770381251949,0.4538152610441767,0.997717372931648,1.0,11/20,32.49%,MAD1L1;APC;TEX14;BUB1;CENPF;TPR;TRIP13;BUB3;KNTC1;TTK;PLK1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3551114159890043,0.9568327381359379,0.5389082462253194,0.9092744536463229,1.0,9/36,14.82%,PCGF6;CHEK1;TFDP1;RING1;MAX;RYBP;TFDP2;UXT;EZH2
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.3054960300074885,-0.956631201029758,0.5128205128205128,0.9959568080952056,1.0,4/21,11.76%,LRP6;GSK3B;DVL3;APC
prerank,negative regulation of axon extension (GO:0030517),-0.2787245785905468,-0.9564821601419238,0.5120772946859904,0.9938747748281296,1.0,9/30,13.00%,SEMA4C;DIP2B;SEMA4G;SEMA4A;CDKL3;SEMA6A;SEMA4B;SEMA3E;SEMA5B
prerank,negative regulation of receptor internalization (GO:0002091),0.43476027645394166,0.9561275788144611,0.5363372093023255,0.9104798563708625,1.0,3/12,10.01%,UBQLN2;WDR54;LRPAP1
prerank,glucose homeostasis (GO:0042593),0.31877672012083064,0.9559610849403456,0.5559105431309904,0.9103587937056711,1.0,14/83,15.24%,IRS1;STAT3;TCF7L2;USF1;TFAP2B;LEPR;INSR;HK1;FOXK1;PPARGC1A;RPS6;BAD;INPP5K;SELENOT
prerank,histone mRNA metabolic process (GO:0008334),0.3695135353080614,0.9559474375652666,0.5332480818414322,0.9098802454649297,1.0,10/27,23.56%,NCBP2;XRN1;DCP2;SNRPG;NCBP1;TUT7;UPF1;MTPAP;EXOSC4;SNRPD3
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.32231640390790406,-0.9559049996037542,0.5517241379310345,0.9932587100077892,1.0,7/17,15.73%,DOCK4;DOCK7;ADAMTS1;IGFBP5;DOCK5;S100A11;VTN
prerank,regulation of focal adhesion assembly (GO:0051893),0.33533476440980287,0.9556632566033345,0.5628604382929643,0.9100373978764137,1.0,11/54,13.90%,DAPK3;KDR;THY1;PEAK1;DUSP3;MYOC;PPM1F;LDB1;LIMS1;NRP1;RAC1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.30619001610907964,0.9556314776356772,0.599591419816139,0.9096005009573963,1.0,49/148,24.80%,PML;TAF4B;TP53RK;DAXX;PAK1IP1;CHEK2;CHEK1;NOP53;RFC4;PPP2R5C;BRIP1;CSNK2B;RRS1;CSNK2A2;MTA2;TAF2;BARD1;PLK3;MAPK14;PRKAG1;SSRP1;TAF3;DYRK2;NOP2;BRPF1;RMI1;TAF15;RPL11;MTOR;BRD7;HDAC1;RFFL;PIN1;SMYD2;ATRIP;JMY;RPL5;STK11;PRDM1;ING5;HDAC2;KAT6A;RAD9A;PDPK1;KAT5;TAF7;PRKAB2;TAF4;TAF11
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.3617442105729944,0.9550990017807933,0.5355392156862745,0.9103444508261017,1.0,8/32,18.79%,TAOK3;CHEK1;NOP53;TRIM39;RINT1;TAOK2;BABAM2;BRSK1
prerank,positive regulation of protein catabolic process (GO:0045732),0.3156540047289951,0.9550820721441945,0.5563751317175974,0.9098765009285348,1.0,26/84,23.72%,WNT5A;SNX33;ADAM8;EGLN2;RILP;AREL1;VPS11;DACT1;BARD1;PLK3;SNX9;SORL1;SMURF1;APOE;VPS28;HSP90AA1;TIPARP;SH3D19;WWP1;VPS35;HUWE1;SMURF2;IDE;MSN;VCP;AXIN1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.3246004839298183,0.9549609074529701,0.5666305525460456,0.9096570860923924,1.0,24/80,23.72%,TRIB3;BIRC2;ARRDC4;FBXW7;PRICKLE1;UBE3A;DCUN1D4;RBX1;UBQLN1;PAXIP1;UBE2L3;BIRC3;MYCBP2;SPRTN;PIN1;RIPK2;HSPBP1;HUWE1;STUB1;DCUN1D5;CUL3;SENP2;XIAP;AXIN1
prerank,protein glycosylation (GO:0006486),0.3109453407730538,0.9549477603527279,0.5918781725888325,0.9091883619073139,1.0,31/125,18.77%,TMEM258;AQP11;COG3;POMT1;TRAK1;MPI;POMT2;GALNT7;B4GALT1;GCNT4;GFPT1;ENTPD5;B4GALT5;ST3GAL1;DAD1;FUT10;GALNT18;MGAT4C;B3GALNT1;NPC1;ALG11;RPN1;TET2;GALNT1;MGAT5;ST8SIA1;MAGT1;MAN1C1;FUT9;STT3B;SERP1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.39454939986581655,0.9548566173336727,0.5380434782608695,0.9088957567046666,1.0,5/20,18.54%,ATP1B3;SLC8A1;TFAP2B;KCNJ2;LACC1
prerank,regulation of bone mineralization (GO:0030500),0.3333677136256141,0.9545982099146113,0.5518018018018018,0.9089975122166944,1.0,13/55,20.47%,ISG15;ACVR1;SLC8A1;NBR1;ANKH;BMPR2;ADGRV1;ENPP1;NELL1;BMPR1A;ACVR2A;BCOR;DDR2
prerank,cell cycle checkpoint signaling (GO:0000075),-0.3659889838422845,-0.9545175220943178,0.5238095238095238,0.9953190320539046,1.0,4/12,18.35%,NABP1;NABP2;BUB1;PLK2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.4462317371541411,0.9544618892262603,0.5401785714285714,0.9088097976081831,1.0,4/10,17.39%,ARRB2;FCGR2B;LGALS9;PTPRC
prerank,protein secretion (GO:0009306),0.3322183199648704,0.954407642528022,0.5614430665163472,0.9084324718600578,1.0,7/56,10.87%,GAL;ABCA1;RAB8B;RAB12;NAGPA;SNX19;TMEM167A
prerank,neuron differentiation (GO:0030182),0.3048449608658996,0.9540787206831038,0.5989795918367347,0.9087167757471066,1.0,25/165,19.46%,WNT11;PITX2;LHX2;LMX1A;WNT5A;RUNX1;CTNNB1;NGRN;WNT7B;NRBP2;SRF;DTNB;MET;XBP1;DDIT4;LDB1;SMARCA1;ADNP2;OPHN1;IER2;HS6ST1;ITM2C;FUT9;BRSK1;PIN1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.4473522749232326,0.9539033971397368,0.5321100917431193,0.9086511025515774,1.0,2/10,2.89%,SOCS1;CD55
prerank,detection of calcium ion (GO:0005513),0.43426577191338706,0.953889693806362,0.5290697674418605,0.9081864295115868,1.0,1/13,0.73%,KCNMB3
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.39044627383833713,0.9534226733001357,0.5128900949796472,0.908782347622132,1.0,5/20,21.95%,SPRY2;SMOC2;NPTN;DSTYK;FGF2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4450923153935162,0.9534046026751862,0.5436746987951807,0.9083209007196303,1.0,3/11,19.29%,SOCS5;ZC3H12A;RC3H2
prerank,regulation of DNA recombination (GO:0000018),0.3584248641816486,0.9533790739896973,0.5281602002503129,0.9078783275625795,1.0,7/32,15.81%,MSH2;CHEK1;RTEL1;SIRT6;PPP4R2;ZRANB3;ZCWPW1
prerank,positive regulation of DNA recombination (GO:0045911),0.37020204482582153,0.9533432275428628,0.5456919060052219,0.9074679439115897,1.0,7/27,15.81%,TIMELESS;ACTR2;MAD2L2;ARID2;SHLD1;PAXIP1;ZCWPW1
prerank,protein O-linked mannosylation (GO:0035269),0.39862800515703645,0.9532086095685094,0.530961791831357,0.9072531079689168,1.0,5/18,16.17%,TMTC1;POMT1;POMT2;CRPPA;TMTC4
prerank,positive regulation of programmed cell death (GO:0043068),0.29645428330509827,0.953206635390915,0.6389167502507522,0.9067585303719498,1.0,41/272,13.37%,ZBP1;TNFSF10;IFIT2;DAPK3;CLU;PRMT2;RARG;GADD45G;TNFRSF8;MLLT11;BCL2L11;SFRP2;PLEKHN1;SIAH1;CTNNB1;ARHGEF7;BCL6;DDX20;FRZB;HTATIP2;ABR;BARD1;HMGB1;VAV1;SPHK2;PRR7;DIABLO;DNM2;PHLDA1;RNF122;RNPS1;RYBP;ARHGEF11;SOS1;PSEN1;RACK1;RPS6;BAD;APBB1;AKAP13;TIAM2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3933481511974019,0.9527458533866384,0.5378486055776892,0.9073210592722354,1.0,4/20,10.07%,CCND2;HSP90AB1;CCND1;PROX1
prerank,regulation of cell development (GO:0060284),0.3562367542740633,0.95215828871511,0.5466507177033493,0.9082181265954243,1.0,5/36,8.45%,PER2;BHLHE40;CTNNB1;CX3CL1;YTHDF2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.3741712324329572,-0.9520791847641016,0.526984126984127,1.0,1.0,5/11,13.81%,CASP8;SLC25A4;YBX3;RIPK1;ARHGEF2
prerank,regulation of DNA repair (GO:0006282),0.346877426787059,0.9514446403145701,0.5506912442396313,0.9094464051928197,1.0,3/44,1.15%,PML;EYA4;TMEM161A
prerank,magnesium ion transport (GO:0015693),-0.35154752947839174,-0.9512276162454291,0.5176848874598071,1.0,1.0,5/12,22.00%,TUSC3;NIPAL3;MMGT1;CNNM4;NIPAL2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.33472977259211,0.9511858214862531,0.541958041958042,0.9095758374539883,1.0,12/49,16.90%,CLU;PTGER4;NOP53;PMEPA1;DACT1;HMGB1;RIOK3;ANKRD27;SORL1;SVIP;JAM3;PEX5
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.36913665204004736,0.9503629820113865,0.5398457583547558,0.9109942441224026,1.0,6/25,13.90%,UBQLN2;WDR54;APP;LRPAP1;PSEN1;RAC1
prerank,positive regulation of developmental process (GO:0051094),0.3045533028178215,0.9502988680302813,0.6046986721144024,0.9106609137299645,1.0,32/164,16.88%,WNT5A;KDR;ESRRB;FIS1;CAMK2B;AGO2;ACVR1;MAD2L2;HSP90AB1;SYDE1;SOX9;ARHGEF7;SRF;GDNF;B4GALT5;SCX;INSR;BMPR2;PHLDB1;XBP1;SORL1;SHLD1;PSEN1;APOE;PAXIP1;CORO1B;RREB1;BMPR1A;SOX5;ANAPC2;LRP8;MDK
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.347442289955094,-0.949939131812586,0.45323741007194246,1.0,1.0,4/13,14.73%,UBAC2;UBE2J1;UBE2G2;YOD1
prerank,negative regulation of potassium ion transport (GO:0043267),0.4226844760795913,0.9494105329853968,0.5404624277456648,0.9122769268744424,1.0,3/13,16.64%,ACTN2;CAB39;STK39
prerank,modulation by symbiont of host process (GO:0044003),-0.3910424472505193,-0.9493471900727543,0.5135135135135135,1.0,1.0,7/10,17.44%,ENO1;MRC1;UBB;PGK1;UBC;UBA52;RPS27A
prerank,translational termination (GO:0006415),0.3135157905831274,0.9492454567034783,0.5816216216216217,0.9121749924586211,1.0,24/95,19.21%,MRPL36;ERAL1;MRPS30;GSPT1;MRPL12;MRPL16;MRPS35;MRPS28;ABCE1;MRPL42;MRPL4;MRPS23;MRPS2;MRPS22;AURKAIP1;MRPL24;ETF1;MRPS10;MRPL13;MTRF1L;MRPL57;MRPS11;MRPL40;MRPL22
prerank,epithelial cell development (GO:0002064),0.3826458877072436,0.9491874964908299,0.5371352785145889,0.9118045274702384,1.0,3/20,9.16%,RILPL1;WNT7B;BFSP1
prerank,DNA packaging (GO:0006323),0.40545541419745934,0.948671290355428,0.5524079320113314,0.9125067926777124,1.0,3/16,10.22%,PRM1;BANF1;CHAF1B
prerank,snRNA transcription (GO:0009301),0.32275267091226645,0.9483346197526105,0.578420467185762,0.9128190163655155,1.0,17/70,17.70%,POLR2G;PHAX;SNAPC2;SRRT;NCBP2;CCNT2;RPAP2;TAF8;POLR2K;ICE2;ELL2;SNAPC5;GTF2E2;USPL1;NCBP1;CCNK;POU2F2
prerank,negative regulation of receptor binding (GO:1900121),0.45325482034848696,0.9481156835068045,0.5565476190476191,0.9128047525599242,1.0,1/10,2.20%,B2M
prerank,negative regulation of interleukin-2 production (GO:0032703),0.39684298511824145,0.9479419848431653,0.5445816186556928,0.9127006019802246,1.0,4/18,17.39%,ZFP36;PRNP;HAVCR2;PTPRC
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.3513350685209401,-0.9476182837008719,0.5098039215686274,1.0,1.0,9/13,29.26%,GLRX3;CIAO1;MMS19;CIAO2A;BOLA2;ISCA1;GLRX5;CIAO2B;CISD3
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.44324625884795865,0.9475120172404163,0.5414781297134238,0.9132007313373058,1.0,5/11,23.78%,TMEM106A;XBP1;JAK2;HDAC2;TAF7
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.33005015347081806,-0.9474839628310006,0.5627705627705628,1.0,1.0,3/15,5.60%,SYK;HSPH1;PNP
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.3370938441746842,-0.9473361637338965,0.5586206896551724,1.0,1.0,4/14,17.31%,RHOA;KLF4;MAP2K5;ITGB1BP1
prerank,regulation of acrosome reaction (GO:0060046),0.45056159420484587,0.9472063531584752,0.5293276108726752,0.9134055571738775,1.0,2/10,21.06%,SPINK13;GLRA1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3535785388169028,0.946747592243779,0.5344619105199516,0.9139856959641217,1.0,11/34,18.85%,CARMIL1;ARHGEF7;MYOC;CIB1;LIMS1;NRP1;RAC1;RREB1;CRK;MDK;TESK1
prerank,detection of mechanical stimulus (GO:0050982),-0.3071135971237874,-0.9467463077706393,0.5282258064516129,1.0,1.0,6/19,26.30%,CDH2;PKD2L1;PKD1L2;PKD2L2;JUP;PKD1L3
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.34992734479442505,-0.9466418708037874,0.48134328358208955,0.9982735856339613,1.0,2/12,2.45%,AKR1B1;STARD3NL
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.44459833602456916,0.9466053626817581,0.5442477876106194,0.9138233408844154,1.0,2/10,9.75%,IFI35;WDFY1
prerank,response to histamine (GO:0034776),-0.3845404460647184,-0.9461884435510375,0.514018691588785,0.9972732624056135,1.0,4/10,24.87%,GABRB1;HRH1;GABRB3;DRD2
prerank,mitochondrial translational elongation (GO:0070125),0.3136761033402797,0.9455949933805925,0.5776330076004343,0.9156809048077134,1.0,22/88,19.21%,MRPL36;ERAL1;MRPS30;MRPL12;MRPL16;MRPS35;MRPS28;GFM1;TUFM;MRPL42;MRPL4;MRPS23;MRPS2;MRPS22;AURKAIP1;MRPL24;MRPS10;MRPL13;MRPL57;MRPS11;MRPL40;MRPL22
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.37224398447781454,0.9454091351034671,0.544766708701135,0.915627197331688,1.0,9/25,23.22%,SMAD2;BMPR2;ZNF423;BMPR1A;RBPJ;ACVR2A;NUMA1;ACVRL1;NOTCH1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.3207958940385568,0.9453995268065265,0.581958195819582,0.9151471857728383,1.0,15/71,18.94%,ISG15;CHMP4B;CTSS;UBE2W;RSPRY1;CTSC;CTSH;NGLY1;LONP1;ZRANB1;ATE1;ADAMTS12;HM13;SOCS6;DDI2
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.27968226761538906,-0.9446988768931388,0.5555555555555556,0.9994932192226192,1.0,11/30,22.31%,TECR;HACD1;ELOVL5;SLC27A4;ELOVL1;ACSL1;ACSL6;ELOVL7;ACSBG1;SLC27A2;ELOVL6
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.30318718018776786,0.944428233487805,0.6083418107833164,0.9168982905573618,1.0,38/151,22.39%,NMRAL1;SLC27A1;SGPP2;MOCS3;CERS6;DEGS1;CSNK2B;CSNK2A2;LPIN2;CEPT1;B4GALT5;NFS1;LPCAT2;VAPB;SPHK2;TNIP1;GCH1;MOCOS;HACD3;APOE;ABHD3;PAM;CHPT1;ACER3;SPTLC2;SGPL1;CERS2;PCYT1A;PCTP;ELOVL4;SLC25A15;SLC44A1;SPTSSA;CHKA;PLPP2;PCYT1B;MGST1;CERT1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.3909471468039898,0.9443077591417349,0.5371352785145889,0.9166672806392431,1.0,7/19,19.46%,CLU;GGA3;PRNP;SORL1;APOE;FLOT2;PIN1
prerank,protein modification process (GO:0036211),0.321114013220571,0.9442667775079375,0.5780911062906724,0.916271413587543,1.0,23/76,24.02%,LIPT1;LOXL2;UBE2L6;USP25;UBE2M;NAGPA;SEPHS1;ST3GAL1;PPP4R2;PRKDC;UBE2L3;GGCX;RPN1;MSRA;SERP1;UBL5;ERO1A;YES1;ABL2;MMP15;FBXW2;PLAT;LOX
prerank,regulation of Notch signaling pathway (GO:0008593),0.31859807801523404,0.9441921717528364,0.6010695187165775,0.9159401224353947,1.0,13/76,11.00%,NOD2;DLK2;STAT3;TM2D3;MMP14;YJEFN3;FBXW7;ENHO;YTHDF2;EGFL7;MAML2;SNW1;NOTCH4
prerank,mucosal immune response (GO:0002385),-0.3272171603975132,-0.9440487974034955,0.5128205128205128,0.999185369982166,1.0,5/15,35.95%,RPL39;DEFA6;OTUD7B;IFNLR1;LTF
prerank,regulation of cell differentiation (GO:0045595),0.3036959099394193,0.9438618357629265,0.6180344478216818,0.9162497321838775,1.0,21/148,11.39%,EIF2AK2;BDNF;BIRC2;DDX5;RUNX1;HSP90AB1;FGFR2;BCL6;TFAP2B;CSF1;SNAI2;SRF;MEGF10;CDK5RAP2;LTK;GDNF;TAF8;ZFP36L1;NOTCH4;PHLDB1;SIK1
prerank,protein insertion into membrane (GO:0051205),-0.2683806963595712,-0.9432668513512897,0.5380116959064327,0.9991023113672994,1.0,9/32,13.91%,TRAM1;CCDC47;EGFR;CYB5A;HMOX1;REEP1;UBE2J2;SEC61G;SEC61B
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.36075691619676176,0.9430862799882536,0.5506172839506173,0.9175370878238339,1.0,7/31,16.79%,PRMT2;RBL1;CDKN2D;DACT1;RB1;DLG1;BRD7
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.43790689016674855,0.9427556954221301,0.5392592592592592,0.9178197648287326,1.0,7/11,27.64%,DIABLO;STK25;STK24;PRKCD;ARL6IP5;MAP3K5;PDCD10
prerank,branched-chain amino acid catabolic process (GO:0009083),0.3854512622086877,0.942569321576648,0.5449871465295629,0.9172562610306828,1.0,11/20,30.01%,AUH;DLD;BCKDK;ACAT1;HIBADH;MCCC1;DBT;ALDH6A1;HSD17B10;BCKDHA;BCAT2
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3854512622086877,0.942569321576648,0.5449871465295629,0.9172562610306828,1.0,11/20,30.01%,AUH;DLD;BCKDK;ACAT1;HIBADH;MCCC1;DBT;ALDH6A1;HSD17B10;BCKDHA;BCAT2
prerank,positive regulation of organelle assembly (GO:1902117),0.3380816172614003,0.9424180281096134,0.5483870967741935,0.9171091218306758,1.0,7/44,10.32%,SDC4;DYNC1H1;KCTD17;LRSAM1;SH3GLB1;CCDC88A;G3BP2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.2907596250810833,-0.9422784280070865,0.5815899581589958,0.9996713601777174,1.0,11/24,17.44%,MAP2K6;CASP8;TAB1;TRAF6;IKBKG;ITCH;UBB;AAMP;UBC;UBA52;RPS27A
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3610281593897367,0.9422644934381409,0.5456821026282853,0.9169703349044378,1.0,9/26,22.76%,KMT2A;SETD3;EEF2KMT;SETD5;TET2;ATPSCKMT;SMYD5;KMT5C;KMT2D
prerank,mitochondrial transport (GO:0006839),0.3311952045970955,0.94215590728106,0.5648252536640361,0.9167045149979309,1.0,14/53,19.56%,FIS1;FBXO7;GDAP1;SLC25A16;TOMM5;STARD3;TSPO;BAD;PITRM1;AIP;HSP90AA1;TOMM40;FLVCR1;BCAP31
prerank,melanosome organization (GO:0032438),0.36519377664544883,0.9420972521838771,0.5532734274711169,0.9163429658594291,1.0,8/26,26.48%,BLOC1S4;LYST;RAB32;DTNBP1;TRAPPC6A;RAB29;AP3B1;SHROOM2
prerank,zymogen activation (GO:0031638),0.34428772608248087,0.9420856937746236,0.5610640870616687,0.915871121360912,1.0,6/39,13.10%,ASPH;PRSS12;MMP14;CTSH;KLK1;BAD
prerank,histone mRNA catabolic process (GO:0071044),0.4013460346886254,0.9415565838537041,0.537463976945245,0.9166319544100825,1.0,6/15,21.94%,XRN1;DCP2;TUT7;UPF1;MTPAP;EXOSC4
prerank,response to amino acid starvation (GO:1990928),0.3177573821474183,0.9413169931758223,0.5838779956427015,0.9166947855463996,1.0,20/72,22.24%,EIF2AK2;MIOS;ATP6V0D1;LARP1;RRAGC;KPTN;SH3GLB1;LAMTOR3;EIF2S1;MTOR;TCIRG1;ATP6V1B2;ATP6V1G1;NPRL2;NPRL3;ATP6V1G2;LAMTOR4;RHEB;WDR59;RRAGA
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.376715250897681,-0.9410026545915832,0.5072886297376094,1.0,1.0,3/10,15.26%,CEACAM1;CD9;PRKG1
prerank,cellular response to starvation (GO:0009267),0.30213917257987355,0.9409140327093971,0.6258919469928644,0.9170858061519735,1.0,37/147,22.24%,EIF2AK2;MYBBP1A;MIOS;ATP6V0D1;LAMP2;RRAGC;KPTN;SH3GLB1;PIK3R4;BMPR2;HSPA8;PRKAG1;ZC3H12A;NUAK2;SIK1;XBP1;KLF10;HNRNPA1;MAP1LC3B;LAMTOR3;EIF2S1;MTOR;TCIRG1;SREBF1;ATP6V1B2;ATP6V1G1;BRSK1;NPRL2;STK24;BECN1;NPRL3;ATP6V1G2;LAMTOR4;RHEB;WDR59;USP33;RRAGA
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.30744787851890787,0.9405009074202991,0.6100104275286757,0.9175406044622432,1.0,21/101,16.96%,AGT;NR1H2;ASPH;PLXNB2;YTHDF1;ZCCHC4;VPS11;CSF1;DACT1;BTRC;NPM1;EIF6;PRKDC;UPF3A;BAD;AURKAIP1;HSP90AA1;RBM3;MTOR;METTL14;IST1
prerank,ribosome biogenesis (GO:0042254),0.30045053523269005,0.9402719674318956,0.6377396569122099,0.9175680393687164,1.0,58/187,22.95%,PWP2;LTV1;MRPL36;XRN2;PAK1IP1;SBDS;DDX27;SENP3;RPL36;NOB1;DDX49;MDN1;NOP53;MRM2;HELQ;NOL9;RPL22;LAS1L;LSG1;RRS1;ABCE1;NOLC1;NPM1;EIF6;DDX54;RPS6;NOP16;WDR43;EXOSC9;RPL30;RPL32;RPL23A;RPL11;DHX37;DDX47;RPL10A;RRP1;RRP1B;PELP1;WDR12;RPL24;RPL37A;RPL3;ESF1;TSC1;MRPL22;UTP3;EMG1;RPL29;URB2;RPL5;RRP9;EXOSC4;UTP15;RPL6;LTO1;NOL6;UTP14A
prerank,negative regulation of heart contraction (GO:0045822),-0.36728831849082555,-0.9395233030865595,0.5302593659942363,1.0,1.0,5/11,22.16%,SPTBN4;PIK3CG;GRK2;FKBP1B;SRI
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.33714574113234835,-0.939474891010857,0.5194805194805194,1.0,1.0,3/14,10.41%,TRAF2;TRAF6;ZFP91
prerank,mRNA processing (GO:0006397),0.2900474768268559,0.9394402629065867,0.6649949849548646,0.919015584920974,1.0,92/287,24.21%,POLR2G;RBM14;DDX5;MAGOHB;TXNL4A;PRPF18;HNRNPH1;RBMX;SRRT;NCBP2;CHERP;HNRNPK;GPATCH1;PRPF40A;WDR33;HNRNPM;DHX9;HNRNPA2B1;SF3B6;NONO;RNMT;BCAS2;POLR2K;RNPC3;HNRNPL;HSPA8;MNAT1;RBM17;RSRC1;SNW1;WDR83;RNPS1;RALY;HNRNPH3;HNRNPA1;PPARGC1A;USP39;RBM41;ZC3H11A;PAPOLA;CHTOP;SART1;BUD31;GEMIN7;SNRPD2;SNRPD1;DBR1;EFTUD2;PCF11;AURKAIP1;DDX39B;RBM15;SNRPG;NCBP1;PRPF40B;DHX16;GEMIN2;SRSF7;SF3B4;SRSF4;METTL14;HNRNPA3;CWF19L1;DDX46;CWC22;SNRPB2;SNRNP48;DDX23;SLU7;LSM5;TBRG4;HNRNPF;UBL5;ERN1;THOC7;SRSF5;SF3A2;PPIH;BUD13;TCERG1;SRSF10;WBP4;SART3;HNRNPUL1;SRSF2;TRA2B;LSM4;MAGOH;SNRPD3;RPRD2;POLR2C;SON
prerank,embryonic limb morphogenesis (GO:0030326),-0.26571525122224293,-0.9393257184211261,0.5480225988700564,0.9993079369409125,1.0,6/34,8.41%,MAP3K20;FBXW4;LRP6;NIPBL;SALL1;TGFB2
prerank,positive regulation of isotype switching (GO:0045830),0.40950745620230794,0.9392471064657899,0.5527426160337553,0.9189525650227192,1.0,4/15,12.59%,CD40;MAD2L2;SHLD1;PAXIP1
prerank,positive regulation of phosphorylation (GO:0042327),0.29397413196897004,0.9390381983327423,0.6599597585513078,0.9189819067322956,1.0,38/240,14.89%,AXL;IRGM;FLT1;KDR;DAXX;SEMA4D;CD40;CCL5;CCND2;SOX9;CCND1;EPHA4;MYDGF;FGFR2;MT3;RET;EPHA6;PPIA;LTK;ENTPD5;MET;LYN;LEPR;APP;INSR;ROR2;TNIK;CIB1;VEGFD;FGF9;PSEN1;RACK1;NRP1;RAC1;DAB2;RB1CC1;HSP90AA1;NPTN
prerank,ephrin receptor signaling pathway (GO:0048013),0.31580131024134234,0.9389689627538363,0.6105032822757112,0.91866665969903,1.0,22/82,15.43%,ACTR2;AP2A1;EPHA4;PAK3;ARHGEF7;ACTR3;EPHA6;LYN;NCK2;GIT1;AP2S1;ARPC5;PTPN11;PSEN1;CHN1;SIPA1L1;RAC1;ACTB;FYN;APH1A;APH1B;CRK
prerank,ERBB signaling pathway (GO:0038127),0.32511202939743167,0.9388495974508712,0.5951327433628318,0.9184423199649792,1.0,14/64,17.67%,CPNE3;GAREM1;CUL5;TGFA;PTPN18;SOX9;BCAR1;NCK2;KIF16B;SOS1;PTPN11;HSP90AA1;CDC37;PLCE1
prerank,polyamine metabolic process (GO:0006595),0.42434775684682213,0.9387219709392033,0.5475841874084919,0.9182371932026553,1.0,3/13,7.64%,SAT1;SMOX;SMS
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.27129117645530015,-0.9386630951684475,0.5687203791469194,0.9989260441907657,1.0,13/27,24.14%,CHSY1;VCAN;CSGALNACT1;B3GAT1;CHST7;CHST15;CHST3;BGN;DCN;PXYLP1;BCAN;UGDH;CSPG5
prerank,macrophage chemotaxis (GO:0048246),0.44204724030363324,0.9386032070890251,0.561119293078056,0.9180079098029752,1.0,3/10,12.39%,CCL5;TAFA4;CXCL17
prerank,response to acidic pH (GO:0010447),0.4168349736802902,0.9384858745205095,0.5466472303206997,0.9177810393669694,1.0,2/13,8.07%,CTSS;RAB11B
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.2985837154107759,0.9381739613812398,0.6224489795918368,0.9180160124250044,1.0,51/166,24.80%,TAF4B;NR1H2;ESR2;POLR2G;ESRRB;RARG;TEAD2;UBTF;TFB2M;TBPL1;TAF2;TAF8;POLR2K;MAML2;MNAT1;NR2C1;RORA;SNW1;NOTCH4;TAF3;PPARGC1A;NR3C1;GTF2E2;TAF1B;NRBP1;TAF15;PPARD;MED27;RBPJ;HDAC1;POLR1G;CAVIN1;TAF1C;BRF1;MED7;NR1D2;CDK9;GTF3C1;NOTCH1;NR2C2AP;BRF2;TAF7;NCOR2;KAT2B;POLR2C;POLR1F;TFAM;CCN2;TAF4;RARB;TAF11
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.39318518396483987,0.9381615769508441,0.5661664392905866,0.9175459966181966,1.0,8/16,25.43%,GSPT1;INSR;ETF1;UPF1;OGFOD1;GLE1;HDAC6;TNF
prerank,phospholipid dephosphorylation (GO:0046839),-0.24991346569703912,-0.9381166811515296,0.5988023952095808,0.9983497358069712,1.0,11/37,16.27%,INPP5F;PLPP4;MTMR1;MTMR4;INPP5B;MTMR9;SYNJ2;MTMR10;PLPPR4;PLPP3;MTM1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4286774953063691,0.9380812450998735,0.5328358208955224,0.9172229799270589,1.0,2/12,10.35%,SKP1;BTRC
prerank,TOR signaling (GO:0031929),0.36324809819238657,0.9378749767765191,0.5472887767969735,0.9172136699340062,1.0,11/26,27.76%,LARP1;RHEBL1;EIF4EBP2;CCDC88A;RPS6;MTOR;NPRL3;TIPRL;FNIP1;RPS6KB2;RPS6KB1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.2918394849643969,0.9378323296547851,0.6817269076305221,0.9168058617739568,1.0,69/348,22.12%,HSPA1B;WNT11;MOV10;DTX3L;RESF1;WNT5A;SPRY2;CLU;PIK3CD;DDRGK1;AGO2;STAT3;SLC38A2;DHX36;SOX9;MT3;ITGB8;CSF1;MAGI2;CTSH;POU3F1;APP;SCX;DNMT1;INSR;MAPK14;PRKAG1;ARRB2;PPM1F;ZC3H12A;FAM98B;CTCF;SCYL2;SETDB2;FGF9;MITF;GSN;STAP1;PSEN1;EPHX2;PPARGC1A;PIK3CB;LIMS1;MYD88;HGS;TLR2;SLC24A3;RPL11;MTOR;RBPJ;LGALS9;TLR3;ATAD1;HINFP;DTNBP1;HOXA5;TERF2;TYROBP;POU3F3;IFNGR1;DDX3X;CD46;RPL5;F3;CITED2;VPS35;FGF2;MAPK9;TASOR
prerank,keratan sulfate biosynthetic process (GO:0018146),0.36346099564602097,0.9377871345274421,0.5698254364089775,0.916407126982841,1.0,7/26,13.19%,FMOD;B4GALT4;B4GALT1;B4GALT5;ST3GAL1;B4GALT2;CHST2
prerank,regulation of macrophage chemotaxis (GO:0010758),0.38013182012391705,0.9375714493576589,0.552665799739922,0.916419306904333,1.0,5/21,16.88%,CCL5;CSF1;STAP1;CXCL17;MDK
prerank,response to UV (GO:0009411),0.30859132035237247,0.9374606681501385,0.6038338658146964,0.9161646121018019,1.0,20/95,15.96%,MSH2;TMEM161A;UVSSA;UBE2B;DHX36;CDKN2D;CCND1;USF1;FEN1;N4BP1;ERCC4;POLK;MEN1;NPM1;ZRANB3;MAP3K4;UBE4B;EIF2S1;BMF;SPRTN
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.41211085939266023,0.9372982072235114,0.5638148667601683,0.9160443580559321,1.0,4/14,16.88%,CCL5;CSF1;CXCL17;MDK
prerank,proton transmembrane transport (GO:1902600),0.35246789610433005,0.936978411306039,0.5565006075334143,0.9162715888839037,1.0,5/36,14.76%,ATP6V0D1;UCP3;SLC46A1;DMAC2L;ATP5PO
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.3730159868121844,-0.9367790653937181,0.5375,1.0,1.0,4/11,15.10%,TGFB1;EGFR;RIPK1;TP53
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3217469040410621,-0.9362460592770059,0.5471014492753623,0.9995233429611874,1.0,4/16,9.21%,ARHGAP44;AUTS2;RASGRF1;PIK3CG
prerank,histone H3-K9 demethylation (GO:0033169),0.42781660770617524,0.9359341133186718,0.5538922155688623,0.9181240842105998,1.0,4/11,15.95%,KDM4D;HR;KDM3B;KDM7A
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.3534897638641396,-0.9357608861034024,0.5271565495207667,0.998613370082852,1.0,4/13,16.32%,EPHB2;SHANK3;CHRNA7;SHISA7
prerank,regulation of intracellular signal transduction (GO:1902531),0.29098644782938166,0.9356420848809197,0.6986986986986987,0.9182875543896788,1.0,109/420,21.28%,PML;TAF4B;TAOK3;TP53RK;WNT5A;DAXX;BIRC2;PAK1IP1;CHEK2;TAGAP;RHOF;SLC15A2;CHEK1;NOP53;RFC4;SYDE1;RRAGC;RHOJ;PPP2R5C;TRAF4;PAK3;ARHGEF7;TMBIM4;ARHGAP4;BRIP1;WDR54;PIP5K1A;CSNK2B;RRS1;CYLD;CSNK2A2;MTA2;MYOC;ABR;PRKAR2B;ENTPD5;LYN;TAF2;BARD1;SYDE2;PLK3;VAV1;MAPK14;PRKAG1;TRAF3;SSRP1;SPHK2;TNIK;AKAP12;STARD8;ARHGAP25;TRAF5;ARHGEF11;SRGAP2;SRGAP3;TAF3;DDIT4;SOS1;ARHGAP21;ARHGAP10;DYRK2;NOP2;BRPF1;CHN1;ARHGAP11A;PIP5K1C;AKAP13;TIAM2;TELO2;ARHGAP39;ARHGAP30;BIRC3;RAC1;DLG1;PRDM11;MINK1;RMI1;CRK;TAF15;MOB3B;TAOK2;RPL11;MTOR;OPHN1;TBCK;BRD7;OCRL;PRKAR2A;BCR;ARHGAP29;RHOT2;HDAC1;RFFL;SPRED1;ARAP1;STK3;ARHGAP24;DIPK2A;PIN1;SMYD2;ARHGAP18;ATRIP;ARHGAP31;JMY;RPL5;STK11;ZFAND6;RHOH;OPTN
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.28313848891030297,-0.9356184385870819,0.5321888412017167,0.9966871687753648,1.0,10/23,34.78%,GABPA;MAPK3;SNCA;GNG2;ABL1;ATP2B4;MAPK1;PRKN;RYR2;KCNQ1
prerank,regulation of lamellipodium organization (GO:1902743),0.41390019086923174,0.9355934493034939,0.5620641562064156,0.9178948973035752,1.0,4/14,13.90%,CARMIL1;PDPN;CAPZB;RAC1
prerank,ncRNA processing (GO:0034470),0.29770960615488873,0.9354822463265015,0.6529588766298897,0.9176520530750971,1.0,63/200,23.63%,PWP2;XRN2;ADAR;TRPT1;AGO2;SBDS;DDX27;SENP3;RPL36;NOB1;DDX49;TARBP2;MDN1;SRRT;NOP53;MRM2;HELQ;NOL9;RPL22;LAS1L;AARS1;HNRNPA2B1;SMAD2;NOLC1;DDX54;RPS6;ADAT1;WDR43;EXOSC9;RPL30;RPL32;RPL23A;RPL11;TUT7;DHX37;DDX47;DICER1;RPL10A;RPP30;PRKRA;RRP1;RRP1B;PELP1;WDR12;RPL24;RPL37A;RPL3;ESF1;UTP3;EMG1;RPL29;RPL5;RRP9;PUS10;EXOSC4;UTP15;RPL6;AGO4;NOL6;UTP14A;RPP21;RRP36;INTS1
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.29557469809362236,-0.9353761489485899,0.5270935960591133,0.9950955304570394,1.0,2/20,2.45%,AKR1B1;STARD3NL
prerank,negative regulation of transposition (GO:0010529),0.4063365548886363,0.9353501048045073,0.5572842998585573,0.9174658636914766,1.0,1/16,0.61%,MOV10
prerank,sulfate transport (GO:0008272),0.4144442966475489,0.9349603851139335,0.5502121640735502,0.917875194850387,1.0,6/14,23.23%,SLC26A1;SLC25A10;SLC26A2;SLC13A4;SLC25A30;SLC26A7
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.3622515020456309,-0.93493310557495,0.48859934853420195,0.9941700749946171,1.0,5/10,21.93%,JARID2;SIRT1;BRCA1;KDM1A;ATRX
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3804868562320909,0.9348476353223945,0.5572327044025157,0.917626848572173,1.0,4/23,18.65%,CNGB1;CAMKMT;METAP2;FNTA
prerank,negative regulation of autophagy (GO:0010507),0.3261963943575832,0.9343911502832869,0.590443686006826,0.9181981362311544,1.0,21/54,25.96%,STAT3;MT3;NRBP2;IL10RA;MET;LEPR;FOXK1;RUBCN;EIF4G3;BMF;MTOR;ZKSCAN3;TSC1;TAB3;TLK2;MCL1;RRAGA;PIK3CA;EIF4E;SIRT2;SNRNP70
prerank,positive regulation by host of viral transcription (GO:0043923),-0.33098300204801473,-0.9342855934656535,0.564748201438849,0.9937728568334389,1.0,3/15,9.90%,SMARCA4;CCNT1;CTDP1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.32058080915598747,-0.9340587952335161,0.5412186379928315,0.9921624620155872,1.0,6/15,30.05%,LRP6;EDA;ROGDI;FOXC1;GLI2;BMP2
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.2298808004942502,-0.9339991203518361,0.6511627906976745,0.9900792506197609,1.0,19/61,21.30%,LPAR1;ARRB1;AUTS2;MMD2;FGF10;RASGRF1;PIK3CG;SHOC2;CRKL;PRAG1;RASGRP4;ARHGEF3;MAP4K4;RASGEF1A;LRRC59;F11R;NET1;F2R;RASGRP1
prerank,protein maturation (GO:0051604),0.3109443935187751,0.933973642983813,0.6023206751054853,0.9186342907543099,1.0,19/95,16.65%,LIPT1;CTSS;ADAMTS3;MMP14;NAA50;LONP2;NFU1;AEBP1;PCSK7;SORL1;NAA35;PSEN1;PITRM1;PTCH1;APH1A;GCSH;APH1B;LMF2;METAP2
prerank,neutral amino acid transport (GO:0015804),0.35781037695402507,0.9338819827682735,0.5414091470951793,0.9183457621708294,1.0,6/28,16.65%,SLC38A2;SLC38A1;SLC38A3;SLC38A6;CTNS;SLC36A4
prerank,heterochromatin organization (GO:0070828),0.4197691734832577,0.9337745076984844,0.563953488372093,0.9181062606373153,1.0,5/14,21.79%,LOXL2;SETDB2;BAHD1;SETD7;SMCHD1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.2804453485562276,-0.9333489837429285,0.5720338983050848,0.9898357646371981,1.0,13/24,29.01%,SEMA4C;SEMA4G;SEMA4A;SEMA6A;SEMA4B;SEMA3E;SEMA5B;SEMA6D;SEMA4F;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.2644495251083765,-0.9333460078201343,0.5829145728643216,0.9875535844905804,1.0,9/30,14.85%,SMARCA4;AR;KDM4C;ZBTB7A;RNF14;SIRT1;FOXP1;SAFB2;KDM1A
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.4299281565200951,0.9328729906548024,0.56006006006006,0.9196788403579468,1.0,3/10,9.13%,SOCS1;RUNX1;HMGB1
prerank,cell chemotaxis (GO:0060326),0.31813459747007444,0.9324834296554594,0.5749440715883669,0.9200662143165776,1.0,11/60,13.56%,CXCR4;ELMO2;PLXNB3;CX3CL1;PIP5K1A;BCAR1;ACKR3;ARRB2;ABCC1;NRP1;CORO1B
prerank,smooth muscle tissue development (GO:0048745),0.43616081970748,0.9322829521423288,0.5613496932515337,0.92003945454138,1.0,3/10,18.18%,PROX1;PTCH1;NF1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.33157543372569936,-0.9320717886100107,0.5598705501618123,0.9889955680067929,1.0,5/14,21.40%,NT5M;ERH;UMPS;NT5E;DHODH
prerank,telomere organization (GO:0032200),0.3331660081416266,0.9318518038528423,0.5690672963400236,0.9205416203095733,1.0,6/43,13.60%,SP100;POLD4;RTEL1;ERCC4;PRKDC;STN1
prerank,artery development (GO:0060840),0.37630989421281363,0.9317373327925657,0.578125,0.9203085294417591,1.0,5/23,20.16%,BMPR2;NRP1;HECTD1;NF1;ACVRL1
prerank,regulation of acute inflammatory response (GO:0002673),0.3928266454425962,0.931704976485858,0.5494791666666666,0.9198905021876141,1.0,1/18,3.66%,ADAM8
prerank,protein localization to chromatin (GO:0071168),0.39282106822818785,0.931575550615199,0.5508819538670285,0.9196804069907656,1.0,3/18,6.35%,MSH2;LRWD1;MCM9
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.3345252061980268,-0.9314213469688738,0.5667870036101083,0.9887653264524768,1.0,4/14,12.68%,SYK;CD81;PTPN22;CCR2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.3206150593191802,0.931328059950666,0.5911602209944752,0.9197360212164319,1.0,20/65,22.66%,PSMB10;SKP1;PSME2;PSMA5;PSME4;CHEK1;PSMA3;PSMB9;RBX1;PSMD2;PSME3;PSMA4;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4
prerank,gluconeogenesis (GO:0006094),0.34182791042175487,0.9312996161790806,0.5793184488836662,0.9193104378173123,1.0,11/39,22.31%,PER2;TPI1;SLC25A1;PGM1;SLC25A10;PPARGC1A;SLC25A12;CRTC2;ALDOC;GOT1;MDH1
prerank,response to estradiol (GO:0032355),0.3527358734396022,0.9309313662027715,0.5777511961722488,0.9196702695017503,1.0,11/31,23.52%,STAT3;CRHBP;CTNNB1;GGT7;SOCS2;LCOR;CCDC62;STRN3;NRIP1;RUVBL2;KAT5
prerank,positive regulation of transporter activity (GO:0032411),0.4130182847381249,0.9306357869323033,0.5591240875912409,0.9198338489877439,1.0,2/13,5.60%,SGK2;KMT2A
prerank,inorganic ion transmembrane transport (GO:0098660),-0.3415576299836989,-0.9304963256527891,0.5343283582089552,0.9892324963075484,1.0,8/12,47.85%,TRPM4;PKD2L1;ABCC8;CACNA1H;P2RX3;RHAG;KCNJ8;ATP1B4
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4303757004251566,0.9303837153771276,0.5594202898550724,0.919913734998626,1.0,2/11,4.25%,ACVR1;USP15
prerank,response to steroid hormone (GO:0048545),0.3572954510876796,0.9300375335816325,0.5609452736318408,0.9202157845739747,1.0,5/31,12.63%,CATSPER4;ABHD2;UBE3A;NR3C1;UBE2L3
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.27357119843079747,-0.9298903721272943,0.5454545454545454,0.9888178000701843,1.0,13/30,22.09%,CASP8;TRAF2;HMOX1;TMBIM1;RIPK1;GSK3B;TRADD;BRCA1;ARHGEF2;FAIM2;FAS;GPX1;TNFAIP3
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.32056090691917083,0.9297409908565104,0.61742006615215,0.920411763371673,1.0,12/67,16.05%,IL15;FLT1;KDR;HCK;EPHA4;FGFR2;LYN;INSR;JAK2;FYN;PIBF1;FGFR3
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.21934014440121774,-0.9290161075873647,0.6721311475409836,0.9892377010011835,1.0,40/87,27.71%,COX16;NDUFAF5;PET100;ECSIT;DMAC2;NDUFAF6;NDUFA9;TMEM126A;TIMM21;AIFM1;NDUFC1;UQCC2;NDUFB7;TTC19;TIMMDC1;UQCC1;NDUFAF1;CHCHD4;NDUFA8;NDUFA3;SCO1;NDUFB8;NDUFA2;SURF1;NDUFB10;NDUFB3;NDUFS3;NDUFV3;COA3;NDUFB4;UQCC3;NDUFS6;NDUFA11;NDUFA1;COX18;NDUFAF8;NDUFA6;SDHAF1;NDUFAF4;NDUFA13
prerank,DNA biosynthetic process (GO:0071897),0.39781739479076894,0.9289980761655505,0.5584239130434783,0.9215773815321567,1.0,3/16,7.74%,POLD4;CDKN2D;PPIA
prerank,regulation of synapse maturation (GO:0090128),-0.37672986336961717,-0.9289181068292879,0.5156695156695157,0.9873114866793542,1.0,4/10,9.13%,ADGRL1;YWHAZ;NRXN1;DAB2IP
prerank,positive regulation of organelle organization (GO:0010638),0.3500367457895327,0.9289086553174115,0.5865853658536585,0.9212951984017321,1.0,5/32,12.32%,IRGM;SYNJ1;FYCO1;KATNBL1;PPARGC1A
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.3282122920250353,-0.9288578128497434,0.5330882352941176,0.9852439486944176,1.0,8/16,23.36%,AKIRIN1;HIF1AN;BTG1;RIPOR2;BOC;MEF2C;LRRC8A;IGFBP3
prerank,regulation of actin filament polymerization (GO:0030833),0.3159625923312837,0.9287156011434113,0.5962389380530974,0.9212398670639104,1.0,27/69,28.92%,HCK;EVL;CARMIL1;PAK3;NCK1;KANK1;SSH3;NCK2;SNX9;PRKCE;DBNL;BAIAP2;BAIAP2L1;ABITRAM;GBA2;ARHGAP18;NCKAP1;PRKCD;TWF1;CDC42EP3;TENM1;PFN2;WASHC5;FER;SLIT2;ARFGEF1;VASP
prerank,synaptic membrane adhesion (GO:0099560),-0.3376579857049221,-0.9285795520678771,0.5608974358974359,0.9837937813555255,1.0,7/14,30.46%,LRFN5;SLITRK1;GPC4;SLITRK3;SLITRK2;PTPRD;NTNG1
prerank,nitric oxide mediated signal transduction (GO:0007263),0.3940906256855736,0.9285624366421067,0.5650929899856938,0.9211310348137678,1.0,1/16,0.65%,AGT
prerank,myeloid leukocyte differentiation (GO:0002573),0.31870318135604014,0.9284594959255998,0.6053811659192825,0.9208781545261557,1.0,7/65,6.88%,PML;IL15;PIK3CD;BATF3;RUNX1;SNX10;CSF1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.3103767952760617,-0.9282517010804963,0.5426621160409556,0.9824951488936775,1.0,4/17,16.78%,NCKAP1L;RAC2;RIPOR2;C1QBP
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.39209102371099747,0.9277803016693015,0.5663956639566395,0.9218963659474714,1.0,3/17,13.47%,KDR;SRF;NRP1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.36248459863852855,-0.9276630511296522,0.5887850467289719,0.9821235756836527,1.0,3/10,10.48%,PDCD4;PTPN22;MAPK8IP1
prerank,muscle cell migration (GO:0014812),-0.3707565467878417,-0.9275921926531207,0.5373563218390804,0.9800664365587932,1.0,5/10,21.62%,ROCK1;AAMP;ITGB1BP1;ITGB3;DDR1
prerank,mitotic chromosome condensation (GO:0007076),0.36310089401412005,0.9272336773763008,0.5592356687898089,0.9226646614917426,1.0,5/26,12.74%,TENT4A;CSNK2B;CSNK2A2;NCAPG2;RB1
prerank,regulation of exit from mitosis (GO:0007096),0.34237050687116083,0.9271309162275084,0.5869565217391305,0.9223907351431326,1.0,8/38,16.23%,CDC26;ANAPC5;ANAPC4;UBE2E1;CDC16;CDC27;ANAPC15;ANAPC2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.26018251927412844,-0.9271078841887197,0.6201117318435754,0.9793298775925138,1.0,10/30,20.10%,ALG5;DPM1;UBE2J1;TUSC3;UGGT2;STT3A;RPN2;FUT8;DPM3;MGAT2
prerank,base-excision repair (GO:0006284),-0.2386431666172119,-0.9268112997313303,0.625,0.9780573696346202,1.0,20/48,21.10%,APEX2;RPA1;RFC2;PARP1;PARG;DNA2;PNKP;RFC3;LIG1;HMGA2;OGG1;NEIL1;NEIL3;RPA3;XPA;RFC5;USP47;POLD1;POLE;POLL
prerank,nucleosome disassembly (GO:0006337),0.4104062600092139,0.9265696068170627,0.5561877667140825,0.9226578159576769,1.0,6/14,19.22%,ARID1A;SMARCE1;SMARCC2;ARID2;SMARCD2;SET
prerank,chromatin disassembly (GO:0031498),0.4104062600092139,0.9265696068170627,0.5561877667140825,0.9226578159576769,1.0,6/14,19.22%,ARID1A;SMARCE1;SMARCC2;ARID2;SMARCD2;SET
prerank,positive regulation of histone modification (GO:0031058),-0.2656057650749982,-0.9264518837527841,0.6073619631901841,0.9769471317977173,1.0,10/33,15.54%,ARRB1;NIPBL;SAP30BP;GLYR1;MAPK3;ZBTB7B;BRCA1;RPS6KA4;KDM1A;ING2
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.362927570481708,-0.9263560319568321,0.540785498489426,0.9750497927501204,1.0,4/10,13.41%,NCKAP1L;C3;TREM2;RAB31
prerank,positive regulation of neurogenesis (GO:0050769),0.3186385390854642,0.9261036450359009,0.6222222222222222,0.9232011357742771,1.0,13/68,14.89%,PLXNA3;PLXNB2;LRP2;PLXNB3;CTNNB1;CX3CL1;CUL7;FBXW8;SNW1;CUX1;TIAM2;NUMBL;NPTN
prerank,synapse organization (GO:0050808),0.2999323720672761,0.9259220776777782,0.6426364572605562,0.9231313346253942,1.0,23/125,16.22%,SLITRK6;PCDHB13;ELFN1;BDNF;CHCHD10;CYFIP1;CX3CL1;PAK3;WNT7B;DOK7;APP;AGRN;SDK1;PSEN1;PCDHB16;ARHGAP39;PPFIA4;CTNND2;DNER;DBNL;DSCAM;NLGN3;C1QB
prerank,positive regulation of embryonic development (GO:0040019),-0.3044622158971272,-0.9258956844721818,0.55893536121673,0.9742475874386162,1.0,3/19,5.06%,CFL1;NIBAN2;RBM19
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.3635569551869391,0.9256810886900787,0.5674300254452926,0.9231629410863267,1.0,6/26,14.63%,IRS1;ARPP19;OSBPL8;INSR;PTPN11;IRS2
prerank,camera-type eye morphogenesis (GO:0048593),-0.37299245521304636,-0.9254754878059593,0.5401662049861495,0.9731992509102282,1.0,2/10,10.55%,LRP6;TENM3
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3372240456989562,0.9253869251346061,0.5659928656361475,0.923321643138781,1.0,5/39,6.06%,SPRY2;TGFA;PTPN18;DUSP3;ARHGEF7
prerank,protein import into mitochondrial matrix (GO:0030150),-0.30636874598173836,-0.9253215180751238,0.562992125984252,0.971521772001672,1.0,8/18,21.84%,TOMM20;DNAJC15;TIMM21;GRPEL1;PAM16;TIMM17A;GRPEL2;ROMO1
prerank,calcium ion transport (GO:0006816),0.3031125207540266,0.9249503206692653,0.64,0.9237938795047859,1.0,20/113,15.79%,TRPM5;TRPM2;CACNA2D4;TRPM6;SLC8A1;CCL5;ITPR1;CACNA1A;P2RX4;MCUR1;TRPM3;CRACR2A;PANX1;PSEN1;MCOLN2;TRPV4;FYN;CHRNB2;TRPM7;SLC24A3
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.3151887064483757,-0.9249285221676141,0.5652173913043478,0.9705277418923213,1.0,9/17,46.84%,SCN3B;KCNH2;RYR2;KCNQ1;SNTA1;KCNE3;KCNE4;KCNJ8;KCNE2
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.4255943972843429,0.9246357028276699,0.5755725190839694,0.923998982714448,1.0,1/11,1.21%,CAMK2D
prerank,regulation of signal transduction (GO:0009966),0.2932674680858344,0.9244373226431148,0.6575481256332321,0.9239705535660504,1.0,41/190,18.52%,SP100;CLU;ACVR1;CD55;KIF26A;RUNX1;GNG4;UBTF;YJEFN3;CX3CL1;FGFR2;ITGA3;AMFR;DOK5;MDFIC;PPIA;NCK1;GDNF;SOCS5;APP;NCK2;PRNP;RORA;GIT1;SNW1;GAS1;SOCS2;RGS16;SHARPIN;PTCH1;FYN;CRK;IRAK1;LLGL1;CSK;ELF1;TULP3;PLCE1;DCDC2;FRRS1L;DTNBP1
prerank,post-translational protein modification (GO:0043687),0.2907792981983533,0.9244101414217819,0.7251755265797393,0.9235426170137806,1.0,86/332,22.66%,PSMB10;SKP1;FBXL16;PSME2;PNPLA2;DCAF17;KLHL20;PSMA5;CUL5;RCN1;FBXO7;PSME4;RBBP5;SERPINC1;LAMC1;LAMB2;FEM1B;FBXW7;TNC;PSMA3;CUL7;UBE2M;CSF1;KLHL13;FBN1;SPSB1;FBXW8;CAND1;RAB11B;PSMB9;UCHL3;SOCS5;MXRA8;RBX1;APP;LRRC41;MEN1;WDR5;COPS7B;WSB2;ELOC;BTRC;ASB7;PSMD2;PDIA6;ASB10;PSME3;APOE;FBXL14;KLHL9;SOCS2;KTN1;FBXL19;DCAF4;PSMA4;FAM20C;RAB11A;LMO7;ASB3;FBXL5;SPARCL1;COPS8;STT3B;PSMD7;ASB1;SOCS6;PSMD8;PSMD9;RAB1A;FBXO30;PSMF1;APLP2;SUMF1;PSMB6;PSMC2;NUB1;PSMD12;SENP8;DCAF5;ASB13;COPS7A;HSP90B1;PTP4A2;RAB2A;FBXW2;PSMD4
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.31960366932836975,0.9243129504810844,0.5997794928335171,0.9232698091745015,1.0,21/61,23.81%,PSMB10;PSME2;PSMA5;PSME4;PSMA3;PSMB9;PSMD2;AZIN1;PSME3;PSMA4;PANK2;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4;PSMA2;NCOR2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.3262041618759508,0.9239454605484326,0.5855855855855856,0.9235967540306741,1.0,13/46,24.01%,IL15;NR1H2;ZNF423;RB1;ACOT13;ALDH1A1;RBPJ;PCTP;STK11;PGAM5;RHEB;NOTCH1;ACOT11
prerank,gastrulation (GO:0007369),0.39909709498232543,0.9237045647661483,0.5581717451523546,0.9236348170805967,1.0,2/15,7.84%,NPHP3;SMAD2
prerank,glucose metabolic process (GO:0006006),0.32132816927361896,0.9235887636345547,0.6068181818181818,0.9234028370285372,1.0,11/58,16.02%,SORD;PER2;TPI1;SLC25A1;TFAP2B;PGM1;SLC25A10;PPARGC1A;IRS2;SLC25A12;PPARD
prerank,regulation of intracellular transport (GO:0032386),0.3417117342551112,0.9234979604813559,0.572429906542056,0.923112296860037,1.0,11/38,18.92%,DYNC1H1;RAB11B;MLC1;DNAJC30;SCFD1;RINT1;GAS1;DYNLT2B;ATPSCKMT;LAMP1;NUMA1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.42644110014427006,0.9234690318502371,0.5746164574616457,0.922696120448779,1.0,4/12,14.57%,TRIB3;ACADL;ERLIN2;PIBF1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.29690365443879724,0.9227880899756625,0.651186790505676,0.923725308144582,1.0,39/138,24.80%,TAF4B;NR1H2;ESR2;POLR2G;ESRRB;RARG;TEAD2;TAF2;TAF8;POLR2K;MAML2;MNAT1;NR2C1;RORA;SNW1;NOTCH4;TAF3;PPARGC1A;NR3C1;GTF2E2;NRBP1;TAF15;PPARD;MED27;RBPJ;HDAC1;MED7;NR1D2;CDK9;NOTCH1;NR2C2AP;TAF7;NCOR2;KAT2B;POLR2C;CCN2;TAF4;RARB;TAF11
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3432088197721076,0.9224824886607668,0.5903465346534653,0.9234390275277676,1.0,5/31,9.74%,POLR2G;NCBP2;RNMT;POLR2K;MNAT1
prerank,7-methylguanosine RNA capping (GO:0009452),0.3432088197721076,0.9224824886607668,0.5903465346534653,0.9234390275277676,1.0,5/31,9.74%,POLR2G;NCBP2;RNMT;POLR2K;MNAT1
prerank,alanine transport (GO:0032328),0.4346898930197092,0.9221854089174152,0.5576923076923077,0.9235817648873702,1.0,5/10,25.51%,SLC38A3;SLC36A4;SLC6A6;SLC6A17;SLC36A1
prerank,mitotic spindle assembly (GO:0090307),0.3307520959974512,0.9221355978945023,0.5729166666666666,0.9232229534558244,1.0,11/42,16.20%,CHEK2;KPNB1;WRAP73;KIF3B;STAG1;ARHGEF10;TOGARAM2;CCDC61;PIBF1;KIF2A;RAB11A
prerank,positive regulation of protein metabolic process (GO:0051247),0.30085662789712725,0.922092736917516,0.6304801670146137,0.9228414989690101,1.0,22/110,16.22%,AGT;NR1H2;WNT5A;CLU;EGLN2;RILP;AREL1;CSF1;DACT1;BARD1;APP;IL17D;SORL1;SMURF1;LDB1;PSEN1;APOE;VPS28;TFR2;PRMT1;TIPARP;IL18
prerank,nucleotide biosynthetic process (GO:0009165),-0.3012617777877791,-0.9216391782504795,0.5212355212355212,0.9777127879438566,1.0,9/18,24.93%,NMNAT2;PNP;PRPSAP1;ME1;RRM2B;RRM1;PPAT;PRPS1;PRPS1L1
prerank,keratan sulfate catabolic process (GO:0042340),0.42511355936582357,0.9215893119135142,0.56973293768546,0.9234972277323963,1.0,5/11,23.94%,FMOD;GLB1;OGN;GALNS;GNS
prerank,regulation of keratinocyte proliferation (GO:0010837),0.3684323054282315,0.9209761766613628,0.5712451861360719,0.9243816802533563,1.0,4/22,10.96%,ZFP36;FGFR2;SNAI2;ZFP36L1
prerank,nervous system development (GO:0007399),0.2882854307232784,0.9208823111577111,0.763,0.9241119890844477,1.0,71/429,16.92%,IGF2BP1;AXL;PCDHA3;SLITRK6;PMP22;PCDHB13;CXCR4;BDNF;NRSN2;IGF2BP3;STAT3;MSI1;ECRG4;CHD7;PAFAH1B3;ANKLE2;SH3GL1;SIAH1;EVL;TMEM223;CHERP;TRAK1;RAPGEFL1;GMFB;CDK5RAP2;DACT1;MET;EIF2B2;BTBD3;GDNF;JRKL;POU3F1;BTBD2;SCD5;GFRA2;PROX1;DHX30;STMN3;FUT10;ALDH1A2;ADGRV1;NAB1;RBFOX1;PPP2R5D;GSN;SDK1;HPCAL4;SCN2A;LDB2;LDB1;PCDHB16;MOBP;ATXN1;FGF13;MYLIP;NELL1;NUMBL;DNER;RBM45;DAGLA;RBFOX3;DBNL;RNF103;NHEJ1;DSCAM;DSCAML1;NLGN3;OPHN1;PCDHA4;MDK;MPZ
prerank,extracellular matrix disassembly (GO:0022617),0.3223825018867453,0.9207800732760381,0.5993265993265994,0.9238498865668877,1.0,8/53,13.03%,CTSS;MMP14;ADAM8;LAMC1;TIMP2;GSN;CAPNS1;CAPN1
prerank,positive regulation of dephosphorylation (GO:0035306),-0.2742380688010906,-0.9204207288036371,0.5905172413793104,0.9790520419614682,1.0,8/27,12.21%,TGFB1;PPP1R16B;PTPA;MTMR9;SYMPK;NSMF;SRC;CAMTA1
prerank,stem cell development (GO:0048864),0.393810380674623,0.9204093030397373,0.5757162346521146,0.9241583299392387,1.0,3/16,8.34%,TCOF1;SNAI2;NOLC1
prerank,catecholamine biosynthetic process (GO:0042423),0.42321716559450817,0.9201993870169956,0.5663189269746647,0.924117582993176,1.0,2/11,10.23%,DDC;GCH1
prerank,selective autophagy (GO:0061912),0.31776777026237163,0.920157291413479,0.5855855855855856,0.923731837821271,1.0,13/56,19.25%,AUP1;DDRGK1;DYNC1H1;DYNC1LI2;NBR1;UBQLN1;MAP1LC3B;DYNLL1;RB1CC1;PEX5;RETREG1;UBE2V1;BECN1
prerank,cellular response to insulin stimulus (GO:0032869),0.29604913589835213,0.9198910500870782,0.63579604578564,0.923852324474309,1.0,27/124,18.41%,NAMPT;TRIB3;IRS1;ATP6V0D1;SLC27A1;RAB8B;ZNF106;GRB10;RAB12;USF1;LPIN2;BCAR1;INSR;PHIP;ZFP36L1;XBP1;SOS1;PRKDC;ENPP1;VAMP2;IRS2;INPP5K;BAIAP2;TCIRG1;ATP6V1B2;ATP6V1G1;CPEB2
prerank,regulation of cytokinesis (GO:0032465),0.3084099981042159,0.9198476330251983,0.6204301075268818,0.9234749267891449,1.0,19/78,19.46%,CDC25B;PKN2;PDXP;PRPF40A;SH3GLB1;KLHL13;ZFYVE26;PLK3;PIK3R4;GIT1;KLHL9;PRKCE;AHCTF1;CALM3;RAB11A;BIRC6;UVRAG;BECN1;PIN1
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.3628818073752927,0.9184660051690012,0.5782051282051283,0.9260345321386486,1.0,7/24,18.67%,CGAS;UBE2B;RAPGEF2;PRKAR2B;PDE3A;PRKAR2A;MGRN1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.35718758430442554,0.9184498159210729,0.5930680359435173,0.9255898186593808,1.0,10/25,24.80%,CTSS;ATP1B3;ACTN2;AKAP9;STK39;GLRX;COX17;ANK2;WNK3;CFTR
prerank,activation of protein kinase activity (GO:0032147),0.30168019498041065,0.9181135064847789,0.6422505307855626,0.9258556947896945,1.0,30/106,23.82%,CALCA;TAOK3;WNT5A;ADCY5;OSBPL8;PAK3;MT3;PPIA;CCDC88A;PRKAR2B;INSR;TNIK;JAK2;PIBF1;MINK1;TAOK2;IL18;MTOR;IRAK1;PRKAR2A;TLR3;COPS8;STK3;STK11;PRKCD;PAK5;ADCY7;PDPK1;AXIN1;ANG
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.32205434016912443,0.9181009615959951,0.5981941309255079,0.9253985441708539,1.0,11/59,16.08%,PLXNB2;CDH13;NECTIN4;PLXNB3;NECTIN3;SDK1;CD84;NPTN;HMCN1;DSCAM;DSCAML1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.31204742471187324,0.91808393226199,0.6137339055793991,0.9249564073405092,1.0,16/70,17.59%,ACTN1;LAMC1;LAMB2;PARVB;PEAK1;RILPL1;YTHDF2;PROX1;SRGAP2;ANTXR1;RB1;NRP1;RAC1;TBCD;OPHN1;ITGA4
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3443923312710411,-0.9179892453547743,0.5524691358024691,0.9839597371190489,1.0,4/12,17.09%,GCLM;GSS;HAGH;GGCT
prerank,positive regulation of signal transduction (GO:0009967),0.2910042777469371,0.9178490252350526,0.7079556898288016,0.924982395485629,1.0,45/238,17.91%,AXL;NOD2;TUBD1;IRS1;BDNF;ADAMTS3;SASH1;STAT3;MYO1C;TM2D3;GRB10;KIF7;LY86;FGFR2;MT3;TRIM39;ENHO;TPD52L1;UCHL5;DACT1;SMOC2;KANK1;MAML2;PHIP;PDCL;SNW1;NOTCH4;XBP1;SORL1;PTPN11;LIMS1;ZRANB1;NRP1;JAK2;NPTN;TLR2;GKAP1;NLGN3;MGAT5;RBPJ;BAX;PTPRC;EPN2;CRADD;DCDC2
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.39811891222122214,0.9177846477431959,0.5724431818181818,0.9246348306745414,1.0,6/14,26.87%,CX3CL1;CST7;PTPRC;LDLR;SYT11;GRN
prerank,mesenchymal cell development (GO:0014031),0.38834234489215996,0.9177517149329258,0.581646423751687,0.9242331802972151,1.0,3/18,8.34%,TCOF1;SNAI2;NOLC1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3363507807330476,0.9176304932658849,0.5885850178359097,0.9240195512380656,1.0,8/40,15.00%,TIMELESS;TIPIN;ETAA1;MCM9;RTEL1;ZRANB3;DDX11;GEN1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.31223279920875435,0.917553955891171,0.6206896551724138,0.9236984019394484,1.0,16/69,17.70%,POLR2G;PHAX;SNAPC2;SRRT;NCBP2;CCNT2;RPAP2;TAF8;POLR2K;ICE2;ELL2;SNAPC5;GTF2E2;NCBP1;CCNK;POU2F2
prerank,regulation of synapse organization (GO:0050807),-0.277632582939192,-0.9171317741603342,0.5540540540540541,0.9842483362860188,1.0,14/26,25.40%,PDLIM5;IL1RAPL1;GRIPAP1;CTNNA2;YWHAZ;ABHD17B;ABHD17C;CLN3;NEDD4;ABL1;MEF2C;KLK8;SLITRK2;MDGA1
prerank,regulation of aerobic respiration (GO:1903715),0.3951989773512813,0.9170004642768296,0.5633802816901409,0.9244228535380501,1.0,8/15,26.00%,NOP53;ABCD1;AK4;COX7A2;IDE;VCP;SLC25A33;COX7A2L
prerank,"transcription, DNA-templated (GO:0006351)",0.287875341076398,0.9169358816431284,0.6984924623115578,0.9240821642747461,1.0,44/207,16.86%,TAF4B;POLR2G;GMEB2;NFX1;SNAPC2;DDX5;RBMX;NCBP2;UBTF;MRPL12;RRAGC;CCNT2;TFB2M;NFKB1;TBPL1;GLIS3;RO60;TFDP1;GTF3C5;POLR3GL;RNMT;TAF2;SCX;POLR2K;IRF9;MNAT1;TWNK;SSRP1;ARRB2;ELOC;RNPS1;XBP1;TAF3;GTF2E2;TAF1B;RREB1;MLLT3;NCBP1;SOX5;TAF15;MEF2A;GTF3C3;CCNK;MED16
prerank,regulation of endocytic recycling (GO:2001135),0.4232740632006427,0.9166968899251395,0.5751824817518248,0.924149366411715,1.0,5/11,23.69%,ACTN2;RAB11B;SORL1;PLA2G4E;ARHGAP1
prerank,modulation by host of symbiont process (GO:0051851),-0.2553152978483612,-0.9164567987389063,0.5957446808510638,0.9839511860641748,1.0,9/31,12.95%,SMARCA4;CCNT1;SAP30BP;REST;NAPEPLD;CX3CR1;CTDP1;CCL3;HMGA2
prerank,regulation of G0 to G1 transition (GO:0070316),0.33679020571859686,0.9156116463591661,0.5970319634703196,0.9260634446860233,1.0,9/38,14.82%,PCGF6;CHEK1;TFDP1;RING1;MAX;RYBP;TFDP2;UXT;EZH2
prerank,positive regulation of growth (GO:0045927),0.3125747063473199,0.9153065947911914,0.6209150326797386,0.9262731875802168,1.0,12/64,15.64%,HYAL1;CXCL16;MMP14;SFRP2;FXN;DDX49;INSR;CIB1;PPM1F;EXOSC9;NCBP1;ADNP2
prerank,epithelial tube morphogenesis (GO:0060562),0.34598441245253514,0.9152799401572497,0.5763125763125763,0.9258475603783753,1.0,5/32,8.66%,ACVR1;CTNNB1;PODXL;CSNK2B;MET
prerank,lipid transport (GO:0006869),0.3012982249526214,0.9149340342748924,0.6506777893639207,0.9261155202466586,1.0,25/97,22.58%,ABCC2;ABCA1;ABCG1;SLC27A1;SLCO1C1;ATP8A1;OSBPL8;NCOA1;PITPNM1;SLCO1B1;ABCD1;APOE;PLEKHA3;NPC2;PPARD;OSBP;MTTP;LDLR;OSBPL2;PCTP;GLTP;CHKA;TNFAIP8L3;CERT1;ABCA5
prerank,establishment of protein localization to membrane (GO:0090150),0.3133503045018905,0.9149046496941649,0.6181619256017505,0.925702791764198,1.0,13/66,16.20%,GOLGA7;MYO1C;AQP11;RTP4;ZDHHC21;ZDHHC20;RAB11B;VPS37A;NACA;NECTIN3;NPC1;TAOK2;RAB11A
prerank,monocarboxylic acid metabolic process (GO:0032787),0.29502954676470533,0.9148967907214453,0.6659751037344398,0.9252440838867676,1.0,21/117,19.08%,AGXT;AOAH;BCO2;ALKBH7;PER2;GRHPR;PTGR1;DLD;CYP26B1;GNPAT;ECHDC3;ALDH1A2;PDHX;LDHB;NPC1;PANK2;PPARD;MCCC1;AASDH;SGPL1;GBA2
prerank,cellular response to reactive oxygen species (GO:0034614),-0.22438787243427954,-0.9145218517878319,0.6339285714285714,0.9873826810997524,1.0,21/59,26.59%,PTPRK;IMPACT;MPV17;PXN;EGFR;MAPK3;TPM1;SIRT1;RIPK1;AKT1;MAPK7;ANXA1;NET1;ECT2;ABL1;ROMO1;TNFAIP3;PDGFRA;PPIF;RPS3;MAPK8
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3047713078532603,0.9144281397890539,0.6425531914893617,0.9257933088798874,1.0,13/86,14.33%,IL15;AGT;SEMA4D;ACVR1;SFRP2;CNOT7;CSPG4;APP;PRNP;PTPN11;NRP1;JAK2;FYN
prerank,neuron apoptotic process (GO:0051402),0.38294750902749936,0.9143670435931662,0.5967078189300411,0.9254431879980947,1.0,4/19,12.20%,SIAH1;APP;DIABLO;SCN2A
prerank,phospholipid biosynthetic process (GO:0008654),0.33156970448571915,0.9143613203687475,0.5907990314769975,0.9249775965606118,1.0,7/36,12.62%,CPNE3;PCYT2;AGPAT5;PIP5K1A;GNPAT;SPHK2;DHDDS
prerank,glycerolipid catabolic process (GO:0046503),0.38248558922441733,0.9137040368640168,0.5813008130081301,0.9259089272116061,1.0,5/19,19.67%,ABHD2;LYPLA2;PNPLA6;ENPP6;PLA2G4E
prerank,Golgi ribbon formation (GO:0090161),-0.32319474401224163,-0.9136684321867895,0.56,0.9877606942043853,1.0,6/13,16.84%,TRIP11;GCC2;PRMT5;MYO18A;GOLPH3;GOLGA2
prerank,cellular component disassembly (GO:0022411),0.31891356765267975,0.9136624209697537,0.6114221724524076,0.925518657583368,1.0,8/53,13.03%,CTSS;MMP14;ADAM8;LAMC1;TIMP2;GSN;CAPNS1;CAPN1
prerank,acute-phase response (GO:0006953),-0.3494075781089686,-0.9136320567879755,0.5655172413793104,0.9857244142769859,1.0,2/12,13.77%,PLSCR1;CEBPB
prerank,lipoprotein catabolic process (GO:0042159),-0.3438317822180327,-0.9134613444868366,0.5481927710843374,0.9841160380093158,1.0,4/11,10.91%,LYPLA1;LYPLAL1;ABHD17B;ABHD17C
prerank,hexose transmembrane transport (GO:0008645),0.37356037356947935,0.9133533838011848,0.6,0.9256782611830736,1.0,4/21,16.02%,SLC2A6;SLC45A3;SLC2A9;PPARD
prerank,triglyceride homeostasis (GO:0070328),0.35936798901767786,0.9127206452039982,0.5860349127182045,0.9265718421814542,1.0,6/26,16.22%,LIPC;RORA;XBP1;APOE;APOC4;IL18
prerank,maturation of 5.8S rRNA (GO:0000460),0.3838641901806643,0.9126417144335391,0.5888888888888889,0.9262542331322999,1.0,6/17,21.94%,NOL9;LAS1L;EIF6;PRKDC;WDR12;EXOSC4
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.3513254194316093,0.9123026939535867,0.5933926302414231,0.9265076485517295,1.0,5/27,14.43%,CAMK2D;CTNNA3;AKAP9;FGF13;DLG1
prerank,heart process (GO:0003015),0.4070917758915339,0.9120454965236102,0.6041958041958042,0.9265622906821847,1.0,1/14,1.18%,PPCS
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.3355202228257153,0.9115135433716945,0.6002386634844868,0.9272110909454884,1.0,7/37,9.07%,POLD4;CHD1L;RFC4;RFC1;ERCC4;RBX1;POLK
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3060179474489343,0.9111543811274276,0.6306010928961748,0.9275527937687119,1.0,11/72,9.89%,POLR2G;UVSSA;POLD4;RFC4;RFC1;ERCC4;RBX1;POLK;POLR2K;MNAT1;COPS7B
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.3847722092502262,0.9109610282782503,0.5912806539509536,0.9274838979488437,1.0,7/18,23.29%,MCM7;MCM4;RFC4;GINS2;GINS4;GINS3;LIG3
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3473657608399644,0.910713053046054,0.6029776674937966,0.9275507288852025,1.0,13/29,29.27%,PWP2;RPS21;RRS1;KRI1;DHX37;MRPS11;UTP3;RRP36;NGDN;BMS1;NOL10;HELB;RPS19
prerank,phagosome maturation (GO:0090382),-0.24847191595700238,-0.9105428146989429,0.6162790697674418,0.9902929204097741,1.0,10/35,18.57%,ATP6V0A1;ATP6V1H;ATP6V1E1;CORO1A;ATP6V1C1;ATP6V1D;ATP6V1A;RAB31;MREG;ATP6V0E2
prerank,metanephros development (GO:0001656),0.3499609790131527,0.9097430139659495,0.6104725415070242,0.9291550019006966,1.0,5/26,18.18%,WNT7B;CTSH;GDNF;PTCH1;NF1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.291278073012887,-0.9092794012449646,0.5458333333333333,0.9916789068768047,1.0,11/21,32.49%,MAD1L1;APC;TEX14;BUB1;CENPF;TPR;TRIP13;BUB3;KNTC1;TTK;PLK1
prerank,ERBB2 signaling pathway (GO:0038128),0.3466429573103708,0.9091048629756837,0.6039850560398505,0.9300304444802376,1.0,11/31,25.64%,CPNE3;CUL5;PTPN18;MYOC;SOS1;HSP90AA1;CDC37;STUB1;ERBB3;PIK3CA;SHC1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.37027046768770794,-0.9089658956896112,0.5449591280653951,0.9904653089933729,1.0,4/10,15.10%,ESR1;THRA;PSMC4;TP53
prerank,transcription by RNA polymerase II (GO:0006366),0.28289427998793626,0.9089314795302604,0.7334669338677354,0.9299200487552534,1.0,61/305,16.92%,TAF4B;NR1H2;ESR2;POLR2G;GMEB2;ESRRB;RARG;NFX1;PHAX;TEAD2;SNAPC2;DDX5;RBMX;SRRT;NCBP2;CDK12;CCNT2;WDR33;NFKB1;TBPL1;GLIS3;TFDP1;RPAP2;RNMT;ELP2;TAF2;TAF8;POLR2K;MAML2;IRF9;MNAT1;NR2C1;SSRP1;RORA;ARRB2;ELOC;SNW1;NOTCH4;XBP1;TAF3;ICE2;ELL2;PPARGC1A;SNAPC5;NR3C1;GTF2E2;PAPOLA;PCF11;RREB1;SNRPG;MLLT3;NCBP1;SOX5;NRBP1;TAF15;PPARD;MED27;CCNK;RBPJ;MED16;ELOF1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.36925263391811985,0.9088309295811744,0.6094986807387863,0.9296677435057116,1.0,8/21,16.93%,RUNX1;LYN;STAP1;FCGR2B;PRKCH;SLC39A10;CD300A;ELF1
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.2545124844631261,-0.9084060388042208,0.6298342541436464,0.9898673813022904,1.0,13/34,24.87%,GRIN2A;GABRG3;GRIN2B;GRIN1;GSK3B;GABRA2;AKT1;GABRA5;MEF2C;CHRNA4;INSYN2A;MAPK8IP2;DRD2
prerank,secretory granule organization (GO:0033363),0.4260674153278028,0.908310111151303,0.5857359635811836,0.9302970079474333,1.0,3/10,18.52%,ABCA1;LYST;DTNBP1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.259842559015073,-0.9076893094098343,0.6262135922330098,0.9896569593842368,1.0,10/31,18.74%,CASP8;PPP3R1;PPP3CC;YWHAQ;YWHAZ;GSK3B;PPP1R13B;TP53;E2F1;BAK1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3942927102357892,0.9076310531730336,0.5809128630705395,0.931249195245097,1.0,5/15,22.97%,ATL1;REEP2;REEP3;RAB10;ZFYVE27
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.4095754215194468,0.9074556175564222,0.6090775988286969,0.9311404451843847,1.0,5/12,24.16%,APOC4;SOAT2;SOAT1;MTTP;ACSL3
prerank,regulation of glucose metabolic process (GO:0010906),0.3379956528540353,0.9072528007297123,0.6130177514792899,0.9311042017577323,1.0,7/34,14.63%,IRS1;RUBCNL;SLC45A3;RORA;FOXK1;BCKDK;IRS2
prerank,hexose metabolic process (GO:0019318),0.3289136871930268,0.9069813622232693,0.6067146282973621,0.9312147523978606,1.0,8/39,16.02%,GALT;SORD;TFAP2B;PGM1;HK1;GALK2;IRS2;PPARD
prerank,regulation of lipid metabolic process (GO:0019216),0.3017261988050075,0.9068691242884791,0.6556503198294243,0.9309864960973278,1.0,24/88,25.45%,HELZ2;NCOA1;EDF1;RUBCNL;FDFT1;TGS1;RORA;GGPS1;PANK2;IRS2;NPC2;PPARD;SREBF1;IDI1;CERS2;NR1D2;CCDC3;ADIPOR1;TNFAIP8L3;HMGCS1;HMGCR;NCOR2;BBS4;PLPP1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.31032323696099606,0.9067807046900707,0.6385542168674698,0.9307009476931669,1.0,17/68,22.90%,TPST1;ACOT9;ACBD6;SULT6B1;HPRT1;AK4;AK3;ENPP1;ACOT13;BAD;ACAT1;OXSM;AMPD3;BPNT1;PDE9A;ENTPD7;OPA1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.41556635587945034,0.9064427554308152,0.575107296137339,0.9309891056298316,1.0,5/13,16.18%,IRS1;ECHDC3;SORL1;PTPN11;GKAP1
prerank,T cell mediated immunity (GO:0002456),0.40007167961631895,0.9063288738191334,0.6031073446327684,0.9307801263486506,1.0,2/13,8.22%,CD55;CTSH
prerank,prostaglandin biosynthetic process (GO:0001516),-0.301331584128382,-0.9062934672616099,0.5555555555555556,0.9915262668407793,1.0,8/18,27.78%,PTGDS;PTGS1;MIF;PTGES;CBR1;HPGDS;PTGIS;PRXL2B
prerank,cellular calcium ion homeostasis (GO:0006874),0.2949918029785156,0.9061829358465363,0.6725025746652935,0.9306094799236778,1.0,19/133,15.85%,PML;CALCA;CCL7;CAMK2D;CD40;SLC8A1;CCL5;KCTD17;SLC30A1;CHERP;VAPB;CCL14;HTR2A;PSEN1;TRPV4;MICU2;NPTN;SLC24A3;HCRTR1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.36306556145495616,0.9054701714560739,0.6088082901554405,0.9316851973851092,1.0,2/22,10.65%,LRP2;ALDH1A2
prerank,negative regulation of neuron projection development (GO:0010977),0.3215196552475274,0.9054168817644447,0.6295045045045045,0.9313324840687099,1.0,20/56,25.19%,THY1;RUFY3;EPHA4;MT3;PAQR3;KANK1;CIB1;MAG;APOE;TRPV4;MYLIP;PTPN9;STMN2;ITM2C;RTN4RL1;HDAC2;RAB29;LINGO1;PTPRS;LRP4
prerank,response to insulin (GO:0032868),0.30005592347549376,0.9045805807347224,0.6444201312910285,0.9326127997432708,1.0,16/80,14.94%,TRIB3;IRS1;SLC27A1;RAB8B;RAB12;USF1;LPIN2;INSR;ZFP36L1;XBP1;EIF6;PRKDC;ENPP1;VAMP2;IRS2;INPP5K
prerank,RNA polyadenylation (GO:0043631),0.3503226196631667,0.9042847636316743,0.5992366412213741,0.9323222322230955,1.0,6/26,14.31%,PNPT1;WDR33;APP;AHCYL1;PAPOLA;PCF11
prerank,mRNA polyadenylation (GO:0006378),0.3503226196631667,0.9042847636316743,0.5992366412213741,0.9323222322230955,1.0,6/26,14.31%,PNPT1;WDR33;APP;AHCYL1;PAPOLA;PCF11
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.22412949327778942,-0.9041496015749665,0.6967213114754098,0.99343575838086,1.0,27/56,27.71%,NDUFAF5;ECSIT;DMAC2;NDUFAF6;NDUFA9;TMEM126A;TIMM21;NDUFC1;NDUFB7;TIMMDC1;NDUFAF1;NDUFA8;NDUFA3;NDUFB8;NDUFA2;NDUFB10;NDUFB3;NDUFS3;NDUFV3;NDUFB4;NDUFS6;NDUFA11;NDUFA1;NDUFAF8;NDUFA6;NDUFAF4;NDUFA13
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.22412949327778942,-0.9041496015749665,0.6967213114754098,0.99343575838086,1.0,27/56,27.71%,NDUFAF5;ECSIT;DMAC2;NDUFAF6;NDUFA9;TMEM126A;TIMM21;NDUFC1;NDUFB7;TIMMDC1;NDUFAF1;NDUFA8;NDUFA3;NDUFB8;NDUFA2;NDUFB10;NDUFB3;NDUFS3;NDUFV3;NDUFB4;NDUFS6;NDUFA11;NDUFA1;NDUFAF8;NDUFA6;NDUFAF4;NDUFA13
prerank,response to light stimulus (GO:0009416),0.3159170007694289,0.9039706688168161,0.6171428571428571,0.9325288499629582,1.0,9/55,15.96%,UVSSA;UBE2B;CDKN2D;USF1;ERCC4;MEN1;ZRANB3;UBE4B;SPRTN
prerank,negative regulation of viral entry into host cell (GO:0046597),0.408876192636362,0.9039189391635242,0.6040462427745664,0.9321750810759041,1.0,3/12,12.02%,LY6E;GSN;TRIM26
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.29290985472571596,-0.9036507594289296,0.6015037593984962,0.9927728651119639,1.0,2/19,1.84%,PPP3R1;PPP3CC
prerank,histone H4 deacetylation (GO:0070933),0.4161643579658565,0.9029909474472748,0.5988023952095808,0.9336532269751816,1.0,6/10,25.35%,HDAC8;HDAC1;HDAC2;HDAC4;SIRT2;SMARCAD1
prerank,integrated stress response signaling (GO:0140467),-0.3278473774304464,-0.9029209842718883,0.57,0.9927300866458194,1.0,6/14,33.89%,IMPACT;HERPUD1;CCL2;EIF2AK3;QRICH1;EIF2AK4
prerank,fatty acid metabolic process (GO:0006631),0.2886589522450092,0.9027862464506832,0.6701680672268907,0.9336119437036814,1.0,23/115,21.94%,MCAT;AOAH;ALKBH7;PER2;ACSL5;LIPC;LPIN2;PEX2;GNPAT;ECHDC3;XBP1;PPARGC1A;PPARD;AASDH;ACOX1;SGPL1;OXSM;GPX4;ELOVL4;PNPLA3;ADIPOR1;PNPLA8;PON3
prerank,vacuolar acidification (GO:0007035),-0.2891924061129304,-0.9025563762690841,0.597457627118644,0.9916225694140467,1.0,9/21,20.78%,ATP6V0A1;ATP6V1H;DMXL1;DMXL2;CLN5;CCDC115;CLN3;ATP6V0E2;TMEM199
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.256490628919619,-0.9024421552759495,0.6402116402116402,0.9898904811365873,1.0,8/33,16.43%,EPN1;PPP1R16B;PKM;E2F2;SEMA6A;CEACAM1;S100A1;KLF4
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.35883069525691325,-0.902014029912332,0.5555555555555556,0.988995337512549,1.0,4/10,9.13%,PPARG;RXRB;RXRA;RARA
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.2611346874009341,-0.9019650514048239,0.6093023255813953,0.987074838543045,1.0,6/29,8.05%,PATL1;EXOSC7;DIS3;DDX6;DCP1A;EXOSC5
prerank,sensory perception of pain (GO:0019233),-0.2852110320342327,-0.9016971255474449,0.6160714285714286,0.985760799061429,1.0,10/21,25.20%,OPRM1;CCR2;KCNA2;PTGES;SCN9A;CHRNA4;CCL2;P2RX7;OPRL1;OPRK1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.3817052389811385,0.9015793491651793,0.601360544217687,0.9356780588243674,1.0,4/19,16.82%,MAD2L2;PPM1F;NOTCH4;PTPRU
prerank,positive regulation of actin nucleation (GO:0051127),0.42503378931592667,0.9009748503506398,0.6047904191616766,0.9364779121883307,1.0,5/11,22.49%,CYFIP1;GSN;WHAMM;NCKAP1;BRK1
prerank,clathrin-dependent endocytosis (GO:0072583),0.35134885813546524,0.9007014266710603,0.6075,0.9365575327166217,1.0,6/26,14.25%,SIGLEC1;AP2A1;FNBP1L;AP2S1;PIP5K1C;SNAP91
prerank,BMP signaling pathway (GO:0030509),0.3111888796626514,0.9006377295129131,0.6293007769145395,0.9362108849224956,1.0,9/62,12.19%,GDF9;ACVR1;DDX5;USP15;SMAD2;SCX;BMPR2;RGMB;SMURF1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3261398547526902,0.9006083233639111,0.6185446009389671,0.9358060393152624,1.0,10/42,15.49%,ARID1B;ARID1A;MBD2;SMARCE1;SMARCC2;MTA2;ACTR8;ACTB;SMARCA1;SMARCD2
prerank,sulfation (GO:0051923),-0.34625598787935885,-0.900382222708618,0.5830618892508144,0.9871320716490618,1.0,4/11,23.05%,UST;SULT1A1;HS3ST5;SULT4A1
prerank,melanocyte differentiation (GO:0030318),0.4174708805140948,0.9002918201216948,0.5988286969253295,0.9359630589658591,1.0,3/11,12.84%,LRMDA;MITF;ENPP1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.3676093067550072,0.900096366884037,0.6114819759679573,0.9358985763278581,1.0,3/21,5.28%,DAPK3;PEAK1;DUSP3
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.31888174396296454,0.8989965480632358,0.6167247386759582,0.9377022970575167,1.0,5/44,12.56%,KCNMB3;ATP1B3;ACTN2;GABBR2;AKAP9
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.27253498114062347,-0.8988572898550814,0.6618357487922706,0.989190364202918,1.0,12/27,27.00%,TAB1;IRAK3;TRAF6;UBB;UBC;UBA52;RPS27A;CD14;BTK;TLR4;HSPD1;TLR5
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.376074464845637,0.898853408937713,0.6005586592178771,0.9375277047870696,1.0,3/17,7.41%,ITGA3;TFAP2B;DOK5
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.28734388623109736,0.8987974178697581,0.6857142857142857,0.9371755719163749,1.0,51/145,26.15%,PSMB10;SKP1;PSME2;PSMA5;MECP2;PSME4;CDC25B;DYNC1H1;CCND1;PSMA3;ACTR1A;RAD51C;MAPRE1;CDK5RAP2;PSMB9;PRKAR2B;RBX1;NEDD1;PSMD2;CEP131;CEP152;CEP70;PSME3;AKAP9;DYNLL1;PSMA4;HSP90AA1;TUBB4B;RAB11A;DCTN3;PAFAH1B1;PSMD7;CEP135;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;HAUS3;PSMD12;YWHAG;PSMD4;PSMA2;YWHAE;TUBA4A;CEP192;HAUS6;DCTN1;PSMD1;PSMD11;CEP57
prerank,prostanoid biosynthetic process (GO:0046457),-0.31844880761332406,-0.8987240616841388,0.5663082437275986,0.9874727609106643,1.0,6/15,27.78%,PTGDS;PTGS1;MIF;PTGES;PTGIS;PRXL2B
prerank,positive regulation of intracellular transport (GO:0032388),0.33009301729230056,0.898606608461943,0.6160388821385177,0.9371171525199846,1.0,17/38,28.55%,ACTN2;RUFY3;DYNC1H1;PLK3;MLC1;CEP131;SORL1;VAMP2;NUMA1;PLA2G4E;STK11;RAB29;TENM1;TBC1D20;STX18;PDCD10;ICE1
prerank,glycolipid metabolic process (GO:0006664),0.3203803800064866,0.8984237636760856,0.6280701754385964,0.9370115153166892,1.0,14/47,22.61%,PIGW;ST6GALNAC4;GBGT1;ST6GALNAC6;NEU1;SCCPDH;B3GALNT1;GLB1;GBA2;PGAP3;GLTP;SUMF1;ARSA;ESYT2
prerank,regulation of establishment of cell polarity (GO:2000114),0.37816766426239895,0.898150587399322,0.6002865329512894,0.9370949944653133,1.0,4/16,12.93%,RUFY3;KANK1;GSN;RACK1
prerank,regulation of cell cycle (GO:0051726),0.2817623473689918,0.8980680832745287,0.7502507522567703,0.9368080945250462,1.0,60/271,21.62%,PML;DAPK3;MYBBP1A;PER2;PNPT1;ZBTB17;BIRC2;GADD45G;CDC26;TARDBP;STAT3;ASAH2;RNF40;TRIM21;CHEK1;NOP53;HSP90AB1;JUNB;CDKN2D;SOX9;SRA1;CCND1;FGFR2;TCF7L2;MAGI2;CYLD;CSNK2A2;BARD1;MEN1;LIN9;PROX1;CDK10;SIK1;NEK6;RB1;RACK1;APBB1;WHAMM;BIRC3;SOX2;MASTL;PRDM11;PHACTR4;RPS15A;PTPRC;ZBTB49;WDR12;GBF1;TBRG4;CTBP1;NEK7;TSC1;BEX2;ERN1;JMY;GADD45A;STK11;CKS2;CITED2;CDK9
prerank,digestive tract development (GO:0048565),-0.2539596338863212,-0.8980248427779325,0.6666666666666666,0.9873884678139502,1.0,6/32,12.02%,COBL;NIPBL;EDNRB;SALL1;TGFB2;CCDC39
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.36719889261529626,0.8979378488728016,0.5986577181208054,0.9365998223606364,1.0,7/19,24.28%,DHX36;ZNF76;ICE2;MTOR;BRF2;CHD8;TENM1
prerank,histone deubiquitination (GO:0016578),0.3769067677262883,0.8978845957279753,0.5878284923928078,0.9362562361478665,1.0,4/18,17.65%,USP21;USP15;ATXN7;ENY2
prerank,chromosome condensation (GO:0030261),0.33080399008334527,0.8973178206072588,0.6207302709069493,0.9369820805431326,1.0,6/36,12.74%,TENT4A;CSNK2B;CSNK2A2;BANF1;NCAPG2;RB1
prerank,neuron projection morphogenesis (GO:0048812),0.2887707181029108,0.8971942922330736,0.6930184804928131,0.9367650076631974,1.0,36/137,19.81%,SLITRK6;TAOK3;BDNF;ATL1;LRP2;CNTNAP1;CTNNB1;GAS7;FGFR2;PAK3;EPB41L3;BTBD3;APP;TNIK;DNM2;ANKRD27;SRGAP2;APBB1;ACTB;CTNND2;MINK1;DBNL;TAOK2;MEF2A;BAIAP2;DSCAML1;LLGL1;NYAP2;DICER1;DCDC2;ABITRAM;DTNBP1;BRSK1;MAP1B;CCK;NCKAP1
prerank,adenine nucleotide transport (GO:0051503),-0.30860260289707586,-0.8969668625136306,0.611336032388664,0.9883044026851437,1.0,6/17,21.25%,SLC25A4;SLC17A9;SLC35B2;SLC25A5;SLC25A42;LRRC8A
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.30065749579186823,0.8968861852660737,0.6598712446351931,0.93693456331275,1.0,15/79,18.18%,AGT;SPRY2;LRP2;BAMBI;BMPER;BMPR2;SKIL;SORL1;SMURF1;HGS;BMPR1A;HTRA3;ADAMTS12;EPN2;ACVR2A
prerank,calcium-ion regulated exocytosis (GO:0017156),0.3491985845360868,0.8968254054254714,0.6040353089533418,0.9366010133282975,1.0,4/27,13.36%,CLTRN;SYT7;SYT3;VAMP2
prerank,cell-cell junction organization (GO:0045216),-0.20104357613110413,-0.896760748213824,0.7590361445783133,0.9868590268515554,1.0,10/79,8.41%,TGFB1;CDH10;CDH2;CTNNA1;CADM3;NECTIN1;ARVCF;SDK2;NLGN2;TGFB2
prerank,transport along microtubule (GO:0010970),-0.3329297086822351,-0.8963743324593588,0.5959595959595959,0.9858889464045315,1.0,7/13,25.88%,SPG11;CDC42;CLIP3;BAG3;DYNC1I2;COPG2;APBA1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.36722465721603315,0.8962879176024042,0.6050531914893617,0.9371970636423061,1.0,3/19,10.58%,CX3CL1;GIT1;ZC3H12A
prerank,maintenance of blood-brain barrier (GO:0035633),-0.25440045827845,-0.8962672532760243,0.6153846153846154,0.984171524500196,1.0,17/30,33.63%,SLC12A2;DMD;LAMA2;JAM2;SLC1A1;F11R;GJB6;LSR;VCL;TJP1;PECAM1;ESAM;OCLN;TJP3;MFSD2A;CLDN1;CDH5
prerank,kidney development (GO:0001822),0.30886135319624075,0.8957464045599272,0.6510359869138496,0.9378896041002914,1.0,8/65,10.64%,AGT;GREB1L;TFAP2B;NPHP3;CTSH;GDNF;PROX1;IFT27
prerank,metal ion export (GO:0070839),-0.2550759757922049,-0.8952801790232932,0.6927374301675978,0.9848142489795161,1.0,14/31,37.92%,ATP1B1;ATP1B2;KCND3;KCNT2;KCNK5;KCNH2;ATP2B4;ATP1A1;ATP1A3;FXYD2;KCNQ1;KCNIP2;ATP1A2;KCNE3
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3261248255425672,0.8952657192767051,0.6113744075829384,0.9383833817685727,1.0,11/41,21.55%,PTGR1;DEGS1;FADS3;SCD5;ABCD1;FADS2;DAGLA;ACOX1;GPX4;DECR2;PNPLA8
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.345793030320012,0.8951785440298583,0.6227106227106227,0.9380817705967345,1.0,1/29,0.40%,SYCP1
prerank,aorta morphogenesis (GO:0035909),0.3781473043344066,0.895167733982632,0.6110363391655451,0.9376345510282578,1.0,5/17,20.16%,TFAP2B;PROX1;BMPR1A;RBPJ;ACVRL1
prerank,membrane fusion (GO:0061025),0.3312231753546779,0.8944771660681471,0.6282208588957056,0.938581208788711,1.0,17/33,30.05%,UBXN2B;DNM2;VAMP2;VTI1B;NAPA;SNAP23;HUWE1;OPA1;RABEP1;DNM3;GCA;CHP1;RABIF;DNM1;NAPG;HACE1;SNAP29
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.4248477653525778,0.8944624687532209,0.6139817629179332,0.9376806212454835,1.0,3/10,13.38%,AP2A1;AP2S1;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.4248477653525778,0.8944624687532209,0.6139817629179332,0.9376806212454835,1.0,3/10,13.38%,AP2A1;AP2S1;MYLIP
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3043359408816767,0.8944220994773373,0.6445396145610278,0.9372973245535396,1.0,16/75,18.85%,AGT;SPRY2;SLC8A1;PAQR3;PRKAR2B;LYN;MEN1;SORL1;APOE;RB1;PIK3CB;INPP5K;CD300A;PRKAR2A;NF1;TESK1
prerank,energy reserve metabolic process (GO:0006112),0.374038068127617,0.8940866121299521,0.6056149732620321,0.9375180273209044,1.0,4/19,16.50%,MT3;GFPT1;LEPR;PHKG2
prerank,negative regulation of histone methylation (GO:0031061),0.4152912733309285,0.8940848918250698,0.6067251461988304,0.9370559778139121,1.0,3/10,9.78%,AASS;DNMT1;WDR5
prerank,cell cycle G1/S phase transition (GO:0044843),0.30497388435048584,0.8938905121265114,0.6407982261640798,0.9369977279917521,1.0,10/61,12.74%,ACVR1;CUL5;GSPT1;CDKN2D;CACUL1;CCND1;PLK3;MNAT1;MAX;RB1
prerank,RNA destabilization (GO:0050779),-0.30510681767350306,-0.8935353516379466,0.5955056179775281,0.9874740166224188,1.0,6/18,13.03%,ROCK1;METTL16;GIGYF2;RIDA;METTL3;ZC3H18
prerank,iron ion transmembrane transport (GO:0034755),0.42938007052670946,0.8933626376336927,0.6200873362445415,0.9376467757709896,1.0,4/10,21.40%,SLC11A2;ABCB7;ABCC5;SLC25A28
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.3660304546937258,0.8932842771725328,0.6177658142664872,0.9373510029742621,1.0,6/20,16.42%,HCK;CCL5;LYN;PRKCE;IL18;IRAK1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.4249348702004063,0.8930621790301088,0.6037441497659907,0.9373553424441904,1.0,3/10,12.94%,ST6GAL1;ST3GAL1;GNE
prerank,negative regulation of ossification (GO:0030279),-0.26985983295103494,-0.8927993447192696,0.6563876651982379,0.987471880334242,1.0,7/23,16.64%,CHSY1;SRGN;TRPM4;CCL3;SMAD6;CCR1;ECM1
prerank,regulation of melanin biosynthetic process (GO:0048021),0.42428530500133066,0.8927769063983898,0.6,0.9374898829603953,1.0,3/10,21.20%,RAPGEF2;CTNS;MFSD12
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.3405949146059283,-0.892724832771412,0.5845697329376854,0.985702710398336,1.0,3/12,14.03%,APOD;SNCA;CBL
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.4042638932966708,0.8926801466464989,0.6201780415430267,0.9372149921565299,1.0,5/12,18.30%,EPHA4;NFIB;MYCBP2;CHRNB2;PAFAH1B1
prerank,regulation of telomere capping (GO:1904353),-0.2721371473620038,-0.8922027593946636,0.6160714285714286,0.985154025104393,1.0,5/23,12.53%,PRKCQ;NBN;MAPK3;PNKP;NABP2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.39409604273714516,0.8921302271134117,0.6223479490806223,0.9378742437824491,1.0,5/14,22.69%,MAD2L2;SHLD1;PAXIP1;HMCES;KMT5C
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.2657183766065739,-0.8919058639647424,0.6325581395348837,0.9840826561721445,1.0,12/24,28.46%,PAK2;RHPN2;CLASP2;WAS;WASF2;F11R;CLASP1;ARHGAP6;PPFIA1;ARHGEF18;TJP1;ARHGAP28
prerank,carboxylic acid transport (GO:0046942),0.3145446845896672,0.8917310005119593,0.6501128668171557,0.938238579383535,1.0,10/55,16.65%,SLC38A2;SLC38A1;SLC38A3;SLC25A10;SLC38A6;SLC7A6;SLC16A13;SLC16A14;SLC16A6;SLC36A4
prerank,glutathione biosynthetic process (GO:0006750),-0.344403049180664,-0.8915575288892162,0.6,0.9830477739808307,1.0,4/11,17.09%,GCLM;GSS;HAGH;GGCT
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.2104298476422353,-0.8913627376570381,0.6785714285714286,0.981584453773774,1.0,11/75,10.83%,SLC12A6;SLC9A9;ATP1B1;SLC12A2;ATP1B2;KCNJ10;SLC39A14;CACNA2D1;SLC8A3;TRPM4;SLC39A12
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2953535519974932,0.8913456841401483,0.6624203821656051,0.9385579164712542,1.0,9/88,6.77%,HAS3;HYAL1;CLU;BCL2L11;SDC4;CX3CL1;CDT1;SH3GLB1;SLF2
prerank,ear morphogenesis (GO:0042471),0.3586567949246483,0.8912749305734764,0.6373333333333333,0.9382433819918605,1.0,3/20,13.68%,CHD7;FGFR2;MYO6
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.365927546012662,0.8910826092871481,0.6105960264900663,0.9381640229173437,1.0,5/19,16.88%,CCL5;CSF1;CXCL17;JAM3;MDK
prerank,regulation of chromosome segregation (GO:0051983),-0.30196722697121464,-0.8910670594013353,0.6058394160583942,0.9804029376626687,1.0,6/16,19.27%,CSNK2A1;RAD18;SMC6;MKI67;BUB1;IHO1
prerank,cellular iron ion homeostasis (GO:0006879),0.31137962188626384,0.8904963127354111,0.6407657657657657,0.9389024024646515,1.0,13/55,20.00%,SKP1;ATP6V0D1;FXN;SLC46A1;SLC11A2;CAND1;TFR2;HMOX2;FBXL5;ATP6V1G1;ABCB7;FLVCR1;ABCG2
prerank,nucleus organization (GO:0006997),0.31849053147060447,0.8904395141281876,0.6450867052023121,0.938548067655497,1.0,11/47,19.62%,CHMP4A;CHMP4B;CHMP1B;ATXN7;SUN2;CHMP3;REEP3;NUP155;CHMP5;NUMA1;NUP133
prerank,positive regulation of protein sumoylation (GO:0033235),0.4135091194083993,0.8902910698263364,0.6008836524300442,0.9384132622404405,1.0,6/10,29.58%,UBA2;PIAS1;HDAC4;PIAS4;GNL3;RWDD3
prerank,purine ribonucleotide catabolic process (GO:0009154),0.3595627576460552,0.8899597023752968,0.6192959582790091,0.9386648097255343,1.0,7/21,21.11%,XDH;HPRT1;NUDT16;NUDT4;ACAT1;AMPD3;PDE9A
prerank,mRNA splice site selection (GO:0006376),0.3413451866350037,0.8893501074660576,0.6373762376237624,0.9393985236595442,1.0,1/30,0.16%,NOL3
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.40190451007795025,0.8892997533105776,0.61,0.9390505703853088,1.0,6/13,23.22%,FGFR2;PIM1;BMPR1A;RBPJ;FGF2;NOTCH1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.31773361042635134,-0.8891231027755436,0.5700636942675159,0.9836668604253362,1.0,7/13,29.95%,NAPEPLD;ZBTB7B;VSTM2A;SOX13;FNDC5;TFE3;METRNL
prerank,cellular response to amino acid starvation (GO:0034198),0.3007605446659746,0.888825547509637,0.6699453551912569,0.9395507978126113,1.0,19/71,22.24%,EIF2AK2;MIOS;ATP6V0D1;RRAGC;KPTN;SH3GLB1;LAMTOR3;EIF2S1;MTOR;TCIRG1;ATP6V1B2;ATP6V1G1;NPRL2;NPRL3;ATP6V1G2;LAMTOR4;RHEB;WDR59;RRAGA
prerank,protein N-linked glycosylation (GO:0006487),0.30328705159321656,0.8887688329859308,0.6594594594594595,0.939188798787259,1.0,22/66,25.24%,TMEM258;ST6GAL1;B4GALT1;GFPT1;ENTPD5;ST3GAL1;DAD1;MGAT4C;ALG13;ALG11;RPN1;MGAT5;MAGT1;MAN1C1;STT3B;KRTCAP2;DDOST;DPAGT1;DOLPP1;TMEM165;PMM2;MGAT5B
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.38411523373296824,0.8881964376525328,0.6152758132956153,0.9398739498459329,1.0,7/15,29.90%,DDRGK1;NPM1;EZH2;CUL3;KLHL18;CDC73;PAF1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.3350559445965189,0.8878383481080291,0.6471306471306472,0.9401388312208675,1.0,6/33,14.82%,PSME2;DDRGK1;FBXW7;TRIM39;PSME3;EZH2
prerank,sodium-independent organic anion transport (GO:0043252),0.43368096822957525,0.8877707394488517,0.6301775147928994,0.9398115740394568,1.0,2/10,6.49%,SLCO1C1;SLCO1B1
prerank,L-amino acid transport (GO:0015807),0.339685958900539,0.8877631980121665,0.6280193236714976,0.9393664187047294,1.0,10/28,25.51%,SLC25A22;SLC38A2;SLC38A3;CTNS;SLC25A12;SLC36A4;SFXN1;SLC1A3;ARL6IP5;SLC36A1
prerank,negative regulation of neuron differentiation (GO:0045665),0.35829498107910557,0.8871705100381938,0.6217277486910995,0.9401166049366367,1.0,2/22,5.41%,B2M;SOX9
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.38707339164207405,0.8871064230583746,0.6200814111261872,0.9397878712814445,1.0,6/14,22.29%,RBMX;RNPS1;SRSF7;SRSF4;PCBP4;SRSF10
prerank,Golgi to plasma membrane transport (GO:0006893),0.3140548351020682,0.8868830528938336,0.6326767091541136,0.9397968728991707,1.0,18/47,24.86%,BLZF1;GOLGA7;GGA3;AMN;EXOC6;ARFGEF2;VAMP2;VAMP4;BBS2;PREPL;LLGL1;VAMP5;GOLPH3L;OPTN;RAB10;RABEP1;EXOC2;COMMD1
prerank,actin filament organization (GO:0007015),0.28612622169500024,0.8868198178057373,0.7193515704154002,0.9394656678676317,1.0,28/151,16.35%,ACTN1;MYO1C;ELMO2;MAD2L2;RHOF;RUFY3;PPP1R9A;EVL;CARMIL1;SAMD14;BCAR1;PROX1;ARHGAP25;CORO7;GSN;FAT1;TMOD3;TRPV4;WHAMM;CORO1B;MYO6;RAC1;DLG1;GAS2L3;SH3BP1;BAIAP2;AIF1;BAIAP2L1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.34604181946488044,-0.8867850704069556,0.6347826086956522,0.987847301003915,1.0,5/11,27.71%,TIMM13;TIMM8B;TIMM9;ROMO1;NDUFA13
prerank,glucose import (GO:0046323),0.39700577811701326,0.8866254696863485,0.5983263598326359,0.9394006207081389,1.0,1/13,2.36%,SLC27A1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.36420109064310896,0.8863332542443728,0.6284953395472703,0.9395040963233712,1.0,6/20,18.13%,SPPL2A;NFKB1;PSEN1;APH1A;APH1B;HM13
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.3238519995863865,0.8861559695530377,0.6340023612750886,0.939398349720538,1.0,7/39,9.07%,POLD4;CHD1L;RFC4;RFC1;ERCC4;RBX1;POLK
prerank,excitatory postsynaptic potential (GO:0060079),-0.2906668836358234,-0.8860932408421933,0.6328671328671329,0.9877530548516588,1.0,9/19,27.09%,GRIN2A;GRIN2B;GRIN1;GSK3B;AKT1;MEF2C;MAPK8IP2;DRD2;GRID2
prerank,membrane repolarization during action potential (GO:0086011),-0.3272284940627771,-0.8860469591175842,0.594059405940594,0.9858508447402781,1.0,8/13,40.13%,ATP1B1;KCND3;KCNH2;ATP1A1;KCNQ1;KCNIP2;KCNE3;KCNE4
prerank,organelle disassembly (GO:1903008),-0.24779535298428973,-0.885950611837742,0.6746987951807228,0.9841126180511621,1.0,9/33,11.70%,UBA5;VRK1;EIF2D;KIF9;ULK2;UFM1;ATG2B;ATG2A;ZFAND1
prerank,artery morphogenesis (GO:0048844),0.3385038372408298,0.8856783228679649,0.6150121065375302,0.9399178005447614,1.0,6/30,18.18%,LRP2;TFAP2B;BMPR2;NRP1;BMPR1A;NF1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.35937083461941965,0.8854671760592783,0.6343085106382979,0.9398860078920249,1.0,6/21,21.95%,DNMT1;LDLRAP1;FGF9;BMPR1A;ERN1;FGF2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.3182637656030177,0.885390514904021,0.6544202066590127,0.9391331747225508,1.0,11/50,20.34%,NUP37;POLR2G;AGO2;NUP153;RAE1;POLR2K;IPO8;NUP155;NUP88;NUP133;NUP43
prerank,regulation of gene silencing by RNA (GO:0060966),0.3182637656030177,0.885390514904021,0.6544202066590127,0.9391331747225508,1.0,11/50,20.34%,NUP37;POLR2G;AGO2;NUP153;RAE1;POLR2K;IPO8;NUP155;NUP88;NUP133;NUP43
prerank,regulation of wound healing (GO:0061041),-0.23130913814332477,-0.885296166641669,0.6906474820143885,0.9838625247894043,1.0,12/42,24.02%,SRSF6;DMTN;EPHB2;VTN;HRAS;ANXA1;CD109;F2R;CAV1;HBEGF;TNFAIP3;ADRA2A
prerank,retrograde axonal transport (GO:0008090),-0.298297185681083,-0.8849218975234044,0.5968992248062015,0.9829058763272336,1.0,3/16,8.92%,DST;MAP1A;FBXW11
prerank,positive regulation of protein polymerization (GO:0032273),0.30038797622882557,0.8848867158505742,0.6607538802660754,0.9396982630607122,1.0,16/65,16.35%,HCK;EVL;CARMIL1;MAPRE1;CDK5RAP2;NCK1;MET;NCK2;SNX9;TPPP3;AKAP9;PRKCE;RAC1;HSP90AA1;BAIAP2;BAIAP2L1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2775346007336896,0.8847543427122374,0.7680722891566265,0.9394997337941888,1.0,48/214,21.95%,NOD2;CCL7;SLAMF1;SPRY2;KDR;GAREM1;CCL5;FBXW7;DUSP3;CX3CL1;FGFR2;MT3;DUSP29;RAPGEF2;CNKSR3;ACKR3;LYN;APP;HMGB1;BMPER;ROR2;ARRB2;TNIP1;CIB1;DUSP26;CCL14;HTR2A;PTPN11;APOE;DUSP10;NRP1;DLG1;MTURN;FGFR3;LGALS9;SPRED3;PTPRC;DSTYK;SPRED1;MFHAS1;PIN1;RANBP9;SIRPA;CCL4;TNFAIP8L3;ROR1;GCNT2;FGF2
prerank,regulation of actomyosin structure organization (GO:0110020),0.389095293658404,0.8844905794863113,0.6180257510729614,0.9395734046698928,1.0,5/13,19.18%,PTGER4;AKAP13;RAC1;ASAP3;TSC1
prerank,actin filament network formation (GO:0051639),0.4044017237166523,0.8842517931833638,0.593245227606461,0.939612286048888,1.0,2/11,6.05%,ACTN1;CARMIL1
prerank,positive regulation of hormone secretion (GO:0046887),-0.29998038221044976,-0.8842284498897784,0.6312292358803987,0.9827103381588493,1.0,14/17,50.65%,SNX4;VAMP7;PLA2G3;C1QTNF3;GRP;HCAR2;SPP1;VAMP8;RASL10B;NMB;EDN3;CYP19A1;EDN1;SOX11
prerank,monocarboxylic acid transport (GO:0015718),0.3158406936310134,0.8840689069959663,0.6551326412918108,0.9394966862856727,1.0,8/51,14.77%,ABCC2;SLC27A1;SLCO1C1;NCOA1;SLCO1B1;SLC16A13;SLC16A14;SLC16A6
prerank,replication fork processing (GO:0031297),0.3266528580293535,0.883922648147598,0.6257594167679222,0.9393132965132949,1.0,6/38,15.00%,SAMHD1;ETAA1;RTEL1;ZRANB3;DDX11;GEN1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.28011652886150396,0.883860701157068,0.7464788732394366,0.9389767684499436,1.0,72/184,28.30%,PSMB10;SKP1;PSME2;PSMA5;CDC26;PSME4;ANAPC5;DYNC1H1;PSMA3;ACTR1A;MAPRE1;CDK5RAP2;PSMB9;ANAPC4;PRKAR2B;UBE2E1;BTRC;NEDD1;ZFP36L1;PSMD2;CEP131;CEP152;CDC16;CDC27;CEP70;NEK6;PSME3;AKAP9;DYNLL1;ANAPC15;PSMA4;HSP90AA1;TUBB4B;ANAPC2;DCTN3;PAFAH1B1;PSMD7;CEP135;PSMD8;PSMD9;PSMF1;APPL2;PSMB6;PSMC2;HAUS3;PSMD12;YWHAG;PSMD4;CUL3;ZFP36L2;PSMA2;PTPN6;KLHL18;TFAP4;YWHAE;TUBA4A;CEP192;SIRT2;HAUS6;DCTN1;PSMD1;PSMD11;CEP57;ANAPC10;CDC14A;SFI1;MAD2L1;HECW2;ANAPC11;CNTRL;DDB1;CEP76
prerank,regulation of MAPK cascade (GO:0043408),0.2822682959551104,0.8837342382917566,0.7231869254341164,0.9388064983678892,1.0,21/157,10.16%,TAOK3;FLT1;KDR;GPR37L1;DHX33;DUSP3;CX3CL1;MYDGF;FGFR2;PAK3;WDR54;GPR37;NBR1;RET;TMEM106A;MYOC;LYN;HMGB1;INSR;ROR2;TNIK
prerank,error-prone translesion synthesis (GO:0042276),0.3618300611473459,0.8836391527639379,0.6121372031662269,0.9385549318876247,1.0,5/21,9.07%,POLE2;MAD2L2;RFC4;RFC1;POLK
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.35849351304053584,-0.8835062251989949,0.6361031518624641,0.9825587675622773,1.0,2/10,6.84%,IMPACT;MVP
prerank,regulation of isotype switching (GO:0045191),0.3867049958701076,0.8834420492014164,0.6131805157593123,0.9384835186783603,1.0,5/14,22.69%,MAD2L2;SHLD1;PAXIP1;HMCES;KMT5C
prerank,cellular response to alcohol (GO:0097306),0.32217387021334043,0.8831820312227154,0.648235294117647,0.938536929146272,1.0,10/42,15.36%,PTGER4;LARP1;ADCY5;OSBPL7;CTNNB1;MLC1;SPHK2;GLRA2;PTCH1;GRAMD1C
prerank,synaptic vesicle exocytosis (GO:0016079),-0.2328525869736307,-0.8831328215713705,0.7202797202797203,0.981606514980514,1.0,14/40,21.91%,SYT2;SYT10;SNCA;RIMS1;SNAP47;STX1B;RIMS3;UNC13A;SYT8;BLOC1S6;RIMS2;SYT1;OTOF;STX1A
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.41800351658820034,0.8830221480429955,0.6151515151515151,0.9383988632266309,1.0,3/10,10.73%,CCT4;CCT7;CCT3
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.3969047955977748,0.8829516120407657,0.61794500723589,0.9380851785421674,1.0,2/13,2.73%,ABCA1;CDH13
prerank,ESCRT complex disassembly (GO:1904896),0.4152851198901698,0.8828007382202723,0.5970149253731343,0.9374679617843711,1.0,4/10,21.99%,CHMP1B;IST1;CHMP5;CHMP1A
prerank,ESCRT III complex disassembly (GO:1904903),0.4152851198901698,0.8828007382202723,0.5970149253731343,0.9374679617843711,1.0,4/10,21.99%,CHMP1B;IST1;CHMP5;CHMP1A
prerank,mitochondrial translational termination (GO:0070126),0.2935784919413912,0.8825529263060489,0.6793478260869565,0.9375086087039015,1.0,21/88,19.21%,MRPL36;ERAL1;MRPS30;MRPL12;MRPL16;MRPS35;MRPS28;MRPL42;MRPL4;MRPS23;MRPS2;MRPS22;AURKAIP1;MRPL24;MRPS10;MRPL13;MTRF1L;MRPL57;MRPS11;MRPL40;MRPL22
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.22823122251976108,-0.8824065094600996,0.6891891891891891,0.9815652796865744,1.0,17/46,23.50%,TGFB1;ANP32B;EFCAB7;GSK3B;PIK3R2;CAMK1;RAPGEF3;TP53;ZIC1;UBR5;DMAP1;BAG3;ECT2;NEDD4;TPR;RBM22;IL1B
prerank,cellular response to metal ion (GO:0071248),0.28819501809139625,0.8821157227612725,0.701844262295082,0.9379005272072248,1.0,16/123,11.05%,CAMK2D;RASA4;CLIC4;WNT5A;DAXX;CPNE3;TRPM2;B2M;CRHBP;MT3;SYT7;SYT3;P2RX4;PRNP;ADGRV1;GLRA2
prerank,negative regulation of B cell activation (GO:0050869),-0.28316158178971035,-0.8817644103783111,0.6203007518796992,0.9811710119061989,1.0,4/21,7.67%,SAMSN1;TNFRSF13B;ID2;BANK1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.29375772279394324,-0.8816040794973592,0.6111111111111112,0.9796156506540962,1.0,3/17,6.48%,ADCY9;ADCY3;PRKACB
prerank,cellular response to osmotic stress (GO:0071470),0.35817018338376205,0.8814928175967506,0.6268068331143233,0.938662634602567,1.0,8/21,21.42%,CAB39;ZFP36L1;SCN2A;TRPV4;OXSR1;STK39;DDX3X;RCSD1
prerank,regulation of mast cell degranulation (GO:0043304),0.3888994908125559,0.8814922502555662,0.6268011527377522,0.9382099260988481,1.0,6/14,16.80%,UNC13D;LYN;SPHK2;CD84;CD300A;LGALS9
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.32559891593921386,-0.8814719450797199,0.6158536585365854,0.9780275641371957,1.0,2/13,5.29%,SYK;FGR
prerank,ketone body metabolic process (GO:1902224),0.4104193247808192,0.881260004365444,0.6233382570162481,0.9382278166988713,1.0,3/10,17.01%,HMGCL;OXCT1;ACAT1
prerank,positive regulation of phosphatase activity (GO:0010922),0.3602334730365578,0.8811021661084585,0.6268260292164675,0.938084195440298,1.0,5/21,16.31%,HSP90AB1;MAGI2;CALM3;CD300A;MTOR
prerank,protein prenylation (GO:0018342),-0.34276426409254857,-0.8809330784777044,0.6210191082802548,0.9774040100135565,1.0,6/10,21.90%,CHML;RABGGTA;PGGT1B;FNTB;CHM;RCE1
prerank,cell junction organization (GO:0034330),0.29976858317208316,0.8805233244713493,0.6804347826086956,0.9387904526615717,1.0,16/71,16.35%,ELFN1;RAB8B;PAK3;WNT7B;APP;AGRN;SDK1;PSEN1;TJP2;LIMS1;PPFIA4;ACTB;CTNND2;SH3BP1;NLGN3;OPHN1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.369344022838749,0.8800430595640413,0.6107954545454546,0.9392964141575599,1.0,2/18,6.21%,CAMK2D;CAB39
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.4114589393654271,0.8799076992547068,0.6336336336336337,0.9391059957566176,1.0,8/10,32.54%,ACADL;ACADS;GCDH;ACADVL;ETFDH;ACAD11;ETFA;ETFB
prerank,fat cell differentiation (GO:0045444),-0.2159250210624026,-0.8798489631827795,0.7614678899082569,0.9782581388143042,1.0,16/57,16.43%,OSBPL11;PPARG;MAFB;BBS9;ZBTB7A;PSMB8;SIRT1;TMEM120A;AKT2;CEBPA;HMGA2;CLIP3;FOXO1;SMAD6;WNT5B;KLF4
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.28342229072470737,0.879761272910773,0.6957424714434061,0.938959323936479,1.0,24/108,21.45%,TNFSF10;CASP4;XDH;NOD1;FIS1;CFLAR;HMGB1;PRR7;PPM1F;DIABLO;GSN;RACK1;BAD;ST18;JAK2;UACA;LGALS9;BAX;CRADD;BCAP31;DDX3X;LCK;MTCH1;F3
prerank,response to X-ray (GO:0010165),0.38193340250721897,0.8792868634749088,0.6243093922651933,0.9394325420850531,1.0,1/14,0.99%,MSH2
prerank,positive regulation of cellular component organization (GO:0051130),0.28681109534054194,0.8791550501913346,0.7077720207253886,0.9392457181562839,1.0,23/107,18.22%,ATP10A;HAS3;HYAL1;CLU;CAMK2B;BCL2L11;RUNX1;CDT1;SH3GLB1;SLF2;INSR;APOE;RB1;RACK1;PLEKHM2;DAB2;TFR2;BMF;ANAPC2;BAX;CBLL1;ABCB7;FNIP2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.3525623552828939,0.8788602288039683,0.6286472148541115,0.9393611584360799,1.0,7/22,21.67%,DHX36;SRF;MED12;PAXIP1;MED16;MED24;PSMC2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.36404225947487046,0.8786347427627733,0.6258234519104084,0.9393663402805291,1.0,2/20,3.74%,CAMK2D;SLC8A1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.32054268630543753,-0.8783436302383102,0.6040268456375839,0.9802740228078396,1.0,6/14,23.37%,CSTF2;FIP1L1;CPSF7;CPSF4;TUT1;CPSF2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.4251195386005743,0.8782292967531248,0.6204268292682927,0.9397104920863072,1.0,3/10,11.82%,NBR1;LYN;MAP2K2
prerank,serine family amino acid catabolic process (GO:0009071),0.4137710343032829,0.8778516670687712,0.6234756097560976,0.9400060493106255,1.0,3/10,15.02%,DLD;SHMT1;GCSH
prerank,protein localization to cilium (GO:0061512),0.3358997358244151,0.8778300179969467,0.645326504481434,0.9396013508766599,1.0,12/32,25.62%,SNX10;TUB;WDR35;ZNF423;ODAD4;WDR19;TULP3;RABEP1;RAB29;IFT140;BBS4;INVS
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.27448613037096603,-0.8775179413241734,0.6637168141592921,0.9804210928676088,1.0,8/22,24.31%,APC;NR2F2;CEBPA;INCA1;CDKN1A;HEXIM1;CDKN1B;CDK5RAP1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.32867993244534627,0.8774975950012296,0.6396063960639606,0.939818082216916,1.0,10/32,19.75%,SEMA4D;CUL7;FBXW8;RAPGEF2;TNIK;CUX1;CHRNB2;CAPRIN1;RAP2A;SS18L1
prerank,positive regulation of cell growth (GO:0030307),0.29185376904699073,0.8774276225392172,0.7036649214659686,0.9395059135684295,1.0,17/96,15.64%,HYAL1;BDNF;SEMA4D;CXCL16;MMP14;SFRP2;FXN;RUFY3;DDX49;SYT3;CIB1;SMURF1;RASAL1;EXOSC9;DBNL;NCBP1;ADNP2
prerank,cardiac muscle contraction (GO:0060048),0.3286497510648009,0.8770510786264851,0.6511350059737157,0.9397663186080608,1.0,6/34,17.44%,CAMK2D;SLC8A1;TNNC1;GSN;SCN1B;TNNI2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.3297638484474243,-0.8770194788353463,0.6126760563380281,0.9797881126405278,1.0,5/13,11.79%,CASP8;GRIN2A;TBC1D10A;NLRC4;CYFIP2
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.2695225977195483,-0.8770020844800572,0.645021645021645,0.9779282483367154,1.0,7/22,16.73%,CDK13;CCNT1;THOC5;BRD4;HMGN1;THOC1;ELL
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.23730715201277558,-0.8766533735214411,0.727810650887574,0.9769651811463916,1.0,8/37,11.40%,DLG4;ITGAV;PINK1;EDNRB;ANKRD13A;ABCA2;SIRT5;BRCA1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.3512549312535219,0.876311207774506,0.6293436293436293,0.9407852886675998,1.0,5/24,9.07%,POLD4;RFC4;POLB;RFC1;POLK
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.23985515769422736,-0.8758162082772712,0.7150537634408602,0.977337584618127,1.0,8/33,17.89%,TGFB1;SMARCA4;PPARG;TGFB2;EGR1;TP53;KLF4;TEAD1
prerank,ceramide catabolic process (GO:0046514),0.3862558873462768,0.8757847507615709,0.6436950146627566,0.941344169069833,1.0,3/14,15.93%,ASAH2;NEU1;ACER3
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.37972220599251166,0.8757588977894757,0.6160108548168249,0.9409496131047017,1.0,2/15,2.65%,AUP1;TMEM129
prerank,protein localization to vacuole (GO:0072665),0.3900154597014435,0.8750014219858309,0.6338028169014085,0.9419949199939988,1.0,6/13,27.15%,KPTN;SH3GLB1;LAMTOR4;SZT2;GLMP;LMBRD1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.35548873273000353,0.8748157938261847,0.6269230769230769,0.9418796355358379,1.0,6/22,18.08%,HSCB;FXN;NFU1;NFS1;CIAPIN1;ABCB7
prerank,positive regulation of cyclase activity (GO:0031281),-0.31359591749212734,-0.8747808074166381,0.6173285198555957,0.9781038456728675,1.0,2/14,5.67%,STIM1;MAPK3
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.40317021031792766,0.8744060957464805,0.6328233657858137,0.9422034830410586,1.0,2/12,5.99%,TIPIN;CDT1
prerank,B cell differentiation (GO:0030183),-0.22919071544650277,-0.8741723674595029,0.6825396825396826,0.9777464208885167,1.0,10/46,17.42%,NFAM1;KLF6;DCAF1;ZBTB7A;LYL1;PTPN2;DNAJB9;JAK3;SLC25A5;ADGRG3
prerank,regulation of cellular protein localization (GO:1903827),0.3087691865358278,0.8733875425366623,0.6528258362168397,0.9437330333462801,1.0,11/45,19.46%,BDNF;SUMO3;HSP90AB1;CTNNB1;RAB11B;VCPIP1;PPM1F;HSP90AA1;CCDC66;GBF1;PIN1
prerank,neuron remodeling (GO:0016322),0.4181167867731037,0.8724689619021517,0.6513761467889908,0.9450686937554477,1.0,2/10,9.06%,CX3CL1;APP
prerank,regulation of protein polymerization (GO:0032271),-0.23812154138696529,-0.8718255974279754,0.7048192771084337,0.9818588643382887,1.0,7/35,11.25%,FCHSD2;PRUNE1;TPPP;COTL1;TTBK1;ARL2;PLEKHG2
prerank,positive regulation of developmental growth (GO:0048639),0.3133033534426093,0.8711772079229292,0.6727066817667045,0.9471249395687698,1.0,9/49,15.17%,BDNF;SEMA4D;RUFY3;SYT3;INSR;AGRN;SMURF1;RASAL1;DBNL
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.29792293119204005,0.8707462352850314,0.6930803571428571,0.947468197434629,1.0,8/66,12.26%,PARP9;DTX3L;MEPCE;CCT4;CCT7;ZC3H12A;CCT3;PSEN1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.271965420313276,-0.8705339712414,0.6692307692307692,0.9832802736003129,1.0,8/22,27.08%,DMD;AHNAK;CACNB1;CBARP;SRI;NOS1AP;DRD2;CRHR1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.353134457371489,0.8704643839218513,0.6319261213720316,0.9475475764226412,1.0,3/21,9.46%,SLC18A2;MT3;ABCD1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.27634077467988694,0.8700137779538664,0.761071060762101,0.9479889702491355,1.0,36/150,18.99%,XDH;TRIB3;SPRY2;SEMA4D;TARDBP;THY1;SFRP2;TARBP2;PMEPA1;PPIA;PAQR3;CNKSR3;NCK1;LYN;NCK2;PRNP;MEN1;CIB1;PPM1F;ZC3H12A;DDIT4;PRKDC;AKT1S1;RB1;ENPP1;RACK1;INPP5K;CALM3;SPRED3;PTPRC;CORO1C;NF1;DTNBP1;SPRED1;TESK1;SNX25
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.29254386689745215,0.8698849817898974,0.6958874458874459,0.9477937145099218,1.0,4/73,1.42%,TNFSF10;CASP4;XDH;NOD1
prerank,leukotriene biosynthetic process (GO:0019370),-0.31162662634259347,-0.8695159491226442,0.6158730158730159,0.9840178089418576,1.0,2/14,4.65%,LTC4S;ALOX5AP
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.2906521461186452,0.8690816532679805,0.7142857142857143,0.9489082976273087,1.0,19/86,21.53%,GDF9;ACVR1;HSP90AB1;CSNK2B;SMAD2;BMPR2;MEN1;SNW1;ZNF423;DAB2;JAK2;BMPR1A;RBPJ;ACVR2A;RBPMS;NUMA1;ACVRL1;STK11;CITED2
prerank,DNA methylation (GO:0006306),-0.27194335767961375,-0.8688759238600667,0.6883720930232559,0.9837463264692339,1.0,13/23,30.28%,EHMT1;KMT2E;N6AMT1;METTL4;TEX15;BEND3;DMAP1;ATRX;PPM1D;BAZ2A;PICK1;ZFP57;FOS
prerank,positive regulation of cytokinesis (GO:0032467),-0.23990350986139325,-0.8687652910234044,0.6511627906976745,0.9821337401562235,1.0,9/32,18.64%,CENPV;CDC42;CIT;KIF20B;RACGAP1;RHOA;KIF23;CSPP1;ECT2
prerank,negative regulation of cell communication (GO:0010648),0.3539148556426881,0.8684848596067993,0.6586021505376344,0.9495928096783711,1.0,3/21,8.85%,ACVR1;KIF26A;SOCS5
prerank,peptidyl-lysine acetylation (GO:0018394),-0.3485388499630754,-0.8682286635704292,0.5982142857142857,0.9815899486625568,1.0,2/10,7.83%,ESCO1;SIRT1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.2508635258876862,-0.8678783109382198,0.6273291925465838,0.9806420553579432,1.0,5/30,7.60%,TGFB1;TGFBR3;TWSG1;TRIM33;PCSK6
prerank,negative regulation of gluconeogenesis (GO:0045721),0.4039028587867469,0.867233420830462,0.6483679525222552,0.9515563936057686,1.0,2/11,13.42%,SIK1;CLK2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.3843902456730437,0.8670548715561973,0.6253561253561254,0.951447252684321,1.0,3/13,11.92%,SOCS1;RUNX1;NKAP
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.2622953422071598,-0.8670174941098641,0.6637168141592921,0.980895229655812,1.0,9/25,17.61%,AR;NCKAP1L;EGFR;SNCA;SRC;MIF;KCTD20;FZD7;GLMN
prerank,sodium ion export across plasma membrane (GO:0036376),-0.32346425486981306,-0.8668201904941844,0.6385135135135135,0.9795551299070119,1.0,2/13,3.63%,ATP1B1;ATP1B2
prerank,negative regulation of RNA splicing (GO:0033119),-0.27871228655832464,-0.8666985635414567,0.6790123456790124,0.9780069747827245,1.0,8/19,20.72%,TMBIM6;RPS26;SRSF6;SFSWAP;PTBP3;C1QBP;PTBP1;U2AF2
prerank,positive regulation of cell communication (GO:0010647),-0.25046421152565373,-0.8665549037194882,0.6862745098039216,0.9765076175193752,1.0,11/28,24.11%,DLG4;HOMER1;ANK3;RIMS1;RIMS3;CDKN2AIP;RIMS2;KCTD13;SYT1;NMU;CD80
prerank,blood vessel morphogenesis (GO:0048514),0.30439304420829755,0.8665350131413653,0.6736958934517203,0.9520378838174612,1.0,10/54,18.18%,FLT1;KDR;CUL7;ITGB8;EGFL7;PROX1;NRP1;AGGF1;RBPJ;NF1
prerank,alpha-amino acid metabolic process (GO:1901605),0.30914738090366833,0.8664982719457479,0.6793103448275862,0.9516574760308625,1.0,11/45,23.00%,MTHFR;THAP4;SLC25A12;GLUD1;FOLH1;MTHFD1;GADL1;MMUT;GPT2;GOT1;RIMKLA
prerank,positive regulation of bone resorption (GO:0045780),0.4001018998295559,0.866430677691928,0.6156028368794326,0.9513270517676823,1.0,2/11,10.08%,ADAM8;DEF8
prerank,negative regulation of phosphorylation (GO:0042326),0.28589328076976633,0.8659463302590718,0.6905781584582441,0.9518067326588366,1.0,17/85,14.94%,XDH;TARDBP;ANKLE2;CDKN2D;PPIA;PAQR3;LYN;PRNP;MEN1;GIT1;CIB1;ZC3H12A;STAP1;PRKDC;DYNLL1;IRS2;INPP5K
prerank,cellular response to interleukin-12 (GO:0071349),0.3077102045186288,0.8658164889559055,0.682648401826484,0.9515990586255297,1.0,16/48,25.45%,PSME2;SOD2;CD47;HNRNPA2B1;PPIA;IL12RB2;HNRNPDL;JAK2;AIP;HNRNPF;SIRPA;TALDO1;MSN;PITPNA;JAK1;ANXA2
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.31416867669783705,0.8656354157394781,0.6685845799769851,0.9514721027670588,1.0,8/45,12.25%,GAREM1;TGFA;SOX9;BCAR1;NCK2;KIF16B;SOS1;PTPN11
prerank,epithelial cell-cell adhesion (GO:0090136),-0.33590162151484876,-0.8654200838675615,0.625,0.9775080435214782,1.0,5/11,30.99%,KIFC3;VCL;JUP;CCN3;CAMSAP3
prerank,regulation of cellular catabolic process (GO:0031329),0.2969643157699528,0.8654071176610143,0.6847345132743363,0.9514628962457715,1.0,8/62,9.46%,DAPK3;TRIB3;LONP2;ITPR1;OSBPL7;RRAGC;CISD2;ABCD1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3463806952352846,0.8650899086311542,0.6604527296937417,0.9516074480130888,1.0,4/21,15.66%,SPRY2;ARHGAP25;LZTR1;SH3BP1
prerank,gene expression (GO:0010467),0.2699633575573276,0.865085437764205,0.83,0.9511637995550347,1.0,88/348,21.25%,APOBEC1;NUP37;POLR2G;MRPL36;XRN2;ADAR;IGF2BP3;AGO2;RPL36;MAGOHB;HARS2;SMG7;HNRNPH1;NUP153;NCBP2;GSPT1;NOL9;RPL22;RRAGC;HNRNPK;EIF4EBP2;RPS21;WDR33;RBMS2;DDX20;NXT1;HNRNPA2B1;RAE1;SCX;POLR2K;HNRNPL;TNIP1;RNPS1;MRPL42;ABCF1;SMG5;SORL1;HNRNPH3;UPF2;DDX54;ZC3H11A;TAF1B;ATXN1;RPS6;CHTOP;DUSP11;RPS11;NUP155;DDX39B;RPL30;MRPL24;RBM39;NCBP1;RBM3;DDX19B;RPL32;SRSF7;MEF2A;RPL23A;LMF2;RPL11;SRSF4;UPF1;YARS2;RPL10A;RPS15A;MRPL13;NUP88;HBS1L;SLU7;SRBD1;RBPMS;RSL24D1;RPL24;RPL37A;FASTKD2;RPL3;MRPS11;HNRNPF;NUP133;RRBP1;GLE1;NUP43;THOC7;RPL29;RPL5;SRSF5;FARSB
prerank,cellular response to estrogen stimulus (GO:0071391),0.3772100231660682,0.8649941119046561,0.6609442060085837,0.950926010578549,1.0,2/14,5.43%,CRHBP;SRA1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.255535680236526,-0.864532167397376,0.6954545454545454,0.9777851998210815,1.0,10/25,22.08%,CDK13;EAF2;LARP7;NELFB;BRD4;EAF1;ELL;NELFE;HEXIM1;NELFA
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.3505191912629599,0.8644472244613151,0.6602564102564102,0.951082996062316,1.0,3/22,5.21%,GOLGA7;ZDHHC21;ZDHHC20
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.3505191912629599,0.8644472244613151,0.6602564102564102,0.951082996062316,1.0,3/22,5.21%,GOLGA7;ZDHHC21;ZDHHC20
prerank,endodermal cell fate commitment (GO:0001711),-0.35607516395208244,-0.8643609225202618,0.6284916201117319,0.9763300049500322,1.0,1/10,1.76%,CTR9
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.19729441717508892,-0.8626358182704061,0.8222222222222222,0.9787179211567646,1.0,25/98,17.90%,CASP8;SORBS1;PPP3R1;CD81;PPP3CC;EGFR;EFCAB7;ANK3;YWHAQ;TCAF1;YWHAZ;EPHB2;MTCL1;CEMIP;AKT2;PRKCI;AKT1;TREM2;CLIP3;PPP1R13B;TP53;E2F1;ITGB1BP1;HRAS;ZDHHC5
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.3332264847048799,0.8624837411275669,0.6662468513853904,0.9543188514560211,1.0,5/28,9.08%,DLK2;MMP14;FBXW7;YTHDF2;EGFL7
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.24583020586415333,-0.8621288082499469,0.7101449275362319,0.9780650633696084,1.0,12/30,20.67%,POLR1A;ERCC3;TBP;TTF1;ERCC2;TAF1D;POLR2F;POLR1C;TAF1A;POLR1H;GTF2H3;GTF2H4
prerank,negative regulation of developmental process (GO:0051093),0.2930948828002308,0.8620308990879162,0.7056892778993435,0.9547326717113852,1.0,8/69,11.06%,WNT11;LOXL2;THY1;SOX9;NFIB;KANK1;NOTCH4;IL17D
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.378513886451368,0.8618337668640177,0.6638297872340425,0.9546455764231502,1.0,6/15,21.48%,ZC3H12C;ZC3H12A;NUDT16;DICER1;RPP30;RNASEH1
prerank,activation of GTPase activity (GO:0090630),0.28576748536415514,0.8618032588763374,0.7193548387096774,0.9542508031028747,1.0,26/89,19.99%,TBC1D1;SYDE1;PIP5K1A;TBC1D8;ABR;RAP1GAP;SYDE2;SIPA1L2;TBC1D8B;ARHGAP25;ARHGEF10;SIPA1L1;TIAM2;TBCK;BCR;TBC1D2;RALGAPB;ARHGAP29;CORO1C;SIPA1L3;TSC1;ARHGAP24;ARHGAP42;SGSM1;SGSM3;TBC1D4
prerank,regulation of cation transmembrane transport (GO:1904062),-0.2518797944158082,-0.8614628595907291,0.6859903381642513,0.9778888687043946,1.0,3/29,5.77%,KCNIP3;SLMAP;HOMER1
prerank,integrin-mediated signaling pathway (GO:0007229),0.29282025685277924,0.8614301919670082,0.7008733624454149,0.9545214006853571,1.0,10/73,13.94%,ISG15;ITGA2;THY1;CD47;HCK;ITGB8;BCAR1;COL3A1;NRP1;DAB2
prerank,chromosome organization (GO:0051276),0.28591191555819045,0.860844398087301,0.7403545359749739,0.95515606406584,1.0,20/99,19.62%,MTHFR;GATAD1;MSH2;HMGN3;LRWD1;CDT1;TCF7L2;RAE1;RBX1;COPS7B;LDB1;HDAC8;SOX2;NUP155;EZH2;BAHD1;HDAC1;COPS8;NDC80;NUP133
prerank,ion homeostasis (GO:0050801),0.32400186982347856,0.8602954190912052,0.6602564102564102,0.9557124690586623,1.0,2/30,5.09%,CAMK2D;SLC12A5
prerank,heart morphogenesis (GO:0003007),0.30415659845505527,0.8599891939870845,0.6903954802259887,0.955841421302167,1.0,7/50,20.16%,ACVR1;CHD7;SOX9;INSR;BMPR1A;FLRT2;ACVRL1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.3475674952305931,0.8599850984387252,0.6535947712418301,0.9553978130881089,1.0,3/23,5.12%,AUP1;TMEM129;SEC16A
prerank,calcium import into the mitochondrion (GO:0036444),0.42368538876307,0.8599744955049428,0.6661608497723824,0.9549683357367372,1.0,5/10,25.82%,MCUR1;MICU2;SMDT1;MICU3;SLC25A23
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.2501379186719086,-0.8597580296372467,0.696969696969697,0.9801591551260571,1.0,8/31,11.79%,PDLIM5;CFL1;ARHGAP44;SRCIN1;PPFIA2;TANC2;SHANK3;ZDHHC15
prerank,negative regulation of locomotion (GO:0040013),-0.33152595434199444,-0.8592585428781514,0.6645161290322581,0.9794815282638504,1.0,5/12,16.00%,FRMD5;SPOCK3;PTPN2;WAS;CCDC125
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.31788151830077066,0.8588260661097683,0.6674786845310596,0.9566458404814696,1.0,8/38,12.63%,FBXW7;SH3GLB1;VPS11;CSNK2A2;RNF31;LEPROT;NPEPPS;UBE2L3
prerank,regulation of Rho protein signal transduction (GO:0035023),0.2924455862286653,0.8585196251823384,0.7111834961997828,0.9567500175317456,1.0,15/72,17.12%,ABCA1;TNFAIP1;ITGA3;MYOC;MET;KANK1;STARD8;COL3A1;APOE;GPR35;AKAP13;NRP1;RAC1;OPHN1;BCR
prerank,regulation of urine volume (GO:0035809),0.4086290444785479,0.8584279329283151,0.670196671709531,0.9564777529239396,1.0,2/10,14.94%,TFAP2B;INPP5K
prerank,regulation of catecholamine secretion (GO:0050433),-0.25123520261195137,-0.85830989291025,0.6881188118811881,0.979865144472568,1.0,15/29,29.30%,SYT2;SYT10;SNCA;GRK2;KCNA2;SYT8;SYT1;CHRNA4;STX1A;CHGA;SYT13;DRD2;SYT5;PRKN;SYT17
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3699870650851955,0.8582049840085639,0.6494413407821229,0.956440789486641,1.0,2/15,4.84%,CHEK2;TIPIN
prerank,cellular response to decreased oxygen levels (GO:0036294),0.29816366226082286,0.8581960447808856,0.7167381974248928,0.9560056980430691,1.0,12/65,13.10%,ADAM8;EGLN2;NOP53;HYOU1;MT3;RORA;UBQLN1;ZFP36L1;AK4;SCN2A;NPEPPS;BAD
prerank,cellular response to oxygen levels (GO:0071453),0.4030390685502766,0.8581156488207929,0.6403641881638846,0.9557035165573513,1.0,1/10,2.09%,ATP6V0D1
prerank,cellular response to organonitrogen compound (GO:0071417),0.28166719033183796,0.8579202124056537,0.7331932773109243,0.9556221936443572,1.0,25/99,22.24%,TRPM2;LARP1;CRHBP;RRAGC;SOX9;CTNNB1;PDXP;RAPGEF2;P2RX4;ZFP36L1;GLRA2;XBP1;AKAP9;LAMTOR3;RAPGEF1;ACTB;INPP5K;MTOR;PDE3A;LAMTOR4;GLRA1;HCN2;GABRB2;HSP90B1;RRAGA
prerank,positive regulation of cilium assembly (GO:0045724),0.35633656506176037,0.8578934430488592,0.6531165311653117,0.9552333233123064,1.0,6/18,21.05%,KCTD17;WRAP73;CCDC88A;SEPTIN9;CEP135;ENTR1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.30536552260560595,-0.8578915712732168,0.6855123674911661,0.9790678821310876,1.0,7/16,25.82%,SNCAIP;FLOT1;RIMS1;MCTP2;CAMK2A;MEF2C;KCNMB4
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.28878465732922626,0.8577460748473208,0.7331910352187834,0.9550868458661222,1.0,22/84,17.54%,DDX5;RBMX;HNRNPK;SRPK1;HNRNPL;SNW1;RNPS1;RBFOX1;HNRNPA1;CELF6;DAZAP1;RBM15;MBNL2;RBFOX3;RBM39;NCBP1;RBM3;SRSF7;SF3B4;SRSF4;PCBP4;CWC22
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.38390106263349033,0.8577342756453533,0.642433234421365,0.9546571735239895,1.0,6/13,29.95%,ALG13;ALG11;DPAGT1;ALG12;ALG9;ALG14
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.3038252831636705,0.8575213627158639,0.6858457997698504,0.9545938990101688,1.0,5/50,9.80%,NOL3;CDKN2D;IGBP1;MT3;DNAJB6
prerank,cAMP biosynthetic process (GO:0006171),0.41116877391570994,0.8571448994271028,0.6596385542168675,0.95487958013326,1.0,2/10,6.16%,ADCY5;ADCY10
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.27275008710638754,-0.8571439833619542,0.6624472573839663,0.9771081794935943,1.0,7/20,30.06%,GSTO1;GSTA3;GSTM1;GSTA4;GSTO2;HPGDS;GSTM5
prerank,glutathione derivative metabolic process (GO:1901685),-0.27275008710638754,-0.8571439833619542,0.6624472573839663,0.9771081794935943,1.0,7/20,30.06%,GSTO1;GSTA3;GSTM1;GSTA4;GSTO2;HPGDS;GSTM5
prerank,potassium ion homeostasis (GO:0055075),0.3452218729144492,0.856189309668832,0.6666666666666666,0.9562365727692305,1.0,4/23,8.76%,ATP1B3;SLC12A5;TFAP2B;SLC12A8
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.2691648681500423,-0.8558846642420475,0.6744186046511628,0.9782619247595606,1.0,3/22,3.34%,PPM1E;DUSP6;PPM1G
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.3409375397432854,0.8558663101324312,0.6750948166877371,0.9563990778918249,1.0,3/23,14.33%,CAMK2D;PRNP;FYN
prerank,aerobic respiration (GO:0009060),0.3507940416349023,0.8548509658538316,0.6556016597510373,0.9578329759561507,1.0,5/20,21.10%,MTFR2;UQCR10;NDUFS8;NDUFS7;SDHB
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.27856694622882394,0.8545859519133557,0.7384937238493724,0.957864578293718,1.0,27/110,18.97%,HELZ2;RPL36;MAGOHB;SMG7;NCBP2;GSPT1;RPL22;RPS21;RNPS1;SMG5;UPF2;UPF3A;RPS6;RPS11;RPL30;ETF1;NCBP1;RPL32;RPL23A;RPL11;UPF1;RPL10A;PPP2R2A;RPS15A;RPL24;RPL37A;RPL3
prerank,cellular response to cAMP (GO:0071320),0.3259787873301611,0.8545120918186854,0.6522277227722773,0.957552291530746,1.0,6/30,14.94%,CRHBP;RAPGEF2;ZFP36L1;AKAP9;RAPGEF1;INPP5K
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.36023320524077274,0.8543215139184178,0.6544715447154471,0.9574648964116923,1.0,3/17,10.07%,CCND2;CCND1;PROX1
prerank,peptide metabolic process (GO:0006518),0.2887831440875681,0.8542887716142027,0.7301075268817204,0.9570762249272746,1.0,12/75,14.18%,ETHE1;ERAP1;ABCB9;CPQ;NLN;AEBP1;GSR;SPCS1;PSEN1;NPEPPS;SPPL3;CTNS
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.36973280771968964,0.854253956295593,0.6680672268907563,0.9566968166783257,1.0,2/15,10.83%,TMC1;ADGRV1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.2543101100558592,-0.8539353829441121,0.717948717948718,0.9811511376135219,1.0,11/25,27.09%,GRIN2A;GRIN2B;GRIN1;GSK3B;AKT1;MEF2C;CHRNA4;INSYN2A;MAPK8IP2;DRD2;GRID2
prerank,Golgi localization (GO:0051645),0.40579555905531256,0.853520815760784,0.6705882352941176,0.957574044361314,1.0,5/11,19.13%,TBCCD1;ARHGAP21;HOOK3;STK25;UVRAG
prerank,receptor metabolic process (GO:0043112),0.3000331197426436,0.8535126505532675,0.6962457337883959,0.9571437435889825,1.0,15/53,19.25%,MVB12A;SH3GLB1;RAB11B;ACKR3;KIF16B;PIK3R4;LDLRAP1;ARRB2;DNM2;SMURF1;ARFGEF2;SNX1;SNX25;UVRAG;BECN1
prerank,rRNA processing (GO:0006364),0.27417996571516334,0.8534938545829296,0.7934893184130214,0.9567367659380036,1.0,49/172,22.08%,PWP2;XRN2;SBDS;DDX27;SENP3;RPL36;NOB1;DDX49;MDN1;RSL1D1;NOP53;MRM2;HELQ;NOL9;RPL22;LAS1L;NOLC1;RIOK3;EIF6;NOP2;PRKDC;DDX54;RPS6;SART1;WDR43;EXOSC9;RPL30;RPL32;RPL23A;RPL11;DHX37;DDX47;RPL10A;RRP1;RRP1B;PELP1;WDR12;RPL24;RPL37A;RPL3;ESF1;UTP3;EMG1;RPL29;RPL5;RRP9;EXOSC4;UTP15;RPL6
prerank,response to metal ion (GO:0010038),0.28844468559747555,0.8532875195824762,0.7273730684326711,0.95668459581495,1.0,10/67,15.21%,LOXL2;FXN;SLC30A5;MT3;SLC11A2;AHCYL1;TFR2;SLC25A12;PAM;CALM3
prerank,secretion (GO:0046903),-0.3022563065890155,-0.853072100136218,0.6546052631578947,0.9812770189857155,1.0,10/14,49.37%,RIMS1;PRKCI;GUCA1B;NPR1;FBLN5;DRD3;VIP;ABCB11;SLC22A2;SLC22A6
prerank,endoplasmic reticulum organization (GO:0007029),0.29271364473006367,0.8529868745086019,0.7054347826086956,0.9568245617989772,1.0,12/72,13.44%,TOR1AIP2;ATL1;REEP2;SEC16A;DOP1B;APP;VAPB;TRAM2;PRNP;VCPIP1;VAMP2;REEP3
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.3892988074900284,0.852730361926428,0.6425406203840472,0.9568602233702256,1.0,4/11,24.04%,LYN;ACOD1;MFHAS1;CYBA
prerank,hydrogen peroxide catabolic process (GO:0042744),0.394709199733219,0.8526537418370483,0.6545718432510885,0.95656106171532,1.0,2/11,14.25%,PXDNL;PRDX2
prerank,Fc receptor signaling pathway (GO:0038093),0.2773178756390816,0.852086752881994,0.7463617463617463,0.957182072920787,1.0,37/110,25.95%,PSMB10;SKP1;PSME2;PSMA5;PSME4;LCP2;PSMA3;NFKB1;NFATC2;PSMB9;LYN;VAV1;BTRC;PSMD2;SOS1;PSME3;PIK3CB;RAC1;PSMA4;PSMD7;PSMD8;PSMD9;TAB3;PSMF1;PSMB6;PSMC2;PSMD12;MAPK9;PSMD4;PDPK1;PSMA2;PIK3CA;MAP2K4;GAB2;SHC1;PSMD1;PSMD11
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.31327904798691963,0.8517679034580499,0.6898148148148148,0.957342540213751,1.0,11/41,20.34%,NUP37;SLC2A6;NUP153;RAE1;PRKAG1;EIF6;NUP155;NUP88;LACC1;NUP133;NUP43
prerank,glycosphingolipid metabolic process (GO:0006687),-0.22902459900337954,-0.8517660766569637,0.7959183673469388,0.9825235737523469,1.0,8/42,9.32%,ST3GAL5;GM2A;CTSA;ASAH1;SMPD3;ST8SIA5;ABCA2;GALC
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.31963982537979974,0.8515360817770723,0.683698296836983,0.9573349971965713,1.0,8/35,16.88%,DAPK3;TRPM2;HCK;STAP1;NRP1;BAIAP2;BAIAP2L1;MDK
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.30165852098797646,0.8514855269978021,0.6702253855278766,0.956976980254834,1.0,6/46,9.82%,SLC27A1;PLA2G12A;AGPAT5;ABHD8;GNPAT;DGKB
prerank,indolalkylamine catabolic process (GO:0046218),-0.35097184178651797,-0.8512977659292843,0.6204819277108434,0.9818130379673322,1.0,4/10,39.99%,KMO;IL4I1;IDO2;KYAT1
prerank,Golgi to lysosome transport (GO:0090160),0.3892871125254221,0.8511376619576037,0.6461086637298091,0.9571853018250733,1.0,4/11,25.08%,ANKFY1;LAMP1;RBSN;CCDC91
prerank,negative regulation of developmental growth (GO:0048640),0.32246438782227793,0.8510209050544326,0.6670838548185232,0.9569575978254725,1.0,7/30,16.05%,MT3;MAG;DUSP10;FGF13;PTCH1;BBS2;FGFR3
prerank,sister chromatid segregation (GO:0000819),-0.2481685228685665,-0.850974690906094,0.7313432835820896,0.9807063018425645,1.0,12/31,23.22%,TOP2B;SMC1A;INO80;KIF18A;TOP2A;CENPK;KNSTRN;NUSAP1;NSL1;CDCA8;DSN1;KIFC1
prerank,steroid biosynthetic process (GO:0006694),0.29714153766214535,0.8507731521301505,0.7158836689038032,0.9569688638549192,1.0,13/56,20.72%,OSBPL7;CH25H;HSD11B1;FDFT1;OSBPL3;DHRS11;CYP27A1;OSBPL9;OSBP;EBP;OSBPL2;CYP39A1;SRD5A1
prerank,negative regulation of cell adhesion (GO:0007162),0.28854258222657236,0.8507147049940107,0.7119386637458927,0.9566470351191184,1.0,8/72,6.89%,PLXNA3;PLXNB2;SEMA4D;CDH13;PLXNB3;CX3CL1;PODXL;SNAI2
prerank,regulation of stress fiber assembly (GO:0051492),0.28445096332886,0.8505055434628982,0.7086021505376344,0.9565965913307443,1.0,14/74,14.94%,WNT11;CD47;PTGER4;EVL;CARMIL1;MYOC;CCDC88A;MET;PPM1F;ARHGEF10;NRP1;RAC1;ASAP3;INPP5K
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.28510501525685383,-0.8505015940585442,0.69140625,0.9800071008550837,1.0,10/17,37.35%,ATP1B1;ATP1B2;FKBP1B;GJD3;GJC1;ATP1A1;ATP1A3;RYR2;CACNA1C;ATP1A2
prerank,lipoprotein localization (GO:0044872),-0.33012368884242094,-0.8504900534212717,0.6566265060240963,0.9782298810776463,1.0,1/11,1.69%,PPARG
prerank,apoptotic process (GO:0006915),0.2693424595321902,0.8504133799564461,0.8084677419354839,0.9563082314586567,1.0,33/203,16.31%,CASP4;CASP7;IFIT2;DAPK3;CXCR4;MCM2;BCL2L11;FEM1B;CASP6;SIAH1;CHEK1;MRPS30;TNFAIP1;RRAGC;CFLAR;PPIA;APP;PLK3;CIB1;DIABLO;AHCYL1;DDIT4;SCN2A;PRKCE;BAD;NDUFS1;JAK2;MYD88;TLR2;TAOK2;BMF;PPARD;MTOR
prerank,neural crest cell migration (GO:0001755),0.3101085753374561,0.8501592457022926,0.6905615292712067,0.9563239580034067,1.0,7/36,18.04%,PITX2;SEMA4D;GDNF;NRP1;PHACTR4;SEMA3D;CORO1C
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.2848017641891206,0.8500778627355196,0.7365010799136069,0.9560285613443597,1.0,12/80,15.24%,TNFSF10;NOD1;FIS1;CDKN2D;IGBP1;MT3;HMGB1;DNAJB6;PPM1F;BAD;SOX2;UACA
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.2797406584627089,0.8499589310025502,0.7507987220447284,0.9558039849553384,1.0,18/102,14.94%,TRIB3;IRS1;RAB8B;CRHBP;ADCY5;RAB12;NFKB1;USF1;LPIN2;PRKAR2B;INSR;ZFP36L1;XBP1;PRKDC;ENPP1;VAMP2;IRS2;INPP5K
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.24334643508380727,-0.8498043298909014,0.7537688442211056,0.9781515319218285,1.0,6/28,9.55%,MAP1A;PRUNE1;FKBP4;SKA2;CLASP2;ARL2
prerank,positive regulation of sodium ion transport (GO:0010765),0.37908278278719076,0.8488071726250827,0.6681749622926093,0.9574153171345681,1.0,5/12,26.99%,CNKSR3;AHCYL1;SCN1B;WNK3;SCN4B
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.27647859084350823,0.8488012951151718,0.7667364016736402,0.9569839621934597,1.0,37/109,25.95%,PSMB10;SKP1;PSME2;PSMA5;PSME4;LCP2;PSMA3;NFKB1;NFATC2;PSMB9;LYN;VAV1;BTRC;PSMD2;SOS1;PSME3;PIK3CB;RAC1;PSMA4;PSMD7;PSMD8;PSMD9;TAB3;PSMF1;PSMB6;PSMC2;PSMD12;MAPK9;PSMD4;PDPK1;PSMA2;PIK3CA;MAP2K4;GAB2;SHC1;PSMD1;PSMD11
prerank,glycoprotein biosynthetic process (GO:0009101),0.2870568503285585,0.8487332630043419,0.7312633832976445,0.9566628511140243,1.0,20/79,22.09%,CANT1;COG3;MPI;TMEM106A;FAM20B;B4GALT5;BMPR2;CSGALNACT2;TNIP1;DAD1;FUT10;B3GALNT1;NPC1;ST8SIA1;FUT9;SERP1;DDOST;XYLT1;GCNT2;CHST11
prerank,negative regulation of protein depolymerization (GO:1901880),0.3368446552600348,0.8486125041822483,0.6692708333333334,0.9564374699627236,1.0,7/24,17.48%,SPEF1;CIB1;ATXN7;FGF13;PLEKHH2;STMN2;CAMSAP2
prerank,GPI anchor biosynthetic process (GO:0006506),0.32188423222597884,0.8484517123826156,0.6889714993804213,0.9563016665945889,1.0,8/30,19.58%,PIGW;GPAA1;PIGV;PGAP2;PIGQ;PIGB;PGAP3;PIGK
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.38158278024670655,0.848312030688704,0.6537931034482759,0.9561187783628238,1.0,4/13,18.20%,ZDHHC21;IRAK1;MDK;FUT9
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.2784772924188131,-0.8481453543808877,0.7084870848708487,0.9803360218612285,1.0,5/18,17.68%,GSK3B;RIMS1;SLC4A8;RIMS3;RIMS2
prerank,regulation of glycolytic process (GO:0006110),0.29173554018644476,0.8478654172274528,0.7274725274725274,0.956547193132456,1.0,24/68,27.81%,NUP37;SLC2A6;NUP153;RAE1;ENTPD5;APP;INSR;PRKAG1;GIT1;EIF6;PSEN1;NUP155;NUP88;NUP133;NUP43;ZBTB20;TIGAR;HDAC4;NUP205;SLC4A4;SEH1L;NUP188;EP300;RANBP2
prerank,phasic smooth muscle contraction (GO:0014821),0.4035778787411599,0.8478477286431999,0.6586921850079744,0.9561437872499481,1.0,2/10,8.80%,PTGER3;GDNF
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.26927518208329043,0.8475528198036418,0.7774390243902439,0.9562149743914327,1.0,41/152,23.79%,PSMB10;DAPK3;PSME2;PSMA5;PSME4;SFRP2;UBE2B;FGFR2;PSMA3;NFKB1;TMEM9;PSMB9;DACT1;BAMBI;USP34;KANK1;PSMD2;PSME3;PLEKHA4;ZRANB1;PSMA4;TLR2;PSMD7;PSMD8;PSMD9;PIN1;PSMF1;SPIN1;DDX3X;PSMB6;USP8;PSMC2;PSMD12;SMURF2;PSMD4;GPRC5B;XIAP;VCP;AXIN1;PSMA2;CAPRIN2
prerank,negative regulation of chemotaxis (GO:0050922),-0.24188719056267718,-0.8474714860832576,0.7540106951871658,0.9801128640088382,1.0,16/31,29.01%,SEMA4C;SEMA4G;SEMA4A;SEMA6A;PTPN2;SEMA4B;SEMA3E;SEMA5B;ANGPT2;SEMA6D;SEMA4F;ROBO1;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.3882885731101494,0.8473036499596636,0.6530303030303031,0.956235276943805,1.0,3/11,13.90%,BCAR1;NRP1;RAC1
prerank,cellular response to lectin (GO:1990858),0.277816314907025,0.8467460527374249,0.7481323372465315,0.9563944488349144,1.0,30/104,24.23%,PSMB10;SKP1;PSME2;PSMA5;PSME4;PAK3;PSMA3;NFKB1;PSMB9;LYN;BTRC;PSMD2;RELB;PSME3;FYN;PSMA4;PSMD7;PSMD8;PSMD9;TAB3;TYROBP;PSMF1;PSMB6;PRKCD;PSMC2;PSMD12;PSMD4;PDPK1;PSMA2;RAF1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.277816314907025,0.8467460527374249,0.7481323372465315,0.9563944488349144,1.0,30/104,24.23%,PSMB10;SKP1;PSME2;PSMA5;PSME4;PAK3;PSMA3;NFKB1;PSMB9;LYN;BTRC;PSMD2;RELB;PSME3;FYN;PSMA4;PSMD7;PSMD8;PSMD9;TAB3;TYROBP;PSMF1;PSMB6;PRKCD;PSMC2;PSMD12;PSMD4;PDPK1;PSMA2;RAF1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.3498133441138939,0.8466224874776791,0.6776315789473685,0.9561655091767697,1.0,4/19,15.33%,ACVR1;BMPR2;SLIT3;BMPR1A
prerank,cilium assembly (GO:0060271),0.26549155300776145,0.8464265424134656,0.8635907723169508,0.9560972576317245,1.0,60/296,18.42%,CNGB1;CEP19;ATP6V0D1;BBIP1;RAB8B;B9D2;KIF3C;ACTR2;CEP162;DYNC1H1;CCDC40;RILP;RILPL1;SNX10;TTC39C;ACTR1A;ACTR3;NPHP3;KIF3B;TMEM80;MAPRE1;CDK5RAP2;PRKAR2B;MKS1;SPATA6;CFAP54;FNBP1L;WDR35;IFT27;NEDD1;TMEM138;CEP131;CEP152;EXOC6;CEP70;GSN;DYNC2LI1;DYNLT2B;AKAP9;DYNLL1;E2F4;PIBF1;DZIP1;CFAP20;HSP90AA1;TMEM67;BBS2;CCDC66;TUBB4B;ARF4;RAB11A;WDR19;DYNC2H1;OCRL;CEP89;DCDC2;DCTN3;GBF1;PAFAH1B1;IFT46
prerank,regulation of gastrulation (GO:0010470),0.37434644875042,0.846410209062715,0.6548295454545454,0.9556842918096942,1.0,3/14,12.93%,SCX;PHLDB1;RACK1
prerank,diacylglycerol metabolic process (GO:0046339),0.3412202012930293,0.8460349881601403,0.6640826873385013,0.9559291526908037,1.0,7/23,18.36%,PNPLA2;DGKB;DGKK;DAGLA;DGKA;PLCE1;DGKI
prerank,positive regulation of RNA splicing (GO:0033120),0.3245372032643489,0.8460306295721267,0.6573511543134872,0.955502366859722,1.0,7/29,15.91%,SLC38A2;RBMX;SNW1;DAZAP1;NCBP1;RBM3;SF3B4
prerank,histone H4-K8 acetylation (GO:0043982),0.3651274107041034,0.8459144491764053,0.6533700137551581,0.9548188201997933,1.0,5/15,23.95%,JADE3;WDR5;KAT8;KAT7;JADE2
prerank,histone H4-K5 acetylation (GO:0043981),0.3651274107041034,0.8459144491764053,0.6533700137551581,0.9548188201997933,1.0,5/15,23.95%,JADE3;WDR5;KAT8;KAT7;JADE2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3510744534996397,0.8458767107379539,0.6688396349413298,0.9544478543065633,1.0,7/18,23.04%,VPS11;CTSC;DACT1;APOE;HSP90AA1;VPS35;MSN
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.27780103740869017,0.8458164933814781,0.7510683760683761,0.9541213559059541,1.0,30/105,24.23%,PSMB10;SKP1;PSME2;PSMA5;PSME4;PAK3;PSMA3;NFKB1;PSMB9;LYN;BTRC;PSMD2;RELB;PSME3;FYN;PSMA4;PSMD7;PSMD8;PSMD9;TAB3;TYROBP;PSMF1;PSMB6;PRKCD;PSMC2;PSMD12;PSMD4;PDPK1;PSMA2;RAF1
prerank,regulation of protein metabolic process (GO:0051246),0.30544886330661286,0.8453741106025282,0.6922169811320755,0.9544815830687825,1.0,11/44,21.65%,CHEK2;HSP90AB1;TMEM9;APP;TRAF3;APOE;HGS;LDLR;SPOP;PLAUR;VPS35
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.359202747364166,0.8452541604099924,0.664,0.9542564018665882,1.0,7/17,25.49%,AUP1;TMEM129;FAF2;HM13;HSP90B1;VCP;DERL2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.3011937186043073,-0.8449206328381147,0.644927536231884,0.9842332018196848,1.0,3/15,6.13%,GRM3;HOMER1;HOMER3
prerank,positive regulation of nuclear division (GO:0051785),0.33350678881230655,0.8447104323556994,0.6608040201005025,0.9547801137929288,1.0,3/25,10.20%,TGFA;INSR;PHIP
prerank,cellular metal ion homeostasis (GO:0006875),0.27746482428551994,0.8447083353130957,0.743455497382199,0.9543471537553023,1.0,15/102,16.74%,CCL7;CD40;ATP1B3;SLC8A1;CCL5;SLC30A1;CHERP;MT3;VAPB;CCL14;HTR2A;TRPV4;NPTN;SLC24A3;KCNJ2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3224424160586686,0.8444847144450924,0.6896120150187734,0.9542892788212359,1.0,7/27,20.60%,THY1;CD47;CCDC88B;IRAK1;MDK;SIRPA;LCK
prerank,positive regulation of potassium ion transport (GO:0043268),0.30967754544274073,0.8443953509539888,0.7069377990430622,0.9540146301050358,1.0,5/38,16.74%,KCNMB3;ACTN2;GABBR2;DLG1;KCNJ2
prerank,regulation of secretion by cell (GO:1903530),0.29805943429879284,0.8443226776445117,0.7180067950169875,0.9537063253223811,1.0,11/54,16.50%,RAB8B;RAB21;RAB12;CPLX1;P3H1;RHBDF2;RIC1;VAMP2;STX4;STXBP5L;LLGL1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.3522175005298176,0.8442634208568753,0.6742627345844504,0.9529527669864574,1.0,4/20,12.26%,ENTPD5;APP;INSR;PSEN1
prerank,positive regulation of glycolytic process (GO:0045821),0.3522175005298176,0.8442634208568753,0.6742627345844504,0.9529527669864574,1.0,4/20,12.26%,ENTPD5;APP;INSR;PSEN1
prerank,nucleic acid-templated transcription (GO:0097659),-0.22177476795333564,-0.8441492398698784,0.7533333333333333,0.9842371919985773,1.0,19/42,25.49%,THRB;DRG1;EPC1;BCL3;PTMA;MMS19;POLR2F;POLR2J;CREBL2;NFKBIB;E2F1;HOXD3;POLR2A;THAP1;PPP5C;NR4A2;PAX8;POLR2L;BAZ2A
prerank,mitotic nuclear division (GO:0140014),0.2859045956308458,0.843576331832486,0.749185667752443,0.9537472003490672,1.0,14/71,16.20%,CHMP4B;CHEK2;KPNB1;WRAP73;KIF3B;STAG1;NCAPG2;ARHGEF10;TOGARAM2;CCDC61;PIBF1;MIS12;KIF2A;RAB11A
prerank,protein localization to lysosome (GO:0061462),0.319409550995841,0.8427060121496834,0.6841448189762797,0.9548564909858479,1.0,11/28,27.15%,KPTN;GGA3;NAGPA;SORL1;HGS;LAMTOR4;M6PR;SZT2;GLMP;NCOA4;LMBRD1
prerank,lipid phosphorylation (GO:0046834),-0.3322073107502871,-0.8426144961361626,0.6350148367952523,0.9861796831240349,1.0,4/10,12.32%,DGKH;DGKZ;DGKD;DGKE
prerank,positive regulation of lipid storage (GO:0010884),-0.2780816094711611,-0.842368162864249,0.7296137339055794,0.9849428001388396,1.0,6/21,14.63%,OSBPL11;SCARB1;C3;EHD1;VSTM2A;LPL
prerank,regulation of protein dephosphorylation (GO:0035304),0.31048319573940736,0.8422593832733457,0.6840193704600485,0.9552356090888291,1.0,16/37,24.87%,ARPP19;ANKLE2;PPIA;PPP6R3;SPPL3;CALM3;PPP1R7;MFHAS1;TSC1;PIN1;PPP2R5A;PRKCD;HSP90B1;ENSA;CALM2;TIPRL
prerank,histone H4-K16 acetylation (GO:0043984),0.34879354818915986,0.8414942886154592,0.671251719394773,0.9560763559634681,1.0,5/19,19.71%,JADE3;KMT2A;WDR5;KAT8;KAT7
prerank,keratan sulfate metabolic process (GO:0042339),0.31376471557440266,0.8408107139214556,0.6838942307692307,0.9568144852622745,1.0,11/31,23.94%,FMOD;B4GALT4;B4GALT1;B4GALT5;ST3GAL1;B4GALT2;CHST2;GLB1;OGN;GALNS;GNS
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.2382450600420185,-0.8405770866297761,0.7448979591836735,0.9870063792612417,1.0,8/31,15.65%,LRRC7;DLG3;CDC42;MTCL1;PRKCI;RHOA;PDZD11;SCRIB
prerank,positive regulation of ion transport (GO:0043270),0.29643935755726597,0.8399742259501355,0.7006960556844548,0.9578852118294311,1.0,10/48,16.16%,ACTN2;CCL5;CNKSR3;GDNF;P2RX4;CRACR2A;AHCYL1;DLG1;CHRNB2;SCN1B
prerank,translational elongation (GO:0006414),0.2755700325277501,0.839580011368443,0.7622080679405521,0.9581495527249342,1.0,23/101,19.21%,MRPL36;ERAL1;MRPS30;MRPL12;MRPL16;MRPS35;MRPS28;GFM1;TUFM;MRPL42;MRPL4;RACK1;MRPS23;MRPS2;MRPS22;AURKAIP1;MRPL24;MRPS10;MRPL13;MRPL57;MRPS11;MRPL40;MRPL22
prerank,triglyceride metabolic process (GO:0006641),-0.21185187117273752,-0.8395198767053639,0.841726618705036,0.9876244534787153,1.0,13/48,22.85%,PLAAT3;MOGAT3;LIPH;DGAT1;SIRT1;SEL1L;GPAM;LPL;GK5;FABP4;CAV1;GPAT4;GPAT3
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.33721058268627785,0.8388140782392227,0.6794701986754967,0.9590581472156021,1.0,5/23,16.10%,MMP14;MAPK14;PROX1;ATP11A;SMYD1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.3852594350193028,0.8387472032427578,0.6900149031296572,0.9587404301776689,1.0,3/12,10.73%,CCT4;CCT7;CCT3
prerank,spliceosomal snRNP assembly (GO:0000387),0.3035722133664793,0.8378959713283765,0.6980676328502415,0.9598283906095235,1.0,14/38,23.56%,DDX20;TGS1;SART1;CLNS1A;GEMIN7;SNRPD2;SNRPD1;SNRPG;GEMIN2;SNUPN;SRSF10;SART3;LSM4;SNRPD3
prerank,modulation by host of viral genome replication (GO:0044827),0.37335411548262104,0.8374658444950217,0.6894502228826151,0.9601387423707229,1.0,4/13,25.59%,ZC3H12A;CCNK;TBC1D20;PPIB
prerank,regulation of BMP signaling pathway (GO:0030510),0.2849112444410879,0.8372267624494736,0.7446120689655172,0.9601465000616498,1.0,20/73,23.22%,LRP2;ITGA3;TFAP2B;SMAD2;BAMBI;BMPER;BMPR2;SKIL;SORL1;ZNF423;SMURF1;BMPR1A;HTRA3;RBPJ;ACVR2A;NUMA1;ACVRL1;SMURF2;XIAP;NOTCH1
prerank,blood vessel endothelial cell migration (GO:0043534),0.3371773992165133,0.8370852234662002,0.7007772020725389,0.9599772230789188,1.0,5/22,21.95%,KDR;SRF;NRP1;MYH9;FGF2
prerank,cardiac cell development (GO:0055006),0.38819113555674356,0.8368785106747993,0.670605612998523,0.9598808798763577,1.0,1/11,3.74%,SLC8A1
prerank,phosphatidylcholine catabolic process (GO:0034638),0.3949019256256006,0.8367262518657519,0.6813509544787077,0.9597055109928995,1.0,4/10,26.85%,LIPC;PLA2G6;PNPLA8;PLA2G4A
prerank,response to nutrient levels (GO:0031667),0.350219125398315,0.8366902180192181,0.6820027063599459,0.9593316991042785,1.0,7/17,33.58%,MTOR;CD68;KCNB1;RPS6KB1;ATF4;EIF4G1;PRKAA1
prerank,chloride transmembrane transport (GO:1902476),-0.21614218252888018,-0.8366054301721727,0.7739130434782608,0.9922766593004767,1.0,14/48,22.22%,SLC12A6;GABRG3;SLC12A2;GABRB1;GLRB;GABRA2;SLC4A8;GLRA3;GABRB3;SLC1A1;SLC12A9;GABRA5;LRRC8A;ANO6
prerank,DNA strand elongation (GO:0022616),0.34718575104937355,0.8357407889279815,0.6600790513833992,0.9605676706877425,1.0,6/18,20.42%,MCM7;MCM4;RFC4;GINS2;GINS4;GINS3
prerank,ATP transport (GO:0015867),-0.34251495651175057,-0.835687890025531,0.6547619047619048,0.9924970816997418,1.0,4/10,19.10%,SLC25A4;SLC17A9;SLC25A5;SLC25A42
prerank,negative regulation of transmembrane transport (GO:0034763),0.394926205815055,0.8355481764691918,0.6789554531490015,0.9604816780457127,1.0,3/10,14.94%,RSC1A1;IRS2;INPP5K
prerank,innate immune response in mucosa (GO:0002227),-0.333782012910206,-0.8354929962270038,0.6956521739130435,0.9911192115774853,1.0,2/10,15.86%,RPL39;DEFA6
prerank,T cell differentiation (GO:0030217),0.3025334786899398,0.8351502897093852,0.7018779342723005,0.9607484046236752,1.0,11/40,23.54%,PIK3CD;CHD7;LEPR;ZFP36L1;LMBR1L;NHEJ1;PTPRC;LCK;RHOH;GLI3;ZFP36L2
prerank,cellular response to ATP (GO:0071318),0.36763695527952867,0.8348994356678637,0.6859259259259259,0.960736805823025,1.0,2/14,8.96%,PDXP;P2RX4
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.341106384686156,0.8348516135930732,0.6750330250990753,0.9603905785740686,1.0,8/21,25.82%,FIS1;MCUR1;MICU2;BCAP31;TGM2;SMDT1;MICU3;SLC25A23
prerank,negative regulation of axonogenesis (GO:0050771),0.32816766773071304,0.8346040194263723,0.7093469910371318,0.9603922955493973,1.0,5/27,13.04%,THY1;RUFY3;MT3;MAG;FGF13
prerank,purine nucleotide metabolic process (GO:0006163),-0.253996233713633,-0.8342117631121447,0.7008928571428571,0.992240100207316,1.0,11/24,24.93%,FHIT;GDA;PNP;PRPSAP1;ITPA;NT5E;GPX1;GUK1;PPAT;PRPS1;PRPS1L1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.33728686421409165,0.8340242188943078,0.7040417209908736,0.9609757030561056,1.0,5/24,14.33%,FIS1;MYO1C;PRNP;CIB1;FYN
prerank,C4-dicarboxylate transport (GO:0015740),0.3753929429219549,0.8338793881865512,0.6830601092896175,0.9608236463354872,1.0,3/14,14.79%,SLC25A22;SLC25A10;SLC25A12
prerank,response to glucose (GO:0009749),0.29460109368194676,0.833776922845047,0.7267508610792193,0.9605825599543192,1.0,12/46,23.33%,TCF7L2;EIF2B2;XBP1;RACK1;VAMP2;IRS2;SELENOT;EIF2B5;EIF2B3;ERN1;ZBTB20;TRA2B
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.395685828529374,0.8336729531620974,0.6696165191740413,0.9603471197962192,1.0,3/10,14.27%,STAT3;LYN;JAK2
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.3192674383047389,-0.8330022174340188,0.6905444126074498,0.9931606463529862,1.0,4/11,23.64%,CEACAM1;AHR;IL4I1;KLRD1
prerank,protein localization to plasma membrane (GO:0072659),0.2691182064608691,0.8326228525268149,0.8035160289555325,0.9617407711983887,1.0,40/129,25.77%,PIGW;RAB8B;ATP1B3;ACTN2;SEC16A;RAB12;ANK1;PIP5K1A;RAPGEF6;RAPGEF2;CCDC88A;EPB41L3;TNIK;EFR3A;NECTIN3;SMURF1;FGF13;PTCH1;DLG1;INPP5K;RAB11A;ASB3;FLOT2;RAP2A;GORASP2;ZDHHC3;RAB10;ZFYVE27;C2CD5;ZDHHC22;PACSIN1;FLNA;ANK2;WNK3;DPP10;DPP6;TNF;KCNB1;RAB3A;TSPAN32
prerank,regulation of insulin secretion (GO:0050796),0.2745320124127512,0.8316496095178876,0.7630180658873539,0.9630468339363903,1.0,10/101,8.44%,PER2;IRS1;CCL5;ADCY5;ITPR1;TCF7L2;TFAP2B;SYT7;KCNS3;CACNA1A
prerank,adrenergic receptor signaling pathway (GO:0071875),0.3421088615898498,0.8313966627853355,0.6811989100817438,0.9630441879492277,1.0,4/20,18.69%,ZDHHC21;RAPGEF2;AKAP13;LMBRD2
prerank,regulation of lamellipodium assembly (GO:0010591),0.31089116295402386,0.8312979657456357,0.7304964539007093,0.9627818712896897,1.0,11/34,24.62%,ACTR2;PLXNB3;CYFIP1;ACTR3;CAPZB;RAC1;PLCE1;NCKAP1;BRK1;TWF1;PIK3CA
prerank,atrial septum development (GO:0003283),0.3770504988439179,0.8309593768662614,0.7113259668508287,0.9629432058143009,1.0,2/13,9.53%,NPHP3;BMPR2
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.3415307665693134,0.830618045240103,0.7014531043593131,0.963085445003054,1.0,11/20,31.65%,MT3;XBP1;CARF;RBPJ;NOTCH1;SMAD1;EP300;CHD6;ATF4;RELA;SESN2
prerank,striated muscle cell development (GO:0055002),-0.30532698319386214,-0.8300979628412924,0.6453900709219859,0.9978421103650469,1.0,10/14,47.86%,CAPN3;PGM5;TMOD1;KLHL41;SDC1;LMOD3;TMOD2;LMOD1;MYH6;TMOD4
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3093007974738713,0.8298834967300835,0.7101449275362319,0.9639076598493522,1.0,6/35,8.63%,POLD4;RFC4;POLB;RFC1;FEN1;MPG
prerank,cellular response to nutrient levels (GO:0031669),0.2847127308282209,0.8297987374479362,0.7427937915742794,0.9636210836762227,1.0,19/62,26.44%,LAMP2;RRAGC;BMPR2;HSPA8;XBP1;KLF10;MAP1LC3B;MTOR;SREBF1;CD68;STK24;TSC1;USP33;RRAGA;ZFYVE1;FNIP1;KCNB1;WRN;EHMT2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.2992371656151968,0.8297501111391218,0.750291715285881,0.963271231125154,1.0,9/45,20.16%,GDF9;ACVR1;CSNK2B;BMPR2;DAB2;BMPR1A;ACVR2A;RBPMS;ACVRL1
prerank,histone lysine demethylation (GO:0070076),0.32420979514684695,0.829594532076938,0.6893453145057766,0.9631185128719678,1.0,6/25,15.95%,KDM4D;HR;KDM3B;RIOX2;KDM8;KDM7A
prerank,muscle cell development (GO:0055001),-0.2382805169209723,-0.8292594723991839,0.764102564102564,0.9979249155237583,1.0,14/30,34.85%,DMD;BIN1;MYOF;NEBL;KDM1A;CXADR;NEB;EFEMP2;SGCZ;RAMP2;SDC1;MYH11;HEY2;HES1
prerank,regulation of centriole replication (GO:0046599),0.35276943168473096,0.8286237778181605,0.6835781041388518,0.9643399063620867,1.0,4/17,14.31%,RBM14;CDK5RAP2;NPM1;CEP295
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2874026605907374,0.8285857968121684,0.7225305216426193,0.9639717525370934,1.0,23/58,28.16%,POLM;POLB;HERC2;ERCC4;BARD1;HMGB1;POLQ;PRKDC;PAXIP1;NSMCE2;DCLRE1A;NHEJ1;BABAM2;UVRAG;DCLRE1C;SUMO1;LIG3;KAT5;NSD2;PIAS4;PRPF19;UBE2N;BABAM1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.28492395684762706,0.8283203057237191,0.721185510428101,0.9640060363610407,1.0,14/60,19.00%,HSP90AB1;RFC4;POLG2;CTNNB1;CCT4;CCT7;SMOC2;CCT3;HNRNPA1;MAP3K4;HSP90AA1;HMBOX1;PTGES3;NEK7
prerank,insulin receptor signaling pathway (GO:0008286),0.2849646856080386,0.8282237153147276,0.7351648351648352,0.9637287279204109,1.0,14/69,17.80%,NAMPT;IRS1;ATP6V0D1;ZNF106;GRB10;BCAR1;INSR;PHIP;SOS1;IRS2;BAIAP2;TCIRG1;ATP6V1B2;ATP6V1G1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.2802128792576122,-0.8281343394077,0.7398373983739838,0.9986247210274856,1.0,3/20,7.19%,TGFB1;NIBAN2;TRAF6
prerank,steroid catabolic process (GO:0006706),0.39431067413138665,0.8279844619156783,0.7016248153618907,0.963700176231338,1.0,1/10,8.32%,HSD11B1
prerank,potassium ion transmembrane transport (GO:0071805),-0.18065847900821258,-0.827840261762785,0.9354838709677419,0.9974281873379981,1.0,47/135,33.95%,SLC12A6;SLC9A9;ATP1B1;SLC12A2;KCNC2;KCNH1;ATP1B2;KCNJ10;NALCN;KCNQ5;KCND2;KCND1;KCND3;KCNK6;KCNK12;PKD2L1;KCNA2;KCNC3;KCNG2;KCNC1;SLC12A9;SLC9A8;KCNT2;KCNJ6;KCNAB1;HCN3;KCNK9;KCNJ13;KCNB2;KCNH5;KCNK5;ABCC8;KCNC4;KCNH2;SLC12A1;KCNQ4;ATP1A1;ATP1A3;FXYD2;KCNJ12;HCN4;LRRC55;KCNJ16;KCNK4;KCNH4;KCNN1;KCNK13
prerank,regulation of epidermal cell differentiation (GO:0045604),0.33680639284866626,0.8277606872713792,0.7023809523809523,0.9636653615371314,1.0,3/21,10.96%,ZFP36;RUNX1;ZFP36L1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.2990844809541138,0.8275710112537193,0.7210965435041716,0.9635641288005408,1.0,2/39,2.63%,KDR;CD40
prerank,peptide cross-linking (GO:0018149),-0.243673068038391,-0.8273855641158023,0.7400881057268722,0.9966824465739519,1.0,17/25,49.35%,F13A1;NDNF;ANXA1;ABCA7;CD247;FCGR3A;TGM4;DSP;EVPL;TGM1;KRT10;TGM6;TGM5;EPB42;TGM7;CD3G;SPRR1A
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.34218556412406104,0.8273752519075304,0.6895161290322581,0.963460293849584,1.0,3/21,7.48%,ADCY5;ADCY10;NPPC
prerank,mitochondrion distribution (GO:0048311),-0.30811872509460325,-0.8268763925258846,0.7010309278350515,0.9960538160620246,1.0,5/12,21.18%,TRAK2;ATCAY;ARMC1;MTM1;MSTO1
prerank,mitotic cytokinesis (GO:0000281),0.2923940555604021,0.8268293173308441,0.7217694994179278,0.9639966750447204,1.0,5/47,10.39%,CHMP4B;SNX33;CUL7;EFHC2;SNX9
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.2893304130516399,0.826740923571162,0.7448979591836735,0.9637098008439419,1.0,20/52,26.58%,ZFP36;CNOT4;CNOT7;TNKS1BP1;DCP2;EXOSC9;PATL2;NT5C3B;TUT7;HBS1L;DCPS;LSM5;PAN3;RC3H2;EXOSC4;LSM4;PDE12;DCP1B;CNOT3;CNOT2
prerank,regulation of mononuclear cell migration (GO:0071675),0.33290613823386617,0.8266878752549193,0.6947368421052632,0.9633720902063664,1.0,6/23,16.88%,CCL5;CSF1;LYN;CXCL17;AIF1;MDK
prerank,actin cytoskeleton reorganization (GO:0031532),0.2914371582820814,0.8266384431608588,0.7463524130190797,0.9630203454808094,1.0,17/63,19.48%,S1PR2;PARVB;SYDE1;PIP5K1A;BCAR1;MKLN1;TNIK;GSN;ANTXR1;TRPV4;SIPA1L1;WHAMM;NRP1;MINK1;MYH9;DTNBP1;RAP2A
prerank,nucleotide-sugar metabolic process (GO:0009225),0.38531016776773064,0.826489990231474,0.6866764275256223,0.9628525041315865,1.0,3/12,14.58%,GALT;GFPT1;SLC35A3
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.36433216064008483,0.8264329433389289,0.6785714285714286,0.9625183125001828,1.0,1/14,1.57%,SPRY2
prerank,cilium-dependent cell motility (GO:0060285),-0.259775573111551,-0.826406995909891,0.7695652173913043,0.9952750280720329,1.0,16/22,41.87%,CCDC39;CFAP44;DNAH8;EFHC1;DNAH2;DNAI3;RSPH9;RFX3;DNAH3;DRC1;GAS8;DNAAF2;DNAH17;CCDC65;DNAH1;TEKT5
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.28527461450146735,0.8263662037591791,0.743047830923248,0.9622049981127211,1.0,16/57,23.50%,LTV1;MRPL36;PAK1IP1;RRS1;TGS1;NPM1;RPS6;NOP16;RPL11;DHX37;WDR12;EMG1;URB2;RPL5;LTO1;RRP36
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.35694210722104536,0.82576779871246,0.685595567867036,0.9627881149441915,1.0,6/16,23.22%,FGFR2;PIM1;BMPR1A;RBPJ;FGF2;NOTCH1
prerank,response to leucine (GO:0043201),-0.32943780325249683,-0.8257536153379681,0.6827794561933535,0.9931821448125631,1.0,2/10,7.56%,RRAGD;LARS1
prerank,cellular response to leucine (GO:0071233),-0.32943780325249683,-0.8257536153379681,0.6827794561933535,0.9931821448125631,1.0,2/10,7.56%,RRAGD;LARS1
prerank,RNA 3'-end processing (GO:0031123),0.28015576445977525,0.8257522320064314,0.7578125,0.9623864567765456,1.0,22/69,24.05%,TENT4A;PNPT1;MAGOHB;NCBP2;WDR33;RNPS1;ZC3H11A;PAPOLA;CHTOP;PCF11;DDX39B;NCBP1;SRSF7;SRSF4;TUT7;SLU7;THOC7;MTPAP;SRSF5;SRSF2;MAGOH;RPRD2
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.27116220275483055,-0.8255870293483466,0.6951672862453532,0.991785527360342,1.0,6/18,13.19%,CCT8;CCT5;CORO2B;CEP120;WRAP53;TREM2
prerank,regulation of DNA replication (GO:0006275),-0.2142855464374382,-0.8253924991963525,0.8275862068965517,0.9904539714837594,1.0,12/49,17.60%,WAPL;FAF1;EGFR;PPP2R1A;ESCO1;SMC3;CDAN1;DNA2;RAD17;S100A11;TERF1;TSPYL2
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.3841324806356923,0.8253245758390428,0.6948148148148148,0.9626700756725862,1.0,3/11,19.90%,STAP1;STX4;TYROBP
prerank,L-glutamate transmembrane transport (GO:0015813),0.3855450747733537,0.8247998640089698,0.7021897810218978,0.9631106403552157,1.0,1/10,0.81%,SLC25A22
prerank,adherens junction organization (GO:0034332),0.2942096199618922,0.824724976132365,0.7304550758459744,0.9628187391427199,1.0,11/48,18.13%,CDH13;NECTIN4;CTNNB1;CDH9;NECTIN3;PIP5K1C;ACTB;TBCD;JAM3;CSK;CADM2
prerank,brain morphogenesis (GO:0048854),0.3723111461880852,0.8246362167244976,0.6819571865443425,0.962538698182437,1.0,5/12,26.52%,VPS51;BBS2;PAFAH1B1;BBS4;PTEN
prerank,membrane lipid biosynthetic process (GO:0046467),0.2857038411802116,0.8244534385189096,0.7330415754923414,0.9624368560646682,1.0,16/58,22.39%,SGPP2;GBGT1;CERS6;DEGS1;VAPB;SCCPDH;SPHK2;HACD3;ACER3;SPTLC2;SGPL1;CERS2;ELOVL4;SPTSSA;PLPP2;CERT1
prerank,microtubule anchoring at centrosome (GO:0034454),-0.33044874585176076,-0.824376849912651,0.6613924050632911,0.9908846356493026,1.0,3/10,5.39%,NINL;KIF3A;PCM1
prerank,transition metal ion homeostasis (GO:0055076),0.32079548849491574,0.8242660723834366,0.7355473554735548,0.9623351043526854,1.0,9/28,25.44%,B2M;MT3;TFR2;HMOX2;FBXL5;ABCB7;XIAP;COMMD1;CP
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.28777898557302456,0.8235985795654208,0.7338530066815144,0.9630350675921389,1.0,13/51,19.00%,XRN1;CTNNB1;DCP2;CCT4;CCT7;CCT3;SMG5;HNRNPA1;STN1;MAP3K4;HMBOX1;TERF2;NEK7
prerank,rRNA metabolic process (GO:0016072),0.2657829124127047,0.8234624866264455,0.8283963227783453,0.9628333719183759,1.0,47/160,22.95%,PWP2;XRN2;SBDS;DDX27;SENP3;RPL36;NOB1;DDX49;MDN1;NOP53;MRM2;HELQ;NOL9;RPL22;XRN1;LAS1L;NOLC1;DDX54;RPS6;WDR43;EXOSC9;RPL30;RPL32;RPL23A;RPL11;DHX37;DDX47;RPL10A;RRP1;RRP1B;PELP1;WDR12;RPL24;RPL37A;RPL3;ESF1;UTP3;TRIR;EMG1;RPL29;RPL5;RRP9;EXOSC4;UTP15;RPL6;NOL6;UTP14A
prerank,protein localization to kinetochore (GO:0034501),-0.2932897921770193,-0.8232957563401833,0.6885245901639344,0.9914988452621023,1.0,8/14,31.63%,RCC2;MTBP;KNL1;SPDL1;BUB3;CDK1;AURKB;TTK
prerank,neurotransmitter uptake (GO:0001504),0.3759710115517192,0.8232078857401145,0.7323529411764705,0.9628308592555017,1.0,1/12,3.40%,SLC38A1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.38265544073267443,0.8230156457591542,0.6863636363636364,0.9627197682565767,1.0,3/11,10.73%,CCT4;CCT7;CCT3
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.26686089678986835,0.8229420767819882,0.8275862068965517,0.9624232918754122,1.0,25/124,16.95%,BLOC1S4;PPP1R9A;CYFIP1;CARMIL1;TBC1D23;MYOC;SAMD14;STMN4;RAPGEF2;LYN;GDNF;APP;HMGB1;STMN3;PLEKHA1;APOE;RB1;CORO1B;RAC1;MAP4;LRP12;PRMT1;RAB11A;OPHN1;STMN2
prerank,smooth muscle cell differentiation (GO:0051145),-0.31054300270117946,-0.8229362749068987,0.7222222222222222,0.9905407627928089,1.0,8/12,37.75%,EDNRB;MRTFB;TMEM204;MEF2C;BMP4;HEY1;HEY2;APLNR
prerank,transepithelial transport (GO:0070633),0.3587283013620307,0.8228600892146412,0.6815561959654178,0.9621306348454627,1.0,4/15,22.20%,ABCC2;ABCC1;ABCG2;SLC1A3
prerank,ceramide biosynthetic process (GO:0046513),0.29602414304390395,0.8228516434217406,0.7141190198366394,0.9617160236154877,1.0,5/40,7.43%,ST6GALNAC4;ASAH2;CERS6;DEGS1;ST6GALNAC6
prerank,cellular response to organic cyclic compound (GO:0071407),0.26310168484336127,0.8225541502272705,0.8159509202453987,0.9617961904746697,1.0,25/141,16.84%,CASP7;TRPM2;CASP6;LARP1;CRHBP;CCL5;ADCY5;CTNNB1;PDXP;RAPGEF2;P2RX4;RORA;ZC3H12A;RIOK3;ZFP36L1;NR3C1;LCOR;AKAP9;UBE2L3;RAPGEF1;ACTB;INPP5K;TIPARP;IL18;PDE3A
prerank,small GTPase mediated signal transduction (GO:0007264),0.267366331422556,0.8220125899258706,0.7914046121593291,0.9622523702556575,1.0,38/103,26.68%,USP50;RHEBL1;RRAGC;RAPGEF6;RAPGEF2;CCDC88A;ABR;DNMT1;MAPK14;G3BP2;HACD3;RIN2;SOS1;RB1;TIAM2;ARHGAP30;RAC1;RREB1;BCR;RUNDC3A;PLCE1;NF1;ARHGAP18;ARHGAP31;RIT1;G3BP1;USP8;RHEB;FGF2;ARHGAP1;RGL2;TRIM28;CDKN2A;SHC1;CHP1;PLD2;RERG;TIAM1
prerank,purine-containing compound catabolic process (GO:0072523),0.36670557176174867,0.8217751411517675,0.6826923076923077,0.9622381388984804,1.0,1/13,1.39%,XDH
prerank,neuronal action potential (GO:0019228),0.3374398520309155,0.821696719382297,0.6912928759894459,0.9619510898678115,1.0,1/22,0.73%,KCNMB3
prerank,cellular response to ketone (GO:1901655),0.3096295331561751,0.8211899445655307,0.7337423312883435,0.9623990587295035,1.0,15/35,28.92%,PTGER4;LARP1;ADCY5;SPHK2;NR3C1;ACOD1;DCPS;MSN;NDOR1;ADAM15;CFTR;NCOA4;ADCY6;GNB1;KLF9
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.2744067122984179,0.8207893465042996,0.7658898305084746,0.9626680085576731,1.0,29/86,26.40%,PSMB10;PSME2;PSMA5;PSME4;EGLN2;CHEK1;PSMA3;BACH1;PSMB9;RBX1;ELOC;PSMD2;PSME3;PSMA4;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4;LIMD1;PSMA2;CUL2;EPAS1;PSMD1;PSMD11;HIGD1A
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.2276527997655874,-0.8206953184332374,0.7741935483870968,0.9934499432653492,1.0,9/32,18.54%,MAP3K3;PIK3C2A;HMOX1;RHOA;JCAD;KLF4;MAP2K5;ITGB1BP1;ANXA1
prerank,synaptic vesicle recycling (GO:0036465),0.30915668534727975,0.8206166469543129,0.7088452088452089,0.9625481756030365,1.0,8/31,17.69%,SYNJ1;SYT7;PIP5K1C;VAMP2;STON1;NLGN3;OPHN1;STON2
prerank,response to glucagon (GO:0033762),-0.267594324080306,-0.8205213894416897,0.7410714285714286,0.9920827249018316,1.0,5/19,16.06%,ADCY9;ADCY3;PRKACB;CRY1;CREB1
prerank,maturation of SSU-rRNA (GO:0030490),0.3083179605433667,0.820482090052774,0.7366459627329193,0.9623505077762633,1.0,14/34,29.83%,PWP2;NOB1;RIOK3;DHX37;MRPS11;UTP3;RRP36;NGDN;BMS1;NOL10;HELB;DDX52;RPS19;TSR3
prerank,N-glycan processing (GO:0006491),0.33541941790792074,0.8204647983378899,0.7185385656292287,0.9619573633983471,1.0,5/18,17.83%,GNPTAB;MAN1A2;GANC;ST8SIA1;MAN1C1
prerank,snRNA metabolic process (GO:0016073),-0.2807480076002788,-0.8202859696075702,0.7174721189591078,0.9908767783144208,1.0,6/17,22.54%,RBM7;INTS10;INTS12;INTS2;TUT1;INTS6
prerank,nucleotide-excision repair (GO:0006289),0.26713982672641656,0.8199066856702228,0.7899159663865546,0.9625012401705463,1.0,14/101,9.89%,POLR2G;UVSSA;POLD4;CHD1L;RFC4;POLB;RFC1;BRIP1;ERCC4;RBX1;POLK;POLR2K;MNAT1;COPS7B
prerank,regulation of protein neddylation (GO:2000434),0.3874983092500823,0.8194361451191182,0.6913946587537092,0.9628664075874911,1.0,6/10,28.70%,DCUN1D4;RPL11;RPL5;DCUN1D5;EPAS1;DCUN1D1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.25285416401881317,-0.8194196286443556,0.757201646090535,0.9910712407598107,1.0,5/21,8.69%,PPP1R8;CRY2;PPP1R16B;PTPA;GSK3B
prerank,embryonic axis specification (GO:0000578),0.35399933305552894,0.8194164270841919,0.705718270571827,0.9624815124159991,1.0,5/15,22.88%,SMAD2;CXXC4;PTCH1;TASOR;RIPPLY2
prerank,amyloid precursor protein catabolic process (GO:0042987),0.3591174966628476,0.8192838158162888,0.6752136752136753,0.9622820993852226,1.0,4/14,15.31%,ABCG1;PSEN1;APH1A;APH1B
prerank,glycoprotein catabolic process (GO:0006516),-0.27689372983846977,-0.8191974902771936,0.7307692307692307,0.9898254136095597,1.0,3/17,5.73%,OGA;CTSL;MANBA
prerank,mitotic spindle organization (GO:0007052),0.26344437246898705,0.8189850920916969,0.8331627430910952,0.9623509587994455,1.0,27/153,14.70%,NUP37;CHEK2;MECP2;SBDS;B9D2;DYNC1H1;KPNB1;KIF2C;WRAP73;DYNC1LI2;KIF3B;EFHC2;MAPRE1;STAG1;NEK9;CENPN;SUN2;ARHGEF10;NEK6;TOGARAM2;DYNLL1;CCDC61;AHCTF1;PIBF1;MAP4;MIS12;KIF2A
prerank,cellular biogenic amine metabolic process (GO:0006576),0.37253195930483435,0.8189814326124892,0.7076461769115442,0.9619336866472932,1.0,2/12,7.64%,DDC;SMS
prerank,growth hormone receptor signaling pathway (GO:0060396),0.36458623044860505,0.8188527913390096,0.6858345021037868,0.9617219798243124,1.0,4/14,14.27%,STAT3;LYN;SOCS2;JAK2
prerank,regulation of interleukin-2 production (GO:0032663),-0.21725413721061737,-0.8186266700173443,0.8027210884353742,0.9892525096219861,1.0,20/43,29.12%,CARD11;TRAF2;PNP;HOMER3;TRAF6;CCR2;CD86;GLMN;ANXA1;IRF4;CD28;TNFAIP3;IL1B;IL1A;CD80;RPS3;VSIG4;HDAC7;CD34;PDE4D
prerank,negative regulation of coagulation (GO:0050819),-0.29016513928038745,-0.8181788266941697,0.7322033898305085,0.9885261093425094,1.0,8/14,40.10%,VTN;HS3ST5;THBD;CD34;PROCR;APOH;ADTRP;TFPI
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.3473487942976289,0.8179457649069555,0.6957708049113234,0.9628085975178927,1.0,4/17,16.67%,ABHD2;NR3C1;UBE2L3;ACOD1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.36650516736927324,0.8177234306378276,0.7041251778093883,0.9627510074965793,1.0,1/13,3.66%,ADAM8
prerank,synaptic vesicle transport (GO:0048489),0.3822327008536808,0.8176551000389767,0.6819571865443425,0.962446672352741,1.0,2/11,10.61%,SYNJ1;DNM2
prerank,chondrocyte differentiation (GO:0002062),0.3096540226724915,0.8176526996335265,0.7274909963985594,0.9620293922649743,1.0,9/32,18.95%,RUNX1;SOX9;SNX19;NFIB;SCX;BMPR2;SOX5;FGFR3;CREB3L2
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.33169180888763405,0.8175722025454968,0.713506139154161,0.9617379692873936,1.0,5/18,23.49%,BDNF;XBP1;HDAC1;NOTCH1;HDAC4
prerank,tryptophan metabolic process (GO:0006568),-0.3263670813001015,-0.8174654713103834,0.6949685534591195,0.9883521430533873,1.0,4/11,39.99%,KMO;IL4I1;IDO2;KYAT1
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.26888843587833916,-0.8171963821214614,0.7451737451737451,0.9871784467124999,1.0,6/18,22.86%,LTBP1;ITGAV;TGFB2;SMAD4;HIF1A;CD200
prerank,regulation of sequestering of triglyceride (GO:0010889),0.35453201473051904,0.8171700704456125,0.701534170153417,0.9620123651346062,1.0,2/15,4.72%,PNPLA2;OSBPL8
prerank,regulation of protein targeting to membrane (GO:0090313),0.31856331338755084,0.8168945661296123,0.7375621890547264,0.9620489560313636,1.0,6/28,14.94%,FIS1;MYO1C;PRNP;CIB1;FYN;INPP5K
prerank,regulation of DNA biosynthetic process (GO:2000278),0.31426231970868884,0.8162443460963128,0.735632183908046,0.9627332545151589,1.0,8/27,21.95%,SMOC2;BMPR2;SMG5;HMBOX1;DACH1;TERF2;ACVRL1;FGF2
prerank,autophagosome assembly (GO:0000045),0.28636469119997027,0.816093860560693,0.75,0.9625448881929003,1.0,8/52,14.55%,IRGM;UBQLN2;RAB43;UBXN2B;UBQLN1;SMURF1;MAP1LC3B;RB1CC1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.320418415648647,-0.8160743352202631,0.707936507936508,0.9877739930784605,1.0,2/10,11.07%,IFT88;WHRN
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.19624725132834958,-0.8159676867446533,0.845360824742268,0.986306551268083,1.0,5/57,4.01%,ADCY9;GNAL;LPAR1;ADCY3;OPRM1
prerank,positive regulation of macrophage activation (GO:0043032),0.34769628552735626,0.8159650530916697,0.7022160664819944,0.9623338401042522,1.0,3/17,14.67%,WNT5A;STAP1;TNIP2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.32502078189653094,0.815723117481223,0.732051282051282,0.962319283304364,1.0,3/23,8.76%,SLC12A5;TFAP2B;SLC12A8
prerank,spindle assembly (GO:0051225),0.2766007423199203,0.8150691670493715,0.7764578833693304,0.9629627597428908,1.0,25/67,26.56%,CHEK2;GOLGA8B;KPNB1;WRAP73;KIF3B;MAPRE1;STAG1;ARHGEF10;NEK6;TOGARAM2;CCDC61;PIBF1;KIF2A;RAB11A;NUMA1;NEK7;STARD9;HAUS3;MAPRE3;FLNA;CEP192;HAUS6;MAPRE2;ABRAXAS2;TUBGCP5
prerank,positive regulation of chromatin organization (GO:1905269),0.3718887983581108,0.8149409549143357,0.7116212338593975,0.9627526832632963,1.0,3/12,18.99%,DAXX;MIER1;TERF2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.3115144070956959,0.8148773905650228,0.7153558052434457,0.9624348972128544,1.0,11/29,27.52%,RBBP5;CTNNB1;TCF7L2;MEN1;PYGO1;HDAC1;KMT2D;KAT5;RUVBL1;EP300;CDC73
prerank,renal water homeostasis (GO:0003091),0.3280480329283026,0.8148162405715258,0.7084967320261438,0.9621165117873328,1.0,6/23,17.07%,ADCY5;TFAP2B;AQP4;PRKAR2B;RAB11A;PRKAR2A
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.3718362516476449,0.8147489410762649,0.7007518796992481,0.9618005952195213,1.0,4/12,19.77%,KPNB1;CLCN2;SREBF1;SEC14L2
prerank,amino acid transport (GO:0006865),0.2895307621859935,0.8145162573229984,0.7545662100456622,0.9617648462895351,1.0,9/49,16.79%,SLC38A2;SLC38A1;SLC38A3;SLC38A6;PDPN;SLC7A6;SLC25A47;SLC36A4;SLC25A45
prerank,metal ion transport (GO:0030001),0.27515562309837593,0.8143695250211499,0.7834394904458599,0.9615833328520973,1.0,17/86,17.64%,TRPM2;LRP2;SLC8A1;CCL5;ITPR1;SLC30A1;SLC30A5;MT3;CACNA1A;PANX1;PSEN1;TRPV4;FYN;CHRNB2;TRPM7;NIPA2;MAGT1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.28998886727143564,0.8142896572481996,0.7561260210035006,0.9612912561751156,1.0,5/47,10.58%,AGT;XDH;DHRS4;MAPK14;ZC3H12A
prerank,embryonic digit morphogenesis (GO:0042733),-0.2722485230515271,-0.8137672356856134,0.7283464566929134,0.9892438238461322,1.0,3/18,14.17%,MAP3K20;SALL1;INTU
prerank,regulation of phospholipase activity (GO:0010517),0.3861245104444561,0.8134123208199165,0.6924219910846954,0.9623340739432368,1.0,4/10,26.35%,FGFR2;FGFR3;PDPK1;LRP1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.30753257847181825,-0.8133094240115037,0.7275541795665634,0.9885231779920433,1.0,3/13,16.84%,ABCA2;ALG10B;GOLGA2
prerank,regulation of cytoplasmic translation (GO:2000765),0.36160829983132153,0.8131107310467831,0.7097222222222223,0.9623904154050893,1.0,2/14,7.25%,DHX36;DHX9
prerank,purine nucleotide catabolic process (GO:0006195),0.36265232171661327,0.8131002969317783,0.6928374655647382,0.9619908513814052,1.0,1/13,1.39%,XDH
prerank,neuron maturation (GO:0042551),0.3438854528722789,0.8128166710490387,0.7207446808510638,0.9620315657063685,1.0,3/18,9.06%,CX3CL1;B4GALT5;APP
prerank,synaptic vesicle localization (GO:0097479),0.36198665114329026,0.8122573579639795,0.6852646638054364,0.9625333815560462,1.0,2/13,10.61%,SYNJ1;DNM2
prerank,regulation of protein catabolic process (GO:0042176),0.266456780703244,0.8120887103818104,0.8018967334035827,0.9623918071657034,1.0,35/99,27.46%,WNT5A;AZIN2;CHEK2;MAD2L2;EGLN2;RILP;AREL1;TMEM9;AGAP2;DACT1;BARD1;AZIN1;SORL1;SMURF1;VPS28;HGS;TIPARP;WWP1;WDR91;PIN1;HUWE1;SMURF2;IDE;HMGCR;VCP;AXIN1;SNX12;FLNA;SIRT2;TNF;SEC22B;SNF8;FMN2;MAD2L1;HECW2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.36000085033754126,0.8120350193089214,0.690856313497823,0.9620596912330515,1.0,4/12,25.43%,THY1;LCK;GCNT2;TNF
prerank,negative regulation of stem cell differentiation (GO:2000737),0.37656826672794363,0.8118720561062562,0.7142857142857143,0.9619319650039895,1.0,2/12,8.45%,ESRRB;YTHDF2
prerank,long-chain fatty acid import into cell (GO:0044539),0.38215884030689706,0.8113899409314705,0.6886035313001605,0.9623017395801775,1.0,1/10,2.36%,SLC27A1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3250889606522783,0.8111154387265742,0.7247119078104993,0.962314761715551,1.0,8/24,24.62%,ACTR2;CYFIP1;ACTR3;RAC1;PLCE1;NCKAP1;BRK1;PIK3CA
prerank,positive regulation of viral transcription (GO:0050434),0.3171866806423089,0.8110675988417517,0.7336683417085427,0.9619845619233123,1.0,4/25,9.30%,POLR2G;DHX9;MDFIC;POLR2K
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.2889834291519016,-0.810877868920435,0.7431906614785992,0.9916621117500459,1.0,4/14,11.13%,CMPK1;NMNAT2;PNP;ME1
prerank,defense response to tumor cell (GO:0002357),-0.3223419308794078,-0.810577714974706,0.7147239263803681,0.9906330959028703,1.0,4/10,16.43%,DAPK1;RBMS3;ABI3;KLF4
prerank,phosphatidic acid metabolic process (GO:0046473),0.2851281468625961,0.8102628367794008,0.7253521126760564,0.9628666842150361,1.0,6/48,9.82%,SLC27A1;PLA2G12A;AGPAT5;ABHD8;GNPAT;DGKB
prerank,regulation of protein kinase activity (GO:0045859),0.2618436985519416,0.8101969384268459,0.7953830010493179,0.96255741953843,1.0,25/106,19.24%,TRIB3;DAXX;LCP2;THY1;TARBP2;CACUL1;TRAF4;MAP2K3;CSF1;AGAP2;PPIA;RAPGEF2;PRKAG1;SNX9;PPM1F;AKT1S1;RB1;INPP5K;PTPRC;PLCE1;NF1;DTNBP1;SPRED1;UVRAG;CAMKK2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3093008744654571,0.8101182286010744,0.7378277153558053,0.9622653869827904,1.0,3/31,8.74%,CLTRN;SYT7;SYT3
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2969277222961923,0.8098868365460054,0.7488372093023256,0.9622444828696807,1.0,10/41,20.34%,NUP37;SLC2A6;NUP153;RAE1;PRKAG1;EIF6;NUP155;NUP88;NUP133;NUP43
prerank,regulation of axon regeneration (GO:0048679),0.369179961367,0.8098177282378891,0.7252252252252253,0.9619493616252256,1.0,6/12,26.87%,EPHA4;CERS2;STK24;RTN4RL1;PTPRS;GRN
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.31912360866078865,0.8094470262716057,0.7284427284427284,0.9621188865704915,1.0,8/25,19.71%,HTATSF1;CCNT2;SETD5;LDB1;WDR43;DDX39B;CCNK;KAT7
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.3664885297582826,0.8088767448647614,0.7027818448023426,0.9622478552344736,1.0,3/12,14.16%,CHERP;CIB1;SPPL3
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.3664885297582826,0.8088767448647614,0.7027818448023426,0.9622478552344736,1.0,3/12,14.16%,CHERP;CIB1;SPPL3
prerank,neuropeptide signaling pathway (GO:0007218),0.2807444773626164,0.808656929150577,0.7517084282460137,0.9622009726505517,1.0,6/58,11.64%,GAL;GPR37;RAPGEF2;GLRA2;GALR1;SORL1
prerank,anion transport (GO:0006820),0.3048812252454635,0.8086339465792146,0.7405602923264312,0.9618267128045827,1.0,9/33,25.50%,SLC19A1;SLCO1B1;TSPO;SLC13A4;SLC4A2;ABCG2;VDAC2;SLC26A7;SLC17A5
prerank,DNA catabolic process (GO:0006308),0.3714615712219228,0.8085058379225017,0.6998491704374057,0.9616266009825764,1.0,1/11,2.26%,XRN2
prerank,response to endoplasmic reticulum stress (GO:0034976),0.2670660086074556,0.808314695603453,0.8179916317991632,0.9615063874958559,1.0,21/107,19.75%,CASP4;TRIB3;DDRGK1;BCL2L11;RNF5;ITPR1;ERP44;HYOU1;SEC16A;ATF6B;NCK1;UBQLN1;RNF185;EIF2S1;BAX;EIF2B5;CREB3L2;BCAP31;ERO1A;GORASP2;ERN1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.275085261542334,0.8078623799127364,0.7839029768467475,0.9618016252608265,1.0,17/72,18.10%,CLU;PFDN5;MAPRE1;KANK1;SSH3;HSPA8;SPEF1;CIB1;ATXN7;PFDN4;APOE;FGF13;PLEKHH2;TBCD;STMN2;CAMSAP2;LDLR
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.2582685352239742,0.8076295546511841,0.8219461697722568,0.9617455118572509,1.0,36/140,20.40%,TAGAP;RHOF;SYDE1;RHOJ;ARHGEF7;ARHGAP4;ABR;SYDE2;VAV1;STARD8;ARHGAP25;ARHGEF11;SRGAP2;SRGAP3;SOS1;ARHGAP21;ARHGAP10;CHN1;ARHGAP11A;AKAP13;TIAM2;ARHGAP39;ARHGAP30;RAC1;SH3BP1;OPHN1;OCRL;BCR;PLCE1;ARHGAP29;RHOT2;ARAP1;ARHGAP24;ARHGAP18;TGM2;ARHGAP31
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.29693551290021725,-0.8075947583710119,0.7414965986394558,0.9948278558508685,1.0,6/13,33.78%,B3GNT2;B3GALT5;B3GALT2;B3GNT7;B3GNT8;B3GNT6
prerank,early endosome to Golgi transport (GO:0034498),-0.3263082378170592,-0.8073888216393633,0.6944444444444444,0.9935760169283931,1.0,3/11,11.06%,SNX8;SURF4;TRAPPC10
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.27688145458913527,0.8073131629701364,0.7851690294438386,0.961827488208912,1.0,14/69,18.18%,IRS1;PIK3CD;PLCB4;LTK;PLCB3;PI4KB;ZFP36L1;PLEKHA1;HTR2A;PIK3CB;IRS2;NYAP2;PLCE1;NF1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3192577422393037,0.8067928944227836,0.7493472584856397,0.962245481656118,1.0,2/24,4.57%,SLC27A1;PLA2G12A
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.27700159787285267,0.8066667162743948,0.7717391304347826,0.962042247552772,1.0,15/67,18.35%,TRPM2;TBC1D1;GAP43;RABEP2;PODXL;TBC1D8;CYLD;P2RX4;CAPZB;DYNC2LI1;DYNLT2B;RAC1;TBC1D2;DCDC2;ABITRAM
prerank,glycolipid biosynthetic process (GO:0009247),0.2963305572785333,0.8066057803135934,0.7505966587112172,0.9617302807371984,1.0,9/38,19.27%,PIGW;GBGT1;PIGV;SCCPDH;PGAP2;ST8SIA1;PIGQ;PIGB;PGAP3
prerank,androgen metabolic process (GO:0008209),0.33297299655372725,0.8065534352826963,0.7349081364829396,0.9613991428568711,1.0,1/18,3.57%,HSD17B7
prerank,odontogenesis (GO:0042476),0.3005915184020177,0.8061358644058129,0.7574316290130797,0.9616576987015266,1.0,2/35,5.98%,PITX2;FGFR2
prerank,intestinal absorption (GO:0050892),0.35984461679439583,0.8059718045431977,0.7068965517241379,0.9615090185280801,1.0,2/13,12.28%,SLC46A1;TJP2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.31196081698924666,0.8057926733753142,0.7049808429118773,0.9613794490287428,1.0,6/27,15.60%,SKP1;MAP3K8;NFKB1;BTRC;TNIP2;TAOK2
prerank,negative regulation of synaptic transmission (GO:0050805),0.32371036041016044,0.8055992488707416,0.7154150197628458,0.961274571775275,1.0,2/23,5.28%,GRIK3;SLC30A1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.3362957759995012,0.8055532252651485,0.7302904564315352,0.9609486506762372,1.0,6/18,22.76%,KMT2A;SETD3;ASH1L;SMYD2;SETD7;KMT2D
prerank,lysosome localization (GO:0032418),0.29651508226370277,0.8054533150188756,0.7260920897284534,0.9607100460179627,1.0,11/37,25.54%,PIK3CD;VPS33A;DEF8;PLEKHM2;SPAG9;KLC2;MYH9;S100A13;HDAC6;KXD1;RAB3A
prerank,aromatic amino acid family metabolic process (GO:0009072),0.3772686393211445,0.8053213299881529,0.7203647416413373,0.9605138536621387,1.0,1/10,4.38%,THAP4
prerank,negative regulation of signaling (GO:0023057),0.31840043036003396,0.8048714115011698,0.7404980340760158,0.9608219518736838,1.0,3/25,8.85%,ACVR1;KIF26A;SOCS5
prerank,protein acylation (GO:0043543),0.2980161804838867,0.8046098396265783,0.7526881720430108,0.960842331365118,1.0,16/38,27.29%,ZDHHC21;ZDHHC20;HHAT;NAT9;ZDHHC13;ZDHHC8;ZDHHC3;ING5;ZDHHC18;KAT6A;ZDHHC22;KAT2B;ZDHHC17;ZDHHC16;ZDHHC7;EP300
prerank,muscle tissue morphogenesis (GO:0060415),-0.2696115410705708,-0.8044804936003831,0.75,0.9976654249745357,1.0,7/16,35.05%,TGFBR3;ZFPM1;EFEMP2;BMP2;BMP4;HEY2;MYLK
prerank,regulation of actin filament bundle assembly (GO:0032231),0.31005869212751774,0.804378620958685,0.745,0.9608093563964722,1.0,5/26,14.35%,PTGER4;CX3CL1;SYNPO;RAC1;ASAP3
prerank,negative regulation of interleukin-1 production (GO:0032692),0.3191878389698309,0.8041571732112135,0.7434895833333334,0.9607579216808927,1.0,3/23,10.58%,CX3CL1;GIT1;ZC3H12A
prerank,cilium organization (GO:0044782),0.25323191499630193,0.8040573401241645,0.8731117824773413,0.9605075479259245,1.0,40/209,18.42%,CNGB1;CEP19;ATP6V0D1;BBIP1;RAB8B;B9D2;ACTR2;CEP162;RILP;RILPL1;SNX10;TTC39C;ACTR3;NPHP3;KIF3B;MKS1;CFAP54;FNBP1L;WDR35;TMEM138;CEP131;EXOC6;GSN;DYNLT2B;DYNLL1;PIBF1;DZIP1;CFAP20;TMEM67;BBS2;CCDC66;ARF4;RAB11A;WDR19;DYNC2H1;OCRL;CEP89;DCDC2;GBF1;IFT46
prerank,central nervous system development (GO:0007417),0.25318095096037374,0.8039649513660297,0.8906720160481444,0.9602449303777963,1.0,49/250,19.94%,CXCR4;PLXNB2;GRIN2D;STAT3;ECRG4;CHD7;PAFAH1B3;ANKLE2;SH3GL1;SYNJ1;PHGDH;CIC;SOX9;PITPNM1;UBE3A;TBC1D23;MEIS3;CDK5RAP2;EIF2B2;NFIB;JRKL;BPTF;PROX1;DHX30;DNAJC30;SCYL2;GSN;DDIT4;HPCAL4;PTPN11;ATXN1;PTCH1;SMARCA1;CTNS;DNER;POU6F1;RNF103;NHEJ1;DSCAML1;NDUFS4;DHX37;VIT;NF1;WWP1;EIF2B5;GBA2;UTP3;NCKAP1;POU3F3
prerank,RNA biosynthetic process (GO:0032774),-0.22654576086281525,-0.803874964478543,0.8,0.9971845797725692,1.0,7/31,18.76%,TAF12;TBP;TTF1;PRMT5;TAF5;TAF10;POLR2A
prerank,positive regulation of wound healing (GO:0090303),0.2998882156833771,0.8032627395721943,0.7356459330143541,0.9609306559872877,1.0,7/36,16.31%,SMOC2;KANK1;HPSE;XBP1;PRKCE;RREB1;MTOR
prerank,negative regulation of protein polymerization (GO:0032272),-0.23402372309202962,-0.803083303603987,0.7567567567567568,0.9970260166603093,1.0,4/27,7.55%,SSH2;DYRK1A;TUBB4A;SNCA
prerank,ribosomal small subunit assembly (GO:0000028),0.3387484766657113,0.802654732777808,0.7254901960784313,0.9614621354496532,1.0,2/16,4.05%,PWP2;ERAL1
prerank,cell projection assembly (GO:0030031),0.3249057128199582,0.80220300630849,0.7133507853403142,0.9617692047430967,1.0,8/22,23.57%,PARVB;CYFIP1;RHOJ;GSN;RAC1;NCKAP1;RHOH;PARVG
prerank,regulation of NMDA receptor activity (GO:2000310),0.30356092143065994,0.8020509633202727,0.7564259485924113,0.9615952692810562,1.0,8/32,16.23%,CAMK2B;ACTN2;CRHBP;GRIA2;APP;CAPN1;DLG1;GRIA4
prerank,triglyceride biosynthetic process (GO:0019432),-0.2740073656472406,-0.8018935465016764,0.7379032258064516,0.9976402526388795,1.0,7/18,26.13%,MOGAT3;DGAT1;GPAM;PCK2;GPAT4;GPAT3;DGAT2
prerank,protein-DNA complex disassembly (GO:0032986),0.34611932875985546,0.8018759863195434,0.7083333333333334,0.9614716365013883,1.0,4/16,8.41%,ARID1A;SMARCE1;SMARCC2;ARID2
prerank,cellular response to sterol (GO:0036315),0.35818432932567046,0.8014255834614931,0.71898355754858,0.9617847360184363,1.0,5/13,15.36%,OSBPL7;MLC1;RORA;PTCH1;GRAMD1C
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.28432875655235545,0.8009013714945601,0.770949720670391,0.9622414782602312,1.0,11/51,18.18%,LRP2;FBN1;BAMBI;BMPER;BMPR2;SKIL;SORL1;SMURF1;BMPR1A;HTRA3;ACVR2A
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.22461176670882113,-0.8004753041724897,0.8031914893617021,0.9986840442005094,1.0,15/30,36.61%,LPAR1;ARRB1;PRAG1;ARHGEF3;F11R;NET1;F2R;ROBO1;LPAR6;GPR18;F2RL2;GPR65;RTN4R;GPR174;LPAR4
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3347856562013965,0.8003684277442901,0.7210242587601078,0.962668718942623,1.0,6/17,23.17%,RNF40;NCBP2;NCBP1;ZC3H3;CDK9;ZC3H14
prerank,cellular response to oxidative stress (GO:0034599),0.26051415611962747,0.800043373101979,0.8251028806584362,0.9627720745139632,1.0,20/118,16.91%,HSPA1B;TMEM161A;PNPT1;SOD2;CYBB;SRXN1;MT3;PPIA;GSR;ZC3H12A;LONP1;PPARGC1A;STX4;EIF2S1;PRDX2;ERCC6L2;ADNP2;MSRA;AIF1;CHCHD2
prerank,organophosphate catabolic process (GO:0046434),0.3681295836491698,0.8000113123482917,0.7311178247734139,0.9624086606629109,1.0,1/11,5.64%,PDXP
prerank,negative regulation of lymphocyte activation (GO:0051250),0.32267669854529124,0.7998676451753904,0.7294429708222812,0.9622242819642642,1.0,6/21,20.23%,DUSP3;LST1;FCGR2B;PIBF1;PAG1;TNFAIP8L2
prerank,ATP synthesis coupled proton transport (GO:0015986),0.34265042816010555,0.7998316442203875,0.7166900420757363,0.9618716679026372,1.0,6/17,26.38%,ATP5MC1;DMAC2L;ATP5PO;ATP5F1B;VPS9D1;STOML2
prerank,catecholamine metabolic process (GO:0006584),0.3410796310726169,0.7988546899041808,0.7111756168359942,0.9630171513159465,1.0,3/14,20.70%,DDC;COMT;RNF180
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.23157162822019262,-0.7988198091102011,0.84375,1.0,1.0,12/29,29.29%,SSH2;CORO1A;FKBP4;SHANK3;SMAD4;SSH1;CLASP1;SHANK1;KANK3;TJP1;KANK4;PRKN
prerank,regulation of rRNA processing (GO:2000232),0.3430038996976364,0.79866126664095,0.71004243281471,0.9629066249518008,1.0,7/16,23.96%,YTHDF2;DIMT1;WDR43;NUDT16;BUD23;UTP15;KAT2B
prerank,canonical glycolysis (GO:0061621),0.32050784927830755,0.7986377433623785,0.7255400254129606,0.9621269223470694,1.0,4/24,10.61%,TPI1;PFKM;HK1;FOXK1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.32050784927830755,0.7986377433623785,0.7255400254129606,0.9621269223470694,1.0,4/24,10.61%,TPI1;PFKM;HK1;FOXK1
prerank,ganglioside metabolic process (GO:0001573),0.32513255215167536,0.7985050318508489,0.7459239130434783,0.9619294855439549,1.0,3/20,9.08%,ST6GALNAC4;ST6GALNAC6;NEU1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.37676272188116317,0.79843206119068,0.6986506746626686,0.9616230827397221,1.0,2/10,10.81%,KLF15;SETD5
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.34563055934554215,0.7983201852439663,0.7128571428571429,0.9613761709257198,1.0,6/13,30.74%,DDX20;SRSF10;SART3;PRPF19;AAR2;USP4
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.37876322247992134,0.7982374474085139,0.7324561403508771,0.9610992266855681,1.0,4/10,19.65%,RTEL1;DCLRE1A;TERF2;DCLRE1C
prerank,nucleotide metabolic process (GO:0009117),0.3224568455197685,0.797603135190597,0.7313054499366286,0.9616787226187337,1.0,6/23,15.34%,ENPP3;DCK;NUDT5;CMPK2;AK4;RNASEH2B
prerank,regulation of proteolysis (GO:0030162),0.2858964394196545,0.7975847479228817,0.7941834451901566,0.9612984687926495,1.0,14/48,23.75%,TM4SF20;ASPH;TRAF3;BTRC;BAD;AURKAIP1;IST1;SPOP;PLAUR;STUB1;HDAC2;CLN6;PLAT;HDAC6
prerank,amide biosynthetic process (GO:0043604),0.2830856516389617,0.7971367312006568,0.7727272727272727,0.9615979014229584,1.0,4/47,6.17%,NMRAL1;ASAH2;CERS6;DEGS1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.2537710995364995,0.7970803890163531,0.8910191725529768,0.9612788102844395,1.0,45/198,21.75%,PIK3CD;PLCB4;ITPKC;STAT3;SYNJ1;ENPP3;PGM2L1;DUSP3;PFKM;PDXP;PPIP5K1;NUDT5;GFPT1;ITPK1;NADK;PLCB3;HK1;CERKL;SPHK2;DUSP28;BCKDK;EPHX2;DUSP10;ENPP1;PIK3CB;INPP4B;DUSP16;PANK2;INPP5K;MTOR;OCRL;NUDT4;PTPRC;PLCE1;DUSP8;PPA1;MINPP1;PTPRB;PLA2G4E;GPX4;PI4KA;LHPP;TNFAIP8L3;PLPP2;ALDOC
prerank,endothelial cell development (GO:0001885),0.3160860631529654,0.7965888239519363,0.7367724867724867,0.9616132761437729,1.0,5/25,17.71%,COL22A1;RAPGEF2;MET;RAPGEF1;COL15A1
prerank,neuron development (GO:0048666),0.256984781316208,0.7964589211318451,0.8463917525773196,0.9614134093981027,1.0,38/141,24.78%,BLOC1S4;RUNX1;PPP1R9A;TBC1D23;SRF;MYOC;SAMD14;STMN4;RAPGEF2;LYN;GDNF;B4GALT5;APP;HMGB1;STMN3;XBP1;APOE;RB1;MAP4;LRP12;TBCD;PRMT1;RAB11A;OPHN1;STMN2;HS6ST1;DTNBP1;GBA2;PLP1;LGI1;TENM4;UNC5A;CDK16;ZFYVE27;PTPRM;SH3GL2;TENM1;PBX4
prerank,glycerophospholipid metabolic process (GO:0006650),0.2682396442846053,0.7957927153720378,0.8016967126193001,0.9620388665594052,1.0,16/75,20.53%,PIGW;CPNE3;SYNJ1;PDXP;PIP5K1A;PIGV;PLCB3;PNPLA6;ABHD3;ENPP6;PAFAH1B1;PIGQ;PIGB;PLA2G4E;PNPLA3;PLA2G6
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.28613231231412406,0.7957065208573508,0.7786885245901639,0.9617740401780013,1.0,10/44,20.65%,PER2;OSBPL7;CH25H;OSBPL3;CYP27A1;OSBPL9;OSBP;EBP;OSBPL2;CYP39A1
prerank,regulation of histone deacetylation (GO:0031063),0.35342082183104095,0.7956776566231832,0.724376731301939,0.9614114191770889,1.0,2/13,9.98%,CAMK2D;SPHK2
prerank,cellular protein metabolic process (GO:0044267),0.24763683952605933,0.7955290281520833,0.951,0.9612348790002402,1.0,88/396,22.31%,LIPT1;LOXL2;UBE2L6;PNPLA2;MRPL36;IGF2BP3;AGO2;CHEK2;RCN1;USP25;RPL36;SERPINC1;HARS2;LAMC1;LAMB2;RNF5;GSPT1;RAB12;RPL22;TNC;EIF4EBP2;RPS21;UBE2M;CSF1;NAGPA;FBN1;SEPHS1;CTSH;MXRA8;APP;PAPPA;MEN1;ST3GAL1;SPCS1;TNIP1;MRPL42;PDIA6;ABCF1;PSEN1;APOE;PPP4R2;PRKDC;UBE2L3;KTN1;GGCX;RPS6;NAPSA;RPN1;SPPL3;APH1A;RPS11;FAM20C;RPL30;MRPL24;APH1B;RPL32;RPL23A;MSRA;RPL11;YARS2;RPL10A;SPARCL1;CSF2RA;RPS15A;MRPL13;HBS1L;SRBD1;HM13;RSL24D1;RPL24;RPL37A;SERP1;RPL3;MRPS11;UBL5;ERO1A;RRBP1;APLP2;RPL29;YES1;RPL5;MSRB1;FARSB;ABL2;RPL6;HSP90B1;IDE;MMP15
prerank,acidic amino acid transport (GO:0015800),0.33641616154042414,0.7952121725413547,0.7336884154460719,0.9613294007232441,1.0,1/17,0.81%,SLC25A22
prerank,inner dynein arm assembly (GO:0036159),0.3752335038861227,0.7948742256090523,0.7358778625954199,0.9614730017290437,1.0,2/10,14.21%,CCDC40;CFAP73
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.3657289212894325,0.7943747744230569,0.7321428571428571,0.9614676754746904,1.0,3/11,16.96%,SYNJ1;INPP5K;OCRL
prerank,inositol phosphate dephosphorylation (GO:0046855),0.3657289212894325,0.7943747744230569,0.7321428571428571,0.9614676754746904,1.0,3/11,16.96%,SYNJ1;INPP5K;OCRL
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.315276017905168,-0.7943261295910281,0.7418397626112759,1.0,1.0,6/11,36.04%,ATP1B1;KCND3;KCNH2;ATP1A1;KCNQ1;KCNIP2
prerank,DNA conformation change (GO:0071103),0.3376770703216851,0.794099536924485,0.7299168975069252,0.9614916804099821,1.0,4/17,14.70%,PRM1;HMGB1;HMGB3;TOP1MT
prerank,neuromuscular process (GO:0050905),-0.2703911600492768,-0.7940565015570207,0.7737226277372263,1.0,1.0,3/16,8.56%,UBA5;AGTPBP1;NRXN1
prerank,actin-myosin filament sliding (GO:0033275),0.29259784203122224,0.7937993854886676,0.7634032634032634,0.9610998212103173,1.0,6/38,20.12%,ACTN2;TNNC1;MYL1;MYH2;TNNI2;TPM3
prerank,muscle filament sliding (GO:0030049),0.29259784203122224,0.7937993854886676,0.7634032634032634,0.9610998212103173,1.0,6/38,20.12%,ACTN2;TNNC1;MYL1;MYH2;TNNI2;TPM3
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.3076154374001175,0.7937404563248629,0.769889840881273,0.9607794381502999,1.0,2/27,3.40%,SLC25A22;SLC38A1
prerank,epidermis development (GO:0008544),0.2767328602954341,0.793696656388199,0.7648351648351648,0.9604436907943504,1.0,2/56,5.98%,EDAR;FGFR2
prerank,regulation of Golgi organization (GO:1903358),-0.26515050448717975,-0.7936687442240359,0.7642585551330798,1.0,1.0,4/17,9.90%,ARMH3;MAPK3;RAB33B;USP6NL
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.3359746172288679,0.7933209368015712,0.7417127071823204,0.9606213922578506,1.0,6/18,21.85%,ZC3H11A;DDX19B;ENY2;DDX19A;NUP133;MCM3AP
prerank,regulation of microtubule depolymerization (GO:0031114),0.31182525870082123,0.7932408056154079,0.7634271099744245,0.960340455030917,1.0,8/25,19.01%,SPEF1;CIB1;ATXN7;TRPV4;FGF13;STMN2;CAMSAP2;MAP1B
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.36904575018471225,0.7927299126437436,0.7138728323699421,0.9607290526855384,1.0,4/12,16.18%,IRS1;SORL1;PTPN11;GKAP1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.3536122340012917,0.7926176509578065,0.7274011299435028,0.9605006127787772,1.0,1/13,6.11%,STX7
prerank,cellular transition metal ion homeostasis (GO:0046916),0.26414010994666903,0.7923695087962964,0.8094218415417559,0.9604755999577308,1.0,23/91,20.88%,SKP1;ATP6V0D1;FXN;SLC46A1;SLC30A1;SLC30A5;MT3;SLC11A2;CAND1;APP;PRNP;COX19;TFR2;SLC39A10;HMOX2;FBXL5;ATP6V1G1;ABCB7;FLVCR1;ABCG2;SLC31A1;LCK;SLC31A2
prerank,neural crest cell differentiation (GO:0014033),0.33417577052833336,0.791885827170702,0.733957219251337,0.9608261405892503,1.0,3/18,8.34%,TCOF1;SNAI2;NOLC1
prerank,stabilization of membrane potential (GO:0030322),0.3331740439828222,0.7915145310820106,0.7268965517241379,0.9610036556901782,1.0,2/16,11.76%,CHCHD10;KCNK3
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.24316060168861006,-0.7913139806591271,0.7629310344827587,1.0,1.0,8/23,20.27%,ZFYVE19;NABP1;NABP2;BUB1;PLK2;CDK5RAP3;VPS4A;SETMAR
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.33048207052578527,0.790967550847927,0.7372764786795049,0.9614606453342078,1.0,2/16,6.87%,PIGW;PIGV
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.33133996790809944,0.7908997373213283,0.73224043715847,0.961160396249739,1.0,5/19,18.99%,XRN1;DCP2;HNRNPA1;STN1;TERF2
prerank,protein export from nucleus (GO:0006611),-0.23663983137710637,-0.7908847461886602,0.7988505747126436,1.0,1.0,10/27,24.12%,TGFB1;STYX;STRADB;XPO5;CCHCR1;EGR2;TPR;RANBP3;XPO7;XPO1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.26914190184162384,0.7904695311546592,0.7898789878987899,0.9614313791992399,1.0,13/62,16.92%,POLR2G;NCBP2;CDK12;CCNT2;ELP2;POLR2K;MNAT1;SSRP1;ELOC;MLLT3;NCBP1;CCNK;ELOF1
prerank,cellular response to estradiol stimulus (GO:0071392),0.3331194984168085,0.7904321185727103,0.7547945205479452,0.9610884936003196,1.0,6/18,23.52%,CRHBP;LCOR;CCDC62;NRIP1;RUVBL2;KAT5
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.2863683804434854,0.7899499532567461,0.774230330672748,0.961395015019513,1.0,18/43,31.13%,ACVR1;ZHX3;WNT7B;BMPR2;NELL1;BMPR1A;ACVR2A;DDR2;FERMT2;IL6R;ATRAID;FBXO5;IL6ST;LRP5;WWTR1;PRKD1;CCN1;IGF1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.3098655478347708,-0.7897777493480913,0.7142857142857143,1.0,1.0,4/10,20.38%,IMPACT;HIF1AN;BAG3;DNAJB1
prerank,sphingolipid catabolic process (GO:0030149),-0.28371263528411905,-0.7891717693209779,0.7108843537414966,1.0,1.0,7/15,25.45%,PDXDC1;SMPDL3A;ASAH1;ACER2;SMPD1;SMPD2;PPT1
prerank,glycogen metabolic process (GO:0005977),0.30733320469119824,0.7891083448933479,0.7627551020408163,0.9623127270680271,1.0,3/27,7.78%,PER2;PGM2L1;PGM1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.2974860744885923,-0.7890444825443417,0.7578616352201258,1.0,1.0,5/11,27.65%,GLRX3;FOXO1;SMAD4;MLIP;ATP2B4
prerank,phosphate ion transport (GO:0006817),0.3380441683325787,0.7888107174165154,0.7570093457943925,0.9623790442661319,1.0,5/16,22.93%,SLC25A10;SLC37A2;SLC20A2;SLC37A1;SLC25A30
prerank,inositol phosphate catabolic process (GO:0071545),0.3561892437711251,0.7887600348002614,0.7271364317841079,0.9620598495571597,1.0,3/12,16.96%,SYNJ1;INPP5K;OCRL
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.2666442400225678,-0.7885836216913353,0.7864768683274022,1.0,1.0,8/17,23.12%,TGFB1;BIN1;ID2;TNFRSF1B;IL34;EGR2;PTPRZ1;CLCF1
prerank,cAMP metabolic process (GO:0046058),0.3563362739586814,0.7882364655608397,0.7173295454545454,0.962414978683184,1.0,2/13,6.16%,ADCY5;ADCY10
prerank,iron-sulfur cluster assembly (GO:0016226),0.3151129433359218,0.7880768701188104,0.7560355781448539,0.9622525227131916,1.0,4/24,9.03%,HSCB;FXN;NFU1;NFS1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.2566121258047329,-0.7879643540456021,0.782051282051282,1.0,1.0,7/20,24.31%,APC;NR2F2;CEBPA;INCA1;HEXIM1;CDKN1B;CDK5RAP1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.3213100761397318,0.787863706668646,0.7448840381991815,0.9621778489079545,1.0,3/19,7.32%,FBXO7;FBXW7;CSNK2A2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.3681897394177178,0.7874575785606674,0.7404580152671756,0.9623882840703198,1.0,2/10,14.76%,ATP5MC1;ATP5PO
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.329425956838424,0.7873369600368642,0.7197278911564626,0.9621535535977073,1.0,4/18,10.73%,DCP2;CCT4;CCT7;CCT3
prerank,positive regulation of JUN kinase activity (GO:0043507),0.3085997639811841,0.7872216672993831,0.7426273458445041,0.9619340970151244,1.0,2/23,2.87%,TAOK3;SASH1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.2969567070749167,-0.7863601398774342,0.7666666666666667,1.0,1.0,6/12,33.78%,B3GNT2;B3GALT5;B3GALT2;B3GNT7;B3GNT8;B3GNT6
prerank,outer dynein arm assembly (GO:0036158),0.342165585279209,0.7858173571596694,0.7225352112676057,0.9636553218869003,1.0,3/14,16.33%,ODAD2;ODAD4;DNAL1
prerank,translation (GO:0006412),0.24835970327968782,0.785354866319585,0.8866396761133604,0.9639710865568506,1.0,47/208,19.03%,VARS1;MRPL36;IGF2BP3;AGO2;RARS1;RPL36;HARS2;IARS2;GSPT1;RPL22;EIF4EBP2;RPS21;MRPL16;AARS1;MRPS28;TUFM;ABCE1;TNIP1;MRPL42;ABCF1;IARS1;RPS6;NARS1;MRPS2;RPS11;RPL30;NOA1;MRPL24;ETF1;RPL32;RPL23A;RPL11;EEF1E1;YARS2;RPL10A;RPS15A;MRPL13;HBS1L;SRBD1;RSL24D1;RPL24;MRPL57;RPL37A;PPA1;FASTKD2;RPL3;MRPS11
prerank,negative regulation of inflammatory response (GO:0050728),0.2491784371094756,0.7852124732976526,0.8888888888888888,0.9637908869530996,1.0,33/182,21.65%,CALCA;AOAH;RXFP2;ENPP3;PTGER4;HCK;ADCY5;PRKAR2B;LYN;FCGR1A;MAPK14;RORA;GIT1;RHBDF2;APOE;CXCL17;RB1;SHARPIN;FYN;PPARD;ACOD1;MDK;PRKAR2A;MYH9;MFHAS1;ADCYAP1R1;SIRPA;TNFAIP8L2;YES1;GPR176;GIPR;PRKCD;VPS35
prerank,protein localization to membrane (GO:0072657),0.2478855680925634,0.7850627950448466,0.8911290322580645,0.9636112555297861,1.0,60/187,26.55%,PIGW;RAB8B;ATP1B3;THY1;ACTN2;SEC16A;RAB12;TM9SF1;ANK1;SH3GLB1;PIP5K1A;MAGI2;RAPGEF6;RAB11B;RAPGEF2;EPB41L3;AGRN;TNIK;EFR3A;SMURF1;ARL5C;FGF13;PTCH1;NPC1;DLG1;NUP155;INPP5K;HGS;RAB11A;RAB32;WDR19;SH3PXD2B;FLOT2;ITGA4;RAP2A;LRRC4;TM9SF4;ZDHHC3;SAV1;RAB10;ZFYVE27;C2CD5;ZDHHC22;RABEP1;RAB29;PACSIN1;FLNA;ANK2;WNK3;DPP10;DPP6;TNF;KCNB1;RAB3A;TSPAN32;FERMT2;TM9SF2;LIN7C;RAB3D;ARL5A
prerank,vesicle transport along microtubule (GO:0047496),0.31983811590151007,0.7849468462548356,0.7565872020075283,0.9633903950647101,1.0,4/23,6.82%,FYCO1;DYNC1H1;TRAK1;KIF3B
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.3193863998490801,0.7843623282644573,0.7483530961791831,0.9638402733261126,1.0,6/20,28.52%,CD40;GSN;ITGA4;PIAS4;ECSCR;PLCG1
prerank,cellular response to light stimulus (GO:0071482),0.2683685704950051,0.7842422345310163,0.8071748878923767,0.9636261831838635,1.0,7/66,10.60%,CNGB1;TMEM161A;DHX36;N4BP1;ERCC4;POLK;NPM1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.2868058117786128,-0.7841501398782642,0.7792642140468228,1.0,1.0,3/13,10.02%,TGFB1;BMP6;NUP93
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.3133597914096417,0.7841449299510965,0.7645536869340233,0.9633780405992002,1.0,2/25,3.85%,PER2;MAD2L2
prerank,negative regulation of protein kinase activity (GO:0006469),0.25928886912258575,0.7839678220178133,0.8175026680896478,0.9632231555303972,1.0,22/88,19.24%,TRIB3;ADAR;THY1;SLC8A1;TARBP2;DUSP3;PPIA;DUSP26;PPM1F;NPM1;SORL1;AKT1S1;DUSP10;RB1;INPP5K;PTPRC;CORO1C;NF1;DTNBP1;SPRED1;TESK1;PTPRB
prerank,glycine metabolic process (GO:0006544),0.35649660562347896,0.7838145293347719,0.7575757575757576,0.9630642281310694,1.0,3/12,15.02%,DLD;SHMT1;GCSH
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.2830473450568869,0.783750858363665,0.7808056872037915,0.9627599261587156,1.0,5/43,8.85%,SPRY2;TGFA;DUSP3;ARHGEF7;SOCS5
prerank,glycoprotein metabolic process (GO:0009100),0.27226867217661727,0.7836758908898849,0.7905935050391937,0.9624617112348273,1.0,8/53,10.66%,ERP44;ST6GALNAC6;MAN1A2;NGLY1;B4GALT5;GANC;TNIP1;HPSE
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.35560776005361994,0.7835611264301092,0.7522388059701492,0.9622433101387383,1.0,5/12,19.55%,PRNP;TMED10;APOE;FLOT2;RANBP9
prerank,ethanol metabolic process (GO:0006067),-0.29694569082253286,-0.7830151225880762,0.7297297297297297,1.0,1.0,3/12,18.67%,ALDH2;ACSS1;SULT1A1
prerank,protein palmitoylation (GO:0018345),0.3035023719117339,0.7830136763135104,0.7755610972568578,0.962639288335016,1.0,12/30,27.22%,GOLGA7;ZDHHC21;ZDHHC20;HHAT;ZDHHC13;ZDHHC8;ZDHHC3;ZDHHC18;ZDHHC22;ZDHHC17;ZDHHC16;ZDHHC7
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.2906860523217888,0.7829329959976105,0.7751479289940828,0.9623560623210893,1.0,10/37,18.42%,KIF3C;KIF3B;WDR35;IFT27;CEP131;DYNC2LI1;DYNLL1;WDR19;DYNC2H1;IFT46
prerank,activation of adenylate cyclase activity (GO:0007190),0.29252346566096366,0.7829082110687409,0.7792682926829269,0.9619981800583209,1.0,3/35,7.01%,RXFP2;ADCY5;TMIGD3
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.33940505168076945,0.7825953262528142,0.7372159090909091,0.9620623048976014,1.0,3/16,14.76%,ATP5MC1;DMAC2L;ATP5PO
prerank,phosphatidylserine metabolic process (GO:0006658),0.29289167263635996,0.7825465741730425,0.7812113720642769,0.9617393449232793,1.0,3/32,4.72%,SLC27A1;PLA2G12A;OSBPL8
prerank,cell junction assembly (GO:0034329),0.2590081201182225,0.7821551640689429,0.8365180467091295,0.9619165517985391,1.0,16/100,16.35%,SLITRK6;PCDHB13;BDNF;CDH9;SDK1;PCDHB16;TRPV4;LIMS1;ACTB;CTNND2;DNER;DBNL;SH3BP1;DSCAM;NLGN3;OPHN1
prerank,peptidyl-proline modification (GO:0018208),-0.23776138088716553,-0.7819313545572696,0.7896995708154506,1.0,1.0,4/25,6.61%,P3H2;PPIL3;FKBP4;PPIL2
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.24529187432195518,0.7816711427989974,0.935,0.9622236236283571,1.0,66/306,20.35%,EXT1;POLR2G;MCM2;MRPL36;TIMELESS;IGF2BP3;AGO2;POLE2;RPL36;HARS2;MCM7;CHEK1;TIPIN;RNASEH2A;GSPT1;MCM4;RFC4;RPL22;RRAGC;EIF4EBP2;RPS21;MCM9;BRIP1;FEN1;TUFM;B4GALT5;BARD1;SCX;POLR2K;PTMS;TNIP1;RNPS1;MRPL42;ABCF1;APOE;ORC3;TAF1B;RPS6;RPS11;TOP1MT;RPL30;RMI1;MRPL24;RECQL5;RPL32;MEF2A;RPL23A;RPL11;UPF1;YARS2;RPL10A;RPS15A;MRPL13;HBS1L;SRBD1;FUT9;RSL24D1;RPL24;RPL37A;RPL3;MRPS11;SET;KAT7;RRBP1;ORC1;ATRIP
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.26326531783497215,0.781531824239975,0.8210412147505423,0.9620363528841787,1.0,18/78,17.35%,MMP14;STX7;ITGA3;STX8;LDLRAP1;RSC1A1;CIB1;PRKCE;VTI1B;DAB2;STX4;ACTB;DLG1;PRKCH;TMEM59;STAC3;PTPN9;ZDHHC8
prerank,negative regulation by host of viral process (GO:0044793),0.3661319612753495,0.7814095954183666,0.7511591962905718,0.9618118842983154,1.0,2/10,16.44%,ZC3H12A;CCNK
prerank,second-messenger-mediated signaling (GO:0019932),0.2571867662196518,0.7811966988362772,0.8168103448275862,0.9617340458732149,1.0,7/82,8.96%,AGT;CXCR4;RCAN1;PPP1R9A;SAMD14;ACKR3;P2RX4
prerank,positive regulation of secretion (GO:0051047),0.35872109932432705,0.7811566078703429,0.7289855072463768,0.9613925312412873,1.0,2/11,24.16%,XBP1;ACSL3
prerank,covalent chromatin modification (GO:0016569),0.3436440383192522,0.781150576311001,0.7333333333333333,0.9610040437765084,1.0,7/14,26.72%,MBD2;MT3;SETD5;HDAC1;HLCS;HELLS;UFL1
prerank,cobalamin metabolic process (GO:0009235),0.329705329143051,0.7807782180332078,0.726790450928382,0.9611553529208967,1.0,7/17,28.02%,AMN;ABCC1;ABCD4;MMUT;MMAB;LMBRD1;CD320
prerank,P-body assembly (GO:0033962),-0.2927719186780655,-0.7801442729570993,0.759375,1.0,1.0,2/12,4.15%,PATL1;DDX6
prerank,regulation of myoblast fusion (GO:1901739),0.3647786619168872,0.779945649104495,0.7276853252647504,0.9619928223992426,1.0,3/11,19.38%,CFLAR;MAPK14;CD53
prerank,negative regulation of GTPase activity (GO:0034260),0.3116724773531748,0.7797862350078553,0.7549668874172185,0.9618372373359145,1.0,5/22,18.41%,RASA4;PLXNB3;LRCH1;RRP1B;CPEB2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.24728624810130903,-0.7795490953071857,0.7991266375545851,1.0,1.0,3/22,13.73%,ATP1B1;HTT;GSTO1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.2905361513212991,0.7795035796861711,0.7900485436893204,0.9618667633773843,1.0,13/34,26.48%,PTPN18;DUSP3;PTPN11;DUSP10;DUSP16;PTPN9;DUSP8;PTPRB;PTPRF;PTPN6;PTPRS;PTPN1;DUSP7
prerank,ceramide transport (GO:0035627),-0.29953421162847876,-0.779243272993005,0.768025078369906,1.0,1.0,4/12,20.49%,PLEKHA8;ABCA2;ABCA13;PLTP
prerank,regulation of phospholipase C activity (GO:1900274),0.341252518999527,0.7787712453345846,0.7557046979865771,0.9625560552439779,1.0,1/15,1.08%,FLT1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.31247661270377236,-0.7787455048219128,0.7304347826086957,1.0,1.0,3/10,16.10%,PDE3B;NEXMIF;ACER2
prerank,pulmonary valve development (GO:0003177),-0.25236385442425424,-0.7787425079355669,0.7868217054263565,1.0,1.0,9/18,37.02%,TGFB2;JAG1;TNFRSF1B;SMAD6;ROBO1;BMP4;HEY1;HEY2;HEYL
prerank,organonitrogen compound catabolic process (GO:1901565),0.27181124140240737,0.778604533125699,0.7916666666666666,0.9623991899878684,1.0,17/57,23.26%,SIAH1;LRSAM1;ERAP1;CPQ;LIPC;UCHL3;BCKDK;NPEPPS;MTOR;GADL1;SGPL1;PLA2G6;PNPLA8;IDE;TRHDE;TXN2;CLN6
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.28473729392956365,0.778500701711686,0.7736289381563594,0.9621589629824957,1.0,10/38,19.64%,NDUFA5;NDUFB9;NDUFB11;NDUFS1;NDUFB5;NDUFS4;NDUFA10;NDUFB6;NDUFS8;NDUFS7
prerank,negative regulation of cell aging (GO:0090344),-0.2702084115400501,-0.7784962067909998,0.8252788104089219,1.0,1.0,4/16,14.76%,MAP3K3;SIRT1;HMGA2;MIF
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.3166611336428616,0.7782032287992748,0.7679045092838196,0.9621833502858901,1.0,6/21,17.48%,SPEF1;CIB1;ATXN7;FGF13;STMN2;CAMSAP2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.311311470945848,0.7779977417605491,0.758575197889182,0.9620846491454448,1.0,2/21,4.72%,PLA2G12A;OSBPL8
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.3172066023089943,0.7777459992045936,0.7629533678756477,0.9620636376887828,1.0,6/22,18.85%,ANKLE2;CDKN2D;STAP1;DYNLL1;INPP5K;TESK1
prerank,acylglycerol biosynthetic process (GO:0046463),0.3097358784512122,0.777345808080147,0.7677664974619289,0.9622621689484215,1.0,7/23,23.88%,PNPLA2;LPIN2;LPGAT1;PLCE1;PNPLA3;ANG;AWAT2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.32618985660941296,0.7773093761096609,0.7556440903054449,0.9619131863175825,1.0,7/18,25.49%,RNF5;AMFR;RNF185;RNF103;TRIM13;EDEM2;DERL2
prerank,protein K63-linked deubiquitination (GO:0070536),0.29222662945154815,0.7768198876002795,0.7702702702702703,0.9622497378593288,1.0,13/31,29.15%,USP50;USP25;CYLD;OTUD1;ZRANB1;BABAM2;USP8;USP33;OTUD5;ABRAXAS2;STAMBPL1;BABAM1;ATXN3
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.3312278545890821,0.7766938468233692,0.765625,0.9620518877237865,1.0,3/16,24.44%,CLDN10;CLDN11;CLDN12
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.2927087532678046,0.7765645201328356,0.7911949685534592,0.9618492563158171,1.0,9/31,18.22%,POLR2G;CNOT7;DCP2;DIS3L2;EXOSC9;NT5C3B;HBS1L;DCPS;LSM5
prerank,establishment of epithelial cell polarity (GO:0090162),-0.2561996972646977,-0.7764805214224502,0.7833333333333333,1.0,1.0,5/19,13.10%,CDC42;CYTH1;MYO18A;GOLPH3;RHOA
prerank,phagolysosome assembly (GO:0001845),0.3446310992550818,0.7763562933883535,0.7325268817204301,0.9617534462057848,1.0,2/12,10.98%,SYT7;RAB14
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.26404349638725305,0.776309894176598,0.8133918770581778,0.9614263801799884,1.0,13/64,16.92%,POLR2G;NCBP2;CDK12;CCNT2;ELP2;POLR2K;MNAT1;SSRP1;ELOC;MLLT3;NCBP1;CCNK;ELOF1
prerank,synaptic vesicle endocytosis (GO:0048488),0.28982073652245877,0.7761837901591316,0.7700729927007299,0.9612147905119103,1.0,12/33,23.84%,SYNJ1;DNM2;PIP5K1C;VAMP2;STON1;SNAP91;NLGN3;OPHN1;STON2;ITSN2;DNM3;PACSIN1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.2688833702551175,-0.7760607555376371,0.7848605577689243,1.0,1.0,9/15,35.40%,ETV4;FOXC1;NME2;NCOA3;BMP4;SFRP4;SFN;TRIM16;SULT2B1
prerank,presynaptic endocytosis (GO:0140238),0.3040396256368444,0.7759409032447758,0.7599486521181001,0.9611666562698556,1.0,7/24,17.69%,SYNJ1;PIP5K1C;VAMP2;STON1;NLGN3;OPHN1;STON2
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.33462875011759263,0.7754534974938114,0.7565337001375516,0.961454447826084,1.0,3/16,16.20%,NAA50;NAA35;NAA25
prerank,protein localization to phagophore assembly site (GO:0034497),-0.2911775550142306,-0.774827569819113,0.743202416918429,1.0,1.0,4/11,32.54%,ATG9A;PACS2;MFN2;ATG9B
prerank,histone methylation (GO:0016571),0.3074862128650988,0.7746157295599877,0.7649253731343284,0.9622754214370439,1.0,7/26,19.50%,PRMT2;NTMT1;NSD3;EZH2;PRMT1;SMYD1;SMYD2
prerank,regulation of nervous system process (GO:0031644),-0.2554189999601719,-0.7744222272581592,0.7782101167315175,1.0,1.0,4/18,15.24%,DLGAP1;SLC8A3;CHRNA7;NPTX1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3079920410149407,0.7743779769875948,0.7672530446549392,0.9622260908888105,1.0,4/22,12.56%,UBAP1;MVB12A;VPS37A;VPS28
prerank,signal peptide processing (GO:0006465),-0.2987867909812427,-0.7742845794638428,0.7603833865814696,1.0,1.0,3/11,13.32%,SEC11C;SPCS3;CLN5
prerank,protein deacetylation (GO:0006476),0.2789328169220201,0.7741443476594445,0.7842424242424243,0.9621542167182847,1.0,12/41,25.28%,RBM14;MTA3;MTA2;SIRT6;MIER1;RCOR3;HDAC1;HDAC2;HDAC4;HDAC6;FLNA;SIRT2
prerank,phagosome-lysosome fusion (GO:0090385),0.3603618698944886,0.7737431012131892,0.7356643356643356,0.9623668428745912,1.0,4/10,29.61%,SYT7;RAB7B;RAB20;RAB7A
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.2756163213972458,0.7736595751787757,0.8100113765642776,0.9620939317744753,1.0,8/46,14.38%,PSME2;SOD2;HNRNPA2B1;PPIA;IL12RB2;HNRNPDL;JAK2;AIP
prerank,Golgi inheritance (GO:0048313),0.3558027860324407,0.7735926971581052,0.7793696275071633,0.9617888445110598,1.0,4/11,18.11%,PLK3;VCPIP1;STK25;GBF1
prerank,positive regulation of protein modification process (GO:0031401),0.24222985338313707,0.7734545648939313,0.9068825910931174,0.9616135495574448,1.0,30/203,15.21%,IRGM;KDR;DAXX;SEMA4D;CD40;ANKLE2;CCND2;SOX9;CCND1;MYDGF;MT3;PPIA;LYN;LEPR;APP;INSR;TNIK;CIB1;VEGFD;FGF9;SVIP;RACK1;RAC1;DAB2;SPPL3;CEP295;RB1CC1;HSP90AA1;NPTN;CALM3
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.2810882782755928,0.7732035706759288,0.7853828306264501,0.9615728054062945,1.0,9/43,20.14%,TAOK3;CHEK1;NOP53;TRIM39;RINT1;TAOK2;BABAM2;BRSK1;ORC1
prerank,leukotriene metabolic process (GO:0006691),0.31473190525867134,0.7731003763761377,0.7523553162853297,0.9613432630594786,1.0,3/19,11.17%,PTGR1;DPEP2;ABCC1
prerank,apoptotic nuclear changes (GO:0030262),0.3052537603756632,0.7730784864033597,0.7710997442455243,0.960980838025493,1.0,6/24,20.97%,KPNB1;HMGB1;DFFA;DNASE2;DICER1;BLCAP
prerank,cellular response to interleukin-4 (GO:0071353),-0.3095311390228241,-0.7724683010203443,0.7314285714285714,1.0,1.0,6/10,33.97%,JAK3;SHPK;LEF1;STAT6;TCF7;GATA3
prerank,protein localization to cell periphery (GO:1990778),0.24827199402968148,0.7722387153634251,0.8854489164086687,0.9617957942290619,1.0,41/133,26.50%,PIGW;RAB8B;ATP1B3;ACTN2;SEC16A;RAB12;ANK1;PIP5K1A;RAPGEF6;RAPGEF2;EPB41L3;TNIK;EFR3A;SMURF1;FGF13;PTCH1;DLG1;INPP5K;RAB11A;WDR19;FLOT2;RAP2A;ZDHHC3;RAB10;ZFYVE27;C2CD5;ZDHHC22;RABEP1;RAB29;PACSIN1;FLNA;ANK2;WNK3;DPP10;DPP6;TNF;KCNB1;RAB3A;TSPAN32;LIN7C;RAB3D
prerank,chondroitin sulfate catabolic process (GO:0030207),0.3392283407827553,0.7721421282149664,0.7393162393162394,0.9615369854804232,1.0,2/13,8.38%,HYAL1;CSPG4
prerank,acetyl-CoA metabolic process (GO:0006084),0.33443712387063146,0.7721053894205582,0.7747252747252747,0.9611941447103921,1.0,1/15,1.18%,PPCS
prerank,regulation of protein kinase A signaling (GO:0010738),0.3174086706206824,0.7720458189406247,0.7670299727520435,0.9608891906885554,1.0,4/20,17.07%,PRKAR2B;AKAP12;ADGRV1;PRKAR2A
prerank,cortical cytoskeleton organization (GO:0030865),0.28124573242268286,0.7718542755584664,0.8061104582843713,0.9607977806677627,1.0,11/41,21.27%,FMNL2;RHOF;EPB41L3;TRPV4;RAC1;DLG1;LLGL1;FMNL3;NCKAP1;RND2;RHOH
prerank,purine ribonucleotide transport (GO:0015868),-0.2702525312050054,-0.7716559392828575,0.7752808988764045,1.0,1.0,5/16,21.25%,SLC25A4;SLC17A9;SLC35B2;SLC25A42;LRRC8A
prerank,fatty acid transmembrane transport (GO:1902001),0.31609611192104314,0.7716045015288441,0.7687165775401069,0.9607636275191171,1.0,2/19,9.46%,SLC27A1;ABCD1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.27826086794728777,-0.7714051750121702,0.7898089171974523,1.0,1.0,5/14,18.54%,PRKCZ;RARA;NFKBID;CD86;ANXA1
prerank,regulation of synapse assembly (GO:0051963),0.2760602404048454,0.7712753606872491,0.7992998833138857,0.9608454538193546,1.0,10/46,16.19%,BDNF;CLSTN1;APP;SETD5;SLIT1;IL1RAP;CLSTN3;CHRNB2;TLR2;NLGN3
prerank,T cell proliferation (GO:0042098),0.3447141830527608,0.7711830581978242,0.7405797101449275,0.960588886559344,1.0,1/13,1.46%,DOCK8
prerank,positive regulation of nervous system development (GO:0051962),0.27531269067263336,0.7710924391317221,0.7838150289017342,0.9603304879766281,1.0,8/42,16.19%,BDNF;CLSTN1;LRP2;SNW1;NUMBL;IL1RAP;CLSTN3;NLGN3
prerank,regulation of lysosomal lumen pH (GO:0035751),0.35379722002164216,0.7709524619373145,0.7582260371959942,0.960128981093275,1.0,2/12,6.83%,TMEM9;VPS33A
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.2508749347434268,0.7703161071259685,0.8686659772492245,0.9606646107126479,1.0,20/125,14.70%,NUP37;MECP2;SBDS;B9D2;DYNC1H1;KPNB1;KIF2C;DYNC1LI2;KIF3B;EFHC2;MAPRE1;NEK9;CENPN;SUN2;NEK6;DYNLL1;AHCTF1;MAP4;MIS12;KIF2A
prerank,positive regulation of lyase activity (GO:0051349),-0.2739761092933821,-0.7702701847349417,0.7818181818181819,1.0,1.0,2/14,6.60%,STIM1;ISCU
prerank,positive regulation of signaling receptor activity (GO:2000273),0.2857444013622465,0.7692926097148223,0.7830882352941176,0.96169363807161,1.0,7/36,18.23%,TGFA;FBXW7;NRP1;BUD31;JAK2;NLGN3;HDAC1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.3266374967939,0.7691808517341592,0.755464480874317,0.9614486511107728,1.0,7/16,26.00%,ABCD1;AK4;COX7A2;VCP;PDE12;SLC25A33;COX7A2L
prerank,heart looping (GO:0001947),0.2855360487816165,0.7691546554261545,0.8131736526946107,0.961095161162273,1.0,4/39,11.23%,CCDC40;NPHP3;SRF;SETDB2
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.30686508342262764,0.768563889386265,0.7704081632653061,0.9615534301954598,1.0,4/25,10.61%,TPI1;PFKM;HK1;FOXK1
prerank,prostanoid metabolic process (GO:0006692),-0.2797127527926779,-0.7679936833735169,0.7859531772575251,1.0,1.0,4/13,18.40%,HPGD;PTGS1;PTGES;GSTM1
prerank,cellular amino acid catabolic process (GO:0009063),0.25393335998464944,0.7677114481032915,0.8451749734888653,0.9623461180783346,1.0,16/87,18.07%,HYKK;AUH;HMGCL;ALDH7A1;DLD;AASS;BCKDK;SHMT1;GCSH;GCDH;PIPOX;GLUD1;ACAT1;HIBADH;MCCC1;GAD1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.30488544779109217,0.7676072571219298,0.7756410256410257,0.9620906913776314,1.0,6/22,20.30%,IFI35;LYN;WDFY1;ACOD1;MFHAS1;APPL2
prerank,positive regulation of cell cycle process (GO:0090068),0.25606456626478663,0.7673563134157215,0.8542976939203354,0.9620850397310348,1.0,15/91,15.54%,TGFA;CDC25B;PKN2;DYNC1H1;FEN1;XRCC3;INSR;UBXN2B;PHIP;DDX11;PRKCE;RANBP1;CEP295;GEN1;NUDT16
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.30926620058295506,-0.7673365138643704,0.7767857142857143,1.0,1.0,1/10,0.09%,DLGAP1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.32084341422974655,0.7669906479528785,0.7662162162162162,0.9622260664610403,1.0,3/18,14.94%,TRIB3;RSC1A1;INPP5K
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.3170548642939361,0.7668031648090744,0.7624161073825504,0.9620997427471579,1.0,3/18,10.49%,KDR;RHOJ;CIB1
prerank,sulfur amino acid catabolic process (GO:0000098),-0.3082355490474008,-0.7664227398343492,0.7801857585139319,1.0,1.0,6/10,35.99%,BLMH;ADO;TST;MPST;CBS;CTH
prerank,positive regulation of catabolic process (GO:0009896),0.2620753926390535,0.7661007006868642,0.8352017937219731,0.9627318734344968,1.0,26/65,29.61%,WNT5A;EGLN2;RILP;AREL1;DACT1;BARD1;SORL1;SMURF1;VPS28;TIPARP;WWP1;HUWE1;SMURF2;IDE;VCP;AXIN1;TNF;SEC22B;SNF8;VSIR;HECW2;DDB1;TRIM32;HACE1;TNFSF12;RAB7A
prerank,regulation of smooth muscle cell migration (GO:0014910),0.3142027702552861,0.7655023834358643,0.7834224598930482,0.9631922431167892,1.0,4/20,15.33%,CCL5;SORL1;NRP1;BMPR1A
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3041173726973563,0.7653803215403783,0.7685305591677504,0.9629776578763334,1.0,6/22,17.84%,NOL9;RPS21;RRS1;KRI1;EXOSC9;WDR12
prerank,regulation of lipid catabolic process (GO:0050994),-0.2475592428797829,-0.7651636335147878,0.8295454545454546,1.0,1.0,2/19,3.11%,PDE3B;ALK
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.22950572606758163,-0.7651064251883847,0.8515625,1.0,1.0,9/23,23.37%,SRCIN1;MVP;SH3BP5;SH3BP5L;CBL;ZFYVE28;DUSP22;CAV1;CHMP6
prerank,neuron projection extension (GO:1990138),0.28541010934335326,0.7647057348940336,0.7932752179327521,0.9635648768603092,1.0,8/32,19.01%,NRP2;HSP90AB1;CYFIP1;CTNNB1;NRP1;HSP90AA1;NLGN3;MAP1B
prerank,iron ion transport (GO:0006826),0.2747716653334486,0.7641493736326865,0.8037383177570093,0.9639753099376118,1.0,11/47,19.37%,ATP6V0D1;SLC11A2;RAB11B;TTYH1;DNM2;TFR2;TCIRG1;ATP6V1B2;ATP6V1G1;ABCB7;ATP6V1G2
prerank,protein lipidation (GO:0006497),0.26485369714817525,0.7639201146000043,0.8063063063063063,0.963924349647274,1.0,22/59,27.88%,PIGW;ZDHHC21;ZDHHC20;PIGV;HHAT;PGAP2;ZDHHC13;ZDHHC8;PIGQ;PIGB;PGAP3;ZDHHC3;ZDHHC18;ZDHHC22;ZDHHC17;PGAP4;ZDHHC16;PIGN;ZDHHC7;ATG12;WDR45B;PIGF
prerank,lymphocyte proliferation (GO:0046651),0.3122424160269183,0.7636784596642806,0.7632978723404256,0.9638564209585531,1.0,4/22,17.39%,CD40;ELF4;LMBR1L;PTPRC
prerank,negative regulation of TORC1 signaling (GO:1904262),0.3353139989489028,0.7635758206247067,0.7726574500768049,0.9636023276440795,1.0,4/13,26.92%,KPTN;STK11;SZT2;SESN1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.30547097144875573,-0.7635570250908872,0.7712609970674487,1.0,1.0,3/10,20.62%,DBI;ABCA7;ABCA3
prerank,calcium ion homeostasis (GO:0055074),0.2536968613661083,0.7635052879015896,0.8663157894736843,0.9633205174249115,1.0,13/95,15.79%,CCL7;CD40;SLC8A1;CCL5;SLC30A1;CHERP;TFAP2B;VAPB;CCL14;HTR2A;TRPV4;NPTN;SLC24A3
prerank,positive regulation of telomere capping (GO:1904355),-0.2596624212972621,-0.763144447776615,0.7862595419847328,1.0,1.0,4/17,12.53%,PRKCQ;MAPK3;PNKP;NABP2
prerank,plasma membrane repair (GO:0001778),-0.279031968435854,-0.7631360132927448,0.7966666666666666,1.0,1.0,3/13,9.75%,AHNAK2;MYOF;ANXA6
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.2729502236864433,-0.7629735017475856,0.7682539682539683,1.0,1.0,6/14,23.36%,TPM1;IGFBP5;TRIB1;PRKG1;MEF2C;IGFBP3
prerank,purine-containing compound salvage (GO:0043101),0.3511872434090536,0.7628546784359423,0.7686781609195402,0.9638422685612456,1.0,3/12,18.84%,DCK;HPRT1;AMPD3
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.30337883400930465,0.7627410225463085,0.792,0.9636135566416966,1.0,5/23,16.68%,KPNB1;HMGB1;DFFA;DNASE2;DICER1
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.25577975111764895,-0.7625581202277046,0.8313725490196079,0.9999729851618924,1.0,4/18,12.87%,GPR137B;MAFB;CCL3;TMEM178A
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3056043510733272,0.7624849100548294,0.7926023778071334,0.9635786277207739,1.0,5/24,13.60%,XRN1;DCP2;ERCC4;HNRNPA1;STN1
prerank,regulation of hemopoiesis (GO:1903706),0.3559475321119546,0.7620183371362291,0.7375366568914956,0.9638342104790808,1.0,2/10,11.06%,RUNX1;IL17D
prerank,regulation of protein autophosphorylation (GO:0031952),0.2764320929510975,0.7618097001381652,0.8031400966183575,0.9637273359641414,1.0,11/36,20.50%,PPP2R5C;TNKS1BP1;MOB1B;PPP2R5D;ENPP1;CALM3;TAOK2;TESK1;RAP2A;PPP2R5A;DDX3X
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.249658075599338,-0.7615316869465573,0.8225806451612904,1.0,1.0,4/19,9.98%,PNP;ADK;APRT;TYMS
prerank,positive regulation of myelination (GO:0031643),-0.29536829884745197,-0.761466304971687,0.7610062893081762,0.9985392681937849,1.0,5/11,21.85%,TPPP;RNF10;TNFRSF1B;EGR2;NCMAP
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.27860687863483863,0.7609168349394416,0.7992788461538461,0.9645639610134829,1.0,7/36,14.86%,DHFR;ZDHHC21;GCH1;DNM2;APOE;PIK3CB;HSP90AA1
prerank,inositol lipid-mediated signaling (GO:0048017),0.2699612725616932,0.7606734480247834,0.8112359550561797,0.9644960209735495,1.0,8/50,14.63%,IRS1;PIK3CD;PLCB4;ADAP2;PLCB3;PI4KB;PIK3CB;IRS2
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.35111744239298404,0.7604571057922981,0.7534039334341907,0.9644015136430987,1.0,4/11,19.78%,RAPGEF6;RAPGEF2;TJP2;RAB1A
prerank,prostaglandin metabolic process (GO:0006693),-0.22837806021366494,-0.7604564327770545,0.8773584905660378,0.9985311133651081,1.0,9/26,27.78%,HPGD;PTGDS;PTGS1;MIF;PTGES;GSTM1;HPGDS;PTGIS;PRXL2B
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.29645119167768375,0.7601524288757385,0.7861799217731421,0.9644514276485436,1.0,1/24,1.72%,KDR
prerank,positive regulation of vascular permeability (GO:0043117),-0.2795097839819343,-0.7597058010469403,0.8151815181518152,0.9980550229446309,1.0,7/12,32.02%,TGFB1;BMP6;PDE2A;FGFBP3;TJP1;OCLN;TJP3
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.3214848067774174,0.7595264325289087,0.7690217391304348,0.9649192517958844,1.0,5/17,16.35%,HCK;STAP1;NRP1;BAIAP2;BAIAP2L1
prerank,limb development (GO:0060173),0.2964029324809347,0.7594359869924875,0.803088803088803,0.9646409769075177,1.0,2/28,3.31%,COMP;CHD7
prerank,membrane repolarization (GO:0086009),-0.2664656785959557,-0.7588687284082586,0.8274647887323944,0.9978316486831482,1.0,3/15,10.51%,ATP1B1;ATP1B2;KCND3
prerank,inorganic cation transmembrane transport (GO:0098662),0.23948544593496313,0.7588344467012466,0.9386317907444668,0.965101101030309,1.0,26/268,12.83%,TRPM5;TRPM2;ATP6V0D1;CACNA2D4;UCP3;TRPM6;ATP1B3;KCNH8;SLC8A1;SLC46A1;SLC30A1;SLC30A5;ASIC4;SLC11A2;KCNS3;CACNA1A;P2RX4;KCNA4;CCDC51;TRPM3;DMAC2L;SLC30A6;KCNK3;SCN2A;MCOLN2;TRPV4
prerank,regulation of execution phase of apoptosis (GO:1900117),0.3493767542354519,0.7586255423931234,0.7837037037037037,0.9650089558953772,1.0,5/11,28.08%,ZC3H12A;DFFA;SIRT2;BCL2L1;FZD3
prerank,negative regulation of cholesterol transport (GO:0032375),0.3578185154942134,0.7585922114862718,0.760061919504644,0.9646657920436719,1.0,1/10,6.29%,NFKB1
prerank,chemical synaptic transmission (GO:0007268),0.23926573988189084,0.7584993395647971,0.9479479479479479,0.9644186339734128,1.0,46/284,19.24%,CHRNA9;PDE7B;PMP22;PCDHB13;GRIN2D;GRIK3;SLC18A2;CRHBP;UTS2;SLC12A5;CPLX1;GRIA2;PTCHD1;PRKAR2B;CACNA1A;MYCBPAP;HSPA8;GLRA2;RAPSN;GABBR2;KCNK3;HTR2A;PCDHB16;APOE;AKAP9;HTR1F;VAMP2;NAPB;BSN;NAPA;DLG1;MINK1;CHRNB2;GRID1;HCRTR1;NLGN3;GRIA4;STAC3;MPZ;PRKAR2A;SLC32A1;GAD1;PAFAH1B1;BRSK1;GABRG1;CAMKK2
prerank,regulation of plasminogen activation (GO:0010755),0.3473055353779126,0.7582711333233093,0.7896995708154506,0.9643401410078949,1.0,1/12,3.81%,RUNX1
prerank,regulation of cilium assembly (GO:1902017),0.2607219438165476,0.7579265030538678,0.8404371584699454,0.964434933574143,1.0,21/62,25.79%,TBC1D1;KCTD17;RABEP2;TBC1D8;CYLD;CCDC88A;CDK10;ODF2L;DYNC2LI1;DYNLT2B;TBC1D2;DCDC2;TESK1;SGSM3;ENTR1;IFT140;TBC1D2B;BBS4;EVI5L;TBC1D20;TBC1D17
prerank,regulation of actin filament-based movement (GO:1903115),0.35272273017291367,0.7573531293031468,0.7727930535455861,0.9648281491309861,1.0,3/10,24.63%,PDPN;PDE4B;ANK2
prerank,determination of heart left/right asymmetry (GO:0061371),0.27662370280525295,0.7568873537828917,0.8278688524590164,0.9650857152716423,1.0,4/42,11.23%,CCDC40;NPHP3;SRF;SETDB2
prerank,cell-cell junction assembly (GO:0007043),0.2597582887887673,0.7564037933856169,0.8523862375138734,0.9653844224989241,1.0,12/63,17.34%,CNTNAP1;PKN2;CTNNB1;CDH9;EPB41L3;TRPV4;PIP5K1C;ACTB;CTNND2;TBCD;JAM3;CLDN11
prerank,positive regulation of histone acetylation (GO:0035066),0.30329116108122034,0.7563540643526182,0.7891332470892626,0.9650661443414267,1.0,8/23,22.34%,TADA2A;TADA2B;SPHK2;PPARGC1A;PAXIP1;BRD7;KAT7;RUVBL2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.24370695355410638,-0.7563042777890946,0.8200836820083682,1.0,1.0,6/20,14.35%,ARRB1;DIP2B;GLYR1;MAPK3;BRCA1;RPS6KA4
prerank,peptidyl-proline hydroxylation (GO:0019511),0.3515108209388864,0.756136980016935,0.7548872180451128,0.9649871797613805,1.0,2/11,4.13%,P4HA1;EGLN2
prerank,cellular response to hexose stimulus (GO:0071331),-0.23270528605122798,-0.755708883759568,0.8571428571428571,0.9996227305340577,1.0,7/23,21.21%,SLC39A14;SLC2A5;PCK2;IGF1R;PDK3;SLC26A6;SOX4
prerank,actomyosin structure organization (GO:0031032),0.25765572234318507,0.7553256468955086,0.8502732240437159,0.9656949346502108,1.0,8/75,12.77%,MYOZ2;CSRP1;ACTN2;TNFAIP1;FRMD6;EPB41L3;TMOD3;EPB41L5
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.30927990976088954,0.7551762117560558,0.7831978319783198,0.9655240021380499,1.0,4/18,16.50%,RUFY3;KANK1;RACK1;LLGL1
prerank,tetrapyrrole metabolic process (GO:0033013),0.3167165493732514,0.7550588132126972,0.7694369973190348,0.9653023264464347,1.0,7/18,28.02%,AMN;ABCC1;ABCD4;MMUT;MMAB;LMBRD1;CD320
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.3350631355352215,0.7549952220392067,0.7859195402298851,0.9650171533421147,1.0,1/14,2.63%,CD40
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3047040154391784,0.7549187849429358,0.7747395833333334,0.9647454176881507,1.0,9/22,24.62%,AEBP1;HSPA8;APOE;AKAP13;CAMSAP2;MAP1B;GBA2;MAPRE3;PIK3CA
prerank,smoothened signaling pathway (GO:0007224),-0.21435257290554072,-0.7547075352221928,0.8755980861244019,0.9996221078352268,1.0,15/32,26.60%,PKD2L1;ULK3;HIPK1;TTBK2;TCTN2;GPC2;DISP3;HIPK2;EVC2;TCTN3;TMEM231;TMEM17;STIL;GLI2;MAP3K10
prerank,cristae formation (GO:0042407),0.2921405176522612,0.7545627366063805,0.8090452261306532,0.9648684439833961,1.0,5/27,14.76%,ATP5MC1;CHCHD6;DMAC2L;SAMM50;ATP5PO
prerank,negative regulation of insulin secretion (GO:0046676),0.3196681068123206,0.7535880731001777,0.7816411682892906,0.9657697491972081,1.0,5/17,25.44%,IRS1;MIDN;PSMD9;PIM3;KCNB1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.2045521534031381,-0.7529835193257557,0.9096045197740112,1.0,1.0,12/34,22.09%,TICAM2;IRAK3;DAB2IP;TREM2;CACTIN;OTUD4;SMPDL3B;TYRO3;CD14;LRRC14;NLRP2B;TNFAIP3
prerank,actin filament-based transport (GO:0099515),0.3125332960221966,0.7524132333141517,0.789261744966443,0.9669913994203498,1.0,4/21,13.68%,MYO1C;FNBP1L;SUN2;MYO6
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.32358387198594474,0.7518338809596271,0.7714285714285715,0.9673783661790563,1.0,6/16,22.59%,NCBP2;SART1;DDX23;DCPS;PRPF39;WBP4
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.26933325761087484,0.7515347633065896,0.805045871559633,0.9673962766005035,1.0,12/45,23.82%,BRINP3;CHEK1;CTNNB1;BCL6;ZFP36L1;GAS1;AURKAIP1;ZWILCH;WEE1;TOM1L2;ZFP36L2;ZWINT
prerank,arachidonic acid metabolic process (GO:0019369),-0.20851393547093644,-0.7514230335320313,0.9080459770114943,1.0,1.0,14/35,30.34%,PTGDS;PTGS1;MGLL;CYP2A6;FAAH;PTGES;CBR1;GPX1;HPGDS;EPHX1;PTGIS;PLA2G4C;CYP1A1;ALOXE3
prerank,axonemal dynein complex assembly (GO:0070286),0.29030223559103013,0.7513386993365345,0.8015267175572519,0.9672755976455478,1.0,5/27,16.33%,ODAD2;CCDC40;ODAD4;CFAP73;DNAL1
prerank,negative regulation of platelet activation (GO:0010544),-0.2586792779499641,-0.7513302530901609,0.835016835016835,1.0,1.0,5/16,24.09%,CEACAM1;CD9;PRKG1;THBD;PDGFRA
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.28589051323992093,0.7512216727905922,0.8085889570552147,0.967044837284228,1.0,6/31,16.77%,LRP2;TNNC1;FGFR2;PROX1;BMPR1A;RBPJ
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.2970810711469856,0.7511351930813983,0.7904269081500647,0.9667651790228776,1.0,3/26,9.98%,SLC18A2;ABCD1;SPHK2
prerank,microtubule bundle formation (GO:0001578),-0.20312312647284758,-0.7508079663379994,0.9044117647058824,0.9992377590309338,1.0,7/42,9.41%,TTLL3;CLIP1;TPPP;NCKAP5L;MARK4;AAAS;MTCL1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.3359086103990504,0.7502985689624634,0.7700831024930748,0.9674960962354824,1.0,6/13,26.02%,SEC16A;SORL1;BCAP31;TM9SF4;EDEM2;EDEM1
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.24747962911198837,-0.7498534861055565,0.8254545454545454,0.9991968809186155,1.0,6/17,21.20%,CEACAM1;CEBPB;CD24;KLF7;MAFF;CAV1
prerank,response to ATP (GO:0033198),0.310908606494283,0.7498226920536343,0.8035961272475796,0.9677571422433989,1.0,4/18,22.40%,PDXP;P2RX4;HSP90B1;ABCC9
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.2791609539037002,-0.7490508242490553,0.8035714285714286,0.9988237677599283,1.0,6/13,41.68%,SCN3B;GJC1;KCNQ1;CACNA1C;CACNB2;KCNJ5
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.27462871602736966,-0.7489423239200336,0.8207547169811321,0.9974607717301656,1.0,2/13,9.13%,NIBAN2;DAB2IP
prerank,mRNA modification (GO:0016556),0.3031595121050347,0.7483339588432694,0.7997382198952879,0.9693511629499588,1.0,7/22,19.33%,TRMT61B;TRMT10C;ZC3H13;PUS7;METTL14;CBLL1;WTAP
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.2483246513169022,0.7481911697705326,0.8569915254237288,0.9691578850979166,1.0,8/90,8.84%,CXCR4;PER2;GADD45G;GRB10;DYNC1H1;ACADL;SIRT6;LEPR
prerank,heart development (GO:0007507),-0.15639788109277775,-0.7479835536391668,1.0,0.9973233998815755,1.0,17/150,10.46%,PDLIM5;TGFB1;CASP8;SGCD;NTRK3;TGFBR3;NIPBL;ZFPM2;SALL1;CACYBP;ID2;TGFB2;TSC2;LDB3;SMYD4;PDLIM1;KDM6B
prerank,negative regulation of microtubule polymerization (GO:0031115),0.3432784019642741,0.7474958948457381,0.7787610619469026,0.9696903602464731,1.0,4/12,16.95%,ARHGEF7;MAPRE1;TBCD;STMN2
prerank,neuron migration (GO:0001764),0.26639315844269146,0.7474243594120001,0.826530612244898,0.9694015605987242,1.0,14/48,19.80%,TUBB2B;RAPGEF2;DDIT4;FGF13;NRP1;RAC1;DNER;LRP12;PEX13;DCDC2;PAFAH1B1;MARK1;MAP1B;CCK
prerank,autophagosome organization (GO:1905037),0.2619560364214107,0.7472980024778054,0.8246606334841629,0.9691814334051726,1.0,7/50,14.55%,IRGM;UBQLN2;RAB43;UBXN2B;UBQLN1;MAP1LC3B;RB1CC1
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.27253862020161873,0.7471880045858629,0.8266978922716628,0.9689495474584588,1.0,5/39,11.62%,MAD2L2;PODXL;PPM1F;NOTCH4;FXYD5
prerank,aerobic electron transport chain (GO:0019646),0.2517112279705619,0.7471639316423256,0.8471615720524017,0.9685981636259453,1.0,15/68,20.26%,UQCRQ;NDUFA5;NDUFB9;NDUFB11;NDUFS1;UQCR10;AFG1L;CYC1;NDUFB5;NDUFS4;NDUFA10;NDUFB6;NDUFS8;NDUFS7;SDHD
prerank,digestive tract morphogenesis (GO:0048546),-0.26713813984999446,-0.7470235567902532,0.8074324324324325,0.9971789291294293,1.0,2/14,7.16%,NIPBL;ID2
prerank,methylguanosine-cap decapping (GO:0110156),-0.29536133056522595,-0.7468122355601867,0.7926136363636364,0.9959868494993245,1.0,2/10,6.15%,PATL1;DCP1A
prerank,icosanoid secretion (GO:0032309),-0.2809674965845867,-0.7462524818673074,0.8145454545454546,0.9953081375058391,1.0,7/12,40.65%,ANXA1;DRD2;NMUR2;BDKRB2;PLA2G5;DRD3;ACE
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.3187271229616924,0.7462050894768757,0.7594405594405594,0.9695149411383595,1.0,6/15,25.43%,NSMAF;SPHK2;RACK1;PLA2G6;PRKCD;TNF
prerank,cellular response to increased oxygen levels (GO:0036295),0.34301375177883764,0.7459506885122058,0.7757847533632287,0.9694707232638077,1.0,1/11,2.09%,ATP6V0D1
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.23717837143236342,-0.7455193882799791,0.8414096916299559,0.9948111236294594,1.0,5/20,16.42%,ST3GAL6;ST3GAL3;B3GALT5;B3GALT2;FUT8
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.287692790219293,0.7451989687040533,0.8199481865284974,0.9700802348442343,1.0,11/27,27.19%,FBXO7;EFHC2;CCDC88A;PSEN1;FCGR2B;MARK1;BRSK1;VPS35;NTNG2;PTEN;ULK4
prerank,acylglycerol metabolic process (GO:0006639),0.277349054900858,0.7448646829668205,0.815035799522673,0.9701457931311724,1.0,9/37,20.00%,PNPLA2;ABHD2;DGKB;DGKK;LYPLA2;APOE;DGKA;DGKI;PNPLA3
prerank,positive regulation of phospholipase C activity (GO:0010863),0.2717118132755852,0.7447868289463861,0.8143712574850299,0.9698668534119065,1.0,3/40,5.54%,FLT1;BDNF;GNA15
prerank,mRNA methylation (GO:0080009),0.3226094798961694,0.7441729110579631,0.7901234567901234,0.970291431169436,1.0,6/15,19.33%,TRMT61B;TRMT10C;ZC3H13;METTL14;CBLL1;WTAP
prerank,protein localization to chromosome (GO:0034502),0.2779721729041807,0.7441514928259468,0.8162762022194822,0.969937713034391,1.0,6/34,12.74%,MSH2;HASPIN;MCM9;SLF2;CTCF;RB1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.31532949934290033,0.7439954816605299,0.7838214783821479,0.969762635005147,1.0,2/17,4.37%,S1PR2;ZDHHC21
prerank,regulation of RNA splicing (GO:0043484),0.25429767113027757,0.7439372657620695,0.8656554712892741,0.9694565524861646,1.0,27/69,29.52%,FASTK;SLC38A2;HNRNPH1;HNRNPK;CLK3;SRPK1;HNRNPL;HNRNPH3;CLK2;MBNL2;RBM39;RRP1B;CWC22;HNRNPF;ERN1;SRSF10;TRA2B;SON;ZNF326;FUS;SNRNP70;SRPK2;KHDRBS2;SETX;PIK3R1;KHDRBS1;QKI
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3112047311926138,0.74324745229423,0.7833333333333333,0.9699681483056001,1.0,7/17,29.95%,DHDDS;ALG13;DPAGT1;DOLPP1;ALG12;ALG9;ALG14
prerank,copper ion transport (GO:0006825),0.3460691886598246,0.7421835494077802,0.7973568281938326,0.9709967676429995,1.0,5/11,25.59%,SLC11A2;SLC31A1;SLC31A2;COX17;ATP7B
prerank,actin filament polymerization (GO:0030041),0.2834484952429806,0.7420724340495795,0.816953316953317,0.9707610011252946,1.0,12/29,27.78%,GAS7;CORO7;GSN;RAC1;JAK2;AIF1;TTC17;MSRB1;ANG;DIAPH1;WASHC5;WASF1
prerank,regulation of peptidase activity (GO:0052547),0.3066881492752953,0.7417539767782535,0.8045822102425876,0.9708169606309972,1.0,5/19,18.40%,PSMA3;CTSH;CST7;HDAC1;SVBP
prerank,phosphate ion transmembrane transport (GO:0035435),0.3381017163502899,0.741133986211066,0.7925311203319502,0.9712607844088165,1.0,5/12,22.93%,SLC25A10;SLC37A2;SLC20A2;SLC37A1;SLC25A30
prerank,tRNA processing (GO:0008033),0.2545098727650836,0.7411036582092476,0.844542447629548,0.9709149132062841,1.0,13/61,17.83%,TRMT9B;TRPT1;ADAT2;TRMT1;AARS1;TSEN2;FAM98B;WDR4;TRMT10C;ADAT1;RTCB;RPP30;TSEN34
prerank,GPI anchor metabolic process (GO:0006505),0.28582143700015605,0.7410655154942349,0.7929292929292929,0.9705835380972809,1.0,6/26,19.27%,PIGW;PIGV;PGAP2;PIGQ;PIGB;PGAP3
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.20867929913555844,-0.7408092021107342,0.9148936170212766,1.0,1.0,7/32,16.10%,SORBS1;ASAH1;C3;AKT1;CEACAM1;CREB1;CREBL2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.24907612680060864,0.7403458074608056,0.8521358159912377,0.9711517358175636,1.0,12/72,13.89%,XRN2;POLD4;CHD1L;RFC4;RFC1;FEN1;ERCC4;RBX1;POLK;ZC3H12A;ENPP1;RNASE1
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.22505120787193306,-0.7402501935038077,0.856,0.9993792831787465,1.0,6/22,23.75%,SLC16A2;ID2;KDM1A;PTPRZ1;DISP3;SHCBP1
prerank,positive regulation of exocytosis (GO:0045921),0.2755554818713765,0.7399758155091076,0.8284671532846716,0.9712330937238336,1.0,13/35,28.07%,SDC4;UNC13D;CADPS2;RAB2B;HGS;CADPS;TSG101;CFTR;RAB3A;SNF8;RAB3D;SDCBP;PDCD6IP
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.28177449658768566,-0.7399509511727038,0.802547770700637,0.9982659169198637,1.0,2/11,5.87%,REST;PINK1
prerank,hydrogen peroxide metabolic process (GO:0042743),0.30630014495400676,0.7398897374765561,0.8102094240837696,0.9709596023062265,1.0,5/19,24.04%,PXDNL;PRDX2;ACOX1;PRDX3;CYBA
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.2512136830482797,-0.7395174301587337,0.8283582089552238,0.9973939793817868,1.0,4/16,16.24%,DPYSL3;NT5M;CRMP1;NT5E
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.23860068952636687,-0.7393577733524634,0.850909090909091,0.9961042435479635,1.0,6/18,20.41%,NCKAP1L;METTL3;CCR2;IKZF3;IL4I1;ABL1
prerank,V(D)J recombination (GO:0033151),-0.28445241171778163,-0.7392735799493856,0.809375,0.9947382954428575,1.0,3/11,12.66%,XRCC4;DCAF1;LIG1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.3156322423708875,0.7392222675992871,0.7861035422343324,0.9714575526528703,1.0,2/16,7.43%,ST6GALNAC4;ST6GALNAC6
prerank,regulation of keratinocyte differentiation (GO:0045616),0.2927018692717204,0.7387920941046907,0.8250950570342205,0.9716226879297376,1.0,5/24,18.92%,ZFP36;RUNX1;ZFP36L1;PRKCH;NUMA1
prerank,mammary gland development (GO:0030879),0.30215700518270766,0.7383626914796507,0.8,0.9717959713634855,1.0,3/21,14.27%,WNT7B;NOTCH4;JAK2
prerank,negative regulation of protein modification process (GO:0031400),0.24470656640490374,0.7377120532968662,0.8976293103448276,0.97228118678419,1.0,13/79,13.09%,XDH;TARDBP;ARPP19;P3H1;PPIA;PAQR3;LYN;PRNP;MEN1;CIB1;ZC3H12A;PRKDC;CDYL
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.28817613900769423,0.737059832231456,0.8318804483188045,0.972778231634496,1.0,4/28,12.34%,YTHDF1;EPHA4;APP;APOE
prerank,positive regulation of immunoglobulin production (GO:0002639),0.2730679660801958,0.7368095868842409,0.8444444444444444,0.9727150222629751,1.0,8/31,22.69%,MAD2L2;XBP1;SHLD1;PAXIP1;STX4;PTPRC;HMCES;KMT5C
prerank,acute inflammatory response (GO:0002526),-0.22456724185528062,-0.7354968764054384,0.8925233644859814,0.998345728603151,1.0,10/23,48.56%,PLSCR1;CEBPB;ANO6;LBP;HPR;HP;SIGIRR;CRP;VNN1;CD6
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.26430869064844653,-0.7353956420045523,0.8430034129692833,0.996976081182528,1.0,2/15,10.51%,ATP1B1;KCND3
prerank,pharyngeal system development (GO:0060037),0.31818236236712505,0.7353929103556894,0.7917241379310345,0.9741757344623331,1.0,3/15,15.33%,BMPR2;PTCH1;BMPR1A
prerank,female gamete generation (GO:0007292),0.2813289498140501,0.7350486993711224,0.813200498132005,0.974241851797924,1.0,6/29,22.76%,GDF9;MCM9;MARF1;MDK;MEI4;KMT2D
prerank,chloride transport (GO:0006821),0.24807012943902254,0.7348757098524299,0.8582417582417582,0.9740900547530438,1.0,18/74,23.23%,CLIC4;SLC26A1;SLC12A5;CLCN2;CLCN6;SLC12A8;TTYH1;GLRA2;ANO10;ANO5;CLCN1;GABRG1;GLRA1;GABRB2;SLC1A3;CLIC1;GABRA3;SLC26A7
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.24682602541375034,0.7343663473662589,0.8621064060803475,0.9743833656005673,1.0,15/69,20.26%,UQCRQ;NDUFA5;NDUFB9;NDUFB11;NDUFS1;UQCR10;AFG1L;CYC1;NDUFB5;NDUFS4;NDUFA10;NDUFB6;NDUFS8;NDUFS7;SDHD
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.29140796693002424,-0.734365171452013,0.7959770114942529,0.996842118530003,1.0,4/10,24.21%,NIPSNAP2;CACNA2D1;SRI;NOS1AP
prerank,cardiocyte differentiation (GO:0035051),-0.2962482666882677,-0.7337780188917463,0.7852564102564102,0.9961438276105893,1.0,4/10,19.31%,TGFB2;KDM6B;EEF1AKMT4-ECE2;CBY1
prerank,establishment of vesicle localization (GO:0051650),0.30644986828198684,0.733569433238257,0.8160762942779292,0.9750595693773819,1.0,7/18,27.46%,SYNJ1;DNM2;RAB11A;TESK1;CCDC186;SYT11;CDK5
prerank,regulation of embryonic development (GO:0045995),0.2801982133096406,0.7333857204298766,0.8333333333333334,0.9749143081037276,1.0,6/34,11.26%,DHX36;NPHP3;B4GALT5;INSR;RAB14;PHLDB1
prerank,positive regulation of protein maturation (GO:1903319),0.3387167175169027,0.7329482875077239,0.8044444444444444,0.9750977991300536,1.0,2/11,14.72%,ADAM8;TFR2
prerank,UV protection (GO:0009650),-0.2829773926932671,-0.7328820781771654,0.8258258258258259,0.9957803634354828,1.0,7/10,38.41%,ERCC2;CAT;XPA;GPX1;SCARA3;ERCC5;MFAP4
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.2567662189988615,0.7326022901878964,0.8473019517795637,0.975146131761596,1.0,11/52,13.10%,FBXW7;SH3GLB1;VPS11;CSNK2A2;TFDP1;RNF31;LEPROT;TFDP2;NPEPPS;UBE2L3;BAD
prerank,mitochondrion disassembly (GO:0061726),0.2716099479436028,0.7323926896385035,0.8259303721488596,0.9750402401136616,1.0,7/34,20.07%,FIS1;FBXO7;CISD2;MAP1LC3B;RB1CC1;BECN1;FUNDC1
prerank,protein dephosphorylation (GO:0006470),0.23630983005304532,0.7323741720958943,0.9091847265221878,0.9746791226869101,1.0,45/135,26.63%,EYA4;PTPN18;DUSP3;PPP2R5C;PDXP;SBF1;DUSP29;TIMM50;RPAP2;NCK1;PTPN7;BTRC;DUSP26;PPM1F;PPP2R5D;PTPN11;PPP4R2;DUSP10;DUSP16;DUSP11;PTPN9;PTPRU;PPP2R2A;EYA2;PTPRC;DUSP8;PTPRB;PTPRF;PPTC7;PPP2R5A;LHPP;STK11;PPP2R3A;PTPRM;PPP1R12A;PTPN6;PTPRS;PPM1H;PDP1;EYA3;PTPN1;PPM1A;DUSP7;PTEN;EYA1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.3147324732217132,0.7319954508550738,0.7910447761194029,0.9747695089056436,1.0,4/14,19.78%,SEC24D;SEC23A;SEC24A;RAB1A
prerank,eye photoreceptor cell development (GO:0042462),0.3159847023486895,0.7316562493909924,0.8011126564673157,0.9748057461346781,1.0,1/15,3.55%,THY1
prerank,cellular response to amino acid stimulus (GO:0071230),0.27167602696066495,0.7312464666768657,0.8437118437118437,0.9749328341487693,1.0,11/33,23.90%,RRAGC;GLRA2;XBP1;LAMTOR3;FYN;MTOR;LAMTOR4;GLRA1;RRAGA;UBR2;UBR1
prerank,actin filament depolymerization (GO:0030042),-0.28094473766687894,-0.7312370310672107,0.8131147540983606,0.9964235224148951,1.0,2/11,5.14%,CFL1;MICAL1
prerank,cellular response to acid chemical (GO:0071229),0.2824247267883044,0.7310044574351048,0.8280657395701644,0.9748616899993964,1.0,8/27,22.24%,RRAGC;GLRA2;XBP1;LAMTOR3;MTOR;LAMTOR4;GLRA1;RRAGA
prerank,regulation of dephosphorylation (GO:0035303),0.32137564047768236,0.7302125967258836,0.810126582278481,0.9754560063469874,1.0,4/15,14.94%,SMG7;IGBP1;SMG5;INPP5K
prerank,membrane depolarization during action potential (GO:0086010),0.28202800979199344,0.7291423732306858,0.800747198007472,0.9764059083015141,1.0,6/26,21.71%,SLC8A1;SCN2A;SCN1B;KCNJ2;SCN8A;HCN2
prerank,negative regulation of cell cycle process (GO:0010948),0.25084239253194773,0.7288859738752567,0.8549450549450549,0.976348744703483,1.0,11/61,14.82%,PCGF6;CHEK1;TFDP1;PPP1R10;RING1;MAX;RYBP;TFDP2;UXT;AURKAIP1;EZH2
prerank,acyl-CoA metabolic process (GO:0006637),0.2684261912388044,0.7286035537418837,0.8439450686641697,0.9763213383894943,1.0,3/35,6.64%,ACOT9;MCEE;ACBD6
prerank,regulation of cell motility (GO:2000145),0.23508579019253778,0.7285047480379718,0.9086188992731049,0.9760649413646286,1.0,27/121,22.52%,DAPK3;PLXNA3;SGK3;PLXNB2;SPATA13;PKN2;PLXNB3;OSGIN1;TBCCD1;FGF9;LDB2;LDB1;RAC1;CFAP20;KIF2A;AMOTL2;MINK1;CRK;MEMO1;CAVIN1;PIN1;ARHGAP18;DOCK10;CCDC25;ABL2;FGF2;ERBB3
prerank,carboxylic acid catabolic process (GO:0046395),-0.2737280570926882,-0.7284813892921228,0.8349514563106796,0.998551732612002,1.0,6/12,29.76%,GNPDA1;NPL;IL4I1;ACOT8;GNPDA2;NAGK
prerank,mitochondrial fusion (GO:0008053),0.309408304394363,0.7284214811564937,0.7801899592944369,0.9757845232745734,1.0,4/18,17.12%,FIS1;GDAP1;MIGA2;BAX
prerank,histone H4 acetylation (GO:0043967),0.25521041585296644,0.7283656263552307,0.8348623853211009,0.9754773786262364,1.0,22/47,31.29%,JADE3;KMT2A;EP400;WDR5;APBB1;KAT8;KAT7;PER1;RUVBL2;ING5;JADE2;ACTL6A;ZZZ3;RUVBL1;EP300;BRD8;CHD5;YEATS4;HCFC1;MORF4L1;JADE1;OGT
prerank,regulation of chromatin organization (GO:1902275),0.3141409911664427,0.7281328848184523,0.8002812939521801,0.9753976563440334,1.0,5/14,21.62%,SSRP1;SETD5;MLLT3;TLK2;CDK9
prerank,vasoconstriction (GO:0042310),0.33608244276675026,0.7268244922760475,0.7979197622585439,0.9766489621156882,1.0,1/11,3.74%,SLC8A1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.24154821475644236,0.7266812545396241,0.8918067226890757,0.9764506626254245,1.0,22/87,22.85%,BST2;DAPK3;TRPM2;RHOF;PAK3;CCDC88A;CDK10;RAC1;CRK;TAOK2;SH3BP1;BAIAP2;MTOR;MDK;TESK1;ARHGAP18;RND2;RHOH;PRKCD;ABL2;IQGAP2;TWF1
prerank,negative regulation of catabolic process (GO:0009895),0.2569515039146754,0.7260907119411341,0.8646441073512252,0.9767777060170922,1.0,18/47,27.38%,AZIN2;MAD2L2;RILP;AGAP2;GIT1;AZIN1;PIN1;HMGCR;TIGAR;HDAC4;SNX12;BSCL2;FLNA;SIRT2;TNF;FMN2;ZDHHC7;MAD2L1
prerank,hemidesmosome assembly (GO:0031581),0.33408359129730575,0.7257590274411712,0.8069381598793364,0.9768125773600104,1.0,1/11,3.79%,LAMC1
prerank,signal release from synapse (GO:0099643),0.26385236883592444,0.7254625817060353,0.845422116527943,0.976786645175186,1.0,17/43,27.69%,CPLX1;HSPA8;PIP5K1C;VAMP2;SLC32A1;GAD1;BRSK1;STXBP3;PCLO;SYN1;GRM4;RAB3A;DNAJC5;LIN7C;SNPH;CDK5;CPLX2
prerank,transferrin transport (GO:0033572),0.27152893010793167,0.7253509398462569,0.8375,0.9765578339628517,1.0,8/33,19.37%,ATP6V0D1;RAB11B;DNM2;TFR2;TCIRG1;ATP6V1B2;ATP6V1G1;ATP6V1G2
prerank,regulation of hippo signaling (GO:0035330),-0.24053768857555974,-0.725310323397346,0.8372093023255814,1.0,1.0,3/17,7.68%,SCHIP1;WTIP;CIT
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.26906775143395123,-0.725064735751644,0.864406779661017,1.0,1.0,4/13,19.81%,NT5M;OGG1;NEIL1;DUT
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.23320771539602414,-0.7247514595242742,0.8816326530612245,0.9989142072945855,1.0,6/20,17.09%,GCLM;GSS;PLOD2;PLSCR1;HAGH;GGCT
prerank,visual system development (GO:0150063),-0.19564342619169972,-0.7246560253014748,0.9084967320261438,0.9975357403075702,1.0,14/37,29.53%,PBX2;C3;TGFB2;MEIS2;HIPK1;BMPR1B;HIPK2;SMG9;FOXC1;SALL2;FREM2;MAB21L2;RAB18;MEIS1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.26833173472923116,0.7242242626520679,0.8569696969696969,0.9775644197582394,1.0,7/35,17.01%,SLC25A1;HMGCL;SCD5;GGT7;PAM;GCDH;ACAT1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.23873041013818577,-0.7241689212918773,0.8702928870292888,0.9966815121277464,1.0,3/20,8.41%,TGFBR3;PDCD4;TGFB2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.25814318723565577,0.7234931106701561,0.8374851720047449,0.9780795200832993,1.0,7/45,13.97%,PNPT1;SLC38A2;DDX5;NFKB1;DIMT1;MAP2K2;WDR43
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.3139033789454999,0.7228537728003503,0.7962962962962963,0.9785074768157344,1.0,7/15,27.14%,CCT4;CCT7;CCT3;RUVBL2;NHP2;RUVBL1;TCP1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.27419444175696095,-0.722676885929214,0.8248407643312102,0.9956270828560213,1.0,6/12,31.48%,RCC2;DMTN;ITGB1BP1;AP1AR;FBLN1;SPRY4
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.27419444175696095,-0.722676885929214,0.8248407643312102,0.9956270828560213,1.0,6/12,31.48%,RCC2;DMTN;ITGB1BP1;AP1AR;FBLN1;SPRY4
prerank,positive regulation of hemostasis (GO:1900048),-0.29238738241254103,-0.7226334093125408,0.8068535825545171,0.9927480472025573,1.0,4/10,28.22%,DMTN;ENPP4;F2R;ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),-0.29238738241254103,-0.7226334093125408,0.8068535825545171,0.9927480472025573,1.0,4/10,28.22%,DMTN;ENPP4;F2R;ST3GAL4
prerank,heart contraction (GO:0060047),-0.19461207326974816,-0.7225341746011861,0.9657534246575342,0.9914226296848878,1.0,6/41,13.22%,SGCD;ATP1B1;DMD;TPM1;GRK2;SCN3B
prerank,regulation of cell size (GO:0008361),0.2918549896309962,0.7220470614305573,0.8484455958549223,0.9791205782147875,1.0,7/23,23.04%,RARG;VAV1;AKT1S1;RAC1;MTOR;LAMTOR4;MSN
prerank,peptidyl-threonine modification (GO:0018210),0.2475945970647854,0.7217475242026166,0.8758389261744967,0.9790973112482645,1.0,12/66,16.64%,CAMK2D;ACVR1;CHEK1;CSNK2B;CSNK2A2;GALNTL6;CDK10;DYRK2;PRKDC;GALNT1;OXSR1;STK39
prerank,ovarian follicle development (GO:0001541),0.3217091933061441,0.7217392517778441,0.8065902578796562,0.9787278751065427,1.0,4/13,27.56%,EIF2B2;EIF2B5;ANG;EIF2B4
prerank,anterograde trans-synaptic signaling (GO:0098916),0.22936733288381772,0.721614196069441,0.9477911646586346,0.9785008745282282,1.0,34/224,19.24%,CHRNA9;PDE7B;PMP22;PCDHB13;SLC18A2;UTS2;SLC12A5;CPLX1;GRIA2;PTCHD1;PRKAR2B;CACNA1A;MYCBPAP;GLRA2;RAPSN;GABBR2;KCNK3;HTR2A;PCDHB16;AKAP9;HTR1F;BSN;DLG1;MINK1;CHRNB2;HCRTR1;NLGN3;GRIA4;MPZ;PRKAR2A;GAD1;PAFAH1B1;GABRG1;CAMKK2
prerank,glucan catabolic process (GO:0009251),-0.2501134094046235,-0.7211452181982787,0.863013698630137,0.9917258051557708,1.0,2/15,4.69%,PYGB;PGM2
prerank,serine family amino acid biosynthetic process (GO:0009070),0.3238910946499458,0.7210215482605589,0.8072992700729927,0.9788373819388025,1.0,2/12,8.12%,PHGDH;SEPHS1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.23860275023059352,0.7210194604423108,0.8983050847457628,0.9784626531713752,1.0,22/94,18.82%,B9D2;CEP162;DYNC1H1;ACTR1A;MAPRE1;CDK5RAP2;PRKAR2B;MKS1;NEDD1;CEP131;CEP152;CEP70;AKAP9;DYNLL1;HSP90AA1;TMEM67;TUBB4B;RAB11A;CEP89;DCTN3;PAFAH1B1;CEP135
prerank,peptidyl-lysine methylation (GO:0018022),0.28313168775762526,0.7209639939775175,0.8236040609137056,0.9781595943827359,1.0,7/26,20.88%,METTL21A;SETD3;EEF2KMT;SMYD1;ATPSCKMT;SMYD2;SETD7
prerank,regulation of muscle cell differentiation (GO:0051147),0.2718322569798511,0.7207897596747616,0.8486352357320099,0.9779905563809616,1.0,7/31,15.90%,CTNNB1;FGFR2;SRF;MEGF10;MAPK14;SPAG9;MEF2A
prerank,regulation of gluconeogenesis (GO:0006111),0.2788383416083913,0.7206813751140365,0.8418430884184309,0.9777518740099366,1.0,4/27,13.42%,ARPP19;SIK1;PPARGC1A;CLK2
prerank,regulation of cellular amide metabolic process (GO:0034248),0.27289797055986387,0.7197629934591901,0.8429447852760736,0.9784782221839979,1.0,6/32,10.70%,TCOF1;CYFIP1;NOLC1;APP;TMED10;PUM3
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.3220356258316625,0.71952880441994,0.8129395218002813,0.9783766538705041,1.0,3/13,23.22%,SFRP2;RBPJ;NOTCH1
prerank,cellular glucose homeostasis (GO:0001678),-0.19057278672919248,-0.7195215585199136,0.9393939393939394,0.99225161094098,1.0,11/41,21.25%,FOXK2;SLC39A14;SIRT1;PIK3R2;FOXO1;PCK2;IGF1R;PDK3;HIF1A;SOX4;LRRC8A
prerank,muscle contraction (GO:0006936),0.2336804876670846,0.7189714457488726,0.9282051282051282,0.9786991366403095,1.0,15/126,17.58%,ASPH;UTRN;MYL9;SLC8A1;ACTN2;UTS2;TNNC1;MYL1;ARHGEF11;TMOD3;MYH2;CHRNB2;SSPN;TNNI2;CLCN1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.34437736099348326,0.7189442778459679,0.8094512195121951,0.978354500016225,1.0,2/10,15.21%,GPR35;CALM3
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.22945910465715214,-0.7185563165095472,0.9041666666666667,0.9919723853606047,1.0,3/21,10.02%,TGFB1;BMP6;NUP93
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.2563856192493147,0.7185030483379682,0.8620283018867925,0.9785142484650009,1.0,6/43,12.48%,STAT3;DDX5;SOX9;SRF;NFIB;NR3C1
prerank,tRNA export from nucleus (GO:0006409),0.2740387063985739,0.7182093441015773,0.8571428571428571,0.9781228173695715,1.0,12/32,27.81%,NUP37;NUP153;RAE1;NUP155;NUP88;NUP133;NUP43;NOL6;NUP205;SEH1L;NUP188;RANBP2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.2740387063985739,0.7182093441015773,0.8571428571428571,0.9781228173695715,1.0,12/32,27.81%,NUP37;NUP153;RAE1;NUP155;NUP88;NUP133;NUP43;NOL6;NUP205;SEH1L;NUP188;RANBP2
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.257935967731995,0.718197831795089,0.8537455410225921,0.9777584513283851,1.0,13/40,27.53%,BCO2;ABCD1;RNF122;BAD;NDUFS1;BAX;PRDX3;VCP;ARL6IP5;SLC25A33;STOML2;BCL2L1;PRELID1
prerank,positive regulation of leukocyte activation (GO:0002696),0.301984724294525,0.7177635282060149,0.8194254445964432,0.9778988684481954,1.0,1/18,1.52%,WNT5A
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.2983946919411419,0.7170980700740321,0.819918144611187,0.9783195208367144,1.0,5/18,31.65%,LYN;MDK;IL6R;SLIT2;MTUS1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2610101936113169,0.7170072638462024,0.858343337334934,0.9780678250968498,1.0,7/39,18.40%,ABCA1;RAB8B;RAB12;TMEM167A;MIA2;MTTP;SVBP
prerank,response to lipid (GO:0033993),0.23692892728372614,0.7164708313409953,0.9203354297693921,0.978307511093925,1.0,16/105,16.80%,TMEM161A;ABCG1;RARG;STAT3;CDKN2D;SOX9;CTNNB1;SLPI;CTSH;GCH1;GGT7;SOCS2;JAK2;PPARD;IRAK1;LGALS9
prerank,negative regulation of double-strand break repair (GO:2000780),0.2733337605307006,0.7162605971485961,0.8506731946144431,0.9781829095162569,1.0,8/30,22.11%,CGAS;MAD2L2;POLQ;SHLD1;KLHL15;SMCHD1;FBH1;UBQLN4
prerank,regulation of cation channel activity (GO:2001257),0.23623676307817873,0.7159836106652882,0.9117021276595745,0.9781227912503871,1.0,15/89,16.23%,CAMK2D;CTSS;CAMK2B;ACTN2;CRHBP;CNIH3;GRIA2;NETO1;APP;CAPN1;FGF13;VAMP2;DLG1;MINK1;GRIA4
prerank,regulation of macroautophagy (GO:0016241),0.23147163612115934,0.7156752625491276,0.9149159663865546,0.9781112803836899,1.0,26/105,22.24%,KDR;ATP6V0D1;LARP1;UBQLN2;RRAGC;SH3GLB1;NRBP2;WAC;PRKAG1;UBQLN1;CAPNS1;LAMTOR3;CAPN1;RB1CC1;VPS26A;MTOR;ATP6V1B2;ATP6V1G1;TSC1;ATP6V1G2;ERN1;LAMTOR4;TRIM13;VPS35;RHEB;RRAGA
prerank,ventricular septum morphogenesis (GO:0060412),0.27919243068765315,0.7155940119844726,0.8327044025157233,0.9778381874890576,1.0,5/27,15.33%,ACVR1;BMPR2;PROX1;SLIT3;BMPR1A
prerank,nuclear envelope organization (GO:0006998),0.29458844758148056,0.7155914704202391,0.852,0.9774663304239284,1.0,4/20,14.75%,TOR1AIP1;SUN2;REEP3;NUP155
prerank,defense response to fungus (GO:0050832),0.2978399416243611,0.7153614125959378,0.8122332859174964,0.9773588434906962,1.0,2/17,8.60%,RNASE7;FAM3A
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.3294002749330566,0.7152088375395896,0.8371428571428572,0.9771540804318848,1.0,6/12,25.48%,CEP19;HOOK3;NIN;BICD2;BBS4;DCTN1
prerank,glucose transmembrane transport (GO:1904659),0.2974724408973097,0.7145697717388423,0.8274044795783926,0.9775057052862084,1.0,3/18,16.02%,SLC2A6;SLC2A9;PPARD
prerank,glycine transport (GO:0015816),0.34446397188049205,0.7141713631095106,0.8133140376266281,0.9776167349539893,1.0,10/10,65.58%,SLC6A17;SLC36A1;SLC6A20;SLC6A9;SLC7A8;SLC6A5;SLC38A5;SLC36A3;SLC25A38;SLC36A2
prerank,positive regulation of metabolic process (GO:0009893),0.23713722331978868,0.7141548235529016,0.9220917822838848,0.9772618179142838,1.0,9/103,9.33%,CXCR4;PER2;GADD45G;GRB10;DYNC1H1;ACADL;SIRT6;LEPR;INSR
prerank,aggrephagy (GO:0035973),0.2771542863900769,0.7140931530690146,0.8440251572327044,0.9769571219765704,1.0,10/27,27.79%,DYNC1H1;DYNC1LI2;UBQLN1;DYNLL1;UBE2V1;HDAC6;WDFY3;CFTR;DYNC1LI1;UBE2N
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.2969168173455552,0.7138559941405757,0.824468085106383,0.9768804187435935,1.0,3/19,15.10%,RAPSN;APOE;CHRNB2
prerank,regulation of fibrinolysis (GO:0051917),0.3185169373753739,0.7137192000216567,0.8232695139911634,0.9766812993452382,1.0,1/13,6.61%,USF1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.2323460376780054,0.7136272513988648,0.9173553719008265,0.9764078774704623,1.0,12/116,14.33%,CALCA;RXFP2;PTGER4;HCK;ADCY5;PRKAR2B;LYN;FCGR1A;MAPK14;RHBDF2;FCGR2B;FYN
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.26288421792498207,0.7121218690458484,0.8690909090909091,0.9777904558418645,1.0,4/33,16.88%,KDR;TCF7L2;TNIP2;MDK
prerank,positive regulation of interleukin-13 production (GO:0032736),0.33543040131636703,0.7120625938399409,0.8190045248868778,0.9774838387970631,1.0,3/10,16.80%,SPHK2;IL18;LGALS9
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.2631888553541525,-0.7119023582764213,0.8295081967213115,0.998433151253235,1.0,7/13,27.29%,LARP7;NELFB;NELFE;HEXIM1;NELFA;SUPT4H1;RNF168
prerank,pigment granule transport (GO:0051904),-0.2306395129030503,-0.7113820222587675,0.8975409836065574,0.99615450799615,1.0,7/18,24.45%,BBS5;BLOC1S5;BLOC1S6;MREG;RAB27A;ARL6;MKKS
prerank,melanosome transport (GO:0032402),-0.2306395129030503,-0.7113820222587675,0.8975409836065574,0.99615450799615,1.0,7/18,24.45%,BBS5;BLOC1S5;BLOC1S6;MREG;RAB27A;ARL6;MKKS
prerank,primary alcohol metabolic process (GO:0034308),-0.21596242573565053,-0.711276912020373,0.8711111111111111,0.9948362054370038,1.0,2/25,5.15%,GPD2;NAPEPLD
prerank,cranial nerve development (GO:0021545),0.3277968298907694,0.7110555480365386,0.8192955589586524,0.9783110140910062,1.0,3/11,22.52%,CHD7;CHRNB2;ERBB3
prerank,carbohydrate biosynthetic process (GO:0016051),-0.2234507562957274,-0.7108878683906747,0.9116279069767442,0.9938476576149592,1.0,5/21,16.42%,ST3GAL6;ST3GAL3;B3GALT5;B3GALT2;FUT8
prerank,Rap protein signal transduction (GO:0032486),0.3272434422828769,0.71076126261986,0.8151658767772512,0.9782753556154968,1.0,4/10,19.85%,RAPGEF2;RAPGEF1;RAP2A;SGSM3
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.20691369938483267,-0.7098417850864697,0.9396984924623115,0.9936056597925631,1.0,14/30,40.13%,CACNA2D1;SCN3B;GJC1;SCN2B;KCNH2;CACNA1G;ATP1A1;RYR2;KCNQ1;SNTA1;CACNA1C;KCNE3;FGF12;KCNE4
prerank,membrane depolarization (GO:0051899),0.26792370659431175,0.7097751711517332,0.8453105968331304,0.979074401179503,1.0,6/32,17.93%,CACNA1A;P2RX4;SCN2A;CHRNB2;SCN1B;SCN8A
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.26264652000294975,0.7097487855052165,0.8411910669975186,0.9787275567810664,1.0,6/33,12.25%,SFRP2;SNAI2;RET;LYN;CIB1;PTPN11
prerank,positive regulation of mitochondrial translation (GO:0070131),0.31024030470772646,0.7096898589811292,0.8161244695898161,0.9784169564710364,1.0,4/14,18.72%,NGRN;RCC1L;TRMT10C;FASTKD2
prerank,icosanoid metabolic process (GO:0006690),-0.18537950638324618,-0.709382014891312,0.9415584415584416,0.9927058558479671,1.0,8/40,16.58%,HPGD;LTC4S;ALOX5AP;PTGS1;ABCC10;MGLL;GGT5;FAAH
prerank,neurotransmitter transport (GO:0006836),0.24047463353789836,0.7093029880823203,0.9045553145336226,0.978497627608311,1.0,20/73,27.37%,SLC18A2;SLC38A2;SLC38A1;SYNJ1;CPLX1;HSPA8;VAMP2;PPFIA4;SLC32A1;GAD1;BRSK1;STXBP3;SLC1A3;SYN1;GRM4;RAB3A;DNAJC5;LIN7C;SNPH;GLS2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.30410598620706153,0.7086994383353957,0.8386206896551724,0.9788310509781114,1.0,4/17,16.77%,ACVR1;SNAI2;BMPR1A;RBPJ
prerank,regulation of astrocyte differentiation (GO:0048710),-0.2648023138063601,-0.708529305373073,0.865814696485623,0.9922014810748291,1.0,2/12,7.16%,BIN1;ID2
prerank,positive regulation of secretion by cell (GO:1903532),0.23983114145569115,0.7083395336171913,0.8964401294498382,0.9788591244165895,1.0,20/70,25.54%,ABCG1;ADAM8;PPIA;UNC13D;BAIAP3;P2RX4;CADPS2;TMED10;RAB2B;APBB1;DTNBP1;GOLPH3L;CD33;CADPS;FRMD4A;ANG;CD2AP;CFTR;KCNB1;RAB3A
prerank,ventricular septum development (GO:0003281),0.263810886840115,0.7069021767018945,0.8564705882352941,0.9801479897714809,1.0,7/37,17.28%,ACVR1;BMPR2;PROX1;SLIT3;MATR3;BMPR1A;HECTD1
prerank,estrogen metabolic process (GO:0008210),0.31031205748489915,0.7067644456849124,0.8190883190883191,0.9799230157430295,1.0,1/15,3.57%,HSD17B7
prerank,negative regulation of cellular senescence (GO:2000773),-0.2618287804505618,-0.7066953286019237,0.8910891089108911,0.9927772712018549,1.0,3/13,12.95%,MAP3K3;SIRT1;HMGA2
prerank,gas transport (GO:0015669),-0.27725282840173604,-0.7064786706338582,0.8484848484848485,0.9915774361687116,1.0,2/10,19.34%,IPCEF1;MYC
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.27849274052076445,0.7062050576934956,0.8439897698209718,0.9801851223070649,1.0,5/23,13.57%,HOOK2;CCDC88A;HOOK1;CCDC88B;HOOK3
prerank,JNK cascade (GO:0007254),0.2581596462523062,0.7061941709497037,0.887816646562123,0.9798224953602761,1.0,3/40,4.11%,NOD2;NOD1;PTGER4
prerank,positive regulation of intracellular protein transport (GO:0090316),0.22597615046305802,0.7059010391369541,0.9280575539568345,0.9797677132608923,1.0,25/144,14.33%,FIS1;MYO1C;RUFY3;SEC16A;FBXW7;TCF7L2;SH3GLB1;VPS11;CSNK2A2;TFDP1;RNF31;LEPROT;PLK3;PRNP;CIB1;ZC3H12A;CEP131;TFDP2;SORL1;PSEN1;NPEPPS;UBE2L3;BAD;VAMP2;FYN
prerank,regulation of immunoglobulin production (GO:0002637),-0.21707473582569803,-0.7053820882751402,0.9153225806451613,0.9913106934165486,1.0,7/23,23.12%,SASH3;EPHB2;VAMP3;DNAJB9;CD86;PHB2;CLCF1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.3350357238137014,0.7052416110468299,0.8338192419825073,0.980175295860151,1.0,1/10,4.85%,HSP90AB1
prerank,action potential (GO:0001508),0.2559462865416887,0.7046524759911533,0.8720657276995305,0.9804712264985951,1.0,3/44,6.07%,KCNMB3;GNA15;GNA14
prerank,fatty acid transport (GO:0015908),0.29470989208422455,0.7046342234785075,0.8424753867791842,0.9801189517449377,1.0,3/17,16.02%,SLC27A1;APOE;PPARD
prerank,divalent inorganic cation homeostasis (GO:0072507),0.27839285740511754,0.7044789313793876,0.8419117647058824,0.9799284969897746,1.0,3/25,6.71%,SLC8A1;MT3;TFAP2B
prerank,regulation of integrin activation (GO:0033623),0.3076526972870107,0.7040100820604748,0.8330935251798561,0.980091639678253,1.0,5/15,25.78%,PTGER4;JAM3;FARP2;PIEZO1;FERMT2
prerank,meiosis I (GO:0007127),0.2833120430058493,0.7038619436672086,0.8507078507078507,0.979890298450633,1.0,3/23,19.28%,BCL2L11;ZCWPW1;PTTG1
prerank,positive regulation of protein transport (GO:0051222),0.23964485564808757,0.7038307651927779,0.896551724137931,0.979557045976952,1.0,11/67,13.36%,ABCG1;ADAM8;RUFY3;PPIA;PLK3;TMED10;CEP131;VPS28;RACK1;APBB1;VAMP2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.22178905035257854,-0.7035689590784426,0.8963963963963963,0.9919093363029924,1.0,6/22,20.09%,RPL23;SPRED2;UBB;RPL37;CDK5RAP3;HEXIM1
prerank,membrane assembly (GO:0071709),0.2623921403856798,0.7035350138657549,0.864963503649635,0.979516226390267,1.0,6/34,16.97%,CHMP4B;TLCD2;UBXN2B;STX4;NLGN3;FLOT2
prerank,negative regulation of cilium assembly (GO:1902018),0.3194990429347745,0.702808369949532,0.8285302593659942,0.9799797144634699,1.0,4/12,18.85%,CDK10;ODF2L;MAP4;TESK1
prerank,sulfur compound catabolic process (GO:0044273),0.2576243020567731,0.702773904418081,0.8883553421368547,0.979642244691893,1.0,12/38,23.94%,HYAL1;FMOD;CSPG4;GGT7;ACAT1;GADL1;GLB1;CHAC2;OGN;GALNS;TXN2;GNS
prerank,response to prostaglandin E (GO:0034695),0.33135619448572856,0.7021670065186264,0.7984848484848485,0.9799453495451338,1.0,1/10,4.11%,PTGER4
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.29691607645914636,0.7018607144469109,0.8263888888888888,0.9799291362512031,1.0,4/16,15.53%,VAMP2;LYST;PLEKHM2;TUBB4B
prerank,modulation of chemical synaptic transmission (GO:0050804),0.23144762551552978,0.7015558157771732,0.922675026123302,0.9799023029424802,1.0,38/107,27.69%,BDNF;CLSTN1;GRIK3;CPLX1;EIF4EBP2;BAIAP3;ABR;CACNA1A;APP;AKAP9;IQSEC2;CLSTN3;CHRNB2;GRID1;NLGN3;LRP8;OPHN1;BCR;DGKI;LRRC4;LGI1;MCTP1;BEGAIN;GRIK4;SYN1;GRM7;DLGAP4;DLGAP3;GRM4;GRIK5;GRIK2;CLSTN2;TNF;DLGAP2;PTEN;CDK5;ITGB1;CPLX2
prerank,anterior/posterior axis specification (GO:0009948),0.30633515414076706,0.7015110815677024,0.8365650969529086,0.9795760008414708,1.0,15/15,69.40%,TASOR;RIPPLY2;WLS;DDIT3;SKI;MESP2;SIX2;WNT8A;CDX1;TBXT;TBX3;SHH;HOXD8;LHX1;FZD5
prerank,cellular response to drug (GO:0035690),0.2785926921540818,0.7014896339066234,0.8551099611901681,0.9792294556778178,1.0,3/25,10.54%,AIM2;CRHBP;PPM1F
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.2277548956521395,0.7007167225561374,0.933058702368692,0.9797176187993878,1.0,9/117,9.63%,CALCA;RXFP2;PTGER4;HCK;ADCY5;PRKAR2B;LYN;FCGR1A;MAPK14
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.2159733602003387,-0.6990162713623006,0.9291044776119403,0.9954567149250404,1.0,2/23,2.35%,HPGD;LTC4S
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.3184895109823899,0.6988439367780238,0.8350668647845468,0.981408458527698,1.0,1/12,2.71%,CHEK2
prerank,cGMP metabolic process (GO:0046068),0.321074967131257,0.6984250421407904,0.8243831640058055,0.9814940618850424,1.0,4/12,26.19%,NPPC;NPR2;PDE9A;GUCY1B1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.32237995442607825,0.6983679712086066,0.8343283582089552,0.9811920221169725,1.0,3/11,15.09%,PLEKHA4;DAB2;MLLT3
prerank,oogenesis (GO:0048477),0.3022816144192319,0.6978673721078609,0.8457223001402524,0.9813821697450628,1.0,5/15,26.50%,MARF1;MDK;MEI4;KMT2D;FMN2
prerank,epiboly involved in wound healing (GO:0090505),0.29937516048796253,0.6974847216482122,0.8326241134751773,0.9814267996748427,1.0,2/16,9.05%,MRTFA;PDPN
prerank,axoneme assembly (GO:0035082),-0.20002287983922507,-0.6974101056220857,0.9289617486338798,0.9957810076914989,1.0,19/30,40.35%,DNAI4;TTLL3;CCDC39;DNAAF3;RSPH9;FOXJ1;DCX;CFAP74;JHY;DNAJB13;CFAP206;DRC1;GAS8;DNAAF2;RSPH1;RP1;RSPH4A;DNAAF1;CCDC65
prerank,aortic valve development (GO:0003176),0.25648150195895786,0.6972259473278387,0.8706166868198307,0.9813442413422166,1.0,5/34,12.74%,SOX9;SNAI2;BMPR2;SLIT3;RB1
prerank,regulation of cholesterol efflux (GO:0010874),0.26484625079548735,0.6969576736802776,0.8869123252858958,0.9812761203671874,1.0,6/30,19.23%,NR1H2;YJEFN3;APOE;PTCH1;ZDHHC8;TTC39B
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.2591186821427634,0.6969302387444726,0.8665865384615384,0.9809414539283345,1.0,6/31,17.17%,PEX7;TOMM40L;TIMM50;PEX2;PEX5;TOMM40
prerank,mammary gland epithelium development (GO:0061180),-0.24925629392175352,-0.6969240303671143,0.8833333333333333,0.9948588110418046,1.0,5/14,20.25%,ID2;AKT2;AKT1;SCRIB;WNT4
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.2682107158546703,-0.6965443259990545,0.8637873754152824,0.993805589052286,1.0,5/12,24.11%,PAEP;CARD9;RASGRP1;IL1B;CD80
prerank,central nervous system neuron differentiation (GO:0021953),0.2631801078325574,0.6962852720642585,0.8763769889840881,0.9812519229433819,1.0,3/33,10.07%,LMX1A;CTNNB1;PROX1
prerank,heme biosynthetic process (GO:0006783),0.2814127522213219,0.6960865274322994,0.8545918367346939,0.9810947369996412,1.0,6/22,20.00%,FXN;TSPO;UROS;PGRMC1;FLVCR1;ABCG2
prerank,protein hydroxylation (GO:0018126),0.29998202384916,0.6951035139214614,0.8304635761589404,0.981785661428226,1.0,5/15,19.15%,ASPH;P3H1;VIPAS39;JMJD4;OGFOD1
prerank,regulation of exosomal secretion (GO:1903541),0.28734701260656026,0.6942969430066551,0.842896174863388,0.9823250332513658,1.0,8/19,29.61%,SDC4;CHMP3;HGS;TSG101;SNF8;SDCBP;PDCD6IP;RAB7A
prerank,regulation of calcium ion transport (GO:0051924),0.2438323099291413,0.694250619398591,0.8943181818181818,0.9820143802443679,1.0,8/54,14.94%,CAMK2B;CCL5;GRAMD2A;CTNNB1;P2RX4;CRACR2A;CD84;INPP5K
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.23137293152157506,-0.6936246093972177,0.8754578754578755,0.9954093816658223,1.0,7/18,25.69%,COX16;PET100;TIMM21;SCO1;SURF1;COA3;COX18
prerank,positive regulation of cell killing (GO:0031343),0.311654124747133,0.6933614870866144,0.8525073746312685,0.9826340029169472,1.0,1/13,1.52%,WNT5A
prerank,cardiac atrium morphogenesis (GO:0003209),0.3003662921069779,0.6931060669672326,0.8540829986613119,0.9825452357591191,1.0,2/16,10.07%,BMPR2;PROX1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.24790834100346978,0.6925261542295729,0.8872093023255814,0.9828147002935496,1.0,8/46,13.90%,LAMC1;LAMB2;PARVB;PEAK1;SRGAP2;ANTXR1;NRP1;RAC1
prerank,regulation of neuroinflammatory response (GO:0150077),-0.23040662459639674,-0.6922255969618497,0.924812030075188,0.9954498935648767,1.0,6/19,25.37%,TNFRSF1B;TREM2;CD200R1;CD200;IL1B;NUPR1
prerank,regulation of catabolic process (GO:0009894),0.2903266276738267,0.6920746238083662,0.8337912087912088,0.9829249216177796,1.0,2/18,6.60%,CHEK2;TMEM9
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.24236168544862716,-0.6916454290859044,0.9146757679180887,0.9945740515806222,1.0,6/15,18.40%,SPCS3;RAB3GAP2;SEC61G;SEC61A1;ZFAND2B;SRPRB
prerank,regulation of dendritic spine development (GO:0060998),0.28826212615558733,0.6905184576576364,0.853625170998632,0.9842620796681879,1.0,3/19,12.34%,CAMK2B;PSEN1;APOE
prerank,histone H3-K36 demethylation (GO:0070544),0.3247557137190778,0.6904453607595157,0.837593984962406,0.9839732415631252,1.0,3/10,15.95%,RIOX2;KDM8;KDM7A
prerank,positive regulation of integrin activation (GO:0033625),-0.27674002569285194,-0.6901553517639635,0.8823529411764706,0.9947093683488586,1.0,3/11,28.57%,SRC;SKAP1;RAP1B
prerank,positive regulation of cell development (GO:0010720),0.26075858618221953,0.6899635983745332,0.8697788697788698,0.9841246907312117,1.0,8/31,21.67%,LRP2;SNW1;BAD;NUMBL;PDE3A;TYROBP;TGM2;FAIM
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.2741315574399273,0.6897849086197132,0.8686868686868687,0.9839407345976279,1.0,1/24,1.21%,CAMK2D
prerank,neurotransmitter secretion (GO:0007269),0.2499099674852143,0.6896391250037409,0.8887573964497042,0.9837275751068718,1.0,17/44,27.69%,CPLX1;HSPA8;PIP5K1C;VAMP2;SLC32A1;GAD1;BRSK1;STXBP3;PCLO;SYN1;GRM4;RAB3A;DNAJC5;LIN7C;SNPH;CDK5;CPLX2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.23947511082512496,0.6895140453551476,0.9104308390022676,0.9834953978095167,1.0,10/59,16.64%,CAMK2D;ACVR1;CHEK1;CSNK2B;CSNK2A2;CDK10;DYRK2;PRKDC;OXSR1;STK39
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.2590558156887072,0.6894824318938079,0.8731884057971014,0.9831566423746767,1.0,8/32,19.00%,CTNNB1;CCT4;CCT7;CCT3;HNRNPA1;MAP3K4;HMBOX1;NEK7
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.23005967266929797,-0.6893347351873116,0.8918918918918919,0.9941402146098051,1.0,5/18,19.09%,PTPN22;AKT1;JAK3;ASS1;IL4I1
prerank,endoderm formation (GO:0001706),0.26038778250115996,0.6893321707259855,0.8872901678657075,0.9829556635973591,1.0,3/35,7.31%,MMP14;COL4A2;COL8A1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.2645699441040287,0.6893181214495705,0.8669201520912547,0.9826015879293519,1.0,10/28,25.43%,DAXX;DIABLO;DDX47;BAX;CRADD;DDX3X;ZDHHC3;DEDD;DELE1;TNF
prerank,positive regulation of biosynthetic process (GO:0009891),-0.18323276388491833,-0.6887565977891533,0.9540229885057471,0.9932811174305215,1.0,16/40,31.04%,TGFB1;SORBS1;GRIN1;AKT1;CREB1;CREBL2;SUCO;WNT4;MTPN;F2R;RAB27A;TLR4;VIM;CREB3L1;ADGRB1;BMP4
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.27659181432415386,0.688716504426743,0.8798955613577023,0.9828639158711419,1.0,3/21,11.45%,BCL2L11;NCK1;XBP1
prerank,mesoderm development (GO:0007498),0.28921271935598797,0.6886255285203309,0.8509234828496042,0.9825904587093874,1.0,3/18,14.27%,HCK;IKZF1;JAK2
prerank,dephosphorylation (GO:0016311),0.22145409608618266,0.6879258330799437,0.948559670781893,0.9829426392183463,1.0,48/147,26.52%,SGPP2;PTPN18;DUSP3;PPP2R5C;PDXP;SBF1;DUSP29;TIMM50;PTPN7;BTRC;DUSP28;DUSP26;PPM1F;PPP2R5D;EPHX2;PPP4R2;DUSP10;DUSP16;DUSP11;INPP5K;PTPN9;PTPRU;PPP2R2A;PTPRC;DUSP8;PTPRB;PTPRF;PPP2R5A;LHPP;STK11;PLPP2;PPP2R3A;PTPRM;PLPPR2;PPP1R12A;PLPPR1;FRA10AC1;PTPN6;PTPRS;PPM1H;PLPP6;PDP1;PLPP1;PTPN1;NT5C;PPM1A;DUSP7;PTEN
prerank,regulation of mast cell activation (GO:0033003),0.3272701147616415,0.6876287979841772,0.8372434017595308,0.9828940087717567,1.0,3/10,18.64%,LYN;CD84;CD300LF
prerank,T cell differentiation in thymus (GO:0033077),0.301813158282803,0.6870422040515997,0.8504273504273504,0.9831535864508238,1.0,4/14,23.54%,ZFP36L1;PTPRC;GLI3;ZFP36L2
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.24982664752671035,0.6863770499087986,0.8962264150943396,0.9835089102555934,1.0,8/39,19.30%,TCF7L2;MYRIP;BAD;IRS2;TFR2;SELENOT;GLUD1;PSMD9
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.2517261210885675,-0.6858435468304093,0.8922558922558923,0.994784261517841,1.0,3/14,20.44%,PTPN2;TRAIP;NLRP2B
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.2364891532235785,0.6856953648831082,0.9004474272930649,0.9838549779870668,1.0,8/56,17.99%,CHMP4B;SNX33;CUL7;EFHC2;SNX9;SEPTIN9;IST1;DCTN3
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.2488336065349881,-0.6846102061789567,0.8661971830985915,0.9945262341014298,1.0,5/14,30.79%,CHAT;NOS1;MOXD1;ACHE;ALDH9A1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.29385632462569833,0.6845564866965111,0.8675862068965517,0.9846737628819523,1.0,3/16,11.15%,RORA;FOXK1;BCKDK
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.26351467885102703,0.6844262277849631,0.8853904282115869,0.9844344100965271,1.0,4/29,19.90%,STX7;STAP1;LAMP1;TYROBP
prerank,melanosome localization (GO:0032400),0.2774418552498628,0.6842626723730425,0.8783958602846055,0.9842446309223193,1.0,7/21,26.48%,VPS33A;RAB11B;BBS2;RAB11A;BBS7;BBS4;SHROOM2
prerank,cortical actin cytoskeleton organization (GO:0030866),0.2778408474541984,0.6838026930852427,0.8681318681318682,0.9843789352323083,1.0,5/20,19.81%,FMNL2;DLG1;LLGL1;FMNL3;NCKAP1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.2830101109046472,-0.682942588038131,0.8672566371681416,0.9946481608494923,1.0,2/10,9.15%,GABRG3;GABRA2
prerank,proteasome assembly (GO:0043248),0.31384265227818564,0.6828082431015116,0.8548148148148148,0.9850134550018728,1.0,7/11,29.18%,PSMG2;OTUD6B;PSMD9;ADRM1;PSMD4;PSMD11;PSMG1
prerank,establishment of spindle orientation (GO:0051294),0.2659912704870471,0.6826424399716531,0.8935128518971848,0.9848274101018213,1.0,7/28,19.17%,CDK5RAP2;UBXN2B;MAP4;LLGL1;PAFAH1B1;NUMA1;NDC80
prerank,oligosaccharide metabolic process (GO:0009311),0.24276112643495434,0.6823691586527264,0.8816837315130831,0.9847382788820721,1.0,7/46,18.20%,ST6GALNAC4;ST6GALNAC6;B4GALT1;NEU1;MAN2C1;ST8SIA1;FUT9
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.27956471014528805,0.6823538410800218,0.8605898123324397,0.9843933591434144,1.0,1/19,1.35%,CLIC4
prerank,epithelial cell differentiation (GO:0030855),0.22846082110222624,0.6823119648151602,0.9391025641025641,0.984068111185459,1.0,18/88,25.64%,KDR;TDRD7;CASP6;FGFR2;EDF1;PROX1;HNRNPH3;E2F4;DAB2;ANXA4;HDAC1;CNN3;ALDOC;HDAC2;RAB10;ANXA7;ACADVL;PIH1D1
prerank,protein depolymerization (GO:0051261),0.2686069050053615,0.6821896591569628,0.8869346733668342,0.9838199909710758,1.0,9/27,22.85%,KIF2C;STMN4;STMN3;GSN;KIF2A;STMN2;CFL2;DSTN;TWF1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.22765180732347737,0.6819081415093885,0.9229946524064171,0.9837436785331781,1.0,21/95,22.24%,SPRY2;PMEPA1;HSP90AB1;ITGA3;SMAD2;BAMBI;MEN1;DKK3;SNW1;SKIL;SMURF1;DAB2;HTRA3;SPRED3;SPRED1;SNX25;PIN1;STK11;CITED2;SMURF2;STUB1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.2863105733926763,0.6818955526898773,0.8551724137931035,0.9833884517663666,1.0,7/17,27.95%,SLC8A1;SCN1B;KCNJ2;HCN2;ANK2;SCN4B;CACNA1D
prerank,regulation of dendrite extension (GO:1903859),-0.22435002413364435,-0.6818899726127942,0.9119718309859155,0.9942856302889795,1.0,7/18,23.06%,SYT2;RNF157;RIMS1;UNC13A;RIMS2;SYT1;CPNE5
prerank,regulation of Ras protein signal transduction (GO:0046578),0.2261456741589773,0.6818125697638809,0.9317697228144989,0.9831091706584113,1.0,16/85,17.67%,SPRY2;DENND1A;LYN;KANK1;VAV1;STARD8;AKAP13;RAPGEF1;JAK2;IRS2;LZTR1;SH3BP1;DENND4A;OPHN1;BCR;PLCE1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.2888695907534384,0.6806645954081469,0.8753581661891118,0.9839458980674084,1.0,6/16,23.07%,ABCD1;ZC3H12A;CHID1;SIRPA;APPL2;ADCY7
prerank,cardiac conduction system development (GO:0003161),-0.21042744706259164,-0.6806284922890613,0.9488372093023256,0.9940778770976936,1.0,11/24,43.52%,SMAD4;GJB6;CACNA1G;BMP4;HCN4;HEY1;HEY2;MSC;GJA5;MSX1;SHOX2
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.2068040509633482,-0.6805406390809688,0.925,0.9927793300741676,1.0,12/25,30.30%,ITGAV;PARVA;NINJ1;CD200R1;ITGB3;CXADR;ITGB7;CD200;ITGB2;JUP;CD2;DSG2
prerank,Ras protein signal transduction (GO:0007265),0.21668712897232614,0.6801691571264463,0.9628482972136223,0.984090941432133,1.0,38/137,24.01%,USP50;CDH13;KPNB1;CYFIP1;ARHGAP4;RAPGEF6;RAPGEF2;PDPN;DNMT1;MAPK14;G3BP2;ARHGEF11;HACD3;SOS1;RB1;RAPGEF1;RAC1;RREB1;DBNL;PHACTR4;AIF1;PLCE1;ARHGAP29;NF1;RAP2A;NCKAP1;SGSM3;CTNNAL1;RIT1;G3BP1;RHOH;USP8;FGF2;BRK1;FARP2;ARHGAP1;CDC42EP3;RGL2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.24169945600727485,0.680167815649504,0.8920780711825488,0.9837275474904883,1.0,10/52,15.16%,DDX5;RBMX;HNRNPL;RNPS1;RBFOX1;HNRNPA1;CELF6;RBM15;MBNL2;RBFOX3
prerank,glutathione metabolic process (GO:0006749),0.2499461665805114,0.6799836853339043,0.8888888888888888,0.9835397596103699,1.0,7/38,20.69%,ETHE1;GSR;GGT7;CTNS;GCLC;CNDP2;CHAC2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.28178446299872006,0.6797899560125196,0.8779840848806366,0.9833722057305403,1.0,6/20,24.74%,SLC25A1;SCD5;GCDH;ACSL3;FAR2;CBR4
prerank,regulation of cytoskeleton organization (GO:0051493),0.22218406432193907,0.6797437311298138,0.9490114464099896,0.9830496565665124,1.0,18/108,16.31%,BST2;CLIC4;RHOF;SYDE1;PAK3;CYLD;KATNBL1;CCDC88A;SPEF1;STMN3;CDK10;PHLDB1;RAC1;CRK;TAOK2;SH3BP1;BAIAP2;MTOR
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.2245299527227821,0.6796098124335522,0.9406867845993756,0.9828255149671647,1.0,19/104,19.46%,SPRY2;ACVR1;LRP2;PMEPA1;MAGI2;SMAD2;BAMBI;BMPER;BMPR2;SKIL;SORL1;SMURF1;BMPR1A;HTRA3;SPRED3;ACVR2A;SPRED1;SNX25;PIN1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.20885986224157654,-0.6789887517400905,0.9319148936170213,0.9927952839875622,1.0,3/23,9.82%,MBOAT1;PLAAT3;PLBD1
prerank,regulation of potassium ion transport (GO:0043266),-0.1921030088295669,-0.6785023845497782,0.9642857142857143,0.9918883997663416,1.0,11/31,29.44%,KCNIP3;ANK3;FHL1;KCNAB1;ADRA2A;DRD2;NOS1;KIF5B;KCNIP4;KCNH2;PTK2B
prerank,receptor clustering (GO:0043113),0.26360218315384526,0.6783859881411725,0.8737373737373737,0.9837278315475045,1.0,9/27,25.19%,THY1;MAGI2;AGRN;DNAJA3;DLG1;ITGA4;SAV1;FLNA;LRP4
prerank,positive regulation of protein secretion (GO:0050714),0.2324277658474536,0.6782828026133483,0.9252747252747253,0.9834586441891949,1.0,14/69,19.68%,ABCG1;ADAM8;TCF7L2;PPIA;TMED10;MYRIP;BAD;APBB1;IRS2;TLR2;GLUD1;GOLPH3L;PSMD9;CD33
prerank,membrane raft organization (GO:0031579),0.2958522135854172,0.6780948755765288,0.8734525447042641,0.9832921730110032,1.0,3/15,16.97%,YJEFN3;NPC1;FLOT2
prerank,cGMP biosynthetic process (GO:0006182),0.32247521721828437,0.677984810073689,0.841079460269865,0.9830348560813735,1.0,3/10,26.19%,NPPC;NPR2;GUCY1B1
prerank,regulation of fatty acid metabolic process (GO:0019217),0.28515333761470396,0.677529470218826,0.8726752503576538,0.9831492646536389,1.0,5/17,24.40%,EIF6;PANK2;PPARD;ADIPOR1;PRKAB2
prerank,neuromuscular junction development (GO:0007528),0.26684049087817563,0.6772595942742344,0.8691099476439791,0.9830476509592215,1.0,3/24,11.01%,DOK7;AGRN;DNAJA3
prerank,regulation of phosphatase activity (GO:0010921),-0.20870205593190172,-0.6770714354663872,0.9360730593607306,0.9918022495104596,1.0,5/24,14.11%,HTT;PTPA;MTMR9;URI1;ZCCHC9
prerank,positive regulation of rRNA processing (GO:2000234),0.3209339776410798,0.6767898645537881,0.8661538461538462,0.9831560360694164,1.0,4/10,22.04%,DIMT1;WDR43;BUD23;UTP15
prerank,positive regulation of exosomal secretion (GO:1903543),0.29207221733791056,0.676419080693447,0.8354978354978355,0.9831649793247164,1.0,7/15,29.61%,SDC4;HGS;TSG101;SNF8;SDCBP;PDCD6IP;RAB7A
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.29281767955801097,0.6762734454147314,0.8678977272727273,0.9829419101688522,1.0,14/14,70.74%,ECE1;CORIN;NOS3;EDN1;AGTR1;AVPR1A;EDN2;EDN3;OXTR;ACE2;ACE;AVPR2;RASL10B;ENPEP
prerank,amyloid-beta metabolic process (GO:0050435),-0.2383740086684133,-0.6750845737790687,0.9015151515151515,0.9921537504905675,1.0,6/16,24.21%,DYRK1A;MGAT3;BACE1;ABCA7;PSEN2;NCSTN
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.2556763192689699,0.6744353673277484,0.8836317135549873,0.9840661493313001,1.0,5/29,18.82%,ACOT9;ACBD6;ACOT13;ACAT1;OXSM
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.2556763192689699,0.6744353673277484,0.8836317135549873,0.9840661493313001,1.0,5/29,18.82%,ACOT9;ACBD6;ACOT13;ACAT1;OXSM
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.2521350122442517,-0.6741503626438923,0.8636363636363636,0.9915455087911681,1.0,5/12,25.37%,TTBK1;CCL3;TREM2;IL1B;NUPR1
prerank,regulation of multicellular organism growth (GO:0040014),0.2880330217596014,0.6739790467875698,0.8674188998589563,0.984158040397006,1.0,5/15,25.59%,APP;PTCH1;BBS2;STAT5A;PPIB
prerank,fibrinolysis (GO:0042730),0.2987004833950656,0.6738206260255253,0.8708206686930091,0.9839486266991748,1.0,13/13,70.15%,PLAUR;PLAT;SERPINE1;GP1BA;FGG;F2;KRT1;CPB2;HRG;PLG;SERPINB2;SERPINF2;PLAU
prerank,substantia nigra development (GO:0021762),0.24885042538750138,0.6728206873769567,0.9008567931456548,0.9846083417073268,1.0,14/37,27.47%,SEC16A;FGF9;DYNLL1;ACTB;CALM3;GLUD1;PLP1;ZNF148;CALM2;YWHAE;SIRT2;CKB;BASP1;CCDC14
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.2573006762211112,0.6721918831884317,0.9006060606060606,0.9848582050049057,1.0,3/29,10.07%,TNNC1;FGFR2;PROX1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.2643886037425238,0.6721105416752987,0.8826597131681877,0.9845800078026687,1.0,4/24,14.62%,TTLL8;TTLL7;GGCX;CFAP20
prerank,regulation of cardiac muscle contraction (GO:0055117),0.2537371121982792,0.6719907577636814,0.904993909866017,0.9843308382937066,1.0,8/34,24.63%,SLC8A1;P2RX4;ZC3H12A;CALM3;ASB3;PDE4B;CALM2;ANK2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.2824930666280473,0.6718655511027373,0.9016393442622951,0.9840951500890345,1.0,3/18,12.74%,RUNX1;PDPN;RB1
prerank,peptide biosynthetic process (GO:0043043),0.21423644436429118,0.6717648346323217,0.9560776302349336,0.9838323104069023,1.0,35/153,21.25%,MRPL36;IGF2BP3;AGO2;RPL36;HARS2;GSPT1;RPL22;EIF4EBP2;RPS21;TNIP1;MRPL42;ABCF1;GGT7;RPS6;RPS11;RPL30;MRPL24;RPL32;RPL23A;RPL11;YARS2;RPL10A;RPS15A;MRPL13;HBS1L;SRBD1;RSL24D1;RPL24;RPL37A;RPL3;MRPS11;RRBP1;RPL29;RPL5;FARSB
prerank,organic cation transport (GO:0015695),0.2771213591808739,0.6706967436349024,0.8768406961178046,0.9844847075550683,1.0,5/20,28.65%,SLC25A19;SLC44A1;SLC25A26;SLC22A4;SLC5A7
prerank,negative regulation of hippo signaling (GO:0035331),0.30385682120560253,0.6706400495597035,0.8589743589743589,0.9841761640583124,1.0,2/12,9.63%,MAP2K3;MAPK14
prerank,lung epithelium development (GO:0060428),0.3126309527457827,0.6705463152204916,0.8554216867469879,0.9839043630283931,1.0,1/10,6.44%,WNT7B
prerank,hippo signaling (GO:0035329),0.25745617136049315,0.6701227511966791,0.8553459119496856,0.9839660767806082,1.0,7/26,21.28%,TEAD2;MOB1B;TJP2;AMOTL2;STK3;MOB1A;SAV1
prerank,DNA methylation or demethylation (GO:0044728),0.2764034056324579,0.6698595146485328,0.8751677852348994,0.9834910202447177,1.0,3/19,9.13%,GATAD2A;DNMT3A;DNMT1
prerank,DNA alkylation (GO:0006305),0.2764034056324579,0.6698595146485328,0.8751677852348994,0.9834910202447177,1.0,3/19,9.13%,GATAD2A;DNMT3A;DNMT1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.2867646243277963,0.6689999000304295,0.8680851063829788,0.9839730547172723,1.0,5/16,17.43%,SPHK2;DNAJC30;AK4;PPARGC1A;ATPSCKMT
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.3172313653881472,0.6680898476554733,0.8786549707602339,0.9844956027615663,1.0,1/11,1.64%,IRS1
prerank,regulation of transposition (GO:0010528),-0.24575813449065853,-0.6676695964987455,0.8832807570977917,0.995774090317145,1.0,4/13,27.84%,SIRT7;TEX15;DDX4;PIWIL2
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.2946704539937544,0.6669979909965721,0.8794835007173601,0.9851995776232735,1.0,3/14,17.07%,RAPGEF2;PRKAR2B;PRKAR2A
prerank,regulation of actin nucleation (GO:0051125),0.3089550339198379,0.6669884318939244,0.8840579710144928,0.9848464245817578,1.0,3/12,13.56%,GSN;WHAMM;CORO1B
prerank,protein localization to condensed chromosome (GO:1903083),-0.2511667288696907,-0.6669379797859792,0.9135802469135802,0.9950351132533791,1.0,7/12,31.63%,MTBP;KNL1;SPDL1;BUB3;CDK1;AURKB;TTK
prerank,sensory perception of sound (GO:0007605),0.2222149362986783,0.6667201115711872,0.9430379746835443,0.9847524377539896,1.0,8/88,12.53%,TMC1;LRP2;NDUFB9;MYO3B;SNAI2;ALDH7A1;ADGRV1;COL11A2
prerank,regulation of ion transport (GO:0043269),0.22326295146337033,0.6660676821272759,0.9409237379162191,0.9850088728801488,1.0,14/76,20.04%,B2M;SYT7;RAB11B;SYT3;GDNF;P2RX4;SIK1;CA2;VAMP2;CLDN10;CHRNB2;KCNJ2;DTNBP1;PER1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.29490425851135904,0.6659677252286614,0.8924418604651163,0.9847421716467631,1.0,5/13,27.84%,SOCS5;SOCS4;TSG101;CBLB;ZGPAT
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.18571096504232004,-0.6657633332491703,0.9742268041237113,0.9946223725958114,1.0,8/33,22.87%,GCLM;ALDH18A1;DDAH1;NIT2;OAT;PRODH;ALDH4A1;PYCR3
prerank,endodermal cell differentiation (GO:0035987),0.25577764217935595,0.6655962357249691,0.8946078431372549,0.9847515550606777,1.0,3/31,7.31%,MMP14;COL4A2;COL8A1
prerank,histone H2A acetylation (GO:0043968),0.28803698972212155,0.6646956837220855,0.8687589158345221,0.9852379615562203,1.0,8/16,31.02%,EP400;SPHK2;RUVBL2;ACTL6A;RUVBL1;BRD8;YEATS4;MORF4L1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.2524651151787223,-0.6641007047825258,0.8789808917197452,0.9946656404026953,1.0,3/11,15.99%,CEBPB;TP53;ATF3
prerank,positive regulation of telomerase activity (GO:0051973),0.2452287322309112,0.6628690652065484,0.8861209964412812,0.9865650256996146,1.0,8/33,19.00%,HSP90AB1;CTNNB1;CCT4;MAP3K4;HSP90AA1;HMBOX1;PTGES3;NEK7
prerank,cell projection organization (GO:0030030),0.25367373509572644,0.6620186065136905,0.8994910941475827,0.9870148190444725,1.0,5/30,13.90%,PARVB;CYFIP1;RHOJ;GSN;RAC1
prerank,regulation of intracellular pH (GO:0051453),-0.18543114786643977,-0.6618260737772285,0.9664804469273743,0.9951684755033027,1.0,9/34,22.21%,SLC9A9;NOX1;SLC4A8;GPR89B;GPR89A;CLN3;SLC9A8;SLC26A6;SLC4A3
prerank,positive regulation of dendrite extension (GO:1903861),-0.22436448844351184,-0.6616152084134913,0.9145907473309609,0.9939631211552697,1.0,7/17,23.06%,SYT2;RNF157;RIMS1;UNC13A;RIMS2;SYT1;CPNE5
prerank,autophagy of mitochondrion (GO:0000422),0.2413130254880972,0.6614593521454613,0.8990498812351544,0.987190631469344,1.0,7/38,20.07%,FIS1;FBXO7;CISD2;MAP1LC3B;RB1CC1;BECN1;FUNDC1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.20995790380253374,0.6612816256373837,0.9746707193515705,0.9869856889118612,1.0,19/153,12.80%,CAMK2D;SGK3;SGK2;STK38L;PKN2;PNCK;IKBKE;MORC3;MKNK1;CAB39;CSNK2A2;VRK3;MAST3;MAPK14;MAP2K2;NEK6;DYRK2;PRKDC;PRKCE
prerank,regulation of establishment of protein localization (GO:0070201),0.29050063515942326,0.6582063059047377,0.8585714285714285,0.9894285477664501,1.0,4/13,18.82%,GAPVD1;SCFD1;CEP295;CEP135
prerank,regulation of cell-cell adhesion (GO:0022407),0.24168385538226822,0.6581876263805531,0.9054373522458629,0.9890833304629142,1.0,7/39,18.20%,ADAM8;CD47;PODXL;MEGF10;MINK1;FLOT2;FUT9
prerank,dendritic spine organization (GO:0097061),0.26447807327331463,0.6581229814249662,0.9141742522756827,0.9887819536002577,1.0,6/26,14.33%,PAK3;ITGA3;INSR;PRNP;CTNND2;FYN
prerank,positive regulation of cell division (GO:0051781),0.24103263187062882,0.6580466255848715,0.9152941176470588,0.9884826272679493,1.0,3/38,5.98%,CDC25B;PKN2;FGFR2
prerank,renal filtration (GO:0097205),0.3166550573843736,0.6575758961572538,0.8408736349453978,0.9885499092544945,1.0,2/10,10.31%,ITGA3;TBC1D8B
prerank,pteridine-containing compound metabolic process (GO:0042558),0.2898537847649732,0.6574395482594239,0.8907103825136612,0.9883021102539093,1.0,3/13,17.82%,GCH1;HSP90AA1;PRKG2
prerank,cardiac muscle cell action potential (GO:0086001),-0.18510522594025308,-0.6574197647443583,0.9543147208121827,0.99582310038173,1.0,5/30,13.22%,ATP1B1;DMD;CACNA2D1;KCND3;SCN3B
prerank,kinetochore organization (GO:0051383),0.297069168722769,0.6573974243673183,0.8928571428571429,0.9879762196197959,1.0,4/13,19.17%,CDT1;POGZ;MIS12;NDC80
prerank,regulation of TOR signaling (GO:0032006),0.22373252999775156,0.6573915570844079,0.940854326396495,0.9876257037972554,1.0,21/67,26.43%,MIOS;RRAGC;DDIT4;AKT1S1;LAMTOR3;TELO2;TBCK;RFFL;NPRL2;TSC1;NPRL3;LAMTOR4;RHEB;WDR59;RRAGA;UBR2;UBR1;PIK3CA;FNIP1;PIH1D1;SEH1L
prerank,nuclear pore complex assembly (GO:0051292),0.3198390914729704,0.6571184771124854,0.8852459016393442,0.9875152054003017,1.0,2/10,13.94%,NUP153;AHCTF1
prerank,sodium ion transport (GO:0006814),0.2189161109168487,0.6571115647545607,0.945031712473573,0.9871607279929726,1.0,4/85,6.08%,CATSPER4;ATP1B3;SLC8A1;ASIC4
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.2599181789086039,0.6570716640164207,0.8808290155440415,0.986837917782867,1.0,5/23,23.49%,GIT1;SIK1;CLK2;TIGAR;HDAC4
prerank,ceramide metabolic process (GO:0006672),0.22930323500594146,0.6570397783881152,0.9157175398633257,0.9865120564235734,1.0,11/49,21.47%,ASAH2;NSMAF;CERS6;DEGS1;ST6GALNAC6;ACER3;SPTLC2;SGPL1;CERS2;SPTSSA;PLPP2
prerank,actin crosslink formation (GO:0051764),0.2989625882197414,0.656759392325066,0.8497109826589595,0.9864083276248865,1.0,4/12,16.35%,GAS2L3;BAIAP2;AIF1;BAIAP2L1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.2891320411632997,0.6566240003787917,0.8792134831460674,0.9861718769603507,1.0,4/14,20.27%,NCK1;PPM1F;PPP2R2A;PPTC7
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.28112876271241705,0.6561691124495468,0.9066852367688022,0.9862269893656685,1.0,2/16,9.10%,RUNX1;SCX
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.27247965342689,0.6552991694213813,0.8896366083445492,0.9866225633121065,1.0,1/18,1.37%,ALKBH7
prerank,cell junction maintenance (GO:0034331),0.28899216302559144,0.6549794099627597,0.8830985915492958,0.9865572101591864,1.0,1/14,4.40%,CHCHD10
prerank,negative regulation of cell activation (GO:0050866),-0.24134489619602895,-0.6547735113275777,0.8837209302325582,0.996569482946143,1.0,5/14,26.12%,TREM2;CD200;THBD;PDGFRA;EMILIN1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.30588266063227054,0.6543973252899465,0.8776119402985074,0.9867279696644238,1.0,6/11,28.63%,NOP53;DDX11;MTOR;PIH1D1;NCL;SMARCB1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.2525507251221313,0.6543772740611876,0.90920245398773,0.9863847669227624,1.0,9/32,24.53%,SLC30A1;CPLX1;BAIAP3;PREPL;DTNBP1;VPS18;MCTP1;SYN1;SYT11
prerank,engulfment of apoptotic cell (GO:0043652),0.2881519741416416,0.6539371272043615,0.8756983240223464,0.9864284172301044,1.0,3/15,13.90%,XKR7;MEGF10;RAC1
prerank,skeletal system morphogenesis (GO:0048705),-0.17049622958814803,-0.6538400368753072,0.9929078014184397,0.9959423531956679,1.0,9/42,20.59%,DYNC2I1;LRP6;HHIP;RAB33B;HOXC4;HOXD3;HOXC9;FUZ;HOXB9
prerank,regulation of biomineral tissue development (GO:0070167),0.25206231930144246,0.6530402540929864,0.9080459770114943,0.9868585000940054,1.0,4/26,12.84%,SOX9;NBR1;ANKH;ENPP1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.24188067364437604,0.6526022486216646,0.9173859432799013,0.9868899427771098,1.0,9/33,23.22%,MECP2;CSNK2B;HMGB1;APOE;ACVRL1;GADD45A;FGF2;VASH1;NOTCH1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.2237608998830446,-0.6524631861843716,0.9338235294117647,0.9956041396274448,1.0,10/16,46.39%,CD226;RASGRP1;KLRD1;NECTIN2;KLRK1;CADM1;CRTAM;KLRC2;PVR;IL12A
prerank,phospholipid catabolic process (GO:0009395),-0.1991978833752569,-0.6522582504209877,0.954337899543379,0.9943794199439566,1.0,5/24,20.30%,SMPDL3A;PLBD1;ABHD12;GPCPD1;SMPD1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.2514714266550909,0.6517506054297837,0.9092039800995025,0.987278455936328,1.0,6/27,19.50%,DDX5;SNAI2;EEF1E1;SPRED3;SPRED1;SMYD2
prerank,regulation of protein sumoylation (GO:0033233),0.2753909284904279,0.6515468977506101,0.8738127544097694,0.9870912560809411,1.0,6/17,26.85%,CTNNB1;UBA2;PIAS1;HDAC4;PIAS4;GNL3
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.2645290235586281,-0.6511545223778542,0.9090909090909091,0.9938429921546122,1.0,1/10,3.01%,NCKAP1L
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.30562445901030566,0.6510738486283253,0.85625,0.9871752698912357,1.0,2/10,19.29%,ZC3H12A;RC3H2
prerank,positive regulation of ruffle assembly (GO:1900029),-0.23827442298575402,-0.6509031173821668,0.9087947882736156,0.9926658700457499,1.0,6/13,33.67%,EPS8;HRAS;NDEL1;PLEKHM1;EPS8L1;CARMIL2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.2547219078607081,0.6508144602298098,0.8958868894601543,0.9870369174836248,1.0,4/24,17.61%,GRB10;MT3;HGS;EPN2
prerank,regulation of developmental growth (GO:0048638),0.24955996529447708,0.6508034296728832,0.9213759213759214,0.9866891489867404,1.0,5/29,16.05%,APP;INSR;DNM2;APOE;FGFR3
prerank,neuromuscular synaptic transmission (GO:0007274),-0.21501399201830568,-0.6499509293061878,0.9173228346456693,0.9919891045519468,1.0,5/18,27.66%,FCHSD2;DTNA;TSPOAP1;CHAT;FCHSD1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.2561398437722824,0.6487721482570769,0.90153452685422,0.9880981000252607,1.0,4/26,15.21%,THADA;UBQLN1;GPR35;CALM3
prerank,regulation of pH (GO:0006885),0.3011110413658905,0.6482627201047562,0.8795888399412628,0.9881896113952748,1.0,11/11,69.91%,LACC1;SLC9A7;CLCN3;SLC9A1;ATP1A4;ATP6V1B1;SLC26A4;PDK4;ATP6AP1;ATP6V0A4;PDK2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.22885418076353511,-0.6478261609348904,0.9107142857142857,0.992118738175921,1.0,5/14,22.76%,GMPS;ADK;IMPDH2;RFK;PPAT
prerank,positive regulation of DNA replication (GO:0045740),0.28055674648095824,0.6476388820302902,0.9035812672176309,0.9883942251419334,1.0,4/16,19.71%,CDT1;DHX9;STN1;KAT7
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.25415488014577103,0.6464729020552036,0.8991060025542784,0.9890319844360158,1.0,5/22,25.43%,THY1;FLOT2;LCK;GCNT2;TNF
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.21887229198636765,-0.6464486483263635,0.94921875,0.9917683669800479,1.0,11/17,47.87%,CD226;RASGRP1;KLRD1;NECTIN2;KLRK1;CADM1;CRTAM;KLRC2;PVR;IL12A;IL12B
prerank,negative regulation of dephosphorylation (GO:0035305),-0.22413690084049265,-0.6463436690244919,0.9538461538461539,0.99048913550102,1.0,5/18,14.11%,PPP1R8;PPP1R16B;PTPA;URI1;ZCCHC9
prerank,mRNA 3'-end processing (GO:0031124),0.21512265424892035,0.6451702733410695,0.9445048966267682,0.9898041176735569,1.0,33/78,30.72%,MAGOHB;NCBP2;WDR33;APP;AHCYL1;RNPS1;ZC3H11A;PAPOLA;CHTOP;PCF11;DDX39B;NCBP1;SRSF7;SRSF4;SLU7;THOC7;MTPAP;SRSF5;SRSF2;MAGOH;RPRD2;SCAF8;SARNP;CDC73;DDX39A;UPF3B;PABPC1;CPSF3;PAF1;PAPOLG;TENT2;SSU72;U2AF1
prerank,tRNA 5'-end processing (GO:0099116),0.2815622377098227,0.6441437057707766,0.8918918918918919,0.9902981514007124,1.0,5/15,22.98%,TRMT10C;RPP30;RPP14;RPP25L;RPP21
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.25751851627181555,0.6439208166273236,0.9119897959183674,0.9901453085026569,1.0,7/24,23.47%,FXN;TSPO;UROS;PGRMC1;FLVCR1;ABCG2;RSAD1
prerank,myotube cell development (GO:0014904),-0.2599171478784836,-0.6434668839233648,0.8674698795180723,0.9911910795016378,1.0,10/10,74.03%,SELENON;ACTA1;LMOD3;KLHL40;RYR1;MYORG;SIX1;SKI;IGF1;CAV2
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.22501203790562577,0.6431854545004012,0.9493670886075949,0.9903908480524268,1.0,20/52,28.72%,ITGA3;CIB1;PRKCE;RACK1;STX4;DLG1;PRKCH;STAC3;PTPN9;ZDHHC8;PDPK1;ACSL3;WNK3;DPP10;TNF;LRP1;SPTBN1;ITGB1;STAC2;PIK3R1
prerank,glutamate metabolic process (GO:0006536),-0.20996885259671424,-0.6415162162861031,0.9299610894941635,0.9912180615889598,1.0,4/19,18.32%,GCLM;ALDH18A1;OAT;PRODH
prerank,retinol metabolic process (GO:0042572),0.2842835292259411,0.6409730897779314,0.8884120171673819,0.991900450320647,1.0,1/14,7.89%,RDH11
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.30843576805174666,0.6408288638622123,0.8849028400597907,0.9916592768282781,1.0,1/10,6.57%,MT3
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.24149183959017662,0.6404585632444026,0.9238329238329238,0.9915954975552024,1.0,6/33,17.00%,THY1;DUSP3;SH2D1A;PRNP;CD300A;UBASH3A
prerank,positive regulation of lipid transport (GO:0032370),-0.24090852851434913,-0.6400906373746564,0.9093851132686084,0.9908574557573862,1.0,1/12,2.47%,DBI
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.26722495130743695,0.6395714860764975,0.9087136929460581,0.9919952640561213,1.0,3/17,19.67%,PLA2G12A;LPGAT1;PLA2G4E
prerank,positive regulation of collagen metabolic process (GO:0010714),0.2683814166746148,0.639385820109747,0.918809201623816,0.9917694961971861,1.0,2/17,9.10%,RUNX1;SCX
prerank,purine nucleotide biosynthetic process (GO:0006164),0.2940865443635484,0.6386887806253986,0.8916913946587537,0.9919929670790321,1.0,3/12,17.53%,HPRT1;ADSL;MTHFD1
prerank,urogenital system development (GO:0001655),0.2941982078383718,0.6384386895774781,0.8925373134328358,0.9918320090364301,1.0,1/11,5.41%,SOX9
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.2600039820009723,-0.638329098124258,0.9031339031339032,0.9906846506817236,1.0,1/10,0.45%,EHMT1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.2342435013618625,0.6380913266653303,0.94049008168028,0.9917574515671053,1.0,6/41,16.77%,SFRP2;TNNC1;FGFR2;PROX1;BMPR1A;RBPJ
prerank,sterol biosynthetic process (GO:0016126),0.24090102082821438,0.6376063642748591,0.9168704156479217,0.9917789456929009,1.0,9/33,25.21%,HSD17B7;CH25H;FDFT1;GGPS1;IDI1;EBP;HMGCS1;HMGCR;PLPP6
prerank,regulation of telomerase activity (GO:0051972),0.22578631867824114,0.6373167633178338,0.92,0.9916593652001472,1.0,10/45,19.00%,HSP90AB1;CTNNB1;CCT4;ERCC4;MEN1;MAP3K4;HSP90AA1;HMBOX1;PTGES3;NEK7
prerank,positive regulation of ATP metabolic process (GO:1903580),0.24192902701945201,0.6372470632744984,0.9108669108669109,0.9913581102291661,1.0,5/32,12.32%,ENTPD5;APP;INSR;PSEN1;PPARGC1A
prerank,serine family amino acid metabolic process (GO:0009069),0.26929474318179547,0.6369116277696489,0.8995756718528995,0.9912852719305165,1.0,4/16,17.53%,SEPSECS;SHMT1;GCLC;MTHFD1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.2711929698659554,0.6367026533212158,0.9087078651685393,0.9910928407968641,1.0,2/16,17.39%,STX7;PTPRC
prerank,steroid hormone biosynthetic process (GO:0120178),0.2490266678219845,0.6357049891266103,0.9364089775561097,0.991546111337513,1.0,3/29,12.95%,HSD17B7;STARD3;TSPO
prerank,eye photoreceptor cell differentiation (GO:0001754),0.2865169442340165,0.6355306081656708,0.8903508771929824,0.991333197923914,1.0,1/12,2.87%,STAT3
prerank,positive regulation of neutrophil migration (GO:1902624),0.26869121053469947,0.6339022114046693,0.9177126917712691,0.9922598033356528,1.0,3/18,16.88%,ADAM8;RAC1;MDK
prerank,regulation of cellular component size (GO:0032535),0.24375710868628933,0.6331526953989495,0.9304029304029304,0.9924793389081215,1.0,9/30,26.52%,RARG;RAB22A;VAV1;RAC1;MTOR;LAMTOR4;MSN;RIN3;PTEN
prerank,osteoclast differentiation (GO:0030316),0.25363180664046864,0.6331320642047822,0.9144654088050315,0.9921411334750583,1.0,3/22,9.63%,SNX10;CSF1;MAPK14
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.26587384521835444,0.6330064945132945,0.9001367989056087,0.9918887556536788,1.0,2/17,14.78%,PLA2G12A;LPGAT1
prerank,regulation of mitochondrial translation (GO:0070129),0.2598431613377332,0.6325716251387762,0.9101876675603218,0.9918723733976215,1.0,6/21,20.76%,NGRN;RCC1L;ALKBH1;TRMT10C;FASTKD2;MTG2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.2563306120112264,-0.631501670112372,0.9193083573487032,0.9938612280326975,1.0,2/10,6.56%,PDE3B;RNF157
prerank,negative regulation of ATP metabolic process (GO:1903579),0.26581991348971135,0.6303083559068803,0.9172510518934082,0.9932897907403947,1.0,5/17,24.00%,FIS1;GIT1;TIGAR;HDAC4;PDE12
prerank,protein localization to cell-cell junction (GO:0150105),-0.2252522092476499,-0.6296851346526459,0.9379562043795621,0.9936688559935449,1.0,9/15,34.41%,PAK2;SCRIB;F11R;LSR;ARHGEF18;TJP1;TJP3;CDH5;MPP7
prerank,regulation of interleukin-1 production (GO:0032652),0.2706869998201608,0.6291532313648838,0.9033189033189033,0.9938149772852526,1.0,2/15,10.18%,HMGB1;TMED10
prerank,aortic valve morphogenesis (GO:0003180),0.23494266733563507,0.6291279029494152,0.9295426452410384,0.9934779761780385,1.0,4/30,12.74%,SOX9;SNAI2;SLIT3;RB1
prerank,sphingolipid metabolic process (GO:0006665),0.20539090877779936,0.6282622444944258,0.9760416666666667,0.9937647295549829,1.0,26/108,22.61%,SGPP2;ASAH2;NSMAF;CERS6;DEGS1;ST6GALNAC6;NEU1;VAPB;CERKL;SPHK2;HACD3;B3GALNT1;ACER3;GLB1;SPTLC2;SGPL1;CERS2;GBA2;ELOVL4;GLTP;SPTSSA;SUMF1;PLPP2;ARSA;CERT1;ESYT2
prerank,eye development (GO:0001654),0.22258501010437384,0.6280801203017973,0.9526493799323562,0.9935499900123728,1.0,3/54,8.00%,PITX2;FBN1;MEIS3
prerank,peptidyl-arginine modification (GO:0018195),0.27109887263260646,0.6268827822933143,0.9076305220883534,0.994118812614321,1.0,3/15,20.22%,ART4;PRMT1;KRTCAP2
prerank,purine-containing compound biosynthetic process (GO:0072522),0.2481598287013512,0.6263983965473154,0.9256926952141058,0.9941432699021776,1.0,6/25,18.84%,DCK;HPRT1;ADSL;SHMT1;MTHFD1;AMPD3
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.2518215995938414,0.6259952323542278,0.9252217997465145,0.9941013969251065,1.0,3/23,10.75%,ITGA3;SMAD2;DKK3
prerank,establishment of skin barrier (GO:0061436),0.26506927011617337,0.6255597876521394,0.9167842031029619,0.9936914277120338,1.0,1/15,8.66%,MET
prerank,regulation of water loss via skin (GO:0033561),0.26506927011617337,0.6255597876521394,0.9167842031029619,0.9936914277120338,1.0,1/15,8.66%,MET
prerank,negative regulation of interleukin-6 production (GO:0032715),0.24104440592441198,0.6255280992817487,0.9378960709759189,0.9933593705016737,1.0,3/27,10.58%,SLAMF1;CX3CL1;ZC3H12A
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.30176202068809066,0.6251991553810781,0.9141630901287554,0.9932584190988841,1.0,4/10,23.04%,SH3BP1;OPHN1;RAP2A;MSN
prerank,regulation of metal ion transport (GO:0010959),0.26657750432160277,0.6240099062073384,0.9164345403899722,0.9937905039603612,1.0,1/16,2.31%,CAMK2B
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.20680649631237888,0.6239788435735141,0.9782833505687694,0.9934630584087729,1.0,20/112,20.36%,WNT5A;GDF9;ACVR1;USP15;SOX9;SMAD2;BAMBI;ARRB2;ZFP36L1;COL3A1;SMURF1;NR3C1;LIMS1;BMPR1A;SOX5;PDE3A;FNTA;ACVRL1;APPL2;WWOX
prerank,sensory perception of mechanical stimulus (GO:0050954),0.20911325599747485,0.6236406344080444,0.9626068376068376,0.993360390137091,1.0,8/85,12.53%,LRP2;NDUFB9;MYO3B;SNAI2;ALDH7A1;P2RX4;ADGRV1;COL11A2
prerank,negative regulation of TOR signaling (GO:0032007),0.22644358654098337,0.6229799380919046,0.938347718865598,0.9934879780034732,1.0,12/36,26.92%,KPTN;DDIT4;AKT1S1;NPRL2;TSC1;NPRL3;STK11;UBR2;UBR1;FNIP1;SZT2;SESN1
prerank,vesicle transport along actin filament (GO:0030050),0.26106299936290395,0.6227912945768562,0.928763440860215,0.9932842580239284,1.0,3/19,13.68%,MYO1C;FNBP1L;MYO6
prerank,actin polymerization or depolymerization (GO:0008154),0.22142471397500751,0.6226937343986392,0.9526493799323562,0.993004962282185,1.0,15/50,26.01%,EVL;GAS7;CORO7;GSN;RAC1;JAK2;AIF1;CFL2;TTC17;DSTN;MSRB1;TWF1;ANG;DIAPH1;WASHC5
prerank,pore complex assembly (GO:0046931),0.26037768097865105,0.6225939260507254,0.8985695708712613,0.9927283644369621,1.0,4/19,19.09%,NUP153;BAD;AHCTF1;PLEKHA7
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.20891468165655014,0.6225579469986021,0.9741100323624595,0.992397354564187,1.0,21/80,24.95%,ACTR2;KCTD17;CYFIP1;ACTR3;CCDC88A;AGRN;DEF8;FNBP1L;NRP1;RAC1;MIEN1;PLCE1;ARAP1;NCKAP1;ENTR1;BRK1;DOCK11;CDC42EP3;TENM1;PIK3CA;BBS4
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.2406759553342311,0.6225218085435247,0.9329896907216495,0.9920708613742519,1.0,1/27,1.21%,CAMK2D
prerank,neural crest cell development (GO:0014032),0.22239639391158006,0.6214389243509504,0.9603729603729604,0.9925110743472839,1.0,5/44,8.80%,SEMA4D;TCOF1;SNAI2;NOLC1;GDNF
prerank,negative regulation of interferon-beta production (GO:0032688),0.2871175232340937,0.6204923468419502,0.8916030534351145,0.9928251165329602,1.0,4/10,24.57%,RELB;REL;SIRPA;PTPRS
prerank,negative regulation of wound healing (GO:0061045),-0.1813794643953003,-0.6199691648976807,0.9585492227979274,0.9981525462733143,1.0,6/28,24.07%,SLC12A2;CLASP2;VTN;CD109;CLASP1;THBD
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.22269558981099763,-0.6189807535619224,0.9446254071661238,0.9974133880174316,1.0,5/15,24.87%,NLGN2;CLN3;ZDHHC12;CNTNAP4;DRD2
prerank,activation of phospholipase C activity (GO:0007202),0.2341856408813463,0.618763958259895,0.9366286438529785,0.9937070572356373,1.0,3/29,11.91%,BDNF;GNA15;HTR2A
prerank,protein polyglutamylation (GO:0018095),0.2862881712983193,0.6185879768450742,0.9181286549707602,0.9934724845078295,1.0,2/11,14.62%,TTLL7;CFAP20
prerank,response to interleukin-4 (GO:0070670),-0.2501572758637211,-0.6183988033226114,0.9072463768115943,0.9964389662081924,1.0,5/10,33.97%,JAK3;SHPK;LEF1;TCF7;GATA3
prerank,regulation of myelination (GO:0031641),0.24243629207488768,0.6178129475364847,0.9307304785894207,0.9936786476267893,1.0,3/25,8.79%,NKX6-2;TMEM98;CST7
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.2744258168057252,0.6177119020888131,0.920114122681883,0.9933961867662328,1.0,3/14,25.43%,CSF1;TYROBP;TNF
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.2345004749541287,-0.617685973016242,0.9333333333333333,0.9955280560659112,1.0,8/12,39.32%,BIN1;TRPM4;CAV1;JUP;DSG2;RYR2;CACNA1C;DSP
prerank,cGMP-mediated signaling (GO:0019934),0.27373067877334784,0.6159398551677653,0.9193776520509194,0.99428058999166,1.0,5/13,27.86%,APOE;PDE3A;PDE9A;GUCY1B1;HTR2B
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.1998681936419612,-0.6158504046984474,0.9631147540983607,0.9951880068239798,1.0,6/20,18.31%,PPIL3;FKBP4;PPIL2;NKTR;PPIL1;FKBP1B
prerank,natural killer cell mediated immunity (GO:0002228),0.26681738713834957,0.6154085044497121,0.9098591549295775,0.9942948375014705,1.0,3/15,15.53%,LYST;PLEKHM2;TUBB4B
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.1923897122696503,-0.6148497660033138,0.9788135593220338,0.9944330343890774,1.0,10/22,30.39%,NBN;RASSF2;RAP2C;NEK10;TOM1L1;MRE11;RAD50;PDGFC;GREM1;PDGFD
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.23516301815580085,-0.6143365333759865,0.9117647058823529,0.9933570914988721,1.0,6/12,27.29%,LARP7;NELFB;NELFE;HEXIM1;NELFA;RNF168
prerank,response to hydrogen peroxide (GO:0042542),0.22269834838830888,0.6131231764181333,0.9569767441860465,0.9955503114692016,1.0,12/45,23.75%,TRPM2;FXN;PLEKHA1;ANKZF1;FYN;STK25;STK24;SIRPA;PRKCD;OSER1;PRDX3;HDAC6
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.2888438000775906,0.6123278371800972,0.9161849710982659,0.9957521744202346,1.0,3/11,17.78%,AGO2;SOAT1;ITM2C
prerank,regulation of actin filament-based process (GO:0032970),0.20798701948793058,0.6118419339235375,0.971677559912854,0.9957424294458178,1.0,17/70,22.76%,BST2;RHOF;PAK3;CCDC88A;CDK10;RAC1;CRK;TAOK2;SH3BP1;BAIAP2;MTOR;TESK1;ARHGAP18;RND2;RHOH;PRKCD;IQGAP2
prerank,negative regulation of actin filament polymerization (GO:0030837),0.24444628563833537,0.6112862924370751,0.9423328964613368,0.9957614688635053,1.0,9/22,29.85%,KANK1;SSH3;GSN;PRKCD;TWF1;PFN2;SLIT2;ARFGEF1;PFN1
prerank,manganese ion transport (GO:0006828),0.27011228604416193,0.6111765001424097,0.9212707182320442,0.9954882046189646,1.0,6/14,28.80%,SLC11A2;TRPC4;TRPC1;TMEM165;SLC11A1;TRPC7
prerank,regulation of axon extension (GO:0030516),0.22769498164594068,0.6097818657467807,0.9491124260355029,0.996065067202639,1.0,6/37,15.17%,RUFY3;MT3;DNM2;MAG;APOE;DBNL
prerank,L-serine metabolic process (GO:0006563),0.285545287080642,0.6096441653501393,0.900611620795107,0.9958053750421635,1.0,2/10,13.77%,PHGDH;SHMT1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.22772733944322704,-0.6096004008982173,0.9366666666666666,0.99455776312186,1.0,3/12,23.50%,CCR2;IL1R1;IL1B
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.22112341988172793,0.6086752596884992,0.9516324062877872,0.9960975426667964,1.0,5/38,16.74%,CAMK2D;CTNNA3;AKAP9;SCN1B;KCNJ2
prerank,regulation of striated muscle contraction (GO:0006942),-0.18040292153956855,-0.6086483770255489,0.9894179894179894,0.9937067349066602,1.0,13/27,37.35%,DMD;SLC8A3;GRK2;TNNI1;SRI;NOS1;HCN4;RNF207;RYR2;MYL2;MYBPC3;TNNT3;ATP1A2
prerank,histone H3-K4 trimethylation (GO:0080182),0.27904647160358875,0.6072461806578614,0.9030303030303031,0.9966806720154011,1.0,3/11,22.76%,KMT2A;TET2;KMT2D
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.2451755844875282,-0.6068924106742929,0.9514285714285714,0.9932610899372295,1.0,3/10,22.34%,ANK3;CAV1;KCNAB1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.19281891028886855,0.6065472596781062,0.9948612538540597,0.9967939981840274,1.0,25/159,21.77%,PCDHB13;PLXNB2;CDH13;ACVR1;NECTIN4;PLXNB3;CDH9;NECTIN3;MAG;SDK1;PCDHB16;CD84;CLDN10;NPTN;HMCN1;DSCAM;DSCAML1;MPZ;CLDN11;LRRC4;PTPRF;FGFRL1;VCAM1;TENM4;KIRREL3
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.21188097984963614,0.6052467052837959,0.9597238204833142,0.9972577461873335,1.0,19/52,28.72%,ITGA3;CIB1;PRKCE;STX4;DLG1;PRKCH;STAC3;PTPN9;ZDHHC8;NUMA1;PDPK1;WNK3;DPP10;TNF;LRP1;SPTBN1;ITGB1;STAC2;PIK3R1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.24147147957594634,-0.6043404949446629,0.9411764705882353,0.9931654428161735,1.0,1/10,3.12%,LRP6
prerank,cardiolipin metabolic process (GO:0032048),0.26662805061837946,0.6041978719446837,0.9195402298850575,0.9976290554784479,1.0,4/13,21.55%,SLC27A1;HADHA;PLA2G6;PNPLA8
prerank,neuron projection fasciculation (GO:0106030),0.28598501412298416,0.6038003905952576,0.9216589861751152,0.9975301454891051,1.0,1/10,5.75%,EPHA4
prerank,regulation of cell communication (GO:0010646),0.22701312505841964,0.6019125198363751,0.9576783555018138,0.9983942544546568,1.0,2/35,3.74%,CAMK2D;SLC8A1
prerank,regulation of B cell differentiation (GO:0045577),0.253643490004141,0.6015198746755676,0.9298245614035088,0.9982997452523668,1.0,4/17,15.89%,MMP14;ZFP36L1;XBP1;CD27
prerank,cellular response to hydrogen peroxide (GO:0070301),0.22895940360552663,0.6014411615045318,0.9511599511599511,0.997992329447596,1.0,8/33,23.75%,TRPM2;FXN;PLEKHA1;ANKZF1;SIRPA;PRKCD;OSER1;HDAC6
prerank,glial cell differentiation (GO:0010001),0.22951516568559358,0.6008192020393088,0.9571788413098237,0.9980267574628029,1.0,3/28,8.82%,STAT3;SOX9;NFIB
prerank,polarized epithelial cell differentiation (GO:0030859),0.2713568546712122,0.6007993310430566,0.9320388349514563,0.9976867761495565,1.0,6/13,27.22%,SH3BP1;OPHN1;RAP2A;RAB10;MSN;ZDHHC7
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.24430398371612105,-0.599478194434041,0.9361702127659575,0.994120323690546,1.0,4/10,33.41%,HERPUD1;CCL2;EIF2AK3;QRICH1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.2199526617428574,0.5988678690530927,0.9520383693045563,0.9985178569224094,1.0,5/37,11.26%,CYLD;MAPRE1;STMN4;STMN3;PHLDB1
prerank,negative regulation of glycolytic process (GO:0045820),-0.2409701839578795,-0.5984240704402892,0.9316239316239316,0.9919866605545058,1.0,1/10,2.11%,CBFA2T3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.2409701839578795,-0.5984240704402892,0.9316239316239316,0.9919866605545058,1.0,1/10,2.11%,CBFA2T3
prerank,tRNA transport (GO:0051031),0.2256038299294725,0.5979275409212207,0.948502994011976,0.998721990620569,1.0,12/35,27.81%,NUP37;NUP153;RAE1;NUP155;NUP88;NUP133;NUP43;NOL6;NUP205;SEH1L;NUP188;RANBP2
prerank,positive regulation of axon extension (GO:0045773),0.24499275757223038,0.5978267336182252,0.954367666232073,0.9984294461280425,1.0,4/22,15.86%,RUFY3;NRP1;DBNL;DSCAM
prerank,glycogen catabolic process (GO:0005980),0.2576315163013554,0.5975728225175629,0.9264497878359265,0.9982363087062811,1.0,3/15,16.50%,PGM2L1;RB1CC1;PHKG2
prerank,axonal transport of mitochondrion (GO:0019896),0.27420590151104907,0.5972436315380777,0.9190751445086706,0.9980937725543809,1.0,1/11,5.76%,TRAK1
prerank,regulation of interleukin-13 production (GO:0032656),0.2656764106618181,0.5971329653667091,0.9128571428571428,0.9978056375890015,1.0,3/13,16.80%,SPHK2;IL18;LGALS9
prerank,sphingolipid biosynthetic process (GO:0030148),0.20293725670919555,0.5968369997512798,0.9730312837108953,0.9976376087118641,1.0,16/71,22.39%,SGPP2;ASAH2;CERS6;DEGS1;VAPB;SPHK2;HACD3;ACER3;ST8SIA1;SPTLC2;SGPL1;CERS2;ELOVL4;SPTSSA;PLPP2;CERT1
prerank,negative regulation of hormone secretion (GO:0046888),-0.23735955525231894,-0.5961230401249212,0.9454022988505747,0.9917366882065473,1.0,2/10,23.50%,OSM;IL1B
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.20521865306462794,0.5958201636884977,0.9719730941704036,0.997913185933171,1.0,6/54,16.74%,KCNMB3;CAB39;GABBR2;DLG1;STK39;KCNJ2
prerank,transcription preinitiation complex assembly (GO:0070897),0.2730258621572166,0.5954554638834749,0.9273255813953488,0.9977854120429368,1.0,2/12,12.89%,BDP1;TAF1B
prerank,mitochondrial membrane organization (GO:0007006),0.22450989874142355,0.594836862945017,0.9490291262135923,0.9977993471564955,1.0,5/32,13.10%,RCC1L;CHCHD6;TIMM50;SAMM50;BAD
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.2794927140621831,0.594129804456138,0.9295558958652373,0.9978660970177341,1.0,1/10,5.99%,CDT1
prerank,positive regulation of blood coagulation (GO:0030194),0.25345071707610367,0.5940461995134882,0.9439124487004104,0.9975673825356351,1.0,2/17,10.66%,USF1;HPSE
prerank,intermediate filament organization (GO:0045109),0.25095940083875923,0.5927966370153224,0.9352226720647774,0.9979438535757369,1.0,2/17,9.80%,BFSP1;DNAJB6
prerank,"wound healing, spreading of cells (GO:0044319)",0.23490019990698757,0.5926692894979098,0.925,0.9976643179599867,1.0,9/24,31.63%,MRTFA;PDPN;ARHGAP24;ACVRL1;FLNA;PDCD10;CCN1;TOR1A;ARHGAP35
prerank,regulation of macrophage activation (GO:0043030),0.22543323099339727,0.5915645678784449,0.9433497536945813,0.9979613656200399,1.0,4/30,14.67%,WNT5A;ZC3H12A;FCGR2B;TNIP2
prerank,axonal fasciculation (GO:0007413),0.2671259544017179,0.5913494905171975,0.9422799422799423,0.997737915556139,1.0,1/12,5.75%,EPHA4
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.19679435098716397,0.5911516348234164,0.9796355841371919,0.9975142704362282,1.0,17/82,18.82%,DYNC1H1;ACTR1A;MAPRE1;CDK5RAP2;PRKAR2B;NPM1;NEDD1;CEP131;CEP152;CEP70;AKAP9;DYNLL1;HSP90AA1;TUBB4B;DCTN3;PAFAH1B1;CEP135
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.21395387139161037,0.5897973331547247,0.9734104046242774,0.9979308525992997,1.0,5/44,9.80%,CDKN2D;IGBP1;MT3;CST7;DNAJB6
prerank,clathrin coat assembly (GO:0048268),0.256603492891496,0.5896110336091103,0.9353932584269663,0.9976862257104913,1.0,2/15,10.58%,NSG2;AP2S1
prerank,regulation of regulated secretory pathway (GO:1903305),0.21967457865385218,0.5895668885515553,0.9588235294117647,0.9973627823092267,1.0,12/34,26.75%,SYT7;UNC13D;SYT3;PREPL;DTNBP1;VPS18;SYN1;SYT11;SYT12;RAB3A;RAB3D;SYT4
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.26254681671499774,0.5894672164326359,0.924822695035461,0.99707114890278,1.0,3/13,17.39%,JAK2;MGAT5;PTPRC
prerank,positive regulation of calcium ion transport (GO:0051928),0.21879857686320303,0.5885710313085947,0.9671532846715328,0.9972252484428843,1.0,4/36,10.75%,CCL5;P2RX4;SPHK2;CRACR2A
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.25994048843230483,0.5883278351603645,0.9302649930264993,0.9970243441961191,1.0,3/14,16.22%,IL17D;CD84;IL18
prerank,secondary alcohol biosynthetic process (GO:1902653),0.2255629022921993,0.5882269210447635,0.9543209876543209,0.9967236690245144,1.0,9/30,27.10%,HSD17B7;FDFT1;GGPS1;IDI1;EBP;HMGCS1;HMGCR;PLPP6;ACAT2
prerank,positive regulation of protein processing (GO:0010954),0.2409819720656862,0.5866414414270849,0.9374167776298269,0.9972926532481045,1.0,3/19,18.17%,ADAM8;GSN;MYH9
prerank,placenta development (GO:0001890),0.26569684589860554,0.5862242466272147,0.9389880952380952,0.9971760127463378,1.0,1/12,6.27%,CUL7
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.24622144459608855,0.5857371096428062,0.9402390438247012,0.9971028782370076,1.0,2/18,9.53%,GNA15;AGRN
prerank,signal transduction by p53 class mediator (GO:0072331),0.2224785335915012,0.5850404384240386,0.9473023839397742,0.9971523215737705,1.0,4/30,13.68%,MYBBP1A;DDX5;PAXIP1;MYO6
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.2512796084425119,0.5841726100794358,0.9435483870967742,0.9972657721790597,1.0,8/16,31.01%,ATIC;ADSL;AMPD3;LHPP;PAICS;ADSS2;PFAS;AMPD2
prerank,spermatid development (GO:0007286),0.22367750086119897,0.5831559879447124,0.9722891566265061,0.9974732487974741,1.0,4/32,14.26%,NME5;CIB1;CDYL;ZMYND15
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.22324150880092722,0.5829944707620524,0.9629629629629629,0.9972168640496536,1.0,5/29,14.87%,CAMK2B;NETO1;APP;APOE;SYNGR1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.23705069136565662,0.5829588619797249,0.9445178335535006,0.9968889919637411,1.0,6/21,27.95%,AKAP9;SCN1B;FLNA;ANK2;SCN4B;CACNA1D
prerank,establishment of mitotic spindle localization (GO:0040001),0.22645048736413198,0.5818672496476346,0.956949569495695,0.9970914905611061,1.0,6/28,19.17%,KPNB1;CDK5RAP2;UBXN2B;PAFAH1B1;NUMA1;NDC80
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.2733128382209194,0.5812095364568879,0.9233128834355828,0.9970975157491215,1.0,1/10,6.71%,NT5C3A
prerank,lipid modification (GO:0030258),0.2128008689466625,0.579586340312388,0.9732360097323601,0.9976036265010609,1.0,11/37,25.45%,SGPP2;DGKB;DGKK;EPHX2;DGKA;DGKI;PLPP2;PLPPR2;PLPPR1;PLPP6;PLPP1
prerank,heart trabecula morphogenesis (GO:0061384),-0.1865477410722748,-0.578022778992631,0.9769230769230769,0.9979966179932844,1.0,13/18,46.81%,TGFBR3;TGFB2;S1PR1;BMP5;TEK;HEY1;BMP7;NOG;ADGRG6;DLL4;RBP4;ENG;NRG1
prerank,negative regulation of phosphatase activity (GO:0010923),0.2292279124086606,0.5759985935845446,0.9569620253164557,0.9991144538313803,1.0,4/25,14.97%,SEMA4D;PPP1R11;PPP1R26;MASTL
prerank,regulation of sodium ion transport (GO:0002028),0.21123729781219835,0.5734749300767301,0.9711417816813049,1.0,1.0,6/34,16.16%,CNKSR3;P2RX4;AHCYL1;SIK1;DLG1;SCN1B
prerank,smooth muscle contraction (GO:0006939),0.2514553206312712,0.5733380428574176,0.943213296398892,0.9997216340861563,1.0,2/14,15.10%,SLC8A1;CHRNB2
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.2489893507124376,0.5716422234746694,0.9354838709677419,1.0,1.0,2/13,15.78%,UBA2;UBA1
prerank,protein deneddylation (GO:0000338),0.272383124684184,0.5712039355829158,0.9295558958652373,1.0,1.0,3/10,22.06%,COPS7B;COPS8;COPS7A
prerank,regulation of organelle organization (GO:0033043),0.1905619614704287,0.5702468976373536,0.986272439281943,1.0,1.0,8/80,12.56%,CLIC4;FIS1;SYDE1;CDT1;VPS11;SPEF1;STMN3;AKAP9
prerank,anterior/posterior pattern specification (GO:0009952),0.20369037428382747,0.5694880859238669,0.9809843400447428,1.0,1.0,5/53,12.43%,BHLHE40;SMAD2;HOXA9;BMPR2;HOXB6
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.25988964231386347,0.5692290901768764,0.9544787077826725,1.0,1.0,2/12,11.86%,NEK9;NEK6
prerank,regulation of collagen biosynthetic process (GO:0032965),0.23689644571465998,0.5684394162810142,0.9742895805142084,1.0,1.0,2/19,9.10%,RUNX1;SCX
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.24666956680600605,0.5680024702778352,0.9442119944211994,0.9999177049691121,1.0,3/15,11.86%,CDC16;CDC27;NEK6
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.2495108232542143,0.5679513953990147,0.9382352941176471,0.999593966263984,1.0,3/13,18.96%,GFPT1;SLC35A3;UAP1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.24493422833213122,0.5672171318299211,0.948509485094851,0.99958866461361,1.0,5/17,22.49%,CYFIP1;GMFB;CORO1B;NCKAP1;BRK1
prerank,myeloid cell differentiation (GO:0030099),0.20430024724730034,0.566209322800523,0.9860950173812283,0.9996987875084247,1.0,11/47,22.92%,RUNX1;LYN;IKZF1;JAK2;TET2;KAT8;SNRK;FLVCR1;MFHAS1;PRDX3;KAT6A
prerank,positive regulation of locomotion (GO:0040017),0.2196995982835937,0.5655289127681418,0.9641025641025641,0.9996628703577387,1.0,6/27,20.59%,PPM1F;STX4;CFAP20;AIF1;CAVIN1;CCDC25
prerank,female gonad development (GO:0008585),-0.1808566887677447,-0.5654741726470134,0.9790794979079498,1.0,1.0,5/19,23.35%,NR2F2;CEBPB;NUP107;INHBA;COL9A3
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.2576544895749754,0.565451176579675,0.9509954058192955,0.9993563435375041,1.0,3/12,18.26%,ABCD1;FADS2;ACOX1
prerank,telomere capping (GO:0016233),0.24293777585276077,0.565416376752528,0.9539106145251397,0.9990295384363568,1.0,5/16,19.65%,PRKDC;STN1;DCLRE1A;TERF2;DCLRE1C
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.23566569575039467,0.5653356488080036,0.9470108695652174,0.9987210122362857,1.0,2/17,13.31%,RAPGEF2;AKAP13
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.21890709017283932,-0.5649659553762224,0.9647435897435898,0.9988357399973727,1.0,3/11,22.16%,GSTO1;FKBP1B;SRI
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.21890709017283932,-0.5649659553762224,0.9647435897435898,0.9988357399973727,1.0,3/11,22.16%,GSTO1;FKBP1B;SRI
prerank,negative regulation of hemostasis (GO:1900047),-0.21208315993394175,-0.5649324054328708,0.975,0.9975236381738898,1.0,6/12,40.10%,VTN;THBD;CD34;APOH;ADTRP;TFPI
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.24850073507214715,0.563387060730568,0.9558404558404558,0.9992556900023771,1.0,7/15,31.28%,BMPER;FGF2;PDPK1;JAK1;SMAD1;FGF1;JMJD8
prerank,oligodendrocyte differentiation (GO:0048709),0.23347052294564052,0.5632328814064379,0.9551630434782609,0.998974706512826,1.0,4/19,18.89%,SOX9;EIF2B2;EIF2B5;EIF2B3
prerank,leukocyte cell-cell adhesion (GO:0007159),0.22735164790295298,0.5621908295868293,0.9674054758800521,0.9990996881840951,1.0,3/24,10.15%,SEMA4D;CCL5;TNIP1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.25848167986165077,0.5615826291837894,0.9462209302325582,0.9990280085267321,1.0,3/12,22.27%,IDH1;GLUD1;IDH3A
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.24435140811732903,0.5595020546251082,0.9532967032967034,0.9995739724383679,1.0,2/15,17.53%,FGFR2;MTHFD1
prerank,dicarboxylic acid catabolic process (GO:0043649),0.24841993487929043,0.5584071396351479,0.9579579579579579,0.9996972322428705,1.0,4/13,26.69%,GLUD1;GAD1;GOT1;MTHFS
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.19295061407620395,0.5564975809131986,0.9888517279821628,1.0,1.0,15/65,23.42%,SPRY2;PMEPA1;FBN1;SMAD2;BAMBI;SKIL;SMURF1;HTRA3;SPRED3;SPRED1;SNX25;PIN1;SMURF2;STUB1;PDPK1
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.2069423967593459,-0.5564932693429824,0.972027972027972,0.9989480432046053,1.0,4/13,25.18%,DDAH1;PRODH;ALDH4A1;NOS1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.24955777702899995,0.555999481778607,0.9510791366906475,1.0,1.0,6/12,30.16%,ATIC;ADSL;LHPP;PAICS;ADSS2;PFAS
prerank,nucleoside catabolic process (GO:0009164),0.2547228118168485,0.5548292860273811,0.943939393939394,1.0,1.0,4/11,29.47%,NT5C3A;DERA;NT5C;DPYD
prerank,spinal cord development (GO:0021510),0.254466656117879,0.5527789566246002,0.947289156626506,1.0,1.0,2/12,18.18%,VIT;NF1
prerank,inorganic anion transmembrane transport (GO:0098661),0.1895782541538763,0.5515888741509921,0.9891304347826086,1.0,1.0,17/63,22.96%,SLC12A5;SLC25A10;SLC12A8;GLRA2;SLC26A2;SLC37A2;ANO5;CLCN1;SLC20A2;GABRG1;SLC37A1;SLC5A6;GLRA1;GABRB2;SLC1A3;SLC25A30;GABRA3
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.23159659718585407,0.5514757893204499,0.9789473684210527,1.0,1.0,4/17,23.05%,VAMP2;KCNRG;KCNS1;SUMO1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.2625545746207443,0.5507557549433191,0.9473684210526315,1.0,1.0,1/10,4.54%,GAP43
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.18995247071858923,0.5499089665787407,0.9903948772678762,1.0,1.0,11/75,18.67%,CNGB1;GNG4;CCL5;CAMKMT;GIT1;RGS16;METAP2;TULP3;PLCE1;FNTA;MGRN1
prerank,mitochondrion transport along microtubule (GO:0047497),0.2467795777868102,0.549887998131338,0.9550072568940493,1.0,1.0,5/13,27.43%,UXT;RHOT2;OPA1;LRPPRC;MAP1S
prerank,peptidyl-methionine modification (GO:0018206),0.2521560898985643,0.5498159905251898,0.9507042253521126,0.9997412623923209,1.0,2/12,16.65%,NAA25;METAP2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.2015354818197237,0.5493513781505956,0.9829268292682927,0.9995716614715155,1.0,5/37,15.33%,SOD2;DNMT1;LDLRAP1;FGF9;BMPR1A
prerank,amino acid import (GO:0043090),0.22355382581704694,0.5488173327115022,0.9730820995962315,0.9994346095033119,1.0,6/21,26.95%,SFXN2;SFXN1;SLC6A6;SLC1A3;SLC36A1;SLC22A4
prerank,response to molecule of bacterial origin (GO:0002237),0.18671251158320162,0.5478010086750207,0.9847328244274809,0.9994507905277392,1.0,18/69,27.05%,C4B;SLPI;GCH1;GGT7;FCGR2B;JAK2;IRAK1;ACOD1;LGALS9;PRDX3;PELI1;IRF5;OTUD5;SIRT2;MAPKAPK2;NOCT;FER;LY96
prerank,I-kappaB phosphorylation (GO:0007252),0.2584523837467309,0.5469537161963691,0.9517543859649122,0.9994448939500007,1.0,3/10,23.37%,TLR2;TLR3;TLR7
prerank,cellular glucan metabolic process (GO:0006073),-0.2110734941735939,-0.5455481521327458,0.9761904761904762,1.0,1.0,8/11,46.35%,GSK3B;PPP1R3C;GBE1;PRKAG2;PYGM;PHKB;PHKA1;G6PC1
prerank,synaptic vesicle membrane organization (GO:0048499),0.2300070882413781,0.5450250645332385,0.9698216735253772,0.9998088330009917,1.0,3/17,14.87%,STX4;SNAP23;SYNGR1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.25594780816008367,0.5438524822165436,0.9587628865979382,0.9998968804425986,1.0,3/11,17.33%,UNC93B1;TNIP2;TLR3
prerank,GTP metabolic process (GO:0046039),-0.19385687629853193,-0.5437320872855735,0.9812734082397003,1.0,1.0,7/15,31.81%,MFN1;RHOQ;IMPDH2;GTPBP1;GNAI3;IMPDH1;EFL1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.21912508078138074,0.5436016659970345,0.9784263959390863,0.999646977518955,1.0,5/24,22.12%,DNMT3A;DNMT1;EZH2;SMYD5;TASOR
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.21160221179662825,0.5420694394713808,0.9761904761904762,0.9998596625246587,1.0,8/28,25.38%,PAK3;DBNL;SH3BP1;ABITRAM;GBA2;ARHGAP18;BRK1;PFN2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.2178637681936622,0.5402268147875834,0.9654289372599232,1.0,1.0,11/24,32.65%,MT3;ATF6B;RBPJ;NOTCH1;ATF6;CHD6;ATF4;KLF2;HSF1;SESN2;DDIT3
prerank,establishment of melanosome localization (GO:0032401),0.22409910344678308,0.539426809608622,0.9642857142857143,1.0,1.0,6/19,26.48%,RAB11B;BBS2;RAB11A;BBS7;BBS4;SHROOM2
prerank,2-oxoglutarate metabolic process (GO:0006103),0.2373813853542336,0.5377953314196896,0.9739507959479016,1.0,1.0,3/13,22.04%,IDH1;GPT2;GOT1
prerank,circulatory system development (GO:0072359),0.17503304313391116,0.5373173032497646,0.9958419958419958,1.0,1.0,26/118,24.77%,ACVR1;FBXW7;SOX9;SRF;FBN1;ADAP2;NOTCH4;COL3A1;PTPN11;AKAP13;POU6F1;MEF2A;PDLIM3;SH3PXD2B;MTHFD1;PLCE1;NF1;ACVRL1;BCOR;STK11;CITED2;ERBB3;NOTCH1;KAT2B;PIK3CA;ECE1
prerank,Notch signaling involved in heart development (GO:0061314),0.24996029623028485,0.5363189500744097,0.9581529581529582,1.0,1.0,3/11,23.22%,SNAI2;RBPJ;NOTCH1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.21329071711420533,0.5355352205447004,0.9690322580645161,1.0,1.0,3/23,17.44%,ARRB2;LGALS9;LAMP1
prerank,regulation of response to oxidative stress (GO:1902882),0.2517584842749259,0.5348681617936808,0.9623493975903614,0.9999000009748407,1.0,2/11,12.06%,ABCD1;GGT7
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.1877903606858032,0.5335899745547695,0.9942987457240593,0.999988059605444,1.0,1/53,0.65%,AGT
prerank,establishment of mitotic spindle orientation (GO:0000132),0.2109944959785128,0.5270813636858724,0.9811794228356336,1.0,1.0,8/23,27.50%,CDK5RAP2;UBXN2B;PAFAH1B1;NUMA1;NDC80;DCTN1;MAD2L1;ITGB1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.21757144822838356,0.5269941865730193,0.9801324503311258,1.0,1.0,7/20,28.85%,AGRN;CHRNB2;LY6G6D;RGS10;CHRM3;CDK5R1;GNB1
prerank,T cell activation involved in immune response (GO:0002286),0.23917137476459505,0.5258877320248267,0.9719350073855244,1.0,1.0,12/12,76.10%,MDK;SLC11A1;LILRB1;IFNK;F2RL1;CD74;TNFSF18;ICAM1;EIF2AK4;ITGAL;FCER1G;LCP1
prerank,negative regulation of vascular permeability (GO:0043116),-0.19391432820614143,-0.5251157415257319,0.9777777777777777,1.0,1.0,5/12,35.32%,DDAH1;CEACAM1;PDE2A;RAMP2;CLDN5
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.23561256193678515,0.5249816341574618,0.976551724137931,1.0,1.0,3/12,20.60%,MDK;FUT9;LCK
prerank,"base-excision repair, AP site formation (GO:0006285)",0.22277381284851772,0.5234588989296133,0.9752407152682255,1.0,1.0,4/17,18.99%,MPG;TDG;NEIL2;TERF2
prerank,cholesterol biosynthetic process (GO:0006695),0.19985396795560656,0.5230709196979094,0.9901719901719902,1.0,1.0,9/31,27.10%,HSD17B7;FDFT1;GGPS1;IDI1;EBP;HMGCS1;HMGCR;PLPP6;ACAT2
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.2106044350308861,-0.5227135646913567,0.9804469273743017,1.0,1.0,3/10,20.33%,FGF10;MAP4K4;ADAM9
prerank,establishment of endothelial barrier (GO:0061028),0.20223784403188683,0.5221067908846385,0.9846743295019157,1.0,1.0,4/29,13.45%,RAPGEF6;RAPGEF2;TJP2;RAPGEF1
prerank,linoleic acid metabolic process (GO:0043651),0.2217953722352463,0.5217489438077306,0.9578059071729957,1.0,1.0,2/17,12.41%,ABCD1;FADS2
prerank,long-chain fatty acid transport (GO:0015909),0.19476504299557196,0.5216286139172627,0.9913258983890955,1.0,1.0,3/30,12.34%,SLC27A1;ABCD1;APOE
prerank,negative regulation of signaling receptor activity (GO:2000272),0.20307794600277967,0.5215309629929846,0.9920424403183024,1.0,1.0,7/25,27.84%,CRHBP;SOCS5;SOCS4;TSG101;TNF;CBLB;ZGPAT
prerank,long-chain fatty acid metabolic process (GO:0001676),0.178275774090814,0.5185243142710408,0.9954597048808173,1.0,1.0,13/64,24.32%,ASAH2;ACADL;ACSL5;ABCD1;EPHX2;FADS2;DAGLA;ACOX1;GPX4;PNPLA3;PNPLA8;ACSL3;AIG1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.17936837915411408,-0.5171988686920874,0.9962264150943396,1.0,1.0,7/16,30.39%,PIK3C2A;RGS14;ABL1;PDGFRA;PDGFC;PDGFRB;PDGFD
prerank,regulation of T cell differentiation (GO:0045580),0.1932103641877654,0.5171716496058635,0.991358024691358,1.0,1.0,6/33,22.21%,RUNX1;NFATC2;XBP1;MDK;RHOH;PRDM1
prerank,nuclear membrane disassembly (GO:0051081),0.22909482206254583,0.5129558112400061,0.9817158931082982,1.0,1.0,2/14,11.86%,NEK9;NEK6
prerank,protein O-linked glycosylation via serine (GO:0018242),0.24469212688356404,0.5123031283844252,0.9761549925484352,1.0,1.0,3/10,25.24%,GALNT1;GALNT13;MGAT5B
prerank,nuclear pore organization (GO:0006999),0.23011559436692713,0.5116321182294294,0.9761904761904762,1.0,1.0,5/14,26.43%,NUP153;AHCTF1;NUP133;NUP205;SEH1L
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.17112452535733677,-0.5103260830604693,0.9927536231884058,1.0,1.0,8/16,38.07%,SALL1;MYC;PAX8;BMP2;BMP4;FOXD1;SHH;NPNT
prerank,hematopoietic stem cell differentiation (GO:0060218),0.23691984009889624,0.5099194218608054,0.9693877551020408,1.0,1.0,2/10,15.09%,LMBR1L;MLLT3
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.24416759048911668,0.5091063508555075,0.966275659824047,1.0,1.0,2/10,18.92%,PRKCH;NUMA1
prerank,regulation of dopamine secretion (GO:0014059),0.2024879391145077,0.5080027776881131,0.9805194805194806,1.0,1.0,5/25,18.52%,SYT7;SYT3;GDNF;CHRNB2;DTNBP1
prerank,glycerophospholipid catabolic process (GO:0046475),0.19807519200478557,0.5073420875925431,0.9848866498740554,1.0,1.0,6/27,21.55%,LIPC;PNPLA6;ENPP6;PLA2G4E;PLA2G6;PNPLA8
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.17400313971742543,-0.5024800273630865,0.9962406015037594,1.0,1.0,17/17,82.62%,HMGA2;KDM1A;PDCD2;CCNE1;N4BP2L2;TERT;THPO;CITED1;SOX11;NANOG;EPCAM;GJA1;LTBP3;HNRNPU;FERMT2;KAT7;PTPRC
prerank,striated muscle contraction (GO:0006941),0.17672557868496802,0.5009726932592388,0.9977502812148481,1.0,1.0,8/53,22.05%,SLC8A1;TNNC1;ARHGEF11;SCN1B;STAC3;TNNI2;RCSD1;MYH14
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.2272815572100189,0.4994814781766721,0.975,1.0,1.0,2/12,14.17%,STX4;SNAP23
prerank,protein acetylation (GO:0006473),0.18895606347770247,0.4948749350218368,0.9951573849878934,1.0,1.0,7/30,23.96%,NAA50;NAA35;NAT9;ING5;KAT6A;KAT5;KAT2B
prerank,negative regulation of establishment of protein localization (GO:1904950),0.23507151013230113,0.4937102371866167,0.984399375975039,1.0,1.0,4/10,26.65%,PPM1F;SNX12;NDFIP1;DNAJA1
prerank,amino sugar biosynthetic process (GO:0046349),-0.18151445563137084,-0.4922768747106125,0.9969512195121951,1.0,1.0,6/12,32.34%,GNPDA1;PGM3;GNPDA2;NAGK;GFPT2;NANP
prerank,inner mitochondrial membrane organization (GO:0007007),0.17464296316127603,0.49188068669900303,0.9929906542056075,1.0,1.0,10/47,23.42%,ATP5MC1;CHCHD6;DMAC2L;SAMM50;ATP5PO;GHITM;MTX1;ATP5F1B;OPA1;TIMM29
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.20333864334728471,0.4909330391773596,0.9947575360419397,1.0,1.0,7/20,26.38%,MCUR1;MICU2;SMDT1;MICU3;SLC25A23;PMPCB;STOML2
prerank,tRNA 5'-leader removal (GO:0001682),0.2207015240781347,0.4888615760900176,0.9839883551673945,1.0,1.0,4/13,22.98%,RPP30;RPP14;RPP25L;RPP21
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.18567214962012243,-0.4859171753151937,0.9857549857549858,1.0,1.0,5/11,30.33%,MIF;NBL1;CCN3;GREM1;DUSP1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.20678226283011103,0.4852904437552763,0.9891304347826086,1.0,1.0,2/17,13.10%,SOX9;BAD
prerank,regulation of biosynthetic process (GO:0009889),0.2195461339751324,0.4832255444899551,0.9852941176470589,1.0,1.0,1/11,9.98%,SPHK2
prerank,aorta development (GO:0035904),0.21318472219797463,0.48270963427368774,0.9828571428571429,1.0,1.0,2/14,17.28%,TFAP2B;HECTD1
prerank,positive regulation of behavior (GO:0048520),0.2305345170006888,0.4805375560978389,0.9876543209876543,1.0,1.0,2/10,23.61%,CFAP20;AGRP
prerank,cytosolic calcium ion transport (GO:0060401),0.18794969248900067,0.4797077434723893,0.9913473423980222,1.0,1.0,3/28,13.16%,SLC8A1;MCUR1;MICU2
prerank,rRNA pseudouridine synthesis (GO:0031118),0.22593110677177572,0.4761273651882668,0.9877862595419847,1.0,1.0,3/10,24.55%,GAR1;RPUSD1;NHP2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.16432249152329526,-0.475708738686383,0.9959839357429718,1.0,1.0,16/16,83.59%,TRAF6;RHOA;ITGB2;ST3GAL4;FUT4;ETS1;ALOX5;SELE;SELP;FUT7;IL6;RELA;NFAT5;TNF;MDK;IRAK1
prerank,cell differentiation in hindbrain (GO:0021533),0.22301593453750498,0.4756137264802453,0.9833333333333333,1.0,1.0,2/11,16.35%,PROX1;OPHN1
prerank,negative regulation of calcium ion transport (GO:0051926),0.20592097288686895,0.47518758064892397,0.9809663250366032,1.0,1.0,3/15,19.68%,SLC30A1;INPP5K;CD33
prerank,negative regulation of ion transport (GO:0043271),0.18875252408921797,0.47399975377345704,0.9973404255319149,1.0,1.0,5/24,24.70%,ACTN2;INPP5K;CD33;SYT11;WNK3
prerank,cardiac myofibril assembly (GO:0055003),0.2037253823853317,0.47380848644931906,0.9918032786885246,1.0,1.0,3/15,22.75%,PROX1;MEF2A;NRAP
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.21120266401641474,0.4736289374867208,0.9825072886297376,1.0,1.0,4/13,22.90%,AK4;AK3;ENTPD7;OPA1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.20014850912176874,0.473365009844668,0.987603305785124,1.0,1.0,4/17,26.99%,AKAP9;SCN1B;ANK2;SCN4B
prerank,potassium ion transport (GO:0006813),0.15216457495452596,0.47280349279811396,1.0,1.0,1.0,7/120,11.76%,KCNMB3;ATP1B3;KCNH8;KCNS3;KCNA4;CCDC51;KCNK3
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.17800403760441894,-0.47208025580642604,0.9884057971014493,1.0,1.0,5/11,29.96%,GNPDA1;PGM3;GNPDA2;NAGK;GFPT2
prerank,establishment of apical/basal cell polarity (GO:0035089),0.20741593350193874,0.4663144136032414,0.9916201117318436,1.0,1.0,4/14,23.04%,SH3BP1;OPHN1;RAP2A;MSN
prerank,regulation of cellular pH (GO:0030641),-0.1355774197911617,-0.4654285067872723,1.0,0.9998542403144698,1.0,15/29,41.53%,SLC9A9;SLC4A8;CLN3;SLC9A8;SLC26A6;SLC4A3;SLC4A9;SLC4A10;SLC4A7;ATP6AP1;SLC9A4;SLC9B1;SLC9A3;SLC4A1;SLC4A5
prerank,dendrite self-avoidance (GO:0070593),0.19665630157799274,0.4635504746062895,0.997275204359673,1.0,1.0,3/16,16.08%,NPTN;DSCAM;DSCAML1
prerank,sensory organ development (GO:0007423),0.16381382474218814,0.46354492646942874,0.9977477477477478,1.0,1.0,12/51,26.48%,CHD7;MEIS3;SOX2;SH3PXD2B;SIPA1L3;ADAMTS18;SMCHD1;ECE1;PBX4;ATF6;ZDHHC16;SHROOM2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.19579347949467735,0.4625698699905335,0.9958391123439667,1.0,1.0,6/18,28.67%,CHCHD10;BAX;SLC35F6;FZD9;BID;MPV17L
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.17318358196645883,-0.45750315208315845,0.9938461538461538,0.9991727425147487,1.0,4/12,26.70%,VANGL2;SCRIB;FUZ;TRAF3IP1
prerank,negative regulation of secretion (GO:0051048),0.21360938254678039,0.45524924356504476,0.989345509893455,1.0,1.0,1/10,8.39%,PTGER3
prerank,positive regulation of response to wounding (GO:1903036),0.17965495788072913,0.4478683623406469,0.9962311557788944,1.0,1.0,7/24,28.73%,KANK1;PRKCE;MDK;INSL3;GRN;ITGB1;ARFGEF1
prerank,regulation of keratinocyte migration (GO:0051547),0.20075907255065045,0.43896638901745105,0.9880952380952381,1.0,1.0,4/12,26.52%,MTOR;IQSEC1;MAPRE2;PTEN
prerank,negative regulation of blood coagulation (GO:0030195),0.15757042253521142,0.43753444986286044,0.9987980769230769,1.0,1.0,38/38,84.28%,APOE;PLAUR;F3;F8;PLAT;SERPING1;SERPINE1;C1QTNF1;GP1BA;NOS3;FGG;F2;KRT1;KNG1;PROC;CPB2;SERPINE2;PDGFA;EDN1;PDGFB;HRG;F12;PLG;KLKB1;F11;SERPINB2;TFPI;ADTRP;SERPINF2;APOH;F10;PLAU;CD34;F7;PDGFRA;THBD;A2M;VTN
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.20664912767521038,0.43317679899725425,0.9955555555555555,1.0,1.0,2/10,19.09%,MYD88;CD68
prerank,mitochondrial protein processing (GO:0034982),0.1999189065951366,0.43026693795013093,0.9954682779456193,1.0,1.0,5/11,32.11%,MIPEP;PMPCB;STOML2;ATP23;IMMP2L
prerank,negative regulation of cation channel activity (GO:2001258),0.17004319325455236,0.42979004884130284,0.9974554707379135,1.0,1.0,3/26,15.21%,UBQLN1;GPR35;CALM3
prerank,regulation of membrane repolarization (GO:0060306),0.19040934870514217,0.42839720355524924,0.9943262411347518,1.0,1.0,3/13,24.82%,AKAP9;KCNJ2;YWHAE
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.19962284497566196,0.42683154799090356,0.9940298507462687,1.0,1.0,4/10,26.51%,ZNHIT3;RUVBL2;PIH1D1;RUVBL1
prerank,lipoprotein biosynthetic process (GO:0042158),0.19667552013570028,0.42491762902463687,0.9955423476968797,1.0,1.0,1/11,12.34%,APOE
prerank,positive regulation of calcium ion import (GO:0090280),0.19370150362179,0.4245254872709493,0.9881656804733728,1.0,1.0,1/12,9.98%,SPHK2
prerank,peptidyl-amino acid modification (GO:0018193),0.20480793371830294,0.42383046252153794,0.9955156950672646,0.9998845788818378,1.0,10/10,79.53%,METAP2;FKBP7;ATP7A;APOA1;APOA2;METAP1D;PDF;FKBP10;METAP1;TTLL4
prerank,intracellular lipid transport (GO:0032365),0.16801798509381466,0.4180665325495125,0.994729907773386,0.9999002344248615,1.0,5/21,24.40%,ABCD1;NPC2;ABCD4;CERT1;PRKAB2
prerank,striated muscle cell differentiation (GO:0051146),0.17804302334993977,0.4115000749650595,0.9919571045576407,0.999932383203604,1.0,2/16,13.31%,SIK1;AKAP13
prerank,cardiac ventricle development (GO:0003231),-0.13164175354854918,-0.4006600575585357,1.0,0.9997128324504414,1.0,20/20,86.86%,SALL1;PDE2A;HEY1;HEY2;GATA3;HES1;MDM4;HEYL;DLL4;GJA5;ENG;STRA6;TMEM65;TBX5;GATA4;SCN5A;DAND5;NOTCH1;HECTD1;MATR3
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.15313002885402138,0.39888451907767924,1.0,1.0,1.0,2/31,8.81%,FGFR2;HOXA9
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.17054476778242986,0.38541627016398355,0.99721059972106,1.0,1.0,2/14,15.61%,LIMS1;PHACTR4
prerank,cardiac muscle tissue development (GO:0048738),0.12492411160940585,0.3512368605653655,1.0,1.0,1.0,4/50,15.33%,BMPR2;SIK1;AKAP13;BMPR1A
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.15754143790030736,0.349930057247683,1.0,1.0,1.0,5/13,29.73%,FBN1;CD46;FSTL1;DAND5;CHRDL1
prerank,regulation of ion transmembrane transport (GO:0034765),0.12938137524973933,0.3480289955666362,1.0,0.999827505217715,1.0,7/33,27.57%,AHCYL1;AKAP9;KCNJ2;WNK3;YWHAE;CHRM3;KCNJ9
